PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Dong, C				Dong, Chen			Seventeen on inflammation	NATURE IMMUNOLOGY			English	Article							CELLS; DISTINCT; LINEAGE	In October 2005, we, alongside the laboratory of Casey Weaver, identified a third type of helper T cells that produce the cytokine IL-17, important for the regulation of tissue inflammation.	[Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing, Peoples R China; [Dong, Chen] Tsinghua Univ, Sch Med, Beijing, Peoples R China	Tsinghua University; Tsinghua University	Dong, C (corresponding author), Tsinghua Univ, Inst Immunol, Beijing, Peoples R China.; Dong, C (corresponding author), Tsinghua Univ, Sch Med, Beijing, Peoples R China.	chendong@tsinghua.edu.cn	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130	Arthritis Foundation; NIAMS	Arthritis Foundation; NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	I thank my many former and current colleagues and collaborators, as well as the Arthritis Foundation and NIAMS for funding, during the exciting course of my work.	Dong C, 2003, J AUTOIMMUN, V21, P255, DOI 10.1016/S0896-8411(03)00119-7; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Dong C, 2008, NAT REV IMMUNOL, V8, P337, DOI 10.1038/nri2295; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Lai YP, 2016, INT IMMUNOL, V28, P181, DOI 10.1093/intimm/dxv063; Langrish CL, 2005, J EXP MED, V201, P233, DOI 10.1084/jem.20041257; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261	8	2	3	2	16	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					821	822		10.1038/s41590-020-0649-x	http://dx.doi.org/10.1038/s41590-020-0649-x		JUL 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32616860				2022-12-18	WOS:000545059300002
J	Lukens, JR; Anand, PK				Lukens, John R.; Anand, Paras K.			Adapt(ed) to repair - T(H)2 immune responses in the bladder promote recurrent infections	NATURE IMMUNOLOGY			English	Editorial Material							URINARY-TRACT-INFECTION	A new study reports that T(H)2-coordinated tissue repair takes precedence over long-term protective immunity in urinary tract infections. Although effective in the interim, this can lead to recurrent infections and bladder dysfunction.	[Lukens, John R.] Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22908 USA; [Anand, Paras K.] Imperial Coll London, Dept Infect Dis, Fac Med, London, England	University of Virginia; Imperial College London	Lukens, JR (corresponding author), Univ Virginia, Sch Med, Dept Neurosci, Ctr Brain Immunol & Glia BIG, Charlottesville, VA 22908 USA.; Anand, PK (corresponding author), Imperial Coll London, Dept Infect Dis, Fac Med, London, England.	Jrl7n@virginia.edu; paras.anand@imperial.ac.uk		Anand, Paras/0000-0003-2503-3653; Lukens, John/0000-0002-6795-0866	Medical Research Council [MR/S00968X/1] Funding Source: Medline; MRC [MR/S00968X/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Choi HW, 2016, IMMUNITY, V45, P1258, DOI 10.1016/j.immuni.2016.11.003; Fairweather D, 2008, AM J PATHOL, V173, P600, DOI 10.2353/ajpath.2008.071008; Flores-Mireles AL, 2015, NAT REV MICROBIOL, V13, P269, DOI 10.1038/nrmicro3432; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; Hamilton C, 2017, NAT REV UROL, V14, P284, DOI 10.1038/nrurol.2017.25; McLellan LK, 2016, TRENDS MOL MED, V22, P946, DOI 10.1016/j.molmed.2016.09.003; Mehta P, 2020, LANCET, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Nagamatsu K, 2015, P NATL ACAD SCI USA, V112, pE871, DOI 10.1073/pnas.1500374112; Song JM, 2009, P NATL ACAD SCI USA, V106, P14966, DOI 10.1073/pnas.0900527106; Thomas-White K, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03968-5; Walker JA, 2018, NAT REV IMMUNOL, V18, P121, DOI 10.1038/nri.2017.118; Wu JX, 2020, NAT IMMUNOL, V21, P671, DOI 10.1038/s41590-020-0688-3	12	2	2	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					597	599		10.1038/s41590-020-0689-2	http://dx.doi.org/10.1038/s41590-020-0689-2		MAY 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32424364	Bronze, Green Submitted			2022-12-18	WOS:000533852800001
J	Muppidi, JR; Klein, U				Muppidi, Jagan R.; Klein, Ulf			Directing traffic in the germinal center roundabout	NATURE IMMUNOLOGY			English	Editorial Material							CENTER DARK; ZONE; DYNAMICS	B cells undergo iterative rounds of somatic hypermutation and selection for high-affinity antigen binding in the germinal center microenvironment. Two new studies provide insights into the temporal and spatial control mechanisms that act within B cells and follicular dendritic cells to jointly govern B cell differentiation and cell traffic within the GC.	[Muppidi, Jagan R.] NCI, Lymphoid Malignancies Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Klein, Ulf] Univ Leeds, Leeds Inst Med Res St Jamess, Div Haematol & Immunol, Leeds, W Yorkshire, England	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Leeds	Klein, U (corresponding author), Univ Leeds, Leeds Inst Med Res St Jamess, Div Haematol & Immunol, Leeds, W Yorkshire, England.	U.P.Klein@leeds.ac.uk		Muppidi, Jagan/0000-0002-2639-4226				Allen CDC, 2004, NAT IMMUNOL, V5, P943, DOI 10.1038/ni1100; Bannard O, 2013, IMMUNITY, V39, P912, DOI 10.1016/j.immuni.2013.08.038; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Chou C, 2016, IMMUNITY, V45, P570, DOI 10.1016/j.immuni.2016.07.023; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Jarjour M, 2014, J EXP MED, V211, P1109, DOI 10.1084/jem.20132409; Kennedy DE, 2020, NAT IMMUNOL, V21, P660, DOI 10.1038/s41590-020-0660-2; Krautler NJ, 2012, CELL, V150, P194, DOI 10.1016/j.cell.2012.05.032; Krishnamurty AT, 2020, NAT IMMUNOL, V21, P369, DOI 10.1038/s41590-020-0635-3; McHeyzer-Williams LJ, 2015, NAT IMMUNOL, V16, P296, DOI 10.1038/ni.3095; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Milpied P, 2018, NAT IMMUNOL, V19, P1013, DOI 10.1038/s41590-018-0181-4; Pikor NB, 2020, NAT IMMUNOL, V21, P649, DOI 10.1038/s41590-020-0672-y; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Rodda LB, 2015, J IMMUNOL, V195, P4781, DOI 10.4049/jimmunol.1501191; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Weisel FJ, 2020, NAT IMMUNOL, V21, P331, DOI 10.1038/s41590-020-0598-4; Wright GW, 2020, CANCER CELL, V37, P551, DOI 10.1016/j.ccell.2020.03.015	18	2	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					599	601		10.1038/s41590-020-0690-9	http://dx.doi.org/10.1038/s41590-020-0690-9		MAY 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32424358	Green Accepted			2022-12-18	WOS:000533852800010
J	Petiti, L; Pace, L				Petiti, Luca; Pace, Luigia			The persistence of stemness	NATURE IMMUNOLOGY			English	Editorial Material								Epigenetic modifications are associated with distinct stages of autoreactive CD8(+) T cell differentiation. DNA methylation and chromatin changes guide the acquisition of a memory-like phenotype and sustain prolonged autoimmune effector responses.	[Petiti, Luca; Pace, Luigia] FPO IRCCS, Italian Inst Genom Med, Armenise Harvard Immune Regulat Unit, Turin, Italy	IRCCS Fondazione del Piemonte per l'Oncologia; Italian Institute for Genomic Medicine (IIGM)	Pace, L (corresponding author), FPO IRCCS, Italian Inst Genom Med, Armenise Harvard Immune Regulat Unit, Turin, Italy.	luigia.pace@iigm.it						Abdelsamed HA, 2020, NAT IMMUNOL, V21, P578, DOI 10.1038/s41590-020-0633-5; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Henning AN, 2018, NAT REV IMMUNOL, V18, P340, DOI 10.1038/nri.2017.146; Kelsey G, 2017, SCIENCE, V358, P69, DOI 10.1126/science.aan6826; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Kurachi M, 2014, NAT IMMUNOL, V15, P373, DOI 10.1038/ni.2834; Malta TM, 2018, CELL, V173, P338, DOI 10.1016/j.cell.2018.03.034; Pace L, 2020, CURR OPIN IMMUNOL, V63, P43, DOI 10.1016/j.coi.2020.01.002; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Skowera A, 2015, DIABETES, V64, P916, DOI 10.2337/db14-0332; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yeo L, 2018, J CLIN INVEST, V128, P3460, DOI 10.1172/JCI120555; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144	14	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					492	494		10.1038/s41590-020-0644-2	http://dx.doi.org/10.1038/s41590-020-0644-2		MAR 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32231299				2022-12-18	WOS:000522383000001
J	Ciofani, M				Ciofani, Maria			T gamma delta 17 cells build up the nerve	NATURE IMMUNOLOGY			English	Editorial Material							DELTA T-CELLS; BROWN	gamma delta T cells are critical contributors to tissue homeostasis. Recent research identifies an unexpected role for gamma delta T cell-derived IL-17F in promoting sympathetic innervation and tissue thermogenesis through the induction of the cytokine TGF-beta in adipose cells.	[Ciofani, Maria] Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA; [Ciofani, Maria] Duke Univ, Ctr Adv Genom Technol, Durham, NC 27706 USA	Duke University; Duke University	Ciofani, M (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27706 USA.; Ciofani, M (corresponding author), Duke Univ, Ctr Adv Genom Technol, Durham, NC 27706 USA.	maria.ciofani@duke.edu		Ciofani, Maria/0000-0001-6472-5260				Betz MJ, 2015, DIABETES, V64, P2352, DOI 10.2337/db15-0146; Do JS, 2010, J IMMUNOL, V184, P1675, DOI 10.4049/jimmunol.0903539; Hu B, 2020, NATURE, V578, P610, DOI 10.1038/s41586-020-2028-z; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Li SI, 2017, CELL TRANSPLANT, V26, P381, DOI 10.3727/096368916X693824; Mattson MP, 2008, NEUROMOL MED, V10, P157, DOI 10.1007/s12017-007-8021-y; McCorry LK, 2007, AM J PHARM EDUC, V71, DOI 10.5688/aj710478; Ono T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10928; Papotto PH, 2017, NAT IMMUNOL, V18, P604, DOI 10.1038/ni.3726; Parker ME, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00042; Ribeiro M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay5199; Villarroya F, 2018, CELL METAB, V27, P954, DOI 10.1016/j.cmet.2018.04.006; Zeng X, 2019, NATURE, V569, P229, DOI 10.1038/s41586-019-1156-9	13	2	2	1	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					367	368		10.1038/s41590-020-0642-4	http://dx.doi.org/10.1038/s41590-020-0642-4		MAR 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32205887				2022-12-18	WOS:000520399800001
J	Galani, IE; Klechevsky, E; Andreakos, E				Galani, Ioanna E.; Klechevsky, Eynav; Andreakos, Evangelos			Human and translational immunology in the third millennium: progress, challenges and opportunities	NATURE IMMUNOLOGY			English	Editorial Material							TRAINED IMMUNITY; INFECTION; CELL; RESPONSES; VACCINE; IMMUNOGENICITY; INFLAMMATION; MICROBIOTA; INDUCTION; SAFETY	Internationally renowned scientists gathered at the 2nd Human & Translational Immunology Conference in Kos, Greece, to discuss the latest advances in translational immunology, especially vaccinology, infectious diseases and tumor immunotherapy.	[Galani, Ioanna E.; Andreakos, Evangelos] Acad Athens, Biomed Res Fdn, Ctr Clin Expt Surg & Translat Res, Lab Immunobiol, Athens, Greece; [Klechevsky, Eynav] Washington Univ, Sch Med, Dept Pathol & Immunol, Div Immunobiol, St Louis, MO 63130 USA	Academy of Athens; Washington University (WUSTL)	Andreakos, E (corresponding author), Acad Athens, Biomed Res Fdn, Ctr Clin Expt Surg & Translat Res, Lab Immunobiol, Athens, Greece.; Klechevsky, E (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Div Immunobiol, St Louis, MO 63130 USA.	eklechevsky@wustl.edu; vandreakos@bioacademy.gr	Galani, Ioanna Evdokia/AAM-3546-2021	Galani, Ioanna Evdokia/0000-0002-0965-3863; Klechevsky, Eynav/0000-0001-6121-1571				Alpert A, 2019, NAT MED, V25, P487, DOI 10.1038/s41591-019-0381-y; Andreakos E, 2019, CURR OPIN IMMUNOL, V56, P67, DOI 10.1016/j.coi.2018.10.007; Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Becattini S, 2015, SCIENCE, V347, P400, DOI 10.1126/science.1260668; Bekkering S, 2018, CELL, V172, P135, DOI 10.1016/j.cell.2017.11.025; Bergamaschi C, 2008, J BIOL CHEM, V283, P4189, DOI 10.1074/jbc.M705725200; Bloom DE, 2018, P NATL ACAD SCI USA, V115, P12868, DOI 10.1073/pnas.1717157115; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Corren J, 2017, NEW ENGL J MED, V377, P936, DOI 10.1056/NEJMoa1704064; Dominguez-Andres J., 2019, CELL METAB, V29; Drolet M, 2019, LANCET, V394, P497, DOI 10.1016/S0140-6736(19)30298-3; Dubois S, 2002, IMMUNITY, V17, P537, DOI 10.1016/S1074-7613(02)00429-6; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Glanville J, 2017, NATURE, V547, P94, DOI 10.1038/nature22976; Hagan T, 2019, CELL, V178, P1313, DOI 10.1016/j.cell.2019.08.010; Hawkridge T, 2008, J INFECT DIS, V198, P544, DOI 10.1086/590185; Joosten SA, 2019, VACCINE, V37, P3022, DOI 10.1016/j.vaccine.2019.04.050; Klechevsky E, 2015, ADV EXP MED BIOL, V850, P43, DOI 10.1007/978-3-319-15774-0_4; Koltsida O, 2011, EMBO MOL MED, V3, P348, DOI 10.1002/emmm.201100142; Korenfeld D, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.96101; Kreiter S, 2015, NATURE, V520, P692, DOI 10.1038/nature14426; Lee J, 2019, CELL HOST MICROBE, V25, P367, DOI 10.1016/j.chom.2019.01.010; Lynn DJ, 2018, J LEUKOCYTE BIOL, V103, P225, DOI 10.1189/jlb.5MR0617-216R; Martins F, 2019, NAT REV CLIN ONCOL, V16, P563, DOI 10.1038/s41571-019-0218-0; Melandri D, 2018, NAT IMMUNOL, V19, P1352, DOI 10.1038/s41590-018-0253-5; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Onishi M, 2015, J IMMUNOL, V194, P2673, DOI 10.4049/jimmunol.1402027; Penn-Nicholson A, 2015, VACCINE, V33, P4025, DOI 10.1016/j.vaccine.2015.05.088; Rodrigues PF, 2018, NAT IMMUNOL, V19, P711, DOI 10.1038/s41590-018-0136-9; Saligrama N, 2019, NATURE, V572, P481, DOI 10.1038/s41586-019-1467-x; Samstein RM, 2019, NAT GENET, V51, P202, DOI 10.1038/s41588-018-0312-8; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Stadler CR, 2017, NAT MED, V23, P815, DOI 10.1038/nm.4356; Stelekati E, 2018, CELL REP, V23, P2142, DOI 10.1016/j.celrep.2018.04.038; Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513; Tomic A., 2019, J IMMUNOL	38	2	2	3	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1568	1573		10.1038/s41590-019-0543-6	http://dx.doi.org/10.1038/s41590-019-0543-6			6	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31745346	Bronze			2022-12-18	WOS:000497949800011
J	Visan, I				Visan, Ioana			Histone lactylation	NATURE IMMUNOLOGY			English	Editorial Material																			0	2	2	9	32	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2019	20	12					1558	1558		10.1038/s41590-019-0551-6	http://dx.doi.org/10.1038/s41590-019-0551-6			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JP0GI	31745344	Bronze			2022-12-18	WOS:000497949800003
J	Arazi, A; Rao, DA; Berthier, CC; Davidson, A; Liu, YY; Hoover, PJ; Chicoine, A; Eisenhaure, TM; Jonsson, AH; Li, SQ; Lieb, DJ; Zhang, F; Slowikowski, K; Browne, EP; Noma, A; Sutherby, D; Steelman, S; Smilek, DE; Tosta, P; Apruzzese, W; Massarotti, E; Dall'Era, M; Park, M; Kamen, DL; Furie, RA; Payan-Schober, F; Pendergraft, WF; McInnis, EA; Buyon, JP; Petri, MA; Putterman, C; Kalunian, KC; Woodle, ES; Lederer, JA; Hildeman, DA; Nusbaum, C; Raychaudhuri, S; Kretzler, M; Anolik, JH; Brenner, MB; Wofsy, D; Hacohen, N; Diamond, B				Arazi, Arnon; Rao, Deepak A.; Berthier, Celine C.; Davidson, Anne; Liu, Yanyan; Hoover, Paul J.; Chicoine, Adam; Eisenhaure, Thomas M.; Jonsson, A. Helena; Li, Shuqiang; Lieb, David J.; Zhang, Fan; Slowikowski, Kamil; Browne, Edward P.; Noma, Akiko; Sutherby, Danielle; Steelman, Scott; Smilek, Dawn E.; Tosta, Patti; Apruzzese, William; Massarotti, Elena; Dall'Era, Maria; Park, Meyeon; Kamen, Diane L.; Furie, Richard A.; Payan-Schober, Fernanda; Pendergraft, William F., III; McInnis, Elizabeth A.; Buyon, Jill P.; Petri, Michelle A.; Putterman, Chaim; Kalunian, Kenneth C.; Woodle, E. Steve; Lederer, James A.; Hildeman, David A.; Nusbaum, Chad; Raychaudhuri, Soumya; Kretzler, Matthias; Anolik, Jennifer H.; Brenner, Michael B.; Wofsy, David; Hacohen, Nir; Diamond, Betty		Accelerating Med Partnership SLE	The immune cell landscape in kidneys of patients with lupus nephritis (vol 20, pg 902, 2019)	NATURE IMMUNOLOGY			English	Correction													Woodle, E. Steve/N-8059-2013; Kalunian, Kenneth/AAK-6424-2020; Hildeman, David/AAA-1757-2020; Putterman, Chaim/AFR-0429-2022	Woodle, E. Steve/0000-0003-4280-0842; Hildeman, David/0000-0002-0421-8483; Buyon, Jill/0000-0002-3852-7129; Kalunian, Kenneth/0000-0003-0261-3102; Anolik, Jennifer/0000-0002-1450-1549; Cunningham, Melissa/0000-0002-9207-1986; Raychaudhuri, Soumya/0000-0002-1901-8265; Fava, Andrea/0000-0001-6738-4836; Eisenhaure, Thomas/0000-0003-3999-3540				Arazi A, 2019, NAT IMMUNOL, V20, P902, DOI 10.1038/s41590-019-0398-x	1	2	3	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1404	1404		10.1038/s41590-019-0473-3	http://dx.doi.org/10.1038/s41590-019-0473-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31409923	Bronze			2022-12-18	WOS:000486615900023
J	Cella, M; Gamini, R; Secca, C; Collins, PL; Zhao, SR; Peng, V; Robinette, ML; Schettini, J; Zaitsev, K; Gordon, W; Bando, JK; Yomogida, K; Cortez, V; Fronick, C; Fulton, R; Lin, LL; Gilfillan, S; Flavell, RA; Shan, L; Artyomov, MN; Bowman, M; Oltz, EM; Jelinsky, SA; Colonna, M				Cella, Marina; Gamini, Ramya; Secca, Cristiane; Collins, Patrick L.; Zhao, Shanrong; Peng, Vincent; Robinette, Michelle L.; Schettini, Jorge; Zaitsev, Konstantin; Gordon, William; Bando, Jennifer K.; Yomogida, Kentaro; Cortez, Victor; Fronick, Catrina; Fulton, Robert; Lin, Lih-Ling; Gilfillan, Susan; Flavell, Richard A.; Shan, Liang; Artyomov, Maxim N.; Bowman, Michael; Oltz, Eugene M.; Jelinsky, Scott A.; Colonna, Marco			Subsets of ILC3-ILC1-like cells generate a diversity spectrum of innate lymphoid cells in human mucosal tissues (vol 20, pg 980, 2019)	NATURE IMMUNOLOGY			English	Correction													da Silva, Cristiane Sécca/AAV-5468-2021; Collins, Patrick/AAN-7599-2020; Shan, Liang/ABB-9210-2021; Zaitsev, Konstantin/AAU-5733-2021	da Silva, Cristiane Sécca/0000-0003-4433-8962; Collins, Patrick/0000-0003-4550-4272; Zaitsev, Konstantin/0000-0003-3749-0886; Cella, Marina/0000-0003-1230-1313; Robinette, Michelle/0000-0003-0965-5225; Peng, Vincent/0000-0002-0301-2985	NICHD NIH HHS [K12 HD076224] Funding Source: Medline	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Cella M, 2019, NAT IMMUNOL, V20, P980, DOI 10.1038/s41590-019-0425-y	1	2	2	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1405	1405		10.1038/s41590-019-0474-2	http://dx.doi.org/10.1038/s41590-019-0474-2			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31388149	Bronze			2022-12-18	WOS:000486615900024
J	Boraschi, D; Apte, RN; Martin, MU				Boraschi, Diana; Apte, Ron N.; Martin, Michael U.			ANTIBODY THERAPY One hits (almost) all	NATURE IMMUNOLOGY			English	Editorial Material							INTERLEUKIN-1; FAMILY; INFLAMMATION; IL-1		[Boraschi, Diana] CNR, Naples, Italy; [Apte, Ron N.] Ben Gurion Univ Negev, Beer Sheva, Israel; [Martin, Michael U.] Univ Giessen, Giessen, Germany	Consiglio Nazionale delle Ricerche (CNR); Ben Gurion University; Justus Liebig University Giessen	Boraschi, D (corresponding author), CNR, Naples, Italy.	diana.boraschi@cnr.it; rapte@bgu.ac.il; michael.martin@bio.uni-giessen.de	Boraschi, Diana/AAA-7171-2020	Boraschi, Diana/0000-0002-3953-4056				Bassoy EY, 2018, IMMUNOL REV, V281, P169, DOI 10.1111/imr.12610; Boraschi D, 2018, IMMUNOL REV, V281, P197, DOI 10.1111/imr.12606; Borthwick LA, 2016, SEMIN IMMUNOPATHOL, V38, P517, DOI 10.1007/s00281-016-0559-z; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P389, DOI 10.1016/j.smim.2013.10.001; Dinarello CA, 2012, NAT REV DRUG DISCOV, V11, P633, DOI 10.1038/nrd3800; Hojen J, 2019, NAT IMMUNOL, DOI [10.1038/s41590-019-XXXX, DOI 10.1038/S41590-019-XXXX]; Johnston A, 2017, J ALLERGY CLIN IMMUN, V140, P109, DOI 10.1016/j.jaci.2016.08.056; Li TS, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aan2585; Martin NT, 2016, NAT IMMUNOL, V17, P122, DOI 10.1038/ni.3370; Philippidis A, GENETIC ENG BIOTECH; Rider P, 2013, SEMIN IMMUNOL, V25, P430, DOI 10.1016/j.smim.2013.10.005; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Schork NJ, 2015, NATURE, V520, P609, DOI 10.1038/520609a; Yasuda K, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20030649	15	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1095	1097		10.1038/s41590-019-0463-5	http://dx.doi.org/10.1038/s41590-019-0463-5			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31427774				2022-12-18	WOS:000482212600009
J	Guilliams, M; Tamura, T				Guilliams, Martin; Tamura, Tomohiko			DENDRITIC CELLS Decrypting DC development	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTION FACTOR; IRF8; COMMITMENT		[Guilliams, Martin] VIB, Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium; [Guilliams, Martin] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium; [Tamura, Tomohiko] Yokohama City Univ, Grad Sch Med, Dept Immunol, Yokohama, Kanagawa, Japan; [Tamura, Tomohiko] Yokohama City Univ, Adv Med Res Ctr, Yokohama, Kanagawa, Japan	Flanders Institute for Biotechnology (VIB); Ghent University; Yokohama City University; Yokohama City University	Guilliams, M (corresponding author), VIB, Ctr Inflammat Res, Lab Myeloid Cell Ontogeny & Funct Specializat, Ghent, Belgium.; Guilliams, M (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	martin.guilliams@irc.vib-ugent.be; tamurat@yokohama-cu.ac.jp	Guilliams, Martin/N-7803-2013	Guilliams, Martin/0000-0003-3525-7570; Tamura, Tomohiko/0000-0002-9664-1747				Anderson DA, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028613; Bagadia P, 2019, NAT IMMUNOL, V20, P1174, DOI 10.1038/s41590-019-0449-3; Dress RJ, 2019, NAT IMMUNOL, V20, P852, DOI 10.1038/s41590-019-0420-3; Durai V, 2019, NAT IMMUNOL, V20, P1161, DOI 10.1038/s41590-019-0450-x; Ginhoux F, 2016, IMMUNITY, V44, P439, DOI 10.1016/j.immuni.2016.02.024; Grajales-Reyes GE, 2015, NAT IMMUNOL, V16, P708, DOI 10.1038/ni.3197; Guilliams M, 2014, NAT REV IMMUNOL, V14, P571, DOI 10.1038/nri3712; Kashiwada M, 2011, BLOOD, V117, P6193, DOI 10.1182/blood-2010-07-295873; Kurotaki D, 2019, BLOOD, V133, P1803, DOI 10.1182/blood-2018-06-857789; Kurotaki D, 2018, CELL REP, V22, P2628, DOI 10.1016/j.celrep.2018.02.048; Kurotaki D, 2016, J INTERF CYTOK RES, V36, P433, DOI 10.1089/jir.2015.0138; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Schoenfelder S, 2019, NAT REV GENET, V20, P437, DOI 10.1038/s41576-019-0128-0; Schonheit J, 2013, CELL REP, V3, P1617, DOI 10.1016/j.celrep.2013.04.007; Scott CL, 2016, J EXP MED, V213, P897, DOI 10.1084/jem.20151715; Sichien D, 2016, IMMUNITY, V45, P626, DOI 10.1016/j.immuni.2016.08.013; Wu XD, 2016, P NATL ACAD SCI USA, V113, P14775, DOI 10.1073/pnas.1611408114	17	2	2	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1090	1092		10.1038/s41590-019-0457-3	http://dx.doi.org/10.1038/s41590-019-0457-3			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31406381				2022-12-18	WOS:000482212600007
J	Visan, I				Visan, Ioana			MACROPHAGES Wound healing	NATURE IMMUNOLOGY			English	Editorial Material																			0	2	2	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2019	20	9					1089	1089		10.1038/s41590-019-0484-0	http://dx.doi.org/10.1038/s41590-019-0484-0			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IS5SK	31431724	Bronze			2022-12-18	WOS:000482212600004
J	Gubser, C; Pitman, MC; Lewin, SR				Gubser, Celine; Pitman, Matthew C.; Lewin, Sharon R.			CD4(+) T cell signatures in HIV infection	NATURE IMMUNOLOGY			English	Editorial Material									[Gubser, Celine; Pitman, Matthew C.; Lewin, Sharon R.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Lewin, Sharon R.] Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Lewin, Sharon R.] Monash Univ, Melbourne, Vic, Australia	University of Melbourne; Florey Institute of Neuroscience & Mental Health; Monash University	Lewin, SR (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Lewin, SR (corresponding author), Alfred Hosp, Dept Infect Dis, Melbourne, Vic, Australia.; Lewin, SR (corresponding author), Monash Univ, Melbourne, Vic, Australia.	sharon.lewin@unimelb.edu.au	Lewin, Sharon/Z-3297-2019; Gubser, Celine/AHC-4953-2022	Lewin, Sharon Ruth/0000-0002-0330-8241; Pitman, Matthew Corder/0000-0001-9296-2159				Banga R, 2016, NAT MED, V22, P754, DOI 10.1038/nm.4113; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Caskey M, 2019, NAT MED, V25, P547, DOI 10.1038/s41591-019-0412-8; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Gautam R, 2016, NATURE, V533, P105, DOI 10.1038/nature17677; Kahan SM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aap9339; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Miyauchi K, 2016, NAT IMMUNOL, V17, P1447, DOI 10.1038/ni.3563; Morou A, 2019, NAT IMMUNOL, V20, P1059, DOI 10.1038/s41590-019-0418-x; Olson AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086719; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810	11	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					948	950		10.1038/s41590-019-0447-5	http://dx.doi.org/10.1038/s41590-019-0447-5			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31308542				2022-12-18	WOS:000476621200007
J	Roselli, F; Huber-Lang, M				Roselli, Francesco; Huber-Lang, Markus			TREM1-ors shake the brain and gut after stroke	NATURE IMMUNOLOGY			English	Editorial Material									[Roselli, Francesco] German Ctr Neurodegenerat Dis DZNE Ulm, Ulm, Germany; [Roselli, Francesco] Neurozentrum Ulm, Ulm, Germany; [Huber-Lang, Markus] Ulm Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany		Huber-Lang, M (corresponding author), Ulm Univ Hosp Ulm, Inst Clin & Expt Trauma Immunol, Ulm, Germany.	markus.huber-lang@uniklinik-ulm.de	Huber-Lang, Markus/AAJ-2209-2020; roselli, francesco/O-8847-2019	roselli, francesco/0000-0001-9935-6899				Cuvier V, 2018, BRIT J CLIN PHARMACO, V84, P2270, DOI 10.1111/bcp.13668; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Huang J, 1999, SCIENCE, V285, P595, DOI 10.1126/science.285.5427.595; Jolly L, 2018, CARDIOVASC RES, V114, P907, DOI 10.1093/cvr/cvy018; Joy MT, 2019, CELL, V176, P1143, DOI 10.1016/j.cell.2019.01.044; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Liu QK, 2019, NAT IMMUNOL, V20, P1023, DOI 10.1038/s41590-019-0421-2; Owens R, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00056; Raggi F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01097; Rasid O, 2018, MICROBES INFECT, V20, P156, DOI 10.1016/j.micinf.2017.12.008; Stanley D, 2016, NAT MED, V22, P1277, DOI 10.1038/nm.4194; Szigeti K, 2015, J CEREBR BLOOD F MET, V35, P1921, DOI 10.1038/jcbfm.2015.174; Weber B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003900	13	2	2	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2019	20	8					950	952		10.1038/s41590-019-0443-9	http://dx.doi.org/10.1038/s41590-019-0443-9			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IK5JJ	31285627				2022-12-18	WOS:000476621200008
J	Janaka, SK; Evans, DT				Janaka, Sanath Kumar; Evans, David T.			HIV IMMUNITY A SNP of lncRNA gives HIV-1 a boost	NATURE IMMUNOLOGY			English	Editorial Material									[Janaka, Sanath Kumar; Evans, David T.] Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI 53706 USA; [Evans, David T.] Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA	University of Wisconsin System; University of Wisconsin Madison	Evans, DT (corresponding author), Univ Wisconsin Madison, Dept Pathol & Lab Med, Madison, WI 53706 USA.; Evans, DT (corresponding author), Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA.	dtevans2@wisc.edu	Janaka, Sanath Kumar/AAE-8500-2021	Janaka, Sanath Kumar/0000-0003-2341-1526	NIAID NIH HHS [R01 AI095098] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095098] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Cornella N, 2017, J BIOL CHEM, V292, P19674, DOI 10.1074/jbc.M117.795591; Kulkarni S, 2019, NAT IMMUNOL, V20, P824, DOI 10.1038/s41590-019-0406-1; McLaren PJ, 2015, P NATL ACAD SCI USA, V112, P14658, DOI 10.1073/pnas.1514867112; Mozzi A, 2018, INFECT GENET EVOL, V66, P286, DOI 10.1016/j.meegid.2017.09.028; Noh JH, 2018, WIRES RNA, V9, DOI 10.1002/wrna.1471; Vangelista L, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01981	6	2	3	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					778	780		10.1038/s41590-019-0422-1	http://dx.doi.org/10.1038/s41590-019-0422-1			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31209401				2022-12-18	WOS:000471891900009
J	O'Doherty, U; Freed, EO				O'Doherty, Una; Freed, Eric O.			Heavy metal protease takes a tiki torch to HIV assembly	NATURE IMMUNOLOGY			English	Editorial Material								The plasma membrane-associated metalloprotease TRABD2A degrades the HIV Gag polyprotein and restricts virion assembly.	[O'Doherty, Una] Univ Penn, Div Transfus Med & Therapeut Pathol, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Freed, Eric O.] NCI, Virus Cell Interact Sect, HIV Dynam & Replicat Program, Ctr Canc Res, Frederick, MD 21701 USA	University of Pennsylvania; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	O'Doherty, U (corresponding author), Univ Penn, Div Transfus Med & Therapeut Pathol, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	unao@pennmedicine.upenn.edu; efreed@nih.gov		O'Doherty, Una T/0000-0003-3572-0078	Intramural NIH HHS [Z01 BC010619] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC011720] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Baldauf HM, 2012, NAT MED, V18, P1682, DOI 10.1038/nm.2964; Baxter AE, 2018, RETROVIROLOGY, V15, DOI 10.1186/s12977-018-0392-7; DeMaster LK, 2016, J VIROL, V90, P2165, DOI 10.1128/JVI.01913-15; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Harris RS, 2012, J BIOL CHEM, V287, P40875, DOI 10.1074/jbc.R112.416925; Hong FY, 2018, VIROLOGY, V521, P51, DOI 10.1016/j.virol.2018.05.018; Lassen KG, 2006, PLOS PATHOG, V2, P650, DOI 10.1371/journal.ppat.0020068; Liang GX, 2019, NAT IMMUNOL, V20, P711, DOI 10.1038/s41590-019-0385-2; Mbonye U, 2017, ANNU REV VIROL, V4, P261, DOI 10.1146/annurev-virology-101416-041646; Pace MJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002818; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Stefanova I, 2002, NATURE, V420, P429, DOI 10.1038/nature01146; Wiegand A, 2017, P NATL ACAD SCI USA, V114, pE3659, DOI 10.1073/pnas.1617961114; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L; Zhang XJ, 2012, CELL, V149, P1565, DOI 10.1016/j.cell.2012.04.039	15	2	2	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					668	669		10.1038/s41590-019-0387-0	http://dx.doi.org/10.1038/s41590-019-0387-0			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31061529	Green Accepted			2022-12-18	WOS:000468505100007
J	Dempsey, LA				Dempsey, Laurie A.			Functional degradation	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					517	517		10.1038/s41590-019-0392-3	http://dx.doi.org/10.1038/s41590-019-0392-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30996328	Bronze			2022-12-18	WOS:000465084800003
J	Dempsey, LA				Dempsey, Laurie A.			Distinct S1PR roles	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	2	2	2	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					517	517		10.1038/s41590-019-0393-2	http://dx.doi.org/10.1038/s41590-019-0393-2			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30996327	Bronze			2022-12-18	WOS:000465084800004
J	Dick, SA; Macklin, JA; Nejat, S; Momen, A; Clemente-Casares, X; Althagafi, MG; Chen, JM; Kantores, C; Hosseinzadeh, S; Aronoff, L; Wong, A; Zaman, R; Barbu, I; Besla, R; Lavine, KJ; Razani, B; Ginhoux, F; Husain, M; Cybulsky, MI; Robbins, CS; Epelman, S				Dick, Sarah A.; Macklin, Jillian A.; Nejat, Sara; Momen, Abdul; Clemente-Casares, Xavier; Althagafi, Marwan G.; Chen, Jinmiao; Kantores, Crystal; Hosseinzadeh, Siyavash; Aronoff, Laura; Wong, Anthony; Zaman, Rysa; Barbu, Iulia; Besla, Rickvinder; Lavine, Kory J.; Razani, Babak; Ginhoux, Florent; Husain, Mansoor; Cybulsky, Myron I.; Robbins, Clinton S.; Epelman, Slava			Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction (vol 20, pg 29, 2018)	NATURE IMMUNOLOGY			English	Correction													Chen, Jinmiao/ABE-5601-2021; Zaman, Rysa/AAT-5881-2021; Cybulsky, Myron I./AAD-6539-2019; Epelman, Slava/AAO-1728-2020	Zaman, Rysa/0000-0002-0007-4128; Epelman, Slava/0000-0003-3400-4475				Dick SA, 2019, NAT IMMUNOL, V20, P664, DOI 10.1038/s41590-019-0363-8	1	2	2	2	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					664	664		10.1038/s41590-019-0363-8	http://dx.doi.org/10.1038/s41590-019-0363-8			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET		Bronze			2022-12-18	WOS:000465084800024
J	Wieland, SF; Heim, MH				Wieland, Stefan F.; Heim, Markus H.			The IFN-lambda Pony Express	NATURE IMMUNOLOGY			English	Editorial Material								The mechanisms by which the cytokine IFN-lambda regulates adaptive immune responses are poorly understood. A new study now reveals a novel IFN-lambda-mediated signal-transmission system that enhances immunity after infection of the mouse respiratory tract with influenza virus.	[Wieland, Stefan F.; Heim, Markus H.] Univ Basel, Univ Basel Hosp, Dept Biomed, Basel, Switzerland; [Heim, Markus H.] Univ Hosp Basel, Div Gastroenterol & Hepatol, Basel, Switzerland	University of Basel; University of Basel	Wieland, SF (corresponding author), Univ Basel, Univ Basel Hosp, Dept Biomed, Basel, Switzerland.	stefan.wieland@unibas.ch	Heim, Markus/A-7526-2008	Heim, Markus/0000-0002-7523-4894				de Groen RA, 2015, J LEUKOCYTE BIOL, V98, P623, DOI 10.1189/jlb.3A0215-041RR; Heim MH, 2016, J HEPATOL, V65, pS22, DOI 10.1016/j.jhep.2016.07.037; Hoffmann HH, 2015, TRENDS IMMUNOL, V36, P124, DOI 10.1016/j.it.2015.01.004; Kim DY, 2011, J IMMUNOL, V186, P4253, DOI 10.4049/jimmunol.0903794; Lasfar A, 2006, CANCER RES, V66, P4468, DOI 10.1158/0008-5472.CAN-05-3653; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; Morrow MP, 2009, BLOOD, V113, P5868, DOI 10.1182/blood-2008-11-190520; Sage PT, 2016, IMMUNOL REV, V271, P246, DOI 10.1111/imr.12411; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Syedbasha M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00119; Van Roey GA, 2012, EUR J IMMUNOL, V42, P353, DOI 10.1002/eji.201141787; Ye L, 2019, NAT IMMUNOL, V20, P593, DOI 10.1038/s41590-019-0345-x	12	2	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					522	524		10.1038/s41590-019-0362-9	http://dx.doi.org/10.1038/s41590-019-0362-9			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30911106				2022-12-18	WOS:000465084800008
J	Cheng, WC; Tsui, YC; Ragusa, S; Koelzer, VH; Mina, M; Franco, F; Laubli, H; Tschumi, B; Speiser, D; Romero, P; Zippelius, A; Petrova, TV; Mertz, K; Ciriello, G; Ho, PC				Cheng, Wan-Chen; Tsui, Yao-Chen; Ragusa, Simone; Koelzer, Viktor H.; Mina, Marco; Franco, Fabien; Laubli, Heinz; Tschumi, Benjamin; Speiser, Daniel; Romero, Pedro; Zippelius, Alfred; Petrova, Tatiana V.; Mertz, Kirsten; Ciriello, Giovanni; Ho, Ping-Chih			Uncoupling protein 2 reprograms the tumor microenvironment to support the anti-tumor immune cycle (vol 20, pg 206, 2019)	NATURE IMMUNOLOGY			English	Correction													Mertz, Kirsten/AAY-1660-2020; Speiser, Daniel E./F-2173-2013	Mertz, Kirsten/0000-0002-3074-6925; Koelzer, Viktor/0000-0001-9206-4885				Cheng WC, 2019, NAT IMMUNOL, V20, P206, DOI 10.1038/s41590-018-0290-0	1	2	2	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					515	516		10.1038/s41590-019-0359-4	http://dx.doi.org/10.1038/s41590-019-0359-4			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30862953	Bronze			2022-12-18	WOS:000461904200023
J	Dunning, J; Blankley, S; Hoang, LT; Cox, M; Graham, CM; James, PL; Bloom, CI; Chaussabel, D; Banchereau, J; Brett, SJ; Moffatt, MF; O'Garra, A; Openshaw, PJM; Habibi, MS; Johnston, SL; Hansel, TT; Levin, M; Thwaites, RS; Warner, JO; Cookson, WO; Gazzard, BG; Hay, A; McCauley, J; Aylin, P; Ashby, D; Barclay, WS; Elderfield, RA; Nadel, S; Herberg, JA; Drumright, LN; Garcia-Alvarez, L; Holmes, AH; Kon, OM; Aston, SJ; Gordon, SB; Hussell, T; Thompson, C; Zambon, MC; Baillie, KJ; Hume, DA; Simmonds, P; Hayward, A; Smyth, RL; McNamara, PS; Semple, MG; Nguyen-Van-Tam, JS; Ho, LP; McMichael, AJ; Kellam, P; Adamson, WE; Carman, WF; Griffiths, MJ				Dunning, Jake; Blankley, Simon; Hoang, Long T.; Cox, Mike; Graham, Christine M.; James, Philip L.; Bloom, Chloe I.; Chaussabel, Damien; Banchereau, Jacques; Brett, Stephen J.; Moffatt, Miriam F.; O'Garra, Anne; Openshaw, Peter J. M.; Habibi, Maximillian S.; Johnston, Sebastian L.; Hansel, Trevor T.; Levin, Mike; Thwaites, Ryan S.; Warner, John O.; Cookson, William O.; Gazzard, Brian G.; Hay, Alan; McCauley, John; Aylin, Paul; Ashby, Deborah; Barclay, Wendy S.; Elderfield, Ruth A.; Nadel, Simon; Herberg, Jethro A.; Drumright, Lydia N.; Garcia-Alvarez, Laura; Holmes, Alison H.; Kon, Onn M.; Aston, Stephen J.; Gordon, Stephen B.; Hussell, Tracy; Thompson, Catherine; Zambon, Maria C.; Baillie, Kenneth J.; Hume, David A.; Simmonds, Peter; Hayward, Andrew; Smyth, Rosalind L.; McNamara, Paul S.; Semple, Malcolm G.; Nguyen-Van-Tam, Jonathan S.; Ho, Ling-Pei; McMichael, Andrew J.; Kellam, Paul; Adamson, Walt E.; Carman, William F.; Griffiths, Mark J.		MOSAIC Investigators	Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza (vol 19, pg 625, 2018)	NATURE IMMUNOLOGY			English	Correction									[Dunning, Jake] Publ Hlth England, Natl Infect Serv, London, England; [Dunning, Jake; Hoang, Long T.; Openshaw, Peter J. M.; Habibi, Maximillian S.; Johnston, Sebastian L.; Hansel, Trevor T.; Levin, Mike; Thwaites, Ryan S.; Warner, John O.; Kon, Onn M.] Imperial Coll London, Natl Heart and Lung Inst, Resp Infect Sect, London, England; [Blankley, Simon; Graham, Christine M.; Bloom, Chloe I.; O'Garra, Anne] Francis Crick Inst, Lab Immunoregulat & Infect, London, England; [Cox, Mike; James, Philip L.; Moffatt, Miriam F.; Cookson, William O.] Imperial Coll London, Genom Med, Natl Heart & Lung Inst, London, England; [Chaussabel, Damien] Sidra Med & Res Ctr, Doha, Qatar; [Banchereau, Jacques] Jackson Lab Genom Med, Farmington, CT USA; [Brett, Stephen J.] Imperial Coll London, Natl Heart & Lung Inst, Surg & Canc, London, England; [Gazzard, Brian G.] Chelsea & Westminster NHS Fdn Trust, London, England; [Hay, Alan; McCauley, John] World Influenza Ctr, Francis Crick Inst, London, England; [Aylin, Paul; Ashby, Deborah] Imperial Coll London, Sch Publ Hlth, London, England; [Barclay, Wendy S.; Elderfield, Ruth A.] Imperial Coll London, Dept Virol, London, England; [Nadel, Simon; Herberg, Jethro A.] Imperial Coll London, Dept Pediat, London, England; [Nadel, Simon; Kon, Onn M.] Imperial Coll Healthcare Trust, Dept Resp Med, London, England; [Drumright, Lydia N.; Garcia-Alvarez, Laura; Holmes, Alison H.] Imperial Coll London, Ctr Infect Prevent, London, England; [Aston, Stephen J.; Gordon, Stephen B.] Liverpool Sch & Trop Med, Resp Infect Grp, Liverpool, Merseyside, England; [Hussell, Tracy] MCCIR, Manchester, Lancs, England; [Thompson, Catherine; Zambon, Maria C.] Public Hlth England, London, England; [Baillie, Kenneth J.; Hume, David A.; Simmonds, Peter] Univ Edinburgh, Roslin Inst, Edinburgh, Midlothian, Scotland; [Hayward, Andrew] UCL, London, England; [Smyth, Rosalind L.] UCL Inst Child Hlth, London, England; [McNamara, Paul S.; Semple, Malcolm G.] Univ Liverpool, Liverpool, Merseyside, England; [Nguyen-Van-Tam, Jonathan S.] Univ Nottingham, Nottingham, England; [Ho, Ling-Pei; McMichael, Andrew J.] Univ Oxford, Oxford, England; [Kellam, Paul] Wellcome Trust Sanger Inst, London, England; [Adamson, Walt E.; Carman, William F.] West Scotland Specialist Virol Ctr, Glasgow, Lanark, Scotland; [Griffiths, Mark J.] Royal Brompton & Harefield NHS Fdn Trust, London, England	Public Health England; Imperial College London; Francis Crick Institute; Imperial College London; Sidra Medical & Research Center; Jackson Laboratory; Imperial College London; Imperial College London; Francis Crick Institute; Imperial College London; Imperial College London; Imperial College London; Imperial College London; Liverpool School of Tropical Medicine; Public Health England; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of London; University College London; University of London; University College London; University of Liverpool; University of Nottingham; University of Oxford; Wellcome Trust Sanger Institute; Royal Brompton & Harefield NHS Foundation Trust	Dunning, J (corresponding author), Publ Hlth England, Natl Infect Serv, London, England.; Dunning, J (corresponding author), Imperial Coll London, Natl Heart and Lung Inst, Resp Infect Sect, London, England.		Openshaw, Peter/AAL-9442-2020; Chaussabel, Damien/AAX-1909-2020; Baillie, John Kenneth/F-3124-2011; Hoang, Long/ABC-7442-2020; Dunning, Jake/U-7181-2019; Cookson, William/HHC-1790-2022; Semple, Malcolm Gracie/A-8790-2008; Ho, Ling-Pei/AAL-4776-2021; Warner, John/AAF-9587-2020; Johnston, Sebastian Lennox/I-2423-2012; Baillie, Kenneth/AEK-6650-2022; Hussell, Tracy/O-4630-2014	Openshaw, Peter/0000-0002-7220-2555; Baillie, John Kenneth/0000-0001-5258-793X; Hoang, Long/0000-0002-6808-6758; Dunning, Jake/0000-0002-4035-4562; Semple, Malcolm Gracie/0000-0001-9700-0418; Johnston, Sebastian Lennox/0000-0003-3009-9200; Baillie, Kenneth/0000-0001-5258-793X; Hussell, Tracy/0000-0001-7186-6141; Thwaites, Ryan/0000-0003-3052-2793; Drumright, Lydia/0000-0002-3361-8080; Barclay, Wendy/0000-0002-3948-0895; Nguyen-Van-Tam, Jonathan/0000-0003-2579-4655; Hume, David/0000-0002-2615-1478; Aylin, Paul/0000-0003-4589-1743; Kellam, Paul/0000-0003-3166-4734; O'Garra, Anne/0000-0001-9845-6134; Blankley, Simon/0000-0001-9602-9075; Simmonds, Peter/0000-0002-7964-4700; Herberg, Jethro/0000-0001-6941-6491; Cox, Michael/0000-0002-4002-1506; Griffiths, Mark/0000-0002-1615-1896; Banchereau, Jacques/0000-0003-3535-7221	EU FP7 PREPARE project [602525]; MRC [MC_U117565642, MC_G1001212] Funding Source: UKRI	EU FP7 PREPARE project; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	P.J.M.O. was supported by EU FP7 PREPARE project 602525.	Dunning J, 2018, NAT IMMUNOL, V19, P625, DOI 10.1038/s41590-018-0111-5	1	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					373	373		10.1038/s41590-019-0328-y	http://dx.doi.org/10.1038/s41590-019-0328-y			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30728492	Bronze, Green Submitted			2022-12-18	WOS:000458893600022
J	Gabrysova, L; Alvarez-Martinez, M; Luisier, R; Cox, LS; Sodenkamp, J; Hosking, C; Perez-Mazliah, D; Whicher, C; Kannan, Y; Potempa, K; Wu, XM; Bhaw, L; Wende, H; Sieweke, MH; Elgar, G; Wilson, M; Briscoe, J; Metzis, V; Langhorne, J; Luscombe, NM; O'Garra, A				Gabrysova, Leona; Alvarez-Martinez, Marisol; Luisier, Raphaelle; Cox, Luke S.; Sodenkamp, Jan; Hosking, Caroline; Perez-Mazliah, Damian; Whicher, Charlotte; Kannan, Yashaswini; Potempa, Krzysztof; Wu, Xuemei; Bhaw, Leena; Wende, Hagen; Sieweke, Michael H.; Elgar, Greg; Wilson, Mark; Briscoe, James; Metzis, Vicki; Langhorne, Jean; Luscombe, Nicholas M.; O'Garra, Anne			c-Maf controls immune responses by regulating disease-specific gene networks and repressing IL-2 in CD4(+) T cells (vol 19, pg 497, 2018)	NATURE IMMUNOLOGY			English	Correction													Perez-Mazliah, Damian/AAN-3767-2021; Luisier, Raphaelle/AAA-9283-2022; Sieweke, Michael/AAR-7515-2020	Perez-Mazliah, Damian/0000-0002-2156-2585; Sieweke, Michael/0000-0002-3228-9537; Cox, Luke/0000-0002-5477-8622; Hosking, Caroline/0000-0003-4238-5650; O'Garra, Anne/0000-0001-9845-6134; Gabrysova, Leona/0000-0003-3529-1306; Wende, Hagen/0000-0002-9168-8095	MRC [MC_U117565642] Funding Source: UKRI; Medical Research Council [MC_U117565642] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Gabrysova L, 2018, NAT IMMUNOL, V19, P497, DOI 10.1038/s41590-018-0083-5	1	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					374	374		10.1038/s41590-019-0331-3	http://dx.doi.org/10.1038/s41590-019-0331-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30733606	Bronze			2022-12-18	WOS:000458893600024
J	Kohlgruber, AC; Gal-Oz, ST; LaMarche, NM; Shimazaki, M; Duquette, D; Koay, HF; Nguyen, HN; Mina, AI; Paras, T; Tavakkoli, A; von Andrian, U; Uldrich, AP; Godfrey, DI; Banks, AS; Shay, T; Brenner, MB; Lynch, L				Kohlgruber, Ayano C.; Gal-Oz, Shani T.; LaMarche, Nelson M.; Shimazaki, Moto; Duquette, Danielle; Koay, Hui-Fern; Nguyen, Hung N.; Mina, Amir I.; Paras, Tyler; Tavakkoli, Ali; von Andrian, Ulrich; Uldrich, Adam P.; Godfrey, Dale I.; Banks, Alexander S.; Shay, Tal; Brenner, Michael B.; Lynch, Lydia			gamma delta T cells producing interleukin-17A regulate adipose regulatory T cell homeostasis and thermogenesis (vol 19, pg 464, 2018)	NATURE IMMUNOLOGY			English	Correction									[Kohlgruber, Ayano C.; LaMarche, Nelson M.; Shimazaki, Moto; Nguyen, Hung N.; Paras, Tyler; Brenner, Michael B.; Lynch, Lydia] Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA; [Kohlgruber, Ayano C.; LaMarche, Nelson M.; von Andrian, Ulrich] Harvard Med Sch, Div Med Sci, Boston, MA USA; [Gal-Oz, Shani T.; Shay, Tal] Ben Gurion Univ Negev, Dept Life Sci, Beer Sheva, Israel; [Duquette, Danielle; Mina, Amir I.; Banks, Alexander S.; Lynch, Lydia] Brigham & Womens Hosp, Dept Med, Div Endocrinol, 75 Francis St, Boston, MA 02115 USA; [Koay, Hui-Fern; Uldrich, Adam P.; Godfrey, Dale I.] Univ Melbourne, Peter Doherty Inst Infect & Immun, Dept Microbiol & Immunol, Parkville, Vic, Australia; [Koay, Hui-Fern; Uldrich, Adam P.; Godfrey, Dale I.] Univ Melbourne, ARC Ctr Excellence Adv Mol Imaging, Parkville, Vic, Australia; [Tavakkoli, Ali] Brigham & Womens Hosp, Dept Gen & Gastrointestinal Surg, 75 Francis St, Boston, MA 02115 USA; [von Andrian, Ulrich] Harvard Med Sch, Dept Microbiol & Immunol, Boston, MA USA; [Lynch, Lydia] Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Ben Gurion University; Harvard University; Brigham & Women's Hospital; University of Melbourne; University of Melbourne; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Trinity College Dublin	Brenner, MB; Lynch, L (corresponding author), Brigham & Womens Hosp, Div Rheumatol Immunol & Allergy, 75 Francis St, Boston, MA 02115 USA.; Lynch, L (corresponding author), Brigham & Womens Hosp, Dept Med, Div Endocrinol, 75 Francis St, Boston, MA 02115 USA.; Lynch, L (corresponding author), Trinity Coll Dublin, Sch Biochem & Immunol, Dublin, Ireland.	mbrenner@research.bwh.harvard.edu; llynch@bwh.harvard.edu	Lynch, Lydia/ABD-5598-2021; Shay, Tal/J-4028-2016; Gal-Oz, Shani Talia/AAE-9478-2019; Uldrich, Adam/AAX-3785-2020	Shay, Tal/0000-0003-0755-1350; Gal-Oz, Shani Talia/0000-0001-7775-2006; 	NIH [R01 AI11304603]; ERC [679173]; National Health and Medical Research Council of Australia [1013667]; Australian Research Council Future Fellowship [FT140100278]; National Health and Medical Research Council of Australia Senior Principal Research Fellowship [1117766]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Future Fellowship(Australian Research Council); National Health and Medical Research Council of Australia Senior Principal Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	We thank A.T. Chicoine, flow cytometry core manager at the Human Immunology Center at BWH, for flow cytometry sorting. We thank D. Sant'Angelo (Rutgers Cancer Institute) for providing Zbtb16<SUP>-/-</SUP> mice and R. O'Brien (National Jewish Health) for providing Vg4/6<SUP>-/-</SUP>mice. Supported by NIH grant R01 AI11304603 (to M.B.B.), ERC Starting Grant 679173 (to L.L.), the National Health and Medical Research Council of Australia (1013667), an Australian Research Council Future Fellowship (FT140100278 for A.P.U.) and a National Health and Medical Research Council of Australia Senior Principal Research Fellowship (1117766 for D.I.G.).	Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2	1	2	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					373	373		10.1038/s41590-019-0330-4	http://dx.doi.org/10.1038/s41590-019-0330-4			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30728493	Bronze			2022-12-18	WOS:000458893600021
J	Good-Jacobson, KL				Good-Jacobson, Kim L.			B cells turn on, tune in with LSD1	NATURE IMMUNOLOGY			English	Editorial Material							GERMINAL CENTER FORMATION; EZH2; MUTATIONS	The histone demethylase LSD1 partners with the transcription factor BCL6 to initiate the formation of germinal centers.	[Good-Jacobson, Kim L.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia; [Good-Jacobson, Kim L.] Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic, Australia	Monash University; Monash University	Good-Jacobson, KL (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic, Australia.; Good-Jacobson, KL (corresponding author), Monash Univ, Infect & Immun Program, Biomed Discovery Inst, Clayton, Vic, Australia.	kim.jacobson@monash.edu		Good-Jacobson, Kim/0000-0003-1891-7274				Arkin MR, 2014, CHEM BIOL, V21, P1102, DOI 10.1016/j.chembiol.2014.09.001; Beguelin W, 2016, CANCER CELL, V30, P197, DOI 10.1016/j.ccell.2016.07.006; Beguelin W, 2013, CANCER CELL, V23, P677, DOI 10.1016/j.ccr.2013.04.011; Bennett RL, 2018, ANNU REV PHARMACOL, V58, P187, DOI 10.1146/annurev-pharmtox-010716-105106; Caganova M, 2013, J CLIN INVEST, V123, P5009, DOI 10.1172/JCI70626; Hatzi K, 2019, NAT IMMUNOL, V20, P86, DOI 10.1038/s41590-018-0273-1; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Pasqualucci L, 2003, BLOOD, V101, P2914, DOI 10.1182/blood-2002-11-3387; Shaknovich R, 2011, BLOOD, V118, P3559, DOI 10.1182/blood-2011-06-357996; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Zhang JY, 2015, NAT MED, V21, P1190, DOI 10.1038/nm.3940	13	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					3	5		10.1038/s41590-018-0281-1	http://dx.doi.org/10.1038/s41590-018-0281-1			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30538329				2022-12-18	WOS:000456273900007
J	Chavarria-Smith, J; Hazenbos, WLW; Campagne, MV				Chavarria-Smith, Joseph; Hazenbos, Wouter L. W.; Campagne, Menno van Lookeren			Humoral immunity goes hormonal	NATURE IMMUNOLOGY			English	Editorial Material							RESPONSES; BACTERIA		[Chavarria-Smith, Joseph; Campagne, Menno van Lookeren] Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA; [Hazenbos, Wouter L. W.] Genentech Inc, Dept Infect Dis, San Francisco, CA USA	Roche Holding; Genentech; Roche Holding; Genentech	Campagne, MV (corresponding author), Genentech Inc, Dept Immunol, San Francisco, CA 94080 USA.	menno@gene.com						Broadley SP, 2016, CELL HOST MICROBE, V20, P36, DOI 10.1016/j.chom.2016.05.023; Campagne MV, 2018, SEMIN IMMUNOL, V37, P4, DOI [10.1010/j.smim.2018.02.007, 10.1016/j.smim.2018.02.007]; Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585; Hickey MJ, 2009, NAT REV IMMUNOL, V9, P364, DOI 10.1038/nri2532; Jackson-Jones LH, 2018, CURR OPIN IMMUNOL, V50, P9, DOI 10.1016/j.coi.2017.10.006; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Rollenske T, 2018, NAT IMMUNOL, V19, P617, DOI 10.1038/s41590-018-0106-2; Zeng ZT, 2018, NAT IMMUNOL, V19, P1100, DOI 10.1038/s41590-018-0211-2; Zeng ZT, 2016, CELL HOST MICROBE, V20, P99, DOI 10.1016/j.chom.2016.06.002	11	2	2	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2018	19	10					1044	1046		10.1038/s41590-018-0216-x	http://dx.doi.org/10.1038/s41590-018-0216-x			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GV3BU	30232411				2022-12-18	WOS:000445968600009
J	Machiels, B; Dourcy, M; Xiao, X; Javaux, J; Mesnil, C; Sabatel, C; Desmecht, D; Lallemand, F; Martinive, P; Hammad, H; Guilliams, M; Dewals, B; Vanderplasschen, A; Lambrecht, BN; Bureau, F; Gillet, L				Machiels, Benedicte; Dourcy, Mickael; Xiao, Xue; Javaux, Justine; Mesnil, Claire; Sabatel, Catherine; Desmecht, Daniel; Lallemand, Francois; Martinive, Philippe; Hammad, Hamida; Guilliams, Martin; Dewals, Benjamin; Vanderplasschen, Alain; Lambrecht, Bart N.; Bureau, Fabrice; Gillet, Laurent			A gammaherpesvirus provides protection against allergic asthma by inducing the replacement of resident alveolar macrophages with regulatory monocytes (vol 18, pg 1310, 2017)	NATURE IMMUNOLOGY			English	Correction													Lambrecht, Bart N/K-2484-2014; Dewals, Benjamin G./AAL-5754-2021; Hammad, Hamida/J-9391-2015	Lambrecht, Bart N/0000-0003-4376-6834; Dewals, Benjamin G./0000-0003-1497-0799; Gillet, Laurent/0000-0002-1047-2525; Hammad, Hamida/0000-0003-3762-8603				Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857	1	2	2	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					1035	1035		10.1038/s41590-017-0024-8	http://dx.doi.org/10.1038/s41590-017-0024-8			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	29955109	Bronze			2022-12-18	WOS:000442365100026
J	Ravens, S; Schultze-Florey, C; Raha, S; Sandrock, I; Drenker, M; Oberdorfer, L; Reinhardt, A; Ravens, I; Beck, M; Geffers, R; von Kaisenberg, C; Heuser, M; Thol, F; Ganser, A; Forster, R; Koenecke, C; Prinz, I				Ravens, Sarina; Schultze-Florey, Christian; Raha, Solaiman; Sandrock, Inga; Drenker, Melanie; Oberdorfer, Linda; Reinhardt, Annika; Ravens, Inga; Beck, Maleen; Geffers, Robert; von Kaisenberg, Constantin; Heuser, Michael; Thol, Felicitas; Ganser, Arnold; Forster, Reinhold; Koenecke, Christian; Prinz, Immo			Human gamma delta T cells are quickly reconstituted after stem-cell transplantation and show adaptive clonal expansion in response to viral infection (vol 18, pg 393, 2017)	NATURE IMMUNOLOGY			English	Correction													von Kaisenberg, Constantin/AAR-2756-2021; Heuser, Michael/S-2363-2017; Prinz, Immo/A-3026-2010; Koenecke, Christian/C-3138-2009	Heuser, Michael/0000-0001-5318-9044; Prinz, Immo/0000-0002-8789-9578; Koenecke, Christian/0000-0001-7025-1735; Forster, Reinhold/0000-0001-6190-7923	Deutsche Forschungsgemeinschaft [SFB900/B8, PR727/4-1]; Deutsche Jose Carreras Leukamie-Stiftung e.V. [DJCLS R12/29]; German Federal Ministry of Education and Research [01EO1302]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutsche Jose Carreras Leukamie-Stiftung e.V.; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	In the version of this article initially published, a source of funding (Deutsche Jose Carreras Leukamie-Stiftung e.V. (DJCLS R12/29 to C.K. and I.P.)) was not included in the Acknowledgments section. The correct statement is as follows: "Supported by Deutsche Forschungsgemeinschaft, (SFB900/B8 to C.K. and I.P.; and PR727/4-1 to I.P.), Deutsche Jose Carreras Leukamie-Stiftung e.V. (DJCLS R12/29 to C.K. and I.P.) and the German Federal Ministry of Education and Research (01EO1302 to C.S.-F., C.K. and I.P)." The error has been corrected in the HTML and PDF versions of the article.	Ravens S, 2017, NAT IMMUNOL, V18, P393, DOI 10.1038/ni.3686	1	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					1037	1037		10.1038/s41590-018-0054-x	http://dx.doi.org/10.1038/s41590-018-0054-x			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	29449629	Bronze			2022-12-18	WOS:000442365100030
J	Zhang, MY; Dong, Y; Hu, FX; Yang, D; Zhao, QH; Lv, C; Wang, Y; Xia, CX; Weng, QT; Liu, XF; Li, C; Zhou, PQ; Wang, TJ; Guan, YX; Guo, RQ; Liu, LJ; Geng, Y; Wu, HL; Du, J; Hu, Z; Xu, S; Chen, JK; He, AB; Liu, B; Wang, DM; Yang, YG; Wang, JY				Zhang, Mengyun; Dong, Yong; Hu, Fangxiao; Yang, Dan; Zhao, Qianhao; Lv, Cui; Wang, Ying; Xia, Chengxiang; Weng, Qitong; Liu, Xiaofei; Li, Chen; Zhou, Peiqing; Wang, Tongjie; Guan, Yuxian; Guo, Rongqun; Liu, Lijuan; Geng, Yang; Wu, Hongling; Du, Juan; Hu, Zheng; Xu, Sheng; Chen, Jiekai; He, Aibin; Liu, Bing; Wang, Demin; Yang, Yong-Guang; Wang, Jinyong			Transcription factor Hoxb5 reprograms B cells into functional T lymphocytes (vol 19, pg 279, 2018)	NATURE IMMUNOLOGY			English	Correction													He, Aibin/AAI-1639-2019; Zhao, Sponge/GQQ-8273-2022; Wang, Demin/AAX-4449-2020; Xia, Chengxiang/AAB-5099-2022	He, Aibin/0000-0002-3489-2305; Wang, Demin/0000-0001-5549-3795; Zhao, Qianhao/0000-0001-5514-5862	NHLBI NIH HHS [R01 HL130724] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130724] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079087] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Zhang MY, 2018, NAT IMMUNOL, V19, P279, DOI 10.1038/s41590-018-0046-x	1	2	2	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					1036	1036		10.1038/s41590-018-0154-7	http://dx.doi.org/10.1038/s41590-018-0154-7			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	29915300	Bronze			2022-12-18	WOS:000442365100029
J	Dempsey, LA				Dempsey, Laurie A.			Autophagy & MDSCs	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	2	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					787	787		10.1038/s41590-018-0173-4	http://dx.doi.org/10.1038/s41590-018-0173-4			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN9AM	30026474				2022-12-18	WOS:000439470900009
J	Phan, TG; Tangye, SG				Phan, Tri Giang; Tangye, Stuart G.			B cells race the clock to get a second wind	NATURE IMMUNOLOGY			English	Editorial Material									[Phan, Tri Giang; Tangye, Stuart G.] Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW, Australia; [Phan, Tri Giang; Tangye, Stuart G.] UNSW Sydney, Fac Med, St Vincents Clin Sch, Darlinghurst, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Phan, TG; Tangye, SG (corresponding author), Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW, Australia.; Phan, TG; Tangye, SG (corresponding author), UNSW Sydney, Fac Med, St Vincents Clin Sch, Darlinghurst, NSW, Australia.	t.phan@garvan.org.au; s.tangye@garvan.org.au	Tangye, Stuart G/H-4023-2014; Phan, Tri/G-3937-2012	Tangye, Stuart G/0000-0002-5360-5180; Phan, Tri/0000-0002-4909-2984				Akkaya M, 2018, NAT IMMUNOL, V19, P255, DOI 10.1038/s41590-018-0052-z; Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Jung S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00966; Nutt SL, 2015, NAT REV IMMUNOL, V15, P160, DOI 10.1038/nri3795; Pearson TS, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0342-7; Sandoval H, 2018, MITOCHONDRION, V41, P58, DOI 10.1016/j.mito.2017.11.005; Tangye SG, 2015, CELL, V162, DOI 10.1016/j.cell.2015.07.055; Tangye SG, 2011, TRENDS IMMUNOL, V32, P595, DOI 10.1016/j.it.2011.09.001; Tangye SG, 2009, EUR J IMMUNOL, V39, P2065, DOI 10.1002/eji.200939531; Tellier J, 2016, NAT IMMUNOL, V17, P323, DOI 10.1038/ni.3348; Walker MA, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/164309	12	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					791	793		10.1038/s41590-018-0166-3	http://dx.doi.org/10.1038/s41590-018-0166-3			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HJ6CZ	29988092				2022-12-18	WOS:000457272600001
J	Visan, I				Visan, Ioana			Fiber against flu	NATURE IMMUNOLOGY			English	Editorial Material																			0	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					647	647		10.1038/s41590-018-0147-6	http://dx.doi.org/10.1038/s41590-018-0147-6			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29925990	Bronze			2022-12-18	WOS:000436341300002
J	Dempsey, LA				Dempsey, Laurie A.			ROR alpha in T-reg cells	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					510	510		10.1038/s41590-018-0099-x	http://dx.doi.org/10.1038/s41590-018-0099-x			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29670233	Bronze			2022-12-18	WOS:000433041500005
J	Oakes, PW; Fowell, DJ				Oakes, Patrick W.; Fowell, Deborah J.			CCR7 fuels and LFA-1 grips	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL MIGRATION; IN-VIVO; CHEMOKINES; MOTILITY		[Oakes, Patrick W.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Oakes, Patrick W.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Fowell, Deborah J.] Univ Rochester, Med Ctr, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Fowell, DJ (corresponding author), Univ Rochester, Med Ctr, Dept Microbiol & Immunol, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA.	deborah_fowell@urmc.rochester.edu		Oakes, Patrick/0000-0001-9951-1318	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI102851, R01AI072690] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI072690, P01 AI102851] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Hickman HD, 2015, IMMUNITY, V42, P524, DOI 10.1016/j.immuni.2015.02.009; Hons M, 2018, NAT IMMUNOL, V19, P606, DOI 10.1038/s41590-018-0109-z; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Nordenfelt P, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01848-y; Overstreet MG, 2013, NAT IMMUNOL, V14, P949, DOI 10.1038/ni.2682; Paluch EK, 2016, ANNU REV CELL DEV BI, V32, P469, DOI 10.1146/annurev-cellbio-111315-125341; Schulz O, 2016, ANNU REV IMMUNOL, V34, P203, DOI 10.1146/annurev-immunol-041015-055649; Springer TA, 2012, CURR OPIN CELL BIOL, V24, P107, DOI 10.1016/j.ceb.2011.10.004; te Boekhorst V, 2016, ANNU REV CELL DEV BI, V32, P491, DOI 10.1146/annurev-cellbio-111315-125201; Walch JM, 2013, J CLIN INVEST, V123, P2663, DOI 10.1172/JCI66722; Woolf E, 2007, NAT IMMUNOL, V8, P1076, DOI 10.1038/ni1499; Worbs T, 2007, J EXP MED, V204, P489, DOI 10.1084/jem.20061706	13	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					516	518		10.1038/s41590-018-0118-y	http://dx.doi.org/10.1038/s41590-018-0118-y			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777210	Green Accepted			2022-12-18	WOS:000433041500016
J	Visan, I				Visan, Ioana			Mn potentiates cGAS	NATURE IMMUNOLOGY			English	Editorial Material																			0	2	3	1	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					511	511		10.1038/s41590-018-0126-y	http://dx.doi.org/10.1038/s41590-018-0126-y			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777215	Bronze			2022-12-18	WOS:000433041500012
J	Watzl, C				Watzl, Carsten			Adaptive responses of innate lymphocytes	NATURE IMMUNOLOGY			English	Editorial Material							HUMAN CYTOMEGALOVIRUS-INFECTION; NK CELLS; RECEPTOR; RECOGNITION; CANCER; MEMORY	The activating natural killer cell receptor NKG2C can specifically recognize peptides derived from the cytomegalovirus protein UL40 in the context of HLA-E. This drives the expansion of a population of adaptive NKG2C(+) natural killer cells.	[Watzl, Carsten] TU Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany	Dortmund University of Technology; Leibniz Institut for Arbeitsforschung an der TU Dortmund (IFADO)	Watzl, C (corresponding author), TU Dortmund, Leibniz Res Ctr Working Environm & Human Factors, Dortmund, Germany.	watzl@ifado.de	Watzl, Carsten/B-4911-2013	Watzl, Carsten/0000-0001-5195-0995				Arase H, 2002, SCIENCE, V296, P1323, DOI 10.1126/science.1070884; Bjorkstrom NK, 2011, J EXP MED, V208, P13, DOI 10.1084/jem.20100762; Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9; Della Chiesa M, 2014, J IMMUNOL, V192, P1471, DOI 10.4049/jimmunol.1302053; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Halenius A, 2015, CELL MOL IMMUNOL, V12, P139, DOI 10.1038/cmi.2014.105; Hammer Q, 2018, NAT IMMUNOL, V19, P453, DOI 10.1038/s41590-018-0082-6; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Lee J, 2015, IMMUNITY, V42, P431, DOI 10.1016/j.immuni.2015.02.013; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Smith HRC, 2002, P NATL ACAD SCI USA, V99, P8826, DOI 10.1073/pnas.092258599; Watzl C, 2014, ADV IMMUNOL, V124, P137, DOI 10.1016/B978-0-12-800147-9.00005-4	12	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					426	427		10.1038/s41590-018-0088-0	http://dx.doi.org/10.1038/s41590-018-0088-0			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	29670228				2022-12-18	WOS:000430562400002
J	Kopf, M; Nielsen, PJ				Kopf, Manfred; Nielsen, Peter J.			Training myeloid precursors with fungi, bacteria and chips	NATURE IMMUNOLOGY			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; INFLAMMASOME ACTIVATION; IMMUNITY; DIET; INDUCTION; PROGRAMS		[Kopf, Manfred; Nielsen, Peter J.] Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Kopf, M; Nielsen, PJ (corresponding author), Swiss Fed Inst Technol, Inst Mol Hlth Sci, Zurich, Switzerland.	manfred.kopf@biol.ethz.ch; pnielsen@web.de	Kopf, Manfred/B-6907-2009	Kopf, Manfred/0000-0002-0628-7140				Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Bekkering S, 2018, CELL, V172, P135, DOI 10.1016/j.cell.2017.11.025; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Freigang S, 2011, EUR J IMMUNOL, V41, P2040, DOI 10.1002/eji.201041316; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Hackam DG, 2006, LANCET, V367, P413, DOI 10.1016/S0140-6736(06)68041-0; Huypens P, 2016, NAT GENET, V48, P497, DOI 10.1038/ng.3527; Jiang YG, 2012, BIOCHEM BIOPH RES CO, V425, P121, DOI 10.1016/j.bbrc.2012.07.011; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Manzel A, 2014, CURR ALLERGY ASTHM R, V14, DOI 10.1007/s11882-013-0404-6; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Ng SF, 2010, NATURE, V467, P963, DOI 10.1038/nature09491; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Sylvester RJ, 2002, J UROLOGY, V168, P1964, DOI 10.1016/S0022-5347(05)64273-5; van den Hoek HL, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d7281	19	2	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					320	322		10.1038/s41590-018-0073-7	http://dx.doi.org/10.1038/s41590-018-0073-7			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29563630				2022-12-18	WOS:000428151000010
J	Moretta, L; Mantovani, A				Moretta, Lorenzo; Mantovani, Alberto			Alessandro Moretta 1953-2018 obituary	NATURE IMMUNOLOGY			English	Biographical-Item									[Moretta, Lorenzo] Bambino Gesu Pediat Hosp, Rome, Italy; [Mantovani, Alberto] Humanitas Univ, Ist Clin Humanitas, Milan, Italy	IRCCS Bambino Gesu; Humanitas University; IRCCS Humanitas Research Hospital	Mantovani, A (corresponding author), Humanitas Univ, Ist Clin Humanitas, Milan, Italy.	alberto.mantovani@humanitasresearch.it	Moretta, Lorenzo/AAA-7239-2020; Mantovani, Alberto/HCI-7449-2022	Moretta, Lorenzo/0000-0003-4658-1747; Mantovani, Alberto/0000-0001-5578-236X					0	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					315	315		10.1038/s41590-018-0075-5	http://dx.doi.org/10.1038/s41590-018-0075-5			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29563619	Bronze			2022-12-18	WOS:000428151000001
J	Bowie, AG				Bowie, Andrew G.			Self-RNA sentinels signal viral invasion	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNITY; DNA		[Bowie, Andrew G.] Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland	Trinity College Dublin	Bowie, AG (corresponding author), Trinity Coll Dublin, Trinity Biomed Sci Inst, Sch Biochem & Immunol, Dublin, Ireland.	agbowie@tcd.ie		Bowie, Andrew/0000-0001-5316-4373				Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Chiang J. J, 2017, NAT IMMUNOL; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Goubau D, 2014, NATURE, V514, P372, DOI 10.1038/nature13590; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Ogunjimi B, 2017, J CLIN INVEST, V127, P3543, DOI [10.1172/JCI92280, 10.1172/jci92280]; Orzalli MH, 2014, ANNU REV MICROBIOL, V68, P477, DOI 10.1146/annurev-micro-091313-103409; Schlee M, 2016, NAT REV IMMUNOL, V16, P566, DOI 10.1038/nri.2016.78; Spoel SH, 2012, NAT REV IMMUNOL, V12, P89, DOI 10.1038/nri3141; West AP, 2015, NATURE, V520, P553, DOI 10.1038/nature14156	12	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					4	5		10.1038/s41590-017-0010-1	http://dx.doi.org/10.1038/s41590-017-0010-1			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS4MA	29242544				2022-12-18	WOS:000419765300006
J	Delacher, M; Imbusch, CD; Weichenhan, D; Breiling, A; Hotz-Wagenblatt, A; Trager, U; Hofer, AC; Kagebein, D; Wang, Q; Frauhammer, F; Mallm, JP; Bauer, K; Herrmann, C; Lang, PA; Brors, B; Plass, C; Feuerer, M				Delacher, Michael; Imbusch, Charles D.; Weichenhan, Dieter; Breiling, Achim; Hotz-Wagenblatt, Agnes; Traeger, Ulrike; Hofer, Ann-Cathrin; Kaegebein, Danny; Wang, Qi; Frauhammer, Felix; Mallm, Jan-Philipp; Bauer, Katharina; Herrmann, Carl; Lang, Philipp A.; Brors, Benedikt; Plass, Christoph; Feuerer, Markus			Genome-wide DNA-methylation landscape defines specialization of regulatory T cells in tissues (vol 18, pg 1160, 2017)	NATURE IMMUNOLOGY			English	Correction													Brors, Benedikt/E-5620-2013	Brors, Benedikt/0000-0001-5940-3101; Mallm, Jan-Philipp/0000-0002-7059-4030				Delacher M, 2017, NAT IMMUNOL, V18, P1160, DOI 10.1038/ni.3799	1	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1361	1361		10.1038/ni1217-1361b	http://dx.doi.org/10.1038/ni1217-1361b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29144491	Bronze			2022-12-18	WOS:000415324900015
J	Kitagawa, Y; Ohkura, N; Kidani, Y; Vandenbon, A; Hirota, K; Kawakami, R; Yasuda, K; Motooka, D; Nakamura, S; Kondo, M; Taniuchi, I; Kohwi-Shigematsu, T; Sakaguchi, S				Kitagawa, Yohko; Ohkura, Naganari; Kidani, Yujiro; Vandenbon, Alexis; Hirota, Keiji; Kawakami, Ryoji; Yasuda, Keiko; Motooka, Daisuke; Nakamura, Shota; Kondo, Motonari; Taniuchi, Ichiro; Kohwi-Shigematsu, Terumi; Sakaguchi, Shimon			Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment (vol 18, pg 173, 2017)	NATURE IMMUNOLOGY			English	Correction													Vandenbon, Alexis/N-4428-2019; Sakaguchi, Shimon/C-9535-2009	Hirota, Keiji/0000-0002-4737-0661				Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646	1	2	4	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1270	1270		10.1038/ni1117-1270a	http://dx.doi.org/10.1038/ni1117-1270a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	29044238	Bronze			2022-12-18	WOS:000413457300013
J	Fehervari, Z				Fehervari, Zoltan			Testicular macrophage origin	NATURE IMMUNOLOGY			English	Editorial Material																			0	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1067	1067						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28926535	Bronze			2022-12-18	WOS:000411134000010
J	Hemann, EA; Schwerk, J; Savan, R				Hemann, Emily A.; Schwerk, Johannes; Savan, Ram			IFN-lambda 'guts' neutrophil-mediated inflammation	NATURE IMMUNOLOGY			English	Editorial Material							ANTIVIRAL PROTECTION; INTERFERON; EXPRESSION; INFECTION; VIRUS	Interferon-l (IFN-lambda) curbs neutrophil-mediated intestinal inflammation by diminishing the production of reactive oxygen species and subsequent oxidative stress. This regulatory process is unique to IFN-lambda and is independent of interferon-induced transcription and translation programs.	[Hemann, Emily A.; Schwerk, Johannes; Savan, Ram] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Savan, R (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	savanram@uw.edu	Schwerk, Johannes/AAN-2937-2020	Savan, Ram/0000-0002-3087-1355; Schwerk, Johannes/0000-0002-5964-7162; Hemann, Emily/0000-0002-6398-3492	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI108765] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI108765] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blazek K, 2015, J EXP MED, V212, P845, DOI 10.1084/jem.20140995; Bolen CR, 2014, HEPATOLOGY, V59, P1262, DOI 10.1002/hep.26657; Broggi A, 2017, NAT IMMUNOL, V18, P1084, DOI 10.1038/ni.3821; Davidson S, 2016, EMBO MOL MED, V8, P1099, DOI 10.15252/emmm.201606413; Galani IE, 2017, IMMUNITY, V46, P875, DOI 10.1016/j.immuni.2017.04.025; Jilg N, 2014, HEPATOLOGY, V59, P1250, DOI 10.1002/hep.26653; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; McFarland AP, 2014, NAT IMMUNOL, V15, P72, DOI 10.1038/ni.2758; Odendall C, 2014, NAT IMMUNOL, V15, P717, DOI 10.1038/ni.2915; Sheppard P, 2003, NAT IMMUNOL, V4, P63, DOI 10.1038/ni873; Sommereyns C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000017; Trinchieri G, 2010, J EXP MED, V207, P2053, DOI 10.1084/jem.20101664	13	2	2	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1061	1062		10.1038/ni.3834	http://dx.doi.org/10.1038/ni.3834			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28926532	Green Accepted			2022-12-18	WOS:000411134000002
J	Lee, CH; Romain, G; Yan, WP; Watanabe, M; Charab, W; Todorova, B; Lee, J; Triplett, K; Donkor, M; Lungu, OI; Lux, A; Marshall, N; Lindorfer, MA; Richard-Le Goff, O; Balbino, B; Kang, TH; Tanno, H; Delidakis, G; Alford, C; Taylor, RP; Nimmerjahn, F; Varadarajan, N; Bruhns, P; Zhang, YJ; Georgiou, G				Lee, Chang-Han; Romain, Gabrielle; Yan, Wupeng; Watanabe, Makiko; Charab, Wissam; Todorova, Biliana; Lee, Jiwon; Triplett, Kendra; Donkor, Moses; Lungu, Oana I.; Lux, Anja; Marshall, Nicholas; Lindorfer, Margaret A.; Richard-Le Goff, Odile; Balbino, Bianca; Kang, Tae Hyun; Tanno, Hidetaka; Delidakis, George; Alford, Corrine; Taylor, Ronald P.; Nimmerjahn, Falk; Varadarajan, Navin; Bruhns, Pierre; Zhang, Yan Jessie; Georgiou, George			IgG Fc domains that bind C1q but not effector Fc gamma receptors delineate the importance of complement-mediated effector functions (vol 18, pg 889, 2017)	NATURE IMMUNOLOGY			English	Correction													Bruhns, Pierre/F-5567-2013	Bruhns, Pierre/0000-0002-4709-8936				CHANGHAN L, 2017, NAT IMMUNOL, V18, P889	1	2	2	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1173	1173		10.1038/ni1017-1173c	http://dx.doi.org/10.1038/ni1017-1173c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28926542	Bronze			2022-12-18	WOS:000411134000023
J	Tsokos, GC				Tsokos, George C.			Fat T cells go to the joint	NATURE IMMUNOLOGY			English	Editorial Material							RHEUMATOID-ARTHRITIS	Poor glycolysis and increased fatty-acid synthesis feed the locomotion machinery in T cells from people with rheumatoid arthritis and allow these cells to enter the synovium and propagate joint inflammation and destruction.	[Tsokos, George C.] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tsokos, GC (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	gtsokos@bidmc.harvard.edu	tsokos, george C/O-3360-2013	tsokos, george C/0000-0001-9589-2360				Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Firestein GS, 2017, IMMUNITY, V46, P183, DOI 10.1016/j.immuni.2017.02.006; Ishigaki K, 2017, NAT GENET, V49, P1120, DOI 10.1038/ng.3885; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Olenchock BA, 2017, IMMUNITY, V46, P703, DOI 10.1016/j.immuni.2017.04.013; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Shen Y, 2017, NAT IMMUNOL, V18, P1025, DOI 10.1038/ni.3808; Shirai T, 2016, J EXP MED, V213, P337, DOI 10.1084/jem.20150900; Terao C, 2016, ANNU REV GENOM HUM G, V17, P273, DOI 10.1146/annurev-genom-090314-045919; Tsokos GC, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf4953; Weyand CM, 2017, NAT REV RHEUMATOL, V13, P1, DOI 10.1038/nrrheum.2017.49	12	2	2	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2017	18	9					955	956		10.1038/ni.3810	http://dx.doi.org/10.1038/ni.3810			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FE3TD	28829450				2022-12-18	WOS:000408137700002
J	van der Poel, CE; Carroll, MC				van der Poel, Cees E.; Carroll, Michael C.			Untangling Fc and complement receptors to kill tumors	NATURE IMMUNOLOGY			English	Editorial Material							ANTI-CD20 MONOCLONAL-ANTIBODY; CYTOKINE-RELEASE SYNDROME; EFFECTOR FUNCTIONS; ACTIVATION; RITUXIMAB; THERAPY	Uncoupling of activation of Fc receptors via a mutant IgG1 Fc domain shows a direct role for complement receptors in antibody-dependent tumor killing.	[van der Poel, Cees E.; Carroll, Michael C.] Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [van der Poel, Cees E.; Carroll, Michael C.] Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School	Carroll, MC (corresponding author), Boston Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA.; Carroll, MC (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	michael.carroll@childrens.harvard.edu						Bajic G, 2015, EMBO J, V34, P2735, DOI 10.15252/embj.201591881; Biburger M, 2014, ADV IMMUNOL, V124, P67, DOI 10.1016/B978-0-12-800147-9.00003-0; Bournazos S, 2015, IMMUNOL REV, V268, P88, DOI 10.1111/imr.12343; Bruhns P, 2015, IMMUNOL REV, V268, P25, DOI 10.1111/imr.12350; Cartron G, 2002, BLOOD, V99, P754, DOI 10.1182/blood.V99.3.754; DiLillo DJ, 2015, CANCER IMMUNOL RES, V3, P704, DOI 10.1158/2326-6066.CIR-15-0120; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Idusogie EE, 2001, J IMMUNOL, V166, P2571, DOI 10.4049/jimmunol.166.4.2571; Lee CH, 2017, NAT IMMUNOL, V18, P889, DOI 10.1038/ni.3770; Meyer S, 2014, MABS-AUSTIN, V6, P1133, DOI 10.4161/mabs.29670; Teachey DT, 2013, BLOOD, V121, P5154, DOI 10.1182/blood-2013-02-485623; Weiner GJ, 2015, NAT REV CANCER, V15, P361, DOI 10.1038/nrc3930; Weng WK, 2003, J CLIN ONCOL, V21, P3940, DOI 10.1200/JCO.2003.05.013; Winkler U, 1999, BLOOD, V94, P2217, DOI 10.1182/blood.V94.7.2217.419k02_2217_2224	14	2	2	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					874	875		10.1038/ni.3797	http://dx.doi.org/10.1038/ni.3797			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28722723				2022-12-18	WOS:000405821100009
J	McGeachy, MJ				McGeachy, Mandy J.			A Hippo in the Fox(p3) house	NATURE IMMUNOLOGY			English	Editorial Material							PATHWAY; CANCER		[McGeachy, Mandy J.] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	McGeachy, MJ (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	mandymcgeachy@pitt.edu						Du XR, 2014, J IMMUNOL, V192, P1525, DOI 10.4049/jimmunol.1301060; Geng J, 2017, NAT IMMUNOL, V18, P800, DOI 10.1038/ni.3748; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Li J, 2015, J BIOL CHEM, V290, P30762, DOI 10.1074/jbc.M115.668442; Nehme NT, 2012, BLOOD, V119, P3458, DOI 10.1182/blood-2011-09-378364; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Yu FX, 2015, CELL, V163, P811, DOI 10.1016/j.cell.2015.10.044; Zhou L, 2009, CURR OPIN IMMUNOL, V21, P146, DOI 10.1016/j.coi.2009.03.001	8	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2017	18	7					709	711		10.1038/ni.3769	http://dx.doi.org/10.1038/ni.3769			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EY0VD	28632715				2022-12-18	WOS:000403676300003
J	Dovat, S; Payne, KJ				Dovat, Sinisa; Payne, Kimberly J.			STAT5 alters the state of transcriptional networks, driving aggressive leukemia	NATURE IMMUNOLOGY			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; IKZF1	The transcription factor STAT5 acts as an oncoprotein in B cell acute lymphoblastic leukemia, competing with the transcription factors NF-kappa B and Ikaros for binding to DNA.	[Dovat, Sinisa] Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA; [Payne, Kimberly J.] Loma Linda Univ, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Loma Linda University	Dovat, S (corresponding author), Penn State Univ, Coll Med, Dept Pediat, Hershey, PA 17033 USA.	sdovat@hmc.psu.edu; kpayne@llu.edu	Payne, Kimberly/AAS-6814-2020	Payne, Kimberly/0000-0002-7025-5821; Dovat, Sinisa/0000-0003-3906-6165				Heltemes-Harris LM, 2012, CURR OPIN IMMUNOL, V24, P146, DOI 10.1016/j.coi.2012.01.015; Hoelbl A, 2010, EMBO MOL MED, V2, P98, DOI 10.1002/emmm.201000062; Inaba H, 2013, LANCET, V381, P1943, DOI 10.1016/S0140-6736(12)62187-4; Katerndahl CDS, 2017, NAT IMMUNOL, V18, P694, DOI 10.1038/ni.3716; Kuiper RP, 2010, LEUKEMIA, V24, P1258, DOI 10.1038/leu.2010.87; Malin S, 2010, CURR OPIN IMMUNOL, V22, P168, DOI 10.1016/j.coi.2010.02.004; Malin S, 2010, NAT IMMUNOL, V11, P171, DOI 10.1038/ni.1827; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Murphy Sherry L, 2013, Natl Vital Stat Rep, V61, P1; Schwaller J, 2000, MOL CELL, V6, P693, DOI 10.1016/S1097-2765(00)00067-8; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035	12	2	2	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					597	598		10.1038/ni.3747	http://dx.doi.org/10.1038/ni.3747			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EV1QJ	28518152				2022-12-18	WOS:000401520900002
J	Fehervari, Z				Fehervari, Zoltan			Glioma immune evasion	NATURE IMMUNOLOGY			English	Editorial Material																			0	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					487	487		10.1038/ni.3736	http://dx.doi.org/10.1038/ni.3736			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FU7JY	28418388	Bronze			2022-12-18	WOS:000424029600006
J	Kitagawa, Y; Ohkura, N; Kidani, Y; Vandenbon, A; Hirota, K; Kawakami, R; Yasuda, K; Motooka, D; Nakamura, S; Kondo, M; Taniuchi, I; Kohwi-Shigematsu, T; Sakaguchi, S				Kitagawa, Yohko; Ohkura, Naganari; Kidani, Yujiro; Vandenbon, Alexis; Hirota, Keiji; Kawakami, Ryoji; Yasuda, Keiko; Motooka, Daisuke; Nakamura, Shota; Kondo, Motonari; Taniuchi, Ichiro; Kohwi-Shigematsu, Terumi; Sakaguchi, Shimon			Guidance of regulatory T cell development by Satb1-dependent super-enhancer establishment (vol 18, pg 173, 2017)	NATURE IMMUNOLOGY			English	Correction													Vandenbon, Alexis/N-4428-2019; Sakaguchi, Shimon/C-9535-2009	Hirota, Keiji/0000-0002-4737-0661				Kitagawa Y, 2017, NAT IMMUNOL, V18, P173, DOI 10.1038/ni.3646	1	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					474	474		10.1038/ni0417-474d	http://dx.doi.org/10.1038/ni0417-474d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28323270				2022-12-18	WOS:000396815800018
J	Wortis, HH				Wortis, Henry H.			To B-1 or not to B-1	NATURE IMMUNOLOGY			English	Editorial Material							B-CELLS; FETAL; LYMPHOPOIESIS	The transcription factor Bhlhe41 determines the survival and repertoire of B-1a cells.	[Wortis, Henry H.] Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA	Tufts University	Wortis, HH (corresponding author), Tufts Univ, Sch Med, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA.	henry.wortis@tufts.edu						Baumgarth N, 2005, SPRINGER SEMIN IMMUN, V26, P347, DOI 10.1007/s00281-004-0182-2; Bertolino E, 2005, NAT IMMUNOL, V6, P836, DOI 10.1038/ni1226; Griffin DO, 2011, J EXP MED, V208, P2566, DOI 10.1084/jem.20111761; Hayakawa K, 1999, SCIENCE, V285, P113, DOI 10.1126/science.285.5424.113; HAYAKAWA K, 1983, J EXP MED, V157, P202, DOI 10.1084/jem.157.1.202; Kreslavsky T, 2017, NAT IMMUNOL, V18, P442, DOI 10.1038/ni.3694; Lam KP, 1999, J EXP MED, V190, P471, DOI 10.1084/jem.190.4.471; Montecino-Rodriguez E, 2016, IMMUNITY, V45, P527, DOI 10.1016/j.immuni.2016.07.012; Thiriot A, 2007, J IMMUNOL, V179, P6568, DOI 10.4049/jimmunol.179.10.6568; Yuan J, 2012, SCIENCE, V335, P1195, DOI 10.1126/science.1216557; Zhou Y, 2015, J EXP MED, V212, P569, DOI 10.1084/jem.20141510	11	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2017	18	4					365	366		10.1038/ni.3715	http://dx.doi.org/10.1038/ni.3715			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EO6PU	28323267				2022-12-18	WOS:000396815800001
J	Hjorth, M; Febbraio, MA				Hjorth, Marit; Febbraio, Mark A.			IL-1 beta delivers a sweet deal	NATURE IMMUNOLOGY			English	Editorial Material								Interleukin 1 beta (IL-1 beta) is a cytokine associated with inflammation, obesity and metabolic dysregulation. Surprisingly, IL-1 beta is also required for maintaining steady-state glucose homeostasis by potentiating postprandial insulin secretion.	[Hjorth, Marit; Febbraio, Mark A.] Garvan Inst Med Res, Cellular & Mol Metab Lab, Diabet & Metab Div, Darlinghurst, NSW, Australia	Garvan Institute of Medical Research	Febbraio, MA (corresponding author), Garvan Inst Med Res, Cellular & Mol Metab Lab, Diabet & Metab Div, Darlinghurst, NSW, Australia.	m.febbraio@garvan.org.au	Febbraio, Mark/AAE-9632-2019; Hjorth, Marit/AAC-6110-2020	Hjorth, Marit/0000-0001-8067-714X; Febbraio, Mark/0000-0002-9296-4418				DELREY A, 1987, AM J PHYSIOL, V253, pR794, DOI 10.1152/ajpregu.1987.253.5.R794; Dinarello CA, 2011, BLOOD, V117, P3720, DOI 10.1182/blood-2010-07-273417; Dror E, 2017, NAT IMMUNOL, V18, P283, DOI 10.1038/ni.3659; Febbraio MA, 2014, TRENDS ENDOCRIN MET, V25, P312, DOI 10.1016/j.tem.2014.02.004; Haneklaus M, 2015, IMMUNOL REV, V265, P53, DOI 10.1111/imr.12285; Larsen CM, 2007, NEW ENGL J MED, V356, P1517, DOI 10.1056/NEJMoa065213; Mathis D, 2011, NAT REV IMMUNOL, V11, P81, DOI 10.1038/nri2922; Ridker PM, 2011, AM HEART J, V162, P597, DOI 10.1016/j.ahj.2011.06.012; Wen HT, 2011, NAT IMMUNOL, V12, P408, DOI 10.1038/ni.2022	9	2	2	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					247	248		10.1038/ni.3681	http://dx.doi.org/10.1038/ni.3681			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28198823				2022-12-18	WOS:000394413400001
J	Pagan, AJ; Ramakrishnan, L				Pagan, Antonio J.; Ramakrishnan, Lalita			TORmented macrophages spontaneously form granulomas	NATURE IMMUNOLOGY			English	Editorial Material							MTOR; POLARIZATION; PATHWAY; DISEASE	Elevated signaling via the metabolic checkpoint kinase mTORC1 in macrophages stimulates spontaneous granuloma formation in mice and is associated with the progression of sarcoidosis in humans.	[Pagan, Antonio J.; Ramakrishnan, Lalita] Univ Cambridge, MRC Lab Mol Biol, Dept Med, Mol Immun Unit, Cambridge, England	MRC Laboratory Molecular Biology; University of Cambridge	Pagan, AJ (corresponding author), Univ Cambridge, MRC Lab Mol Biol, Dept Med, Mol Immun Unit, Cambridge, England.	ap825@cam.ac.uk; lr404@cam.ac.uk	Pagan, Antonio/AAB-1604-2019	Ramakrishnan, Lalita/0000-0003-0692-5533	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI054503] Funding Source: NIH RePORTER; NIAID NIH HHS [R37 AI054503] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Byles V, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3834; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cronan MR, 2016, IMMUNITY, V45, P861, DOI 10.1016/j.immuni.2016.09.014; Esteves T, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0332-z; Herrtwich L, 2016, CELL, V167, P1264, DOI 10.1016/j.cell.2016.09.054; Linke M, 2017, NAT IMMUNOL, V18, P293, DOI 10.1038/ni.3655; Ramakrishnan L, 2012, NAT REV IMMUNOL, V12, P352, DOI 10.1038/nri3211; Sengupta S, 2010, MOL CELL, V40, P310, DOI 10.1016/j.molcel.2010.09.026; Thien A, 2015, DEV CELL, V32, P617, DOI 10.1016/j.devcel.2015.01.026; Weichhart T, 2015, NAT REV IMMUNOL, V15, P599, DOI 10.1038/nri3901; Wilson MS, 2007, IMMUNOL CELL BIOL, V85, P148, DOI 10.1038/sj.icb.7100014; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696	12	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					252	253		10.1038/ni.3689	http://dx.doi.org/10.1038/ni.3689			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EL1WZ	28198828				2022-12-18	WOS:000394413400004
J	Buttgereit, A; Lelios, I; Yu, XY; Vrohlings, M; Krakoski, NR; Gautier, EL; Nishinakamura, R; Becher, B; Greter, M				Buttgereit, Anne; Lelios, Iva; Yu, Xueyang; Vrohlings, Melissa; Krakoski, Natalie R.; Gautier, Emmanuel L.; Nishinakamura, Ryuichi; Becher, Burkhard; Greter, Melanie			Sall1 is a transcriptional regulator defining microglia identity and function (vol 17, pg 1397, 2016)	NATURE IMMUNOLOGY			English	Correction													Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Greter, Melanie/0000-0002-7220-5369				Buttgereit A, 2016, NAT IMMUNOL, V17, P1397, DOI 10.1038/ni.3585	1	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					246	246		10.1038/ni0217-246c	http://dx.doi.org/10.1038/ni0217-246c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28102208	Bronze			2022-12-18	WOS:000392360900020
J	Dempsey, LA				Dempsey, Laurie A.			CD148 function in B-1 cells	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2017	18	1					14	14		10.1038/ni.3652	http://dx.doi.org/10.1038/ni.3652			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FF2QO	27984571				2022-12-18	WOS:000408742100003
J	Roose, JP				Roose, Jeroen P.			Lost GRP on cytotoxicity?	NATURE IMMUNOLOGY			English	Editorial Material								Deficiency in the RASGRP1 guanine-nucleotide-exchange factor leads to a novel primary immunodeficiency with impaired activation and proliferation of T cells and B cells and defective killing by cytotoxic T cells and natural killer cells.	[Roose, Jeroen P.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Roose, JP (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	jeroen.roose@ucsf.edu		Roose, Jeroen/0000-0003-4746-2811	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104789, P01AI091580] Funding Source: NIH RePORTER; NIAID NIH HHS [P01 AI091580, R01 AI104789] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bartlett A, 2013, J IMMUNOL, V191, P3605, DOI 10.4049/jimmunol.1202892; Coughlin JJ, 2005, J IMMUNOL, V175, P7179, DOI 10.4049/jimmunol.175.11.7179; Daley SR, 2013, ELIFE, V2, DOI 10.7554/eLife.01020; Dower NA, 2000, NAT IMMUNOL, V1, P317, DOI 10.1038/79766; Iwig JS, 2013, ELIFE, V2, DOI 10.7554/eLife.00813; Ksionda Olga, 2013, Front Biol (Beijing), V8, P508; Liston A, 2008, NAT REV IMMUNOL, V8, P545, DOI 10.1038/nri2336; Liu Y, 2007, J EXP MED, V204, P93, DOI 10.1084/jem.20061598; Okamura SM, 2006, J BIOL CHEM, V281, P36132, DOI 10.1074/jbc.M605093200; Priatel JJ, 2002, IMMUNITY, V17, P617, DOI 10.1016/S1074-7613(02)00451-X; Rapali P, 2011, FEBS J, V278, P2980, DOI 10.1111/j.1742-4658.2011.08254.x; Seltzer E., 2016, NAT IMMUNOL, V17, P1352	12	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1339	1340		10.1038/ni.3620	http://dx.doi.org/10.1038/ni.3620			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27849207				2022-12-18	WOS:000388056400003
J	Torre, S; Polyak, MJ; Langlais, D; Fodil, N; Kennedy, JM; Radovanovic, I; Berghout, J; Leiva-Torkes, GA; Krawczyk, CM; Ilangumaran, S; Mossman, K; Liang, C; Knobeloch, KP; Healy, LM; Antel, J; Arbour, N; Prat, A; Majewski, J; Lathrop, M; Vidal, SM; Gros, P				Torre, Sabrina; Polyak, Maria J.; Langlais, David; Fodil, Nassima; Kennedy, James M.; Radovanovic, Irena; Berghout, Joanne; Leiva-Torkes, Gabriel A.; Krawczyk, Connie M.; Ilangumaran, Subburaj; Mossman, Karen; Liang, Chen; Knobeloch, Klaus-Peter; Healy, Luke M.; Antel, Jack; Arbour, Nathalie; Prat, Alexandre; Majewski, Jacek; Lathrop, Mark; Vidal, Silvia M.; Gros, Philippe			USP15 regulates type I interferon response and is required for pathogenesis of neuroinflammation	NATURE IMMUNOLOGY			English	Correction													Langlais, David/ABE-8455-2020; Berghout, Joanne/M-5493-2017	Langlais, David/0000-0003-4429-0110; Berghout, Joanne/0000-0002-9250-9159; Ilangumaran, Subburaj/0000-0002-7563-576X; Leiva-Torres, Gabriel Andre/0000-0002-8144-1443; Prat, Alexandre/0000-0001-6188-0580; antel, jack/0000-0002-5148-0636				Torre S, 2017, NAT IMMUNOL, V18, P54, DOI 10.1038/ni.3581	1	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1479	1479		10.1038/ni1216-1479c	http://dx.doi.org/10.1038/ni1216-1479c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27849203	Bronze			2022-12-18	WOS:000388056400020
J	Vely, F; Barlogis, V; Vallentin, B; Neven, B; Piperoglou, C; Ebbo, M; Perchet, T; Petit, M; Yessaad, N; Touzot, F; Bruneau, J; Mahlaoui, N; Zucchini, N; Farnarier, C; Michel, G; Moshous, D; Blanche, S; Dujardin, A; Spits, H; Distler, JHW; Ramming, A; Picard, C; Golub, R; Fischer, A; Vivier, E				Vely, Frederic; Barlogis, Vincent; Vallentin, Blandine; Neven, Benedicte; Piperoglou, Christelle; Ebbo, Mikael; Perchet, Thibaut; Petit, Maxime; Yessaad, Nadia; Touzot, Fabien; Bruneau, Julie; Mahlaoui, Nizar; Zucchini, Nicolas; Farnarier, Catherine; Michel, Gerard; Moshous, Despina; Blanche, Stephane; Dujardin, Arnaud; Spits, Hergen; Distler, Joerg H. W.; Ramming, Andreas; Picard, Capucine; Golub, Rachel; Fischer, Alain; Vivier, Eric			Evidence of innate lymphoid cell redundancy in humans (vol 17, pg 1291, 2016)	NATURE IMMUNOLOGY			English	Correction									[Ebbo, Mikael] Hop La Timone, APHM, Serv Med Interne, Marseille, France; [Perchet, Thibaut; Petit, Maxime; Golub, Rachel] Inst Pasteur, INSERM, Unite Lymphopoiese, Paris, France; [Perchet, Thibaut; Petit, Maxime; Golub, Rachel] Univ Paris Diderot, Sorbonne Paris Cite, Cellule Pasteur, Paris, France; [Yessaad, Nadia] Aix Marseille Univ, MI mAbs Consortium, Marseille, France; [Touzot, Fabien] Hop Necker Enfants Malad, AP HP, Biotherapy Unit, Paris, France; [Bruneau, Julie] Hop Necker Enfants Malad, AP HP, Serv Anatomopathol, Paris, France; [Zucchini, Nicolas] BD Biosci, Le Pont De Claix, France; [Dujardin, Arnaud] Innate Pharma, Marseille, France; [Spits, Hergen] Univ Amsterdam, Acad Med Ctr, Arizona Amsterdam, Netherlands; [Distler, Joerg H. W.; Ramming, Andreas] Univ Erlangen Nurnberg, Dept Internal Med Rheumatol & Immunol, Erlangen, Germany; [Picard, Capucine] Hop Necker Enfants Malad, AP HP, Study Ctr Immunodeficiencies, Paris, France; [Fischer, Alain] Coll France, Paris, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Amsterdam; University of Erlangen Nuremberg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; College de France			Touzot, Fabien/T-7797-2018; Rachel, GOLUB/M-7188-2014; Vély, Frédéric/HHM-3894-2022; MAHLAOUI, Nizar/AAH-6103-2020; Moshous, Despina/B-7507-2017; Vivier, Eric/F-8939-2010; Distler, Oliver/AAE-6225-2019	Touzot, Fabien/0000-0002-0889-4905; Rachel, GOLUB/0000-0002-2306-5363; MAHLAOUI, Nizar/0000-0002-0030-8094; Moshous, Despina/0000-0001-6719-3693; Vivier, Eric/0000-0001-7022-8287; Distler, Oliver/0000-0002-0546-8310; Bruneau, Julie/0000-0001-5519-8489				Vely F, 2016, NAT IMMUNOL, V17, P1291, DOI 10.1038/ni.3553	1	2	2	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1479	1479		10.1038/ni1216-1479b	http://dx.doi.org/10.1038/ni1216-1479b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27849206	Bronze			2022-12-18	WOS:000388056400019
J	Amagai, M				Amagai, Masayuki			Cracking the code of skin inflammation with CD1a	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; URUSHIOL; PSORIASIS; ALPHA; MICE	CD1a on Langerhans cells in the epidermis is the lipid receptor for the plant-derived allergen urushiol and self lipids and is a key amplifier of inflammatory responses in urushiol-induced contact dermatitis as well as in psoriasis.	[Amagai, Masayuki] Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan; [Amagai, Masayuki] RIKEN, Ctr Integrat Med Sci, Lab Skin Homeostasis, Yokohama, Kanagawa, Japan	Keio University; RIKEN	Amagai, M (corresponding author), Keio Univ, Sch Med, Dept Dermatol, Tokyo, Japan.; Amagai, M (corresponding author), RIKEN, Ctr Integrat Med Sci, Lab Skin Homeostasis, Yokohama, Kanagawa, Japan.	amagai@med.keio.ac.jp	Amagai, Masayuki/K-5325-2013	Amagai, Masayuki/0000-0003-3314-7052				de Jong A, 2010, NAT IMMUNOL, V11, P1102, DOI 10.1038/ni.1956; Gudjonsson JE, 2009, J INVEST DERMATOL, V129, P2795, DOI 10.1038/jid.2009.173; KALISH RS, 1990, J IMMUNOL, V145, P3706; KALISH RS, 1994, J CLIN INVEST, V93, P2039, DOI 10.1172/JCI117198; Kim JH, 2016, NAT IMMUNOL, V17, P1159, DOI 10.1038/ni.3523; Kobayashi C, 2012, J INVEST DERMATOL, V132, P241, DOI 10.1038/jid.2011.280; Moody DB, 2004, SCIENCE, V303, P527, DOI 10.1126/science.1089353; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Schmidt M, 2010, NAT IMMUNOL, V11, P814, DOI 10.1038/ni.1919; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; Wakabayashi T, 2005, IMMUNOL CELL BIOL, V83, P18, DOI 10.1111/j.1440-1711.2005.01310.x	12	2	2	0	17	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1133	1134		10.1038/ni.3557	http://dx.doi.org/10.1038/ni.3557			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27648537				2022-12-18	WOS:000384302900001
J	Locci, M; Wu, JE; Arumemi, F; Mikulski, Z; Dahlberg, C; Miller, AT; Crotty, S				Locci, Michela; Wu, Jennifer E.; Arumemi, Fortuna; Mikulski, Zbigniew; Dahlberg, Carol; Miller, Andrew T.; Crotty, Shane			Activin A programs the differentiation of human T-FH cells (vol 17, pg 976, 2016)	NATURE IMMUNOLOGY			English	Correction													Crotty, Shane/AAC-6703-2019; Wu, Jennifer/GRX-1831-2022; Crotty, Shane/AAE-8446-2019	Crotty, Shane/0000-0002-6484-6262; 				Locci M, 2016, NAT IMMUNOL, V17, P976, DOI 10.1038/ni.3494	1	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1235	1235		10.1038/ni1016-1235d	http://dx.doi.org/10.1038/ni1016-1235d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27648551	Bronze			2022-12-18	WOS:000384302900018
J	Swanson, KV; Ting, JPY				Swanson, Karen V.; Ting, Jenny P-Y			Reining in uncontrolled inflammasome with PKA	NATURE IMMUNOLOGY			English	Editorial Material							NLRP3 INFLAMMASOME; ACTIVATION; MACROPHAGES; RECEPTOR	New findings show that the NLRP3 inflammasome is inactivated by disassembly of the inflammasome mediated by the kinase PKA and that this regulation might be negated in NLRP3-gain-of-function diseases.	[Swanson, Karen V.; Ting, Jenny P-Y] Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Swanson, Karen V.; Ting, Jenny P-Y] Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA; [Ting, Jenny P-Y] Univ North Carolina Chapel Hill, Ctr Translat Immunol, Chapel Hill, NC 27599 USA; [Ting, Jenny P-Y] Univ North Carolina Chapel Hill, Inst Inflammatory Dis, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Ting, JPY (corresponding author), Univ North Carolina Chapel Hill, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.; Ting, JPY (corresponding author), Univ North Carolina Chapel Hill, Dept Genet, Chapel Hill, NC 27599 USA.; Ting, JPY (corresponding author), Univ North Carolina Chapel Hill, Ctr Translat Immunol, Chapel Hill, NC 27599 USA.; Ting, JPY (corresponding author), Univ North Carolina Chapel Hill, Inst Inflammatory Dis, Chapel Hill, NC 27599 USA.	jenny_ting@med.unc.edu		Swanson, Karen V/0000-0003-3105-0599				BRANDWEIN SR, 1986, J BIOL CHEM, V261, P8624; Broderick L, 2015, ANNU REV PATHOL-MECH, V10, P395, DOI 10.1146/annurev-pathol-012414-040431; Duncan JA, 2007, P NATL ACAD SCI USA, V104, P8041, DOI 10.1073/pnas.0611496104; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Lamkanfi M, 2014, CELL, V157, P1013, DOI 10.1016/j.cell.2014.04.007; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lee GS, 2012, NATURE, V492, P123, DOI 10.1038/nature11588; Sokolowska M, 2015, J IMMUNOL, V194, P5472, DOI 10.4049/jimmunol.1401343; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang J., CELL MOL IMMUNOL, DOI http://dx.doi.org/10.1038/cmi.2016.29(27June2016)	13	2	2	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2016	17	10					1137	1138		10.1038/ni.3556	http://dx.doi.org/10.1038/ni.3556			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DX3VD	27648539	Green Submitted			2022-12-18	WOS:000384302900003
J	Li, X; Zhang, Q; Ding, YY; Liu, YQ; Zhao, DZ; Zhao, K; Shen, QC; Liu, XG; Zhu, XH; Li, N; Cheng, ZY; Fan, GP; Wang, QQ; Cao, XT				Li, Xia; Zhang, Qian; Ding, Yuanyuan; Liu, Yiqi; Zhao, Dezhi; Zhao, Kai; Shen, Qicong; Liu, Xingguang; Zhu, Xuhui; Li, Nan; Cheng, Zhongyi; Fan, Guoping; Wang, Qingqing; Cao, Xuetao			Methyltransferase Dnmt3a upregulates HDAC9 to deacetylate the kinase TBK1 for activation of antiviral innate immunity (vol 17, pg 806, 2016)	NATURE IMMUNOLOGY			English	Correction													shen, qicong/GYJ-2803-2022					Li X, 2016, NAT IMMUNOL, V17, P806, DOI 10.1038/ni.3464	1	2	2	1	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8					1005	1005		10.1038/ni0816-1005d	http://dx.doi.org/10.1038/ni0816-1005d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK	27434014	Bronze			2022-12-18	WOS:000380647000022
J	Formenti, SC; Demaria, S; Barcellos-Hoff, MH; McBride, WH				Formenti, Silvia C.; Demaria, Sandra; Barcellos-Hoff, Mary Helen; McBride, William H.			Subverting misconceptions about radiation therapy	NATURE IMMUNOLOGY			English	Letter							RADIOTHERAPY; EXPOSURE		[Formenti, Silvia C.; Demaria, Sandra] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY USA; [Barcellos-Hoff, Mary Helen] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA; [McBride, William H.] Univ Calif Los Angeles, Div Mol & Cellular Oncol, Los Angeles, CA USA	Cornell University; University of California System; University of California San Francisco; University of California System; University of California Los Angeles	Formenti, SC (corresponding author), Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY USA.; McBride, WH (corresponding author), Univ Calif Los Angeles, Div Mol & Cellular Oncol, Los Angeles, CA USA.	formenti@cornell.edu; wmcbride@mednet.ucla.edu	Demaria, Sandra/AAA-5816-2020	Demaria, Sandra/0000-0003-4426-0499; Barcellos-Hoff, Mary Helen/0000-0002-5994-9558	NCI NIH HHS [R01 CA101752] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bath-Hextall FJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003412.pub2; Brody JD, 2010, J CLIN ONCOL, V28, P4324, DOI 10.1200/JCO.2010.28.9793; Cummings RJ, 2012, J IMMUNOL, V189, P4247, DOI 10.4049/jimmunol.1201371; Demaria S, 2005, INT J RADIAT ONCOL, V63, P655, DOI 10.1016/j.ijrobp.2005.06.032; GOLDEN EB, 2013, IMMUNOL RES, V1, P365, DOI DOI 10.1158/2326-6066.CIR-13-0115; Golden EB, 2015, LANCET ONCOL, V16, P795, DOI 10.1016/S1470-2045(15)00054-6; Locke J, 2001, INT J RADIAT ONCOL, V51, P748, DOI 10.1016/S0360-3016(01)01656-X; Nguyen DH, 2011, CANCER CELL, V19, P640, DOI 10.1016/j.ccr.2011.03.011; Price JG, 2015, NAT IMMUNOL, V16, P1060, DOI 10.1038/ni.3270; Sugiyama H, 2014, RADIAT RES, V181, P531, DOI 10.1667/RR13494.1	10	2	2	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					345	345		10.1038/ni.3363	http://dx.doi.org/10.1038/ni.3363			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	27002831	Bronze			2022-12-18	WOS:000372508000001
J	Xia, PY; Ye, BQ; Wang, S; Zhu, XX; Du, Y; Xiong, Z; Tian, Y; Fan, ZS				Xia, Pengyan; Ye, Buqing; Wang, Shuo; Zhu, Xiaoxiao; Du, Ying; Xiong, Zhen; Tian, Yong; Fan, Zusen			Glutamylation of the DNA sensor cGAS regulates its binding and synthase activity in antiviral immunity (vol 17, pg 369, 2016)	NATURE IMMUNOLOGY			English	Correction																		Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356	1	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					469	469		10.1038/ni0416-469e	http://dx.doi.org/10.1038/ni0416-469e			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	27002845	Bronze			2022-12-18	WOS:000372508000026
J	Carretero, R; Sektioglu, IM; Garbi, N; Salgado, OC; Beckhove, P; Hammerling, GJ				Carretero, Rafael; Sektioglu, Ibrahim M.; Garbi, Natalio; Salgado, Oscar C.; Beckhove, Philipp; Haemmerling, Guenter J.			Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8(+) T cells (vol 16, pg 609, 2015)	NATURE IMMUNOLOGY			English	Correction																		Carretero R, 2015, NAT IMMUNOL, V16, P609, DOI 10.1038/ni.3159	1	2	3	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					214	214		10.1038/ni0216-214b	http://dx.doi.org/10.1038/ni0216-214b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26784268	Bronze			2022-12-18	WOS:000368571500016
J	Kidd, BA				Kidd, Brian A.			Decoding the immune response to successful influenza vaccination	NATURE IMMUNOLOGY			English	Editorial Material							VACCINES; SYSTEMS; BIOLOGY; HUMANS	Systems immunology identifies molecular and cellular signatures associated with adverse clinical events and antibody response to a vaccine against H1N1 influenza virus.	[Kidd, Brian A.] Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA; [Kidd, Brian A.] Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Kidd, BA (corresponding author), Icahn Sch Med Mt Sinai, Dept Genet & Genom Sci, New York, NY 10029 USA.; Kidd, BA (corresponding author), Icahn Sch Med Mt Sinai, Icahn Inst Genom & Multiscale Biol, New York, NY 10029 USA.	brian.kidd@mssm.edu		Kidd, Brian/0000-0003-2110-1145				Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Davidson MW, 2015, SCI REP-UK, V5, DOI 10.1038/srep08154; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Kidd BA, 2014, NAT IMMUNOL, V15, P118, DOI 10.1038/ni.2787; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Maecker HT, 2012, NAT REV RHEUMATOL, V8, P317, DOI 10.1038/nrrheum.2012.66; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111; Schadt EE, 2010, NAT REV GENET, V11, P647, DOI 10.1038/nrg2857; Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031	12	2	2	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					113	114		10.1038/ni.3372	http://dx.doi.org/10.1038/ni.3372			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26784255				2022-12-18	WOS:000368571500001
J	Millar, DG; Ohashi, PS				Millar, Douglas G.; Ohashi, Pamela S.			Central tolerance: what you see is what you don't get!	NATURE IMMUNOLOGY			English	Editorial Material							REGULATORY T-CELLS; EXPRESSION	Thymic selection shapes the repertoire of potentially autoreactive thymocytes that are allowed to mature. The expression pattern of self antigen seen by thymocytes determines the number and functional ability of autoreactive T cells.	[Millar, Douglas G.; Ohashi, Pamela S.] Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada; [Ohashi, Pamela S.] Univ Toronto, Dept Med Biophys & Immunol, Toronto, ON, Canada	University of Toronto; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto	Ohashi, PS (corresponding author), Princess Margaret Canc Ctr, Campbell Family Inst Breast Canc Res, Toronto, ON, Canada.; Ohashi, PS (corresponding author), Univ Toronto, Dept Med Biophys & Immunol, Toronto, ON, Canada.	pohashi@uhnres.utoronto.ca		Millar, Douglas/0000-0002-8640-7148; Ohashi, Pamela S./0000-0003-2915-9317				Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Hogquist KA, 2005, NAT REV IMMUNOL, V5, P772, DOI 10.1038/nri1707; Hsieh CS, 2012, NAT REV IMMUNOL, V12, P157, DOI 10.1038/nri3155; Malchow S, 2013, SCIENCE, V339, P1219, DOI 10.1126/science.1233913; Malhotra D, 2016, NAT IMMUNOL, V17, P187, DOI 10.1038/ni.3327; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Munn DH, 2016, CURR OPIN IMMUNOL, V39, P1, DOI 10.1016/j.coi.2015.10.009; Nguyen LT, 2002, J EXP MED, V195, P423, DOI 10.1084/jem.20010032; Schumacher TN, 2015, SCIENCE, V348, P69, DOI 10.1126/science.aaa4971; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017	11	2	2	0	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2016	17	2					115	116		10.1038/ni.3373	http://dx.doi.org/10.1038/ni.3373			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DB5RO	26784256				2022-12-18	WOS:000368571500002
J	Kubo, M				Kubo, Masato			TCF-1 and LEF-1 help launch the T-FH program	NATURE IMMUNOLOGY			English	Editorial Material							CELL DIFFERENTIATION; PATHWAY; FATE	Follicular helper T cells (T-FH cells) differentiate from naive T cells, but the picture of this differentiation process remains incomplete. Two studies now identify the related transcriptional regulators TCF-1 and LEF-1 as important early participants in this process.	[Kubo, Masato] Tokyo Univ Sci, Res Inst Biomed Sci, Chiba, Japan; [Kubo, Masato] RIKEN, Ctr Integrat Med Sci IMS, Yokohama, Kanagawa, Japan	Tokyo University of Science; RIKEN	Kubo, M (corresponding author), Tokyo Univ Sci, Res Inst Biomed Sci, Chiba, Japan.	masato.kubo@riken.jp	Kubo, Masato/A-5918-2016		Grants-in-Aid for Scientific Research [15H01267] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Choi YS, 2015, NAT IMMUNOL, V16, P980, DOI 10.1038/ni.3226; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Kali T., 2012, J EXP MED, V209, P2079; Nuneva R. I., 2009, SCIENCE, V325, P1001; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Xu LF, 2015, NAT IMMUNOL, V16, P991, DOI 10.1038/ni.3229; Xue HH, 2012, ANN NY ACAD SCI, V1247, P16, DOI 10.1111/j.1749-6632.2011.06302.x; Yu Q, 2009, NAT IMMUNOL, V10, P992, DOI 10.1038/ni.1762; Zaretsky AG, 2009, J EXP MED, V206, P991, DOI 10.1084/jem.20090303	13	2	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					900	901		10.1038/ni.3254	http://dx.doi.org/10.1038/ni.3254			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26287589				2022-12-18	WOS:000359876900006
J	Perez-Shibayama, C; Ludewig, B				Perez-Shibayama, Christian; Ludewig, Burkhard			Tuning up FALCs: immunological shielding in the body cavities	NATURE IMMUNOLOGY			English	Editorial Material							LYMPH-NODE; CELLS	Fat-associated lymphoid clusters (FALCs) are non-classical secondary lymphoid organs of the body cavities. The formation and maturation of FALCs are driven by tumor-necrosis factor and are further enhanced by invariant natural killer T cells.	[Perez-Shibayama, Christian; Ludewig, Burkhard] Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland	Kantonsspital St. Gallen	Perez-Shibayama, C (corresponding author), Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland.	burkhard.ludewig@kssg.ch						Ansel KM, 2002, IMMUNITY, V16, P67, DOI 10.1016/S1074-7613(01)00257-6; Benezech C, 2015, NAT IMMUNOL, V16, P819, DOI 10.1038/ni.3215; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Fletcher AL, 2015, NAT REV IMMUNOL, V15, P350, DOI 10.1038/nri3846; Junt T, 2008, NAT REV IMMUNOL, V8, P764, DOI 10.1038/nri2414; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Onder L, 2013, J EXP MED, V210, P465, DOI 10.1084/jem.20121462; Platell C, 2000, WORLD J GASTROENTERO, V6, P169; Randall TD, 2008, ANNU REV IMMUNOL, V26, P627, DOI 10.1146/annurev.immunol.26.021607.090257; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014	10	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					796	798		10.1038/ni.3228	http://dx.doi.org/10.1038/ni.3228			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26194279				2022-12-18	WOS:000358299200005
J	Shen, ZJ; Malter, JS				Shen, Zhong-Jian; Malter, James S.			XBP1, a determinant of the eosinophil lineage	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTION FACTOR; STRESS; IRE1; MICE; ER	Targeted deletion of the transcription factor XBP1 in hematopoietic stem cells selectively prevents eosinophil maturation in the bone marrow without affecting other lineages of the immune system.	[Shen, Zhong-Jian; Malter, James S.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Shen, ZJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA.	zhong.shen@utsouthwestern.edu; james.malter@utsouthwestern.edu			NHLBI NIH HHS [P01 HL088594] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL088594] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARKER RL, 1988, J EXP MED, V168, P1493, DOI 10.1084/jem.168.4.1493; Bettigole SE, 2015, NAT IMMUNOL, V16, P829, DOI 10.1038/ni.3225; Doyle AD, 2013, BLOOD, V122, P781, DOI 10.1182/blood-2013-01-473405; Humbles AA, 2004, SCIENCE, V305, P1776, DOI 10.1126/science.1100283; Lee JJ, 2004, SCIENCE, V305, P1773, DOI 10.1126/science.1099472; Navarro S, 2008, CELL MOL LIFE SCI, V65, P324, DOI 10.1007/s00018-007-7499-7; Navarro S, 2010, J NEUROIMMUNOL, V227, P60, DOI 10.1016/j.jneuroim.2010.06.012; Reimold AM, 2000, GENE DEV, V14, P152; Todd DJ, 2009, J EXP MED, V206, P2151, DOI 10.1084/jem.20090738; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	11	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8					793	794		10.1038/ni.3214	http://dx.doi.org/10.1038/ni.3214			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT	26194277	Green Accepted			2022-12-18	WOS:000358299200003
J	Onizawa, M; Oshima, S; Schulze-Topphoff, U; Oses-Prieto, JA; Lu, T; Tavares, R; Prodhomme, T; Duong, B; Whang, MI; Advincula, R; Agelidis, A; Barrera, J; Wu, H; Burlingame, A; Malynn, BA; Zamvil, SS; Ma, A				Onizawa, Michio; Oshima, Shigeru; Schulze-Topphoff, Ulf; Oses-Prieto, Juan A.; Lu, Timothy; Tavares, Rita; Prodhomme, Thomas; Duong, Bao; Whang, Michael I.; Advincula, Rommel; Agelidis, Alex; Barrera, Julio; Wu, Hao; Burlingame, Alma; Malynn, Barbara A.; Zamvil, Scott S.; Ma, Averil			The ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosis (vol 16, pg 618, 2015)	NATURE IMMUNOLOGY			English	Correction														Agelidis, Alex/0000-0002-6582-1630; Tavares, Rita/0000-0002-1654-4454; Oses-Prieto, Juan/0000-0003-4759-2341	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, R01AI117908] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK095693, T32DK007007, R01DK071939] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007334, R01 AI117908] Funding Source: Medline; NIDDK NIH HHS [R01 DK095693, R01 DK071939, T32 DK007007] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Onizawa M, 2015, NAT IMMUNOL, V16, P618, DOI 10.1038/ni.3172	1	2	4	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					785	785		10.1038/ni0715-785c	http://dx.doi.org/10.1038/ni0715-785c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26086145	Green Accepted, Bronze			2022-12-18	WOS:000356445600017
J	Zhang, Q; Kuang, H; Chen, C; Yan, J; Do-Umehara, HC; Liu, XY; Dada, L; Ridge, KM; Chandel, NS; Liu, J				Zhang, Qiao; Kuang, Hong; Chen, Cong; Yan, Jie; Do-Umehara, Hanh Chi; Liu, Xin-yuan; Dada, Laura; Ridge, Karen M.; Chandel, Navdeep S.; Liu, Jing			The kinase Jnk2 promotes stress-induced mitophagy by targeting the small mitochondrial form of the tumor suppressor ARF for degradation (vol 16, pg 458, 2015)	NATURE IMMUNOLOGY			English	Correction													Liu, Xinyuan/HDM-5505-2022					Zhang Q, 2015, NAT IMMUNOL, V16, P458, DOI 10.1038/ni.3130	1	2	3	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					785	785		10.1038/ni0715-785b	http://dx.doi.org/10.1038/ni0715-785b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26086147	Bronze			2022-12-18	WOS:000356445600016
J	Egawa, T				Egawa, Takeshi			Continued mission of ThPOK	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL LINEAGE; FATE; RUNX3; CD4; DIFFERENTIATION; COMMITMENT; POK	ThPOK, the critical transcription factor for differentiation of the helper T cell lineage in the thymus, continues to function as a gatekeeper to maintain helper T cell identity by repressing the transcription factor Runx3 in mature T cells.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Egawa, T (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	tegawa@wustl.edu		Egawa, Takeshi/0000-0001-7489-1051	NIAID NIH HHS [R01 AI097244] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI097244] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Egawa T, 2008, NAT IMMUNOL, V9, P1131, DOI 10.1038/ni.1652; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; Honda K, 2012, ANNU REV IMMUNOL, V30, P759, DOI 10.1146/annurev-immunol-020711-074937; Luckey MA, 2014, NAT IMMUNOL, V15, P638, DOI 10.1038/ni.2917; Mucida D, 2013, NAT IMMUNOL, V14, P281, DOI 10.1038/ni.2523; Muroi S, 2008, NAT IMMUNOL, V9, P1113, DOI 10.1038/ni.1650; Reis BS, 2013, NAT IMMUNOL, V14, P271, DOI 10.1038/ni.2518; Singer A, 2008, NAT REV IMMUNOL, V8, P788, DOI 10.1038/nri2416; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Vacchio MS, 2014, NAT IMMUNOL, V15, P947, DOI 10.1038/ni.2960; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001	12	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					900	902		10.1038/ni.2988	http://dx.doi.org/10.1038/ni.2988			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25232811				2022-12-18	WOS:000342564800002
J	Luallen, RJ; Troemel, ER				Luallen, Robert J.; Troemel, Emily R.			Breaking barriers: a GPCR triggers immunity in nematodes	NATURE IMMUNOLOGY			English	Editorial Material							CAENORHABDITIS-ELEGANS; C. ELEGANS; MECHANISMS; RECEPTORS; DEFENSE	A ligand and G protein-coupled receptor activate antimicrobial gene expression in the Caenorhabditis elegans epidermis, in response to wounding and to infection with a fungal pathogen.	[Luallen, Robert J.; Troemel, Emily R.] Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Luallen, RJ (corresponding author), Univ Calif San Diego, Sect Cell & Dev Biol, Div Biol Sci, La Jolla, CA 92093 USA.	etroemel@ucsd.edu		Luallen, Robert/0000-0001-7657-2791				Aoki R, 2011, J NEUROSCI, V31, P16603, DOI 10.1523/JNEUROSCI.4018-11.2011; Cordeiro JV, 2013, NAT REV MOL CELL BIO, V14, P249, DOI 10.1038/nrm3541; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; Kleino A, 2012, CELL HOST MICROBE, V11, P320, DOI 10.1016/j.chom.2012.04.002; Piccinini AM, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/672395; Pukkila-Worley R, 2012, CURR OPIN IMMUNOL, V24, P3, DOI 10.1016/j.coi.2011.10.004; Rajamuthiah R, 2014, VIRULENCE, V5, P697, DOI 10.4161/viru.29091; Robbins GR, 2014, MOL CELL, V54, P297, DOI 10.1016/j.molcel.2014.03.029; Van Crombruggen K, 2013, CELL MOL LIFE SCI, V70, P4307, DOI 10.1007/s00018-013-1356-7; Xu SH, 2011, CURR BIOL, V21, P1960, DOI 10.1016/j.cub.2011.10.050; Ziegler K, 2009, CELL HOST MICROBE, V5, P341, DOI 10.1016/j.chom.2009.03.006; Zipfel C, 2014, TRENDS IMMUNOL, V35, P345, DOI 10.1016/j.it.2014.05.004; Zugasti O, 2014, NAT IMMUNOL, V15, P833, DOI 10.1038/ni.2957	13	2	4	3	18	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					826	828		10.1038/ni.2963	http://dx.doi.org/10.1038/ni.2963			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25137464				2022-12-18	WOS:000340739400007
J	Mookerjee-Basu, J; Kappes, DJ				Mookerjee-Basu, Jayati; Kappes, Dietmar J.			New ingredients for brewing CD4(+) T (cells): TCF-1 and LEF-1	NATURE IMMUNOLOGY			English	Editorial Material							THYMOCYTE DIFFERENTIATION; TRANSCRIPTION FACTORS; LINEAGE COMMITMENT; POSITIVE SELECTION; REPRESSION; POK	The transcription factors TCF-1 and LEF-1 have diverse roles in differentiation into the CD4(+) lineage through means both dependent on and independent of the transcription factor Th-POK.	[Mookerjee-Basu, Jayati; Kappes, Dietmar J.] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Mookerjee-Basu, J (corresponding author), Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	dj_kappes@fccc.edu						Egawa T, 2007, J EXP MED, V204, P1945, DOI 10.1084/jem.20070133; He X, 2005, NATURE, V433, P826, DOI 10.1038/nature03338; He X, 2008, IMMUNITY, V28, P346, DOI 10.1016/j.immuni.2008.02.006; Sarafova SD, 2005, IMMUNITY, V23, P75, DOI 10.1016/j.immuni.2005.05.011; Setoguchi R, 2008, SCIENCE, V319, P822, DOI 10.1126/science.1151844; Steinke FC, 2014, NAT IMMUNOL, V15, P646, DOI 10.1038/ni.2897; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Taniuchi I, 2002, CELL, V111, P621, DOI 10.1016/S0092-8674(02)01111-X; VERBEEK S, 1995, NATURE, V374, P70, DOI 10.1038/374070a0; Yu SY, 2012, IMMUNITY, V37, P813, DOI 10.1016/j.immuni.2012.08.009	10	2	3	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					593	594		10.1038/ni.2927	http://dx.doi.org/10.1038/ni.2927			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24940944				2022-12-18	WOS:000337715600002
J	Yu, D; Chen, YP; Leong, YA				Yu, Di; Chen, Yaping; Leong, Yew Ann			Navigating double negatives: new pathways for regulating T-FH differentiation	NATURE IMMUNOLOGY			English	Editorial Material							FOXO TRANSCRIPTION FACTORS; ANTIBODY-RESPONSES; CELLS	The transcription factors Foxp1 and Foxo1 inhibit the differentiation of follicular helper T cells. On the other hand, the E3 ligase Itch targets Foxo1 for degradation to promote such differentiation.	[Yu, Di; Chen, Yaping; Leong, Yew Ann] Monash Univ, Sch Biomed Sci, Lab Mol Immunomodulat, Clayton, Vic, Australia	Monash University	Yu, D (corresponding author), Monash Univ, Sch Biomed Sci, Lab Mol Immunomodulat, Clayton, Vic, Australia.	di.yu@monash.edu	Yu, Di/C-2163-2009	Yu, Di/0000-0003-1721-8922; Leong, Yew Ann/0000-0002-0999-7084				Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Fang DY, 2002, NAT IMMUNOL, V3, P281, DOI 10.1038/ni763; Feng XM, 2011, NAT IMMUNOL, V12, P544, DOI 10.1038/ni.2034; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Hedrick SM, 2012, NAT REV IMMUNOL, V12, P649, DOI 10.1038/nri3278; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Wang HK, 2014, NAT IMMUNOL, V15, P667, DOI 10.1038/ni.2890; Xiao NM, 2014, NAT IMMUNOL, V15, P657, DOI 10.1038/ni.2912; Yu D, 2010, TRENDS IMMUNOL, V31, P377, DOI 10.1016/j.it.2010.07.001	11	2	2	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2014	15	7					597	599		10.1038/ni.2922	http://dx.doi.org/10.1038/ni.2922			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AJ5IJ	24940946	Bronze			2022-12-18	WOS:000337715600004
J	Gray, DHD; Liston, A				Gray, Daniel H. D.; Liston, Adrian			Uhrf to T-reg cells: reinforcing the mucosal peacekeepers	NATURE IMMUNOLOGY			English	Editorial Material							METABOLITES; INDUCTION	The colonization of the colon with commensal microflora drives the induction and population expansion of regulatory T cells, an immunological adaption needed to prevent mucosal inflammation. The epigenetic modifier Uhrf1 acts as a key molecular mediator of such expansion and the establishment of a harmonious mucosal environment.	[Gray, Daniel H. D.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia; [Gray, Daniel H. D.] Univ Melbourne, Dept Med Biol, Melbourne, Vic, Australia; [Liston, Adrian] VIB, Autoimmune Genet Lab, Louvain, Belgium; [Liston, Adrian] Univ Louvain, Dept Microbiol & Immunol, Louvain, Belgium	Walter & Eliza Hall Institute; University of Melbourne; Flanders Institute for Biotechnology (VIB)	Gray, DHD (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3050, Australia.	dgray@wehi.edu.au; adrian.liston@vib.be	Gray, Daniel HD/A-3293-2013; Liston, Adrian/G-8606-2013	Gray, Daniel HD/0000-0002-8457-8242; Liston, Adrian/0000-0002-6272-4085				Amado IF, 2013, J EXP MED, V210, P2707, DOI 10.1084/jem.20122759; Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Atarashi K, 2013, NATURE, V500, P232, DOI 10.1038/nature12331; Cording S, 2014, MUCOSAL IMMUNOL, V7, P359, DOI 10.1038/mi.2013.54; Cording S, 2013, EUR J MICROBIOL IMMU, V3, P1, DOI 10.1556/EuJMI.3.2013.1.1; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Lathrop SK, 2011, NATURE, V478, P250, DOI 10.1038/nature10434; Obata Y, 2014, NAT IMMUNOL, V15, P571, DOI 10.1038/ni.2886; Pierson W, 2013, NAT IMMUNOL, V14, P959, DOI 10.1038/ni.2649; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165	11	2	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					533	534		10.1038/ni.2893	http://dx.doi.org/10.1038/ni.2893			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24840991				2022-12-18	WOS:000336419300008
J	Martin, CE; Surh, CD				Martin, Christopher E.; Surh, Charles D.			Self-gratification yields not-so-naive T cells	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNOLOGICAL SYNAPSE; SENSITIVITY; RECOGNITION; ACTIVATION; AVIDITY; PEPTIDE; MHC		[Martin, Christopher E.; Surh, Charles D.] La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA; [Martin, Christopher E.] Scripps Res Inst, Kellogg Sch Sci & Technol, Doctoral Program Chem & Biol Sci, La Jolla, CA 92037 USA; [Surh, Charles D.] Acad Immunol & Microbiol, Inst Basic Sci, Pohang, South Korea; [Surh, Charles D.] Pohang Univ Sci & Technol, Dept Integrat Biosci & Biotechnol, Pohang, South Korea	La Jolla Institute for Immunology; Scripps Research Institute; Institute for Basic Science - Korea (IBS); Pohang University of Science & Technology (POSTECH)	Martin, CE (corresponding author), La Jolla Inst Allergy & Immunol, Div Dev Immunol, La Jolla, CA 92037 USA.	csurh@ibs.re.kr						Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Gascoigne NRJ, 2010, CURR TOP MICROBIOL, V340, P171, DOI 10.1007/978-3-642-03858-7_9; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2007, SEMIN IMMUNOL, V19, P236, DOI 10.1016/j.smim.2007.04.003; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109; Yachi PP, 2005, NAT IMMUNOL, V6, P785, DOI 10.1038/ni1220	9	2	2	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					217	219		10.1038/ni.2832	http://dx.doi.org/10.1038/ni.2832			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY	24549065				2022-12-18	WOS:000331683100005
J	Haining, WN				Haining, W. Nicholas			Strength in numbers: comparing vaccine signatures the modular way	NATURE IMMUNOLOGY			English	News Item							YELLOW-FEVER VACCINE; SYSTEMS BIOLOGY; RESPONSES; HUMANS	Gene-expression signatures of the human vaccine response can be complex and noisy. Li et al. develop a new collection of gene-expression modules and use it to compare the response to five different vaccines.	[Haining, W. Nicholas] Dana Farber Canc Inst, Boston, MA 02115 USA; [Haining, W. Nicholas] Harvard Univ, Sch Med, Boston, MA USA; [Haining, W. Nicholas] Broad Inst MIT & Harvard, Cambridge, MA USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Haining, WN (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.	nicholas_haining@dfci.harvard.edu						Amit I, 2009, SCIENCE, V326, P257, DOI 10.1126/science.1179050; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; Haining WN, 2010, IMMUNITY, V32, P152, DOI 10.1016/j.immuni.2010.02.001; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ravindran R., 2013, SCIENCE         1205, DOI [10.1126/science.1246829, DOI 10.1126/SCIENCE.1246829]; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Shen-Orr SS, 2010, NAT METHODS, V7, P287, DOI [10.1038/NMETH.1439, 10.1038/nmeth.1439]; Tan Y, 2014, EUR J IMMUNOL, V44, P285, DOI 10.1002/eji.201343657; Wagner GP, 2007, NAT REV GENET, V8, P921, DOI 10.1038/nrg2267	14	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					139	141		10.1038/ni.2807	http://dx.doi.org/10.1038/ni.2807			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV	24448573	Bronze			2022-12-18	WOS:000330150600007
J	Delker, RK; Papavasiliou, FN				Delker, Rebecca K.; Papavasiliou, F. Nina			You break it, you fix it: functions for AID downstream of deamination	NATURE IMMUNOLOGY			English	Editorial Material							CLASS-SWITCH RECOMBINATION; DNA-END RESECTION; PROTEIN-KINASE-A; SOMATIC HYPERMUTATION; PHOSPHORYLATION; DIVERSIFICATION	In a phosphorylation-dependent positive feedback loop, the cytidine deaminase AID amplifies the generation of double-strand DNA breaks, which shows it can also function downstream of deamination.	[Delker, Rebecca K.; Papavasiliou, F. Nina] Rockefeller Univ, Lab Lymphocyte Biol, New York, NY 10021 USA; [Delker, Rebecca K.] Rockefeller Univ, Rockefeller Grad Program, New York, NY 10021 USA	Rockefeller University; Rockefeller University	Delker, RK (corresponding author), Rockefeller Univ, Lab Lymphocyte Biol, 1230 York Ave, New York, NY 10021 USA.	papavasiliou@rockefeller.edu			NCI NIH HHS [R01 CA098495] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA098495] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Basu U, 2005, NATURE, V438, P508, DOI 10.1038/nature04255; Basu U, 2009, BIOCHEM SOC T, V37, P561, DOI 10.1042/BST0370561; Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chen H, 2013, MOL CELL, V50, P589, DOI 10.1016/j.molcel.2013.04.032; Cheng HL, 2009, P NATL ACAD SCI USA, V106, P2717, DOI 10.1073/pnas.0812304106; Flajnik MF, 2010, NAT REV GENET, V11, P47, DOI 10.1038/nrg2703; Keim C, 2013, GENE DEV, V27, P1, DOI 10.1101/gad.200014.112; Litman GW, 2005, ADV IMMUNOL, V87, P209, DOI 10.1016/S0065-2776(05)87006-3; Mimitou EP, 2011, DNA REPAIR, V10, P344, DOI 10.1016/j.dnarep.2010.12.004; Stavnezer J, 2006, TRENDS GENET, V22, P23, DOI 10.1016/j.tig.2005.11.002; Vuong BQ, 2013, NAT IMMUNOL, V14, P1183, DOI 10.1038/ni.2732; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Xu ZM, 2012, NAT REV IMMUNOL, V12, P517, DOI 10.1038/nri3216; Yamane A, 2013, CELL REP, V3, P138, DOI 10.1016/j.celrep.2012.12.006	14	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1112	1114						3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24145783				2022-12-18	WOS:000326023400006
J	Gothert, JR				Goethert, Joachim R.			Bypassing T cell 'exhaustion'	NATURE IMMUNOLOGY			English	Editorial Material							CHRONIC VIRAL-INFECTION; DIFFERENTIATION; HYPOXIA	The hypoxia-inducible factor (HIF) pathway controls diverse aspects of the immunological response. Enhanced HIF activity is able to extend and potentiate the effector response of CD8(+) T cells against chronic infections and tumor growth.	Univ Hosp Essen, West German Canc Ctr, Dept Hematol, Essen, Germany	University of Duisburg Essen	Gothert, JR (corresponding author), Univ Hosp Essen, West German Canc Ctr, Dept Hematol, Essen, Germany.	joachim.goethert@uni-duisburg-essen.de		Gothert, Joachim/0000-0001-8957-6732				Baitsch L, 2011, J CLIN INVEST, V121, P2350, DOI 10.1172/JCI46102; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Doedens AL, 2013, NAT IMMUNOL, V14, P1173, DOI 10.1038/ni.2714; Gothert J.R., 2013, CANC IMMUNOL IMMUNOT; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Li MQ, 2011, J CELL MOL MED, V15, P187, DOI 10.1111/j.1582-4934.2010.01238.x; McNamee EN, 2013, IMMUNOL RES, V55, P58, DOI 10.1007/s12026-012-8349-8; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Wherry EJ, 2011, NAT IMMUNOL, V12, P492, DOI 10.1038/ni.2035; Zhou Q, 2011, BLOOD, V117, P4501, DOI 10.1182/blood-2010-10-310425; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	15	2	2	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2013	14	11					1114	1116						4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	239KV	24145784				2022-12-18	WOS:000326023400007
J	Aksoy, E; Taboubi, S; Torres, D; Delbauve, S; Hachani, A; Whitehead, MA; Pearce, WP; Berenjeno-Martin, I; Nock, G; Filloux, A; Beyaert, R; Flamand, V; Vanhaesebroeck, B				Aksoy, Ezra; Taboubi, Salma; Torres, David; Delbauve, Sandrine; Hachani, Abderrahman; Whitehead, Maria A.; Pearce, Wayne P.; Berenjeno-Martin, Inma; Nock, Gemma; Filloux, Alain; Beyaert, Rudi; Flamand, Veronique; Vanhaesebroeck, Bart			The p110 delta isoform of the kinase PI(3)K controls the subcellular compartmentalization of TLR4 signaling and protects from endotoxic shock (vol 13, pg 1045, 2012)	NATURE IMMUNOLOGY			English	Correction													Hachani, Abderrahman/AAV-3320-2020; Beyaert, Rudi/B-2589-2009; Hachani, Abderrahman/H-1801-2013	Hachani, Abderrahman/0000-0001-8032-2154; Beyaert, Rudi/0000-0002-5704-582X; Aksoy, Ezra/0000-0002-6962-1572; Flamand, Veronique/0000-0002-8906-3758	MRC [MR/J006874/1] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Aksoy E, 2012, NAT IMMUNOL, V13, P1045, DOI 10.1038/ni.2426	1	2	2	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					877	877		10.1038/ni0813-877d	http://dx.doi.org/10.1038/ni0813-877d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN		Bronze			2022-12-18	WOS:000322010600025
J	Crispe, IN; Pierce, RH				Crispe, Ian N.; Pierce, Robert H.			Killer T cells find meaningful encounters through iMATEs	NATURE IMMUNOLOGY			English	Editorial Material							SINUSOIDAL-ENDOTHELIAL-CELLS; IN-VIVO; LIVER; LYMPHOCYTES		[Crispe, Ian N.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Pierce, Robert H.] Merck Res Labs, Dept Pathol, Palo Alto, CA USA	University of Washington; University of Washington Seattle; Merck & Company	Crispe, IN (corresponding author), Univ Washington, Dept Pathol, Seattle, WA 98195 USA.	crispen@uw.edu		Pierce, MD, Robert Hamilton/0000-0002-2677-144X				Bertolino P, 1998, EUR J IMMUNOL, V28, P221, DOI 10.1002/(SICI)1521-4141(199801)28:01<221::AID-IMMU221>3.3.CO;2-6; Eberl G, 2005, NAT REV IMMUNOL, V5, P413, DOI 10.1038/nri1600; Huang LR, 2013, NAT IMMUNOL, V14, P574, DOI 10.1038/ni.2573; Ilvanov II, 2006, CURR TOP MICROBIOL, V308, P59; Kakimi K, 2001, J EXP MED, V194, P1755, DOI 10.1084/jem.194.12.1755; Klein I, 2006, J EXP MED, V203, P437, DOI 10.1084/jem.20051775; Limmer A, 2005, EUR J IMMUNOL, V35, P2970, DOI 10.1002/eji.200526034; Lohse AW, 1996, GASTROENTEROLOGY, V110, P1175, DOI 10.1053/gast.1996.v110.pm8613007; Palma E, 2007, J CONTROL RELEASE, V120, P95, DOI 10.1016/j.jconrel.2007.03.016; Polakos NK, 2006, AM J PATHOL, V168, P1169, DOI 10.2353/ajpath.2006.050875; Winau F, 2007, IMMUNITY, V26, P117, DOI 10.1016/j.immuni.2006.11.011	11	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					533	534		10.1038/ni.2620	http://dx.doi.org/10.1038/ni.2620			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23685817				2022-12-18	WOS:000319107600005
J	Seiler, MP; Mathew, R; Liszewski, MK; Spooner, CJ; Barr, K; Meng, FY; Singh, H; Bendelac, A				Seiler, Michael P.; Mathew, Rebecca; Liszewski, Megan K.; Spooner, Chauncey J.; Barr, Kenneth; Meng, Fanyong; Singh, Harinder; Bendelac, Albert			Elevated and sustained expression of the transcription factors Egr1 and Egr2 controls NKT lineage differentiation in response to TCR signaling (vol 13, pg 264, 2012)	NATURE IMMUNOLOGY			English	Correction														Barr, Kenneth/0000-0002-0769-7053				Seiler MP, 2012, NAT IMMUNOL, V13, P264, DOI 10.1038/ni.2230	1	2	2	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					413	413		10.1038/ni0413-413d	http://dx.doi.org/10.1038/ni0413-413d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG		Bronze			2022-12-18	WOS:000316648700020
J	Ceulemans, S; Kolls, JK				Ceulemans, Steven; Kolls, Jay K.			Can the SBIR and STIR programs advance research goals?	NATURE IMMUNOLOGY			English	Article								With diminishing grant support for traditional funding in immunology, can the small-business program leverage a research program? The small-business grants programs offered by the US National Institutes of Health and other organizations support high-risk, early-stage technology commercialization at small businesses.	[Ceulemans, Steven] Birmingham Business Alliance, Technol Based Econ Dev Off, Birmingham, AL 35203 USA; [Kolls, Jay K.] Univ Pittsburgh, Sch Med, Dept Pediat, Dept Immunol,Childrens Hosp Pittsburgh,Med Ctr, Pittsburgh, PA 15261 USA; [Kolls, Jay K.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Sch Med, Richard King Mellon Fdn Inst Pediat Res,Med Ctr, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Ceulemans, S (corresponding author), Birmingham Business Alliance, Technol Based Econ Dev Off, Birmingham, AL 35203 USA.	jay.kolls@chp.edu	Kolls, Jay/AAH-1829-2019	Kolls, Jay/0000-0001-5151-6304				[Anonymous], 2012, FED REG, V77; Audretsch DB, 2011, HANDBOOK OF RESEARCH ON INNOVATION AND ENTREPRENEURSHIP, P1; Block F., 2008, DO INNOVATIONS COME; Gaebler Ventures, 2012, INV CO FOUND QUALC S; Gansler JS, 2009, VENTURE FUNDING AND THE NIH SBIR PROGRAM, P1; Milman G., 2012, SECRETS NIH SMALL BU; The United States Government, 2012, AW; The United States Government, 2012, FREQ ASK QUEST; The United States Government, 2012, APPL; The United States Government, 2011, QUALC IND SBIR HALL; US Department of Health and Human Services, 2012, SMALL BUS INN RES SB; Wessner C.W., 2008, ASSESSMENT SBIR PROG, P1	12	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					192	195		10.1038/ni.2495	http://dx.doi.org/10.1038/ni.2495			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23416667				2022-12-18	WOS:000315065400004
J	Ubeda, C; Pamer, EG				Ubeda, Caries; Pamer, Eric G.			Securing the border: lymphotoxin, IL-23 and IL-22 keep out the bad guys and 'fatten' the homeland	NATURE IMMUNOLOGY			English	Editorial Material							INNATE; MICROBIOTA; IMMUNITY; OBESITY; PATHWAY; MICE	The axis of lymphotoxin and its receptor LT beta R influences the composition of the host gut microbiome, leading to excessive weight gain in hosts fed a high-fat diet.	[Ubeda, Caries] Ctr Super Invest Salud Publ, Valencia, Spain; [Pamer, Eric G.] Mem Sloan Kettering Canc Ctr, New York, NY USA	Memorial Sloan Kettering Cancer Center	Ubeda, C (corresponding author), Ctr Super Invest Salud Publ, Valencia, Spain.	pamere@mskcc.org	Ubeda, Carles/L-6815-2014	Ubeda, Carles/0000-0003-0560-4658				Cash HL, 2006, SCIENCE, V313, P1126, DOI 10.1126/science.1127119; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Kiss EA, 2011, SCIENCE, V334, P1561, DOI 10.1126/science.1214914; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Mahajan A, 2010, J MOL MED, V88, P515, DOI 10.1007/s00109-010-0594-5; Ota N, 2011, NAT IMMUNOL, V12, P941, DOI 10.1038/ni.2089; Tumanov AV, 2011, CELL HOST MICROBE, V10, P44, DOI 10.1016/j.chom.2011.06.002; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Ubeda C, 2012, J EXP MED, V209, P1445, DOI 10.1084/jem.20120504; Upadhyay V, 2012, NAT IMMUNOL, V13, P947, DOI 10.1038/ni.2403; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Zheng Y, 2008, NAT MED, V14, P282, DOI 10.1038/nm1720	14	2	2	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					940	941		10.1038/ni.2425	http://dx.doi.org/10.1038/ni.2425			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22990898				2022-12-18	WOS:000309038600007
J	Malissen, B				Malissen, Bernard			A voltage-gated sodium channel mediates positive selection of T cells	NATURE IMMUNOLOGY			English	Editorial Material								The activation of T cells requires the entry of calcium ions through the plasma membrane. A study now identifies a voltage-gated sodium channel as being essential for the sustained entry of calcium needed for the developmental process of positive selection.	Aix Marseille Univ, Ctr Immunol Marseille Luminy, CNRS, INSERM,U1104,UMR 7280, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Malissen, B (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, CNRS, INSERM,U1104,UMR 7280, Marseille, France.	bernardm@ciml.univ-mrs.fr	Malissen, Bernard/AAK-4659-2020	Malissen, Bernard/0000-0003-1340-9342				Catterall WA, 2010, NEUROSCI LETT, V486, P107, DOI 10.1016/j.neulet.2010.08.085; Daniels MA, 2006, NATURE, V444, P724, DOI 10.1038/nature05269; Davey GM, 1998, J EXP MED, V188, P1867, DOI 10.1084/jem.188.10.1867; Ebert PJR, 2009, NAT IMMUNOL, V10, P1162, DOI 10.1038/ni.1797; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Lo WL, 2012, NAT IMMUNOL, V13, P880, DOI 10.1038/ni.2379; Lo WL, 2009, NAT IMMUNOL, V10, P1155, DOI 10.1038/ni.1796; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; Moran AE, 2012, IMMUNOLOGY, V135, P261, DOI 10.1111/j.1365-2567.2011.03547.x; Niemeyer BA, 2011, IMMUNITY, V35, P315, DOI 10.1016/j.immuni.2011.09.001; Omilusik K, 2011, IMMUNITY, V35, P349, DOI 10.1016/j.immuni.2011.07.011; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0	12	2	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					810	812		10.1038/ni.2400	http://dx.doi.org/10.1038/ni.2400			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK	22910385				2022-12-18	WOS:000307863600006
J	Yamane, A; Resch, W; Nussezweig, M; Casellas, R				Yamane, Arito; Resch, Wolfgang; Nussezweig, Michel; Casellas, Rafael			Reassessing genomic targeting of AID Response	NATURE IMMUNOLOGY			English	Letter							CLASS-SWITCH RECOMBINATION; RNA-POLYMERASE-II; RECURRENT CHROMOSOMAL TRANSLOCATIONS; INDUCED CYTIDINE DEAMINASE; B-LYMPHOCYTES; SOMATIC HYPERMUTATION; SEQUENCING REVEALS; IG GENES; DNA; REGION		[Yamane, Arito; Resch, Wolfgang; Casellas, Rafael] NIAMSD, US NIH, Bethesda, MD 20892 USA; [Nussezweig, Michel] Rockefeller Univ, Lab Mol Immunol, New York, NY 10021 USA; [Nussezweig, Michel] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA; [Casellas, Rafael] NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); Rockefeller University; Howard Hughes Medical Institute; Rockefeller University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Yamane, A (corresponding author), NIAMSD, US NIH, Bethesda, MD 20892 USA.	casellar@mail.nih.gov	Yamane, Arito/A-2959-2013	Resch, Wolfgang/0000-0001-7594-5963				Chaudhuri J, 2004, NATURE, V430, P992, DOI 10.1038/nature02821; Chiarle R, 2011, CELL, V147, P107, DOI 10.1016/j.cell.2011.07.049; Dayal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024571; Hakim O, 2012, NATURE, V484, P69, DOI 10.1038/nature10909; Jeevan-Raj BP, 2011, J EXP MED, V208, P1649, DOI 10.1084/jem.20110118; Klein IA, 2011, CELL, V147, P95, DOI 10.1016/j.cell.2011.07.048; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Maeda K, 2010, J BIOL CHEM, V285, P23945, DOI 10.1074/jbc.M110.131441; Nambu Y, 2003, SCIENCE, V302, P2137, DOI 10.1126/science.1092481; Pavri R, 2010, CELL, V143, P122, DOI 10.1016/j.cell.2010.09.017; Rada C, 2002, P NATL ACAD SCI USA, V99, P7003, DOI 10.1073/pnas.092160999; Rai K, 2010, CELL, V142, P930, DOI 10.1016/j.cell.2010.08.030; Rajagopal D, 2009, J EXP MED, V206, P1237, DOI 10.1084/jem.20082514; Ranjit S, 2011, J IMMUNOL, V187, P2464, DOI 10.4049/jimmunol.1101406; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wang LL, 2009, J EXP MED, V206, P1817, DOI 10.1084/jem.20081678; Yamane A, 2011, NAT IMMUNOL, V12, P62, DOI 10.1038/ni.1964; Zan H, 2011, MOL IMMUNOL, V48, P610, DOI 10.1016/j.molimm.2010.10.023; Zhang Y, 2012, CELL, V148, P908, DOI 10.1016/j.cell.2012.02.002	22	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2012	13	9					798	800		10.1038/ni.2368	http://dx.doi.org/10.1038/ni.2368			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	993MK					2022-12-18	WOS:000307863600002
J	Di, AK; Gao, XP; Qian, F; Kawamura, T; Han, J; Hecquet, C; Ye, RD; Vogel, SM; Malik, AB				Di, Anke; Gao, Xiao-Pei; Qian, Feng; Kawamura, Takeshi; Han, Jin; Hecquet, Claudie; Ye, Richard D.; Vogel, Stephen M.; Malik, Asrar B.			The redox-sensitive cation channel TRPM2 modulates phagocyte ROS production and inflammation (vol 13, pg 29, 2012)	NATURE IMMUNOLOGY			English	Correction													Ye, Richard/O-5223-2016; Ye, Richard/ABF-2413-2020	Ye, Richard/0000-0002-2164-5620; Ye, Richard/0000-0002-2164-5620; Malik, Asrar/0000-0002-8205-7128				Di AK, 2012, NAT IMMUNOL, V13, P29, DOI 10.1038/ni.2171	1	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					621	621		10.1038/ni0612-621e	http://dx.doi.org/10.1038/ni0612-621e			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO		Bronze			2022-12-18	WOS:000304203900021
J	Stritesky, GL; Hogquist, KA				Stritesky, Gretta L.; Hogquist, Kristin A.			Death diverted, but to what?	NATURE IMMUNOLOGY			English	Editorial Material							INTESTINAL INTRAEPITHELIAL LYMPHOCYTES; NEGATIVE SELECTION; NATURAL-KILLER; T-CELLS; THYMOCYTES; PRECURSORS; THYMUS; MICE; CD8		[Stritesky, Gretta L.; Hogquist, Kristin A.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Stritesky, Gretta L.; Hogquist, Kristin A.] Univ Minnesota, Ctr Immunol, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Stritesky, GL (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.	hogqu001@umn.edu		Hogquist, Kristin/0000-0001-9963-5687				Casey KA, 2012, J IMMUNOL, V188, P4866, DOI 10.4049/jimmunol.1200402; Gangadharan D, 2006, IMMUNITY, V25, P631, DOI 10.1016/j.immuni.2006.08.018; Hayday A, 2008, MUCOSAL IMMUNOL, V1, P172, DOI 10.1038/mi.2008.8; Jiang W, 2010, BLOOD, V115, P4431, DOI 10.1182/blood-2009-11-254698; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Olivares-Villagomez D, 2010, IMMUNOL LETT, V134, P1, DOI 10.1016/j.imlet.2010.09.004; Pobezinsky LA, 2012, NAT IMMUNOL, V13, P569, DOI 10.1038/ni.2292; ROCHA B, 1991, J EXP MED, V173, P483, DOI 10.1084/jem.173.2.483; Sato T, 2005, IMMUNITY, V22, P317, DOI 10.1016/j.immuni.2005.01.012; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Walunas TL, 1996, J IMMUNOL, V156, P1006	12	2	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					528	530		10.1038/ni.2311	http://dx.doi.org/10.1038/ni.2311			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22610242				2022-12-18	WOS:000304203900005
J	Brutkiewicz, RR; Dent, AL				Brutkiewicz, Randy R.; Dent, Alexander L.			Lipids-(sic)-Us: peroxisome generation of iNKT ligands	NATURE IMMUNOLOGY			English	Editorial Material							KILLER T-CELLS; NKT CELLS; ISOGLOBOTRIHEXOSYLCERAMIDE; DEFICIENCY; SELECTION	The identification of the natural lipids that select invariant natural killer T cells (iNKT cells) in vivo has been somewhat elusive and controversial. A new study shows that ether-bonded phospholipids, generated mainly in peroxisomes, are responsible for the development of a major subpopulation of iNKT cells.	[Brutkiewicz, Randy R.; Dent, Alexander L.] Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington	Brutkiewicz, RR (corresponding author), Indiana Univ Sch Med, Dept Microbiol & Immunol, Indianapolis, IN USA.	rbrutkie@iupui.edu		Brutkiewicz, Randy/0000-0002-7396-480X				Albu DI, 2011, P NATL ACAD SCI USA, V108, P6211, DOI 10.1073/pnas.1014304108; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Brennan PJ, 2011, NAT IMMUNOL, V12, P1202, DOI 10.1038/ni.2143; Brutkiewicz RR, 2006, J IMMUNOL, V177, P769, DOI 10.4049/jimmunol.177.2.769; Facciotti F, 2012, NAT IMMUNOL, V13, P474, DOI 10.1038/ni.2245; Gadola SD, 2006, J EXP MED, V203, P2293, DOI 10.1084/jem.20060921; Pei B, 2011, J IMMUNOL, V186, P1348, DOI 10.4049/jimmunol.1001008; Porubsky S, 2007, P NATL ACAD SCI USA, V104, P5977, DOI 10.1073/pnas.0611139104; Speak AO, 2007, P NATL ACAD SCI USA, V104, P5971, DOI 10.1073/pnas.0607285104; WANDERS RJA, 1992, J INHERIT METAB DIS, V15, P389, DOI 10.1007/BF02435984; Wanders RJA, 2006, BBA-MOL CELL RES, V1763, P1707, DOI 10.1016/j.bbamcr.2006.08.010; Zhou DP, 2004, SCIENCE, V306, P1786, DOI 10.1126/science.1103440	12	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					435	436		10.1038/ni.2288	http://dx.doi.org/10.1038/ni.2288			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22513327				2022-12-18	WOS:000303048400006
J	Chervonsky, AV				Chervonsky, Alexander V.			Solving the plot: early events are the key to diabetes intervention	NATURE IMMUNOLOGY			English	Editorial Material							NOD MICE; CELL	Type 1 diabetes is usually diagnosed after most insulin-producing islets of Langerhans have already been destroyed. However, magnetic resonance imaging can be used to predict the onset of type 1 diabetes, and a benign prognosis correlates with the presence of anti-inflammatory tissue-resident macrophages.	Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago	Chervonsky, AV (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.	achervon@bsd.uchicago.edu		Chervonsky, Alexander/0000-0001-7547-871X				DiLorenzo TP, 2011, DIABETES-METAB RES, V27, P778, DOI 10.1002/dmrr.1251; Enee E, 2008, J IMMUNOL, V180, P5430, DOI 10.4049/jimmunol.180.8.5430; Fierabracci A, 2011, DIABETES-METAB RES, V27, P216, DOI 10.1002/dmrr.1165; Fu WX, 2012, NAT IMMUNOL, V13, P361, DOI 10.1038/ni.2233; Gaglia JL, 2011, J CLIN INVEST, V121, P442, DOI 10.1172/JCI44339; JANSEN A, 1994, DIABETES, V43, P667, DOI 10.2337/diabetes.43.5.667; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Miyanishi M, 2007, NATURE, V450, P435, DOI 10.1038/nature06307; Serreze DV, 2011, DIABETES, V60, P2914, DOI 10.2337/db11-0705; Turvey SE, 2005, J CLIN INVEST, V115, P2454, DOI 10.1172/JCI25048; Vogt L, 2006, J CLIN INVEST, V116, P2817, DOI 10.1172/JCI25673; Winter WE, 2011, CLIN CHEM, V57, P168, DOI 10.1373/clinchem.2010.148205	12	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					311	312						2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22430775				2022-12-18	WOS:000301886800002
J	Coppieters, KT; von Herrath, MG				Coppieters, Ken T.; von Herrath, Matthias G.			Motifs for a deadly encounter	NATURE IMMUNOLOGY			English	Editorial Material							SELF-PEPTIDE; AUTOIMMUNITY; CELLS	It is unknown how T cell antigen receptors from autoreactive CD8(+) T cells recognize self. A new paper shows that an unorthodox, low-affinity way of interacting with targets may be at the basis of autoimmunity.	[Coppieters, Ken T.] Ghent Univ Hosp, Unit Mol Immunol & Inflammat, Dept Rheumatol, Ghent, Belgium; [von Herrath, Matthias G.] La Jolla Inst Allergy & Immunol, Type Diabet Ctr 1, La Jolla, CA USA	Ghent University; Ghent University Hospital; La Jolla Institute for Immunology	Coppieters, KT (corresponding author), Ghent Univ Hosp, Unit Mol Immunol & Inflammat, Dept Rheumatol, Ghent, Belgium.	matthias@liai.org			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI092453] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI092453] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bulek M., 2011, NAT IMMUNOL, V13, P237; Coppieters KT, 2012, J EXP MED, V209, P51, DOI 10.1084/jem.20111187; Ding YH, 1999, IMMUNITY, V11, P45, DOI 10.1016/S1074-7613(00)80080-1; Hahn M, 2005, NAT IMMUNOL, V6, P490, DOI 10.1038/ni1187; Han BY, 2005, NAT MED, V11, P645, DOI 10.1038/nm1250; Li YL, 2005, EMBO J, V24, P2968, DOI 10.1038/sj.emboj.7600771; Mohan JF, 2010, NAT IMMUNOL, V11, P350, DOI 10.1038/ni.1850; Sethi DK, 2011, J EXP MED, V208, P91, DOI 10.1084/jem.20100725; Skowera A, 2008, J CLIN INVEST, V118, P3390, DOI 10.1172/JCI35449; von Herrath MG, 2003, NAT REV MICROBIOL, V1, P151, DOI 10.1038/nrmicro754; VONHERRATH MG, 1994, IMMUNITY, V1, P231, DOI 10.1016/1074-7613(94)90101-5; Wooldridge L., 2012, J BIOL CHEM, V11, P68	12	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2012	13	3					205	206		10.1038/ni.2226	http://dx.doi.org/10.1038/ni.2226			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	895QF	22344274	Green Accepted			2022-12-18	WOS:000300510600003
J	Zhang, ZQ; Yuan, B; Bao, MS; Lu, N; Kim, T; Liu, YJ				Zhang, Zhiqiang; Yuan, Bin; Bao, Musheng; Lu, Ning; Kim, Taeil; Liu, Yong-Jun			The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells (vol 12, pg 959, 2011)	NATURE IMMUNOLOGY			English	Correction																		Zhang ZQ, 2011, NAT IMMUNOL, V12, P959, DOI 10.1038/ni.2091	1	2	2	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					196	196		10.1038/ni0212-196b	http://dx.doi.org/10.1038/ni0212-196b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL		Bronze			2022-12-18	WOS:000299315000018
J	Rangel-Moreno, J; Carragher, DM; Garcia-Hernandez, MD; Hwang, JY; Kusser, K; Hartson, L; Kolls, JK; Khader, SA; Randall, TD				Rangel-Moreno, Javier; Carragher, Damian M.; Garcia-Hernandez, Maria de la Luz; Hwang, Ji Young; Kusser, Kim; Hartson, Louise; Kolls, Jay K.; Khader, Shabaana A.; Randall, Troy D.			Induction of BALT in the absence of IL-17 reply	NATURE IMMUNOLOGY			English	Letter							LYMPHOID-TISSUE IBALT		[Rangel-Moreno, Javier; Garcia-Hernandez, Maria de la Luz; Hwang, Ji Young; Kusser, Kim; Hartson, Louise; Randall, Troy D.] Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Carragher, Damian M.] Trudeau Inst Inc, Saranac Lake, NY 12983 USA; [Kolls, Jay K.] Louisiana State Univ, Hlth Sci Ctr, Dept Genet, New Orleans, LA USA; [Khader, Shabaana A.] Univ Pittsburgh, Sch Med, Dept Pediat, Div Infect Dis, Pittsburgh, PA 15261 USA	University of Rochester; Trudeau Institute; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Rangel-Moreno, J (corresponding author), Univ Rochester, Med Ctr, Dept Med, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA.	troy_randall@urmc.rochester.edu	Carragher, Damian/O-4183-2019; Carragher, Damian/E-6673-2016; Kolls, Jay/AAH-1829-2019	Carragher, Damian/0000-0003-4341-4943; Carragher, Damian/0000-0003-4341-4943; Kolls, Jay/0000-0001-5151-6304; Rangel-Moreno, Javier/0000-0002-9738-1182				Cucak H, 2009, IMMUNITY, V31, P491, DOI 10.1016/j.immuni.2009.07.005; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Khader SA, 2009, J IMMUNOL, V183, P8004, DOI 10.4049/jimmunol.0901937; Kobayashi M, 2004, P NATL ACAD SCI USA, V101, P17807, DOI 10.1073/pnas.0407503101; Kocks JR, 2007, J EXP MED, V204, P723, DOI 10.1084/jem.20061424; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Rangel-Moreno J, 2006, J CLIN INVEST, V116, P3183, DOI 10.1172/JCI28756; Rangel-Moreno J, 2011, NAT IMMUNOL, V12, P639, DOI 10.1038/ni.2053; Tilg H, 2009, EUR CYTOKINE NETW, V20, P1, DOI 10.1684/ecn.2009.0141	11	2	2	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2012	13	1					2	2		10.1038/ni.2168	http://dx.doi.org/10.1038/ni.2168			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	866VB		Bronze			2022-12-18	WOS:000298412800002
J	Hafler, JP				Hafler, Janet P.			Effective presentations: tips for success	NATURE IMMUNOLOGY			English	Article							FACULTY-DEVELOPMENT; STRATEGIES	Presentations are given in a variety of environments, and effective strategies can be used to improve a speaker's presenting skills.	Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA	Yale University	Hafler, JP (corresponding author), Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA.	janet.hafler@yale.edu						Bing-You Robert G, 2009, J Grad Med Educ, V1, P100, DOI 10.4300/01.01.0016; BLIGH D, 2001, WHATS USE LECT, P1; DEWEY J, 1929, EXPERIENCE NATURE, P1; ENTWISTLE N, 2000, HIGHER ED RES DEV, V19, P1; IRBY DM, 1991, ACAD MED, V66, P54, DOI 10.1097/00001888-199101000-00017; Kolb D.A., 1984, EXPERIENTIAL LEARNIN, P1; MCKEACHIE W, 2001, TEACHING TIPS STRATE, P22; MEZIROW J, 1991, TRANSFORMATIVE DIMEN, P1; NILSON L, 2010, TEACHING ITS BEST, P113; SCHON D, 1983, REFLECTIVE PRACTITIO, P168; Steinert Y, 1999, MED TEACH, V21, P37; Svinicki MD, 2011, INNOV CHANG PROF EDU, V6, P131, DOI 10.1007/978-94-007-0271-4_7; Wilkerson L, 1998, ACAD MED, V73, P387, DOI 10.1097/00001888-199804000-00011; [No title captured]	14	2	2	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2011	12	11					1021	1023		10.1038/ni.2119	http://dx.doi.org/10.1038/ni.2119			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841GG	22012432				2022-12-18	WOS:000296500100003
J	Croxford, JL; Gasser, S				Croxford, J. Ludovic; Gasser, Stephan			Damage control: how HIV survives the editor APOBEC3G	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR; LIGANDS; NKG2D; VPR	The antiviral factor APOBEC3G upregulates the expression of ligands for the activating receptor NKG2D via DNA damage induced by the viral protein Vpr in cells infected with human immunodeficiency virus. The virus overcomes greater susceptibility to natural killer cell-mediated lysis by targeting APOBEC3G for degradation.	[Croxford, J. Ludovic; Gasser, Stephan] Natl Univ Singapore, Immunol Programme, Dept Microbiol, Singapore 117548, Singapore	National University of Singapore	Croxford, JL (corresponding author), Natl Univ Singapore, Immunol Programme, Dept Microbiol, Singapore 117548, Singapore.	micsg@nus.edu.sg	gasser, stephan/A-2309-2013	Gasser, Stephan/0000-0002-5616-0914				Altfeld M, 2011, NAT REV IMMUNOL, V11, P176, DOI 10.1038/nri2935; Cerboni C, 2007, J GEN VIROL, V88, P242, DOI 10.1099/vir.0.82125-0; Chiu YL, 2008, ANNU REV IMMUNOL, V26, P317, DOI 10.1146/annurev.immunol.26.021607.090350; Gasser S, 2005, NATURE, V436, P1186, DOI 10.1038/nature03884; Harris R, 2008, NAT BIOTECHNOL, V26, P1089, DOI 10.1038/nbt1008-1089; Langevin C, 2009, J VIROL, V83, P10256, DOI 10.1128/JVI.02654-08; Mulder LCF, 2008, P NATL ACAD SCI USA, V105, P5501, DOI 10.1073/pnas.0710190105; Nolting A, 2010, VIROLOGY, V406, P12, DOI 10.1016/j.virol.2010.05.014; Norman JM, 2011, NAT IMMUNOL, V12, P975, DOI 10.1038/ni.2087; Planelles V, 2010, MOL ASPECTS MED, V31, P398, DOI 10.1016/j.mam.2010.05.002; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495	11	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2011	12	10					925	927		10.1038/ni.2115	http://dx.doi.org/10.1038/ni.2115			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	822XS	21934670				2022-12-18	WOS:000295084500005
J	Puneet, P; McGrath, MA; Tay, HK; Al-Riyami, L; Rzepecka, J; Moochhala, SM; Pervaiz, S; Harnett, MM; Harnett, W; Melendez, AJ				Puneet, Padmam; McGrath, Mairi A.; Tay, Hwee Kee; Al-Riyami, Lamyaa; Rzepecka, Justyna; Moochhala, Shabbir M.; Pervaiz, Shazib; Harnett, Margaret M.; Harnett, William; Melendez, Alirio J.			The helminth product ES-62 protects against septic shock via Toll-like receptor 4-dependent autophagosomal degradation of the adaptor MyD88 (Retraction of vol 12, pg 344, 2011)	NATURE IMMUNOLOGY			English	Correction														MOOCHHALA, SHABBIR/0000-0003-4521-3192				Puneet P, 2011, NAT IMMUNOL, V12, P344, DOI 10.1038/ni.2004	1	2	5	0	22	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					804	804		10.1038/ni0811-804a	http://dx.doi.org/10.1038/ni0811-804a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT		Bronze			2022-12-18	WOS:000292870700019
J	[Anonymous]				[Anonymous]			Remembering things past	NATURE IMMUNOLOGY			English	Editorial Material								Memory is the signature property of the adaptive response, and vaccination is a hugely important medical interventionun-derstanding the former will help perfect the latter.											0	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2011	12	6					461	461						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	765LI	21587307	Bronze			2022-12-18	WOS:000290707100001
J	Maecker, HT; McCoy, JP				Maecker, Holden T.; McCoy, J. Philip, Jr.		FOCIS Human Immunophenotyping	A model for harmonizing flow cytometry in clinical trials (vol 11, pg 975, 2010)	NATURE IMMUNOLOGY			English	Correction													mccoy, john philip/ABD-9348-2021					Maecker HT, 2010, NAT IMMUNOL, V11, P975, DOI 10.1038/ni1110-975	1	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					271	271		10.1038/ni0311-271d	http://dx.doi.org/10.1038/ni0311-271d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ		Bronze, Green Accepted			2022-12-18	WOS:000287354400018
J	Brink, R				Brink, Robert			New friends for bone marrow plasma cells	NATURE IMMUNOLOGY			English	Editorial Material							MAINTENANCE; SURVIVAL; NICHES; MEMORY		St Vincents Hosp, Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia	Garvan Institute of Medical Research; St Vincents Hospital Sydney	Brink, R (corresponding author), St Vincents Hosp, Garvan Inst Med Res, Program Immunol, Darlinghurst, NSW 2010, Australia.	r.brink@garvan.org.au	Brink, Robert/B-7910-2010	Brink, Robert/0000-0002-9586-3655				Belnoue E, 2008, BLOOD, V111, P2755, DOI 10.1182/blood-2007-09-110858; DiLillo DJ, 2008, J IMMUNOL, V180, P361, DOI 10.4049/jimmunol.180.1.361; Ma Q, 1999, IMMUNITY, V10, P463, DOI 10.1016/S1074-7613(00)80046-1; Manz RA, 2005, ANNU REV IMMUNOL, V23, P367, DOI 10.1146/annurev.immunol.23.021704.115723; O'Connor BP, 2004, J EXP MED, V199, P91, DOI 10.1084/jem.20031330; Oh IH, 2010, STEM CELLS, V28, P1243, DOI 10.1002/stem.453; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Tokoyoda K, 2010, NAT REV IMMUNOL, V10, P193, DOI 10.1038/nri2727; Van TC, 2011, NAT IMMUNOL, V12, P151, DOI 10.1038/ni.1981; Winter O, 2010, BLOOD, V116, P1867, DOI 10.1182/blood-2009-12-259457	11	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2011	12	2					115	117		10.1038/ni0211-115	http://dx.doi.org/10.1038/ni0211-115			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	708QF	21245901				2022-12-18	WOS:000286378400004
J	Welinder, E; Murre, C				Welinder, Eva; Murre, Cornelis			Ldb1, a new guardian of hematopoietic stem cell maintenance	NATURE IMMUNOLOGY			English	Editorial Material							PROTEINS; BINDING; E2A		[Welinder, Eva; Murre, Cornelis] Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Welinder, E (corresponding author), Univ Calif San Diego, Dept Mol Biol, Div Biol Sci, La Jolla, CA 92093 USA.	murre@biomail.ucsd.edu						Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; LI, 2011, NAT IMMUNOL, V12, P129; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Matthews JM, 2003, EMBO REP, V4, P1132, DOI 10.1038/sj.embor.7400030; Semerad CL, 2009, P NATL ACAD SCI USA, V106, P1930, DOI 10.1073/pnas.0808866106; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Song SH, 2007, MOL CELL, V28, P810, DOI 10.1016/j.molcel.2007.09.025; Souroullas GP, 2009, CELL STEM CELL, V4, P180, DOI 10.1016/j.stem.2009.01.001; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145	11	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2011	12	2					113	114		10.1038/ni0211-113	http://dx.doi.org/10.1038/ni0211-113			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	708QF	21245899				2022-12-18	WOS:000286378400002
J	[Anonymous]				[Anonymous]			Support for peer review	NATURE IMMUNOLOGY			English	Editorial Material														Dempsey, Laurie/0000-0002-3304-796X					0	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2010	11	12					1063	1063		10.1038/ni1210-1063	http://dx.doi.org/10.1038/ni1210-1063			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	680UX	21079625	Bronze			2022-12-18	WOS:000284262200001
J	Nedjic, J; Aifantis, I				Nedjic, Jelena; Aifantis, Iannis			RNA-binding proteins come out of the shadows	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL LEUKEMIA; IMMUNE-SYSTEM; NOTCH1	Notch1 has an indispensable role in T cell development and NOTCH1 acts as a potent oncogene in T cell leukemia. New data now reveal the role of RNA-binding proteins in regulating the stability of Notch1 mRNA and the induction of T cell leukemia.	[Nedjic, Jelena; Aifantis, Iannis] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Nedjic, Jelena; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY USA	Howard Hughes Medical Institute; New York University; New York University	Nedjic, J (corresponding author), NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA.	jelena.nedjic@nyumc.org; iannis.aifantis@nyumc.org			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Al-Souhibani N, 2010, ONCOGENE, V29, P4205, DOI 10.1038/onc.2010.168; Allman D, 2001, J EXP MED, V194, P99, DOI 10.1084/jem.194.1.99; Blackshear PJ, 2002, BIOCHEM SOC T, V30, P945, DOI 10.1042/BST0300945; Hodson DJ, 2010, NAT IMMUNOL, V11, P717, DOI 10.1038/ni.1901; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; O'Connell RM, 2010, NAT REV IMMUNOL, V10, P111, DOI 10.1038/nri2708; Radtke F, 2010, IMMUNITY, V32, P14, DOI 10.1016/j.immuni.2010.01.004; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709	12	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					697	698		10.1038/ni0810-697	http://dx.doi.org/10.1038/ni0810-697			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20644579				2022-12-18	WOS:000280149400010
J	Randall, KL; Lambe, T; Johnson, AL; Treanor, B; Kucharska, E; Domaschenz, H; Whittle, B; Tze, LE; Enders, A; Crockford, TL; Bouriez-Jones, T; Alston, D; Cyster, JG; Lenardo, MJ; Mackay, F; Deenick, EK; Tangye, SG; Chan, TD; Camidge, T; Brink, R; Vinuesa, CG; Batista, FD; Cornall, RJ; Goodnow, CC				Randall, Katrina L.; Lambe, Teresa; Johnson, Andy L.; Treanor, Bebhinn; Kucharska, Edyta; Domaschenz, Heather; Whittle, Belinda; Tze, Lina E.; Enders, Anselm; Crockford, Tanya L.; Bouriez-Jones, Tiphaine; Alston, Duncan; Cyster, Jason G.; Lenardo, Michael J.; Mackay, Fabienne; Deenick, Elissa K.; Tangye, Stuart G.; Chan, Tyani D.; Camidge, Tahra; Brink, Robert; Vinuesa, Carola G.; Batista, Facundo D.; Cornall, Richard J.; Goodnow, Christopher C.			Dock8 mutations cripple B cell immunological synapses, germinal centers and long-lived antibody production (vol 10, pg 1283, 2009)	NATURE IMMUNOLOGY			English	Correction													Vinuesa, Carola G/B-1108-2010; Deenick, Elissa/AAY-8998-2020; Camidge, David Ross/AAG-9144-2019; Tangye, Stuart G/H-4023-2014; Mackay, Fabienne/B-7440-2008; Lambe, Teresa/E-5733-2016; Enders, Anselm/B-1165-2011; Randall, Katrina L/F-1883-2013	Vinuesa, Carola G/0000-0001-9799-0298; Deenick, Elissa/0000-0002-9271-0004; Tangye, Stuart G/0000-0002-5360-5180; Mackay, Fabienne/0000-0002-6074-2693; Lambe, Teresa/0000-0001-7711-897X; Enders, Anselm/0000-0001-5933-6463; Brink, Robert/0000-0002-9586-3655; Chan, Tyani/0000-0001-9276-8479				Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820	1	2	2	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					644	644		10.1038/ni0710-644a	http://dx.doi.org/10.1038/ni0710-644a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO		Bronze			2022-12-18	WOS:000278926400021
J	Rothenberg, EV				Rothenberg, Ellen V.			B cell specification from the genome up	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTION FACTORS; FOXO1; ENHANCERS; DISTINCT; GENES; EBF1		CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Rothenberg, EV (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	evroth@its.caltech.edu		Rothenberg, Ellen/0000-0002-3901-347X				Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Davidson E.H., 2006, REGULATORY GENOME GE; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Ghisletti S, 2010, IMMUNITY, V32, P317, DOI 10.1016/j.immuni.2010.02.008; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Lukin K, 2008, SEMIN IMMUNOL, V20, P221, DOI 10.1016/j.smim.2008.07.004; Lukin K, 2010, P NATL ACAD SCI USA, V107, P7869, DOI 10.1073/pnas.1003525107; Mandel EM, 2010, CURR OPIN IMMUNOL, V22, P161, DOI 10.1016/j.coi.2010.01.010; Singh H, 2005, P NATL ACAD SCI USA, V102, P4949, DOI 10.1073/pnas.0500480102; TREIBER T, 2010, IMMUNITY        0506, DOI DOI 10.1016/J.IMMUNI.2010.04.013	13	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2010	11	7					572	574		10.1038/ni0710-572	http://dx.doi.org/10.1038/ni0710-572			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	612TO	20562842				2022-12-18	WOS:000278926400012
J	Du, CS; Liu, C; Kang, JH; Zhao, GX; Ye, ZQ; Huang, SC; Li, ZX; Wu, ZY; Pei, G				Du, Changsheng; Liu, Chang; Kang, Jiuhong; Zhao, Guixian; Ye, Zhiqiang; Huang, Shichao; Li, Zhenxin; Wu, Zhiying; Pei, Gang			MicroRNA miR-326 regulates T-H-17 differentiation and is associated with the pathogenesis of multiple sclerosis (vol 10, pg 1252, 2009)	NATURE IMMUNOLOGY			English	Correction													Ye, Zhi-Qiang/N-8513-2014	Ye, Zhi-Qiang/0000-0002-8822-6148				Du CS, 2009, NAT IMMUNOL, V10, P1252, DOI 10.1038/ni.1798	1	2	3	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					543	543		10.1038/ni0610-543d	http://dx.doi.org/10.1038/ni0610-543d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV		Bronze			2022-12-18	WOS:000277821300019
J	Hewitt, SL; Yin, B; Ji, YH; Chaumeil, J; Marszalek, K; Tenthorey, J; Salvagiotto, G; Steinel, N; Ramsey, LB; Ghysdael, J; Farrar, MA; Sleckman, BP; Schatz, DG; Busslinger, M; Bassing, CH; Skok, JA				Hewitt, Susannah L.; Yin, Bu; Ji, Yanhong; Chaumeil, Julie; Marszalek, Katarzyna; Tenthorey, Jeannette; Salvagiotto, Giorgia; Steinel, Natalie; Ramsey, Laura B.; Ghysdael, Jacques; Farrar, Michael A.; Sleckman, Barry P.; Schatz, David G.; Busslinger, Meinrad; Bassing, Craig H.; Skok, Jane A.			RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci (vol 10, pg 655, 2009)	NATURE IMMUNOLOGY			English	Correction													Ramsey, Laura/ABD-6113-2020; Skok, Jane/ABF-7249-2020; Farrar, Michael A/M-7802-2013; Steinel, Natalie C/R-3682-2018; Yin, Bu/A-2327-2011; Schatz, David/A-6748-2013	Ramsey, Laura/0000-0001-6417-3961; Skok, Jane/0000-0002-4145-1516; Schatz, David/0000-0002-5669-1176; Steinel, Natalie/0000-0002-7585-8402				Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735	1	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2010	11	4					355	356		10.1038/ni0410-355	http://dx.doi.org/10.1038/ni0410-355			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	572RC		Bronze			2022-12-18	WOS:000275849500016
J	Farez, MF; Quintana, FJ; Gandhi, R; Izquierdo, G; Lucas, M; Weiner, HL				Farez, Mauricio F.; Quintana, Francisco J.; Gandhi, Roopali; Izquierdo, Guillermo; Lucas, Miguel; Weiner, Howard L.			Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE (vol 10, pg 958, 2009)	NATURE IMMUNOLOGY			English	Correction							EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS						Quintana, Francisco Javier/AAB-6915-2020					Farez MF, 2009, NAT IMMUNOL, V10, P958, DOI 10.1038/ni.1775; Scott GS, 2004, J PHARMACOL EXP THER, V310, P1053, DOI 10.1124/jpet.103.063214; Scott GS, 2001, J NEUROIMMUNOL, V117, P78, DOI 10.1016/S0165-5728(01)00329-0	3	2	2	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					97	97		10.1038/ni0110-97c	http://dx.doi.org/10.1038/ni0110-97c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE		Bronze			2022-12-18	WOS:000272855300022
J	Salek-Ardakani, S; Croft, M				Salek-Ardakani, Shahram; Croft, Michael			T cells need Nod too?	NATURE IMMUNOLOGY			English	Editorial Material							KAPPA-B; TOXOPLASMA-GONDII; C-REL; CONTRIBUTES; RESPONSES; KINASE; P50	Nucleotide-binding oligomerization domain 2 (Nod2) is required for sensing of intracellular bacteria and subsequent inflammatory responses. Unexpectedly, new evidence suggests that Nod2 influences T helper cell signaling, proliferation and differentiation and effector responses against Toxoplasma gondii.	[Salek-Ardakani, Shahram; Croft, Michael] La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA USA	La Jolla Institute for Immunology	Salek-Ardakani, S (corresponding author), La Jolla Inst Allergy & Immunol, Div Mol Immunol, San Diego, CA USA.	ssalek@liai.org; mick@liai.org			NATIONAL CANCER INSTITUTE [R01CA091837] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070535, R01AI042944, R21AI077079, R01AI067341, R01AI049453] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA091837, R01 CA091837-07] Funding Source: Medline; NIAID NIH HHS [R01 AI049453-07, R01 AI067341, R01 AI067341-04, R01 AI049453, U19 AI070535-040003, R01 AI042944, R01 AI042944-10A2, R21 AI077079, R21 AI077079-02, U19 AI070535] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Gelman AE, 2006, IMMUNITY, V25, P783, DOI 10.1016/j.immuni.2006.08.023; GHOSH P, 1993, P NATL ACAD SCI USA, V90, P1696, DOI 10.1073/pnas.90.5.1696; Hall HTL, 2008, EUR J IMMUNOL, V38, P64, DOI 10.1002/eji.200737393; Ishimaru N, 2006, NAT IMMUNOL, V7, P763, DOI 10.1038/ni1351; Penack O, 2009, J EXP MED, V206, P2101, DOI 10.1084/jem.20090623; Reichmann G, 1999, J IMMUNOL, V163, P3354; Sanchez-Valdepenas C, 2006, J IMMUNOL, V176, P4666, DOI 10.4049/jimmunol.176.8.4666; Shaw MH, 2009, NAT IMMUNOL, V10, P1267, DOI 10.1038/ni.1816; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Villegas EN, 2002, INFECT IMMUN, V70, P4757, DOI 10.1128/IAI.70.9.4757-4761.2002; Zhao Y, 2009, J IMMUNOL, V182, P6278, DOI 10.4049/jimmunol.0803682; Zheng Y, 2003, J EXP MED, V197, P861, DOI 10.1084/jem.20021610	13	2	2	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1231	1233		10.1038/ni1209-1231	http://dx.doi.org/10.1038/ni1209-1231			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19915621	Green Accepted			2022-12-18	WOS:000271872800004
J	Carosella, ED				Carosella, Edgardo D.			Jean Dausset 1916-2009 OBITUARY	NATURE IMMUNOLOGY			English	Biographical-Item									[Carosella, Edgardo D.] French Atom Energy Agcy, Paris, France; [Carosella, Edgardo D.] Hosp St Louis, Hematoimmunol Dept, Paris, France	CEA; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Louis - APHP; UDICE-French Research Universities; Universite Paris Cite	Carosella, ED (corresponding author), French Atom Energy Agcy, Paris, France.	edgardo.carosella@cea.fr							0	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2009	10	8					797	797		10.1038/ni0809-797	http://dx.doi.org/10.1038/ni0809-797			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	472OM	19621036	Bronze			2022-12-18	WOS:000268141400002
J	Bogdan, C				Bogdan, Christian			ASMase: the tailor of cytotoxic T cell granule exocytosis	NATURE IMMUNOLOGY			English	Editorial Material							ACID SPHINGOMYELINASE; SECRETION; RELEASE; DEATH	Deficiency in acid sphingomyelinase causes lysosomal storage of sphingomyelin, mediates resistance to stress-induced apoptosis and alters susceptibility to certain infections. New work links acid sphingomyelinase to the granule exocytosis of cytotoxic T cells.	Univ Clin Erlangen, Inst Microbiol, Erlangen, Germany	University of Erlangen Nuremberg	Bogdan, C (corresponding author), Univ Clin Erlangen, Inst Microbiol, Erlangen, Germany.	christian.bogdan@uk-erlangen.de		Bogdan, Christian/0000-0002-2300-0631				Catalfamo M, 2004, IMMUNITY, V20, P219, DOI 10.1016/S1074-7613(04)00027-5; Henkart PA, 2004, ADV IMMUNOL, V83, P233; Herz J, 2009, NAT IMMUNOL, V10, P761, DOI 10.1038/ni.1757; Huse M, 2008, NAT IMMUNOL, V9, P1105, DOI 10.1038/ni.f.215; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; Makedonas G, 2009, J IMMUNOL, V182, P5560, DOI 10.4049/jimmunol.0803945; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; Raja SM, 2002, J BIOL CHEM, V277, P49523, DOI 10.1074/jbc.M209607200; Schramm M, 2008, CELL MICROBIOL, V10, P1839, DOI 10.1111/j.1462-5822.2008.01169.x; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Utermohlen O, 2003, J IMMUNOL, V170, P2621, DOI 10.4049/jimmunol.170.5.2621	12	2	2	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2009	10	7					683	685		10.1038/ni0709-683	http://dx.doi.org/10.1038/ni0709-683			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	459WF	19536191				2022-12-18	WOS:000267142600005
J	Margulies, DH				Margulies, David H.			Antigen-processing and presentation pathways select antigenic HIV peptides in the fight against viral evolution	NATURE IMMUNOLOGY			English	Editorial Material								The evolution of immunodominant epitopes in HIV-1 Gag proteins correlates with quantitative measures of several antigen processing events. Thus, peptides recognized by CD8(+) cytolytic T cells are selected by their ability to pass through the antigen processing pathway, as well as by their binding to HLA molecules.	NIAID, Mol Biol Sect, Immunol Lab, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Margulies, DH (corresponding author), NIAID, Mol Biol Sect, Immunol Lab, Natl Inst Hlth, 9000 Rockville Pike, Bethesda, MD 20892 USA.	dhm@nih.gov		Margulies, David/0000-0001-8530-7375	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000622, ZIAAI000394, Z01AI000622] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Abele R, 2004, PHYSIOLOGY, V19, P216, DOI 10.1152/physiol.00002.2004; Iversen AKN, 2006, NAT IMMUNOL, V7, P179, DOI 10.1038/ni1298; Kanaseki T, 2006, IMMUNITY, V25, P795, DOI 10.1016/j.immuni.2006.09.012; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Tenzer S, 2009, NAT IMMUNOL, V10, P636, DOI 10.1038/ni.1728; Yewdell JTW, 1999, ANNU REV IMMUNOL, V17, P51, DOI 10.1146/annurev.immunol.17.1.51	6	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2009	10	6					566	568		10.1038/ni0609-566	http://dx.doi.org/10.1038/ni0609-566			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	450EP	19448656	Bronze			2022-12-18	WOS:000266384100006
J	Hamerman, JA; Tchao, NK; Lowell, CA; Lanier, LL				Hamerman, Jessica A.; Tchao, Nadia K.; Lowell, Clifford A.; Lanier, Lewis L.			Enhanced Toll-like receptor responses in the absence of signaling adaptor DAP12 (vol 6, pg 579, 2005)	NATURE IMMUNOLOGY			English	Correction													Lanier, Lewis L/E-2139-2014	Lanier, Lewis L/0000-0003-1308-3952				Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204	1	2	2	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					223	223		10.1038/ni0209-223b	http://dx.doi.org/10.1038/ni0209-223b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM		Bronze			2022-12-18	WOS:000263178500017
J	Zhang, FP; Meng, GX; Strober, W				Zhang, Fuping; Meng, Guangxun; Strober, Warren			Interactions among the transcription factors Runx1, ROR gamma t and Foxp3 regulate the differentiation of interleukin 17-producing T cells (vol 9, pg 1297, 2008)	NATURE IMMUNOLOGY			English	Correction																		Zhang FP, 2008, NAT IMMUNOL, V9, P1297, DOI 10.1038/ni.1663	1	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					223	223		10.1038/ni0209-223a	http://dx.doi.org/10.1038/ni0209-223a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM		Bronze			2022-12-18	WOS:000263178500016
J	Hildeman, D; Janssen, E				Hildeman, David; Janssen, Edith			IFN-gamma and self-absorbed CD4(+) T cells: a regulatory double negative	NATURE IMMUNOLOGY			English	Editorial Material							AUTOPHAGY; BIM; AUTOIMMUNITY; APOPTOSIS; FAS; LYMPHOCYTES; SURVIVAL	Interferon-gamma exerts many effects on the immune system. A new report shows that it induces both autophagy and Irgm1, a GTPase that protects activated CD4(+) T cells from executing autophagy.	[Hildeman, David] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Div Immunol, Cincinnati, OH 45229 USA; [Janssen, Edith] Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Div Mol Immunol, Cincinnati, OH 45229 USA; [Janssen, Edith] Univ Cincinnati, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Hildeman, D (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Dept Pediat, Div Immunol, Cincinnati, OH 45229 USA.	hilsv5@cchmc.org	Hildeman, David/AAA-1757-2020; Hildeman, David/I-4884-2015	Hildeman, David/0000-0002-0421-8483; Hildeman, David/0000-0002-0421-8483	NIAID NIH HHS [R21 AI079545] Funding Source: Medline; NIMH NIH HHS [R01 MH099078] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI079545] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH099078] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BENTAL M, 1993, MAGN RESON MED, V29, P317, DOI 10.1002/mrm.1910290307; Feng CG, 2008, NAT IMMUNOL, V9, P1279, DOI 10.1038/ni.1653; Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163; Fox CJ, 2005, NAT REV IMMUNOL, V5, P844, DOI 10.1038/nri1710; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Hughes PD, 2008, IMMUNITY, V28, P197, DOI 10.1016/j.immuni.2007.12.017; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Pua HH, 2007, J EXP MED, V204, P25, DOI 10.1084/jem.20061303; Refaeli Y, 2002, J EXP MED, V196, P999, DOI 10.1084/JEM.20020666; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Weant AE, 2008, IMMUNITY, V28, P218, DOI 10.1016/j.immuni.2007.12.014; Wojciechowski S, 2006, EUR J IMMUNOL, V36, P1694, DOI 10.1002/eji.200635897; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102	15	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2008	9	11					1210	1212		10.1038/ni1108-1210	http://dx.doi.org/10.1038/ni1108-1210			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363EA	18936780	Green Accepted			2022-12-18	WOS:000260248600007
J	Beemiller, P; Krummel, MF				Beemiller, Peter; Krummel, Matthew F.			Distinct functions for HS1 in chemosensory versus adhesive signaling	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION; PROTEIN; CYTOHESIN-1; EXCHANGE; POLARITY; CDC42; RHO	Host immunity requires cytotoxic lymphocytes that are able to move toward their targets but are also able to stop after identifying target cells and then establish stable cell-cell contact. A new study shows that separate phosphorylation sites in HS1, an actin cytoskeleton-remodeling factor, can regulate both processes.	[Beemiller, Peter; Krummel, Matthew F.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Beemiller, P (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA.	matthew.krummel@ucsf.edu		Beemiller, Peter/0000-0002-2736-3405				Barber DF, 2004, J IMMUNOL, V173, P3653, DOI 10.4049/jimmunol.173.6.3653; Borroto A, 2000, EUR J IMMUNOL, V30, P3403, DOI 10.1002/1521-4141(2000012)30:12<3403::AID-IMMU3403>3.0.CO;2-H; Butler B, 2008, NAT IMMUNOL, V9, P887, DOI 10.1038/ni.1630; Crespo P, 1997, NATURE, V385, P169, DOI 10.1038/385169a0; del Pozo MA, 2003, J IMMUNOL, V170, P41, DOI 10.4049/jimmunol.170.1.41; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Kolanus W, 1996, CELL, V86, P233, DOI 10.1016/S0092-8674(00)80095-1; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Pestonjamasp KN, 2006, BLOOD, V108, P2814, DOI 10.1182/blood-2006-01-010363; Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003; Van Keymeulen A, 2006, J CELL BIOL, V174, P437, DOI 10.1083/jcb.200604113; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Xu JS, 2003, CELL, V114, P201, DOI 10.1016/S0092-8674(03)00555-5; Zeng R, 2003, J IMMUNOL, V171, P1360, DOI 10.4049/jimmunol.171.3.1360	15	2	2	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8								10.1038/ni0808-833	http://dx.doi.org/10.1038/ni0808-833			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18645589				2022-12-18	WOS:000257780700004
J	Bryceson, YT; Ljunggren, HG				Bryceson, Yenan T.; Ljunggren, Hans-Gustaf			Arrestin NK cell cytotoxicity	NATURE IMMUNOLOGY			English	Editorial Material							TYROSINE-PHOSPHATASE SHP-1; INHIBITORY RECEPTORS	A key regulator of the balance of signals that activate effector mechanisms versus those that restrain them, beta-arrestin 2 mediates the inhibition of natural killer cell cytotoxicity.	[Bryceson, Yenan T.; Ljunggren, Hans-Gustaf] Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Stockholm, Sweden; [Bryceson, Yenan T.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA	Karolinska Institutet; Karolinska University Hospital; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Bryceson, YT (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Dept Med, Ctr Infect Med, S-14186 Stockholm, Sweden.	yenan.bryceson@gmail.com; hans-gustaf.ljunggren@ki.se	Bryceson, Yenan T/D-2121-2018	Bryceson, Yenan T/0000-0002-7783-9934				Beebe KD, 2000, BIOCHEMISTRY-US, V39, P13251, DOI 10.1021/bi0014397; Bryceson YT, 2008, CURR OPIN IMMUNOL, V20, P344, DOI 10.1016/j.coi.2008.03.005; Burshtyn DN, 1996, IMMUNITY, V4, P77, DOI 10.1016/S1074-7613(00)80300-3; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Hof P, 1998, CELL, V92, P441, DOI 10.1016/S0092-8674(00)80938-1; LONG EO, IMMUNOL REV IN PRESS; Lowin-Kropf B, 2000, J IMMUNOL, V165, P1314, DOI 10.4049/jimmunol.165.3.1314; Olcese L, 1996, J IMMUNOL, V156, P4531; Ravetch JV, 2000, SCIENCE, V290, P84, DOI 10.1126/science.290.5489.84; Stebbins CC, 2003, MOL CELL BIOL, V23, P6291, DOI 10.1128/MCB.23.17.6291-6299.2003; Yu MC, 2008, NAT IMMUNOL, V9, P898, DOI 10.1038/ni.1635	11	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					835	836		10.1038/ni0808-835	http://dx.doi.org/10.1038/ni0808-835			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18645590				2022-12-18	WOS:000257780700005
J	Delgado, JC; Jensen, PE				Delgado, Julio C.; Jensen, Peter E.			Cat and mouse	NATURE IMMUNOLOGY			English	Editorial Material							I-PRESENTED PEPTIDES; CD8 T-CELLS; TOXOPLASMA-GONDII; ENDOPLASMIC-RETICULUM; ANTIGEN; INFECTION; IMMUNITY; ERAP1	New findings show that ERAAP, an endoplasmic reticulum aminopeptidase involved in antigen processing, helps mice survive encounters with a feline-derived parasite.	[Delgado, Julio C.; Jensen, Peter E.] Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah	Delgado, JC (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84112 USA.	julio.delgado@path.utah.edu; peter.jensen@path.utah.edu						Blanchard N, 2008, NAT IMMUNOL, V9, P937, DOI 10.1038/ni.1629; Denkers EY, 1998, CLIN MICROBIOL REV, V11, P569, DOI 10.1128/CMR.11.4.569; Dzierszinski F, 2007, INFECT IMMUN, V75, P5200, DOI 10.1128/IAI.00954-07; Firat E, 2007, J IMMUNOL, V178, P2241, DOI 10.4049/jimmunol.178.4.2241; Gubbels MJ, 2005, INFECT IMMUN, V73, P703, DOI 10.1128/IAI.73.2.703-711.2005; Kwok LY, 2003, J IMMUNOL, V170, P1949, DOI 10.4049/jimmunol.170.4.1949; Lang C, 2007, PARASITOL RES, V100, P191, DOI 10.1007/s00436-006-0306-9; Luder CGK, 2001, EUR J IMMUNOL, V31, P1475, DOI 10.1002/1521-4141(200105)31:5&lt;1475::AID-IMMU1475&gt;3.0.CO;2-C; Martin DL, 2006, PLOS PATHOG, V2, P731, DOI 10.1371/journal.ppat.0020077; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Murali-Krishna K, 1998, IMMUNITY, V8, P177, DOI 10.1016/S1074-7613(00)80470-7; Saric T, 2002, NAT IMMUNOL, V3, P1169, DOI 10.1038/ni859; Serwold T, 2002, NATURE, V419, P480, DOI 10.1038/nature01074; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; York IA, 2006, P NATL ACAD SCI USA, V103, P9202, DOI 10.1073/pnas.0603095103	15	2	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8								10.1038/ni0808-829	http://dx.doi.org/10.1038/ni0808-829			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN	18645587				2022-12-18	WOS:000257780700002
J	Fitzgerald, DC; Zhang, GX; Ei-Behi, M; Fonseca-Kelly, Z; Li, H; Yu, S; Saris, CJ; Gran, B; Ciric, B; Rostami, A				Fitzgerald, Denise C.; Zhang, Guang-Xian; Ei-Behi, Mohamed; Fonseca-Kelly, Zoee; Li, Hongmei; Yu, Shuo; Saris, Christiaan J.; Gran, Bruno; Ciric, Bogoljub; Rostami, Abdolmohamad			Suppression of autoimmune inflammation of the central nervous system by interleukin 10 secreted by interleukin 27-stimulated T cells (vol 8, pg 1372, 2007)	NATURE IMMUNOLOGY			English	Correction																		Fitzgerald DC, 2007, NAT IMMUNOL, V8, P1372, DOI 10.1038/ni1540	1	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2008	9	1					105	105		10.1038/ni0108-105d	http://dx.doi.org/10.1038/ni0108-105d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	243TS		Bronze			2022-12-18	WOS:000251820800020
J	Vieira, P; Vosshenrich, C; Cumano, A; Muller, W; Di Santo, JP; de Sousa, AP; Lalanne, AI				Vieira, Paulo; Vosshenrich, Christian; Cumano, Ana; Mueller, Werner; Di Santo, James P.; de Sousa, Ana Pereira; Lalanne, Ana Ines			TSLP-mediated fetal B lymphopoiesis? - Reply	NATURE IMMUNOLOGY			English	Letter							THYMIC STROMAL LYMPHOPOIETIN; CELL DEVELOPMENT; RECEPTOR		Inst Pasteur, INSERM, U668, Unite Dev Lymphocytes, F-75724 Paris 15, France; Inst Pasteur, INSERM, U668, Unite Cytokines & Dev Lymphoide, F-75724 Paris, France; Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of Manchester	Vieira, P (corresponding author), Inst Pasteur, INSERM, U668, Unite Dev Lymphocytes, F-75724 Paris 15, France.	pvieira@pasteur.fr	Di Santo, James P/M-4298-2014; VOUGNY, Marie-Christine/K-8938-2017; Muller, Werner/B-9044-2008; Vieira, Paulo/D-4500-2013; Vosshenrich, Christian/M-6523-2014	Di Santo, James P/0000-0002-7146-1862; Muller, Werner/0000-0002-1297-9725; Vieira, Paulo/0000-0003-1307-5119; Vosshenrich, Christian/0000-0002-4407-8649				Al-Shami A, 2004, J EXP MED, V200, P159, DOI 10.1084/jem.20031975; Carpino N, 2004, MOL CELL BIOL, V24, P2584, DOI 10.1128/MCB.24.6.2584-2592.2004; Carvalho TL, 2001, J EXP MED, V194, P1141, DOI 10.1084/jem.194.8.1141; Montecino-Rodriguez E, 2006, NAT IMMUNOL, V7, P293, DOI 10.1038/ni1301; Vosshenrich CAJ, 2003, NAT IMMUNOL, V4, P773, DOI 10.1038/ni956; Vosshenrich CAJ, 2004, P NATL ACAD SCI USA, V101, P11070, DOI 10.1073/pnas.0402919101	6	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2007	8	9					898	898		10.1038/ni0907-898	http://dx.doi.org/10.1038/ni0907-898			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	202QN					2022-12-18	WOS:000248918200003
J	Hammer, GE; Shastri, N				Hammer, Gianna E.; Shastri, Nilabh			Construction and destruction of MHC class I in the peptide-loading complex	NATURE IMMUNOLOGY			English	Editorial Material							TAPASIN; REPERTOIRE; OPTIMIZATION; DEFICIENT; CARGO; MICE		Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Hammer, GE (corresponding author), Univ Calif Berkeley, Div Immunol, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	nshastri@berkeley.edu		Hammer, Gianna/0000-0001-6959-858X				Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Dick TP, 2004, CELL MOL LIFE SCI, V61, P547, DOI 10.1007/s00018-003-3271-9; Dick TP, 2002, IMMUNITY, V16, P87, DOI 10.1016/S1074-7613(02)00263-7; Elliott T, 2005, IMMUNOL REV, V207, P89, DOI 10.1111/j.0105-2896.2005.00311.x; Garber K, 2007, J NATL CANCER I, V99, P105, DOI 10.1093/jnci/djk046; Garbi N, 2006, NAT IMMUNOL, V7, P93, DOI 10.1038/ni1288; Garbi N, 2000, NAT IMMUNOL, V1, P234, DOI 10.1038/79775; Hammer GE, 2007, IMMUNITY, V26, P397, DOI 10.1016/j.immuni.2007.04.003; Howarth M, 2004, P NATL ACAD SCI USA, V101, P11737, DOI 10.1073/pnas.0306294101; Kienast A, 2007, NAT IMMUNOL, V8, P864, DOI 10.1038/ni1483; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; Purcell AW, 2001, J IMMUNOL, V166, P1016, DOI 10.4049/jimmunol.166.2.1016; Wearsch PA, 2007, NAT IMMUNOL, V8, P873, DOI 10.1038/ni1485; Williams AP, 2002, IMMUNITY, V16, P509, DOI 10.1016/S1074-7613(02)00304-7	14	2	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					793	794		10.1038/ni0807-793	http://dx.doi.org/10.1038/ni0807-793			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17641657				2022-12-18	WOS:000248169400004
J	Herzenberg, LA				Herzenberg, Leonore A.			Epitope-specific regulation: the elephant in the bathtub	NATURE IMMUNOLOGY			English	Editorial Material							ANTIGEN-SPECIFIC SUPPRESSOR; T-CELL INTERACTIONS; ANTIBODY-RESPONSES; INDUCTION; EXPRESSION; MECHANISM; MEMORY		Stanford Univ, Dept Genet, Stanford, CA 94305 USA	Stanford University	Herzenberg, LA (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	leeherz@stanford.edu						CANTOR H, 1976, J EXP MED, V143, P1391, DOI 10.1084/jem.143.6.1391; GERSHON RK, 1975, TRANSPLANT REV-DENMA, V26, P170; HERZENBERG LA, 1982, ANN NY ACAD SCI, V399, P368, DOI 10.1111/j.1749-6632.1982.tb25690.x; HERZENBERG LA, 1982, EUR J IMMUNOL, V12, P814, DOI 10.1002/eji.1830121004; HERZENBERG LA, 1980, NATURE, V285, P664, DOI 10.1038/285664a0; HERZENBERG LA, 1982, J EXP MED, V155, P1741, DOI 10.1084/jem.155.6.1741; HERZENBERG LA, 1982, J EXP MED, V155, P1730, DOI 10.1084/jem.155.6.1730; HERZENBERG LA, 1980, EUR J IMMUNOL, V10, P1, DOI 10.1002/eji.1830100102; HERZENBERG LA, 1983, ANNU REV IMMUNOL, V1, P609, DOI 10.1146/annurev.iy.01.040183.003141; HERZENBERG LA, 1982, IMMUNOL REV, V67, P5, DOI 10.1111/j.1600-065X.1982.tb01053.x; HERZENBERG LA, 1982, NATURE, V295, P329, DOI 10.1038/295329a0; JANEWAY CA, 1979, FED PROC, V38, P2071; JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102; KAPP JA, 1982, J IMMUNOL, V128, P2447; OKUMURA K, 1973, NATURE-NEW BIOL, V245, P180, DOI 10.1038/newbio245180a0; Tada T, 1979, Adv Immunol, V28, P1; TAKEMORI T, 1984, IMMUNOL REV, V79, P103, DOI 10.1111/j.1600-065X.1984.tb00489.x; TANIGUCHI M, 1980, J EXP MED, V151, P517, DOI 10.1084/jem.151.3.517; WALTENBAUGH C, 1981, J EXP MED, V154, P1570, DOI 10.1084/jem.154.5.1570	19	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					783	786		10.1038/ni0807-783	http://dx.doi.org/10.1038/ni0807-783			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB	17641654				2022-12-18	WOS:000248169400002
J	Bolland, D; Corcoran, A				Bolland, Daniel; Corcoran, Anne			Somatic hypermutation is a matter of choice	NATURE IMMUNOLOGY			English	Editorial Material							ALLELIC INCLUSION; METHYLATION; LOCUS; ASSOCIATION	Allelic exclusion acts to ensure lymphocytes express only one antigen receptor on their surfaces. Differences in DNA methylation are now shown to distinguish alleles for subsequent somatic hypermutation steps leading to antibody affinity maturation.	Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB22 3AT, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Bolland, D (corresponding author), Babraham Inst, Lab Chromatin & Gene Express, Cambridge CB22 3AT, England.	anne.corcoran@bbsrc.ac.uk	Bolland, Daniel/AAE-5185-2020	Bolland, Daniel/0000-0003-3674-9913	Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C163] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Corcoran AE, 2005, SEMIN IMMUNOL, V17, P141, DOI 10.1016/j.smim.2005.01.002; Delpy L, 2004, J IMMUNOL, V173, P1842, DOI 10.4049/jimmunol.173.3.1842; DINOIA JM, 2007, ANN REV BIOCH; Fraenkel S, 2007, NAT IMMUNOL, V8, P715, DOI 10.1038/ni1476; Gerdes T, 2004, NAT IMMUNOL, V5, P1282, DOI 10.1038/ni1133; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Jolly CJ, 2001, IMMUNOL CELL BIOL, V79, P18, DOI 10.1046/j.1440-1711.2001.00968.x; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Liu Z, 2006, IMMUNITY, V24, P405, DOI 10.1016/j.immuni.2006.02.001; Odegard VH, 2006, NAT REV IMMUNOL, V6, P573, DOI 10.1038/nri1896; Skok JA, 2001, NAT IMMUNOL, V2, P848, DOI 10.1038/ni0901-848; Sonoda E, 1997, IMMUNITY, V6, P225, DOI 10.1016/S1074-7613(00)80325-8	13	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					676	679		10.1038/nio707-677	http://dx.doi.org/10.1038/nio707-677			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ	17579643				2022-12-18	WOS:000247718100006
J	Tian, J; Avalos, AM; Mao, SY; Chen, B; Senthil, K; Wu, H; Parroche, P; Drabic, S; Golenbock, D; Sirois, C; Hua, J; An, LL; Audoly, L; La Rosa, G; Bierhaus, A; Naworth, P; Marshak-Rothstein, A; Crow, MK; Fitzgerald, KA; Latz, E; Kiener, PA; Coyle, AJ				Tian, Jane; Avalos, Ana Maria; Mao, Su-Yau; Chen, Bo; Senthil, Kannaki; Wu, Herren; Parroche, Peggy; Drabic, Stacey; Golenbock, Douglas; Sirois, Cherilyn; Hua, Jing; An, Ling Ling; Audoly, Laurent; La Rosa, Greg; Bierhaus, Angelika; Naworth, Peter; Marshak-Rothstein, Ann; Crow, Mary K.; Fitzgerald, Katherine A.; Latz, Eicke; Kiener, Peter A.; Coyle, Anthony J.			Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE (vol 8, pg 487, 2007)	NATURE IMMUNOLOGY			English	Correction													Fitzgerald, Katherine/ABE-6317-2020; Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666				Tian J, 2007, NAT IMMUNOL, V8, P487, DOI 10.1038/ni1457	1	2	2	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					780	780		10.1038/ni0707-780b	http://dx.doi.org/10.1038/ni0707-780b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ		Bronze			2022-12-18	WOS:000247718100020
J	Bromley, SK; Luster, AD				Bromley, Shannon K.; Luster, Andrew D.			Turning up the heat on HEVs	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR; FEVER; TEMPERATURE; CYTOKINE; GP130; IL-6	Fever is a beneficial systemic response to infection. Such a thermal increase triggers enhanced lymph node recruitment of lymphocytes by augmenting high endothelial venule expression of the homing molecules ICAM-1 and CCL21.	Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Bromley, SK (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Immunol & Inflammatory Dis,Div Rheumatol Alle, Charlestown, MA 02129 USA.	luster.andrew@mgh.harvard.edu	Luster, Andrew/ABE-6504-2020	Luster, Andrew/0000-0001-9679-7912				Chen Q, 2004, IMMUNITY, V20, P59, DOI 10.1016/S1074-7613(03)00358-3; Chen Q, 2006, NAT IMMUNOL, V7, P1299, DOI 10.1038/ni1406; Evans SS, 2001, BLOOD, V97, P2727, DOI 10.1182/blood.V97.9.2727; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Hasday JD, 2001, J APPL PHYSIOL, V90, P90, DOI 10.1152/jappl.2001.90.1.90; Jiang QQ, 2000, INFECT IMMUN, V68, P1265, DOI 10.1128/IAI.68.3.1265-1270.2000; Jones SA, 2002, BBA-MOL CELL RES, V1592, P251, DOI 10.1016/S0167-4889(02)00319-1; Jostock T, 2001, EUR J BIOCHEM, V268, P160, DOI 10.1046/j.1432-1327.2001.01867.x; KLUGER MJ, 1975, SCIENCE, V188, P166, DOI 10.1126/science.1114347; Romano M, 1997, IMMUNITY, V6, P315, DOI 10.1016/S1074-7613(00)80334-9; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222	12	2	2	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2006	7	12					1288	1290		10.1038/ni1206-1288	http://dx.doi.org/10.1038/ni1206-1288			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	106TU	17110949				2022-12-18	WOS:000242125200010
J	Felix, NJ; Allen, PM				Felix, Nathan J.; Allen, Paul M.			Learning from the lost: new insights into TCR specificity	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL REPERTOIRE; BINDING; PEPTIDES; ANTIGEN		Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Felix, NJ (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	pallen@wustl.edu						CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; DONERMEYER DL, IN PRESS J IMMUNOL; Fremont DH, 1996, SCIENCE, V272, P1001, DOI 10.1126/science.272.5264.1001; Garcia KC, 2005, CELL, V122, P333, DOI 10.1016/j.cell.2005.07.015; Huseby ES, 2006, NAT IMMUNOL, V7, P1191, DOI 10.1038/ni1401; Huseby ES, 2005, CELL, V122, P247, DOI 10.1016/j.cell.2005.05.013; Huseby ES, 2003, P NATL ACAD SCI USA, V100, P11565, DOI 10.1073/pnas.1934636100; Kersh GJ, 1998, IMMUNITY, V9, P817, DOI 10.1016/S1074-7613(00)80647-0; Krogsgaard M, 2005, NAT IMMUNOL, V6, P239, DOI 10.1038/ni1173; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; REAY PA, 1994, J IMMUNOL, V152, P3946; Rudolph MG, 2006, ANNU REV IMMUNOL, V24, P419, DOI 10.1146/annurev.immunol.23.021704.115658	12	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1127	1128		10.1038/ni1106-1127	http://dx.doi.org/10.1038/ni1106-1127			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17053792				2022-12-18	WOS:000241437200002
J	de Villartay, JP				de Villartay, Jean-Pierre			Passera ou ne passera pas - accessibility is key	NATURE IMMUNOLOGY			English	Editorial Material							V(D)J RECOMBINATION; PHD; REARRANGEMENT; LOCUS	Immunoglobulin and T cell receptor (TCR) germline transcription is associated with V(D)J recombination of these loci. New work formally demonstrates that transcriptional read-through of the TCR-J(alpha) cluster indeed regulates TCR-J(alpha) rearrangements.	Hop Necker Enfants Malad, INSERM, U768, Unite Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France; Univ Paris 05, Fac Med Rene Descartes, F-75005 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	de Villartay, JP (corresponding author), Hop Necker Enfants Malad, INSERM, U768, Unite Dev Normal & Pathol Syst Immunitaire, F-75015 Paris, France.	devillar@necker.fr	de Villartay, jean pierre/H-9353-2017	de Villartay, jean pierre/0000-0001-5987-0463				Abarrategui I, 2006, NAT IMMUNOL, V7, P1109, DOI 10.1038/ni1379; Aguilera A, 2002, EMBO J, V21, P195, DOI 10.1093/emboj/21.3.195; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Callebaut I, 1998, CELL MOL LIFE SCI, V54, P880, DOI 10.1007/s000180050216; Elkin SK, 2005, J BIOL CHEM, V280, P28701, DOI 10.1074/jbc.M504731200; Hawwari A, 2005, NAT IMMUNOL, V6, P481, DOI 10.1038/ni1189; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Krangel MS, 2004, IMMUNOL REV, V200, P224, DOI 10.1111/j.0105-2896.2004.00155.x; McMurry MT, 2000, SCIENCE, V287, P495, DOI 10.1126/science.287.5452.495; Mellor J, 2006, CELL, V126, P22, DOI 10.1016/j.cell.2006.06.028; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Villey I, 1996, IMMUNITY, V5, P331, DOI 10.1016/S1074-7613(00)80259-9; YANCOPOULOS GD, 1985, CELL, V40, P271, DOI 10.1016/0092-8674(85)90141-2; Zhang ZX, 2006, NAT IMMUNOL, V7, P616, DOI 10.1038/ni1339	14	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1019	1021		10.1038/ni1006-1019	http://dx.doi.org/10.1038/ni1006-1019			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16985496				2022-12-18	WOS:000241437100005
J	[Anonymous]				[Anonymous]			A matter of trust	NATURE IMMUNOLOGY			English	Editorial Material								Recent instances of potential conflicts of interest involving authors and journal editors may tarnish public confidence in the integrity of science journals.											0	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1005	1005		10.1038/ni1006-1005	http://dx.doi.org/10.1038/ni1006-1005			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16985491	Bronze			2022-12-18	WOS:000241437100001
J	Ma, A; Turer, E				Ma, Averil; Turer, Emre			E2 enzymes: expanding the 'ubi-verse' of immune signaling	NATURE IMMUNOLOGY			English	Editorial Material							UBIQUITIN-CONJUGATING ENZYME; KINASE; ACTIVATION; REQUIRES; PROTEIN; LIGASE; TAK1; SITE; A20	Analysis of mice lacking the E2 ubiquitin-conjugating enzyme Ubc13 provides unexpected results regarding which ubiquitination events may regulate immune receptor signaling activity.	Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Ma, A (corresponding author), Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA.	averil.ma@ucsf.edu						Abbott DW, 2004, CURR BIOL, V14, P2217, DOI 10.1016/j.cub.2004.12.032; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; CHEN ZJ, 1995, GENE DEV, V9, P1586, DOI 10.1101/gad.9.13.1586; Chen ZJJ, 2005, NAT CELL BIOL, V7, P758, DOI 10.1038/ncb0805-758; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Joazeiro CAP, 1999, SCIENCE, V286, P309, DOI 10.1126/science.286.5438.309; Liu YC, 2005, NAT REV IMMUNOL, V5, P941, DOI 10.1038/nri1731; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Wang C, 2001, NATURE, V412, P346, DOI 10.1038/35085597; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367; Zhou HL, 2004, NATURE, V427, P167, DOI 10.1038/nature02273	12	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					903	904		10.1038/ni0906-903	http://dx.doi.org/10.1038/ni0906-903			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL	16924251				2022-12-18	WOS:000239942300006
J	Bjorkman, PJ				Bjorkman, Pamela J.			Finding the groove	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL-RECEPTOR; ANTIGEN-BINDING SITE; HISTOCOMPATIBILITY ANTIGENS; INFLUENZA-VIRUS; CLASS-II; RECOGNITION; PEPTIDE; COMPLEX; GLYCOPROTEIN; HYPOTHESIS	Envisioning how T cells might recognize antigen presented by major histocompatibility complex molecules proved to be a formidable challenge. Pamela Bjorkman describes her journey to provide structural insights into how such recognition is achieved.	CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA; CALTECH, Div Biol 11496, Pasadena, CA 91125 USA	California Institute of Technology; Howard Hughes Medical Institute; California Institute of Technology	Bjorkman, PJ (corresponding author), CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA.	bjorkman@caltech.edu						BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; BUUS S, 1988, SCIENCE, V242, P1045, DOI 10.1126/science.3194755; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; HOPE H, 1990, ANNU REV BIOPHYS BIO, V19, P107; HUNIG TR, 1982, J EXP MED, V155, P111, DOI 10.1084/jem.155.1.111; JANEWAY CA, 1976, SCAND J IMMUNOL, V5, P993, DOI 10.1111/j.1365-3083.1976.tb03051.x; McIntosh R, 2005, TRENDS CELL BIOL, V15, P43, DOI 10.1016/j.tcb.2004.11.009; Reinherz EL, 1999, SCIENCE, V286, P1913, DOI 10.1126/science.286.5446.1913; SHIMONKEVITZ R, 1983, J EXP MED, V158, P303, DOI 10.1084/jem.158.2.303; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; TURNER MJ, 1975, J BIOL CHEM, V250, P4512; VARGHESE JN, 1983, NATURE, V303, P35, DOI 10.1038/303035a0; WILSON IA, 1981, NATURE, V289, P366, DOI 10.1038/289366a0; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	19	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2006	7	8					787	789		10.1038/ni0806-787	http://dx.doi.org/10.1038/ni0806-787			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	065GH	16855599				2022-12-18	WOS:000239147200003
J	[Anonymous]				[Anonymous]			Pathogenesis: Of host and pathogen	NATURE IMMUNOLOGY			English	Editorial Material																			0	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2006	7	3					217	217						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	012SR	16482163				2022-12-18	WOS:000235360400001
J	Carter, RW; Tough, DF				Carter, RW; Tough, DF			'3d' effects on global immunity	NATURE IMMUNOLOGY			English	Editorial Material							TOLL-LIKE RECEPTOR-7; CPG-DNA; TLR9	'Forward' genetic approaches for elucidating function can lead to unexpected findings. A single missense mutation is found to disrupt both antigen presentation and nucleic acid Toll-like receptor signaling, two processes involving endocytic pathways.	Inst Vaccine Res Compton, Newbury RG20 7NN, Berks, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute	Carter, RW (corresponding author), Inst Vaccine Res Compton, Newbury RG20 7NN, Berks, England.	david.tough@jenner.ac.uk						Ahmad-Nejad P, 2002, EUR J IMMUNOL, V32, P1958, DOI 10.1002/1521-4141(200207)32:7<1958::AID-IMMU1958>3.0.CO;2-U; Cresswell P, 2005, IMMUNOL REV, V207, P145, DOI 10.1111/j.0105-2896.2005.00316.x; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Heil F, 2003, EUR J IMMUNOL, V33, P2987, DOI 10.1002/eji.200324238; Hoebe K, 2003, NATURE, V424, P743, DOI 10.1038/nature01889; Kashuba VI, 2002, GENE, V283, P209, DOI 10.1016/S0378-1119(01)00856-3; Latz E, 2004, NAT IMMUNOL, V5, P190, DOI 10.1038/ni1028; Lee J, 2003, P NATL ACAD SCI USA, V100, P6646, DOI 10.1073/pnas.0631696100; Leifer CA, 2004, J IMMUNOL, V173, P1179, DOI 10.4049/jimmunol.173.2.1179; Matsumoto M, 2003, J IMMUNOL, V171, P3154, DOI 10.4049/jimmunol.171.6.3154; Tabeta K, 2004, P NATL ACAD SCI USA, V101, P3516, DOI 10.1073/pnas.0400525101; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297	12	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2006	7	2					127	128		10.1038/ni0206-127	http://dx.doi.org/10.1038/ni0206-127			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	005DB	16424888				2022-12-18	WOS:000234801700006
J	Bousso, P				Bousso, P			Lymph node choreography: T-reg cells join the dance	NATURE IMMUNOLOGY			English	Editorial Material							DENDRITIC CELLS; TOLERANCE; DYNAMICS; CD4(+)CD25(+); HOMEOSTASIS; INDUCTION	How regulatory T cells dampen T cell responses in vivo remains unclear. Direct visualization of regulatory T cell activity in an autoimmune setting provides exciting new insights into regulatory T cell-mediated suppression.	Inst Pasteur, Inst Natl Sante & Rech Med, U668, Dept Immunol, F-75015 Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Bousso, P (corresponding author), Inst Pasteur, Inst Natl Sante & Rech Med, U668, Dept Immunol, F-75015 Paris, France.	bousso@pasteur.fr	BOUSSO, Philippe/M-6547-2014	BOUSSO, Philippe/0000-0002-6362-561X				Bousso P, 2003, NAT IMMUNOL, V4, P579, DOI 10.1038/ni928; Celli S, 2005, J EXP MED, V202, P1271, DOI 10.1084/jem.20051018; Hugues S, 2004, NAT IMMUNOL, V5, P1235, DOI 10.1038/ni1134; Kretschmer K, 2005, NAT IMMUNOL, V6, P1219, DOI 10.1038/ni1265; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Miller MJ, 2004, J EXP MED, V200, P847, DOI 10.1084/jem.20041236; Paust S, 2004, P NATL ACAD SCI USA, V101, P10398, DOI 10.1073/pnas.0403342101; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Salomon B, 2000, IMMUNITY, V12, P431, DOI 10.1016/S1074-7613(00)80195-8; Tang QZ, 2006, NAT IMMUNOL, V7, P83, DOI 10.1038/ni1289; Tang QZ, 2003, J IMMUNOL, V171, P3348, DOI 10.4049/jimmunol.171.7.3348; von Boehmer H, 2005, NAT IMMUNOL, V6, P338, DOI 10.1038/ni1180; Zinselmeyer BH, 2005, J EXP MED, V201, P1815, DOI 10.1084/jem.20050203	13	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2006	7	1					11	13		10.1038/ni0106-11	http://dx.doi.org/10.1038/ni0106-11			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	995XZ	16357850				2022-12-18	WOS:000234139700005
J	Wienands, J				Wienands, J			Unraveling B cell receptor mechanics	NATURE IMMUNOLOGY			English	Editorial Material							SIGNALS		Univ Gottingen, Fac Med, Dept Cellular & Mol Immunol, D-37073 Gottingen, Germany	University of Gottingen	Wienands, J (corresponding author), Univ Gottingen, Fac Med, Dept Cellular & Mol Immunol, D-37073 Gottingen, Germany.	jwienan@uni-goettingen.de						Benschop RJ, 2001, IMMUNITY, V14, P33, DOI 10.1016/S1074-7613(01)00087-5; BROUNS GS, 1995, INT IMMUNOL, V7, P359, DOI 10.1093/intimm/7.3.359; COOKE MP, 1994, J EXP MED, V179, P425, DOI 10.1084/jem.179.2.425; Gauld SB, 2005, NAT IMMUNOL, V6, P1160, DOI 10.1038/ni1256; GOODNOW CC, 1991, NATURE, V352, P532, DOI 10.1038/352532a0; Healy JI, 1997, IMMUNITY, V6, P419, DOI 10.1016/S1074-7613(00)80285-X; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Nemazee D, 2000, CURR TOP MICROBIOL, V245, P57; RETH M, 1992, ANNU REV IMMUNOL, V10, P97, DOI 10.1146/annurev.iy.10.040192.000525; Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453; Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Vilen BJ, 1999, IMMUNITY, V10, P239, DOI 10.1016/S1074-7613(00)80024-2	13	2	2	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1072	1074		10.1038/ni1105-1072	http://dx.doi.org/10.1038/ni1105-1072			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD	16239921				2022-12-18	WOS:000232833300006
J	Jones, EY				Jones, EY			Favorite flavors of surfaces	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL-RECEPTOR; INFLUENZA-A; STRUCTURAL BASIS; RECOGNITION; COMPLEX; SELECTION; PEPTIDE; HLA-A2	Different peptide antigens induce T cell repertoires of very different diversity. An analysis of the effect on T cell receptor usage of re-engineering peptide features indicates that a lack of prominent side chains presented for recognition limits the T cell repertoire.	Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford, England	University of Oxford; Wellcome Centre for Human Genetics	Jones, EY (corresponding author), Univ Oxford, Div Struct Biol, Wellcome Trust Ctr Human Genet, Oxford, England.	yvonne@strubi.ox.ac.uk	Jones, Yvonne/N-8111-2019; Jones, Yvonne/J-2293-2016	Jones, Yvonne/0000-0002-3834-1893; Jones, Yvonne/0000-0002-3834-1893				Davis MM, 2003, NAT IMMUNOL, V4, P649, DOI 10.1038/ni0703-649; Garboczi DN, 1996, NATURE, V384, P134, DOI 10.1038/384134a0; Garcia KC, 1996, SCIENCE, V274, P209, DOI 10.1126/science.274.5285.209; Kjer-Nielsen L, 2003, IMMUNITY, V18, P53, DOI 10.1016/S1074-7613(02)00513-7; Lee JK, 2004, J EXP MED, V200, P1455, DOI 10.1084/jem.20041251; LEHNER PJ, 1995, J EXP MED, V181, P79, DOI 10.1084/jem.181.1.79; Meijers R, 2005, J MOL BIOL, V345, P1099, DOI 10.1016/j.jmb.2004.11.023; MOSS PAH, 1991, P NATL ACAD SCI USA, V88, P8987, DOI 10.1073/pnas.88.20.8987; Price DA, 2004, IMMUNITY, V21, P793, DOI 10.1016/j.immuni.2004.10.010; Stewart-Jones GBE, 2003, NAT IMMUNOL, V4, P657, DOI 10.1038/ni942; Turner SJ, 2005, NAT IMMUNOL, V6, P382, DOI 10.1038/ni1175	11	2	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2005	6	4					365	366		10.1038/ni0405-365	http://dx.doi.org/10.1038/ni0405-365			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	909KY	15785764				2022-12-18	WOS:000227860000008
J	Sen, R				Sen, R			A move to exclude	NATURE IMMUNOLOGY			English	Editorial Material							HEAVY-CHAIN GENE; PRE-B CELLS; ALLELIC EXCLUSION; KAPPA LOCUS; ACTIVATION; PAX5; REARRANGEMENTS; RECOMBINATION; EXPRESSION	It is not clear how lymphocytes establish monoallelic gene expression of antigen receptor genes. New data linking local chromatin modifications with nuclear movements provide a framework for deciphering this process.	NIA, Mol & Cellular Biol Lab, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Sen, R (corresponding author), NIA, Mol & Cellular Biol Lab, Baltimore, MD 21224 USA.	rs465z@nih.gov			NATIONAL INSTITUTE ON AGING [Z01AG000383] Funding Source: NIH RePORTER	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bergman Y, 2003, CURR OPIN IMMUNOL, V15, P176, DOI 10.1016/S0952-7915(03)00016-5; Bolland DJ, 2004, NAT IMMUNOL, V5, P630, DOI 10.1038/ni1068; Chowdhury D, 2003, IMMUNITY, V18, P229, DOI 10.1016/S1074-7613(03)00030-X; Chowdhury D, 2001, EMBO J, V20, P6394, DOI 10.1093/emboj/20.22.6394; Fuxa M, 2004, GENE DEV, V18, P411, DOI 10.1101/gad.291504; Goldmit M, 2005, NAT IMMUNOL, V6, P198, DOI 10.1038/ni1154; Hesslein DGT, 2003, GENE DEV, V17, P37, DOI 10.1101/gad.1031403; Johnson K, 2004, NAT IMMUNOL, V5, P853, DOI 10.1038/ni1099; Kosak ST, 2002, SCIENCE, V296, P158, DOI 10.1126/science.1068768; Liang HE, 2004, CELL, V118, P19, DOI 10.1016/j.cell.2004.06.019; Roldan E, 2005, NAT IMMUNOL, V6, P31, DOI 10.1038/ni1150; Shaffer AL, 1997, IMMUNITY, V6, P131, DOI 10.1016/S1074-7613(00)80420-3	12	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					128	130		10.1038/ni0205-128	http://dx.doi.org/10.1038/ni0205-128			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15662439				2022-12-18	WOS:000226468100007
J	Palmer, E				Palmer, E			Signaling negative selection: is MINK the missing link?	NATURE IMMUNOLOGY			English	Editorial Material							THYMOCYTES; KINASES; MEMBER; MEKK1; BIM; ERK; NCK	The signaling pathways distinguishing positive and negative thymic selection are critical for establishing T cell immunity and tolerance. The kinase MINK might be an important component that differentiates these two events.	Univ Basel Hosp, Dept Res, Lab Transplantat Immunol & Nephrol, CH-4031 Basel, Switzerland	University of Basel	Palmer, E (corresponding author), Univ Basel Hosp, Dept Res, Lab Transplantat Immunol & Nephrol, Hebelstr 20, CH-4031 Basel, Switzerland.	ed.palmer@unibas.ch						Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Dan I, 2000, FEBS LETT, V469, P19, DOI 10.1016/S0014-5793(00)01247-3; Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; HY Y, IN PRESS J BIOL CHEM; McCarty N, 2005, NAT IMMUNOL, V6, P65, DOI 10.1038/ni1145; Rincon M, 1998, J EXP MED, V188, P1817, DOI 10.1084/jem.188.10.1817; Su YC, 1997, EMBO J, V16, P1279, DOI 10.1093/emboj/16.6.1279; Sugawara T, 1998, IMMUNITY, V9, P565, DOI 10.1016/S1074-7613(00)80639-1; Werlen G, 2003, SCIENCE, V299, P1859, DOI 10.1126/science.1067833; Werlen G, 2000, NATURE, V406, P422, DOI 10.1038/35019094; Whitfield J, 2001, NEURON, V29, P629, DOI 10.1016/S0896-6273(01)00239-2; Xu SC, 1997, J BIOL CHEM, V272, P32056, DOI 10.1074/jbc.272.51.32056	12	2	3	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					9	10		10.1038/ni0105-9	http://dx.doi.org/10.1038/ni0105-9			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA	15611773				2022-12-18	WOS:000225888500003
J	Weill, JC; Reynaud, CA				Weill, JC; Reynaud, CA			RPA tightens AID to DNA ... editing	NATURE IMMUNOLOGY			English	Editorial Material							CLASS SWITCH RECOMBINATION; CYTIDINE DEAMINASE AID; HYPERMUTATION	A recent paper in Nature identifies replication protein A as the key binding partner of AID for B cell somatic hypermutation.	Fac Med Necker Enfants Malad, INSERM, U373, F-75730 Paris 15, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Paris	Weill, JC (corresponding author), Fac Med Necker Enfants Malad, INSERM, U373, 156 rue Vaugirard, F-75730 Paris 15, France.	weil@necker.fr; reynaud@necker.fr						Barreto V, 2003, MOL CELL, V12, P501, DOI 10.1016/S1097-2765(03)00309-5; Brar SS, 2004, J BIOL CHEM, V279, P26395, DOI 10.1074/jbc.M403503200; Chaudhuri J, 2003, NATURE, V422, P726, DOI 10.1038/nature01574; CHAUDHURI J, 2004, NATURE, DOI DOI 10.1039/NATURE02821; Honjo T, 2004, IMMUNITY, V20, P659, DOI 10.1016/j.immuni.2004.05.011; Ito S, 2004, P NATL ACAD SCI USA, V101, P1975, DOI 10.1073/pnas.0307335101; MCBRIDE K, 2004, J EXP MED, V9, P235; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Revy P, 2000, CELL, V102, P565, DOI 10.1016/S0092-8674(00)00079-9; Reynaud CA, 2003, NAT IMMUNOL, V4, P631, DOI 10.1038/ni0703-631; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61	12	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					876	878		10.1038/ni0904-876	http://dx.doi.org/10.1038/ni0904-876			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15334081				2022-12-18	WOS:000223612500007
J	Quill, H; Giovanni, M				Quill, H; Giovanni, M			Working with dangerous bugs	NATURE IMMUNOLOGY			English	Editorial Material								As part of the national effort in the US to protect civilians from bioterrorist attacks, the US National Institute of Allergy and Infectious Diseases (NIAID) was charged with the development of diverse research resources. The NIAID Resources for Biodefense Research program is forging new collaborations between immunologists and infectious disease experts and is reinvigorating research in the general area of immune protection against pathogenic infection.	NIAID, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Quill, H (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	hquill@niaid.nih.gov							0	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2004	5	8					765	767		10.1038/ni0804-765	http://dx.doi.org/10.1038/ni0804-765			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	841TX	15282555				2022-12-18	WOS:000222955600003
J	Gunn, MD; Kelsoe, G				Gunn, MD; Kelsoe, G			Should we B-leavin' now?	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR; FTY720; CELLS; S1P(1); EGRESS	For lymphocytes to function properly, they must move to and recognize precise anatomical locations. To do so, lymphocytes must decipher cues from a panoply of competing traffic signals.	Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University; Duke University	Gunn, MD (corresponding author), Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA.	michael.gunn@duke.edu		Gunn, Michael/0000-0003-4602-0667				Aki FT, 2003, EXPERT OPIN BIOL TH, V3, P665; Allende ML, 2004, J BIOL CHEM, V279, P15396, DOI 10.1074/jbc.M314291200; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Cinamon G, 2004, NAT IMMUNOL, V5, P713, DOI 10.1038/ni1083; Graler MH, 2004, FASEB J, V18, P551, DOI 10.1096/fj.03-0910fje; Guinamard R, 2000, NAT IMMUNOL, V1, P31, DOI 10.1038/76882; Henning G, 2001, J EXP MED, V194, P1875, DOI 10.1084/jem.194.12.1875; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; Rosen H, 2003, IMMUNOL REV, V195, P160, DOI 10.1034/j.1600-065X.2003.00068.x; Sanna MG, 2004, J BIOL CHEM, V279, P13839, DOI 10.1074/jbc.M311743200	11	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2004	5	7					703	704		10.1038/ni0704-703	http://dx.doi.org/10.1038/ni0704-703			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	833IO	15224099				2022-12-18	WOS:000222331200015
J	Winoto, A				Winoto, A			Cutting into innate immunity	NATURE IMMUNOLOGY			English	Editorial Material							FUSION PROTEIN; SEPTIC SHOCK; APOPTOSIS; ACTIVATION; CASPASES; BETA	Human caspase-12, unlike that found in the mouse, is not involved in apoptosis and thus its physiological function is unclear. However, a unique polymorphism of human caspase-12 has demonstrated its importance in innate immunity.	Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Winoto, A (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Immunol, Berkeley, CA 94720 USA.	winoto@berkeley.edu						Abraham E, 2001, CRIT CARE MED, V29, P503, DOI 10.1097/00003246-200103000-00006; Alexander WS, 2004, ANNU REV IMMUNOL, V22, P503, DOI 10.1146/annurev.immunol.22.091003.090312; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Egen JG, 2002, NAT IMMUNOL, V3, P611, DOI 10.1038/ni0702-611; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Inohara N, 2003, NAT REV IMMUNOL, V3, P371, DOI 10.1038/nri1086; Kobayashi K, 2002, CELL, V110, P191, DOI 10.1016/S0092-8674(02)00827-9; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Pasare C, 2003, CURR OPIN IMMUNOL, V15, P677, DOI 10.1016/j.coi.2003.09.002; Pasparakis M, 1996, J EXP MED, V184, P1397, DOI 10.1084/jem.184.4.1397; Saleh M, 2004, NATURE, V429, P75, DOI 10.1038/nature02451	12	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2004	5	6					563	564		10.1038/ni0604-563	http://dx.doi.org/10.1038/ni0604-563			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	824DH	15164013				2022-12-18	WOS:000221664000005
J	Hodgkin, J				Hodgkin, J			Dissecting worm immunity	NATURE IMMUNOLOGY			English	Editorial Material							CAENORHABDITIS-ELEGANS; INNATE IMMUNITY; PROTEIN; PATHWAY; SARM	The function of the mammalian TIR domain adaptor protein SARM is unclear. In Caenorhabditis elegans, however, the homolog of SARM controls the induction of peptides involved in innate immunity.	Univ Oxford, Dept Biochem, Genet Unit, Oxford OX1 3QU, England	University of Oxford	Hodgkin, J (corresponding author), Univ Oxford, Dept Biochem, Genet Unit, S Parks Rd, Oxford OX1 3QU, England.	jah@bioch.ox.ac.uk						Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Kato Y, 2002, BIOCHEM J, V361, P221, DOI 10.1042/0264-6021:3610221; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Mallo GV, 2002, CURR BIOL, V12, P1209, DOI 10.1016/S0960-9822(02)00928-4; Mink M, 2001, GENOMICS, V74, P234, DOI 10.1006/geno.2001.6548; Nathoo AN, 2001, P NATL ACAD SCI USA, V98, P14000, DOI 10.1073/pnas.241231298; O'Neill LAJ, 2003, TRENDS IMMUNOL, V24, P287, DOI 10.1016/S1471-4906(03)00115-7; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X	8	2	11	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2004	5	5					471	472		10.1038/ni0504-471	http://dx.doi.org/10.1038/ni0504-471			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	816HN	15116111				2022-12-18	WOS:000221101100007
J	Rothenberg, EV				Rothenberg, EV			From totipotency to T in a dish	NATURE IMMUNOLOGY			English	Editorial Material							EMBRYONIC STEM-CELLS; IN-VITRO GENERATION; EXPRESSION; NOTCH1; PU.1	Given the right sequence of cues, embryonic stem cells can develop into any cell type found in the body. New work shows how manipulation of supportive stromal cells to provide essential Delta-Notch interactions allows embryonic stem cells to develop into functional T lymphocytes during in vitro culture.	CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA	California Institute of Technology	Rothenberg, EV (corresponding author), CALTECH, Div Biol 156 29, Pasadena, CA 91125 USA.	evroth@its.caltech.edu		Rothenberg, Ellen/0000-0002-3901-347X				de Pooter RF, 2003, BLOOD, V102, P1649, DOI 10.1182/blood-2003-01-0224; Fisher RC, 1998, MOL CELL BIOL, V18, P4347, DOI 10.1128/MCB.18.7.4347; Jaleco AC, 2001, J EXP MED, V194, P991, DOI 10.1084/jem.194.7.991; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Olson MC, 1995, IMMUNITY, V3, P703, DOI 10.1016/1074-7613(95)90060-8; POTOCNIK AJ, 1994, EMBO J, V13, P5274, DOI 10.1002/j.1460-2075.1994.tb06861.x; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; SIMON MC, 1992, NAT GENET, V1, P92, DOI 10.1038/ng0592-92; Zuniga-Pflucker JC, 2004, NAT REV IMMUNOL, V4, P67, DOI 10.1038/nri1257	12	2	4	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2004	5	4					359	360		10.1038/ni0404-359	http://dx.doi.org/10.1038/ni0404-359			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	807QL	15052264				2022-12-18	WOS:000220515900007
J	Reith, W				Reith, W			ComPLEXIN new targets for CIITA	NATURE IMMUNOLOGY			English	Editorial Material							CLASS-II TRANSACTIVATOR; T-CELL ACTIVATION; EXPRESSION; SEMAPHORINS; RECEPTORS; GUIDANCE	Growing evidence indicates immune and nervous systems use common mechanisms to mediate intercellular communication. Adding to this list is the discovery that dendritic cells modulate T cell interactions through expression of the neuronal receptor plexin-A1, which is regulated by the transcriptional activator CIITA.	Univ Geneva, Sch Med, Dept Genet & Microbiol, CMU, CH-1211 Geneva 4, Switzerland	University of Geneva	Reith, W (corresponding author), Univ Geneva, Sch Med, Dept Genet & Microbiol, CMU, 1 Rue Michel Servet, CH-1211 Geneva 4, Switzerland.							Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Kikutani H, 2003, NAT REV IMMUNOL, V3, P159, DOI 10.1038/nri1003; Kumanogoh A, 2002, NATURE, V419, P629, DOI 10.1038/nature01037; Landmann S, 2001, J EXP MED, V194, P379, DOI 10.1084/jem.194.4.379; Nagarajan UM, 2002, J IMMUNOL, V169, P5078, DOI 10.4049/jimmunol.169.9.5078; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Shi W, 2000, IMMUNITY, V13, P633, DOI 10.1016/S1074-7613(00)00063-7; Tamagnone L, 1999, CELL, V99, P71, DOI 10.1016/S0092-8674(00)80063-X; Tamagnone L, 2000, TRENDS CELL BIOL, V10, P377, DOI 10.1016/S0962-8924(00)01816-X; Ting JPY, 2002, CELL, V109, pS21, DOI 10.1016/S0092-8674(02)00696-7; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Wong AW, 2003, NAT IMMUNOL, V4, P891, DOI 10.1038/ni960	12	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2003	4	9					819	820		10.1038/ni0903-819	http://dx.doi.org/10.1038/ni0903-819			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	715YN	12942078				2022-12-18	WOS:000185002200004
J	Fink, PJ				Fink, PJ			Deadbeat neighbors influence thymocyte lineage commitment	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; HOMEOSTATIC PROLIFERATION; NEGATIVE SELECTION; COMPETITION; DECISION; THYMUS		Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Fink, PJ (corresponding author), Univ Washington, Dept Immunol, HSB-1607H,Campus Box 357650, Seattle, WA 98195 USA.							Butz EA, 1998, IMMUNITY, V8, P167, DOI 10.1016/S1074-7613(00)80469-0; Canelles M, 2003, NAT IMMUNOL, V4, P756, DOI 10.1038/ni953; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Germain RN, 2002, NAT REV IMMUNOL, V2, P309, DOI 10.1038/nri798; Goverman J, 1997, IMMUNOL TODAY, V18, P204; Kedl RM, 2002, NAT IMMUNOL, V3, P27, DOI 10.1038/ni742; Lind EF, 2001, J EXP MED, V194, P127, DOI 10.1084/jem.194.2.127; Moses CT, 2003, P NATL ACAD SCI USA, V100, P1185, DOI 10.1073/pnas.0334572100; Singer A, 2002, CURR OPIN IMMUNOL, V14, P207, DOI 10.1016/S0952-7915(02)00323-0; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; SURH CD, 1994, NATURE, V372, P100, DOI 10.1038/372100a0; Troy AE, 2003, J IMMUNOL, V170, P672, DOI 10.4049/jimmunol.170.2.672	12	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					727	728		10.1038/ni0803-727	http://dx.doi.org/10.1038/ni0803-727			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12888791				2022-12-18	WOS:000184441500007
J	Pope, M				Pope, M			Nefarious abuse	NATURE IMMUNOLOGY			English	Editorial Material							HIV; INFECTION; CELLS; ACTIVATION		Populat Council, Ctr Biomed Res, New York, NY 10021 USA	Population Council	Pope, M (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.							DEACON NJ, 1995, SCIENCE, V270, P988, DOI 10.1126/science.270.5238.988; Fackler OT, 2002, IMMUNITY, V16, P493, DOI 10.1016/S1074-7613(02)00307-2; Frank I., 2002, Current Molecular Medicine (Hilversum), V2, P229, DOI 10.2174/1566524024605716; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Martinez-Maza O, 2002, CURR OPIN ONCOL, V14, P528, DOI 10.1097/00001622-200209000-00009; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Peterlin BM, 2003, NAT REV IMMUNOL, V3, P97, DOI 10.1038/nri998; PINCHUK LM, 1994, IMMUNITY, V1, P317, DOI 10.1016/1074-7613(94)90083-3; Sousa CRE, 2001, IMMUNITY, V14, P495; Swingler S, 1999, NAT MED, V5, P997, DOI 10.1038/12433; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Zhang ZQ, 1999, SCIENCE, V286, P1353, DOI 10.1126/science.286.5443.1353	12	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					729	730		10.1038/ni0803-729	http://dx.doi.org/10.1038/ni0803-729			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12888792				2022-12-18	WOS:000184441500008
J	Underhill, D				Underhill, D			Toll gets tied in a knot	NATURE IMMUNOLOGY			English	Editorial Material							DROSOPHILA TOLL; RECEPTORS; RECOGNITION; IMMUNITY		Inst Syst Biol, Seattle, WA 98103 USA	Institute for Systems Biology (ISB)	Underhill, D (corresponding author), Inst Syst Biol, 1441 N 34th St, Seattle, WA 98103 USA.		UNDERHILL, DAVID/ABE-2185-2021	Underhill, David/0000-0002-2989-658X				Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; O'Neill LAJ, 1998, J LEUKOCYTE BIOL, V63, P650, DOI 10.1002/jlb.63.6.650; Ozinsky A, 2000, P NATL ACAD SCI USA, V97, P13766, DOI 10.1073/pnas.250476497; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Underhill DM, 2002, CURR OPIN IMMUNOL, V14, P103, DOI 10.1016/S0952-7915(01)00304-1; Weber ANR, 2003, NAT IMMUNOL, V4, P794, DOI 10.1038/ni955	9	2	2	0	2	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2003	4	8					723	724		10.1038/ni0803-723	http://dx.doi.org/10.1038/ni0803-723			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	706FA	12888789				2022-12-18	WOS:000184441500005
J	Tesselaar, K; Arens, R; van Schijndel, GMW; Baars, PA; van der Valk, MA; Borst, J; van Oers, MHJ; van Lier, RAW				Tesselaar, K; Arens, R; van Schijndel, GMW; Baars, PA; van der Valk, MA; Borst, J; van Oers, MHJ; van Lier, RAW			Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions (vol 4, pg 49, 2003)	NATURE IMMUNOLOGY			English	Correction														Tesselaar, Kiki/0000-0002-9847-0814; van Lier, Rene/0000-0002-3201-7144				Tesselaar K, 2003, NAT IMMUNOL, V4, P49, DOI 10.1038/ni869	1	2	2	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2003	4	3					295	295		10.1038/ni0303-295	http://dx.doi.org/10.1038/ni0303-295			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	649HH		Bronze			2022-12-18	WOS:000181201000020
J	Barnhart, BC; Peter, ME				Barnhart, BC; Peter, ME			Two faces of caspase-8	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL PROLIFERATION; NF-KAPPA-B; ACTIVATION; FADD; FADD/MORT1; APOPTOSIS; MICE	A deficit of caspase-8 should presumably lead to over-activation of lymphocytes. A recent report in Nature from Lenardo's group, however, describes humans with a severe caspase-8 deficiency whose T cells, counter-intuitively, have impaired activation abilities.	Univ Chicago, Ben May Inst Canc Res, Chicago, IL 60637 USA	University of Chicago	Barnhart, BC (corresponding author), Univ Chicago, Ben May Inst Canc Res, 924 E 57th St, Chicago, IL 60637 USA.			Peter, Marcus Ernst/0000-0003-3216-036X				Alam A, 1999, J EXP MED, V190, P1879, DOI 10.1084/jem.190.12.1879; CERRETTI DP, 1992, SCIENCE, V256, P97, DOI 10.1126/science.1373520; Chaudhary PM, 2000, ONCOGENE, V19, P4451, DOI 10.1038/sj.onc.1203812; Hu WH, 2000, J BIOL CHEM, V275, P10838, DOI 10.1074/jbc.275.15.10838; Kennedy NJ, 1999, J EXP MED, V190, P1891, DOI 10.1084/jem.190.12.1891; Newton K, 1998, EMBO J, V17, P706, DOI 10.1093/emboj/17.3.706; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Walsh CM, 1998, IMMUNITY, V8, P439, DOI 10.1016/S1074-7613(00)80549-X; Yeh WC, 1998, SCIENCE, V279, P1954, DOI 10.1126/science.279.5358.1954; Zhang JK, 1998, NATURE, V392, P296, DOI 10.1038/32681; Zornig M, 1998, CURR BIOL, V8, P467, DOI 10.1016/S0960-9822(98)70182-4	12	2	2	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2002	3	10					896	898		10.1038/ni1002-896	http://dx.doi.org/10.1038/ni1002-896			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	597VU	12352964				2022-12-18	WOS:000178242100007
J	Locksley, RM				Locksley, RM			Blood lines	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; SELECTION		Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Immunol Microbiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, C-443 521 Parnassus Ave, San Francisco, CA 94143 USA.							Bendelac A, 2001, NAT REV IMMUNOL, V1, P177, DOI 10.1038/35105052; Benlagha K, 2002, SCIENCE, V296, P553, DOI 10.1126/science.1069017; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Eberl G, 1998, IMMUNITY, V9, P345, DOI 10.1016/S1074-7613(00)80617-2; Kerksiek KM, 1999, J EXP MED, V190, P195, DOI 10.1084/jem.190.2.195; Leishman AJ, 2002, IMMUNITY, V16, P355, DOI 10.1016/S1074-7613(02)00284-4; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Maurice MM, 2001, P NATL ACAD SCI USA, V98, P7437, DOI 10.1073/pnas.141143298; Reinhardt RL, 2001, NATURE, V410, P101, DOI 10.1038/35065111; Urdahl KB, 2002, NAT IMMUNOL, V3, P772, DOI 10.1038/ni814	10	2	2	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					705	706		10.1038/ni0802-705	http://dx.doi.org/10.1038/ni0802-705			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12145653				2022-12-18	WOS:000177118500005
J	Marchalonis, JJ; Cone, RE				Marchalonis, JJ; Cone, RE			IgT lives! A matter of semantics?	NATURE IMMUNOLOGY			English	Letter							T-CELL RECEPTOR; BETA-CHAIN; IMMUNOGLOBULIN; ANTIGEN		Univ Arizona, Coll Med, AHSC, Tucson, AZ 85724 USA; Univ Connecticut, Hlth Sci Ctr, Farmington, CT 06030 USA	University of Arizona; University of Connecticut	Marchalonis, JJ (corresponding author), Univ Arizona, Coll Med, AHSC, Tucson, AZ 85724 USA.							Chien YH, 1996, ANNU REV IMMUNOL, V14, P511, DOI 10.1146/annurev.immunol.14.1.511; CONE RE, 1974, BIOCHEMISTRY-US, V140, P345, DOI 10.1042/bj1400345; CONE RE, 1974, IMMUNOLOGY, V26, P49; FELLAH JS, 1993, P NATL ACAD SCI USA, V90, P6811, DOI 10.1073/pnas.90.14.6811; GREAVES M, 1975, NATURE, V256, P92, DOI 10.1038/256092a0; KAYMAZ H, 1993, INT IMMUNOL, V5, P491, DOI 10.1093/intimm/5.5.491; Marchalonis JJ, 1998, ADV IMMUNOL, V70, P417, DOI 10.1016/S0065-2776(08)60392-2; MARCHALONIS JJ, 1973, TRANSPLANT REV-DENMA, V14, P3; Marchalonis JJ, 1997, P SOC EXP BIOL MED, V216, P303; RAST JP, 1994, P NATL ACAD SCI USA, V91, P9248, DOI 10.1073/pnas.91.20.9248; Silverstein AM, 2002, NAT IMMUNOL, V3, P105, DOI 10.1038/ni0202-105	11	2	2	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2002	3	8					697	697		10.1038/ni0802-697	http://dx.doi.org/10.1038/ni0802-697			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	578LF	12145650				2022-12-18	WOS:000177118500002
J	Sprent, J; Uittenbogaart, CH; Fink, PJ				Sprent, J; Uittenbogaart, CH; Fink, PJ			A season for midwinter immunology	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; LYMPHOCYTES; SURVIVAL; SELECTION; NAIVE		Scripps Res Inst, Dept Immunol, La Jolla, CA 92037 USA; Univ Calif Los Angeles, Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Microbiol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Immunol, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Sch Med, Dept Mol Genet, Los Angeles, CA 90095 USA; Univ Washington, Dept Immunol, Seattle, WA 98195 USA	Scripps Research Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Washington; University of Washington Seattle	Sprent, J (corresponding author), Scripps Res Inst, Dept Immunol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jsprent@scripps.edu; pfink@uwashington.edu						Arakawa H, 2002, SCIENCE, V295, P1301, DOI 10.1126/science.1067308; Bensinger SJ, 2001, J EXP MED, V194, P427, DOI 10.1084/jem.194.4.427; Fink PJ, 2000, IMMUNOL TODAY, V21, P561, DOI 10.1016/S0167-5699(00)01734-5; Freitas AA, 2000, ANNU REV IMMUNOL, V18, P83, DOI 10.1146/annurev.immunol.18.1.83; Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508; Heath WR, 2001, NAT REV IMMUNOL, V1, P126, DOI 10.1038/35100512; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Huang CY, 2002, J IMMUNOL, V168, P3259, DOI 10.4049/jimmunol.168.7.3259; Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302; McGargill MA, 2000, NAT IMMUNOL, V1, P336, DOI 10.1038/79790; Mitchell TC, 2001, NAT IMMUNOL, V2, P397, DOI 10.1038/87692; Nemazee D, 2000, ANNU REV IMMUNOL, V18, P19, DOI 10.1146/annurev.immunol.18.1.19; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Sakaguchi S, 2001, IMMUNOL REV, V182, P18, DOI 10.1034/j.1600-065X.2001.1820102.x; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Sprent J, 2002, ANNU REV IMMUNOL, V20, P551, DOI 10.1146/annurev.immunol.20.100101.151926; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098	18	2	2	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					414	416		10.1038/ni0502-414	http://dx.doi.org/10.1038/ni0502-414			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11976714				2022-12-18	WOS:000175411200005
J	Shigeo, K				Shigeo, K			Beating a kinase?	NATURE IMMUNOLOGY			English	News Item							BRUTONS TYROSINE KINASE; PROTEIN; PATHWAYS; BTK	All kinases must be tightly regulated. Isolation of a novel molecule called IBtk identifies a potential mechanism for the regulation of Bruton's tyrosine kinase in B cells.	Keio Univ, Dept Microbiol & Immunol, Sch Med, Tokyo 1608582, Japan	Keio University	Shigeo, K (corresponding author), Keio Univ, Dept Microbiol & Immunol, Sch Med, Tokyo 1608582, Japan.							Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Kawakami Y, 2000, P NATL ACAD SCI USA, V97, P7423, DOI 10.1073/pnas.120175097; Liu WM, 2001, NAT IMMUNOL, V2, P939, DOI 10.1038/ni1001-939; Marshall AJ, 2000, IMMUNOL REV, V176, P30; Okada T, 2000, IMMUNITY, V13, P817, DOI 10.1016/S1074-7613(00)00079-0; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Shan XC, 2000, MOL CELL BIOL, V20, P6945, DOI 10.1128/MCB.20.18.6945-6957.2000; Sidorenko SP, 1996, IMMUNITY, V5, P353, DOI 10.1016/S1074-7613(00)80261-7; Tsukada S, 2001, ADV IMMUNOL, V77, P123, DOI 10.1016/S0065-2776(01)77016-2; Wakioka T, 2001, NATURE, V412, P647, DOI 10.1038/35088082; Webb CF, 2000, J IMMUNOL, V165, P6956, DOI 10.4049/jimmunol.165.12.6956; Yamadori T, 1999, P NATL ACAD SCI USA, V96, P6341, DOI 10.1073/pnas.96.11.6341; Yasukawa H, 2000, ANNU REV IMMUNOL, V18, P143, DOI 10.1146/annurev.immunol.18.1.143	14	2	2	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					897	898		10.1038/ni1001-897	http://dx.doi.org/10.1038/ni1001-897			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11577340				2022-12-18	WOS:000171361500004
J	Silverstein, AM				Silverstein, AM			The end of immunology?	NATURE IMMUNOLOGY			English	Editorial Material									Johns Hopkins Sch Med, Inst Hist Med, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Medicine	Silverstein, AM (corresponding author), Johns Hopkins Sch Med, Inst Hist Med, 1900 E Monument St, Baltimore, MD 21205 USA.							Breinl F., 1930, Z PHYSL CHEM, V192, P45; BURNET, 1956, AUST J SCI, V20, P67; BURNET, 1959, CLONAL SELECTION THE; Bush V., 1945, SCI ENDLESS FRONTIER, DOI DOI 10.1016/j.techsoc.2019.03.007; CLAPESATTLE H, 1984, DR WEBB COLORADO SPR, P401; CRICK F, 1988, WHAT MAD PURSUITS PE; EDELMAN GM, 1969, P NATL ACAD SCI USA, V63, P78, DOI 10.1073/pnas.63.1.78; Erlich P, 1897, KLIN JB JENA, V6, P299; GLASS B, 1971, SCIENCE, V171, P23, DOI 10.1126/science.171.3966.23; GLASS B, 1979, Q REV BIOL, V54, P31, DOI 10.1086/410982; Hawking Stephen, 1981, PHYS B           JAN, P15; Horgan John, 1997, END SCI; JAMES P, 1994, STRATEGEMATICON; JEFFREY E, 1940, J PATENT OFF SOC JUL, P479; JERNE NK, 1969, AUSTRALAS ANN MED, V18, P345; JERNE NK, 1967, COLD SPRING HARB SYM, V32, P591; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; KAY LE, 1985, J HIST BIOL, V18, P207, DOI 10.1007/BF00120110; KOSHLAND DE, 1995, SCIENCE, V267, P1575, DOI 10.1126/science.7886434; Kuhn T, 2012, STRUCTURE SCI REVOLU, V4th, DOI DOI 10.7208/CHICAGO/9780226458144.001.0001; Lanouette William, 1992, GENIUS SHADOWS BIOGR; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; LINDLEY D, 1993, END PHYSICS; LINDLEY D, 1993, END PHYSICS, P255; MEDAWAR PB, 1984, LIMITS SCI; METCHNIKOFF, 1968, COMP PATHOLOGY INFLA; Michelson A. A., 1968, PHYS TODAY       APR, P9; Pauling L, 1940, J AM CHEM SOC, V62, P2643, DOI 10.1021/ja01867a018; PAULING L, 1949, SCIENCE, V110, P64; PAULING L, 1939, NATURE CHEM BAND; Pressman D, 1968, STRUCTURAL BASIS ANT; Silverstein AM, 2000, NAT IMMUNOL, V1, P93, DOI 10.1038/77874; Silverstein AM, 1999, HIST SCI, V37, P407, DOI 10.1177/007327539903700402; Silverstein AM, 1999, CELL IMMUNOL, V194, P213, DOI 10.1006/cimm.1999.1505; STENT G, 1969, COMING GOLDEN AGE VI; SZILARD L, 1960, P NATL ACAD SCI USA, V44, P293; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323; TALMAGE DW, 1959, SCIENCE, V129, P1643, DOI 10.1126/science.129.3364.1643; VIRCHOW R, 1956, B HIST MED, V30, P538	39	2	2	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					893	895		10.1038/ni1001-893	http://dx.doi.org/10.1038/ni1001-893			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11577339				2022-12-18	WOS:000171361500003
J	Asnagli, H; Murphy, KM				Asnagli, H; Murphy, KM			The functional genomics experience (are you experienced?)	NATURE IMMUNOLOGY			English	News Item							CYTOKINE GENE-EXPRESSION; CUTTING EDGE; T-CELLS; IL-4; CLUSTER; REGION; IDENTIFICATION; INTERLEUKIN-4; SEQUENCE	The era of genomic-wide sequence analysis promises to yield new insights in global regulatory gene control. Comparative genome studies have identified a critical regulator of T(H)2 cytokine expression.	Washington Univ, Sch Med, Dept Pathol & Immunol, Howard Hughes Med Inst, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL)	Asnagli, H (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, Howard Hughes Med Inst, 660 S Euclid Ave,Box 8118, St Louis, MO 63110 USA.							Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Frazer KA, 1997, GENOME RES, V7, P495, DOI 10.1101/gr.7.5.495; Lacy DA, 2000, J IMMUNOL, V164, P4569, DOI 10.4049/jimmunol.164.9.4569; Lee GR, 2001, IMMUNITY, V14, P447, DOI 10.1016/S1074-7613(01)00125-X; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Mohrs M, 2001, NAT IMMUNOL, V2, P842, DOI 10.1038/ni0901-842; PENNACCHIO LA, 1997, NATURE REV GENET, V7, P495; Ranganath S, 1998, J IMMUNOL, V161, P3822; Sherman MA, 1999, EUR J IMMUNOL, V29, P1235, DOI 10.1002/(SICI)1521-4141(199904)29:04<1235::AID-IMMU1235>3.3.CO;2-S; Szabo SJ, 1997, CURR OPIN IMMUNOL, V9, P776, DOI 10.1016/S0952-7915(97)80177-X; Takemoto N, 2000, J IMMUNOL, V165, P6687, DOI 10.4049/jimmunol.165.12.6687; Takemoto N, 1998, INT IMMUNOL, V10, P1981, DOI 10.1093/intimm/10.12.1981; Wenner CA, 1997, J IMMUNOL, V158, P765; Zheng WP, 1997, CELL, V89, P587, DOI 10.1016/S0092-8674(00)80240-8	14	2	2	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					826	828		10.1038/ni0901-826	http://dx.doi.org/10.1038/ni0901-826			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM	11526395				2022-12-18	WOS:000170781200020
J	Lee, KH				Lee, KH			Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type I diabetes (vol 2, pg 501, 2001)	NATURE IMMUNOLOGY			English	Correction																		Lee KH, 2001, NAT IMMUNOL, V2, P501, DOI 10.1038/88694	1	2	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2001	2	9					889	889						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	468WM					2022-12-18	WOS:000170781200031
J	Locksley, RM				Locksley, RM			Flying doctors	NATURE IMMUNOLOGY			English	News Item							CUTANEOUS LEISHMANIASIS; VECTOR; SALIVA		Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; Univ Calif San Francisco, Dept Immunol Microbiol, San Francisco, CA 94143 USA	Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Locksley, RM (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	locksley@medicine.ucsf.edu						Belkaid Y, 1998, J EXP MED, V188, P1941, DOI 10.1084/jem.188.10.1941; Charlab R, 1999, P NATL ACAD SCI USA, V96, P15155, DOI 10.1073/pnas.96.26.15155; FRYAUFF DJ, 1993, AM J TROP MED HYG, V49, P598, DOI 10.4269/ajtmh.1993.49.598; Kamanaka M, 1996, IMMUNITY, V4, P275, DOI 10.1016/S1074-7613(00)80435-5; Kamhawi S, 2000, SCIENCE, V290, P1351, DOI 10.1126/science.290.5495.1351; LAKE JA, 1988, P NATL ACAD SCI USA, V85, P4779, DOI 10.1073/pnas.85.13.4779; LEWIS DJ, 1987, ANN TROP MED PARASIT, V81, P173, DOI 10.1080/00034983.1987.11812109; Matthews DJ, 2000, J IMMUNOL, V164, P1458, DOI 10.4049/jimmunol.164.3.1458; REINER SL, 1995, ANNU REV IMMUNOL, V13, P151, DOI 10.1146/annurev.iy.13.040195.001055; SCHLEIN Y, 1992, P NATL ACAD SCI USA, V89, P9944, DOI 10.1073/pnas.89.20.9944; Stark KR, 1996, PARASITOL TODAY, V12, P430, DOI 10.1016/0169-4758(96)10064-8; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436	12	2	2	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					457	458		10.1038/82695	http://dx.doi.org/10.1038/82695			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101861				2022-12-18	WOS:000165724600004
J	Tan, BH; Modlin, RL				Tan, BH; Modlin, RL			Drosophila, the savvy exterminator	NATURE IMMUNOLOGY			English	Letter							IMMUNITY		Univ Calif Los Angeles, Sch Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Tan, BH (corresponding author), Univ Calif Los Angeles, Sch Med, 10833 Le Conte Ave, Los Angeles, CA 90095 USA.		Modlin, Robert L/M-7941-2014	Modlin, Robert L/0000-0003-4720-031X				Fenton MJ, 2000, NAT IMMUNOL, V1, P279, DOI 10.1038/79719; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Lemaitre B, 1997, P NATL ACAD SCI USA, V94, P14614, DOI 10.1073/pnas.94.26.14614; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; O'Neil DA, 1999, J IMMUNOL, V163, P6718; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tauszig S, 2000, P NATL ACAD SCI USA, V97, P10520, DOI 10.1073/pnas.180130797	9	2	2	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					361	361		10.1038/80793	http://dx.doi.org/10.1038/80793			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062488	Bronze			2022-12-18	WOS:000165076100002
J	Fenton, MJ				Fenton, MJ			Signal transduction on the fly	NATURE IMMUNOLOGY			English	News Item							DROSOPHILA; PROTEINS; COMPLEX		Boston Univ, Sch Med, Ctr Pulm, Dept Med, Boston, MA 02118 USA	Boston University	Fenton, MJ (corresponding author), Boston Univ, Sch Med, Ctr Pulm, Dept Med, Boston, MA 02118 USA.							Han ZS, 1999, J BIOL CHEM, V274, P21355, DOI 10.1074/jbc.274.30.21355; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Manfruelli P, 1999, EMBO J, V18, P3380, DOI 10.1093/emboj/18.12.3380; Means TK, 2000, CYTOKINE GROWTH F R, V11, P219, DOI 10.1016/S1359-6101(00)00006-X; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3; Williams MJ, 1997, EMBO J, V16, P6120, DOI 10.1093/emboj/16.20.6120	10	2	2	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					279	281		10.1038/79719	http://dx.doi.org/10.1038/79719			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017096				2022-12-18	WOS:000089869700008
J	Canfield, S; Rothman, P				Canfield, S; Rothman, P			T(H)2 inflammation repressed by chemokines	NATURE IMMUNOLOGY			English	News Item							BCL-6; CELLS; TRANSCRIPTION; EXPRESSION; RESPONSES; STAT6; GENE; MICE	The proto-oncogene BCL6 participates in the regulation of immune responses; a lack of it leads to generalized type 2 inflammation. Macrophage chemokine genes have now been identified as targets for BCL-6 repression and perhaps induce this inflammation.	Columbia Univ, Dept Med, Lab Allergy & Inflammatory Lung Dis, New York, NY 10032 USA	Columbia University	Canfield, S (corresponding author), Columbia Univ, Dept Med, Lab Allergy & Inflammatory Lung Dis, 630 W 168th St, New York, NY 10032 USA.							Braun MC, 2000, J IMMUNOL, V164, P3009, DOI 10.4049/jimmunol.164.6.3009; CATTORETTI G, 1995, BLOOD, V86, P45, DOI 10.1182/blood.V86.1.45.bloodjournal86145; Dent AL, 1998, P NATL ACAD SCI USA, V95, P13823, DOI 10.1073/pnas.95.23.13823; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Gu L, 2000, NATURE, V404, P407, DOI 10.1038/35006097; Harris MB, 1999, MOL CELL BIOL, V19, P7264; Kaplan MH, 1996, IMMUNITY, V4, P313, DOI 10.1016/S1074-7613(00)80439-2; Karpus WJ, 1997, J IMMUNOL, V158, P4129; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; Magram J, 1996, ANN NY ACAD SCI, V795, P60, DOI 10.1111/j.1749-6632.1996.tb52655.x; Mattner F, 1996, EUR J IMMUNOL, V26, P1553, DOI 10.1002/eji.1830260722; TONEY, 2000, NATURE IMMUNOL, V1, P214; Trinchieri G, 1998, Int Rev Immunol, V16, P365, DOI 10.3109/08830189809043002; Yamochi T, 1997, LEUKEMIA, V11, P694, DOI 10.1038/sj.leu.2400631; YE BHH, 1993, CANCER RES, V53, P2732; YE HB, 1997, NAT GENET, V16, P161	16	2	2	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					189	190		10.1038/79720	http://dx.doi.org/10.1038/79720			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973271				2022-12-18	WOS:000089815100006
J	Nicholson, LB; Kuchroo, VK				Nicholson, LB; Kuchroo, VK			Selecting killers: the line between life and death	NATURE IMMUNOLOGY			English	News Item							T-CELL; AUTOIMMUNE-DISEASE; REPERTOIRES; PEPTIDE	How do T cells that are specific for pancreatic islet cell antigens cause diabetes? A recent paper in Nature provides evidence from NOD mice that the killer T cells responsible increase their avidity as the disease progresses-removing the high avidity clones prevents disease.	Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Nicholson, LB (corresponding author), Brigham & Womens Hosp, Ctr Neurol Dis, 77 Ave Louis Pasteur, Boston, MA 02115 USA.							Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Anderson B, 1999, P NATL ACAD SCI USA, V96, P9311, DOI 10.1073/pnas.96.16.9311; Andre I, 1996, P NATL ACAD SCI USA, V93, P2260, DOI 10.1073/pnas.93.6.2260; Das MP, 1997, J EXP MED, V186, P867, DOI 10.1084/jem.186.6.867; DEBOER RJ, 1994, J THEOR BIOL, V169, P375, DOI 10.1006/jtbi.1994.1160; KATZ JD, 1993, CELL, V74, P1089, DOI 10.1016/0092-8674(93)90730-E; Mason D, 1998, CURR OPIN IMMUNOL, V10, P649, DOI 10.1016/S0952-7915(98)80084-8; Nicholson LB, 1998, IMMUNOLOGIST, V6, P151; Nicholson LB, 1998, P NATL ACAD SCI USA, V95, P264, DOI 10.1073/pnas.95.1.264; NICHOLSON LB, 1995, IMMUNITY, V3, P397, DOI 10.1016/1074-7613(95)90169-8; Thornton AM, 1998, J EXP MED, V188, P287, DOI 10.1084/jem.188.2.287; Verdaguer J, 1997, J EXP MED, V186, P1663, DOI 10.1084/jem.186.10.1663; WICKETT RR, 1995, SKIN PHARMACOL, V8, P179; Wong FS, 1999, J AUTOIMMUN, V13, P290, DOI 10.1006/jaut.1999.0322; Wong FS, 1999, NAT MED, V5, P1026, DOI 10.1038/12465	15	2	2	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2000	1	3					192	194		10.1038/79726	http://dx.doi.org/10.1038/79726			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	363BY	10973273				2022-12-18	WOS:000089815100008
J	Hagan, T; Gerritsen, B; Tomalin, LE; Fourati, S; Mule, MP; Chawla, DG; Rychkov, D; Henrich, E; Miller, HER; Diray-Arce, J; Dunn, P; Lee, A; Levy, O; Gottardo, R; Sarwal, MM; Tsang, JS; Suarez-Farinas, M; Sekaly, RP; Kleinstein, SH; Pulendran, B				Hagan, Thomas; Gerritsen, Bram; Tomalin, Lewis E.; Fourati, Slim; Mule, Matthew P.; Chawla, Daniel G.; Rychkov, Dmitri; Henrich, Evan; Miller, Helen E. R.; Diray-Arce, Joann; Dunn, Patrick; Lee, Audrey; Levy, Ofer; Gottardo, Raphael; Sarwal, Minne M.; Tsang, John S.; Suarez-Farinas, Mayte; Sekaly, Rafick-Pierre; Kleinstein, Steven H.; Pulendran, Bali		Human Immunology Project Consortiu	Transcriptional atlas of the human immune response to 13 vaccines reveals a common predictor of vaccine-induced antibody responses	NATURE IMMUNOLOGY			English	Article; Early Access							YELLOW-FEVER VACCINE; INFLUENZA VACCINATION; GENE-EXPRESSION; SEASONAL INFLUENZA; SYSTEMS-ANALYSIS; EXPLORATION; ACTIVATION; SIGNATURES; CORRELATE; BIOLOGY	Systems vaccinology has defined molecular signatures and mechanisms of immunity to vaccination. However, comparative analysis of immunity to different vaccines is lacking. We integrated transcriptional data of over 3,000 samples, from 820 adults across 28 studies of 13 vaccines and analyzed vaccination-induced signatures of antibody responses. Most vaccines induced signatures of innate immunity and plasmablasts at days 1 and 7, respectively, after vaccination. However, the yellow fever vaccine induced an early transient signature of T and B cell activation at day 1, followed by delayed antiviral/interferon and plasmablast signatures that peaked at days 7 and 14-21, respectively. Thus, there was no evidence for a 'universal signature' that predicted antibody response to all vaccines. However, accounting for the asynchronous nature of responses, we defined a time-adjusted signature that predicted antibody responses across vaccines. These results provide a transcriptional atlas of immunity to vaccination and define a common, time-adjusted signature of antibody responses. Pulendran and colleagues perform a comparative analysis of transcriptional responses of healthy young adults across 13 different vaccines. They find that while a common transcriptional program is shared across many vaccines, there is significant heterogeneity especially in the kinetics of immune responses.	[Hagan, Thomas] Cincinnati Childrens Hosp Med Ctr, Div Infect Dis, Cincinnati, OH 45229 USA; [Hagan, Thomas] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Gerritsen, Bram; Chawla, Daniel G.; Kleinstein, Steven H.] Yale Sch Med, Dept Pathol, New Haven, CT 06510 USA; [Tomalin, Lewis E.; Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, Ctr Biostat, New York, NY 10029 USA; [Fourati, Slim; Sekaly, Rafick-Pierre] Emory Univ, Sch Med, Atlanta, GA USA; [Mule, Matthew P.; Tsang, John S.] NIH, Multiscale Syst Biol Sect, Lab Immune Syst Biol, NIAID, Bldg 10, Bethesda, MD 20892 USA; [Mule, Matthew P.; Tsang, John S.] NIH, Ctr Human Immunol CHI, Bldg 10, Bethesda, MD 20892 USA; [Mule, Matthew P.] Univ Cambridge, NIH Oxford Cambridge Scholars Program, Cambridge, England; [Rychkov, Dmitri; Sarwal, Minne M.] Univ Calif San Francisco, Div Transplant Surg, San Francisco, CA 94143 USA; [Henrich, Evan; Miller, Helen E. R.; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Diray-Arce, Joann; Levy, Ofer] Boston Childrens Hosp, Precis Vaccines Program, Boston, MA USA; [Diray-Arce, Joann; Levy, Ofer] Harvard Med Sch, Boston, MA 02115 USA; [Dunn, Patrick] NG Hlth Solut, ImmPort Curat Team, Rockville, MD USA; [Lee, Audrey; Pulendran, Bali] Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA; [Levy, Ofer] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Gottardo, Raphael] Univ Lausanne, Lausanne, Switzerland; [Gottardo, Raphael] Lausanne Univ Hosp, Lausanne, Switzerland; [Gottardo, Raphael] Swiss Inst Bioinformat, Lausanne, Switzerland	Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Yale University; Icahn School of Medicine at Mount Sinai; Emory University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; University of Cambridge; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Stanford University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics	Kleinstein, SH (corresponding author), Yale Sch Med, Dept Pathol, New Haven, CT 06510 USA.; Pulendran, B (corresponding author), Stanford Univ, Sch Med, Inst Immun Transplantat & Infect, Stanford, CA 94305 USA.	steven.kleinstein@yale.edu; bpulend@stanford.edu		Chawla, Daniel/0000-0001-7667-9337	National Institute of Allergy and Infectious Diseases (NIAID); NIH [R37 DK057665, R01 AI048638, U19 AI057266, U19 AI167903]; Intramural Program of NIAID; NIH supporting the Trans-NIH Center for Human Immunology; Department of Pediatrics at Boston Children's Hospital; Bill and Melinda Gates Foundation; Violetta L. Horton and Soffer Endowments	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Program of NIAID; NIH supporting the Trans-NIH Center for Human Immunology; Department of Pediatrics at Boston Children's Hospital; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Violetta L. Horton and Soffer Endowments	This research was performed as a project of the HIPC and supported by the National Institute of Allergy and Infectious Diseases (NIAID). This work was supported in part by NIH grants U19AI118608, U19AI128949, U19AI090023, U19AI118626, U19AI089992, U19AI128914, U19AI128910, U19AI118610 and U19AI128913 and the Intramural Program of NIAID and NIH supporting the Trans-NIH Center for Human Immunology. O.L. is supported in part by the Department of Pediatrics at Boston Children's Hospital. Work in the laboratory of B.P. is supported in part by the NIH (R37 DK057665, R01 AI048638, U19 AI057266 and U19 AI167903), Bill and Melinda Gates Foundation, Open Philanthropy and the Violetta L. Horton and Soffer Endowments to B.P	Moro-Garcia MA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00107; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Arunachalam PS, 2021, NATURE, V596, P410, DOI 10.1038/s41586-021-03791-x; Avey S, 2020, J IMMUNOL, V204, P1661, DOI 10.4049/jimmunol.1900922; Banchereau R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6283; Bhattacharya S, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.15; Bucasas KL, 2011, J INFECT DIS, V203, P921, DOI 10.1093/infdis/jiq156; Bulteau R, 2022, NAT METHODS, V19, P969, DOI 10.1038/s41592-022-01540-0; Dewey M., 2020, METAP META ANAL SIGN; Diray-Arce J., 2021, BIORXIV, DOI [10.1101/2021.11.05.465336, DOI 10.1101/2021.11.05.465336]; Fourati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10369; Frasca D, 2009, CURR OPIN IMMUNOL, V21, P425, DOI 10.1016/j.coi.2009.06.001; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gasparini R, 2011, HUM VACCINES, V7, P170, DOI 10.4161/hv.7.2.13717; Gaucher D, 2008, J EXP MED, V205, P3119, DOI 10.1084/jem.20082292; GRANOFF DM, 1993, VACCINE, V11, pS46, DOI 10.1016/0264-410X(93)90160-Y; Hagan T, 2019, CELL, V178, P1313, DOI 10.1016/j.cell.2019.08.010; Hagan T, 2015, VACCINE, V33, P5294, DOI 10.1016/j.vaccine.2015.03.072; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Kasturi SP, 2011, NATURE, V470, P543, DOI 10.1038/nature09737; Kazmin D, 2017, P NATL ACAD SCI USA, V114, P2425, DOI 10.1073/pnas.1621489114; Kollmann TR, 2012, IMMUNITY, V37, P771, DOI 10.1016/j.immuni.2012.10.014; Kotliarov Y, 2020, NAT MED, V26, P618, DOI 10.1038/s41591-020-0769-8; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Li SZ, 2017, CELL, V169, P862, DOI 10.1016/j.cell.2017.04.026; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Nakaya HI, 2011, NAT IMMUNOL, V12, P786, DOI 10.1038/ni.2067; Obermoser G, 2013, IMMUNITY, V38, P831, DOI 10.1016/j.immuni.2012.12.008; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Panda A, 2010, J IMMUNOL, V184, P2518, DOI 10.4049/jimmunol.0901022; Plotkin SA, 2010, CLIN VACCINE IMMUNOL, V17, P1055, DOI 10.1128/CVI.00131-10; Pulendran B, 2014, P NATL ACAD SCI USA, V111, P12300, DOI 10.1073/pnas.1400476111; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Pulendran B, 2009, NAT REV IMMUNOL, V9, P741, DOI 10.1038/nri2629; Querec T, 2006, J EXP MED, V203, P413, DOI 10.1084/jem.20051720; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Ravindran R, 2014, SCIENCE, V343, P313, DOI 10.1126/science.1246829; Rechtien A, 2017, CELL REP, V20, P2251, DOI 10.1016/j.celrep.2017.08.023; Scherer A, 2009, BATCH EFFECTS NOISE; Smith GL, 2013, J GEN VIROL, V94, P2367, DOI 10.1099/vir.0.055921-0; Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328; Thakar J, 2015, AGING-US, V7, P38, DOI 10.18632/aging.100720; Thurmond S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120712; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031; Yaari G, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt660; Zak DE, 2012, P NATL ACAD SCI USA, V109, pE3503, DOI 10.1073/pnas.1208972109	47	1	1	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01328-6	http://dx.doi.org/10.1038/s41590-022-01328-6		OCT 2022	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5V0GW	36316475	Green Submitted, Bronze			2022-12-18	WOS:000876917700005
J	Kashiwagi, M; Figueroa, DS; Ay, F; Morgan, BA; Georgopoulos, K				Kashiwagi, Mariko; Figueroa, Daniela Salgado; Ay, Ferhat; Morgan, Bruce A.; Georgopoulos, Katia			A double-negative thymocyte-specific enhancer augments Notch1 signaling to direct early T cell progenitor expansion, lineage restriction and beta-selection	NATURE IMMUNOLOGY			English	Article							DELTA-LIKE 4; B-CELL; PRE-TCR; GENE; EXPRESSION; DIFFERENTIATION; SURVIVAL; LIGAND; TRANSCRIPTION; DELETION	T cell differentiation requires Notch1 signaling. In the present study, we show that an enhancer upstream of Notch1 active in double-negative (DN) mouse thymocytes is responsible for raising Notch1 signaling intrathymically. This enhancer is required to expand multipotent progenitors intrathymically while delaying early differentiation until lineage restrictions have been established. Early thymic progenitors lacking the enhancer show accelerated differentiation through the DN stages and increased frequency of B, innate lymphoid (IL) and natural killer (NK) cell differentiation. Transcription regulators for T cell lineage restriction and commitment are expressed normally, but IL and NK cell gene expression persists after T cell lineage commitment and T cell receptor beta VDJ recombination, Cd3 expression and beta-selection have been impaired. This Notch1 enhancer is inactive in double-positive (DP) thymocytes. Its aberrant reactivation at this stage in Ikaros mutants is required for leukemogenesis. Thus, the DN-specific Notch1 enhancer harnesses the regulatory architecture of DN and DP thymocytes to achieve carefully orchestrated changes in Notch1 signaling required for early lineage restrictions and normal T cell differentiation. Notch signaling is required for T cell development. Georgopoulos and colleagues identify an enhancer that specifically boosts Notch1 expression in early thymic progenitors through the DN3 stage, expanding the less committed multipotent progenitors and preparing these cells for faithful lineage commitment.	[Kashiwagi, Mariko; Morgan, Bruce A.; Georgopoulos, Katia] Harvard Med Sch, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Charlestown, MA 02115 USA; [Figueroa, Daniela Salgado; Ay, Ferhat] La Jolla Inst Immunol, Ctr Autoimmun, La Jolla, CA USA; [Figueroa, Daniela Salgado; Ay, Ferhat] La Jolla Inst Immunol, Ctr Inflammat & Canc Immunotherapy, La Jolla, CA USA; [Figueroa, Daniela Salgado; Ay, Ferhat] Univ Calif San Diego, Bioinformat & Syst Biol Program, La Jolla, CA 92093 USA; [Ay, Ferhat] Univ Calif San Diego, Dept Pediat, La Jolla, CA 92093 USA	Harvard University; Massachusetts General Hospital; La Jolla Institute for Immunology; La Jolla Institute for Immunology; University of California System; University of California San Diego; University of California System; University of California San Diego	Kashiwagi, M; Georgopoulos, K (corresponding author), Harvard Med Sch, Cutaneous Biol Res Ctr, Massachusetts Gen Hosp, Charlestown, MA 02115 USA.	mariko.kashiwagi@cbrc2.mgh.harvard.edu; katia.georgopoulos@cbrc2.mgh.harvard.edu		Salgado Figueroa, Daniela/0000-0001-6476-7612	National Institutes of Health [R01HL140622, R01CA158006, R21AR074748, R35GM128938]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Petrie at the Scripps Research Institute for providing us sorted ex vivo T cell progenitors. We thank K. White, J. M. Park and F. Gounari for critical review of the manuscript and E. Wu and R. Czyzewski for mouse husbandry. Research was supported by the National Institutes of Health (grant nos. R01HL140622 and R01CA158006 to K.G., R21AR074748 to B.A.M. and R35GM128938 to F.A.). Gene targeting was performed at the Cutaneous Biology Research Center (CBRC) and at the targeting core at the University of Chicago. Cell sorting was performed at the Flow and Mass Cytometry Core/Massachusetts General Hospital and at CBRC. High-throughput RNA-seq was performed at the Bauer Center for Genomic research at Harvard University and at CBRC.	Ashworth TD, 2010, BLOOD, V116, P5455, DOI 10.1182/blood-2010-05-286328; Bergen V, 2020, NAT BIOTECHNOL, V38, DOI 10.1038/s41587-020-0591-3; Chen ELY, 2019, NAT IMMUNOL, V20, P1456, DOI 10.1038/s41590-019-0518-7; Ciofani M, 2004, J IMMUNOL, V172, P5230, DOI 10.4049/jimmunol.172.9.5230; Ciofani M, 2005, NAT IMMUNOL, V6, P881, DOI 10.1038/ni1234; CLEVERS H, 1988, P NATL ACAD SCI USA, V85, P8623, DOI 10.1073/pnas.85.22.8623; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dorsch M, 2002, BLOOD, V100, P2046, DOI 10.1182/blood.V100.6.2046.h81802002046_2046_2055; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; GEORGOPOULOS K, 1988, EMBO J, V7, P2401, DOI 10.1002/j.1460-2075.1988.tb03085.x; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hosokawa H, 2018, NAT IMMUNOL, V19, P1427, DOI 10.1038/s41590-018-0238-4; Hozumi K, 2008, J EXP MED, V205, P2507, DOI 10.1084/jem.20080134; Hu GQ, 2018, IMMUNITY, V48, P227, DOI 10.1016/j.immuni.2018.01.013; Hu YG, 2016, GENE DEV, V30, P1971, DOI 10.1101/gad.283762.116; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Inlay MA, 2009, GENE DEV, V23, P2376, DOI 10.1101/gad.1836009; Jeannet R, 2010, BLOOD, V116, P5443, DOI 10.1182/blood-2010-05-286658; Joshi I, 2014, NAT IMMUNOL, V15, P294, DOI 10.1038/ni.2821; Kaul A, 2020, NAT PROTOC, V15, P991, DOI 10.1038/s41596-019-0273-0; Koch U, 2008, J EXP MED, V205, P2515, DOI 10.1084/jem.20080829; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; Li XY, 2008, J EXP MED, V205, P2851, DOI 10.1084/jem.20081561; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Maillard I, 2006, J EXP MED, V203, P2239, DOI 10.1084/jem.20061020; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Miyazaki M, 2017, IMMUNITY, V46, P818, DOI 10.1016/j.immuni.2017.04.022; Mohtashami M, 2016, METHODS MOL BIOL, V1323, P159, DOI 10.1007/978-1-4939-2809-5_14; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Ng SYM, 2009, IMMUNITY, V30, P493, DOI 10.1016/j.immuni.2009.01.014; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Ramirez F, 2014, NUCLEIC ACIDS RES, V42, pW187, DOI 10.1093/nar/gku365; Ramond C, 2014, NAT IMMUNOL, V15, P27, DOI 10.1038/ni.2782; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rothenberg EV, 2016, ADV IMMUNOL, V129, P109, DOI 10.1016/bs.ai.2015.09.002; Sambandam A, 2005, NAT IMMUNOL, V6, P663, DOI 10.1038/ni1216; Satoh-Takayama N, 2010, J EXP MED, V207, P273, DOI 10.1084/jem.20092029; Schmitt TM, 2004, J EXP MED, V200, P469, DOI 10.1084/jem.20040394; Seillet C, 2016, CELL REP, V17, P436, DOI 10.1016/j.celrep.2016.09.025; Servant N, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0831-x; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Suliman S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024937; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Tan JB, 2005, NAT IMMUNOL, V6, P671, DOI 10.1038/ni1217; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Tikhonova AN, 2019, NATURE, V569, P222, DOI 10.1038/s41586-019-1104-8; Tsuji H, 2003, CARCINOGENESIS, V24, P1257, DOI 10.1093/carcin/bgg071; Wakabayashi Y, 2003, NAT IMMUNOL, V4, P533, DOI 10.1038/ni927; Wilson A, 2001, J EXP MED, V194, P1003, DOI 10.1084/jem.194.7.1003; Wolfer A, 2002, IMMUNITY, V16, P869, DOI 10.1016/S1074-7613(02)00330-8; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Yoshida T, 2010, CURR OPIN IMMUNOL, V22, P154, DOI 10.1016/j.coi.2010.02.011; Yu VWC, 2015, J EXP MED, V212, P759, DOI 10.1084/jem.20141843; Yui MA, 2014, NAT REV IMMUNOL, V14, P529, DOI 10.1038/nri3702; Zhou W, 2019, CELL SYST, V9, P321, DOI 10.1016/j.cels.2019.09.008; Zook EC, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aao2139	68	1	1	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1628	+		10.1038/s41590-022-01322-y	http://dx.doi.org/10.1038/s41590-022-01322-y		OCT 2022	36	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36316479				2022-12-18	WOS:000876917700006
J	Liu, X; Yao, JC; Zhao, YS; Wang, JB; Qi, H				Liu, Xin; Yao, Jiacheng; Zhao, Yongshan; Wang, Jianbin; Qi, Hai			Heterogeneous plasma cells and long-lived subsets in response to immunization, autoantigen and microbiota	NATURE IMMUNOLOGY			English	Article							BONE-MARROW; AFFINITY MATURATION; HUMORAL IMMUNITY; SURVIVAL NICHE; MEMORY; HEAVY; INDUCTION; INNATE; B-1A; IGM	Durable antibody-mediated responses require long-lived plasma cells; however, these cells are difficult to identify. Hai Qi and colleagues now phenotypically identify these cells and show their heterogeneity. Durable antibody immunity depends on long-lived plasma cells (LLPCs) that primarily reside in the bone marrow (BM). However, due to LLPC rarity, it has not been possible to define their phenotypes or determine their heterogeneity. By single-cell mRNA sequencing, cytometry and a genetic pulse-chase mouse model, we show that IgG and IgM LLPCs display an EpCAM(hi)CXCR3(-) phenotype, whereas IgA LLPCs are Ly6A(hi)Tigit(-). While IgG and IgA LLPCs are mainly contributed by somatically hypermutated cells following immunization or infection, cells with innate properties and public antibodies are found in IgA and IgM LLPC compartments. Particularly, IgM LLPCs are highly enriched with public clones shared among different individual animals, differentiated in a T cell-independent manner and have affinity for self-antigens and microbial-derived antigens. Taken together, our work reveals different routes toward LLPC development and paves the way for deeper understanding of cellular and molecular underpinnings of long-term antibody immunity.	[Liu, Xin; Zhao, Yongshan; Qi, Hai] Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China; [Liu, Xin; Zhao, Yongshan; Qi, Hai] Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing, Peoples R China; [Liu, Xin; Zhao, Yongshan; Qi, Hai] Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing, Peoples R China; [Yao, Jiacheng] Peking Univ, Coll Chem & Mol Engn, Beijing, Peoples R China; [Yao, Jiacheng] Peking Univ, Beijing Adv Innovat Ctr Genom ICG, Biomed Pioneering Innovat Ctr Biop, Beijing, Peoples R China; [Wang, Jianbin; Qi, Hai] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Wang, Jianbin; Qi, Hai] Tsinghua Univ, NexVac Res Ctr, Beijing, Peoples R China; [Wang, Jianbin; Qi, Hai] Tsinghua Univ, Beijing Frontier Res Ctr Biol Struct, Beijing, Peoples R China; [Qi, Hai] Tsinghua Univ, Beijing Key Lab Immunol Res Chron Dis, Beijing, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Peking University; Peking University; Tsinghua University; Tsinghua University; Tsinghua University; Tsinghua University	Qi, H (corresponding author), Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Sch Med, Dept Basic Med Sci, Beijing, Peoples R China.; Wang, JB; Qi, H (corresponding author), Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China.; Wang, JB; Qi, H (corresponding author), Tsinghua Univ, NexVac Res Ctr, Beijing, Peoples R China.; Wang, JB; Qi, H (corresponding author), Tsinghua Univ, Beijing Frontier Res Ctr Biol Struct, Beijing, Peoples R China.; Qi, H (corresponding author), Tsinghua Univ, Beijing Key Lab Immunol Res Chron Dis, Beijing, Peoples R China.	jianbinwang@tsinghua.edu.cn; qihai@tsinghua.edu.cn		Liu, Xin/0000-0002-6634-4012	National Key R&D Program of China (Ministry of Science and Technology) [2018YFE0200300, 2018YFA0800200]; National Natural Science Foundation of China [31830023, 81621002, 81761128019, 32070908]; Tsinghua-Peking Center for Life Sciences; Beijing Municipal Science & Technology Commission; Beijing Frontier Research Center for Biological Structure; Bill & Melinda Gates Foundation; Howard Hughes Medical Institute	National Key R&D Program of China (Ministry of Science and Technology); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua-Peking Center for Life Sciences; Beijing Municipal Science & Technology Commission(Beijing Municipal Science & Technology Commission); Beijing Frontier Research Center for Biological Structure; Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank C. Qin from the ILAS in the Chinese Academy of Medical Sciences for providing the GF mice. We thank Y. Lu from AbCipher Bio-technology for assistance with monoclonal IgM antibody expression and purification. This work was funded in part by the National Key R&D Program of China (Ministry of Science and Technology, 2018YFE0200300 to H.Q. and 2018YFA0800200 to J.W.), the National Natural Science Foundation of China (grants 31830023, 81621002 and 81761128019 to H.Q. and grant 32070908 to X.L.), the Tsinghua-Peking Center for Life Sciences, the Beijing Municipal Science & Technology Commission and the Beijing Frontier Research Center for Biological Structure. This work was also funded in part by the Bill & Melinda Gates Foundation and the Howard Hughes Medical Institute. The findings and conclusions within are those of the authors and do not necessarily reflect positions or policies of the Bill & Melinda Gates Foundation or the Howard Hughes Medical Institute.	ALLEN D, 1988, EMBO J, V7, P1995, DOI 10.1002/j.1460-2075.1988.tb03038.x; Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Baumgarth N, 2011, NAT REV IMMUNOL, V11, P34, DOI 10.1038/nri2901; Benet Z, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108733; Blanc P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13600; Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Cassese G, 2003, J IMMUNOL, V171, P1684, DOI 10.4049/jimmunol.171.4.1684; Doron I, 2021, CELL, V184, P1017, DOI 10.1016/j.cell.2021.01.016; Fairfax KA, 2007, J IMMUNOL, V178, P4104, DOI 10.4049/jimmunol.178.7.4104; Fooksman DR, 2010, IMMUNITY, V33, P118, DOI 10.1016/j.immuni.2010.06.015; Gires O, 2020, CANCER METAST REV, V39, P969, DOI 10.1007/s10555-020-09898-3; Haas KM, 2005, IMMUNITY, V23, P7, DOI 10.1016/j.immuni.2005.04.011; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; HARDY RR, 1989, J IMMUNOL, V142, P3643; HIBI T, 1986, EUR J IMMUNOL, V16, P139, DOI 10.1002/eji.1830160206; Higgins BW, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2121260119; Jegaskanda S, 2018, J VIROL, V92, DOI 10.1128/JVI.01970-17; Kaminski DA, 2006, J IMMUNOL, V177, P6025, DOI 10.4049/jimmunol.177.9.6025; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Lam WY, 2018, CELL REP, V24, P2479, DOI 10.1016/j.celrep.2018.07.084; Ledergor G, 2018, NAT MED, V24, P1867, DOI 10.1038/s41591-018-0269-2; Lemke A, 2016, MUCOSAL IMMUNOL, V9, P83, DOI 10.1038/mi.2015.38; Maetzel D, 2009, NAT CELL BIOL, V11, P162, DOI 10.1038/ncb1824; O'Connor BP, 2002, J EXP MED, V195, P737, DOI 10.1084/jem.20011626; Racine R, 2011, J IMMUNOL, V186, P1011, DOI 10.4049/jimmunol.1002836; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rasheed MAU, 2013, J VIROL, V87, P7737, DOI 10.1128/JVI.00063-13; Reynolds AE, 2015, J IMMUNOL, V194, P231, DOI 10.4049/jimmunol.1401203; Robinson MJ, 2020, IMMUNOL REV, V296, P87, DOI 10.1111/imr.12895; Roco JA, 2019, IMMUNITY, V51, P337, DOI 10.1016/j.immuni.2019.07.001; Seidl KJ, 1997, INT IMMUNOL, V9, P689, DOI 10.1093/intimm/9.5.689; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; TERSTAPPEN LWMM, 1990, BLOOD, V76, P1739; Wakabayashi C, 2002, SCIENCE, V298, P2392, DOI 10.1126/science.1076963; Wan ZP, 2015, ELIFE, V4, DOI 10.7554/eLife.06925; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004; Whittle JRR, 2014, J VIROL, V88, P4047, DOI 10.1128/JVI.03422-13; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilmore JR, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.791095; Wilmore JR, 2018, CELL HOST MICROBE, V23, P302, DOI 10.1016/j.chom.2018.01.005; Wolf AI, 2011, J CLIN INVEST, V121, P3954, DOI 10.1172/JCI57362; Wols HAM, 2002, J IMMUNOL, V169, P4213, DOI 10.4049/jimmunol.169.8.4213; Wong JB, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12824-z; Xu AQ, 2020, ELIFE, V9, DOI 10.7554/eLife.59850; Yang Y, 2015, ELIFE, V4, DOI 10.7554/eLife.09083; Yang Y, 2012, P NATL ACAD SCI USA, V109, P5388, DOI 10.1073/pnas.1121627109; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; Yoshikawa S, 2009, INT IMMUNOL, V21, P43, DOI 10.1093/intimm/dxn122; Zehentmeier S, 2014, EUR J IMMUNOL, V44, P2306, DOI 10.1002/eji.201344313; Zhang MG, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abg4328; Zhang R, 2021, CELL MOL IMMUNOL, V18, P1222, DOI 10.1038/s41423-021-00669-w	56	1	1	4	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1564	+		10.1038/s41590-022-01345-5	http://dx.doi.org/10.1038/s41590-022-01345-5		OCT 2022	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36316480	Bronze			2022-12-18	WOS:000876908500002
J	Ruckert, T; Lareau, CA; Mashreghi, MF; Ludwig, LS; Romagnani, C				Ruckert, Timo; Lareau, Caleb A.; Mashreghi, Mir-Farzin; Ludwig, Leif S.; Romagnani, Chiara			Clonal expansion and epigenetic inheritance of long-lasting NK cell memory	NATURE IMMUNOLOGY			English	Article							NATURAL-KILLER-CELLS; CYTOMEGALOVIRUS-INFECTION; INNATE; RECOGNITION; MODULATION; PROTECTION; IMMUNITY; LINEAGE; SUBSET; FATE	Clonal expansion of cells with somatically diversified receptors and their long-term maintenance as memory cells is a hallmark of adaptive immunity. Here, we studied pathogen-specific adaptation within the innate immune system, tracking natural killer (NK) cell memory to human cytomegalovirus (HCMV) infection. Leveraging single-cell multiomic maps of ex vivo NK cells and somatic mitochondrial DNA mutations as endogenous barcodes, we reveal substantial clonal expansion of adaptive NK cells in HCMV+ individuals. NK cell clonotypes were characterized by a convergent inflammatory memory signature enriched for AP1 motifs superimposed on a private set of clone-specific accessible chromatin regions. NK cell clones were stably maintained in specific epigenetic states over time, revealing that clonal inheritance of chromatin accessibility shapes the epigenetic memory repertoire. Together, we identify clonal expansion and persistence within the human innate immune system, suggesting that these mechanisms have evolved independent of antigen-receptor diversification.	[Ruckert, Timo; Romagnani, Chiara] Leibniz Inst, Deutsch Rheuma Forschungszentrum Berlin DRFZ, Innate Immun, Berlin, Germany; [Lareau, Caleb A.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Mashreghi, Mir-Farzin] Leibniz Inst, Deutsch Rheuma Forschungszentrum Berlin DRFZ, Therapeut Gene Regulat, Berlin, Germany; [Ludwig, Leif S.] Charite Univ Med Berlin, Berlin Inst Hlth, Berlin, Germany; [Ludwig, Leif S.] Max Delbruck Ctr Mol Med, Helmholtz Assoc MDC, Inst Med Syst Biol BIMSB, Berlin, Germany; [Romagnani, Chiara] Charite Univ Med Berlin, Berlin, Germany; [Romagnani, Chiara] Free Univ Berlin, Berlin, Germany; [Romagnani, Chiara] Humboldt Univ, Med Klin Gastroenterol Infektiol & Rheumatol, Berlin, Germany; [Romagnani, Chiara] Leibniz Sci Campus Chron Inflammat, Berlin, Germany	Stanford University; Berlin Institute of Health; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin	Ruckert, T; Romagnani, C (corresponding author), Leibniz Inst, Deutsch Rheuma Forschungszentrum Berlin DRFZ, Innate Immun, Berlin, Germany.; Romagnani, C (corresponding author), Charite Univ Med Berlin, Berlin, Germany.; Romagnani, C (corresponding author), Free Univ Berlin, Berlin, Germany.; Romagnani, C (corresponding author), Humboldt Univ, Med Klin Gastroenterol Infektiol & Rheumatol, Berlin, Germany.; Romagnani, C (corresponding author), Leibniz Sci Campus Chron Inflammat, Berlin, Germany.	timo.rueckert@drfz.de; romagnani@drfz.de	; Romagnani, Chiara/E-4708-2016	Mashreghi, Mir-Farzin/0000-0002-8015-6907; Ruckert, Timo/0000-0003-1433-1372; Romagnani, Chiara/0000-0002-5167-7463; Lareau, Caleb/0000-0003-4179-4807	ERC Advanced Grant 'MEM-CLONK' [101055157]; Deutsche Forschungsgemeinschaft (DFG) [SPP 1937 (RO3565/4-2), SFB TRR241 B02]; Leibniz-Science Campus Chronic Inflammation, Leibniz-Kooperative Exzellenz [K259/2019]; Berlin Health Innovations (BHI) Validation Fund; European Union	ERC Advanced Grant 'MEM-CLONK'; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Leibniz-Science Campus Chronic Inflammation, Leibniz-Kooperative Exzellenz; Berlin Health Innovations (BHI) Validation Fund; European Union(European Commission)	We thank members of the Romagnani group, G. Gasteiger, D.R. Withers, T. Schuler and T.N. Haschler for critically reading the manuscript. We are grateful for support by the DRFZ flow cytometry core facility for assistance with cell sorting. We thank O. Knight and P. Durek for help with setting up bioinformatic pipelines and the DRFZ lab managers, M. Klemm and G. Guerra, for technical support. This work was funded by the ERC Advanced Grant 'MEM-CLONK' (101055157) to C.R., the Deutsche Forschungsgemeinschaft (DFG) grants SPP 1937 (RO3565/4-2) and SFB TRR241 B02 to C.R., Leibniz-Science Campus Chronic Inflammation, Leibniz-Kooperative Exzellenz K259/2019 to C.R. and Berlin Health Innovations (BHI) Validation Fund to C.R. and T.R. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.	Adams NM, 2020, NAT REV IMMUNOL, V20, P694, DOI 10.1038/s41577-020-0307-4; Adams NM, 2019, IMMUNITY, V50, P1381, DOI 10.1016/j.immuni.2019.04.009; Berry R, 2020, NAT REV IMMUNOL, V20, P113, DOI 10.1038/s41577-019-0225-5; Beziat V, 2013, BLOOD, V121, P2678, DOI 10.1182/blood-2012-10-459545; Borrego F, 1998, J EXP MED, V187, P813, DOI 10.1084/jem.187.5.813; Bray NL, 2016, NAT BIOTECHNOL, V34, P888, DOI 10.1038/nbt0816-888d; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Cichocki F, 2018, J EXP MED, V215, P2379, DOI 10.1084/jem.20172168; Collins PL, 2019, CELL, V176, P348, DOI 10.1016/j.cell.2018.11.045; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Corat MAF, 2017, BLOOD, V129, P1940, DOI 10.1182/blood-2016-08-734285; Cossarizza A, 2021, EUR J IMMUNOL, V51, P2708, DOI 10.1002/eji.202170126; Crinier A, 2018, IMMUNITY, V49, P971, DOI 10.1016/j.immuni.2018.09.009; de Laval B, 2020, CELL STEM CELL, V26, P657, DOI 10.1016/j.stem.2020.01.017; Flommersfeld S, 2021, IMMUNITY, V54, P2288, DOI 10.1016/j.immuni.2021.08.002; Foley B, 2012, BLOOD, V119, P2665, DOI 10.1182/blood-2011-10-386995; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Grassmann S, 2020, NAT IMMUNOL, V21, P1563, DOI 10.1038/s41590-020-00807-y; Grassmann S, 2019, IMMUNITY, V50, P1391, DOI 10.1016/j.immuni.2019.04.015; Guma M, 2004, BLOOD, V104, P3664, DOI 10.1182/blood-2004-05-2058; Hammer Q, 2018, NAT IMMUNOL, V19, P800, DOI 10.1038/s41590-018-0163-6; Hammer Q, 2018, NAT IMMUNOL, V19, P453, DOI 10.1038/s41590-018-0082-6; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Hartmann FJ, 2021, NAT BIOTECHNOL, V39, DOI 10.1038/s41587-020-0651-8; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Holmes TD, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abc9801; Horowitz A, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006702; Juelke K, 2010, BLOOD, V116, P1299, DOI 10.1182/blood-2009-11-253286; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Lareau CA, 2021, NAT BIOTECHNOL, V39, P451, DOI 10.1038/s41587-020-0645-6; Larsen SB, 2021, CELL STEM CELL, V28, P1758, DOI 10.1016/j.stem.2021.07.001; Lau CM, 2018, NAT IMMUNOL, V19, P963, DOI 10.1038/s41590-018-0176-1; Liu LL, 2016, CELL REP, V15, P1088, DOI 10.1016/j.celrep.2016.04.005; Lopez-Verges S, 2011, P NATL ACAD SCI USA, V108, P14725, DOI 10.1073/pnas.1110900108; Ludwig LS, 2019, CELL, V176, P1325, DOI 10.1016/j.cell.2019.01.022; Luetke-Eversloh M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004441; Lun Aaron T L, 2016, F1000Res, V5, P2122; Melsted P, 2021, NAT BIOTECHNOL, V39, P813, DOI 10.1038/s41587-021-00870-2; Milush JM, 2009, BLOOD, V114, P4823, DOI 10.1182/blood-2009-04-216374; Mimitou EP, 2021, NAT BIOTECHNOL, V39, P1246, DOI 10.1038/s41587-021-00927-2; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Mold J. E., 2022, BIORXIV, DOI [10.1101/2022.02.14.480352, DOI 10.1101/2022.02.14.480352]; Moskowitz DM, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag0192; Nabekura T, 2016, J EXP MED, V213, P2745, DOI 10.1084/jem.20160726; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Ntranos V, 2019, NAT METHODS, V16, P163, DOI 10.1038/s41592-018-0303-9; Ostuni R, 2013, CELL, V152, P157, DOI 10.1016/j.cell.2012.12.018; Pradeu T, 2018, IMMUNOL REV, V283, P7, DOI 10.1111/imr.12652; Roelli P., 2019, ZENODO, DOI [10.5281/zenodo.2590196, DOI 10.5281/ZENODO.2590196]; Scharer CD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04125-8; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schlums H, 2017, BLOOD, V129, P1927, DOI 10.1182/blood-2016-08-734236; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Shaffer SM, 2020, CELL, V182, P947, DOI 10.1016/j.cell.2020.07.003; Smith SL, 2020, BLOOD ADV, V4, P1388, DOI 10.1182/bloodadvances.2019000699; Stoeckius M, 2017, NAT METHODS, V14, P865, DOI [10.1038/NMETH.4380, 10.1038/nmeth.4380]; Stuart T, 2021, NAT METHODS, V18, P1333, DOI 10.1038/s41592-021-01282-5; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sun JC, 2012, J EXP MED, V209, P947, DOI 10.1084/jem.20111760; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Truitt LL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02381; Vales-Gomez M, 1999, EMBO J, V18, P4250, DOI 10.1093/emboj/18.15.4250; Wiedemann GM, 2021, NAT IMMUNOL, V22, P627, DOI 10.1038/s41590-021-00909-1; Wu CF, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat9781; Yang C, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11947-7; Yukawa M, 2020, J EXP MED, V217, DOI 10.1084/jem.20182009; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Ziegenhain C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-26152-8	70	1	1	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1551	+		10.1038/s41590-022-01327-7	http://dx.doi.org/10.1038/s41590-022-01327-7		OCT 2022	36	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36289449	Green Published, Green Accepted, hybrid			2022-12-18	WOS:000873358100001
J	Wu, R; Ohara, RA; Jo, S; Liu, TT; Ferris, ST; Ou, FY; Kim, S; Theisen, DJ; Anderson, DA; Wong, BW; Gershon, T; Schreiber, RD; Murphy, TL; Murphy, KM				Wu, Renee; Ohara, Ray A.; Jo, Suin; Liu, Tian-Tian; Ferris, Stephen T.; Ou, Feiya; Kim, Sunkyung; Theisen, Derek J.; Anderson, David A.; Wong, Brian W.; Gershon, Timothy; Schreiber, Robert D.; Murphy, Theresa L.; Murphy, Kenneth M.			Mechanisms of CD40-dependent cDC1 licensing beyond costimulation	NATURE IMMUNOLOGY			English	Article							CYTOTOXIC T-LYMPHOCYTES; CANCER-INDUCED APOPTOSIS; B-CELL PROLIFERATION; BCL-X-L; DENDRITIC CELLS; TRANSCRIPTION FACTOR; ANTIVIRAL IMMUNITY; UP-REGULATION; IN-VITRO; CD40	CD40 signaling in classical type 1 dendritic cells (cDC1s) is required for CD8 T cell-mediated tumor rejection, but the underlying mechanisms are incompletely understood. Here, we identified CD40-induced genes in cDC1s, including Cd70, Tnfsf9, Ptgs2 and Bcl2l1, and examined their contributions to anti-tumor immunity. cDC1-specific inactivation of CD70 and COX-2, and global CD27 inactivation, only partially impaired tumor rejection or tumor-specific CD8 T cell expansion. Loss of 4-1BB, alone or in Cd27(-/-) mice, did not further impair anti-tumor immunity. However, cDC1-specific CD40 inactivation reduced cDC1 mitochondrial transmembrane potential and increased caspase activation in tumor-draining lymph nodes, reducing migratory cDC1 numbers in vivo. Similar impairments occurred during in vitro antigen presentation by Cd40(-/-) cDC1s to CD8(+) T cells, which were reversed by re-expression of Bcl2l1. Thus, CD40 signaling in cDC1s not only induces costimulatory ligands for CD8(+) T cells but also induces Bcl2l1 that sustains cDC1 survival during priming of anti-tumor responses. CD40 is typically understood as a costimulatory molecule. Here, the authors show CD4(+) T cell-induced CD40 signaling in conventional type 1 dendritic cells results in complicated gene expression that can enhance CD8(+) T cell priming by various underappreciated and independent mechanisms.	[Wu, Renee; Ohara, Ray A.; Jo, Suin; Liu, Tian-Tian; Ferris, Stephen T.; Ou, Feiya; Kim, Sunkyung; Theisen, Derek J.; Anderson, David A.; Schreiber, Robert D.; Murphy, Theresa L.; Murphy, Kenneth M.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA; [Wong, Brian W.] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Gershon, Timothy] Univ N Carolina, Sch Med, Dept Neurol, Chapel Hill, NC 27515 USA; [Schreiber, Robert D.] Washington Univ, Sch Med, Andrew M & Jane M Bursky Ctr Human Immunol & Immu, St Louis, MO USA; [Schreiber, Robert D.] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Gershon, Timothy] Emory Univ, Sch Med, Dept Pediat, ECC Room 254, Atlanta, GA USA	Washington University (WUSTL); Washington University (WUSTL); University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Washington University (WUSTL); Emory University	Murphy, KM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	kmurphy@wustl.edu	; Wong, Brian/B-6168-2009	Ferris, Stephen/0000-0003-3340-2607; Ohara, Ray/0000-0001-7897-3169; Wong, Brian/0000-0001-8447-3064	NIH [R01AI150297, R01CA248919, R21AI164142, R01CA190700, T32CA009547, F30CA247262]; Cancer Research Institute	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute	This publication is solely the responsibility of the authors and does not necessarily represent the official view of the National Institutes of Health (NIH). This work was supported by the NIH (R01AI150297, R01CA248919, and R21AI164142 to K.M. M., R01CA190700 and T32CA009547 to R.D.S, and F30CA247262 to R.W.) S.T.F. is a Cancer Research Institute Irvington Fellow supported by the Cancer Research Institute. We thank J. M. White at the Department of Pathology & Immunology Transgenic Mouse Core at Washington University in St. Louis and the Genetic Editing and iPS Cell Center at Washington University in St. Louis for the generation of mouse models, the Genome Technology Access Center at the Department of Genetics at Washington University School of Medicine in St. Louis for help with genomic analysis, the Andrew M. and Jane M. Bursky Center for Human Immunology and Immunotherapy Programs and Alvin J. Siteman Comprehensive Cancer Center for help with tetramer production, and the Diabetes Research Core (NIH P30 DK020579) for help with extracellular flux assays.	Ahonen CL, 2002, NAT IMMUNOL, V3, P451, DOI 10.1038/ni792; Ahrends T, 2017, IMMUNITY, V47, P848, DOI 10.1016/j.immuni.2017.10.009; Ahrends T, 2016, CANCER RES, V76, P2921, DOI 10.1158/0008-5472.CAN-15-3130; Andersen RS, 2012, NAT PROTOC, V7, P891, DOI 10.1038/nprot.2012.037; Anderson DA, 2020, P NATL ACAD SCI USA, V117, P4885, DOI 10.1073/pnas.1915060117; Ardouin L, 2016, IMMUNITY, V45, P305, DOI 10.1016/j.immuni.2016.07.019; ARMITAGE RJ, 1992, NATURE, V357, P80, DOI 10.1038/357080a0; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bjorck P, 1997, INT IMMUNOL, V9, P365, DOI 10.1093/intimm/9.3.365; Borrow P, 1996, J EXP MED, V183, P2129, DOI 10.1084/jem.183.5.2129; Borrow P, 1998, J VIROL, V72, P7440, DOI 10.1128/JVI.72.9.7440-7449.1998; Borst J, 2018, NAT REV IMMUNOL, V18, P635, DOI 10.1038/s41577-018-0044-0; Bourgeois C, 2002, SCIENCE, V297, P2060, DOI 10.1126/science.1072615; Bullock TNJ, 2005, J IMMUNOL, V174, P710, DOI 10.4049/jimmunol.174.2.710; CANTOR H, 1975, J EXP MED, V141, P1390, DOI 10.1084/jem.141.6.1390; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chen M, 2006, SCIENCE, V311, P1160, DOI 10.1126/science.1122545; Chen M, 2007, BLOOD, V109, P4360, DOI 10.1182/blood-2006-11-056424; Chen M, 2007, MOL IMMUNOL, V44, P2558, DOI 10.1016/j.molimm.2006.12.020; Cheng EHYA, 2001, MOL CELL, V8, P705, DOI 10.1016/S1097-2765(01)00320-3; Choi K, 1998, DEVELOPMENT, V125, P725; CLARK EA, 1986, P NATL ACAD SCI USA, V83, P4494, DOI 10.1073/pnas.83.12.4494; Daniels NJ, 2016, MUCOSAL IMMUNOL, V9, P229, DOI 10.1038/mi.2015.55; Darzynkiewicz Z, 2017, METHODS MOL BIOL, V1644, P61, DOI 10.1007/978-1-4939-7187-9_5; Diamond MS, 2011, J EXP MED, V208, P1989, DOI 10.1084/jem.20101158; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Feau S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1948; Ferris ST, 2020, NATURE, V584, P624, DOI 10.1038/s41586-020-2611-3; Gallagher E, 2007, NAT IMMUNOL, V8, P57, DOI 10.1038/ni1421; Grillot DAM, 1996, J EXP MED, V183, P381, DOI 10.1084/jem.183.2.381; Hendriks J, 2000, NAT IMMUNOL, V1, P433, DOI 10.1038/80877; Hernandez MGH, 2008, J IMMUNOL, V180, P4382, DOI 10.4049/jimmunol.180.7.4382; Hildner K, 2008, SCIENCE, V322, P1097, DOI 10.1126/science.1164206; HOLLENBAUGH D, 1992, EMBO J, V11, P4313, DOI 10.1002/j.1460-2075.1992.tb05530.x; Hor JL, 2015, IMMUNITY, V43, P554, DOI 10.1016/j.immuni.2015.07.020; Ishikawa T, 2006, GENESIS, V44, P143, DOI 10.1002/gene.20192; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kim S, 2020, IMMUNITY, V53, P759, DOI 10.1016/j.immuni.2020.07.018; Koebel CM, 2007, NATURE, V450, P903, DOI 10.1038/nature06309; Krause P, 2009, BLOOD, V113, P2451, DOI 10.1182/blood-2008-05-157123; Kretzer NM, 2016, J EXP MED, V213, P2871, DOI 10.1084/jem.20160597; Laidlaw BJ, 2021, NAT REV IMMUNOL, V21, P209, DOI 10.1038/s41577-020-00446-2; Lee BO, 2003, J EXP MED, V198, P1759, DOI 10.1084/jem.20031440; Lundqvist A, 2002, CANCER IMMUNOL IMMUN, V51, P139, DOI 10.1007/s00262-002-0265-7; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Matsue H, 1999, J IMMUNOL, V162, P5287; Miga AJ, 2001, EUR J IMMUNOL, V31, P959, DOI 10.1002/1521-4141(200103)31:3<959::AID-IMMU959>3.0.CO;2-A; Munitic I, 2013, J IMMUNOL, V190, P1169, DOI 10.4049/jimmunol.1202353; Nopora K, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00348; Oba T, 2020, J IMMUNOL, V205, P1867, DOI 10.4049/jimmunol.2000347; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Ouyang W, 1998, IMMUNITY, V9, P745, DOI 10.1016/S1074-7613(00)80671-8; Pirtskhalaishvili G, 2000, BRIT J CANCER, V83, P506, DOI 10.1054/bjoc.2000.1289; Pirtskhalaishvili G, 2000, J IMMUNOL, V165, P1956, DOI 10.4049/jimmunol.165.4.1956; Lenicov FR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01441; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Ridge JP, 1998, NATURE, V393, P474, DOI 10.1038/30989; Riol-Blanco L, 2009, NAT IMMUNOL, V10, P753, DOI 10.1038/ni.1750; Ruhland MK, 2020, CANCER CELL, V37, P786, DOI 10.1016/j.ccell.2020.05.002; Ryan EP, 2005, J IMMUNOL, V174, P2619, DOI 10.4049/jimmunol.174.5.2619; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; SPRIGGS MK, 1992, J EXP MED, V176, P1543, DOI 10.1084/jem.176.6.1543; Sreeramkumar V, 2012, IMMUNOL CELL BIOL, V90, P579, DOI 10.1038/icb.2011.75; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Taraban VY, 2006, J IMMUNOL, V177, P2969, DOI 10.4049/jimmunol.177.5.2969; Theisen DJ, 2019, CANCER IMMUNOL RES, V7, P29, DOI 10.1158/2326-6066.CIR-18-0138; Theisen DJ, 2018, SCIENCE, V362, P694, DOI 10.1126/science.aat5030; Toebes M, 2006, NAT MED, V12, P246, DOI 10.1038/nm1360; XU JC, 1994, IMMUNITY, V1, P423, DOI 10.1016/1074-7613(94)90073-6; Yu Y, 2007, J BIOL CHEM, V282, P1498, DOI 10.1074/jbc.M609930200; Zelenay S, 2015, CELL, V162, P1257, DOI 10.1016/j.cell.2015.08.015; Zhang N, 2005, J IMMUNOL, V174, P6967, DOI 10.4049/jimmunol.174.11.6967; Zhang XH, 1996, CELL IMMUNOL, V173, P149, DOI 10.1006/cimm.1996.0260	76	1	1	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1536	+		10.1038/s41590-022-01324-w	http://dx.doi.org/10.1038/s41590-022-01324-w		OCT 2022	35	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36271147				2022-12-18	WOS:000870950100002
J	Wang, WQ; Xu, Y; Wang, L; Zhu, ZZ; Aodeng, SRT; Chen, H; Cai, MH; Huang, ZH; Han, JB; Wang, L; Lin, YX; Hu, Y; Zhou, LR; Wang, XW; Zha, Y; Jiang, WH; Gao, ZQ; He, W; Lv, W; Zhang, JM				Wang, Weiqing; Xu, Yi; Wang, Lun; Zhu, Zhenzhen; Aodeng, Surita; Chen, Hui; Cai, Menghua; Huang, Zhihao; Han, Jinbo; Wang, Lei; Lin, Yuxi; Hu, Yu; Zhou, Liangrui; Wang, Xiaowei; Zha, Yang; Jiang, Weihong; Gao, Zhiqiang; He, Wei; Lv, Wei; Zhang, Jianmin			Single-cell profiling identifies mechanisms of inflammatory heterogeneity in chronic rhinosinusitis	NATURE IMMUNOLOGY			English	Article							ARACHIDONIC-ACID; EOSINOPHILS; RECRUITMENT; PATHWAYS; EOXINS	Zhang and colleagues use single-cell RNA sequencing on the nasal mucosa to identify cell subsets and molecules that specifically contribute to the pathogenesis of chronic rhinosinusitis subtypes. The heterogeneous cellular microenvironment of human airway chronic inflammatory diseases, including chronic rhinosinusitis (CRS) and asthma, is still poorly understood. Here, we performed single-cell RNA sequencing (scRNA-seq) on the nasal mucosa of healthy individuals and patients with three subtypes of CRS and identified disease-specific cell subsets and molecules that specifically contribute to the pathogenesis of CRS subtypes. As such, ALOX15(+) macrophages contributed to the type 2 immunity-driven pathogenesis of one subtype of CRS, eosinophilic CRS with nasal polyps (eCRSwNP), by secreting chemokines that recruited eosinophils, monocytes and T helper 2 (T(H)2) cells. An inhibitor of ALOX15 reduced the release of proinflammatory chemokines in human macrophages and inhibited the overactivation of type 2 immunity in a mouse model of eosinophilic rhinosinusitis. Our findings advance the understanding of the heterogeneous immune microenvironment and the pathogenesis of CRS subtypes and identify potential therapeutic approaches for the treatment of CRS and potentially other type 2 immunity-mediated diseases.	[Wang, Weiqing; Zhu, Zhenzhen; Aodeng, Surita; Han, Jinbo; Wang, Lei; Lin, Yuxi; Wang, Xiaowei; Zha, Yang; Gao, Zhiqiang; Lv, Wei] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Otolaryngol, Beijing, Peoples R China; [Xu, Yi; Chen, Hui; Cai, Menghua; Hu, Yu; He, Wei; Zhang, Jianmin] Chinese Acad Med Sci, Inst Basic Med Sci, CAMS Key Lab T Cell & Immunotherapy, Dept Immunol, Beijing, Peoples R China; [Xu, Yi; Chen, Hui; Cai, Menghua; Hu, Yu; He, Wei; Zhang, Jianmin] Peking Union Med Coll, Sch Basic Med, State Key Lab Med Mol Biol, Beijing, Peoples R China; [Wang, Lun] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Internal Med, Beijing, Peoples R China; [Huang, Zhihao] Analyt Biosci Ltd, Beijing, Peoples R China; [Zhou, Liangrui] Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Pathol, Beijing, Peoples R China; [Jiang, Weihong] Cent South Univ, Xiangya Hosp, Natl Clin Res Ctr Geriatr Disorders, Dept Otolaryngol Head & Neck Surg, Changsha, Peoples R China; [Zhang, Jianmin] Changzhou Xitaihu Inst Frontier Technol Cell Ther, Changzhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking Union Medical College Hospital; Central South University	Lv, W (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Peking Union Med Coll Hosp, Dept Otolaryngol, Beijing, Peoples R China.; He, W; Zhang, JM (corresponding author), Chinese Acad Med Sci, Inst Basic Med Sci, CAMS Key Lab T Cell & Immunotherapy, Dept Immunol, Beijing, Peoples R China.; He, W; Zhang, JM (corresponding author), Peking Union Med Coll, Sch Basic Med, State Key Lab Med Mol Biol, Beijing, Peoples R China.; Zhang, JM (corresponding author), Changzhou Xitaihu Inst Frontier Technol Cell Ther, Changzhou, Peoples R China.	heweingd@126.com; lili20020615@sina.com; jzhang42@163.com		Xu, Yi/0000-0002-3445-7012; Wang, Weiqing/0000-0002-9440-1117	National Natural Science Foundation of China [82071027, 82101200, 82071791, 81602503, 91542117, 81673010, U20A20374, 81471574]; Natural Science Foundation of Beijing [7202162]; CAMS Innovation Fund for Medical Sciences [2021-I2M-1-005, 2021-I2M-1-035, 2021-I2M-1-053]; Non-profit Central Research Institute Fund of Chinese Academy of Medical Science [2019XK320034]; CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses [2017PT31014, 2018PT32004, 2018PT31052]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Beijing(Beijing Natural Science Foundation); CAMS Innovation Fund for Medical Sciences; Non-profit Central Research Institute Fund of Chinese Academy of Medical Science; CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses	We thank C. Liu and X. Yang for technical support with the development of murine rhinosinusitis models and Q. Yang and X. Chen from Guidon Pharmaceutics for technical support with the MACS and Luminex assays. We also thank H. Weng for her help refining the wording of this manuscript. Extended Data Fig. 10 was created using BioRender.com. This project was supported by grants from the National Natural Science Foundation of China (82071027 to W.L.; 82101200 to W.W.; 82071791 and 81602503 to J.Z.; and 91542117, 81673010, U20A20374 and 81471574 to W.H.), the Natural Science Foundation of Beijing (7202162 to W.L.), the CAMS Innovation Fund for Medical Sciences (2021-I2M-1-005 to J.Z.; 2021-I2M-1-035 to H.C.; and 2021-I2M-1-053 to Y.X.), the Non-profit Central Research Institute Fund of Chinese Academy of Medical Science (2019XK320034 to W.L.) and CAMS Central Public Welfare Scientific Research Institute Basal Research Expenses (2017PT31014 and 2018PT32004 to H.C. and 2018PT31052 to J.Z.).	Azizi E, 2018, CELL, V174, P1293, DOI 10.1016/j.cell.2018.05.060; Bachert C, 2020, NAT REV DIS PRIMERS, V6, DOI 10.1038/s41572-020-00218-1; Bottcher JP, 2018, CELL, V172, P1022, DOI 10.1016/j.cell.2018.01.004; Braga FAV, 2019, NAT MED, V25, P1153, DOI 10.1038/s41591-019-0468-5; Buchheit KM, 2020, J ALLERGY CLIN IMMUN, V145, P1574, DOI 10.1016/j.jaci.2020.02.035; Cao PP, 2019, ANN ALLERG ASTHMA IM, V122, P33, DOI 10.1016/j.anai.2018.10.014; Collin M, 2018, IMMUNOLOGY, V154, P3, DOI 10.1111/imm.12888; Culemann S, 2019, NATURE, V572, P670, DOI 10.1038/s41586-019-1471-1; Das UN, 2018, J ADV RES, V11, P57, DOI 10.1016/j.jare.2018.01.001; David BA, 2019, IMMUNOL REV, V289, P9, DOI 10.1111/imr.12757; Delemarre T, 2021, J ALLERGY CLIN IMMUN, V148, P327, DOI 10.1016/j.jaci.2021.03.024; Efremova M, 2020, NAT PROTOC, V15, P1484, DOI 10.1038/s41596-020-0292-x; Eguiluz-Gracia I, 2016, J ALLERGY CLIN IMMUN, V137, P1872, DOI 10.1016/j.jaci.2015.11.025; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fonseka CY, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aaq0305; Gibbings SL, 2017, AM J RESP CELL MOL, V57, P66, DOI 10.1165/rcmb.2016-0361OC; Global Initiative for Asthma, 2021, GLOB STRAT ASTHM MAN; Guo XY, 2018, NAT MED, V24, P978, DOI 10.1038/s41591-018-0045-3; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Hawkins FJ, 2021, CELL STEM CELL, V28, P79, DOI 10.1016/j.stem.2020.09.017; He Y, 2016, TRENDS BIOCHEM SCI, V41, P1012, DOI 10.1016/j.tibs.2016.09.002; Helmink BA, 2020, NATURE, V577, P549, DOI 10.1038/s41586-019-1922-8; Karin N, 2016, J LEUKOCYTE BIOL, V99, P857, DOI 10.1189/jlb.2MR0915-441R; Kristjansson RP, 2019, NAT GENET, V51, P267, DOI 10.1038/s41588-018-0314-6; Lambrechts D, 2018, NAT MED, V24, P1277, DOI 10.1038/s41591-018-0096-5; Li ZP, 2019, J ALLERGY CLIN IMMUN, V144, P1228, DOI 10.1016/j.jaci.2019.06.037; Lou HF, 2019, EXPERT REV CLIN IMMU, V15, P1171, DOI 10.1080/1744666X.2020.1679626; Lugrin J, 2018, IMMUNOL REV, V281, P99, DOI 10.1111/imr.12618; Mei HE, 2016, CYTOM PART A, V89A, P292, DOI 10.1002/cyto.a.22778; Miller JC, 2012, NAT IMMUNOL, V13, P888, DOI 10.1038/ni.2370; Minhas PS, 2019, NAT IMMUNOL, V20, P50, DOI 10.1038/s41590-018-0255-3; Montoro DT, 2018, NATURE, V560, P319, DOI 10.1038/s41586-018-0393-7; Ordovas-Montanes J, 2018, NATURE, V560, P649, DOI 10.1038/s41586-018-0449-8; Pavlidis S, 2019, EUR RESPIR J, V53, DOI 10.1183/13993003.00938-2018; Rothe T, 2015, J CLIN INVEST, V125, P1944, DOI 10.1172/JCI78490; Ryan EJ, 2002, J IMMUNOL, V169, P5638, DOI 10.4049/jimmunol.169.10.5638; Sachs-Olsen C, 2010, J ALLERGY CLIN IMMUN, V126, P859, DOI 10.1016/j.jaci.2010.07.015; Samitas K, 2018, ALLERGY, V73, P993, DOI 10.1111/all.13373; Samusik N, 2016, NAT METHODS, V13, P493, DOI [10.1038/NMETH.3863, 10.1038/nmeth.3863]; Schleimer RP, 2017, ANNU REV PATHOL-MECH, V12, P331, DOI 10.1146/annurev-pathol-052016-100401; Shi LL, 2014, AM J RESP CRIT CARE, V190, P628, DOI 10.1164/rccm.201402-0234OC; Snodgrass RG, 2019, FRONT PHARMACOL, V10, DOI 10.3389/fphar.2019.00719; Stevens WW, 2019, J ALLER CL IMM-PRACT, V7, P2812, DOI 10.1016/j.jaip.2019.05.009; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subrata LS, 2009, J IMMUNOL, V183, P2793, DOI 10.4049/jimmunol.0900695; Teufelberger AR, 2018, J ALLERGY CLIN IMMUN, V141, P549, DOI 10.1016/j.jaci.2017.05.004; Tharakan A, 2018, INT FORUM ALLERGY RH, V8, P513, DOI 10.1002/alr.22072; Travaglini KJ, 2020, NATURE, V587, DOI 10.1038/s41586-020-2922-4; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Weizman OE, 2017, CELL, V171, P795, DOI 10.1016/j.cell.2017.09.052; Whitfield ML, 2006, NAT REV CANCER, V6, P99, DOI 10.1038/nrc1802; Whitsett JA, 2015, NAT IMMUNOL, V16, P27, DOI 10.1038/ni.3045; Wolf FA, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1663-x; Wolf FA, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-017-1382-0; Xu XN, 2020, ALLERGY, V75, P769, DOI 10.1111/all.14044; Yan B, 2019, J ALLERGY CLIN IMMUN, V144, P455, DOI 10.1016/j.jaci.2019.03.026; Yii ACA, 2018, ALLERGY, V73, P1964, DOI 10.1111/all.13496; Zhang J, 2019, ONCOTARGETS THER, V12, P4985, DOI 10.2147/OTT.S200643; Zhang L, 2020, CELL, V181, P442, DOI 10.1016/j.cell.2020.03.048; Zhang QM, 2019, CELL, V179, P829, DOI 10.1016/j.cell.2019.10.003; Zilionis R, 2019, IMMUNITY, V50, P1317, DOI 10.1016/j.immuni.2019.03.009; Zimmerman KD, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21038-1; Zuo WL, 2018, AM J RESP CRIT CARE, V198, P1375, DOI 10.1164/rccm.201710-2107OC	65	1	1	12	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2022	23	10					1484	+		10.1038/s41590-022-01312-0	http://dx.doi.org/10.1038/s41590-022-01312-0		SEP 2022	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5G2XG	36138182				2022-12-18	WOS:000856626700002
J	Diniz, MO; Mitsi, E; Swadling, L; Rylance, J; Johnson, M; Goldblatt, D; Ferreira, D; Maini, MK				Diniz, Mariana O.; Mitsi, Elena; Swadling, Leo; Rylance, Jamie; Johnson, Marina; Goldblatt, David; Ferreira, Daniela; Maini, Mala K.			Airway-resident T cells from unexposed individuals cross-recognize SARS-CoV-2	NATURE IMMUNOLOGY			English	Article							CHALLENGE; HEALTH	T cells can contribute to clearance of respiratory viruses that cause acute-resolving infections such as SARS-CoV-2, helping to provide long-lived protection against disease. Recent studies have suggested an additional role for T cells in resisting overt infection: pre-existing cross-reactive responses were preferentially enriched in healthcare workers who had abortive infections(1), and in household contacts protected from infection(2). We hypothesize that such early viral control would require pre-existing cross-reactive memory T cells already resident at the site of infection; such airway-resident responses have been shown to be critical for mediating protection after intranasal vaccination in a murine model of SARS-CoV3. Bronchoalveolar lavage samples from the lower respiratory tract of healthy donors obtained before the COVID-19 pandemic revealed airway-resident, SARS-CoV-2-cross-reactive T cells, which correlated with the strength of human seasonal coronavirus immunity. We therefore demonstrate the potential to harness functional airway-resident SARS-CoV-2-reactive T cells in next-generation mucosal vaccines.	[Diniz, Mariana O.; Swadling, Leo; Maini, Mala K.] UCL, Div Infect & Immun, London, England; [Diniz, Mariana O.; Swadling, Leo; Maini, Mala K.] UCL, Inst Immun & Transplantat, London, England; [Mitsi, Elena; Rylance, Jamie; Ferreira, Daniela] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England; [Johnson, Marina; Goldblatt, David] Inst Child Hlth, London, England; [Ferreira, Daniela] Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England	University of London; University College London; University of London; University College London; Liverpool School of Tropical Medicine; University of London; University College London; University of Oxford	Maini, MK (corresponding author), UCL, Div Infect & Immun, London, England.; Maini, MK (corresponding author), UCL, Inst Immun & Transplantat, London, England.; Ferreira, D (corresponding author), Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England.; Ferreira, D (corresponding author), Univ Oxford, Dept Paediat, Oxford Vaccine Grp, Oxford, England.	Daniela.Ferreira@alstmed.ac.uk; m.maini@ucl.ac.uk	Ferreira, Daniela M/AFF-4763-2022; Goldblatt, David/C-5972-2008	Ferreira, Daniela M/0000-0002-0594-0902; Goldblatt, David/0000-0002-0769-5242; Maini, Mala/0000-0001-6384-1462; Mitsi, Dr Elena/0000-0001-7586-6050	Wellcome Trust Investigator Award [214191/Z/18/Z]; CRUK Immunology grant [26603]; Medical Research Foundation fellowship [044-0001]; Bill and Melinda Gates Foundation [OPP1117728]; UK Medical Research Council [M011569/1]	Wellcome Trust Investigator Award(Wellcome Trust); CRUK Immunology grant; Medical Research Foundation fellowship; Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all the patients and control volunteers who participated in the present study and all the clinical staff who helped with recruitment and sample collection. We thank A. Bertoletti for supplying the pre-pooled Sars-Cov-2 peptides. M.K.M. is supported by Wellcome Trust Investigator Award (no. 214191/Z/18/Z) and CRUK Immunology grant (no.26603), and L.S. by a Medical Research Foundation fellowship (044-0001). Collection of clinical samples was supported by the Bill and Melinda Gates Foundation (grant no. OPP1117728) and the UK Medical Research Council (grant no. M011569/1) awarded to D.M.F.	Afkhami S, 2022, CELL, V185, P896, DOI 10.1016/j.cell.2022.02.005; Almeida ST, 2021, J INFECT DIS, V223, P1590, DOI 10.1093/infdis/jiaa558; Antunes RD, 2021, J INFECT DIS, V224, P70, DOI 10.1093/infdis/jiab176; Bacher P, 2020, IMMUNITY, V53, P1258, DOI 10.1016/j.immuni.2020.11.016; Behr FM, 2020, NAT IMMUNOL, V21, P1070, DOI 10.1038/s41590-020-0723-4; Carniel BF, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.141088; Chung H, 2021, IMMUNE NETW, V21, DOI 10.4110/in.2021.21.e28; Collins AM, 2015, AM J RESP CRIT CARE, V192, P853, DOI 10.1164/rccm.201503-0542OC; Fonseca R, 2020, NAT IMMUNOL, V21, P412, DOI 10.1038/s41590-020-0607-7; Gallais F, 2021, EMERG INFECT DIS, V27, P113, DOI 10.3201/eid2701.203611; Ge CH, 2019, CELL REP, V29, P4236, DOI 10.1016/j.celrep.2019.11.103; Grifoni A, 2020, CELL, V181, P1489, DOI 10.1016/j.cell.2020.05.015; Guvenel A, 2020, J CLIN INVEST, V130, P523, DOI 10.1172/JCI131696; Johnson M, 2020, J CLIN VIROL, V130, DOI 10.1016/j.jcv.2020.104572; Killingley B, 2022, NAT MED, V28, P1031, DOI 10.1038/s41591-022-01780-9; Kundu Rhia, 2022, Nat Commun, V13, P80, DOI 10.1038/s41467-021-27674-x; Le Bert N, 2020, NATURE, V584, P457, DOI 10.1038/s41586-020-2550-z; Loyal L, 2021, SCIENCE, V374, P171, DOI 10.1126/science.abh1823; McMaster SR, 2015, J IMMUNOL, V195, P203, DOI 10.4049/jimmunol.1402975; Meckiff BJ, 2020, CELL, V183, P1340, DOI 10.1016/j.cell.2020.10.001; Mitsi E, 2020, AM J RESP CRIT CARE, V201, P335, DOI 10.1164/rccm.201903-0607OC; Nesterenko PA, 2021, CELL REP, V37, DOI 10.1016/j.celrep.2021.110167; Niessl J, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abk0894; Ogbe A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21856-3; Pallett LJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20200050; Peng YC, 2020, NAT IMMUNOL, V21, P1336, DOI [10.1038/s41590-020-0782-6, 10.1101/2020.06.05.134551]; Piters WAAD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10814-9; Poon MML, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abl9105; Roukens AHE, 2022, NAT IMMUNOL, V23, P23, DOI 10.1038/s41590-021-01095-w; Sekine T, 2020, CELL, V183, P158, DOI 10.1016/j.cell.2020.08.017; Slutter B, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2031; Snyder ME, 2019, CURR OPIN IMMUNOL, V59, P101, DOI 10.1016/j.coi.2019.05.011; Snyder ME, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aav5581; Swadling L, 2022, NATURE, V601, DOI 10.1038/s41586-021-04186-8; Takamura S, 2019, J EXP MED, V216, P2736, DOI 10.1084/jem.20190557; Tan CCS, 2021, INFECT GENET EVOL, V95, DOI 10.1016/j.meegid.2021.105075; Wein AN, 2019, J EXP MED, V216, P2748, DOI 10.1084/jem.20181308; Zaidi SR, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-017-0421-7; Zhao JC, 2016, IMMUNITY, V44, P1379, DOI 10.1016/j.immuni.2016.05.006; Zheng MZM, 2022, MUCOSAL IMMUNOL, V15, P379, DOI 10.1038/s41385-021-00461-z	41	1	1	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2022	23	9								10.1038/s41590-022-01292-1	http://dx.doi.org/10.1038/s41590-022-01292-1		AUG 2022	15	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4O2BH	36038709	Green Published, Green Accepted, hybrid, Green Submitted			2022-12-18	WOS:000847285500001
J	Galluzzi, L; Kroemer, G				Galluzzi, Lorenzo; Kroemer, Guido			Immuno-epigenetic escape of cancer stem cells	NATURE IMMUNOLOGY			English	Editorial Material								The net effect of type I interferon (IFN-I) signaling on tumor control depends on various factors, including the potential engagement of adaptive anticancer immunity. New findings delineate a targetable epigenetic mechanism by which suboptimal IFN-I signaling promotes tumor progression in the context of cancer stem cell expansion and immunoevasion.	[Galluzzi, Lorenzo] Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10021 USA; [Galluzzi, Lorenzo] Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Galluzzi, Lorenzo] Caryl & Israel Englander Inst Precis Med, New York, NY 10021 USA; [Kroemer, Guido] Sorbonne Univ, Univ Paris Cite, Inst Univ France,Inserm U1138, Ctr Rech Cordeliers,Equipe Labellisee Ligue Canc, Paris, France; [Kroemer, Guido] Univ Paris Saclay, Gustave Roussy Canc Ctr, Metabol & Cell Biol Platforms, Villejuif, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, AP HP, Inst Canc Paris CARPEM, Dept Biol, Paris, France	Cornell University; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut Universitaire de France; UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; UNICANCER; Gustave Roussy; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	Galluzzi, L (corresponding author), Weill Cornell Med Coll, Dept Radiat Oncol, New York, NY 10021 USA.; Galluzzi, L (corresponding author), Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA.; Galluzzi, L (corresponding author), Caryl & Israel Englander Inst Precis Med, New York, NY 10021 USA.; Kroemer, G (corresponding author), Sorbonne Univ, Univ Paris Cite, Inst Univ France,Inserm U1138, Ctr Rech Cordeliers,Equipe Labellisee Ligue Canc, Paris, France.; Kroemer, G (corresponding author), Univ Paris Saclay, Gustave Roussy Canc Ctr, Metabol & Cell Biol Platforms, Villejuif, France.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, AP HP, Inst Canc Paris CARPEM, Dept Biol, Paris, France.	deadoc80@gmail.com; kroemer@orange.fr	Kroemer, Guido/B-4263-2013	Kroemer, Guido/0000-0002-9334-4405				Bayik D, 2021, NAT REV CANCER, V21, P526, DOI 10.1038/s41568-021-00366-w; Hopfner KP, 2020, NAT REV MOL CELL BIO, V21, P501, DOI 10.1038/s41580-020-0244-x; Kroemer G, 2022, NAT IMMUNOL, V23, P487, DOI 10.1038/s41590-022-01132-2; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Musella M, 2022, NAT IMMUNOL, V23, P1379, DOI 10.1038/s41590-022-01290-3; Palucka AK, 2016, CELL, V164, P1233, DOI 10.1016/j.cell.2016.01.049; Rehwinkel J, 2020, NAT REV IMMUNOL, V20, P537, DOI 10.1038/s41577-020-0288-3; Rodriguez-Ruiz ME, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1655964; Sistigu A, 2014, NAT MED, V20, P1301, DOI 10.1038/nm.3708; Vanpouille-Box C, 2018, CANCER CELL, V34, P361, DOI 10.1016/j.ccell.2018.05.013; Weichselbaum RR, 2008, P NATL ACAD SCI USA, V105, P18490, DOI 10.1073/pnas.0809242105; Yamazaki T, 2020, NAT IMMUNOL, V21, P1160, DOI 10.1038/s41590-020-0751-0	12	1	1	6	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2022	23	9					1300	1302		10.1038/s41590-022-01293-0	http://dx.doi.org/10.1038/s41590-022-01293-0		AUG 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	4O8VJ	36002649				2022-12-18	WOS:000844434100001
J	Qin, ZR; Fang, XW; Sun, WH; Ma, ZY; Dai, T; Wang, S; Zong, Z; Huang, HZ; Ru, H; Lu, HS; Yang, B; Lin, SX; Zhou, FF; Zhang, L				Qin, Ziran; Fang, Xiuwu; Sun, Wenhuan; Ma, Zhenyu; Dai, Tong; Wang, Shuai; Zong, Zhi; Huang, Huizhe; Ru, Heng; Lu, Huasong; Yang, Bing; Lin, Shixian; Zhou, Fangfang; Zhang, Long			Deactylation by SIRT1 enables liquid-liquid phase separation of IRF3/IRF7 in innate antiviral immunity	NATURE IMMUNOLOGY			English	Article							CRYSTAL-STRUCTURE; IN-SITU; PROTEIN; IRF-3; RESVERATROL; INTERFERONS; EVASION; CELLS	The deacetylase SIRT1 regulates IRF3/IRF7-mediated antiviral interferon signaling. Here the authors show that SIRT1 deactylates the DNA-binding domain resulting in liquid-liquid phase separation of IRF3/IRF7 and that this signaling is inhibited in aging, an effect that can be reversed with a SIRT1 agonist to restore antiviral response. Innate antiviral immunity deteriorates with aging but how this occurs is not entirely clear. Here we identified SIRT1-mediated DNA-binding domain (DBD) deacetylation as a critical step for IRF3/7 activation that is inhibited during aging. Viral-stimulated IRF3 underwent liquid-liquid phase separation (LLPS) with interferon (IFN)-stimulated response element DNA and compartmentalized IRF7 in the nucleus, thereby stimulating type I IFN (IFN-I) expression. SIRT1 deficiency resulted in IRF3/IRF7 hyperacetylation in the DBD, which inhibited LLPS and innate immunity, resulting in increased viral load and mortality in mice. By developing a genetic code expansion orthogonal system, we demonstrated the presence of an acetyl moiety at specific IRF3/IRF7 DBD site/s abolish IRF3/IRF7 LLPS and IFN-I induction. SIRT1 agonists rescued SIRT1 activity in aged mice, restored IFN signaling and thus antagonized viral replication. These findings not only identify a mechanism by which SIRT1 regulates IFN production by affecting IRF3/IRF7 LLPS, but also provide information on the drivers of innate immunosenescence.	[Qin, Ziran; Zhang, Long] Zhejiang Univ, Sch Med, Affiliated Hosp 2, Int Biomed X Res Ctr, Hangzhou, Peoples R China; [Qin, Ziran; Fang, Xiuwu; Sun, Wenhuan; Ma, Zhenyu; Dai, Tong; Wang, Shuai; Zhou, Fangfang] Soochow Univ, Inst Biol, Suzhou, Peoples R China; [Qin, Ziran; Fang, Xiuwu; Sun, Wenhuan; Ma, Zhenyu; Dai, Tong; Wang, Shuai; Zhou, Fangfang] Soochow Univ, Inst Med Sci, Suzhou, Peoples R China; [Zong, Zhi; Ru, Heng; Lu, Huasong; Yang, Bing; Lin, Shixian; Zhang, Long] Zhejiang Univ, MOE Lab Biosyst Homeostasis & Protect, Hangzhou, Peoples R China; [Zong, Zhi; Ru, Heng; Lu, Huasong; Yang, Bing; Lin, Shixian; Zhang, Long] Zhejiang Univ, Innovat Ctr Cell Signaling Network, Life Sci Inst, Hangzhou, Peoples R China; [Huang, Huizhe] Chonqing Med Univ, Fac Basic Med Sci, Chongqing, Peoples R China; [Yang, Bing] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA USA; [Yang, Bing] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Zhang, Long] Zhejiang Univ, Canc Ctr, Hangzhou, Peoples R China	Zhejiang University; Soochow University - China; Soochow University - China; Zhejiang University; Zhejiang University; Chongqing Medical University; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Zhejiang University	Zhang, L (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 2, Int Biomed X Res Ctr, Hangzhou, Peoples R China.; Zhou, FF (corresponding author), Soochow Univ, Inst Biol, Suzhou, Peoples R China.; Zhou, FF (corresponding author), Soochow Univ, Inst Med Sci, Suzhou, Peoples R China.; Zhang, L (corresponding author), Zhejiang Univ, MOE Lab Biosyst Homeostasis & Protect, Hangzhou, Peoples R China.; Zhang, L (corresponding author), Zhejiang Univ, Innovat Ctr Cell Signaling Network, Life Sci Inst, Hangzhou, Peoples R China.; Zhang, L (corresponding author), Zhejiang Univ, Canc Ctr, Hangzhou, Peoples R China.	zhoufangfang@suda.edu.cn; L_Zhang@zju.edu.cn	Dai, Tong/AHD-4834-2022	Dai, Tong/0000-0002-6295-5449	Ministry of Science and Technology of China [2021YFA1101000]; Chinese National Natural Science Funds [U20A20393, U20A201376, 32125016, 31701234, 91753139, 31925013, 31671457, 31870902, 32070907, 32100699, 31871405]; China National Postdoctoral Program for Innovative Talents [BX2021208]; China Postdoctoral Science Foundation [2021M692350]; Zhejiang Natural Science Fund [LD19C070001]; Jiangsu National Science Foundation [19KJA550003]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Chinese National Natural Science Funds(National Natural Science Foundation of China (NSFC)); China National Postdoctoral Program for Innovative Talents; China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Zhejiang Natural Science Fund; Jiangsu National Science Foundation	The current work was supported by a special program from the Ministry of Science and Technology of China (2021YFA1101000), the Chinese National Natural Science Funds (U20A20393, U20A201376, 32125016, 31701234, 91753139, 31925013, 31671457, 31870902, 32070907, 32100699 and 31871405), the China National Postdoctoral Program for Innovative Talents (BX2021208), the China Postdoctoral Science Foundation (2021M692350), the Zhejiang Natural Science Fund (LD19C070001) and Jiangsu National Science Foundation (19KJA550003).	Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Bartleson Juliet M, 2021, Nat Aging, V1, P769, DOI 10.1038/s43587-021-00114-7; Boeynaems S, 2018, TRENDS CELL BIOL, V28, P420, DOI 10.1016/j.tcb.2018.02.004; Bowie AG, 2008, NAT REV IMMUNOL, V8, P911, DOI 10.1038/nri2436; Caillaud A, 2002, J BIOL CHEM, V277, P49417, DOI 10.1074/jbc.M207484200; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Hnisz D, 2017, CELL, V169, P13, DOI 10.1016/j.cell.2017.02.007; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Huai WW, 2019, J EXP MED, V216, P772, DOI 10.1084/jem.20181773; Hyman AA, 2014, ANNU REV CELL DEV BI, V30, P39, DOI 10.1146/annurev-cellbio-100913-013325; Ishikawa H, 2008, NATURE, V455, P674, DOI 10.1038/nature07317; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li MF, 2022, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.808159; Lin RT, 1999, MOL CELL BIOL, V19, P2465; Lu Y, 2020, NAT CELL BIOL, V22, DOI 10.1038/s41556-020-0485-0; McNab F, 2015, NAT REV IMMUNOL, V15, P87, DOI 10.1038/nri3787; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Park A, 2020, CELL HOST MICROBE, V27, P870, DOI 10.1016/j.chom.2020.05.008; Piroth L, 2021, LANCET RESP MED, V9, P251, DOI 10.1016/S2213-2600(20)30527-0; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Sabari BR, 2018, SCIENCE, V361, DOI 10.1126/science.aar3958; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Satoh A, 2013, CELL METAB, V18, P416, DOI 10.1016/j.cmet.2013.07.013; Scheibye-Knudsen M, 2014, CELL METAB, V20, P840, DOI 10.1016/j.cmet.2014.10.005; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Shen C, 2021, CELL, V184, P5759, DOI 10.1016/j.cell.2021.09.032; Shi B, 2021, NATURE, V597, P726, DOI 10.1038/s41586-021-03903-7; Shin Y, 2017, CELL, V168, P159, DOI 10.1016/j.cell.2016.11.054; Soderberg O, 2008, METHODS, V45, P227, DOI 10.1016/j.ymeth.2008.06.014; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Solana R, 2012, SEMIN IMMUNOL, V24, P331, DOI 10.1016/j.smim.2012.04.008; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; Wang B, 2021, SIGNAL TRANSDUCT TAR, V6, DOI 10.1038/s41392-021-00678-1; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156; Yan N, 2012, NAT IMMUNOL, V13, P214, DOI 10.1038/ni.2229; Yang B, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02409-z	41	1	1	16	16	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2022	23	8					1193	+		10.1038/s41590-022-01269-0	http://dx.doi.org/10.1038/s41590-022-01269-0		JUL 2022	34	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3O3AR	35879450	Bronze			2022-12-18	WOS:000829717100005
J	Zhou, FF; Zhang, L				Zhou, Fangfang; Zhang, Long			IRF3 and IRF7 require SIRT1 for liquid-liquid phase separation and transactivation of INF-I	NATURE IMMUNOLOGY			English	Editorial Material									[Zhou, Fangfang] Soochow Univ, Inst Biol, Suzhou, Peoples R China; [Zhou, Fangfang] Soochow Univ, Inst Med Sci, Suzhou, Peoples R China; [Zhang, Long] Zhejiang Univ, Life Sci Inst, Hangzhou, Peoples R China	Soochow University - China; Soochow University - China; Zhejiang University	Zhou, FF (corresponding author), Soochow Univ, Inst Biol, Suzhou, Peoples R China.; Zhou, FF (corresponding author), Soochow Univ, Inst Med Sci, Suzhou, Peoples R China.							Alberti S, 2019, CELL, V176, P419, DOI 10.1016/j.cell.2018.12.035; Bartleson Juliet M, 2021, Nat Aging, V1, P769, DOI 10.1038/s43587-021-00114-7; Pardo PS, 2020, MECH AGEING DEV, V188, DOI 10.1016/j.mad.2020.111249; Piroth L, 2021, LANCET RESP MED, V9, P251, DOI 10.1016/S2213-2600(20)30527-0; Xu CY, 2020, NAT CELL BIOL, V22, P1170, DOI 10.1038/s41556-020-00579-5	5	1	1	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2022	23	8					1144	1145		10.1038/s41590-022-01270-7	http://dx.doi.org/10.1038/s41590-022-01270-7		JUL 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3O3AR	35879453	Green Published, Bronze			2022-12-18	WOS:000829717100004
J	Assen, FP; Abe, J; Hons, M; Hauschild, R; Shamipour, S; Kaufmann, WA; Costanzo, T; Krens, G; Brown, M; Ludewig, B; Hippenmeyer, S; Heisenberg, CP; Weninger, W; Hannezo, E; Luther, SA; Stein, JV; Sixt, M				Assen, Frank P.; Abe, Jun; Hons, Miroslav; Hauschild, Robert; Shamipour, Shayan; Kaufmann, Walter A.; Costanzo, Tommaso; Krens, Gabriel; Brown, Markus; Ludewig, Burkhard; Hippenmeyer, Simon; Heisenberg, Carl-Philipp; Weninger, Wolfgang; Hannezo, Edouard; Luther, Sanjiv A.; Stein, Jens, V; Sixt, Michael			Multitier mechanics control stromal adaptations in the swelling lymph node	NATURE IMMUNOLOGY			English	Article							FIBROBLASTIC RETICULAR CELLS; INTEGRIN ACTIVATION; DENDRITIC CELLS; MOSAIC ANALYSIS; AFFERENT LYMPH; DOUBLE MARKERS; HOMEOSTASIS; GROWTH; ORGANIZATION; PRECURSORS	Lymph nodes (LNs) comprise two main structural elements: fibroblastic reticular cells that form dedicated niches for immune cell interaction and capsular fibroblasts that build a shell around the organ. Immunological challenge causes LNs to increase more than tenfold in size within a few days. Here, we characterized the biomechanics of LN swelling on the cellular and organ scale. We identified lymphocyte trapping by influx and proliferation as drivers of an outward pressure force, causing fibroblastic reticular cells of the T-zone (TRCs) and their associated conduits to stretch. After an initial phase of relaxation, TRCs sensed the resulting strain through cell matrix adhesions, which coordinated local growth and remodeling of the stromal network. While the expanded TRC network readopted its typical configuration, a massive fibrotic reaction of the organ capsule set in and countered further organ expansion. Thus, different fibroblast populations mechanically control LN swelling in a multitier fashion. Sixt and colleagues show that different fibroblast populations in the lymph node mechanically control its swelling in a multitier fashion.	[Assen, Frank P.; Hons, Miroslav; Hauschild, Robert; Shamipour, Shayan; Kaufmann, Walter A.; Costanzo, Tommaso; Krens, Gabriel; Brown, Markus; Hippenmeyer, Simon; Heisenberg, Carl-Philipp; Hannezo, Edouard; Sixt, Michael] Inst Sci & Technol Austria ISTA, Klosterneuburg, Austria; [Assen, Frank P.; Weninger, Wolfgang] Med Univ Vienna, Dept Dermatol, Vienna, Austria; [Abe, Jun; Stein, Jens, V] Univ Fribourg, Dept Oncol Microbiol & Immunol, Fribourg, Switzerland; [Hons, Miroslav] Charles Univ Prague, Fac Med 1, BIOCEV, Vestec, Czech Republic; [Ludewig, Burkhard] Kantonsspital St Gallen, Inst Immunobiol, St Gallen, Switzerland; [Luther, Sanjiv A.] Univ Lausanne, Dept Immunobiol, Epalinges, Switzerland	Institute of Science & Technology - Austria; Medical University of Vienna; University of Fribourg; Charles University Prague; Kantonsspital St. Gallen; University of Lausanne	Assen, FP; Sixt, M (corresponding author), Inst Sci & Technol Austria ISTA, Klosterneuburg, Austria.; Assen, FP (corresponding author), Med Univ Vienna, Dept Dermatol, Vienna, Austria.	frank.assen@meduniwien.ac.at; sixt@ist.ac.at	Luther, Sanjiv/AAP-6525-2020	Luther, Sanjiv/0000-0002-8758-957X; Stein, Jens V/0000-0002-8199-9586; Abe, Jun/0000-0001-7511-4502; SHAMI POUR, Shayan/0000-0002-0635-3873; Kaufmann, Walter Anton/0000-0001-9735-5315; Ludewig, Burkhard/0000-0002-7685-573X; Costanzo, Tommaso/0000-0001-9732-3815; Hons, Miroslav/0000-0002-6625-3348; Sixt, Michael/0000-0002-6620-9179; Assen, Frank/0000-0003-3470-6119	Scientific Service Units of IST Austria; European Research Council [ERC-CoG-72437]; Czech Sciencundation GACR [2024603Y]; Charles University [PRIMUS/20/MED/013]	Scientific Service Units of IST Austria; European Research Council(European Research Council (ERC)European Commission); Czech Sciencundation GACR(Grant Agency of the Czech Republic); Charles University	This research was supported by the Scientific Service Units of IST Austria through resources provided by the Imaging and Optics, Electron Microscopy, Preclinical and Life Science Facilities. We thank C. Moussion for providing anti-PNAd antibody and D. Critchley for Talin1-floxed mice, and E. Papusheva for providing a custom 3D channel alignment script. This work was supported by a European Research Council grant ERC-CoG-72437 to M.S. M.H. was supported by Czech Sciencundation GACR 2024603Y and Charles University PRIMUS/20/MED/013.	Abe J, 2016, J IMMUNOL METHODS, V431, P1, DOI 10.1016/j.jim.2016.01.015; Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Austen K, 2015, NAT CELL BIOL, V17, P1597, DOI 10.1038/ncb3268; Bailey N. T. J., 1990, ELEMENTS STOCHASTIC; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Behrndt M, 2012, SCIENCE, V338, P257, DOI 10.1126/science.1224143; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Chai Q, 2013, IMMUNITY, V38, P1013, DOI 10.1016/j.immuni.2013.03.012; Cheng HW, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09728-3; Choi I, 2011, BLOOD, V117, P362, DOI 10.1182/blood-2010-07-298562; Choi SY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14293-1; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Colombelli J, 2004, REV SCI INSTRUM, V75, P472, DOI 10.1063/1.1641163; Contreras X, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109274; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Delarue M, 2016, NAT PHYS, V12, P762, DOI 10.1038/NPHYS3741; Devi S, 2021, IMMUNITY, V54, P1219, DOI 10.1016/j.immuni.2021.03.025; Druzd D, 2017, IMMUNITY, V46, P120, DOI 10.1016/j.immuni.2016.12.011; Ester M., 1996, P 2 INT C KNOWL DISC, P226; Forgacs G, 1998, BIOPHYS J, V74, P2227, DOI 10.1016/S0006-3495(98)77932-9; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Gaya M, 2015, SCIENCE, V347, P667, DOI 10.1126/science.aaa1300; Gorelik L, 2003, J EXP MED, V198, P937, DOI 10.1084/jem.20030789; Hippenmeyer S, 2013, CELL REP, V3, P960, DOI 10.1016/j.celrep.2013.02.002; Kaldjian EP, 2001, INT IMMUNOL, V13, P1243, DOI 10.1093/intimm/13.10.1243; Knop L, 2020, EUR J IMMUNOL, V50, P846, DOI 10.1002/eji.201948368; Krishnamurty AT, 2020, NAT IMMUNOL, V21, P369, DOI 10.1038/s41590-020-0635-3; Kumar V, 2015, IMMUNITY, V42, P719, DOI 10.1016/j.immuni.2015.03.015; Lammermann T, 2008, IMMUNOL REV, V221, P26, DOI 10.1111/j.1600-065X.2008.00592.x; Li WZ, 2019, NAT PROTOC, V14, P1708, DOI 10.1038/s41596-019-0156-4; Link A, 2007, NAT IMMUNOL, V8, P1255, DOI 10.1038/ni1513; Luther SA, 2000, P NATL ACAD SCI USA, V97, P12694, DOI 10.1073/pnas.97.23.12694; Madisen L, 2010, NAT NEUROSCI, V13, P133, DOI 10.1038/nn.2467; Mao YL, 2013, EMBO J, V32, P2790, DOI 10.1038/emboj.2013.197; Matloubian M, 2004, NATURE, V427, P355, DOI 10.1038/nature02284; MCCONNELL I, 1981, IMMUNOLOGY, V42, P217; Mills S, 2019, HISTOLOGY PATHOLOGIS; Mionnet C, 2011, BLOOD, V118, P6115, DOI 10.1182/blood-2011-07-367409; Nakai A, 2014, J EXP MED, V211, P2583, DOI 10.1084/jem.20141132; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; OHTANI O, 1987, ARCH HISTOL CYTOL, V50, P557, DOI 10.1679/aohc.50.557; Panciera T, 2017, NAT REV MOL CELL BIO, V18, P758, DOI 10.1038/nrm.2017.87; Pham THM, 2008, IMMUNITY, V28, P122, DOI 10.1016/j.immuni.2007.11.017; Rodda LB, 2018, IMMUNITY, V48, P1014, DOI 10.1016/j.immuni.2018.04.006; Schaeuble K, 2017, CELL REP, V21, P2500, DOI 10.1016/j.celrep.2017.10.119; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Sixt M, 2005, IMMUNITY, V22, P19, DOI 10.1016/j.immuni.2004.11.013; Smutny M, 2015, METHODS MOL BIOL, V1189, P219, DOI 10.1007/978-1-4939-1164-6_15; Sommer C, 2011, I S BIOMED IMAGING, P230, DOI 10.1109/ISBI.2011.5872394; Sun ZQ, 2019, NAT CELL BIOL, V21, P25, DOI 10.1038/s41556-018-0234-9; Susaki EA, 2014, CELL, V157, P726, DOI 10.1016/j.cell.2014.03.042; Suzuki K, 2016, J EXP MED, V213, P2567, DOI 10.1084/jem.20160723; Thielicke W., 2014, J OPEN RES SOFTWARE, V2, P12, DOI [10.5334/jors.bl, DOI 10.5334/JORS.BL]; USHIKI T, 1995, ANAT REC, V241, P113, DOI 10.1002/ar.1092410115; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111; Young AJ, 1999, SEMIN IMMUNOL, V11, P73, DOI 10.1006/smim.1999.0163; Zheng L, 2008, INT IMMUNOL, V20, P517, DOI 10.1093/intimm/dxn017; Zong H, 2005, CELL, V121, P479, DOI 10.1016/j.cell.2005.02.012	60	1	1	10	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2022	23	8					1246	+		10.1038/s41590-022-01257-4	http://dx.doi.org/10.1038/s41590-022-01257-4		JUL 2022	25	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3O3AR	35817845	hybrid, Green Published			2022-12-18	WOS:000822975900002
J	Yu, D; Walker, LSK; Liu, Z; Linterman, MA; Li, ZG				Yu, Di; Walker, Lucy S. K.; Liu, Zheng; Linterman, Michelle A.; Li, Zhanguo			Targeting T-FH cells in human diseases and vaccination: rationale and practice	NATURE IMMUNOLOGY			English	Review							FOLLICULAR HELPER-CELL; GERMINAL CENTER RESPONSES; CXC CHEMOKINE RECEPTOR-5; MESSENGER-RNA VACCINES; B-CELL; ANTIBODY-RESPONSES; DENDRITIC CELLS; TFH CELLS; INFLUENZA VACCINE; PEYERS-PATCHES	Yu et al. review the roles played by follicular helper T cells in sustaining germinal center B cell responses and vaccination strategies, as well as potential pathogenic autoimmune responses. The identification of CD4(+) T cells localizing to B cell follicles has revolutionized the knowledge of how humoral immunity is generated. Follicular helper T (T-FH) cells support germinal center (GC) formation and regulate clonal selection and differentiation of memory and antibody-secreting B cells, thus controlling antibody affinity maturation and memory. T-FH cells are essential in sustaining protective antibody responses necessary for pathogen clearance in infection and vaccine-mediated protection. Conversely, aberrant and excessive T-FH cell responses mediate and sustain pathogenic antibodies to autoantigens, alloantigens, and allergens, facilitate lymphomagenesis, and even harbor viral reservoirs. T-FH cell generation and function are determined by T cell antigen receptor (TCR), costimulation, and cytokine signals, together with specific metabolic and survival mechanisms. Such regulation is crucial to understanding disease pathogenesis and informing the development of emerging therapies for disease or novel approaches to boost vaccine efficacy.	[Yu, Di] Univ Queensland, Diamantina Inst, Fac Med, Brisbane, Qld, Australia; [Yu, Di] Univ Queensland, Ian Frazer Ctr Childrens Immunotherapy Res, Child Hlth Res Ctr, Fac Med, Brisbane, Qld, Australia; [Walker, Lucy S. K.] UCL, Inst Immun & Transplantat, Div Infect & Immun, Royal Free Campus, London, England; [Liu, Zheng] Huazhong Univ Sci & Technol, Tongji Hosp, Dept Otolaryngol Head & Neck Surg, Tongji Med Coll, Wuhan, Peoples R China; [Linterman, Michelle A.] Babraham Inst, Immunol Programme, Cambridge, England; [Li, Zhanguo] Peking Univ Peoples Hosp, Dept Rheumatol & Immunol, Beijing, Peoples R China	University of Queensland; University of Queensland; University of London; University College London; Huazhong University of Science & Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Peking University	Yu, D (corresponding author), Univ Queensland, Diamantina Inst, Fac Med, Brisbane, Qld, Australia.; Yu, D (corresponding author), Univ Queensland, Ian Frazer Ctr Childrens Immunotherapy Res, Child Hlth Res Ctr, Fac Med, Brisbane, Qld, Australia.	di.yu@uq.edu.au		Walker, Lucy/0000-0001-5986-5015; Liu, Zheng/0000-0002-4168-6702	Bellberry-Viertel Senior Medical Research Fellowship; Australian National Health and Medical Research Council [GNT2009554, GNT1147709, GNT1147769]; Wellcome Investigator Award [220772/Z/20/Z]; Medical Research Council [MR/N001435/1]; Diabetes UK [15/0005253]; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BBS/E/B/000C0427]; EMBO Young Investigator; Lister Prize Fellow; Australian Government	Bellberry-Viertel Senior Medical Research Fellowship; Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Wellcome Investigator Award; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Diabetes UK(Diabetes UK); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EMBO Young Investigator(European Molecular Biology Organization (EMBO)); Lister Prize Fellow; Australian Government(Australian GovernmentCGIAR)	We thank members of the Yu group for constructive discussion and P.F. Canete for editing. D.Y. is supported by the Bellberry-Viertel Senior Medical Research Fellowship and Australian National Health and Medical Research Council grants (GNT2009554, GNT1147709, GNT1147769). L.S.K.W. is supported by a Wellcome Investigator Award (220772/Z/20/Z), the Medical Research Council (MR/N001435/1) and Diabetes UK (15/0005253). M.A.L is supported by funding from the Biotechnology and Biological Sciences Research Council (BBS/E/B/000C0407, BBS/E/B/000C0427) and is an EMBO Young Investigator and Lister Prize Fellow. This research was carried out at the Translational Research Institute, Woolloongabba, QLD 4102, Australia. The Translational Research Institute is supported by a grant from the Australian Government.	Agache I, 2019, J CLIN INVEST, V129, P1493, DOI 10.1172/JCI124611; Akkaya M, 2020, NAT REV IMMUNOL, V20, P229, DOI 10.1038/s41577-019-0244-2; Alameh MG, 2021, IMMUNITY, V54, P2877, DOI 10.1016/j.immuni.2021.11.001; Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Asrir A, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00843-7; Audia S, 2017, J AUTOIMMUN, V77, P89, DOI 10.1016/j.jaut.2016.11.002; Bai X, 2020, J IMMUNOL, V204, P2754, DOI 10.4049/jimmunol.2000046; Ballesteros-Tato A, 2012, IMMUNITY, V36, P847, DOI 10.1016/j.immuni.2012.02.012; Basso K, 2015, NAT REV IMMUNOL, V15, P172, DOI 10.1038/nri3814; Baumjohann D, 2013, IMMUNITY, V38, P596, DOI 10.1016/j.immuni.2012.11.020; Bentebibel SE, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005191; Bentebibel SE, 2011, P NATL ACAD SCI USA, V108, pE488, DOI 10.1073/pnas.1100898108; Bindea G, 2013, IMMUNITY, V39, P782, DOI 10.1016/j.immuni.2013.10.003; Boppana S, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009761; Botta D, 2017, NAT IMMUNOL, V18, P1249, DOI 10.1038/ni.3837; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Canete PF, 2019, J EXP MED, V216, P1843, DOI 10.1084/jem.20190493; Chavele KM, 2015, J IMMUNOL, V194, P2482, DOI 10.4049/jimmunol.1401190; Chavez JC, 2020, BLOOD, V136, DOI 10.1182/blood-2020-136465; Chen Z, 2022, TRENDS IMMUNOL, V43, P309, DOI 10.1016/j.it.2022.02.002; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Choi J, 2021, TRENDS IMMUNOL, V42, P336, DOI 10.1016/j.it.2021.02.002; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Clement RL, 2019, NAT IMMUNOL, V20, P1360, DOI 10.1038/s41590-019-0472-4; Crotty S, 2019, IMMUNITY, V50, P1132, DOI 10.1016/j.immuni.2019.04.011; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; Cubas RA, 2013, NAT MED, V19, P494, DOI 10.1038/nm.3109; Cui C, 2021, CELL, V184, P6101, DOI 10.1016/j.cell.2021.11.007; Dan JM, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aau3776; Deng J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23220-x; Deng J, 2019, NAT REV RHEUMATOL, V15, P475, DOI 10.1038/s41584-019-0254-2; Deng J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01226; Deng RS, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00880-2; Denton AE, 2019, J EXP MED, V216, P621, DOI 10.1084/jem.20181216; DiToro D, 2018, SCIENCE, V361, P1086, DOI 10.1126/science.aao2933; Duan LH, 2021, IMMUNITY, V54, P2256, DOI 10.1016/j.immuni.2021.08.028; Ebbo M, 2022, ANN RHEUM DIS, V81, DOI 10.1136/annrheumdis-2020-217010; Edner NM, 2020, NAT REV DRUG DISCOV, V19, P860, DOI 10.1038/s41573-020-0081-9; Ellyard JI, 2012, BLOOD, V120, P812, DOI 10.1182/blood-2011-07-365130; Fahey LM, 2011, J EXP MED, V208, P987, DOI 10.1084/jem.20101773; Faliti CE, 2019, J EXP MED, V216, P317, DOI 10.1084/jem.20171976; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Forcade E, 2016, BLOOD, V127, P2489, DOI 10.1182/blood-2015-12-688895; Fridman WH, 2022, NAT REV CLIN ONCOL, V19, P441, DOI 10.1038/s41571-022-00619-z; Fu GT, 2021, NATURE, V595, P724, DOI 10.1038/s41586-021-03692-z; Fu WW, 2018, J EXP MED, V215, P815, DOI 10.1084/jem.20170901; Globig AM, 2021, CELL MOL GASTROENTER, V11, P1, DOI 10.1016/j.jcmgh.2020.07.005; Gong F, 2020, J CLIN INVEST, V130, P6588, DOI 10.1172/JCI141054; Gonzalez-Figueroa P, 2021, CELL, V184, P1775, DOI 10.1016/j.cell.2021.02.027; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Gowthaman U, 2019, SCIENCE, V365, P883, DOI 10.1126/science.aaw6433; Greczmiel U, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aam8686; Hao H, 2021, ARTHRITIS RHEUMATOL, V73, P132, DOI 10.1002/art.41457; Harb H, 2020, CLIN EXP ALLERGY, V50, P5, DOI 10.1111/cea.13491; Harker JA, 2011, SCIENCE, V334, P825, DOI 10.1126/science.1208421; Haynes NM, 2007, J IMMUNOL, V179, P5099, DOI 10.4049/jimmunol.179.8.5099; He J, 2016, NAT MED, V22, P991, DOI 10.1038/nm.4148; He J, 2013, IMMUNITY, V39, P770, DOI 10.1016/j.immuni.2013.09.007; Herati RS, 2021, CELL REP MED, V2, DOI 10.1016/j.xcrm.2021.100262; Herati RS, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aag2152; Hill DL, 2021, ELIFE, V10, DOI [10.7554/eLife.70554, 10.7554/eLife.70554.sa1, 10.7554/eLife.70554.sa2]; Hirota K, 2013, NAT IMMUNOL, V14, P372, DOI 10.1038/ni.2552; Hung IFN, 2016, LANCET INFECT DIS, V16, P209, DOI 10.1016/S1473-3099(15)00354-0; Ise W, 2014, P NATL ACAD SCI USA, V111, P11792, DOI 10.1073/pnas.1404671111; Jacobsen JT, 2021, SCIENCE, V373, DOI 10.1126/science.abe5146; Jacquemin C, 2015, IMMUNITY, V42, P1159, DOI 10.1016/j.immuni.2015.05.012; Jardine JG, 2016, SCIENCE, V351, P1458, DOI 10.1126/science.aad9195; Johnston RJ, 2012, J EXP MED, V209, P243, DOI 10.1084/jem.20111174; Johnston RJ, 2009, SCIENCE, V325, P1006, DOI 10.1126/science.1175870; Juno JA, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0995-0; Kaneko Naoki, 2020, SSRN, P3652322, DOI [10.1016/j.cell.2020.08.025, 10.2139/ssrn.3652322]; Karnekura R, 2015, CLIN IMMUNOL, V158, P204, DOI 10.1016/j.clim.2015.02.016; Karnell JL, 2019, SCI TRANSL MED, V11, DOI 10.1126/scitranslmed.aar6584; Kato LM, 2014, IMMUNOL CELL BIOL, V92, P49, DOI 10.1038/icb.2013.54; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kerfoot SM, 2011, IMMUNITY, V34, P947, DOI 10.1016/j.immuni.2011.03.024; Kim CH, 2001, J EXP MED, V193, P1373, DOI 10.1084/jem.193.12.1373; Kim ST, 2018, J IMMUNOL, V201, P1359, DOI 10.4049/jimmunol.1701217; Kim W, 2022, NATURE, V604, P141, DOI 10.1038/s41586-022-04527-1; Klimatcheva E, 2015, BMC IMMUNOL, V16, DOI 10.1186/s12865-015-0068-1; Kobayashi T, 2017, J ALLERGY CLIN IMMUN, V139, P300, DOI 10.1016/j.jaci.2016.04.021; Koutsakos M, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan8405; Krishnamoorthy V, 2017, IMMUNITY, V47, P481, DOI 10.1016/j.immuni.2017.09.001; Lau AWY, 2020, CURR OPIN IMMUNOL, V63, P29, DOI 10.1016/j.coi.2019.11.001; Lederer K, 2020, IMMUNITY, V53, P1281, DOI 10.1016/j.immuni.2020.11.009; Lee J. H., BIORXIV, DOI [10.1101/2021.12.20.473537(2021, DOI 10.1101/2021.12.20.473537(2021]; Lee JH, 2021, J EXP MED, V218, DOI 10.1084/jem.20201254; Lee SK, 2011, J EXP MED, V208, P1377, DOI 10.1084/jem.20102065; Leong YA, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00622; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li YM, 2018, TRANSPL IMMUNOL, V46, P1, DOI 10.1016/j.trim.2017.09.005; Liang KL, 2021, CLIN TRANSL IMMUNOL, V10, DOI 10.1002/cti2.1293; Linterman MA, 2009, IMMUNITY, V30, P228, DOI 10.1016/j.immuni.2008.12.015; Locci M, 2013, IMMUNITY, V39, P758, DOI 10.1016/j.immuni.2013.08.031; Longo SK, 2021, NAT REV GENET, V22, P627, DOI 10.1038/s41576-021-00370-8; Lu KT, 2011, IMMUNITY, V35, P622, DOI 10.1016/j.immuni.2011.07.015; Ludwig RJ, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00603; Luthje K, 2012, NAT IMMUNOL, V13, P491, DOI 10.1038/ni.2261; Cano-Romero FL, 2019, AM J TRANSPLANT, V19, P89, DOI 10.1111/ajt.14987; Ma CS, 2016, J CLIN IMMUNOL, V36, pS40, DOI 10.1007/s10875-016-0257-6; Ma CS, 2009, IMMUNOL CELL BIOL, V87, P590, DOI 10.1038/icb.2009.64; Maceiras AR, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15067; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; MILLER JFA, 1968, J EXP MED, V128, P801, DOI 10.1084/jem.128.4.801; Mintz MA, 2020, IMMUNOL REV, V296, P48, DOI 10.1111/imr.12860; Mohammed MT, 2021, AM J TRANSPLANT, V21, P1893, DOI 10.1111/ajt.16484; Morita R, 2011, IMMUNITY, V34, P108, DOI 10.1016/j.immuni.2010.12.012; Mudd PA, 2022, CELL, V185, P603, DOI 10.1016/j.cell.2021.12.026; Nicholson SM, 2017, REPROD TOXICOL, V74, P116, DOI 10.1016/j.reprotox.2017.08.018; Noel G, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI139905; Nurieva RI, 2012, J BIOL CHEM, V287, P11234, DOI 10.1074/jbc.M111.324046; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Obeng-Adjei N, 2015, CELL REP, V13, P425, DOI 10.1016/j.celrep.2015.09.004; Ochando J, 2017, ONCOTARGET, V8, P112116, DOI 10.18632/oncotarget.22788; Odegard JM, 2008, J EXP MED, V205, P2873, DOI 10.1084/jem.20080840; Ols ML, 2016, IMMUNITY, V45, P1052, DOI 10.1016/j.immuni.2016.10.005; Ovcinnikovs V, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aaw0902; Overacre-Delgoffe AE, 2021, IMMUNITY, V54, P2812, DOI 10.1016/j.immuni.2021.11.003; Pampusch MS, 2022, PLOS PATHOG, V18, DOI 10.1371/journal.ppat.1009831; Papa I, 2017, NATURE, V547, P318, DOI 10.1038/nature23013; Pardi N, 2018, NAT REV DRUG DISCOV, V17, P261, DOI 10.1038/nrd.2017.243; Perreau M, 2013, J EXP MED, V210, P143, DOI 10.1084/jem.20121932; Pilkinton MA, 2017, VACCINE, V35, P329, DOI 10.1016/j.vaccine.2016.11.059; Popescu M, 2019, J IMMUNOL, V203, P2415, DOI 10.4049/jimmunol.1900484; Proietti M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08156-z; Proietti M, 2014, IMMUNITY, V41, P789, DOI 10.1016/j.immuni.2014.10.010; Qi H, 2008, NATURE, V455, P764, DOI 10.1038/nature07345; Qi H, 2016, NAT REV IMMUNOL, V16, P612, DOI 10.1038/nri.2016.94; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Ritvo PG, 2018, P NATL ACAD SCI USA, V115, P9604, DOI 10.1073/pnas.1808594115; Ryg-Cornejo V, 2016, CELL REP, V14, P68, DOI 10.1016/j.celrep.2015.12.006; Sage PT, 2020, CURR OPIN IMMUNOL, V67, P68, DOI 10.1016/j.coi.2020.10.009; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Snook JP, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aas9103; Soni C, 2020, IMMUNITY, V52, P1022, DOI 10.1016/j.immuni.2020.04.015; Spolski R, 2014, NAT REV DRUG DISCOV, V13, P381, DOI 10.1038/nrd4296; Stebegg M, 2020, ELIFE, V9, DOI 10.7554/eLife.52473; Tahiliani V, 2017, J IMMUNOL, V198, P218, DOI 10.4049/jimmunol.1601356; Takatsuka S, 2018, NAT IMMUNOL, V19, P1025, DOI 10.1038/s41590-018-0177-0; Tam HH, 2016, P NATL ACAD SCI USA, V113, pE6639, DOI 10.1073/pnas.1606050113; Tangye SG, 2020, J EXP MED, V217, DOI 10.1084/jem.20191638; Teng F, 2016, IMMUNITY, V44, P875, DOI 10.1016/j.immuni.2016.03.013; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Tubo NJ, 2013, CELL, V153, P785, DOI 10.1016/j.cell.2013.04.007; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Ueno H, 2019, CURR OPIN IMMUNOL, V59, P9, DOI 10.1016/j.coi.2019.02.007; Ueno H, 2015, NAT IMMUNOL, V16, P142, DOI 10.1038/ni.3054; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; Vallois D, 2016, BLOOD, V128, P1490, DOI 10.1182/blood-2016-02-698977; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Vinuesa CG, 2009, NAT REV IMMUNOL, V9, P845, DOI 10.1038/nri2637; Visvanathan S, 2019, ANN RHEUM DIS, V78, P754, DOI 10.1136/annrheumdis-2018-214729; Vogel KU, 2013, IMMUNITY, V38, P655, DOI 10.1016/j.immuni.2012.12.004; von Herrath M, 2021, LANCET DIABETES ENDO, V9, P212, DOI 10.1016/S2213-8587(21)00019-X; Wang CW, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-53; Wang CJ, 2015, P NATL ACAD SCI USA, V112, P524, DOI 10.1073/pnas.1414576112; Wang YF, 2017, NAT IMMUNOL, V18, P921, DOI 10.1038/ni.3788; Weinstein JS, 2016, NAT IMMUNOL, V17, P1197, DOI 10.1038/ni.3554; Witalis M, 2020, BLOOD ADV, V4, P868, DOI 10.1182/bloodadvances.2019001114; Xin G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07492-4; Yang JL, 2016, ELIFE, V5, DOI 10.7554/eLife.17936; Yang Y, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109442; Yang ZY, 2020, J EXP MED, V217, DOI 10.1084/jem.20190472; Yao Y, 2021, NAT IMMUNOL, V22, P1127, DOI 10.1038/s41590-021-00996-0; Yao Y, 2021, ALLERGY, V76, P456, DOI 10.1111/all.14639; Yao Y, 2019, J ALLERGY CLIN IMMUN, V144, P118, DOI 10.1016/j.jaci.2019.02.008; Yao Y, 2018, J ALLERGY CLIN IMMUN, V142, P321, DOI 10.1016/j.jaci.2018.03.008; Yin XY, 2021, ANNU REV IMMUNOL, V39, P759, DOI 10.1146/annurev-immunol-101819-025146; Yu D, 2007, NATURE, V450, P299, DOI 10.1038/nature06253; Yu D, 2018, TRENDS IMMUNOL, V39, P965, DOI 10.1016/j.it.2018.10.002; Yu D, 2009, IMMUNITY, V31, P457, DOI 10.1016/j.immuni.2009.07.002; Zeng H, 2016, IMMUNITY, V45, P540, DOI 10.1016/j.immuni.2016.08.017; Zhang J, 2021, NAT MICROBIOL, V6, P51, DOI 10.1038/s41564-020-00824-5	175	1	1	11	11	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2022	23	8					1157	1168		10.1038/s41590-022-01253-8	http://dx.doi.org/10.1038/s41590-022-01253-8		JUL 2022	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3O3AR	35817844				2022-12-18	WOS:000822975900001
J	Phad, GE; Pinto, D; Foglierini, M; Akhmedov, M; Rossi, RL; Malvicini, E; Cassotta, A; Fregni, CS; Bruno, L; Sallusto, F; Lanzavecchia, A				Phad, Ganesh E.; Pinto, Dora; Foglierini, Mathilde; Akhmedov, Murodzhon; Rossi, Riccardo L.; Malvicini, Emilia; Cassotta, Antonino; Fregni, Chiara Silacci; Bruno, Ludovica; Sallusto, Federica; Lanzavecchia, Antonio			Clonal structure, stability and dynamics of human memory B cells and circulating plasmablasts	NATURE IMMUNOLOGY			English	Article							HUMAN MONOCLONAL-ANTIBODIES; ACTIVATION; GENERATION; CHALLENGE; SELECTION; BLOOD; MODEL	Memory B cells persist for a lifetime and rapidly differentiate into antibody-producing plasmablasts and plasma cells upon antigen re-encounter. The clonal relationship and evolution of memory B cells and circulating plasmablasts is not well understood. Using single-cell sequencing combined with isolation of specific antibodies, we found that in two healthy donors, the memory B cell repertoire was dominated by large IgM, IgA and IgG2 clonal families, whereas IgG1 families, including those specific for recall antigens, were of small size. Analysis of multiyear samples demonstrated stability of memory B cell clonal families and revealed that a large fraction of recently generated plasmablasts was derived from long-term memory B cell families and was found recurrently. Collectively, this study provides a systematic description of the structure, stability and dynamics of the human memory B cell pool and suggests that memory B cells may be active at any time point in the generation of plasmablasts. Lanzavecchia and colleagues use single-cell B cell receptor sequencing to examine the clonal structure, stability and dynamics of the B cell repertoire and the relationship between memory B cells and newly generated plasma cells in humans.	[Phad, Ganesh E.; Pinto, Dora; Foglierini, Mathilde; Akhmedov, Murodzhon; Cassotta, Antonino; Fregni, Chiara Silacci; Sallusto, Federica; Lanzavecchia, Antonio] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland; [Akhmedov, Murodzhon] Big Analyt SA, Bellinzona, Switzerland; [Rossi, Riccardo L.; Malvicini, Emilia; Bruno, Ludovica; Lanzavecchia, Antonio] Natl Inst Mol Genet, Milan, Italy; [Sallusto, Federica] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Lanzavecchia, Antonio] Humabs BioMed, Bellinzona, Switzerland	Universita della Svizzera Italiana; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); Swiss Federal Institutes of Technology Domain; ETH Zurich	Phad, GE; Lanzavecchia, A (corresponding author), Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland.; Lanzavecchia, A (corresponding author), Natl Inst Mol Genet, Milan, Italy.; Lanzavecchia, A (corresponding author), Humabs BioMed, Bellinzona, Switzerland.	ganesh.phad@irb.usi.ch; lanzavecchia@ingm.org	Cassotta, Antonino/AAW-2529-2021	Cassotta, Antonino/0000-0001-8674-4294; Sallusto, Federica/0000-0003-3750-2752; Malvicini, Emilia/0000-0003-2286-8954; Rossi, Riccardo/0000-0002-4964-3264; Phad, Ganesh E/0000-0002-0047-6899	European Research Council [885539 ENGRAB]; Fondation Louis-Jeantet; Wenner-Gren Foundation fellowship	European Research Council(European Research Council (ERC)European Commission); Fondation Louis-Jeantet; Wenner-Gren Foundation fellowship	This work was partially supported by grants from the European Research Council (no. 885539 ENGRAB to A.L.) and the Fondation Louis-Jeantet (to A.L.) and a Wenner-Gren Foundation fellowship (to G.E.P). We thank D. Jarrossay, A. Rinaldi, B. Fernandez, I. Giacchetto-Sasselli and P. Paparoditis for help with cell culture, sorting and sequencing experiments. We thank D. Jaffe at 10X Genomics for the help with enclone tool to create honeycomb plots.	Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bittinger K., 2020, ABDIV ALPHA BETA DIV; Briney B, 2019, NATURE, V566, P393, DOI 10.1038/s41586-019-0879-y; Butler A, 2018, NAT BIOTECHNOL, V36, P411, DOI 10.1038/nbt.4096; Corcoran MM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13642; Corti D, 2011, SCIENCE, V333, P850, DOI 10.1126/science.1205669; Davis CW, 2020, SCIENCE, V370, P237, DOI 10.1126/science.aaz8432; Davis CW, 2019, CELL, V177, P1566, DOI 10.1016/j.cell.2019.04.036; DeKosky BJ, 2016, P NATL ACAD SCI USA, V113, pE2636, DOI 10.1073/pnas.1525510113; Dunand CJH, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0238; Ellebedy AH, 2016, NAT IMMUNOL, V17, P1226, DOI 10.1038/ni.3533; FELSENSTEIN J, 1987, J MOL EVOL, V26, P123, DOI 10.1007/BF02111286; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Georgiou G, 2014, NAT BIOTECHNOL, V32, P158, DOI 10.1038/nbt.2782; GOLDING B, 1990, J MOL EVOL, V31, P511, DOI 10.1007/BF02102078; Gupta NT, 2015, BIOINFORMATICS, V31, P3356, DOI 10.1093/bioinformatics/btv359; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; Hoehn KB, 2017, GENETICS, V206, P417, DOI 10.1534/genetics.116.196303; Horns F, 2020, CELL REP, V30, P905, DOI 10.1016/j.celrep.2019.12.063; Horns F, 2016, ELIFE, V5, DOI [10.7554/eLife.16578, 10.7554/eLife.23066]; Joyner CJ, 2022, LIFE SCI ALLIANCE, V5, DOI 10.26508/lsa.202101285; Klein U, 1998, J EXP MED, V188, P1679, DOI 10.1084/jem.188.9.1679; Kruetzmann S, 2003, J EXP MED, V197, P939, DOI 10.1084/jem.20022020; Le Gallou S, 2018, J EXP MED, V215, P2035, DOI 10.1084/jem.20180977; Magri G, 2017, IMMUNITY, V47, P118, DOI 10.1016/j.immuni.2017.06.013; Mikocziova I, 2021, GENES IMMUN, V22, P205, DOI 10.1038/s41435-021-00145-5; Nielsen Sandra C A, 2020, Res Sq, DOI 10.21203/rs.3.rs-27220/v1; Odendahl M, 2005, BLOOD, V105, P1614, DOI 10.1182/blood-2004-07-2507; Pappas L, 2014, NATURE, V516, P418, DOI 10.1038/nature13764; Parameswaran P, 2013, CELL HOST MICROBE, V13, P691, DOI 10.1016/j.chom.2013.05.008; Radbruch A, 2006, NAT REV IMMUNOL, V6, P741, DOI 10.1038/nri1886; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Roco JA, 2019, IMMUNITY, V51, P337, DOI 10.1016/j.immuni.2019.07.001; Soto C, 2019, NATURE, V566, P398, DOI 10.1038/s41586-019-0934-8; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Tiller T, 2008, J IMMUNOL METHODS, V329, P112, DOI 10.1016/j.jim.2007.09.017; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080; Vavrek MJ, 2016, PEERJ, V4, DOI 10.7717/peerj.1720; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Victora GD, 2012, ANNU REV IMMUNOL, V30, P429, DOI 10.1146/annurev-immunol-020711-075032; Weill JC, 2020, CURR OPIN IMMUNOL, V63, P1, DOI 10.1016/j.coi.2019.09.003; Weill JC, 2009, ANNU REV IMMUNOL, V27, P267, DOI 10.1146/annurev.immunol.021908.132607; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890; Ye J, 2013, NUCLEIC ACIDS RES, V41, pW34, DOI 10.1093/nar/gkt382; ZHENG GX, 2017, NATURE, V0008	46	1	1	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2022	23	7					1076	+		10.1038/s41590-022-01230-1	http://dx.doi.org/10.1038/s41590-022-01230-1		JUN 2022	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3A8XY	35761085	hybrid, Green Published			2022-12-18	WOS:000817057200005
J	Chen, XJ; Jaiswal, A; Costliow, Z; Herbst, P; Creasey, EA; Oshiro-Rapley, N; Daly, MJ; Carey, KL; Graham, DB; Xavier, RJ				Chen, Xiangjun; Jaiswal, Alok; Costliow, Zachary; Herbst, Paula; Creasey, Elizabeth A.; Oshiro-Rapley, Noriko; Daly, Mark J.; Carey, Kimberly L.; Graham, Daniel B.; Xavier, Ramnik J.			pH sensing controls tissue inflammation by modulating cellular metabolism and endo-lysosomal function of immune cells	NATURE IMMUNOLOGY			English	Article							TH17 CELLS; UP-REGULATION; REGULATORY T; TH22 CELLS; MECHANISMS; DIFFERENTIATION; RESOLUTION; DISEASE; ROLES; TDAG8	Extracellular acidification occurs in inflamed tissue and the tumor microenvironment; however, a systematic study on how pH sensing contributes to tissue homeostasis is lacking. In the present study, we examine cell type-specific roles of the pH sensor G protein-coupled receptor 65 (GPR65) and its inflammatory disease-associated Ile231Leu-coding variant in inflammation control. GPR65 Ile231Leu knock-in mice are highly susceptible to both bacterial infection-induced and T cell-driven colitis. Mechanistically, GPR65 Ile231Leu elicits a cytokine imbalance through impaired helper type 17 T cell (T(H)17 cell) and T(H)22 cell differentiation and interleukin (IL)-22 production in association with altered cellular metabolism controlled through the cAMP-CREB-DGAT1 axis. In dendritic cells, GPR65 Ile231Leu elevates IL-12 and IL-23 release at acidic pH and alters endo-lysosomal fusion and degradation capacity, resulting in enhanced antigen presentation. The present study highlights GPR65 Ile231Leu as a multistep risk factor in intestinal inflammation and illuminates a mechanism by which pH sensing controls inflammatory circuits and tissue homeostasis. Extracellular microenvironments are more acidic upon tissue damage or in tumors. Xavier and colleagues identify a role for the pH-sensitive, G protein-coupled receptor GPR65 in multiple aspects of immune cell lipid metabolism, disruption of which leads to chronic inflammatory responses.	[Chen, Xiangjun; Jaiswal, Alok; Costliow, Zachary; Creasey, Elizabeth A.; Oshiro-Rapley, Noriko; Daly, Mark J.; Carey, Kimberly L.; Graham, Daniel B.; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Chen, Xiangjun; Herbst, Paula; Creasey, Elizabeth A.; Oshiro-Rapley, Noriko; Graham, Daniel B.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Chen, Xiangjun; Herbst, Paula; Creasey, Elizabeth A.; Oshiro-Rapley, Noriko; Graham, Daniel B.; Xavier, Ramnik J.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Chen, Xiangjun; Oshiro-Rapley, Noriko; Graham, Daniel B.] Harvard Med Sch, Massachusetts Gen Hosp, Expt Med Unit, Boston, MA 02115 USA; [Daly, Mark J.] Harvard Med Sch, Massachusetts Gen Hosp, Analyt & Translat Genet Unit, Boston, MA 02115 USA; [Daly, Mark J.] Inst Mol Med Finland, Helsinki, Finland; [Graham, Daniel B.; Xavier, Ramnik J.] Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Xavier, RJ (corresponding author), Broad Inst MIT & Harvard, Cambridge, MA 02142 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.; Xavier, RJ (corresponding author), Broad Inst MIT & Harvard, Klarman Cell Observ, Cambridge, MA 02142 USA.	xavier@molbio.mgh.harvard.edu			National Institutes of Health [R01 DK117263, RC2 DK114784, U19 AI109725, U19 AI142784]; Helmsley Charitable Trust	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helmsley Charitable Trust	We thank T. Reimels for assistance with editing. This work was supported by funding from the National Institutes of Health (grant nos. R01 DK117263, RC2 DK114784, U19 AI109725 and U19 AI142784 to R.J.X.) and the Helmsley Charitable Trust (to R.J.X.).	Alloatti A, 2015, IMMUNITY, V43, P1087, DOI 10.1016/j.immuni.2015.11.006; Ananthakrishnan AN, 2018, NAT REV GASTRO HEPAT, V15, P39, DOI 10.1038/nrgastro.2017.136; Basu R, 2012, IMMUNITY, V37, P1061, DOI 10.1016/j.immuni.2012.08.024; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Bruno NE, 2014, EMBO J, V33, P1027, DOI 10.1002/embj.201386145; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Cartwright IM, 2020, MUCOSAL IMMUNOL, V13, P230, DOI 10.1038/s41385-019-0237-2; Chitraju C, 2019, J LIPID RES, V60, P1112, DOI 10.1194/jlr.M093112; Chitraju C, 2017, CELL METAB, V26, P407, DOI 10.1016/j.cmet.2017.07.012; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; de Valliere C, 2015, INFLAMM BOWEL DIS, V21, P1269, DOI 10.1097/MIB.0000000000000375; Delamarre L, 2005, SCIENCE, V307, P1630, DOI 10.1126/science.1108003; Dozsa A, 2014, J INVEST DERMATOL, V134, P910, DOI 10.1038/jid.2013.413; Fleming S. J., 2019, PREPRINT; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gagliani N, 2015, NATURE, V523, P221, DOI 10.1038/nature14452; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Geltink RIK, 2018, ANNU REV IMMUNOL, V36, P461, DOI 10.1146/annurev-immunol-042617-053019; Graham DB, 2018, NAT MED, V24, P1762, DOI 10.1038/s41591-018-0203-7; Graham DB, 2010, BLOOD, V116, P3208, DOI 10.1182/blood-2009-10-250415; Gutierrez-Vazquez C, 2018, IMMUNITY, V48, P19, DOI 10.1016/j.immuni.2017.12.012; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; Hardin M, 2014, EUR RESPIR J, V44, P341, DOI 10.1183/09031936.00216013; Hipolito VEB, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000535; Howie D, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01860; Hua SS, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00524; Ihara Y, 2010, P NATL ACAD SCI USA, V107, P17309, DOI 10.1073/pnas.1001165107; Ishigame H, 2009, IMMUNITY, V30, P108, DOI 10.1016/j.immuni.2008.11.009; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Karbanova VH, 2012, BBA-BIOENERGETICS, V1817, P1037, DOI 10.1016/j.bbabio.2012.03.004; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Lassen KG, 2016, IMMUNITY, V44, P1392, DOI 10.1016/j.immuni.2016.05.007; Levin LR, 2015, ANNU REV PHYSIOL, V77, P347, DOI 10.1146/annurev-physiol-021014-071821; Mindell JA, 2012, ANNU REV PHYSIOL, V74, P69, DOI 10.1146/annurev-physiol-012110-142317; Miyazaki M, 2005, P NATL ACAD SCI USA, V102, P12501, DOI 10.1073/pnas.0503132102; Mogi C, 2009, J IMMUNOL, V182, P3243, DOI 10.4049/jimmunol.0803466; Nguyen TB, 2017, DEV CELL, V42, P9, DOI 10.1016/j.devcel.2017.06.003; Nugent SG, 2001, GUT, V48, P571, DOI 10.1136/gut.48.4.571; O'Connor W, 2009, NAT IMMUNOL, V10, P603, DOI 10.1038/ni.1736; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Plank MW, 2017, J IMMUNOL, V198, P2182, DOI 10.4049/jimmunol.1601480; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Rudloff I, 2012, J BIOL CHEM, V287, P4531, DOI 10.1074/jbc.M111.286492; Santori FR, 2015, CELL METAB, V21, P286, DOI 10.1016/j.cmet.2015.01.004; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Schett G, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05800-6; Seki A, 2018, J EXP MED, V215, P985, DOI 10.1084/jem.20171626; Suzuki H, 1998, BIOCHEM BIOPH RES CO, V249, P542, DOI 10.1006/bbrc.1998.9181; Tcymbarevich I, 2019, J CROHNS COLITIS, V13, P245, DOI 10.1093/ecco-jcc/jjy152; Trost M, 2009, IMMUNITY, V30, P143, DOI 10.1016/j.immuni.2008.11.006; van Dierendonck XAMH, 2020, CELL REP, V30, P1811, DOI 10.1016/j.celrep.2020.01.046; Wagner A, 2021, CELL, V184, P4168, DOI 10.1016/j.cell.2021.05.045; Wang C, 2015, CELL, V163, DOI 10.1016/j.cell.2015.10.068; Wang Y, 2018, J CROHNS COLITIS, V12, P355, DOI 10.1093/ecco-jcc/jjx147; Wirasinha RC, 2018, IMMUNOL CELL BIOL, V96, P128, DOI 10.1111/imcb.1031; Wu H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17756-7; Xia Y, 2018, CELL, V175, P1059, DOI 10.1016/j.cell.2018.08.070; Xie L, 2021, J IMMUNOL, V207, P101, DOI 10.4049/jimmunol.2001363; Yambire KF, 2019, ELIFE, V8, DOI 10.7554/eLife.51031	60	1	1	15	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2022	23	7					1063	+		10.1038/s41590-022-01231-0	http://dx.doi.org/10.1038/s41590-022-01231-0		JUN 2022	34	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	3A8XY	35668320				2022-12-18	WOS:000806688000001
J	Asselta, R; Paraboschi, EM; Stravalaci, M; Invernizzi, P; Bonfanti, P; Biondi, A; Pagani, I; Pedotti, M; Doni, A; Scavello, F; Mapelli, SN; Sironi, M; Perucchini, C; Varani, L; Matkovic, M; Cavalli, A; Cesana, D; Gallina, P; Pedemonte, N; Capurro, V; Clementi, N; Mancini, N; Bayarri-Olmos, R; Garred, P; Rappuoli, R; Duga, S; Bottazzi, B; Uguccioni, M; Vicenzi, E; Mantovani, A; Garlanda, C				Asselta, Rosanna; Paraboschi, Elvezia Maria; Stravalaci, Matteo; Invernizzi, Pietro; Bonfanti, Paolo; Biondi, Andrea; Pagani, Isabel; Pedotti, Mattia; Doni, Andrea; Scavello, Francesco; Mapelli, Sarah N.; Sironi, Marina; Perucchini, Chiara; Varani, Luca; Matkovic, Milos; Cavalli, Andrea; Cesana, Daniela; Gallina, Pierangela; Pedemonte, Nicoletta; Capurro, Valeria; Clementi, Nicola; Mancini, Nicasio; Bayarri-Olmos, Rafael; Garred, Peter; Rappuoli, Rino; Duga, Stefano; Bottazzi, Barbara; Uguccioni, Mariagrazia; Vicenzi, Elisa; Mantovani, Alberto; Garlanda, Cecilia			Reply to: Hultstrom et al., Genetic determinants of mannose-binding lectin activity predispose to thromboembolic complications in critical COVID-19. Mannose-binding lectin genetics in COVID-19	NATURE IMMUNOLOGY			English	Editorial Material							ASSOCIATION		[Asselta, Rosanna; Paraboschi, Elvezia Maria; Stravalaci, Matteo; Doni, Andrea; Scavello, Francesco; Mapelli, Sarah N.; Sironi, Marina; Perucchini, Chiara; Duga, Stefano; Bottazzi, Barbara; Mantovani, Alberto; Garlanda, Cecilia] IRCCS Humanitas Res Hosp, Milan, Italy; [Asselta, Rosanna; Paraboschi, Elvezia Maria; Stravalaci, Matteo; Duga, Stefano; Uguccioni, Mariagrazia; Mantovani, Alberto; Garlanda, Cecilia] Humanitas Univ, Dept Biomed Sci, Milan, Italy; [Invernizzi, Pietro] Univ Milano Bicocca, Div Gastroenterol, Dept Med & Surg, Ctr Autoimmune Liver Dis, Monza, Italy; [Invernizzi, Pietro] San Gerardo Hosp, European Reference Network Hepatol Dis, Monza, Italy; [Bonfanti, Paolo] Univ Milano Bicocca, San Gerardo Hosp, Dept Infect Dis, Monza, Italy; [Biondi, Andrea] Univ Milano Bicocca, Fdn MBBM, San Gerardo Hosp, Pediat Dept & Ctr Tettamanti European Reference N, Monza, Italy; [Pagani, Isabel] IRCCS San Raffaele Sci Inst, Viral Pathogenesis & Biosafety Unit, Milan, Italy; [Pedotti, Mattia; Varani, Luca; Matkovic, Milos; Cavalli, Andrea; Uguccioni, Mariagrazia] Univ Svizzera italiana, Inst Res Biomed, Bellinzona, Switzerland; [Cavalli, Andrea] Swiss Inst Bioinformat, Lausanne, Switzerland; [Cesana, Daniela; Gallina, Pierangela] IRCCS, San Raffaele Telethon Inst Gene Therapy, San Raffaele Sci Inst, Milan, Italy; [Pedemonte, Nicoletta; Capurro, Valeria] IRCCS Ist Giannina Gaslini, UOC Genet Med, Genoa, Italy; [Clementi, Nicola; Mancini, Nicasio] Univ Vita Salute San Raffaele, Lab Microbiol & Virol, IRCCS Sci Inst, Milan, Italy; [Bayarri-Olmos, Rafael; Garred, Peter] Univ Vita Salute San Raffaele, Milan, Italy; [Rappuoli, Rino] Copenhagen Univ Hosp, Dept Clin Immunol, Lab Mol Med, Rigshospitalet, Copenhagen, Denmark; [Rappuoli, Rino] Fdn Toscana Life Sci, Monoclonal Antibody Discovery Lab, Siena, Italy; [Mantovani, Alberto] Imperial Coll London, Fac Med, London, England; [Asselta, Rosanna; Paraboschi, Elvezia Maria] Queen Mary Univ London, William Harvey Res Inst, London, England	Humanitas University; University of Milano-Bicocca; San Gerardo Hospital; San Gerardo Hospital; University of Milano-Bicocca; San Gerardo Hospital; University of Milano-Bicocca; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita della Svizzera Italiana; Swiss Institute of Bioinformatics; Fondazione Telethon; San Raffaele Telethon Institute For Gene Therapy (Sr-Tiget); Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Genoa; IRCCS Istituto Giannina Gaslini; Vita-Salute San Raffaele University; Vita-Salute San Raffaele University; University of Copenhagen; Imperial College London; University of London; Queen Mary University London	Mantovani, A; Garlanda, C (corresponding author), IRCCS Humanitas Res Hosp, Milan, Italy.; Mantovani, A; Garlanda, C (corresponding author), Humanitas Univ, Dept Biomed Sci, Milan, Italy.; Mantovani, A (corresponding author), Imperial Coll London, Fac Med, London, England.	alberto.mantovani@humanitasresearch.it; cecilia.garlanda@humanitasresearch.it	Stravalaci, Matteo/AAB-8963-2019; Garlanda, Cecilia/K-4601-2016; Mantovani, Alberto/HCI-7449-2022; sironi, marina/AAB-5757-2020; Asselta, Rosanna/AAC-2367-2019; mapelli, sarah natalia/AAC-6093-2022; Scavello, Francesco/AHE-5653-2022	Stravalaci, Matteo/0000-0002-5636-4204; Garlanda, Cecilia/0000-0002-1510-7703; Mantovani, Alberto/0000-0001-5578-236X; sironi, marina/0000-0002-3342-1149; Asselta, Rosanna/0000-0001-5351-0619; mapelli, sarah natalia/0000-0002-0129-2055; Scavello, Francesco/0000-0002-0297-0946; Bonfanti, Paolo/0000-0001-7289-8823; Cavalli, Andrea/0000-0003-4063-4502; Varani, Luca/0000-0002-0963-0987	Italian Ministry of Health [COVID-2020-12371640]; Italian Ministry of University and Research; Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to the clinic); Fondazione Cariplo (Biobanking of COVID-19 patient samples to support national and international research); AMAF Monza ONLUS; AIRCS; European Union [101003650]; Swiss National Science Foundation [31003A_182270]	Italian Ministry of Health(Ministry of Health, Italy); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to the clinic); Fondazione Cariplo (Biobanking of COVID-19 patient samples to support national and international research); AMAF Monza ONLUS; AIRCS; European Union(European Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was conducted in the framework of, and made possible by, the collective effort of the Humanitas COVID-19 Task Force, the Humanitas Gavazzeni COVID-19 Task Force and the COVID-19 Storm trial. This paper is dedicated to S. Duga, who passed on 10 November 2021 and had made a key contribution to the genetic section of this report. This work was supported by a philanthropic donation by Dolce & Gabbana fashion house (to A.M. and C.G.), by the Italian Ministry of Health for COVID-19 (grant no. COVID-2020-12371640 to A.M. and C.G.), by the Italian Ministry of University and Research (to P.I.), by the Department of Excellence project PREMIA (PREcision MedIcine Approach: bringing biomarker research to the clinic, to P.I.) and by Fondazione Cariplo (Biobanking of COVID-19 patient samples to support national and international research, to A.B.). We also thank the Banca Intesa San Paolo for their generous contribution (to R.A.) and AMAF Monza ONLUS and AIRCS for unrestricted research funding. L.V. received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 101003650 and from the Swiss National Science Foundation (grant no. 31003A_182270).	Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Hultstrom M, 2022, NAT IMMUNOL, V23, P861, DOI 10.1038/s41590-022-01227-w; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Lempp FA, 2021, NATURE, V598, P342, DOI 10.1038/s41586-021-03925-1; MADSEN HO, 1995, J IMMUNOL, V155, P3013; Niemi MEK, 2021, NATURE, V600, P472, DOI 10.1038/s41586-021-03767-x; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Stravalaci M, 2022, NAT IMMUNOL, V23, P275, DOI 10.1038/s41590-021-01114-w	9	1	1	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					865	+		10.1038/s41590-022-01228-9	http://dx.doi.org/10.1038/s41590-022-01228-9		MAY 2022	7	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35624207	Bronze			2022-12-18	WOS:000805549900013
J	Bernard, NJ				Bernard, Nicholas J.			TLR7 drives human lupus	NATURE IMMUNOLOGY			English	Editorial Material												Nick.Bernard@nature.com							0	1	1	2	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					817	817		10.1038/s41590-022-01235-w	http://dx.doi.org/10.1038/s41590-022-01235-w		MAY 2022	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35624216				2022-12-18	WOS:000805549900005
J	Zehn, D; Thimme, R; Lugli, E; de Almeida, GP; Oxenius, A				Zehn, Dietmar; Thimme, Robert; Lugli, Enrico; de Almeida, Gustavo Pereira; Oxenius, Annette			'Stem-like' precursors are the fount to sustain persistent CD8(+) T cell responses	NATURE IMMUNOLOGY			English	Review							CHRONIC INFECTION; MEMORY INFLATION; HUMAN CYTOMEGALOVIRUS; EPIGENETIC LANDSCAPE; EXHAUSTED PHENOTYPE; VIRAL-INFECTION; EFFECTOR; TRANSCRIPTION; PD-1; DIFFERENTIATION	Virus-specific CD8(+) T cells that differentiate in the context of resolved versus persisting infections exhibit divergent phenotypic and functional characteristics, which suggests that their differentiation trajectories are governed by distinct cellular dynamics, developmental pathways and molecular mechanisms. For acute infection, it is long known that antigen-specific T cell populations contain terminally differentiated effector T cells, known as short-lived effector T cells, and proliferation-competent and differentiation-competent memory precursor T cells. More recently, it was identified that a similar functional segregation occurs in chronic infections. A failure to generate proliferation-competent precursor cells in chronic infections and tumors results in the collapse of the T cell response. Thus, these precursor cells are major therapeutic and prophylactic targets of immune interventions. These observations suggest substantial commonality between T cell responses in acute and chronic infections but there are also critical differences. We are therefore reviewing the common features and peculiarities of precursor cells in acute infections, different types of persistent infection and cancer. Zehn and colleagues review the cellular fates and precursor trajectories that allow antigen-specific CD8(+) T cells to persist in the face of chronic infection and cancer.	[Zehn, Dietmar; de Almeida, Gustavo Pereira] Tech Univ Munich, Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, Freising Weihenstephan, Germany; [Thimme, Robert] Univ Freiburg, Fac Med, Dept Med 2, Univ Hosp Freiburg, Freiburg, Germany; [Lugli, Enrico] IRCCS Humanitas Res Hosp, Lab Translat Immunol, Milan, Italy; [Oxenius, Annette] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland	Technical University of Munich; University of Freiburg; Swiss Federal Institutes of Technology Domain; ETH Zurich	Zehn, D (corresponding author), Tech Univ Munich, Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, Freising Weihenstephan, Germany.; Thimme, R (corresponding author), Univ Freiburg, Fac Med, Dept Med 2, Univ Hosp Freiburg, Freiburg, Germany.; Lugli, E (corresponding author), IRCCS Humanitas Res Hosp, Lab Translat Immunol, Milan, Italy.; Oxenius, A (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland.	dietmar.zehn@tum.de; robert.thimme@uniklinik-freiburg.de; enrico.lugli@humanitasresearch.it; aoxenius@micro.biol.ethz.ch	Lugli, Enrico/AAB-7933-2019	Lugli, Enrico/0000-0002-1964-7678; Oxenius, Annette/0000-0002-2079-2354; Zehn, Dietmar/0000-0003-1393-8527	European Research Council consolidator grant (ToCCaTa); German Research Foundation [SFB1054, SFB1371]; Swiss National Science Foundation [IZHRZ0_180552, 310030B_185374]; CRI Lloyd J. Old STAR (CRI award) [3914]; Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 20676]; CRC/TRR 179-Project 01; CRC 1160-Project A02; Associazione Italiana per la Ricerca sul Cancro (AIRC 5x1000) [UniCanVax 22757]	European Research Council consolidator grant (ToCCaTa); German Research Foundation(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); CRI Lloyd J. Old STAR (CRI award); Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); CRC/TRR 179-Project 01; CRC 1160-Project A02; Associazione Italiana per la Ricerca sul Cancro (AIRC 5x1000)(Fondazione AIRC per la ricerca sul cancro)	D.Z. is supported by a European Research Council consolidator grant (ToCCaTa) and grants from the German Research Foundation (SFB1054 and SFB1371). A.O. is supported by the Swiss National Science Foundation (grant no. IZHRZ0_180552 and grant no. 310030B_185374). E.L. is a CRI Lloyd J. Old STAR (CRI award 3914) and is supported by the Associazione Italiana per la Ricerca sul Cancro (AIRC IG 20676 and AIRC 5x1000 UniCanVax 22757). R.T. is supported by CRC/TRR 179-Project 01 and CRC 1160-Project A02.	Abdel-Hakeem MS, 2021, NAT IMMUNOL, V22, P1008, DOI 10.1038/s41590-021-00975-5; Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Baumann NS, 2019, PLOS PATHOG, V15, DOI 10.1371/journal.ppat.1007785; Baumann NS, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006993; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Beltra JC, 2016, P NATL ACAD SCI USA, V113, pE5444, DOI 10.1073/pnas.1604256113; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Bottcher JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9306; Borkner L, 2017, J IMMUNOL, V199, P1737, DOI 10.4049/jimmunol.1602115; Brummelman J, 2018, J EXP MED, V215, P2520, DOI 10.1084/jem.20180684; Buggert M, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004251; Carmona SJ, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1737369; Caushi JX, 2021, NATURE, V596, P126, DOI 10.1038/s41586-021-03752-4; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Charmoy M, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109672; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Chen Y, 2021, NAT IMMUNOL, V22, P996, DOI 10.1038/s41590-021-00965-7; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Clarke J, 2019, J EXP MED, V216, P2128, DOI 10.1084/jem.20190249; Connolly KA, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg7836; Dammeijer F, 2020, CANCER CELL, V38, P685, DOI 10.1016/j.ccell.2020.09.001; Dekhtiarenko I, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006072; Duhen T, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05072-0; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Fraietta JA, 2018, NAT MED, V24, P563, DOI 10.1038/s41591-018-0010-1; Francis DM, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aay3575; Franco F, 2020, NAT METAB, V2, P1001, DOI 10.1038/s42255-020-00280-9; Frebel H, 2012, J EXP MED, V209, P2485, DOI 10.1084/jem.20121015; Gabriel SS, 2021, IMMUNITY, V54, P1698, DOI 10.1016/j.immuni.2021.06.007; Galletti G, 2020, NAT IMMUNOL, V21, P1552, DOI 10.1038/s41590-020-0791-5; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gattinoni L, 2009, NAT MED, V15, P808, DOI 10.1038/nm.1982; Ghoneim HE, 2017, CELL, V170, DOI 10.1016/j.cell.2017.06.007; Grassmann S, 2020, NAT IMMUNOL, V21, P1563, DOI 10.1038/s41590-020-00807-y; Guo YG, 2021, NAT IMMUNOL, V22, P746, DOI 10.1038/s41590-021-00940-2; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Hensel N, 2021, NAT IMMUNOL, V22, P229, DOI 10.1038/s41590-020-00817-w; Highton Andrew J, 2019, Wellcome Open Res, V4, P78, DOI 10.12688/wellcomeopenres.15115.1; HO M, 1990, REV INFECT DIS, V12, pS701; Holtappels R, 2002, J VIROL, V76, P151, DOI 10.1128/JVI.76.1.151-164.2002; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Hutchinson S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014646; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Intlekofer AM, 2005, NAT IMMUNOL, V6, P1236, DOI 10.1038/ni1268; Jadhav RR, 2019, P NATL ACAD SCI USA, V116, P14113, DOI 10.1073/pnas.1903520116; Jeannet G, 2010, P NATL ACAD SCI USA, V107, P9777, DOI 10.1073/pnas.0914127107; Kallies A, 2020, NAT REV IMMUNOL, V20, P128, DOI 10.1038/s41577-019-0223-7; Kanev K, 2019, P NATL ACAD SCI USA, V116, P20070, DOI 10.1073/pnas.1902701116; Kao C, 2011, NAT IMMUNOL, V12, P663, DOI 10.1038/ni.2046; Karimzadeh H, 2019, GASTROENTEROLOGY, V156, P1820, DOI 10.1053/j.gastro.2019.02.003; Karrer U, 2004, J VIROL, V78, P2255, DOI 10.1128/JVI.78.5.2255-2264.2004; Karrer U, 2003, J IMMUNOL, V170, P2022, DOI 10.4049/jimmunol.170.4.2022; Kefalakes H, 2019, GASTROENTEROLOGY, V156, P1805, DOI 10.1053/j.gastro.2019.01.035; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Klenerman P, 2018, IMMUNOL REV, V283, P99, DOI 10.1111/imr.12653; Klenerman P, 2016, NAT REV IMMUNOL, V16, P367, DOI 10.1038/nri.2016.38; Klyushnenkova EN, 2012, J IMMUNOTHER, V35, P390, DOI 10.1097/CJI.0b013e3182585d50; Kusnadi A, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe4782; Leong YA, 2016, NAT IMMUNOL, V17, P1187, DOI 10.1038/ni.3543; Li HJ, 2019, CELL, V176, P775, DOI 10.1016/j.cell.2018.11.043; Liu BL, 2022, NAT CANCER, V3, P108, DOI 10.1038/s43018-021-00292-8; Lugli E, 2020, TRENDS IMMUNOL, V41, P17, DOI 10.1016/j.it.2019.11.004; Lynn RC, 2019, NATURE, V576, P293, DOI 10.1038/s41586-019-1805-z; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Martin MD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02692; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; McLane LM, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109120; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Menner AJ, 2015, J IMMUNOL, V195, P2103, DOI 10.4049/jimmunol.1402607; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Miron M, 2018, J IMMUNOL, V201, P2132, DOI 10.4049/jimmunol.1800716; Nejad EB, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0500-9; NUMAZAKI Y, 1970, AM J EPIDEMIOL, V91, P410, DOI 10.1093/oxfordjournals.aje.a121151; O'Hara GA, 2012, TRENDS IMMUNOL, V33, P84, DOI 10.1016/j.it.2011.11.005; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Oestreich KJ, 2008, J IMMUNOL, V181, P4832, DOI 10.4049/jimmunol.181.7.4832; Oliveira G, 2021, NATURE, V596, P119, DOI 10.1038/s41586-021-03704-y; Omilusik KD, 2019, CURR OPIN IMMUNOL, V58, P89, DOI 10.1016/j.coi.2019.04.009; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2021, J EXP MED, V218, DOI 10.1084/jem.20200920; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Pearce EL, 2003, SCIENCE, V302, P1041, DOI 10.1126/science.1090148; Philip M, 2022, NAT REV IMMUNOL, V22, P209, DOI 10.1038/s41577-021-00574-3; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Pilipow K, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.122299; Poole E, 2015, MED MICROBIOL IMMUN, V204, P421, DOI 10.1007/s00430-015-0401-6; Qiu ZJ, 2015, CANCER IMMUNOL RES, V3, P536, DOI 10.1158/2326-6066.CIR-14-0044; Quinn M, 2015, J IMMUNOL, V194, P1726, DOI 10.4049/jimmunol.1402757; Reeves M, 2013, VIRUSES-BASEL, V5, P1395, DOI 10.3390/v5061395; Reina-Campos M, 2021, NAT REV IMMUNOL, V21, P718, DOI 10.1038/s41577-021-00537-8; Remmerswaal EBM, 2015, J VIROL, V89, P568, DOI 10.1128/JVI.02003-14; Rutishauser RL, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.136648; Sabatino M, 2016, BLOOD, V128, P519, DOI 10.1182/blood-2015-11-683847; Sade-Feldman M, 2018, CELL, V175, P998, DOI 10.1016/j.cell.2018.10.038; Sandu I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18256-4; Schenkel JM, 2021, IMMUNITY, V54, P2338, DOI 10.1016/j.immuni.2021.08.026; Schober K, 2020, NAT IMMUNOL, V21, P434, DOI 10.1038/s41590-020-0628-2; Schuch A, 2019, GUT, V68, P905, DOI 10.1136/gutjnl-2018-316641; Schwartz M, 2019, J VIROL, V93, DOI 10.1128/JVI.00047-19; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Scott-Browne JP, 2016, IMMUNITY, V45, P1327, DOI 10.1016/j.immuni.2016.10.028; Seckert CK, 2011, J GEN VIROL, V92, P1994, DOI 10.1099/vir.0.031815-0; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Seo H, 2021, NAT IMMUNOL, V22, P983, DOI 10.1038/s41590-021-00964-8; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Shin H, 2009, IMMUNITY, V31, P309, DOI 10.1016/j.immuni.2009.06.019; Siddiqui I, 2019, IMMUNITY, V50, P195, DOI 10.1016/j.immuni.2018.12.021; Simoni Y, 2018, NATURE, V557, P575, DOI 10.1038/s41586-018-0130-2; Snell LM, 2018, IMMUNITY, V49, P378, DOI 10.1016/j.immuni.2018.08.002; Snyder CM, 2008, IMMUNITY, V29, P650, DOI 10.1016/j.immuni.2008.07.017; Snyder CM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002295; Spitzer MH, 2017, CELL, V168, P487, DOI 10.1016/j.cell.2016.12.022; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Thimme R, 2021, J HEPATOL, V74, P220, DOI 10.1016/j.jhep.2020.09.022; Thommen DS, 2018, NAT MED, V24, P994, DOI 10.1038/s41591-018-0057-z; Thommen DS, 2018, CANCER CELL, V33, P547, DOI 10.1016/j.ccell.2018.03.012; Tonnerre P, 2021, NAT IMMUNOL, V22, P1030, DOI 10.1038/s41590-021-00982-6; Torti N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002313; Toth I, 2013, J LEUKOCYTE BIOL, V94, P551, DOI 10.1189/jlb.0113018; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; Utzschneider DT, 2016, J EXP MED, V213, P1819, DOI 10.1084/jem.20150598; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Utzschneider DT, 2013, NAT IMMUNOL, V14, P603, DOI 10.1038/ni.2606; van der Leun AM, 2020, NAT REV CANCER, V20, P218, DOI 10.1038/s41568-019-0235-4; van der Waart AB, 2014, BLOOD, V124, P3490, DOI 10.1182/blood-2014-05-578583; Verma V, 2021, NAT IMMUNOL, V22, P53, DOI 10.1038/s41590-020-00818-9; Wagle MV, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23044-9; Weber EW, 2021, SCIENCE, V372, P49, DOI 10.1126/science.aba1786; Welten SPM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16219-3; Welten SPM, 2019, MED MICROBIOL IMMUN, V208, P329, DOI 10.1007/s00430-019-00587-9; Welten SPM, 2018, IMMUNOL REV, V283, P161, DOI 10.1111/imr.12649; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Wieland D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15050; Williams MA, 2006, IMMUNOL REV, V211, P146, DOI 10.1111/j.0105-2896.2006.00389.x; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yao C, 2021, NAT IMMUNOL, V22, P370, DOI 10.1038/s41590-021-00868-7; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yates KB, 2021, NAT IMMUNOL, V22, P1020, DOI 10.1038/s41590-021-00979-1; Yost KE, 2021, SCIENCE, V372, P130, DOI 10.1126/science.abd1329; Yost KE, 2019, NAT MED, V25, P1251, DOI 10.1038/s41591-019-0522-3; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zebley CC, 2020, TRENDS IMMUNOL, V41, P665, DOI 10.1016/j.it.2020.06.008; Zhang YY, 2021, CANCER CELL, V39, P1578, DOI 10.1016/j.ccell.2021.09.010; Zhou XY, 2010, IMMUNITY, V33, P229, DOI 10.1016/j.immuni.2010.08.002	155	1	1	15	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					836	847		10.1038/s41590-022-01219-w	http://dx.doi.org/10.1038/s41590-022-01219-w		MAY 2022	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35624209	Bronze			2022-12-18	WOS:000805549900012
J	Grebinoski, S; Zhang, QX; Cillo, AR; Manne, S; Xiao, HX; Brunazzi, EA; Tabib, T; Cardello, C; Lian, CG; Murphy, GF; Lafyatis, R; Wherry, EJ; Das, J; Workman, CJ; Vignali, DAA				Grebinoski, Stephanie; Zhang, Qianxia; Cillo, Anthony R.; Manne, Sasikanth; Xiao, Hanxi; Brunazzi, Erin A.; Tabib, Tracy; Cardello, Carly; Lian, Christine G.; Murphy, George F.; Lafyatis, Robert; Wherry, E. John; Das, Jishnu; Workman, Creg J.; Vignali, Dario A. A.			Autoreactive CD8(+) T cells are restrained by an exhaustion-like program that is maintained by LAG3	NATURE IMMUNOLOGY			English	Article							PANCREATIC-ISLETS; GENES; PD-1; SUBSETS; MICE	Exhausted T cells are associated with inefficient viral clearance, tumor immunity and response to immunotherapy. Here the authors show CD8(+) T cells in the pancreatic islets have a LAG3-promoted 'restrained' phenotype resembling exhausted cells but maintain effector functions, and LAG3 expression limits pathology in the nonobese diabetic mouse model of type 1 diabetes. Impaired chronic viral and tumor clearance has been attributed to CD8(+) T cell exhaustion, a differentiation state in which T cells have reduced and altered effector function that can be partially reversed upon blockade of inhibitory receptors. The role of the exhaustion program and transcriptional networks that control CD8(+) T cell function and fate in autoimmunity is not clear. Here we show that intra-islet CD8(+) T cells phenotypically, transcriptionally, epigenetically and metabolically possess features of canonically exhausted T cells, yet maintain important differences. This 'restrained' phenotype can be perturbed and disease accelerated by CD8(+) T cell-restricted deletion of the inhibitory receptor lymphocyte activating gene 3 (LAG3). Mechanistically, LAG3-deficient CD8(+) T cells have enhanced effector-like functions, trafficking to the islets, and have a diminished exhausted phenotype, highlighting a physiological role for an exhaustion program in limiting autoimmunity and implicating LAG3 as a target for autoimmune therapy.	[Grebinoski, Stephanie; Zhang, Qianxia; Cillo, Anthony R.; Brunazzi, Erin A.; Cardello, Carly; Workman, Creg J.; Vignali, Dario A. A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA; [Grebinoski, Stephanie; Zhang, Qianxia] Univ Pittsburgh, Grad Program Microbiol & Immunol, Sch Med, Pittsburgh, PA USA; [Grebinoski, Stephanie; Zhang, Qianxia; Cillo, Anthony R.; Brunazzi, Erin A.; Cardello, Carly; Workman, Creg J.; Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA; [Manne, Sasikanth; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Manne, Sasikanth; Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Perelman Sch Med, Philadelphia, PA 19104 USA; [Xiao, Hanxi; Das, Jishnu] Univ Pittsburgh, Sch Med, Dept Immunol, Ctr Syst Immunol, Pittsburgh, PA USA; [Xiao, Hanxi; Das, Jishnu] Univ Pittsburgh, Sch Med, Dept Computat & Syst Biol, Ctr Syst Immunol, Pittsburgh, PA USA; [Xiao, Hanxi] Univ Pittsburgh, Sch Med, CMU Pitt Joint Computat Biol, Pittsburgh, PA USA; [Tabib, Tracy; Lafyatis, Robert] Univ Pittsburgh, Div Rheumatol & Clin Immunol, Sch Med, Pittsburgh, PA USA; [Lian, Christine G.; Murphy, George F.] Brigham & Womens Hosp, Dept Pathol, 75 Francis St, Boston, MA 02115 USA; [Zhang, Qianxia; Lian, Christine G.; Murphy, George F.] Harvard Med Sch, Boston, MA 02115 USA; [Wherry, E. John] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA; [Zhang, Qianxia] Boston Childrens Hosp, Program Cellular & Mol Med, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine; Harvard University; Boston Children's Hospital	Vignali, DAA (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15213 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA.	dvignali@pitt.edu	Zhang, Qianxia/D-7689-2011	Zhang, Qianxia/0000-0002-2885-2147; Cillo, Anthony/0000-0002-3213-3129; Grebinoski, Stephanie/0000-0002-3562-3190	NIH [R01 DK089125, R01 AI144422, P01 AI108545, AI105343, AI117950, AI082630, AI112521, AI115712, AI108545, CA210944, DP2AI164325, U01HG012041, F31 AI147638, T32 AI089443, S10 OD011925]; Parker Institute for Cancer Immunotherapy; Hillman Postdoctoral Fellows for Innovative Cancer Research postdoctoral fellowship	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; Hillman Postdoctoral Fellows for Innovative Cancer Research postdoctoral fellowship	We thank the current and former members in the Vignali laboratory (Vignali-lab. com; @Vignali_Lab) for their constructive comments and advice during this project. The authors also thank the members of P01 AI108545 for their constructive feedback, specifically A. Sharpe and laboratory members (Department of Microbiology and Immunobiology, Harvard Medical School). We thank G. Delgoffe and laboratory members for aid in metabolic studies and protocols (Department of Immunology, University of Pittsburgh; Tumor Microenvironment Center, UPMC Hillman Cancer Center; Cancer Immunology and Immunotherapy Program, UPMC Hillman Cancer Center). We also thank Q. Zhan for help with histology (Department of Pathology, Brigham and Women's Hospital and Harvard Medical School). We thank R. Dadey, H. Yano, L. Andrews, R. Peralta and P. Vignali, members of the Vignali and Delgoffe laboratories, for aid in unpublished experiments. We would also like to thank Clayton Mathews (Department of Pathology, University of Florida) and members of his lab Jing Chen, Sadie Clements, and Mollie Huber for aid and reagents for unpublished experiments. We thank D. Falkner, A. McIntyre, N. Sheng, H. Gunzelman, T. Sturgeon, H. Shen and L. Borghesi from the Immunology Flow Core (current and past) for cell sorting, maintenance and training in the use of cytometers (Department of Immunology, UPSOM). We thank J. Goulet, R. Gerheart, C. Schmidt, J. Latini and the staff of the Division of Laboratory Animal Resources for genotyping and animal husbandry (Department of Immunology, UPSOM). We thank the Littman (The Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine; Howard Hughes Medical Institute) and Taniuchi (Laboratory for Transcriptional Regulation, RIKEN Center for Integrative Medical Sciences) laboratories for the E8iCRE-GFP.C57BL/6 mice and A. Castellaw for breeding them onto the NOD background at St. Jude Children's Research Hospital (Department of Immunology). We also thank the UPMC Genome Core and the University of Pittsburgh HSCRF Genomics Research Core for assistance with next-generation sequencing, and the Pitt Center for Research Computing for computational resources. This work was supported by the NIH (R01 DK089125, R01 AI144422, P01 AI108545 to D.A.A.V.; AI105343, AI117950, AI082630, AI112521, AI115712, AI108545 and CA210944 to E.J.W.; DP2AI164325 and U01HG012041 to J.D. in partial support of his contributions; F31 AI147638 and T32 AI089443 to S.G.). E.J.W. is supported by the Parker Institute for Cancer Immunotherapy, which supports the cancer immunology program at UPenn. A.R.C. is supported by the Hillman Postdoctoral Fellows for Innovative Cancer Research postdoctoral fellowship.; This project benefitted from a Special Order BD LSRFortessa (funded by NIH S10 OD011925) used in the UPSOM Unified Flow Core.	Abdelsamed HA, 2020, NAT IMMUNOL, V21, P578, DOI 10.1038/s41590-020-0633-5; Amrani A, 2000, NATURE, V406, P739, DOI 10.1038/35021081; Andrews LP, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.abc2728; Becht E, 2019, NAT BIOTECHNOL, V37, P38, DOI 10.1038/nbt.4314; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Bettini M, 2011, J IMMUNOL, V187, P3493, DOI 10.4049/jimmunol.1100714; Blackburn SD, 2009, NAT IMMUNOL, V10, P29, DOI 10.1038/ni.1679; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Burke KP, 2021, J EXP MED, V218, DOI 10.1084/jem.20192179; Canale FP, 2018, CANCER RES, V78, P115, DOI 10.1158/0008-5472.CAN-16-2684; Chee J, 2014, J IMMUNOL, V192, P572, DOI 10.4049/jimmunol.1302100; Chen YG, 2018, FRONT ENDOCRINOL, V9, DOI [10.3389/fpls.2018.00779, 10.3389/fendo.2018.00051]; CHRISTIANSON SW, 1993, DIABETES, V42, P44, DOI 10.2337/diabetes.42.1.44; Cillo AR, 2020, IMMUNITY, V52, P183, DOI 10.1016/j.immuni.2019.11.014; Creelan BC, 2019, NAT REV CLIN ONCOL, V16, P277, DOI 10.1038/s41571-019-0182-8; Cusick ME, 2009, NAT METHODS, V6, P39, DOI [10.1038/nmeth.1284, 10.1038/NMETH.1284]; Das J, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-92; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doering TA, 2012, IMMUNITY, V37, P1130, DOI 10.1016/j.immuni.2012.08.021; Dunkler D, 2020, TRANSPL INT, V33, P50, DOI 10.1111/tri.13535; GEARTY SV, NATURE; Godec J, 2016, IMMUNITY, V44, P194, DOI 10.1016/j.immuni.2015.12.006; Grebinoski S, 2020, CURR OPIN IMMUNOL, V67, P1, DOI 10.1016/j.coi.2020.06.001; Gupta PK, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005177; Haghverdi L, 2016, NAT METHODS, V13, P845, DOI 10.1038/nmeth.3971; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; JONES BE, 2022, J IMMUNOL; Kanehisa M, 2019, PROTEIN SCI, V28, P1947, DOI 10.1002/pro.3715; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Kent SC, 2005, NATURE, V435, P224, DOI 10.1038/nature03625; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Komatsu H, 2018, PANCREAS, V47, P533, DOI 10.1097/MPA.0000000000001050; Kotecha Nikesh, 2010, Curr Protoc Cytom, VChapter 10, DOI 10.1002/0471142956.cy1017s53; Krishnamurthy B, 2006, J CLIN INVEST, V116, P3258, DOI 10.1172/JCI29602; Kuric E, 2017, AM J PATHOL, V187, P581, DOI 10.1016/j.ajpath.2016.11.002; Law CW, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-2-r29; Leiter EH., 2001, CURR PROTOC IMMUNOL, V15, p15.19; Lennon GP, 2009, IMMUNITY, V31, P643, DOI 10.1016/j.immuni.2009.07.008; Li J, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02981; Liao YX, 2019, NUCLEIC ACIDS RES, V47, pW199, DOI 10.1093/nar/gkz401; Long SA, 2017, CELL IMMUNOL, V319, P3, DOI 10.1016/j.cellimm.2017.07.007; Long SA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai7793; McKinney EF, 2015, NATURE, V523, P612, DOI 10.1038/nature14468; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nakayama M, 2005, NATURE, V435, P220, DOI 10.1038/nature03523; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Olsson R, 2011, DIABETES, V60, P2350, DOI 10.2337/db09-0490; Olsson R, 2011, DIABETES, V60, P2068, DOI 10.2337/db09-0877; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2019, TRENDS IMMUNOL, V40, P511, DOI 10.1016/j.it.2019.04.002; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Picelli S, 2013, NAT METHODS, V10, P1096, DOI [10.1038/nmeth.2639, 10.1038/NMETH.2639]; Prasad Suchitra, 2012, Rev Diabet Stud, V9, P319, DOI 10.1900/RDS.2012.9.319; Priatel J, 2014, J IMMUNOL, V192; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Rodriguez-Calvo T, 2014, DIABETES, V63, P3880, DOI 10.2337/db14-0549; Roederer M, 2011, CYTOM PART A, V79A, P167, DOI 10.1002/cyto.a.21015; Sato Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194738; Scharping NE, 2021, NAT IMMUNOL, V22, P205, DOI 10.1038/s41590-020-00834-9; Scharping NE, 2016, IMMUNITY, V45, P374, DOI [10.1016/j.immuni.2016.07.009, 10.1016/j.immuni.2016.08.009]; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Seo W, 2021, EXP MOL MED, V53, P202, DOI 10.1038/s12276-021-00568-0; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Skowera A, 2015, DIABETES, V64, P916, DOI 10.2337/db14-0332; Smita S, 2022, JCI INSIGHT, V7, DOI 10.1172/jci.insight.156048; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stoeckius M, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1603-1; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tilstra JS, 2018, J CLIN INVEST, V128, P4884, DOI 10.1172/JCI120859; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Varela-Calvino R, 2017, ARCH IMMUNOL THER EX, V65, P275, DOI 10.1007/s00005-016-0452-4; Watson MJ, 2021, NATURE, V591, P645, DOI 10.1038/s41586-020-03045-2; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiedeman AE, 2020, J CLIN INVEST, V130, P480, DOI 10.1172/JCI126595; Woo SR, 2012, CANCER RES, V72, P917, DOI 10.1158/0008-5472.CAN-11-1620; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yeo L, 2018, J CLIN INVEST, V128, P3460, DOI 10.1172/JCI120555; Zakharov PN, 2020, J EXP MED, V217, DOI 10.1084/jem.20192362; Zhang QX, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aah4569	83	1	1	6	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2022	23	6					868	+		10.1038/s41590-022-01210-5	http://dx.doi.org/10.1038/s41590-022-01210-5		MAY 2022	33	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1X7XB	35618829	Green Accepted			2022-12-18	WOS:000805552300002
J	Yang, ZH; Han, JH				Yang, Zhang-Hua; Han, Jiahuai			INFLAMMASOME Dual ligand engagement for noncanonical inflammasome activation	NATURE IMMUNOLOGY			English	Editorial Material							GASDERMIN D; CASPASES; RNA	The activation of the noncanonical NLRP3 inflammasome can be elicited by the interaction and interdependent activation of caspase-11 and NLRP3 that follows coincident cytosolic detection of lipopolysaccharide and bacterial mRNA from live Gram-negative bacteria.	[Yang, Zhang-Hua; Han, Jiahuai] Xiamen Univ, Sch Med, Canc Res Ctr, Res Unit Cellular Stress,Chinese Acad Med Sci, Xiamen, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Xiamen University	Han, JH (corresponding author), Xiamen Univ, Sch Med, Canc Res Ctr, Res Unit Cellular Stress,Chinese Acad Med Sci, Xiamen, Peoples R China.	jhan@xmu.edu.cn		Yang, Zhang-Hua/0000-0001-8713-1879				Brubaker SW, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101612; Downs KP, 2020, MOL ASPECTS MED, V76, DOI 10.1016/j.mam.2020.100924; Hagar JA, 2013, SCIENCE, V341, P1250, DOI 10.1126/science.1240988; He WT, 2015, CELL RES, V25, P1285, DOI 10.1038/cr.2015.139; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kayagaki N, 2015, NATURE, V526, P666, DOI 10.1038/nature15541; Kayagaki N, 2013, SCIENCE, V341, P1246, DOI 10.1126/science.1240248; Kayagaki N, 2011, NATURE, V479, P117, DOI 10.1038/nature10558; Moretti J., NAT IMMUNOL, DOI [10.1038/s41590-022-01192-4 (2022), DOI 10.1038/S41590-022-01192-4(2022)]; Sander LE, 2011, NATURE, V474, P385, DOI 10.1038/nature10072; Shi JJ, 2015, NATURE, V526, P660, DOI 10.1038/nature15514; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683	12	1	1	4	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					651	653		10.1038/s41590-022-01188-0	http://dx.doi.org/10.1038/s41590-022-01188-0		APR 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35487984				2022-12-18	WOS:000788971400004
J	Moro, A; Gao, Z; Wang, L; Yu, AX; Hsiung, SN; Ban, YG; Yan, AM; Sologon, CM; Chen, XS; Malek, TR				Moro, Alejandro; Gao, Zhen; Wang, Lily; Yu, Aixin; Hsiung, Sunnie; Ban, Yuguang; Yan, Aimin; Sologon, Corneliu M.; Chen, X. Steven; Malek, Thomas R.			Dynamic transcriptional activity and chromatin remodeling of regulatory T cells after varied duration of interleukin-2 receptor signaling	NATURE IMMUNOLOGY			English	Article							DNA METHYLATION; BINDING; MECHANISMS; SEQUENCE; PROGRAM; PATHWAY; COHESIN; PRC2; CTCF; LSH	Regulatory T (T-reg) cells require (interleukin-2) IL-2 for their homeostasis by affecting their proliferation, survival and activation. Here we investigated transcriptional and epigenetic changes after acute, periodic and persistent IL-2 receptor (IL-2R) signaling in mouse peripheral T-reg cells in vivo using IL-2 or the long-acting IL-2-based biologic mouse IL-2-CD25. We show that initially IL-2R-dependent STAT5 transcription factor-dependent pathways enhanced gene activation, chromatin accessibility and metabolic reprogramming to support T-reg cell proliferation. Unexpectedly, at peak proliferation, less accessible chromatin prevailed and was associated with T-reg cell contraction. Restimulation of IL-2R signaling after contraction activated signature IL-2-dependent genes and others associated with effector T-reg cells, whereas genes associated with signal transduction were downregulated to somewhat temper expansion. Thus, IL-2R-dependent T-reg cell homeostasis depends in part on a shift from more accessible chromatin and expansion to less accessible chromatin and contraction. Mouse IL-2-CD25 supported greater expansion and a more extensive transcriptional state than IL-2 in T-reg cells, consistent with greater efficacy to control autoimmunity. Malek and colleagues describe the longitudinal transcriptional and epigenetic changes occurring in regulatory T cells following in vivo stimulation with IL-2 or the biologic IL-2-CD25.	[Moro, Alejandro; Yu, Aixin; Hsiung, Sunnie; Malek, Thomas R.] Univ Miami, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Gao, Zhen; Wang, Lily; Ban, Yuguang; Yan, Aimin; Sologon, Corneliu M.; Chen, X. Steven] Univ Miami, Sylvester Comprehens Canc Ctr, Miami, FL USA; [Wang, Lily; Ban, Yuguang; Chen, X. Steven] Univ Miami, Dept Publ Hlth Sci, Div Biostat, Miami, FL USA; [Wang, Lily] Univ Miami, Miller Sch Med, John P Hussman Inst Human Genom, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami	Malek, TR (corresponding author), Univ Miami, Dept Microbiol & Immunol, Miami, FL 33136 USA.	tmalek@med.miami.edu		Hsiung, Sunnie/0000-0002-4813-7220; Ban, Yuguang/0000-0002-2874-0647	National Institutes of Health (NIH) [P30CA240139]; Bristol Myers Squibb; NIH [R01AI148675]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bristol Myers Squibb(Bristol-Myers Squibb); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank A. S. Savio for technical assistance. J. Enten, P. Guevara, S. Saigh and N. Ward from the Flow Cytometry Core and M. Brooks, Y. Cardentey and J. Kemper from the Oncogenomics Core of the Sylvester Comprehensive Cancer Center (supported by National Institutes of Health (NIH) P30CA240139); and M. Struthers and F. Ramirez-Valle at Bristol Myers Squibb and A. Villarino at the University of Miami for critically reading the manuscript. This research was supported by funding to T.R.M. from Bristol Myers Squibb and the NIH (R01AI148675).	Abbas AK, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat1482; Assenov Y, 2014, NAT METHODS, V11, P1138, DOI [10.1038/NMETH.3115, 10.1038/nmeth.3115]; Bhasin JM, 2016, NUCLEIC ACIDS RES, V44, P5550, DOI 10.1093/nar/gkw477; Bronner C, 2019, GENES-BASEL, V10, DOI 10.3390/genes10010065; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Buszko M, 2020, CURR OPIN IMMUNOL, V67, P18, DOI 10.1016/j.coi.2020.07.001; Chen EY, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-128; Chorro L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07806-6; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Dias S, 2017, IMMUNITY, V46, P78, DOI 10.1016/j.immuni.2016.12.017; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; DONOHUE JH, 1983, J IMMUNOL, V130, P2203; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Geginat J, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00630; Geiman TM, 2000, P NATL ACAD SCI USA, V97, P4772, DOI 10.1073/pnas.97.9.4772; Grasshoff H, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.648408; Gregory MA, 2003, J BIOL CHEM, V278, P51606, DOI 10.1074/jbc.M310722200; Han MM, 2020, NUCLEIC ACIDS RES, V48, P12116, DOI 10.1093/nar/gkaa1003; Haring JS, 2006, IMMUNITY, V25, P19, DOI 10.1016/j.immuni.2006.07.001; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Lawrence M, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003118; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QH, 2011, ANN APPL STAT, V5, P1752, DOI 10.1214/11-AOAS466; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; LOBANENKOV VV, 1990, ONCOGENE, V5, P1743; Loftus RM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04719-2; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Martin MD, 2015, SCI REP-UK, V5, DOI 10.1038/srep18022; Mookerjee SA, 2018, J BIOL CHEM, V293, P12649, DOI 10.1074/jbc.AAC118.004855; Nagraj VP, 2018, NUCLEIC ACIDS RES, V46, pW194, DOI 10.1093/nar/gky464; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nora EP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19283-x; Oh H, 2017, IMMUNITY, V47, P450, DOI 10.1016/j.immuni.2017.08.010; Oliveros J.C., 2007, INTERACTIVE TOOL COM; Parelho V, 2008, CELL, V132, P422, DOI 10.1016/j.cell.2008.01.011; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Petracovici A, 2021, MOL CELL, V81, P2625, DOI 10.1016/j.molcel.2021.03.038; Pol JG, 2020, J EXP MED, V217, DOI 10.1084/jem.20191247; Prlic M, 2008, P NATL ACAD SCI USA, V105, P16689, DOI 10.1073/pnas.0808997105; Rath S, 2021, NUCLEIC ACIDS RES, V49, pD1541, DOI 10.1093/nar/gkaa1011; Rovira-Clave X, 2016, J LEUKOCYTE BIOL, V99, P143, DOI 10.1189/jlb.2A0115-034R; Sakaguchi S, 2013, NAT REV IMMUNOL, V13, P461, DOI 10.1038/nri3464; Saravia J, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaw6443; Sharabi A, 2018, NAT REV DRUG DISCOV, V17, P823, DOI 10.1038/nrd.2018.148; Stowers RS, 2019, NAT BIOMED ENG, V3, P1009, DOI 10.1038/s41551-019-0420-5; Tameni A, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03425-0; Toomer KH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08960-1; Wan YSY, 2007, NATURE, V445, P766, DOI 10.1038/nature05479; Ward NC, 2020, DIABETES, V69, P2400, DOI 10.2337/db20-0186; Ward NC, 2018, J IMMUNOL, V201, P2579, DOI 10.4049/jimmunol.1800907; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7; Yu AX, 2015, DIABETES, V64, P2172, DOI 10.2337/db14-1322; Yu AX, 2009, IMMUNITY, V30, P204, DOI 10.1016/j.immuni.2008.11.014; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	59	1	1	2	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2022	23	5					802	+		10.1038/s41590-022-01179-1	http://dx.doi.org/10.1038/s41590-022-01179-1		APR 2022	24	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	1F1PT	35449416	Green Accepted			2022-12-18	WOS:000784614100003
J	Boissonnas, A; Combadiere, C				Boissonnas, Alexandre; Combadiere, Christophe			Modulating the tumor-associated macrophage landscape	NATURE IMMUNOLOGY			English	Editorial Material							CHEMOKINES	Targeting the post-translational modification enzyme QPCTL prevents the protection of CCL2 and CCL7 from N-terminal degradation, inactivates their chemotactic function and limits the recruitment of pro-tumoral macrophages.	[Boissonnas, Alexandre; Combadiere, Christophe] Sorbonne Univ, INSERM, CNRS, Ctr dImmunol & Malad Infectieuses, Paris, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite	Boissonnas, A (corresponding author), Sorbonne Univ, INSERM, CNRS, Ctr dImmunol & Malad Infectieuses, Paris, France.	alexandre.boissonnas@upmc.fr	Combadiere, Christophe/I-5639-2013; Boissonnas, Alexandre/A-2801-2016	Combadiere, Christophe/0000-0002-1755-4531; Boissonnas, Alexandre/0000-0002-7770-7210				Cynis H, 2011, EMBO MOL MED, V3, P545, DOI 10.1002/emmm.201100158; da Silva RB, 2022, NAT IMMUNOL, V23, P568, DOI 10.1038/s41590-022-01153-x; Guilliams M, 2021, NAT IMMUNOL, V22, P118, DOI 10.1038/s41590-020-00849-2; Hamon P, 2017, BLOOD, V129, P1296, DOI 10.1182/blood-2016-08-732164; Laviron M, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01799; Logtenberg MEW, 2019, NAT MED, V25, P612, DOI 10.1038/s41591-019-0356-z; Loyher PL, 2018, J EXP MED, V215, P2536, DOI 10.1084/jem.20180534; Mantovani A, 2017, NAT REV CLIN ONCOL, V14, P399, DOI 10.1038/nrclinonc.2016.217; Nagarsheth N, 2017, NAT REV IMMUNOL, V17, P559, DOI 10.1038/nri.2017.49; Ozga AJ, 2021, IMMUNITY, V54, P859, DOI 10.1016/j.immuni.2021.01.012; Vanheule V, 2018, CYTOKINE, V109, P29, DOI 10.1016/j.cyto.2018.02.026; Zacarias NVO, 2021, TRENDS PHARMACOL SCI, V42, P912, DOI 10.1016/j.tips.2021.08.001	12	1	1	8	19	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					481	482		10.1038/s41590-022-01159-5	http://dx.doi.org/10.1038/s41590-022-01159-5		MAR 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35314847				2022-12-18	WOS:000771340600003
J	Crowe, JE				Crowe, James E., Jr.			Bispecific antiviral neutralizing antibodies are twice as nice	NATURE IMMUNOLOGY			English	Editorial Material								Increasingly, human monoclonal antibodies have been deployed against COVID-19, but combinations are typically needed for recognition of diverse viral variants. Bispecific antibodies could make the task of manufacturing and delivering combinations more efficient.	[Crowe, James E., Jr.] Vanderbilt Univ, Vanderbilt Vaccine Ctr, Med Ctr, Nashville, TN 37203 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37203 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37203 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Microbiol, Nashville, TN 37203 USA; [Crowe, James E., Jr.] Vanderbilt Univ, Med Ctr, Dept Immunol, Nashville, TN 37203 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Crowe, JE (corresponding author), Vanderbilt Univ, Vanderbilt Vaccine Ctr, Med Ctr, Nashville, TN 37203 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37203 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37203 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Microbiol, Nashville, TN 37203 USA.; Crowe, JE (corresponding author), Vanderbilt Univ, Med Ctr, Dept Immunol, Nashville, TN 37203 USA.	james.crowe@vumc.org	Crowe, James/B-5549-2009	Crowe, James/0000-0002-0049-1079	Takeda Pharmaceuticals; IDBiologics; AstraZeneca	Takeda Pharmaceuticals(Takeda Pharmaceutical Company Ltd); IDBiologics; AstraZeneca(AstraZeneca)	J.E.C. has served as a consultant for Luna Biologics, Merck and GlaxoSmithKline, is a member of the Scientific Advisory Board of Meissa Vaccines, and is a founder of IDBiologics. The Crowe laboratory at Vanderbilt University Medical Center has received sponsored research agreements from Takeda Pharmaceuticals, IDBiologics and AstraZeneca.	Huang YX, 2016, CELL, V165, P1621, DOI 10.1016/j.cell.2016.05.024; Li ZH, 2022, NAT IMMUNOL, V23, P423, DOI 10.1038/s41590-022-01138-w; VanBlargan LA, 2022, NAT MED, V28, P490, DOI 10.1038/s41591-021-01678-y; Xu L, 2017, SCIENCE, V358, P85, DOI 10.1126/science.aan8630; Zost Seth J, 2020, bioRxiv, DOI 10.1101/2020.05.22.111005	5	1	1	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					346	347		10.1038/s41590-022-01147-9	http://dx.doi.org/10.1038/s41590-022-01147-9		FEB 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35228693	Bronze			2022-12-18	WOS:000762163700002
J	Liu, GQ; Gack, MU				Liu, GuanQun; Gack, Michaela U.			VIRAL INFECTION SARS-CoV-2 learned the 'Alpha'bet of immune evasion	NATURE IMMUNOLOGY			English	Editorial Material								Comparative analysis of SARS-CoV-2 isolates uncovers important mutations outside the spike gene that help the Alpha variant to operate under the radar of innate immune surveillance.	[Liu, GuanQun; Gack, Michaela U.] Cleveland Clin Florida Res & Innovat Ctr, Port St Lucie, FL 34987 USA		Gack, MU (corresponding author), Cleveland Clin Florida Res & Innovat Ctr, Port St Lucie, FL 34987 USA.	gackm@ccf.org	Liu, GuanQun/AAJ-2681-2020	Liu, GuanQun/0000-0003-2520-7625				Blanco-Melo D, 2020, CELL, V181, P1036, DOI 10.1016/j.cell.2020.04.026; Chan YK, 2016, NAT REV MICROBIOL, V14, P360, DOI 10.1038/nrmicro.2016.45; Gordon DE, 2020, SCIENCE, V370, P1181, DOI 10.1126/science.abe9403; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Liu GQ, 2021, NAT MICROBIOL, V6, P467, DOI 10.1038/s41564-021-00884-1; Miorin L, 2020, P NATL ACAD SCI USA, V117, P28344, DOI 10.1073/pnas.2016650117; Parker M. D., 2021, PREPRINT BIORXIV, DOI [10.1101/2021.03.02.433156, DOI 10.1101/2021.03.02.433156]; Rehwinkel J, 2020, NAT REV IMMUNOL, V20, P537, DOI 10.1038/s41577-020-0288-3; Sekizuka T., 2021, PREPRINT MEDRXIV, DOI [10.1101/2021.10.11.21264606, DOI 10.1101/2021.10.11.21264606]; Shin D, 2020, NATURE, V587, P657, DOI 10.1038/s41586-020-2601-5; Thorne LG, 2022, NATURE, V602, P487, DOI 10.1038/s41586-021-04352-y; V'kovski P, 2021, NAT REV MICROBIOL, V19, P155, DOI 10.1038/s41579-020-00468-6	12	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					351	353		10.1038/s41590-022-01148-8	http://dx.doi.org/10.1038/s41590-022-01148-8		FEB 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35194206	Bronze			2022-12-18	WOS:000759350000001
J	Grebinoski, S; Gocher-Demske, AM; Vignali, DAA				Grebinoski, Stephanie; Gocher-Demske, Angela M.; Vignali, Dario A. A.			Catch and release: freeing up PD-L1 ameliorates autoimmunity	NATURE IMMUNOLOGY			English	Editorial Material									[Grebinoski, Stephanie; Gocher-Demske, Angela M.; Vignali, Dario A. A.] Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA; [Grebinoski, Stephanie] Univ Pittsburgh, Sch Med, Grad Program Microbiol & Immunol, Pittsburgh, PA USA; [Grebinoski, Stephanie; Gocher-Demske, Angela M.; Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA; [Vignali, Dario A. A.] UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Vignali, DAA (corresponding author), Univ Pittsburgh, Sch Med, Dept Immunol, Pittsburgh, PA 15260 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Tumor Microenvironm Ctr, Pittsburgh, PA 15232 USA.; Vignali, DAA (corresponding author), UPMC Hillman Canc Ctr, Canc Immunol & Immunotherapy Program, Pittsburgh, PA 15232 USA.	dvignali@pitt.edu		Vignali, Dario/0000-0002-2771-5992	National Institutes of Health [R35 CA263850, P01 AI108545, R01s DK089125, AI144422, AI129893, F31 AI147638, T32 AI089443, F32 CA247004, T32 CA082084]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (grants R35 CA263850, P01 AI108545, R01s DK089125, AI144422 & AI129893 to D.A.A.V., F31 AI147638 and T32 AI089443 to S.G, F32 CA247004 and T32 CA082084 to A.M.G.D.)	Burke KP, 2021, J EXP MED, V218, DOI 10.1084/jem.20192179; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Fugger L, 2020, CELL, V181, P63, DOI 10.1016/j.cell.2020.03.007; Gocher AM, 2022, NAT REV IMMUNOL, V22, P158, DOI 10.1038/s41577-021-00566-3; Grebinoski S, 2020, CURR OPIN IMMUNOL, V67, P1, DOI 10.1016/j.coi.2020.06.001; Ikemizu S, 2000, IMMUNITY, V12, P51, DOI 10.1016/S1074-7613(00)80158-2; Kraehenbuehl L, 2022, NAT REV CLIN ONCOL, V19, P37, DOI 10.1038/s41571-021-00552-7; Pauken KE, 2019, TRENDS IMMUNOL, V40, P511, DOI 10.1016/j.it.2019.04.002; RAZIWOLF Z, 1992, P NATL ACAD SCI USA, V89, P4210, DOI 10.1073/pnas.89.9.4210; Sharpe AH, 2018, NAT REV IMMUNOL, V18, P153, DOI 10.1038/nri.2017.108; Sonpavde GP, 2021, FUTURE ONCOL, V17, P2545, DOI 10.2217/fon-2020-1222; Sugiura D., NAT IMMUNOL, DOI [10.1038/s41590-021-01125-7(2022), DOI 10.1038/S41590-021-01125-7(2022)]; Sugiura D, 2019, SCIENCE, V364, P558, DOI 10.1126/science.aav7062; Theofilopoulos AN, 2017, NAT IMMUNOL, V18, P716, DOI 10.1038/ni.3731; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Zhao YL, 2019, IMMUNITY, V51, P1059, DOI 10.1016/j.immuni.2019.11.003	16	1	2	1	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2022	23	3					344	346		10.1038/s41590-022-01140-2	http://dx.doi.org/10.1038/s41590-022-01140-2		FEB 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ZO6EL	35190718				2022-12-18	WOS:000758974500004
J	Jankovic, D; Ciucci, T; Coffman, RL; Coquet, JM; Le Gros, G; Mosmann, TR; Sher, A; Ronchese, F				Jankovic, Dragana; Ciucci, Thomas; Coffman, Robert L.; Coquet, Jonathan M.; Le Gros, Graham; Mosmann, Tim R.; Sher, Alan; Ronchese, Franca			Comment on: Repositioning T-H cell polarization from single cytokines to complex help	NATURE IMMUNOLOGY			English	Letter							CLONE		[Jankovic, Dragana] NIAID, Immunoparasitol Unit, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Ciucci, Thomas; Mosmann, Tim R.] Univ Rochester, Med Ctr, David H Smith Ctr Vaccine Biol & Immunol, Rochester, NY 14642 USA; [Coffman, Robert L.] RLC Consulting, Portola Valley, CA USA; [Coquet, Jonathan M.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Le Gros, Graham; Ronchese, Franca] Malaghan Inst Med Res, Wellington, New Zealand; [Sher, Alan] NIAID, Immunobiol Sect, Lab Parasit Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Rochester; Karolinska Institutet; Malaghan Institute; Victoria University Wellington; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Ronchese, F (corresponding author), Malaghan Inst Med Res, Wellington, New Zealand.	fronchese@malaghan.org.nz	Coquet, Jonathan M/A-5551-2015	Coquet, Jonathan M/0000-0002-5967-4857; Le Gros, Graham/0000-0002-5721-0442; Sher, Alan/0000-0001-7053-2895; Mosmann, Tim/0000-0001-9753-6941; Ciucci, Thomas/0000-0002-5828-0207				Ciucci T, 2019, IMMUNITY, V50, P91, DOI 10.1016/j.immuni.2018.12.019; Eisenbarth SC, 2021, TRENDS IMMUNOL, V42, P658, DOI 10.1016/j.it.2021.06.003; Lonnberg Tapio, 2017, Sci Immunol, V2, DOI 10.1126/sciimmunol.aal2192; Ma, SCI IMMUNOL, V6, DOI [10.1126/sciimmunol.abg6356(2021), DOI 10.1126/SCIIMMUNOL.ABG6356(2021)]; MOSMANN TR, 1987, IMMUNOL TODAY, V8, P223, DOI 10.1016/0167-5699(87)90171-X; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; Seumois G, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba6087; Soon MSF, 2020, NAT IMMUNOL, V21, P1597, DOI 10.1038/s41590-020-0800-8; Tibbitt CA, 2019, IMMUNITY, V51, P169, DOI 10.1016/j.immuni.2019.05.014; Tuzlak S, 2021, NAT IMMUNOL, V22, P1210, DOI 10.1038/s41590-021-01009-w; Wu L, 2020, CELL, V182, P641, DOI 10.1016/j.cell.2020.06.014	11	1	1	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					501	502		10.1038/s41590-022-01144-y	http://dx.doi.org/10.1038/s41590-022-01144-y		FEB 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35190720				2022-12-18	WOS:000758974500005
J	Tuzlak, S; Ginhoux, F; Korn, T; Becher, B				Tuzlak, Selma; Ginhoux, Florent; Korn, Thomas; Becher, Burkhard			Reply to 'Comment on: Repositioning T-H cell polarization from single cytokines to complex help'	NATURE IMMUNOLOGY			English	Letter									[Tuzlak, Selma; Becher, Burkhard] Univ Zurich, Inst Expt Immunol, Zurich, Switzerland; [Ginhoux, Florent] ASTAR, Singapore Immunol Network SIgN, Singapore, Singapore; [Ginhoux, Florent] The Acad, Singhlth Duke NUS Acad Med Ctr, Translat Immunol Inst, Singapore, Singapore; [Ginhoux, Florent] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Immunol, Shanghai, Peoples R China; [Korn, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Expt Neuroimmunol, Munich, Germany; [Korn, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Dept Neurol, Munich, Germany; [Korn, Thomas] Munich Cluster Syst Neurol SyNergy, Munich, Germany	University of Zurich; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); Chinese Academy of Sciences; Shanghai Jiao Tong University; Technical University of Munich; Technical University of Munich; University of Munich	Becher, B (corresponding author), Univ Zurich, Inst Expt Immunol, Zurich, Switzerland.	becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867; Korn, Thomas/0000-0002-3633-0955; Ginhoux, Florent/0000-0002-2857-7755				Ciucci T, 2019, IMMUNITY, V50, P91, DOI 10.1016/j.immuni.2018.12.019; Eberl G, 2018, TRENDS IMMUNOL, V39, P261, DOI 10.1016/j.it.2017.11.004; Jankovic, NAT IMMUNOL, DOI [10.1038/s41590-022-01144-y(2022, DOI 10.1038/S41590-022-01144-Y(2022]; Lonnberg Tapio, 2017, Sci Immunol, V2, DOI 10.1126/sciimmunol.aal2192; Ma JJ, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abg6356; Seumois G, 2020, SCI IMMUNOL, V5, DOI 10.1126/sciimmunol.aba6087; Soon MSF, 2020, NAT IMMUNOL, V21, P1597, DOI 10.1038/s41590-020-0800-8; Tibbitt CA, 2019, IMMUNITY, V51, P169, DOI 10.1016/j.immuni.2019.05.014; Tuzlak S, 2021, NAT IMMUNOL, V22, P1210, DOI 10.1038/s41590-021-01009-w; Wu L, 2020, CELL, V182, P641, DOI 10.1016/j.cell.2020.06.014	10	1	1	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2022	23	4					503	504		10.1038/s41590-022-01142-0	http://dx.doi.org/10.1038/s41590-022-01142-0		FEB 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	0I2BK	35190719				2022-12-18	WOS:000758974500002
J	Spits, H				Spits, Hergen			Neuropilin-1 flags lung-resident type 2 innate lymphoid cells	NATURE IMMUNOLOGY			English	Editorial Material							TGF-BETA-1		[Spits, Hergen] Univ Amsterdam, Dept Expt Immunol, Amsterdam UMC, Amsterdam, Netherlands	University of Amsterdam	Spits, H (corresponding author), Univ Amsterdam, Dept Expt Immunol, Amsterdam UMC, Amsterdam, Netherlands.	hergen.spits@amsterdamumc.nl		Spits, Hergen/0000-0003-3269-8338				Denney L, 2015, IMMUNITY, V43, P945, DOI 10.1016/j.immuni.2015.10.012; Glinka Y, 2011, CARCINOGENESIS, V32, P613, DOI 10.1093/carcin/bgq281; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Ley B, 2012, ANN INTERN MED, V156, P684, DOI 10.7326/0003-4819-156-10-201205150-00004; Mazzurana L, 2021, CELL RES, V31, P554, DOI 10.1038/s41422-020-00445-x; Ricardo-Gonzalez RR, 2018, NAT IMMUNOL, V19, P1093, DOI 10.1038/s41590-018-0201-4; Robinette ML, 2015, NAT IMMUNOL, V16, P306, DOI 10.1038/ni.3094; Rodriguez-Rodriguez N, 2021, ANNU REV IMMUNOL, V39, P167, DOI 10.1146/annurev-immunol-110119-091711; Shikhagaie MM, 2017, CELL REP, V18, P1761, DOI 10.1016/j.celrep.2017.01.063; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wang L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13734-w; Zhang J., NAT IMMUNOL, DOI [10.1038/s41590-021-01097-8(2022), DOI 10.1038/S41590-021-01097-8(2022)]	12	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2022	23	2					151	152		10.1038/s41590-021-01115-9	http://dx.doi.org/10.1038/s41590-021-01115-9		JAN 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	YS1GM	35075282				2022-12-18	WOS:000746478500004
J	Bernard, NJ				Bernard, Nicholas J.			Vaccine thrombosis	NATURE IMMUNOLOGY			English	Editorial Material												nick.bernard@nature.com							0	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					2	2		10.1038/s41590-021-01111-z	http://dx.doi.org/10.1038/s41590-021-01111-z		DEC 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34937923	Bronze			2022-12-18	WOS:000733875700002
J	Moss, P; Ladhani, S				Moss, Paul; Ladhani, Shamez			Cross-reactive adaptive immunity against coronaviruses in young children	NATURE IMMUNOLOGY			English	Editorial Material								Coronavirus-specific antibody and T cell responses were characterized in young children who had been naturally infected with SARS-CoV-2. Immune responses were focused against the spike protein, strong and stable in magnitude, and showed notable cross-reactivity with other human coronaviruses.	[Moss, Paul] Univ Birmingham, Birmingham, W Midlands, England; [Ladhani, Shamez] Publ Hlth England, London, England	University of Birmingham; Public Health England	Moss, P (corresponding author), Univ Birmingham, Birmingham, W Midlands, England.							Consiglio CR, 2020, CELL, V183, P968, DOI 10.1016/j.cell.2020.09.016; Madera S, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81934-w; Meade P, 2020, MBIO, V11, DOI 10.1128/mBio.03243-19; Ng KW, 2020, SCIENCE, V370, P1339, DOI 10.1126/science.abe1107; Saletti G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78506-9	5	1	1	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2022	23	1					11	12		10.1038/s41590-021-01085-y	http://dx.doi.org/10.1038/s41590-021-01085-y		DEC 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XU2FK	34937929	hybrid			2022-12-18	WOS:000733276000003
J	Bernard, NJ				Bernard, Nicholas J.			Another function for red blood cells	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	2	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1469	1469		10.1038/s41590-021-01081-2	http://dx.doi.org/10.1038/s41590-021-01081-2		NOV 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34811540				2022-12-18	WOS:000722315400005
J	Divangahi, M; Javid, B; Kaufmann, E				Divangahi, Maziar; Javid, Babak; Kaufmann, Eva			100 years of antibody solitude in TB	NATURE IMMUNOLOGY			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; TUBERCULOSIS; IMMUNITY; INNATE	Analysis of antibody responses in BCG intravenous vaccination against Mycobacterium tuberculosis in non-human primates show a potential protective role for IgM.	[Divangahi, Maziar; Kaufmann, Eva] McGill Univ Hlth Ctr, Meakins Christie Labs, Dept Med, Dept Microbiol & Immunol,Dept Pathol,McGill Int T, Montreal, PQ, Canada; [Javid, Babak] Univ Calif San Francisco, Div Expt Med, San Francisco, CA 94143 USA	McGill University; University of California System; University of California San Francisco	Divangahi, M (corresponding author), McGill Univ Hlth Ctr, Meakins Christie Labs, Dept Med, Dept Microbiol & Immunol,Dept Pathol,McGill Int T, Montreal, PQ, Canada.	maziar.divangahi@mcgill.ca		Kaufmann, Eva/0000-0001-7965-9200				BARCLAY W R, 1970, Infection and Immunity, V2, P574; Cohen SB, 2018, CELL HOST MICROBE, V24, P439, DOI 10.1016/j.chom.2018.08.001; COSTELLO AMD, 1992, T ROY SOC TROP MED H, V86, P686, DOI 10.1016/0035-9203(92)90192-F; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Darrah PA, 2020, NATURE, V577, P95, DOI 10.1038/s41586-019-1817-8; de Valliere S, 2005, INFECT IMMUN, V73, P6711, DOI 10.1128/IAI.73.10.6711-6720.2005; Encinales L, 2010, MOL IMMUNOL, V47, P1066, DOI 10.1016/j.molimm.2009.11.005; Irvine E. B., NAT IMMUNOL, DOI [10.1038/10.1038/s41590-021-01066-1(2021), DOI 10.1038/10.1038/S41590-021-01066-1(2021)]; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Khan N, 2020, CELL, V183, P752, DOI 10.1016/j.cell.2020.09.062; Li H, 2018, NAT REV IMMUNOL, V18, P591, DOI 10.1038/s41577-018-0028-0; Watson A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-20930-0	12	1	1	0	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1470	1471		10.1038/s41590-021-01071-4	http://dx.doi.org/10.1038/s41590-021-01071-4		NOV 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34811545				2022-12-18	WOS:000722315400006
J	Fehervari, Z				Fehervari, Zoltan			Microbiota shape tumor immunity	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1469	1469		10.1038/s41590-021-01082-1	http://dx.doi.org/10.1038/s41590-021-01082-1		NOV 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34811539				2022-12-18	WOS:000722315400007
J	Coler, B; Waldorf, KA				Coler, Brahm; Waldorf, Kristina Adams			Maternal COVID-19 leaves a lasting immunological impression on the fetus	NATURE IMMUNOLOGY			English	Editorial Material							INFLAMMATION	Whether COVID-19 during pregnancy affects the health of children is unclear. Data now show that SARS-CoV-2 infection of mothers can prime the fetal immune response indirectly even when the virus does not infect the fetus.	[Coler, Brahm; Waldorf, Kristina Adams] Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA; [Coler, Brahm] Washington State Univ, Elson S Floyd Coll Med, Spokane, WA USA; [Waldorf, Kristina Adams] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Washington State University; University of Washington; University of Washington Seattle	Waldorf, KA (corresponding author), Univ Washington, Dept Obstet & Gynecol, Seattle, WA 98195 USA.; Waldorf, KA (corresponding author), Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA.	adamsk@uw.edu	Adams Waldorf, Kristina/F-2608-2013	Adams Waldorf, Kristina/0000-0002-6939-7224				al-Haddad BJS, 2019, AM J OBSTET GYNECOL, V221, P549, DOI 10.1016/j.ajog.2019.06.013; al-Haddad BJS, 2019, JAMA PSYCHIAT, V76, P594, DOI 10.1001/jamapsychiatry.2019.0029; Boulanger-Bertolus J, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00230; CHANY C, 1982, PEDIATRICS, V69, P209; Dauby N, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000571; Gee S, 2021, NAT IMMUNOL, V22, P1490, DOI 10.1038/s41590-021-01049-2; Harari A, 2006, IMMUNOL REV, V211, P236, DOI 10.1111/j.0105-2896.2006.00395.x; Kallapur SG, 2013, J IMMUNOL, V191, P1102, DOI 10.4049/jimmunol.1300270; Liu P, 2020, J ALLERGY CLIN IMMUN, V146, P101, DOI 10.1016/j.jaci.2020.04.038; Nadeau-Vallee M, 2017, J IMMUNOL, V198, P2047, DOI 10.4049/jimmunol.1601600; ROUSSET S, 1984, PEDIATRICS, V73, P218; Wu YT, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003195	12	1	1	1	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2021	22	12					1472	1473		10.1038/s41590-021-01072-3	http://dx.doi.org/10.1038/s41590-021-01072-3		NOV 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	XI5MM	34782774	Bronze			2022-12-18	WOS:000718693700001
J	Joffe, AM; Park, EC; Augustine, A; Jiang, C; PrabhuDas, M; Vazquez-Maldonado, N; Aaby, P; Alter, G; Divangahi, M; Hotez, P; Khader, S; Netea, MG; Petri, WA; Plotkin, S; Thompson, KM				Joffe, Aaron M.; Park, Eun-Chung; Augustine, Alison; Jiang, Chao; PrabhuDas, Mercy; Vazquez-Maldonado, Nancy; Aaby, Peter; Alter, Galit; Divangahi, Maziar; Hotez, Peter; Khader, Shabaana; Netea, Mihai G.; Petri, William A., Jr.; Plotkin, Stanley; Thompson, Kimberly M.			NIAID workshop on secondary vaccine effects	NATURE IMMUNOLOGY			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; TUBERCULOSIS; PREVENTION; MORTALITY; IMMUNITY; MEMORY	On 27-29 July 2021, the National Institute of Allergy and Infectious Diseases (NIAID) hosted a virtual workshop on the topic of secondary vaccine effects to discuss existing evidence, potential immunological mechanisms and associated public health implications.	[Joffe, Aaron M.; Park, Eun-Chung; Augustine, Alison; Jiang, Chao; PrabhuDas, Mercy; Vazquez-Maldonado, Nancy] NIAID, NIH, Rockville, MD 20852 USA; [Aaby, Peter] Bandim Hlth Project, Bissau, Guinea Bissau; [Alter, Galit] MIT, Ragon Inst MGH, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Alter, Galit] Harvard Univ, Cambridge, MA 02138 USA; [Divangahi, Maziar] McGill Univ, Hlth Ctr, Dept Microbiol & Immunol, Meakins Christie Labs,Dept Med,Dept Pathol, Montreal, PQ, Canada; [Divangahi, Maziar] McGill Univ, McGill Int TB Ctr, Montreal, PQ, Canada; [Hotez, Peter] Baylor Coll Med, Texas Childrens Ctr Vaccine Dev, Houston, TX 77030 USA; [Khader, Shabaana] Washington Univ, Sch Med, Dept Mol Microbiol, St Louis, MO 63110 USA; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, Nijmegen, Netherlands; [Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, Nijmegen, Netherlands; [Petri, William A., Jr.] Univ Virginia Hlth Syst, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA; [Plotkin, Stanley] Univ Penn, Perelman Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Thompson, Kimberly M.] Kid Risk Inc, Orlando, FL USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Harvard University; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; McGill University; McGill University; Baylor College of Medicine; Washington University (WUSTL); Radboud University Nijmegen; Radboud University Nijmegen; University of Virginia; University of Pennsylvania; Pennsylvania Medicine	Joffe, AM; Park, EC (corresponding author), NIAID, NIH, Rockville, MD 20852 USA.	ari.joffe@nih.gov; epark@niaid.nih.gov		A Khader, Shabaana/0000-0002-9545-4982; Aaby, Peter/0000-0001-8331-1389				AABY P, 1995, BRIT MED J, V311, P481, DOI 10.1136/bmj.311.7003.481; Aaby P, 2003, LANCET, V361, P2183, DOI 10.1016/S0140-6736(03)13771-3; Agrawal B, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02631; [Anonymous], 2014, SAGE NONSP EFF VACC; Benn CS, 2020, LANCET INFECT DIS, V20, pE274, DOI 10.1016/S1473-3099(19)30742-X; Brook B, 2020, SCI TRANSL MED, V12, DOI 10.1126/scitranslmed.aax4517; Burgess SL, 2020, J CLIN INVEST, V130, P4019, DOI 10.1172/JCI133605; Darrah PA, 2020, NATURE, V577, P95, DOI 10.1038/s41586-019-1817-8; Diaz-Salazar C, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108186; Fanucchi S, 2021, IMMUNITY, V54, P32, DOI 10.1016/j.immuni.2020.10.011; Gerber JE, 2021, HUM VACC IMMUNOTHER, V17, P2999, DOI [10.1080/21645515.2021.1911217, 10.1080/21645515.2020.1859318]; Giamarellos-Bourboulis EJ, 2020, CELL, V183, P315, DOI 10.1016/j.cell.2020.08.051; Grasset EK, 2020, J EXP MED, V217, DOI 10.1084/jem.20201340; Gunti S, 2015, J INFECT DIS, V212, pS42, DOI 10.1093/infdis/jiu512; Higgins JPT, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5170; Hotez PJ, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000683; Idoko OT, 2020, FRONT PEDIATR, V8, DOI 10.3389/fped.2020.00197; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Khan N, 2020, CELL, V183, P752, DOI 10.1016/j.cell.2020.09.062; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kroger A., 2021, ACIP GEN BEST PRACTI; Lima DS, 2021, CELL, V184, P3794, DOI 10.1016/j.cell.2021.05.020; Martin C, VACCINE, DOI [10.1016/j.vaccine.2021.06.049(2021, DOI 10.1016/J.VACCINE.2021.06.049(2021]; Moorlag SJCFM, 2019, CLIN MICROBIOL INFEC, V25, P1473, DOI 10.1016/j.cmi.2019.04.020; Moorlag SJCFM, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108387; Nelde A, 2021, NAT IMMUNOL, V22, P74, DOI 10.1038/s41590-020-00808-x; Nemes E, 2018, NEW ENGL J MED, V379, P138, DOI [10.1056/nejmoa1714021, 10.1056/NEJMoa1714021]; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Thompson KM, 2021, RISK ANAL, V41, P376, DOI 10.1111/risa.13614; Upfill-Brown A, 2017, CLIN INFECT DIS, V65, P414, DOI 10.1093/cid/cix354; Wimmers F, 2021, CELL, V184, P3915, DOI 10.1016/j.cell.2021.05.039	32	1	1	2	7	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1363	1366		10.1038/s41590-021-01054-5	http://dx.doi.org/10.1038/s41590-021-01054-5		OCT 2021	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34686866	Bronze			2022-12-18	WOS:000710074100004
J	Jochems, SP; Ferreira, DM; Smits, HH				Jochems, Simon P.; Ferreira, Daniela M.; Smits, Hermelijn H.			Microbiota and compartment matter in the COVID-19 response	NATURE IMMUNOLOGY			English	Editorial Material							INFECTION; IMMUNITY	During acute COVID-19, there is little correlation between the nose and blood in terms of antibodies or cytokines; instead, these factors are associated with nasal microbiota.	[Jochems, Simon P.; Smits, Hermelijn H.] Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands; [Ferreira, Daniela M.] Univ Liverpool Liverpool Sch Trop Med, Dept Clin Sci, Liverpool, Merseyside, England	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Liverpool School of Tropical Medicine	Jochems, SP (corresponding author), Leiden Univ, Dept Parasitol, Med Ctr, Leiden, Netherlands.	s.p.jochems@lumc.nl	Ferreira, Daniela M/AAE-9881-2022; Jochems, Simon/FFT-0345-2022; Ferreira, Daniela M/AFF-4763-2022; Jochems, Simon/AAT-9156-2021; Smits, Hermelijn/V-4216-2018	Ferreira, Daniela M/0000-0002-0594-0902; Jochems, Simon/0000-0002-4835-1032; Smits, Hermelijn/0000-0001-9279-2890				Arunachalam PS, 2020, SCIENCE, V369, P1210, DOI 10.1126/science.abc6261; Carniel BF, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.141088; Cervia C, 2021, J ALLERGY CLIN IMMUN, V147, P545, DOI 10.1016/j.jaci.2020.10.040; Gupta A., MICROBES INFECT, DOI [10.1016/j.micinf.2021.104880(2021, DOI 10.1016/J.MICINF.2021.104880(2021]; Hadjadj J, 2020, SCIENCE, V369, P718, DOI 10.1126/science.abc6027; Hoepel W, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abf8654; Lee KH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0207898; Lehtinen MJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29793-w; Lei XB, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17665-9; Lewnard JA, 2021, J INFECT DIS, V225, P1710, DOI 10.1093/infdis/jiab128; Mitsi, PREPRINT MEDRXIV, DOI [10.1101/2021.07.22.21260837(2021, DOI 10.1101/2021.07.22.21260837(2021]; Piters WAAD, 2016, AM J RESP CRIT CARE, V194, P1104, DOI 10.1164/rccm.201602-0220OC; Schaupp L, 2020, CELL, V181, P1080, DOI 10.1016/j.cell.2020.04.022; Smith N, 2021, NAT IMMUNOL, V22, P1428, DOI 10.1038/s41590-021-01028-7; Ziegler CGK, 2021, CELL, V184, P4713, DOI 10.1016/j.cell.2021.07.023	15	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2021	22	11					1350	1352		10.1038/s41590-021-01041-w	http://dx.doi.org/10.1038/s41590-021-01041-w		OCT 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	WO5TY	34675388	Bronze			2022-12-18	WOS:000709652200001
J	Herrmann, JR; Simon, DW				Herrmann, Jeremy R.; Simon, Dennis W.			Interfer(on)-ing with vascular repair after acute brain injury	NATURE IMMUNOLOGY			English	Editorial Material									[Herrmann, Jeremy R.; Simon, Dennis W.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15213 USA; [Herrmann, Jeremy R.; Simon, Dennis W.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA; [Simon, Dennis W.] Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh, Inst Neurosci, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Simon, DW (corresponding author), Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA 15213 USA.; Simon, DW (corresponding author), Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA 15213 USA.; Simon, DW (corresponding author), Univ Pittsburgh, Sch Med, UPMC Childrens Hosp Pittsburgh, Inst Neurosci, Pittsburgh, PA 15213 USA.	dennis.simon2@chp.edu		Simon, Dennis/0000-0002-3824-2326				Boehme AK, 2018, STROKE, V49, P2999, DOI 10.1161/STROKEAHA.118.022837; BROUTYBOYE D, 1980, SCIENCE, V208, P516, DOI 10.1126/science.6154315; Di Domizio J, 2020, NAT IMMUNOL, V21, P1034, DOI 10.1038/s41590-020-0721-6; Feigin VL, 2018, NEW ENGL J MED, V379, P2429, DOI 10.1056/NEJMoa1804492; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Kochanek PM, 2016, J NEUROTRAUM, V33, P513, DOI 10.1089/neu.2015.4113; Mastorakos P, 2021, NAT IMMUNOL, V22, P1280, DOI 10.1038/s41590-021-01012-1; Mastorakos P, 2021, NAT NEUROSCI, V24, P245, DOI 10.1038/s41593-020-00773-6; Roselli F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00458; Russo MV, 2018, NAT IMMUNOL, V19, P442, DOI 10.1038/s41590-018-0086-2; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Sun LL, 2015, CELL HOST MICROBE, V17, P85, DOI 10.1016/j.chom.2014.11.004	12	1	1	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1205	1206		10.1038/s41590-021-01034-9	http://dx.doi.org/10.1038/s41590-021-01034-9		SEP 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34556883	Bronze			2022-12-18	WOS:000751833700002
J	Nakaya, HI				Nakaya, Helder I.			Hidden in plain sight: uncovering the role of CREB1 in HIV-1 vaccine-induced immunity	NATURE IMMUNOLOGY			English	Editorial Material							EFFICACY; ALVAC		[Nakaya, Helder I.] Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil; [Nakaya, Helder I.] Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil; [Nakaya, Helder I.] Hosp Israelita Albert Einstein, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Hospital Israelita Albert Einstein	Nakaya, HI (corresponding author), Univ Sao Paulo, Sch Pharmaceut Sci, Dept Clin & Toxicol Anal, Sao Paulo, Brazil.; Nakaya, HI (corresponding author), Univ Sao Paulo, Sci Platform Pasteur, Sao Paulo, Brazil.; Nakaya, HI (corresponding author), Hosp Israelita Albert Einstein, Sao Paulo, Brazil.	helder.nakaya@einstein.br	Nakaya, Helder/A-1397-2010	Nakaya, Helder/0000-0001-5297-9108				Arunachalam PS, 2021, NATURE, V596, P410, DOI 10.1038/s41586-021-03791-x; Gray GE, 2021, NEW ENGL J MED, V384, P1089, DOI 10.1056/NEJMoa2031499; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Nakaya HI, 2012, CURR OPIN HIV AIDS, V7, P24, DOI 10.1097/COH.0b013e32834dc37b; Pulendran B, 2010, IMMUNITY, V33, P516, DOI 10.1016/j.immuni.2010.10.006; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Tomalka JA, 2021, NAT IMMUNOL, V22, P1294, DOI 10.1038/s41590-021-01026-9; Vaccari M, 2016, NAT MED, V22, P762, DOI 10.1038/nm.4105; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Zolla-Pazner S, 2019, CURR OPIN HIV AIDS, V14, P309, DOI 10.1097/COH.0000000000000551	11	1	1	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1199	1200		10.1038/s41590-021-01018-9	http://dx.doi.org/10.1038/s41590-021-01018-9		SEP 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34556875	Bronze			2022-12-18	WOS:000751833700014
J	Murphy, RC; Altman, MC				Murphy, Ryan C.; Altman, Matthew C.			Ignition sequence start: epithelial allergen sensing and regulation of the allergic inflammatory response	NATURE IMMUNOLOGY			English	Editorial Material							INTERLEUKIN-33		[Murphy, Ryan C.] Univ Washington, Div Pulm Crit Care & Sleep Med, Seattle, WA 98195 USA; [Murphy, Ryan C.] Univ Washington, Ctr Lung Biol, Seattle, WA 98195 USA; [Altman, Matthew C.] Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA; [Altman, Matthew C.] Benaroya Res Inst, Syst Immunol Div, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Benaroya Research Institute	Altman, MC (corresponding author), Univ Washington, Dept Med, Div Allergy & Infect Dis, Seattle, WA 98195 USA.; Altman, MC (corresponding author), Benaroya Res Inst, Syst Immunol Div, Seattle, WA 98101 USA.	maltman@benaroyaresearch.org		Altman, Matthew/0000-0002-1784-8505; Murphy, Ryan/0000-0003-0094-0003				Akdis, NAT REV IMMUNOL, DOI [10.1038/s41577-021-00538-7(2021), DOI 10.1038/S41577-021-00538-7(2021)]; Brusilovsky, NAT IMMUNOL, DOI [10.1038/s41590-021-01011-2(2021), DOI 10.1038/S41590-021-01011-2(2021)]; Caldwell JM, 2017, CURR OPIN IMMUNOL, V48, P114, DOI 10.1016/j.coi.2017.08.006; Cayrol C, 2018, NAT IMMUNOL, V19, P375, DOI 10.1038/s41590-018-0067-5; Chan BCL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00364; Han XR, 2020, ALLERGY, V75, P3100, DOI 10.1111/all.14632; Liew FY, 2016, NAT REV IMMUNOL, V16, P676, DOI 10.1038/nri.2016.95; Lin CH, 2015, CELL BIOSCI, V5, DOI 10.1186/s13578-015-0063-5; Luthi AU, 2009, IMMUNITY, V31, P84, DOI 10.1016/j.immuni.2009.05.007; Scott IC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21589-2; Travers J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05485-x; Tsai YM, 2018, INT J MOL MED, V41, P757, DOI 10.3892/ijmm.2017.3310	12	1	1	0	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2021	22	10					1207	1209		10.1038/s41590-021-01005-0	http://dx.doi.org/10.1038/s41590-021-01005-0		SEP 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UZ9IQ	34531561				2022-12-18	WOS:000696445900002
J	Fehervari, Z				Fehervari, Zoltan			Intranasal vaccination	NATURE IMMUNOLOGY			English	Editorial Material												z.fehervari@nature.com							0	1	1	0	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1071	1071		10.1038/s41590-021-01016-x	http://dx.doi.org/10.1038/s41590-021-01016-x		AUG 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34429547	Bronze			2022-12-18	WOS:000687942300002
J	McNamara, HA; Cockburn, IA				McNamara, Hayley A.; Cockburn, Ian A.			Resident T cells seek the perfect place to work from home	NATURE IMMUNOLOGY			English	Editorial Material							TISSUE	CD8(+) resident memory T (T-RM) cells from different tissues form a heterogeneous population. Transforming growth factor (TGF)-beta-independent CD103(-) T-RM cells in the liver retain the ability to move to barrier tissues or return to secondary lymphoid organs.	[McNamara, Hayley A.] Tech Univ Munich, Sch Life Sci Weihenstephan, Div Anim Physiol & Immunol, Freising Weihenstephan, Germany; [Cockburn, Ian A.] Australian Natl Univ, John Curtin Sch Med Res, Div Immunol Inflammat & Infect, Canberra, ACT, Australia	Technical University of Munich; Australian National University; John Curtin School of Medical Research	Cockburn, IA (corresponding author), Australian Natl Univ, John Curtin Sch Med Res, Div Immunol Inflammat & Infect, Canberra, ACT, Australia.	ian.cockburn@anu.edu.au		Cockburn, Ian/0000-0001-8220-9294; McNamara, Hayley/0000-0001-6347-6215				Behr FM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01770; Christo SN, 2021, NAT IMMUNOL, V22, P1140, DOI 10.1038/s41590-021-01004-1; Fernandez-Ruiz D, 2016, IMMUNITY, V45, P889, DOI 10.1016/j.immuni.2016.08.011; Fonseca R, 2020, NAT IMMUNOL, V21, P412, DOI 10.1038/s41590-020-0607-7; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Low JS, 2020, J EXP MED, V217, DOI 10.1084/jem.20192291; Mackay LK, 2016, SCIENCE, V352, P459, DOI 10.1126/science.aad2035; Mackay LK, 2015, IMMUNITY, V43, P1101, DOI 10.1016/j.immuni.2015.11.008; Mackay LK, 2013, NAT IMMUNOL, V14, P1294, DOI 10.1038/ni.2744; McNamara HA, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj1996; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Van Braeckel-Budimir N, 2018, CELL REP, V24, P3374, DOI 10.1016/j.celrep.2018.08.073	12	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1076	1078		10.1038/s41590-021-01003-2	http://dx.doi.org/10.1038/s41590-021-01003-2		AUG 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34426688				2022-12-18	WOS:000687501700001
J	Martin, WJ; Haar, JM				Martin, William John; Haar, Jarrod M.			Mentorship as a mechanism to mobilize inclusion	NATURE IMMUNOLOGY			English	Editorial Material							METAANALYSIS; ANTECEDENTS; DIVERSITY; TARGETS; SUPPORT		[Martin, William John] Minist Business Innovat & Employment, Labour Sci & Enterprise, Wellington, New Zealand; [Haar, Jarrod M.] Auckland Univ Technol, Dept Management, Fac Business Econ & Law, Auckland, Aotearoa, New Zealand	Auckland University of Technology	Martin, WJ (corresponding author), Minist Business Innovat & Employment, Labour Sci & Enterprise, Wellington, New Zealand.	Willy-John.Martin@mbie.govt.nz	Haar, Jarrod/AAA-4486-2022	Haar, Jarrod/0000-0001-8935-4953; Martin, William/0000-0003-1314-5420				Allen TD, 2004, J APPL PSYCHOL, V89, P127, DOI 10.1037/0021-9010.89.1.127; [Anonymous], 2021, NATURE, V593, P313; Droogendyk L, 2016, J SOC ISSUES, V72, P315, DOI 10.1111/josi.12168; Eby LT, 2008, J VOCAT BEHAV, V72, P254, DOI 10.1016/j.jvb.2007.04.005; Eby LTD, 2013, PSYCHOL BULL, V139, P441, DOI 10.1037/a0029279; Garvey R., 2017, COACHING MENTORING T; Ghosh R, 2014, J VOCAT BEHAV, V84, P367, DOI 10.1016/j.jvb.2014.02.009; Haar J., HUM RELAT, DOI [10.1177/00187267211003955(2021, DOI 10.1177/00187267211003955(2021]; Iwasaki A, 2019, NAT IMMUNOL, V20, P1085, DOI 10.1038/s41590-019-0470-6; Jones RJ, 2016, J OCCUP ORGAN PSYCH, V89, P249, DOI 10.1111/joop.12119; Laland KN, 2020, NATURE, V584, P653, DOI 10.1038/d41586-020-02471-6; Louis WR, 2019, SOC PERSONAL PSYCHOL, V13, DOI 10.1111/spc3.12436; McAllister T. G., 2019, MAI J, DOI [10.20507/MAIJournal.2019.8.2.10, DOI 10.20507/MAIJOURNAL.2019.8.2.10]; Pierce SK, 2020, NAT IMMUNOL, V21, P254, DOI 10.1038/s41590-020-0618-4; Rattan A, 2014, PERS SOC PSYCHOL B, V40, P555, DOI 10.1177/0146167213519480; Rauika Mangai, 2020, GUIDE VISION MATAURA; Shore LM, 2011, J MANAGE, V37, P1262, DOI 10.1177/0149206310385943; Sue DW, 2019, AM PSYCHOL, V74, P128, DOI 10.1037/amp0000296; Swartz TH, 2019, J INFECT DIS, V220, pS33, DOI 10.1093/infdis/jiz174	19	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					932	933		10.1038/s41590-021-00976-4	http://dx.doi.org/10.1038/s41590-021-00976-4			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology	TQ1ME	34316070				2022-12-18	WOS:000678050800003
J	Yousif, A; Ghoneim, HE				Yousif, Amir; Ghoneim, Hazem E.			T cell exhaustion-a memory locked behind scars	NATURE IMMUNOLOGY			English	Editorial Material								Following clearance of chronic infections, virus-specific CD8(+) T cells recover a subset of memory-related transcriptome features. Yet their unique open chromatin landscape largely reflects an exhausted or dysfunctional state, limiting their protective memory potential.	[Yousif, Amir; Ghoneim, Hazem E.] Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Ghoneim, Hazem E.] Ohio State Univ, Pelotonia Inst Immunooncol, James Comprehens Canc Ctr, Columbus, OH 43210 USA	Ohio State University; James Cancer Hospital & Solove Research Institute; Ohio State University	Ghoneim, HE (corresponding author), Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.; Ghoneim, HE (corresponding author), Ohio State Univ, Pelotonia Inst Immunooncol, James Comprehens Canc Ctr, Columbus, OH 43210 USA.	Hazem.Ghoneim@osumc.edu						Abdel-Hakeem MS, 2021, NAT IMMUNOL, V22, P1008, DOI 10.1038/s41590-021-00975-5; Gattinoni L, 2017, NAT MED, V23, P18, DOI 10.1038/nm.4241; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Hensel N, 2021, NAT IMMUNOL, V22, P229, DOI 10.1038/s41590-020-00817-w; Holmes JA, 2019, LANCET, V393, P1392, DOI 10.1016/S0140-6736(18)32326-2; Kelsey G, 2017, SCIENCE, V358, P69, DOI 10.1126/science.aan6826; Page N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21109-3; Saadey A., CANC IMMUNOLOGY IMMU; Thucydides B., 1881, HIST PELOPONNESIAN W; Tonnerre P, 2021, NAT IMMUNOL, V22, P1030, DOI 10.1038/s41590-021-00982-6; Yates KB, 2021, NAT IMMUNOL, V22, P1020, DOI 10.1038/s41590-021-00979-1; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144	12	1	1	2	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					938	940		10.1038/s41590-021-00977-3	http://dx.doi.org/10.1038/s41590-021-00977-3			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34312546				2022-12-18	WOS:000677755900002
J	Chevre, R; Soehnlein, O				Chevre, Raphael; Soehnlein, Oliver			Neutrophil life in three acts: a production by different stage directors	NATURE IMMUNOLOGY			English	Editorial Material								Analysis of the transcriptional landscape of inflammatory neutrophils discloses specific transcription factor engagement at the bone marrow-to-blood and the blood-to-tissue transitions.	[Chevre, Raphael; Soehnlein, Oliver] WWU Munster, Ctr Mol Biol Inflammat ZMBE, Inst Expt Pathol ExPat, Munster, Germany; [Soehnlein, Oliver] Karolinska Inst, Dept Physiol & Pharmacol FyFa, Stockholm, Sweden	University of Munster; Karolinska Institutet	Chevre, R; Soehnlein, O (corresponding author), WWU Munster, Ctr Mol Biol Inflammat ZMBE, Inst Expt Pathol ExPat, Munster, Germany.; Soehnlein, O (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol FyFa, Stockholm, Sweden.	raphael.chevre@uni-muenster.de; soehnlein@uni-muenster.de						Bajrami B, 2016, J EXP MED, V213, P1999, DOI 10.1084/jem.20160393; Ballesteros I, 2020, CELL, V183, P1282, DOI 10.1016/j.cell.2020.10.003; Borregaard N, 2007, TRENDS IMMUNOL, V28, P340, DOI 10.1016/j.it.2007.06.002; Ecker S, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1156-8; Ferraro B, 2019, J AM COLL CARDIOL, V73, P2990, DOI 10.1016/j.jacc.2019.03.503; Grassi L, 2018, CELL REP, V24, P2784, DOI 10.1016/j.celrep.2018.08.018; Grieshaber-Bouyer R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-22973-9; Khoyratty TE, 2021, NAT IMMUNOL, V22, P1093, DOI 10.1038/s41590-021-00968-4; Silvestre-Roig C, 2016, BLOOD, V127, P2173, DOI 10.1182/blood-2016-01-688887; Xie XM, 2020, NAT IMMUNOL, V21, P1119, DOI 10.1038/s41590-020-0736-z	10	1	1	2	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1072	1074		10.1038/s41590-021-00997-z	http://dx.doi.org/10.1038/s41590-021-00997-z		JUL 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34326535				2022-12-18	WOS:000679302800003
J	Groom, JR				Groom, Joanna R.			Diversity in science requires mentoring for all, by all	NATURE IMMUNOLOGY			English	Editorial Material									[Groom, Joanna R.] Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia; [Groom, Joanna R.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne	Groom, JR (corresponding author), Walter & Eliza Hall Inst Med Res, Div Immunol, Parkville, Vic, Australia.; Groom, JR (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	groom@wehi.edu.au		Groom, Joanna/0000-0001-5251-7835	Department of Health | National Health and Medical Research Council (NHMRC) [GNT1182649, GNT1137989] Funding Source: Medline	Department of Health | National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia)			0	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2021	22	9					1065	1065		10.1038/s41590-021-00999-x	http://dx.doi.org/10.1038/s41590-021-00999-x		JUL 2021	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	UJ0BE	34326536				2022-12-18	WOS:000679302800001
J	Boi, SK; Lan, X; Youngblood, B				Boi, Shannon K.; Lan, Xin; Youngblood, Ben			BATF targets T cell exhaustion for termination	NATURE IMMUNOLOGY			English	Editorial Material								New reports provide further insight into the role of the transcription factor BATF in pivoting the differentiation of CD8(+) T cells away from T cell exhaustion and facilitating the transition of these cells into potent effectors.	[Boi, Shannon K.; Lan, Xin; Youngblood, Ben] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA; [Lan, Xin] Univ Tennessee, Ctr Hlth Sci, Coll Grad Hlth Sci, Memphis, TN 38163 USA	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	Youngblood, B (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	Benjamin.Youngblood@stjude.org			National Institutes of Health [R01AI114442, R01CA237311, F32CA250155-01A1]; American Lebanese Syrian Associated Charities (ALSAC)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC))	This work was supported by the National Institutes of Health R01AI114442 and R01CA237311 to B.Y. and F32CA250155-01A1 to S.K.B. and by the American Lebanese Syrian Associated Charities (ALSAC) to B.Y. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Chen Y, 2021, Nat. Immunol, DOI 10.1038/s41590-021-00965-7; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Man K, 2017, IMMUNITY, V47, P1129, DOI 10.1016/j.immuni.2017.11.021; Quigley M, 2010, NAT MED, V16, P1147, DOI 10.1038/nm.2232; Seo H, 2021, Nat. Immunol, DOI 10.1038/s41590-021-00964-8; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; Wei J, 2019, NATURE, V576, P471, DOI 10.1038/s41586-019-1821-z; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zheng WT, 2021, BLOOD, V138, P122, DOI 10.1182/blood.2020009309	14	1	1	2	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					936	938		10.1038/s41590-021-00978-2	http://dx.doi.org/10.1038/s41590-021-00978-2		JUL 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34282328				2022-12-18	WOS:000674567000004
J	Ma, YT				Ma, Yuting			Tpt1 the balance toward immunosuppression upon cell death	NATURE IMMUNOLOGY			English	Editorial Material								By engaging Toll-like receptor 2, translationally controlled tumor protein (TCTP) released from necrotic tumor cells can switch on an immunosuppressive network of monocytic and polymorphonuclear myeloid-derived suppressor cells to block antitumor immunity.	[Ma, Yuting] Chinese Acad Med Sci, Inst Syst Med, Beijing, Peoples R China; [Ma, Yuting] Peking Union Med Coll, Beijing, Peoples R China; [Ma, Yuting] Suzhou Inst Syst Med, Suzhou, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Ma, YT (corresponding author), Chinese Acad Med Sci, Inst Syst Med, Beijing, Peoples R China.; Ma, YT (corresponding author), Peking Union Med Coll, Beijing, Peoples R China.; Ma, YT (corresponding author), Suzhou Inst Syst Med, Suzhou, Peoples R China.	yuting_ma1984@163.com						Ahrens S, 2012, IMMUNITY, V36, P635, DOI 10.1016/j.immuni.2012.03.008; Bommer Ulrich-Axel, 2017, Results Probl Cell Differ, V64, P69, DOI 10.1007/978-3-319-67591-6_4; Bommer UA, 2017, CELL COMMUN SIGNAL, V15, DOI 10.1186/s12964-017-0164-3; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Hangai S, 2021, NAT IMMUNOL, V22, P947, DOI 10.1038/s41590-021-00967-5; Hangai S, 2016, P NATL ACAD SCI USA, V113, P3844, DOI 10.1073/pnas.1602023113; Ma YT, 2017, IMMUNOL REV, V280, P194, DOI 10.1111/imr.12586; Seifert L, 2016, NATURE, V532, P245, DOI 10.1038/nature17403; Sterle HA, 2019, BRIT J CANCER, V120, P128, DOI 10.1038/s41416-018-0173-z; Yang XD, 2011, NAT MED, V17, P87, DOI 10.1038/nm.2278; Yatim N, 2017, NAT REV IMMUNOL, V17, P262, DOI 10.1038/nri.2017.9; Yee PP, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19193-y	12	1	1	2	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					940	942		10.1038/s41590-021-00986-2	http://dx.doi.org/10.1038/s41590-021-00986-2		JUL 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34282332				2022-12-18	WOS:000674567000001
J	Block, KE; Jameson, SC				Block, Katharine E.; Jameson, Stephen C.			Inflating the role of stromal cells in CD8(+) T cell memory	NATURE IMMUNOLOGY			English	Editorial Material								Lung fibroblastic stromal cells support inflating memory CD8(+) T cells after vaccination with an adenovirus vector through the creation of organized lymphoid structures that support the metabolic fitness of these expanded antigen-specific T cells.	[Block, Katharine E.; Jameson, Stephen C.] Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Jameson, SC (corresponding author), Univ Minnesota, Sch Med, Dept Lab Med & Pathol, Ctr Immunol, Minneapolis, MN 55455 USA.	james024@umn.edu	Jameson, Stephen C/D-9892-2013	Jameson, Stephen C/0000-0001-9137-1146; Block, Katharine/0000-0001-9488-3577				[Anonymous], 2020, LANCET, V396, P1861, DOI 10.1016/S0140-6736(20)32662-3; Bolinger B, 2013, J IMMUNOL, V190, P4162, DOI 10.4049/jimmunol.1202665; Bonilla WV, 2012, SCIENCE, V335, P984, DOI 10.1126/science.1215418; Coughlan L, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00909; Cupovic J, 2021, NAT IMMUNOL, V22, P1042, DOI 10.1038/s41590-021-00969-3; Gebre MS, 2021, CELL, V184, P1589, DOI 10.1016/j.cell.2021.02.030; Hansen SG, 2011, NATURE, V473, P523, DOI 10.1038/nature10003; Klenerman P, 2016, NAT REV IMMUNOL, V16, P367, DOI 10.1038/nri.2016.38; Krishnamurty AT, 2020, NAT IMMUNOL, V21, P369, DOI 10.1038/s41590-020-0635-3; McLaren JE, 2019, J IMMUNOL, V202, P943, DOI 10.4049/jimmunol.1701757; Quinn M, 2016, IMMUNOTHERAPY-UK, V8, P211, DOI 10.2217/imt.15.110; Torti N, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002313	12	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					942	944		10.1038/s41590-021-00974-6	http://dx.doi.org/10.1038/s41590-021-00974-6		JUL 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34267376	Bronze			2022-12-18	WOS:000673826600003
J	Antanaviciute, A; Fawkner-Corbett, D; Simmons, A				Antanaviciute, Agne; Fawkner-Corbett, David; Simmons, Alison			Common heritage of fibroblasts	NATURE IMMUNOLOGY			English	Editorial Material								Meta-analysis of single-cell RNA sequencing datasets identifies core fibroblasts present in all organs that may give rise to more specialized organ-specific subtypes.	[Antanaviciute, Agne; Fawkner-Corbett, David; Simmons, Alison] Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med WIMM, Med Res Council MRC,Human Immunol Unit, Oxford, England; [Antanaviciute, Agne] Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med WIMM, MRC WIMM Ctr Computat Biol, Oxford, England; [Fawkner-Corbett, David] Univ Oxford, Nuffield Dept Surg Sci, Acad Paediat Surg Unit APSU, Oxford, England; [Simmons, Alison] John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Simmons, A (corresponding author), Univ Oxford, John Radcliffe Hosp, MRC Weatherall Inst Mol Med WIMM, Med Res Council MRC,Human Immunol Unit, Oxford, England.; Simmons, A (corresponding author), John Radcliffe Hosp, Translat Gastroenterol Unit, Oxford, England.	alison.simmons@imm.ox.ac.uk		Simmons, Alison/0000-0003-3454-0710	Medical Research Council [MC_PC_MR/S025952/1, MC_UU_12010/7, MC_UU_00008/7, MR/S036377/1] Funding Source: Medline; Wellcome Trust [219523/Z/19/Z] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Buechler MB, 2021, NATURE, V593, P575, DOI 10.1038/s41586-021-03549-5; Cao JY, 2020, SCIENCE, V370, P808, DOI 10.1126/science.aba7721; Croft AP, 2019, NATURE, V570, P246, DOI 10.1038/s41586-019-1263-7; Elmentaite R, 2020, DEV CELL, V55, P771, DOI 10.1016/j.devcel.2020.11.010; Fawkner-Corbett D, 2021, CELL, V184, P810, DOI 10.1016/j.cell.2020.12.016; Holloway EM, 2021, CELL STEM CELL, V28, P568, DOI 10.1016/j.stem.2020.11.008; Kinchen J, 2018, CELL, V175, P372, DOI 10.1016/j.cell.2018.08.067; Koliaraki V, 2020, NAT IMMUNOL, V21, P974, DOI 10.1038/s41590-020-0741-2; Muhl, 2020, NAT COMMUN, V11; Shoshkes-Carmel M, 2018, NATURE, V557, P242, DOI 10.1038/s41586-018-0084-4	10	1	1	1	3	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2021	22	8					944	946		10.1038/s41590-021-00981-7	http://dx.doi.org/10.1038/s41590-021-00981-7		JUL 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	TP7DL	34262171				2022-12-18	WOS:000673483900001
J	Fercoq, F; Carlin, LM				Fercoq, Frederic; Carlin, Leo M.			"Mind the GAP": RGS1 hinders antitumor lymphocytes	NATURE IMMUNOLOGY			English	Editorial Material							CELL THERAPY; CANCER	Effective anticancer adoptive cellular therapy (ACT) requires sufficient infiltration of injected cytotoxic lymphocytes, but pathophysiology frustrates this. Regulator of G protein signaling 1 limits T cell trafficking to breast tumors and may be targeted to improve ACT.	[Fercoq, Frederic; Carlin, Leo M.] Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland; [Carlin, Leo M.] Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland	Beatson Institute; University of Glasgow	Fercoq, F; Carlin, LM (corresponding author), Canc Res UK Beatson Inst, Glasgow, Lanark, Scotland.; Carlin, LM (corresponding author), Univ Glasgow, Inst Canc Sci, Glasgow, Lanark, Scotland.	f.fercoq@beatson.gla.ac.uk; leo.carlin@glasgow.ac.uk	Carlin, Leo Marc/E-3434-2012; Fercoq, Frederic/AAS-1636-2020	Carlin, Leo Marc/0000-0001-7172-5234; Fercoq, Frederic/0000-0002-4825-024X	Cancer Research UK (CRUK) [A31287] Funding Source: Medline; Breast Cancer Now (BCN) [2019DecPR1424] Funding Source: Medline	Cancer Research UK (CRUK)(Cancer Research UK); Breast Cancer Now (BCN)		Ager A, 2016, BIOCHEM SOC T, V44, P377, DOI 10.1042/BST20150254; Bonifant CL, 2016, MOL THER-ONCOLYTICS, V3, DOI 10.1038/mto.2016.11; Dieci MV, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10020223; George T, 2018, ALLERGY ASTHMA CL IM, V14, DOI 10.1186/s13223-018-0266-5; Huang D, 2021, NAT IMMUNOL, V22, P865, DOI 10.1038/s41590-021-00939-9; Jin LC, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11869-4; Khalil DN, 2016, NAT REV CLIN ONCOL, V13, P273, DOI 10.1038/nrclinonc.2016.25; Kubli SP, 2021, NAT REV DRUG DISCOV, V20, P899, DOI 10.1038/s41573-021-00155-y; Liu YT, 2021, THERANOSTICS, V11, P5365, DOI 10.7150/thno.58390; Liu ZG, 2019, TRENDS PHARMACOL SCI, V40, P613, DOI 10.1016/j.tips.2019.07.001; Patel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7614; Templeton AJ, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju124; Zhao LJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02250	13	1	1	1	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2021	22	7					802	804		10.1038/s41590-021-00961-x	http://dx.doi.org/10.1038/s41590-021-00961-x		JUN 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SZ5TQ	34140677				2022-12-18	WOS:000662827000003
J	Kragesteen, BK; Amit, I				Kragesteen, Bjort K.; Amit, Ido			Heads or tails: histone tail clipping regulates macrophage activity	NATURE IMMUNOLOGY			English	Editorial Material							NEUTROPHIL SERINE PROTEASES; EPIGENETIC LANDSCAPE		[Kragesteen, Bjort K.; Amit, Ido] Weizmann Inst Sci, Dept Immunol, Rehovot, Israel	Weizmann Institute of Science	Kragesteen, BK; Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, Rehovot, Israel.	Bjort.kragesteen@weizmann.ac.il; Ido.amit@weizmann.ac.il						Cheung P, 2021, NAT IMMUNOL, V22, P711, DOI 10.1038/s41590-021-00928-y; Cheung P, 2018, CELL, V173, P1385, DOI 10.1016/j.cell.2018.03.079; Ferrari KJ, 2021, NUCLEIC ACIDS RES, V49, DOI 10.1093/nar/gkaa1228; Meyer-Hoffert U, 2011, CURR OPIN HEMATOL, V18, P19, DOI 10.1097/MOH.0b013e32834115d1; Musselman CA, 2012, NAT STRUCT MOL BIOL, V19, P1218, DOI 10.1038/nsmb.2436; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Santos-Rosa H, 2009, NAT STRUCT MOL BIOL, V16, P17, DOI 10.1038/nsmb.1534; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Vossaert L, 2014, STEM CELL RES, V13, P123, DOI 10.1016/j.scr.2014.05.002; Yasin S, 2018, CURR OPIN RHEUMATOL, V30, P514, DOI 10.1097/BOR.0000000000000526	10	1	1	0	8	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2021	22	6					678	680		10.1038/s41590-021-00941-1	http://dx.doi.org/10.1038/s41590-021-00941-1		MAY 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	SI9TE	34017123				2022-12-18	WOS:000652579200002
J	Wilson, EN; Andreasson, KI				Wilson, Edward N.; Andreasson, Katrin I.			TAM-ping down amyloid in Alzheimer's disease	NATURE IMMUNOLOGY			English	Editorial Material							MICROGLIA		[Wilson, Edward N.; Andreasson, Katrin I.] Stanford Univ, Dept Neurol, Stanford, CA 94305 USA; [Andreasson, Katrin I.] Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA; [Andreasson, Katrin I.] Stanford Univ, Program Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Andreasson, KI (corresponding author), Stanford Univ, Dept Neurol, Stanford, CA 94305 USA.; Andreasson, KI (corresponding author), Stanford Univ, Wu Tsai Neurosci Inst, Stanford, CA 94305 USA.; Andreasson, KI (corresponding author), Stanford Univ, Program Immunol, Stanford, CA 94305 USA.	kandreas@stanford.edu	Wilson, Edward/AFJ-8275-2022	Wilson, Edward/0000-0003-0640-5247	NIH/NIA [1P30 AG066515, RF1 AG053001]	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors are funded by grant nos. NIH/NIA 1P30 AG066515 (K.I.A.), NIH/NIA RF1 AG053001 (K.I.A.) and a Dean's Fellowship (E.N.W.).	Fourgeaud L, 2016, NATURE, V532, P240, DOI 10.1038/nature17630; Haass C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006270; Huang YT, 2021, NAT IMMUNOL, V22, P586, DOI 10.1038/s41590-021-00913-5; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Lew ED, 2014, ELIFE, V3, DOI 10.7554/eLife.03385; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Mattsson N, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.69; Roy ER, 2020, J CLIN INVEST, V130, P1912, DOI 10.1172/JCI133737; Sosna J, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0244-x; Suzuki J, 2016, P NATL ACAD SCI USA, V113, P9509, DOI 10.1073/pnas.1610403113; Wang YM, 2016, J EXP MED, V213, P667, DOI 10.1084/jem.20151948	11	1	1	0	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					543	544		10.1038/s41590-021-00918-0	http://dx.doi.org/10.1038/s41590-021-00918-0		APR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33859407	Green Accepted			2022-12-18	WOS:000640493700002
J	Tsiodras, S				Tsiodras, Sotirios			COVID-19 research and science in the service of public health: the example of Greece	NATURE IMMUNOLOGY			English	Editorial Material								The COVID-19 response in Greece has been swift and flexible, adapting to the evolving pandemic and creating unique opportunities for research.	[Tsiodras, Sotirios] Natl & Kapodistrian Univ Athens, Sch Med, Dept Internal Med 4, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens	Tsiodras, S (corresponding author), Natl & Kapodistrian Univ Athens, Sch Med, Dept Internal Med 4, Athens, Greece.	sotirios.tsiodras@gmail.com		Tsiodras, Sotirios/0000-0002-0463-4321					0	1	1	1	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2021	22	5					531	532		10.1038/s41590-021-00919-z	http://dx.doi.org/10.1038/s41590-021-00919-z		APR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RX5JV	33850323	Bronze			2022-12-18	WOS:000639790500001
J	Cane, S; Bronte, V				Cane, Stefania; Bronte, Vincenzo			Wnt-beta-catenin as an epigenetic switcher in colonic T-reg cells	NATURE IMMUNOLOGY			English	Editorial Material								In the colonic environment, sustained Wnt-beta-catenin activation in regulatory T cells promotes epigenetic rewiring toward proinflammatory ROR gamma t(+) T-reg cells, whose expansion parallels the disease progression from inflammatory bowel disease (IBD) to manifest colorectal cancer (CRC).	[Cane, Stefania; Bronte, Vincenzo] Univ Verona, Dept Med, Sect Immunol, Verona, Italy	University of Verona	Cane, S; Bronte, V (corresponding author), Univ Verona, Dept Med, Sect Immunol, Verona, Italy.	stefania.cane@univr.it; vincenzo.bronte@univr.it		Cane, Stefania/0000-0003-4324-4681	Fondazione Cariverona; Fondazione AIRC [23788]; Cancer Research Institute (Clinic and Laboratory Integration Program, CLIP 2020); European Research Commission (Euronanomed III, Joint Translational Call_2017, Project RESOLVE); PRIN program of MIUR [CUP: B38D19000260006]	Fondazione Cariverona(Fondazione Cariverona); Fondazione AIRC(Fondazione AIRC per la ricerca sul cancro); Cancer Research Institute (Clinic and Laboratory Integration Program, CLIP 2020); European Research Commission (Euronanomed III, Joint Translational Call_2017, Project RESOLVE); PRIN program of MIUR(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Fondazione Cariverona, the Fondazione AIRC (23788), Cancer Research Institute (Clinic and Laboratory Integration Program, CLIP 2020), the European Research Commission (Euronanomed III, Joint Translational Call_2017, Project RESOLVE) and by the PRIN program of MIUR (CUP: B38D19000260006).	Blatner NR, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004566; Hong Y, 2015, CANCER RES, V75, P656, DOI 10.1158/0008-5472.CAN-14-2377; Levine AG, 2017, NATURE, V546, P421, DOI 10.1038/nature22360; Luke JJ, 2019, CLIN CANCER RES, V25, P3074, DOI 10.1158/1078-0432.CCR-18-1942; Ohnmacht C, 2015, SCIENCE, V349, P989, DOI 10.1126/science.aac4263; Quandt J, 2021, NAT IMMUNOL, V22, P471, DOI 10.1038/s41590-021-00889-2; Sefik E, 2015, SCIENCE, V349, P993, DOI 10.1126/science.aaa9420; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; van Loosdregt J, 2013, IMMUNITY, V39, P298, DOI 10.1016/j.immuni.2013.07.019	10	1	1	4	9	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					400	401		10.1038/s41590-021-00904-6	http://dx.doi.org/10.1038/s41590-021-00904-6		MAR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33753943				2022-12-18	WOS:000631489400003
J	Gower, M; Foster, G; Tikhonova, AN				Gower, Mark; Foster, Gena; Tikhonova, Anastasia N.			There won'T be blood	NATURE IMMUNOLOGY			English	Editorial Material								Riok2 haploinsufficiency leads to aberrant T(H)22 skewing and interleukin-22-mediated erythroid dysfunction.	[Gower, Mark] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON, Canada; [Gower, Mark] Univ Toronto, Dept Immunol, Toronto, ON, Canada; [Foster, Gena] Yale Sch Med, Dept Med Oncol, New Haven, CT USA; [Foster, Gena] Yale Sch Med, Dept Immunobiol, New Haven, CT USA; [Tikhonova, Anastasia N.] Univ Hlth Network Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; Yale University; Yale University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Tikhonova, AN (corresponding author), Univ Hlth Network Toronto, Princess Margaret Canc Ctr, Toronto, ON, Canada.	Anastasia.Tikhonova@uhnresearch.ca		Foster, Gena Gora/0000-0003-3482-0579; Tikhonova, Anastasia/0000-0001-6712-1606				Ades L, 2014, LANCET, V383, P2239, DOI 10.1016/S0140-6736(13)61901-7; Balducci L, 2006, CANCER, V106, P2087, DOI 10.1002/cncr.21860; Bhagat TD, 2013, BLOOD, V121, P2875, DOI 10.1182/blood-2011-12-397067; Dutt S, 2011, BLOOD, V117, P2567, DOI 10.1182/blood-2010-07-295238; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Giagounidis AAN, 2006, CLIN CANCER RES, V12, P5, DOI 10.1158/1078-0432.CCR-05-1437; Raundhal M, 2021, NAT IMMUNOL, V22, P520, DOI 10.1038/s41590-021-00895-4; Schneider RK, 2016, NAT MED, V22, P288, DOI 10.1038/nm.4047; Stahl M, 2020, HAEMATOLOGICA, V105, P102, DOI 10.3324/haematol.2019.219345; Stahl M, 2017, CANCER-AM CANCER SOC, V123, P1703, DOI 10.1002/cncr.30585; Wolk K, 2006, CYTOKINE GROWTH F R, V17, P367, DOI 10.1016/j.cytogfr.2006.09.001; Zhang DB, 2020, SCI ADV MATER, V12, P1, DOI 10.1166/sam.2020.3712	12	1	1	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2021	22	4					396	397		10.1038/s41590-021-00893-6	http://dx.doi.org/10.1038/s41590-021-00893-6		MAR 2021	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	RH1GX	33753941				2022-12-18	WOS:000631489400001
J	Cagdas, D				Cagdas, Deniz			Living the SARS-CoV-2 pandemic in Turkey	NATURE IMMUNOLOGY			English	Editorial Material								To cope with the new situation during the pandemic, the Turkish people have united in the fight against SARS-CoV-2 with their healthcare workers, scientists and government. We are waiting for the global pandemic to end soon.	[Cagdas, Deniz] Hacettepe Univ, Sect Pediat Immunol, Ihsan Dogramaci Childrens Hosp, Dept Pediat,Inst Child Hlth,Med Sch, Ankara, Turkey	Hacettepe University	Cagdas, D (corresponding author), Hacettepe Univ, Sect Pediat Immunol, Ihsan Dogramaci Childrens Hosp, Dept Pediat,Inst Child Hlth,Med Sch, Ankara, Turkey.	deniz.ayvaz@hacettepe.edu.tr	Cagdas, Deniz/I-9104-2013	Cagdas, Deniz/0000-0003-2213-4627					0	1	1	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					260	260		10.1038/s41590-021-00887-4	http://dx.doi.org/10.1038/s41590-021-00887-4			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33627882	Bronze			2022-12-18	WOS:000621567200004
J	Lefebvre, MN; Harty, JT				Lefebvre, Mitchell N.; Harty, John T.			gamma delta T cells burst malaria's bubble	NATURE IMMUNOLOGY			English	Editorial Material								New research demonstrates that gamma delta T cells recognize Plasmodium-infected erythrocytes via interaction of the T cell antigen receptor with the phosphoantigen sensor BTN3A1 and subsequently destroy infected cells through either cytotoxic molecule secretion or antibody-dependent phagocytosis.	[Lefebvre, Mitchell N.; Harty, John T.] Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA; [Harty, John T.] Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA	University of Iowa; University of Iowa	Harty, JT (corresponding author), Univ Iowa, Interdisciplinary Grad Program Immunol, Iowa City, IA 52242 USA.; Harty, JT (corresponding author), Univ Iowa, Dept Pathol, Iowa City, IA 52242 USA.	john-harty@uiowa.edu		LeFebvre, Mitchell/0000-0002-7641-7043				[Anonymous], 2012, Wkly Epidemiol Rec, V87, P1; Costa G, 2011, BLOOD, V118, P6952, DOI 10.1182/blood-2011-08-376111; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; Crutcher J. M., 1996, MED MICROBIOLOGY; Farrington LA, 2016, J INFECT DIS, V213, P1483, DOI 10.1093/infdis/jiv600; Guenot M, 2015, INFECT IMMUN, V83, P3816, DOI 10.1128/IAI.00446-15; Hernandez-Castaneda MA, 2020, J IMMUNOL, V204, P1798, DOI 10.4049/jimmunol.1900725; Ishizuka AS, 2016, NAT MED, V22, P614, DOI 10.1038/nm.4110; Junqueira C, 2021, NAT IMMUNOL, V22, P347, DOI 10.1038/s41590-020-00847-4; Lawand M, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00761; Long CA, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a025577; Zaidi I, 2017, J IMMUNOL, V199, P3781, DOI 10.4049/jimmunol.1700314	12	1	1	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2021	22	3					270	272		10.1038/s41590-021-00879-4	http://dx.doi.org/10.1038/s41590-021-00879-4		FEB 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	QM1VU	33547458				2022-12-18	WOS:000615116800001
J	Hatinguais, R; Brown, GD				Hatinguais, Remi; Brown, Gordon D.			Cross-presentation is getting DNGRous	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR; DNGR-1	Following internalization of an actin-bearing ligand, the C-type lectin receptor DNGR-1 promotes phagosome rupture, allowing antigens to access the cytosol and be processed through the MHC-I pathway.	[Hatinguais, Remi; Brown, Gordon D.] Univ Exeter, MRC, Ctr Med Mycol, Exeter, Devon, England	University of Exeter	Hatinguais, R; Brown, GD (corresponding author), Univ Exeter, MRC, Ctr Med Mycol, Exeter, Devon, England.	rh648@exeter.ac.uk; Gordon.brown@exeter.ac.uk		Hatinguais, Remi/0000-0001-5978-6667	MRC [MR/N006364/2] Funding Source: UKRI; Medical Research Council [MR/N006364/2] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Balam S, 2020, EUR J IMMUNOL, V50, P2041, DOI 10.1002/eji.201948501; Canton J, 2021, NAT IMMUNOL, V22, P140, DOI 10.1038/s41590-020-00824-x; Cruz FM, 2017, ANNU REV IMMUNOL, V35, P149, DOI 10.1146/annurev-immunol-041015-055254; Cueto FJ, 2020, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.03146; del Fresno C, 2018, SCIENCE, V362, P351, DOI 10.1126/science.aan8423; Dingjan I, 2016, SCI REP-UK, V6, DOI 10.1038/srep22064; Hanc P, 2016, EMBO J, V35, P2484, DOI 10.15252/embj.201694695; Iborra S, 2012, J CLIN INVEST, V122, P1628, DOI 10.1172/JCI60660; Ma J, 2012, J BIOL CHEM, V287, P34149, DOI 10.1074/jbc.M112.382812; Mastelic-Gavillet B, 2020, EUR J CANCER, V135, P173, DOI 10.1016/j.ejca.2020.04.036; Salazar F, 2018, J INNATE IMMUN, V10, P373, DOI 10.1159/000488539; Sancho D, 2009, NATURE, V458, P899, DOI 10.1038/nature07750; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035	13	1	1	1	5	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					108	110		10.1038/s41590-020-00831-y	http://dx.doi.org/10.1038/s41590-020-00831-y		JAN 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33398180				2022-12-18	WOS:000604865800002
J	Yu, CY; Ardoin, SP				Yu, Chack-Yung; Ardoin, Stacy P.			Complement inhibitor for therapy of CHAPLE	NATURE IMMUNOLOGY			English	Editorial Material							CD55	A new study shows successful immunotherapy of a detrimental gastrointestinal disease using the complement inhibitor eculizumab.	[Yu, Chack-Yung] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH 43205 USA; [Yu, Chack-Yung] Nationwide Childrens Hosp, Div Rheumatol, Columbus, OH 43205 USA; [Yu, Chack-Yung; Ardoin, Stacy P.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA; [Ardoin, Stacy P.] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Ardoin, Stacy P.] Nationwide Childrens Hosp, Div Rheumatol, Columbus, OH 43205 USA; [Ardoin, Stacy P.] Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University	Yu, CY (corresponding author), Nationwide Childrens Hosp, Abigail Wexner Res Inst, Columbus, OH 43205 USA.; Yu, CY (corresponding author), Nationwide Childrens Hosp, Div Rheumatol, Columbus, OH 43205 USA.; Yu, CY; Ardoin, SP (corresponding author), Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA.; Ardoin, SP (corresponding author), Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA.; Ardoin, SP (corresponding author), Nationwide Childrens Hosp, Div Rheumatol, Columbus, OH 43205 USA.; Ardoin, SP (corresponding author), Wexner Med Ctr, Columbus, OH 43210 USA.	chack-yung.yu@nationwidechildrens.org; Stacy.Ardoin@osumc.edu		Yu, Chack-Yung/0000-0002-5218-7503	National Institute of Arthritis Musculoskeletal and Skin Disease grant [R01 AR073311]; National Institutes of Health	National Institute of Arthritis Musculoskeletal and Skin Disease grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors are supported by a National Institute of Arthritis Musculoskeletal and Skin Disease grant (R01 AR073311) from the National Institutes of Health.	Dho SH, 2018, IMMUNE NETW, V18, DOI 10.4110/in.2018.18.e11; DiScipio RG., 2018, COMPLEMENT FACTSBOOK, VSecond Edition, P221; Ekdahl KN, 2016, IMMUNOL REV, V274, P245, DOI 10.1111/imr.12471; Kamitaki N, 2020, NATURE, V582, P577, DOI 10.1038/s41586-020-2277-x; Kurolap A, 2017, NEW ENGL J MED, V377, P87, DOI 10.1056/NEJMc1707173; LACHMANN PJ, 1991, IMMUNOL TODAY, V12, P312, DOI 10.1016/0167-5699(91)90005-E; Lintner KE, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00036; LUBLIN DM, 1989, ANNU REV IMMUNOL, V7, P35, DOI 10.1146/annurev.immunol.7.1.35; Mulvihill E, 2019, LUPUS SCI MED, V6, DOI 10.1136/lupus-2019-000333; Ozen A, 2021, NAT IMMUNOL, V22, P128, DOI 10.1038/s41590-020-00830-z; Ozen A, 2017, NEW ENGL J MED, V377, P52, DOI 10.1056/NEJMoa1615887; Savelli SL, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00885	12	1	1	1	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2021	22	2					106	108		10.1038/s41590-020-00842-9	http://dx.doi.org/10.1038/s41590-020-00842-9		JAN 2021	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PX8XN	33398184	Green Accepted			2022-12-18	WOS:000604865800003
J	Hartl, FA; Beck-Garcia, E; Woessner, NM; Flachsmann, LJ; Cardenas, RMHV; Brandl, SM; Taromi, S; Fiala, GJ; Morath, A; Mishra, P; Yousefi, OS; Zimmermann, J; Hoefflin, N; Kohn, M; Wohrl, BM; Zeiser, R; Schweimer, K; Gunther, S; Schamel, WW; Minguet, S				Hartl, Frederike A.; Beck-Garcia, Esmeralda; Woessner, Nadine M.; Flachsmann, Lea J.; Cardenas, Rubi M. -H. Velasco; Brandl, Simon M.; Taromi, Sanaz; Fiala, Gina J.; Morath, Anna; Mishra, Pankaj; Yousefi, O. Sascha; Zimmermann, Julia; Hoefflin, Nico; Koehn, Maja; Woehrl, Birgitta M.; Zeiser, Robert; Schweimer, Kristian; Guenther, Stefan; Schamel, Wolfgang W.; Minguet, Susana			Noncanonical binding of Lck to CD3 epsilon promotes TCR signaling and CAR function (vol 21, pg 902, 2020)	NATURE IMMUNOLOGY			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				susana.minguet@biologie.uni-freiburg.de	Köhn, Maja/G-5131-2012	Köhn, Maja/0000-0001-8142-3504; Zeiser, Robert/0000-0001-6565-3393; Schweimer, Kristian/0000-0002-3837-8442; Minguet, Susana/0000-0001-8211-5538				Hartl FA, 2020, NAT IMMUNOL, V21, P902, DOI 10.1038/s41590-020-0732-3	1	1	1	0	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2021	22	1					100	101		10.1038/s41590-020-00843-8	http://dx.doi.org/10.1038/s41590-020-00843-8		NOV 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	PG2HK	33214721	Bronze			2022-12-18	WOS:000590958200002
J	Rao, A				Rao, Anjana			Scientific divagations: from signaling and transcription to chromatin changes in T cells	NATURE IMMUNOLOGY			English	Article							GENE-EXPRESSION; FACTOR NFAT; DIFFERENTIATION; CALCINEURIN; CALCIUM; FAMILY; LOCUS; BINDING; ORAI1; FOS	Anjana Rao describes the team effort to define the changes in chromatin accessibility in naive T cells during T(H)1 and T(H)2 cell differentiation after stimulation with TCR ligands and the appropriate cytokines. Her lab showed that differentiated T(H)1 and T(H)2 cells, which produce the cytokines IFN-gamma and IL-4, respectively, displayed distinct patterns of DNase I hypersensitivity, histone acetylation and NFAT1 transcription factor binding around the Ifng and Il4 genes. This project turned them into a 'real' immunology lab!	[Rao, Anjana] La Jolla Inst Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA	La Jolla Institute for Immunology	Rao, A (corresponding author), La Jolla Inst Immunol, Div Signaling & Gene Express, La Jolla, CA 92037 USA.	arao@lji.org		Rao, Anjana/0000-0002-1870-1775	US National Institutes of Health	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	I thank all the members of our labs - students, postdocs, technicians and administrative folks - who have contributed to these various projects over the years. Special thanks to Suneet Agarwal, who delved fearlessly into unfamiliar fields to initiate what was at the time a rather high risk project; provided help and advice to two new graduate students, Debbie Solymar and Dong Lee; and bequeathed us some interesting gene-disrupted mice for Mark Ansel and Debbie Solymar to investigate in later years. Special thanks also to Orly Avni, who gamely (and successfully) struggled with chromatin immunoprecipitation at a time when very few people had mastered this still difficult technique. Thanks to Mark Ansel, who took the gene-disrupted mice off my hands and continued to analyze them when he set up his own lab at UCSF (we were both a little tired of the project by that time). Finally, we are grateful to the US National Institutes of Health for funding the research; typically, however, the applications were funded after the discoveries had all been made, and the study sections took pains to ensure that any post-discovery funding was strictly for pedestrian extensions of the original research.	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Agarwal S, 1998, CURR OPIN IMMUNOL, V10, P345, DOI 10.1016/S0952-7915(98)80174-X; Agarwal S, 2000, IMMUNITY, V12, P643, DOI 10.1016/S1074-7613(00)80215-0; Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135; Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Carey M, 1998, CELL, V92, P5, DOI 10.1016/S0092-8674(00)80893-4; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Chen L, 1998, NATURE, V392, P42, DOI 10.1038/32100; COCKERILL PN, 1993, P NATL ACAD SCI USA, V90, P2466, DOI 10.1073/pnas.90.6.2466; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; FLANAGAN WM, 1991, NATURE, V352, P803, DOI 10.1038/352803a0; Grogan JL, 2001, IMMUNITY, V14, P205, DOI 10.1016/S1074-7613(01)00103-0; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Hogan PG, 2010, ANNU REV IMMUNOL, V28, P491, DOI 10.1146/annurev.immunol.021908.132550; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Iwafuchi-Doi M, 2016, DEVELOPMENT, V143, P1833, DOI 10.1242/dev.133900; JAIN JN, 1993, NATURE, V365, P352, DOI 10.1038/365352a0; Janssen A, 2018, ANNU REV CELL DEV BI, V34, P265, DOI 10.1146/annurev-cellbio-100617-062653; Kadonaga JT, 2019, NAT STRUCT MOL BIOL, V26, P766, DOI 10.1038/s41594-019-0278-y; Lee DU, 2002, IMMUNITY, V16, P649, DOI 10.1016/S1074-7613(02)00314-X; Leonard WJ, 2019, IMMUNITY, V50, P832, DOI 10.1016/j.immuni.2019.03.028; Li HM, 2011, TRENDS CELL BIOL, V21, P91, DOI 10.1016/j.tcb.2010.09.011; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Lio CWJ, 2020, J BIOSCIENCES, V45, DOI 10.1007/s12038-019-9973-4; Loots GG, 2000, SCIENCE, V288, P136, DOI 10.1126/science.288.5463.136; Macian F, 2002, CELL, V109, P719, DOI 10.1016/S0092-8674(02)00767-5; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; MCCAFFREY PG, 1993, SCIENCE, V262, P750, DOI 10.1126/science.8235597; Murphy KM, 2000, ANNU REV IMMUNOL, V18, P451, DOI 10.1146/annurev.immunol.18.1.451; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Rao A, 2009, NAT IMMUNOL, V10, P3, DOI 10.1038/ni0109-3; SEDER RA, 1994, ANNU REV IMMUNOL, V12, P635, DOI 10.1146/annurev.iy.12.040194.003223; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Smith CL, 1997, J BIOL CHEM, V272, P27493, DOI 10.1074/jbc.272.44.27493; Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Vijayanand P, 2012, IMMUNITY, V36, P175, DOI 10.1016/j.immuni.2011.12.014	41	1	1	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2020	21	12					1473	1476		10.1038/s41590-020-00823-y	http://dx.doi.org/10.1038/s41590-020-00823-y		NOV 2020	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OT0EL	33173218	Green Accepted			2022-12-18	WOS:000588223400001
J	Zhang, BC; Nandakumar, R; Reinert, LS; Huang, JR; Laustsen, A; Gao, ZL; Sun, CL; Jensen, SB; Troldborg, A; Assil, S; Berthelsen, MF; Scavenius, C; Zhang, Y; Windross, SJ; Olagnier, D; Prabakaran, T; Bodda, C; Narita, R; Cai, YJ; Zhang, CG; Stenmark, H; Doucet, CM; Noda, T; Guo, Z; Goldbach-Mansky, R; Hartmann, R; Chen, ZJJ; Enghild, JJ; Bak, RO; Thomsen, MK; Paludan, SR				Zhang, Bao-cun; Nandakumar, Ramya; Reinert, Line S.; Huang, Jinrong; Laustsen, Anders; Gao, Zong-liang; Sun, Cheng-long; Jensen, Soren Beck; Troldborg, Anne; Assil, Sonia; Berthelsen, Martin F.; Scavenius, Carsten; Zhang, Yan; Windross, Samuel J.; Olagnier, David; Prabakaran, Thaneas; Bodda, Chiranjeevi; Narita, Ryo; Cai, Yujia; Zhang, Cong-gang; Stenmark, Harald; Doucet, Christine M.; Noda, Takeshi; Guo, Zheng; Goldbach-Mansky, Raphaela; Hartmann, Rune; Chen, Zhijian J.; Enghild, Jan J.; Bak, Rasmus O.; Thomsen, Martin K.; Paludan, Soren R.			STEEP mediates STING ER exit and activation of signaling (vol 21, pg 868, 2020)	NATURE IMMUNOLOGY			English	Correction												srp@biomed.au.dk	Stenmark, Harald/B-8868-2008; Bak, Rasmus O./AAH-9748-2021; Bak, Rasmu/GLT-3180-2022; Scavenius, Carsten/Q-5941-2017	Bak, Rasmus O./0000-0002-7383-0297; Bak, Rasmu/0000-0002-8257-8986; Reinert, Line/0000-0002-8317-0886; Olagnier, David/0000-0001-6912-0674; Hartmann, Rune/0000-0003-1159-066X; Prabakaran, Thaneas/0000-0002-4698-7563; Troldborg, Anne/0000-0002-9501-1268; Thomsen, Martin/0000-0002-5055-7531; Scavenius, Carsten/0000-0002-4304-0681	EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) [786602] Funding Source: Medline; Novo Nordisk Fonden (Novo Nordisk Foundation) [NNF18OC0030274] Funding Source: Medline; EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) [ITN 675278] Funding Source: Medline; Lundbeckfonden (Lundbeck Foundation) [R264-2017-3344, R268-2016-3927] Funding Source: Medline; Sundhed og Sygdom, Det Frie Forskningsråd (Medical Sciences, Danish Council for Independent Research) [5053-00083B] Funding Source: Medline; EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions) [PathAutoBio 796840] Funding Source: Medline	EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council); Novo Nordisk Fonden (Novo Nordisk Foundation); EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020); Lundbeckfonden (Lundbeck Foundation); Sundhed og Sygdom, Det Frie Forskningsråd (Medical Sciences, Danish Council for Independent Research); EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 Marie Skłodowska-Curie Actions (H2020 Excellent Science - Marie Skłodowska-Curie Actions)		Zhang BC, 2020, NAT IMMUNOL, V21, P868, DOI 10.1038/s41590-020-0730-5	1	1	1	0	6	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1468	1469		10.1038/s41590-020-0803-5	http://dx.doi.org/10.1038/s41590-020-0803-5		SEP 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32929276	Bronze			2022-12-18	WOS:000569299600003
J	Scott, DW; Caspi, RR; Moudgil, KD				Scott, David W.; Caspi, Rachel R.; Moudgil, Kamal D.			Noel R. Rose 1927-2020	NATURE IMMUNOLOGY			English	Biographical-Item									[Scott, David W.] Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA; [Caspi, Rachel R.] NEI, NIH, Bethesda, MD 20892 USA; [Moudgil, Kamal D.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Uniformed Services University of the Health Sciences - USA; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); University System of Maryland; University of Maryland Baltimore	Scott, DW (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Med, Bethesda, MD 20814 USA.	David.scott@usuhs.edu						ROSE N, PUBLICATION LIST	1	1	1	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2020	21	11					1306	1306		10.1038/s41590-020-0790-6	http://dx.doi.org/10.1038/s41590-020-0790-6		SEP 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	OD0BT	32895540	Bronze			2022-12-18	WOS:000566874900002
J	Hachim, A; Kavian, N; Cohen, CA; Chin, AWH; Chu, DKW; Mok, CKP; Tsang, OTY; Yeung, YC; Perera, RAPM; Poon, LLM; Peiris, JSM; Valkenburg, SA				Hachim, Asmaa; Kavian, Niloufar; Cohen, Carolyn A.; Chin, Alex W. H.; Chu, Daniel K. W.; Mok, Chris K. P.; Tsang, Owen T. Y.; Yeung, Yiu Cheong; Perera, Ranawaka A. P. M.; Poon, Leo L. M.; Peiris, J. S. Malik; Valkenburg, Sophie A.			ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection (Aug, 10.1038/s41590-020-0773-7, 2020)	NATURE IMMUNOLOGY			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				niloufar@hku.hk; sophiev@hku.hk	Mok, Chris Ka Pun/ABD-2667-2021; Poon, Leo/AAP-6887-2020; -, Ranawaka A.P.M Perera/N-8263-2015	-, Ranawaka A.P.M Perera/0000-0003-3936-1535; Kavian, Niloufar/0000-0003-2829-3311; Reis, AlessanRSS/0000-0001-8486-7469				Hachim A, 2020, NAT IMMUNOL, V21, P1293, DOI 10.1038/s41590-020-0773-7	1	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2020	21	10					1302	1302		10.1038/s41590-020-0788-0	http://dx.doi.org/10.1038/s41590-020-0788-0		AUG 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NR0OB	32855556	Bronze, Green Published			2022-12-18	WOS:000563237600001
J	Wei, HM; Fu, BQ				Wei, Haiming; Fu, Binqing			Make killers sweeter: targeting metabolic checkpoints of NK cells	NATURE IMMUNOLOGY			English	Editorial Material								Group 2 innate lymphoid cells (ILC2s) closely intersect with antitumor immunity. A new study describes how activation of lung-resident ILC2s orchestrates the suppression of natural killer cell-mediated innate antitumor immunity via an eosinophil-mediated metabolic mechanism.	[Wei, Haiming; Fu, Binqing] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Div Life Sci & Med, Hefei, Anhui, Peoples R China; [Wei, Haiming; Fu, Binqing] Univ Sci & Technol China, Inst Immunol, Hefei, Anhui, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Wei, HM; Fu, BQ (corresponding author), Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Div Life Sci & Med, Hefei, Anhui, Peoples R China.; Wei, HM; Fu, BQ (corresponding author), Univ Sci & Technol China, Inst Immunol, Hefei, Anhui, Peoples R China.	ustcwhm@ustc.edu.cn; fbq@ustc.edu.cn	Wei, Haiming/G-7703-2018	Wei, Haiming/0000-0002-1675-6502	Natural Science Foundation of China [81922028]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2019442]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Innovation Promotion Association of the Chinese Academy of Sciences	This work was supported by the Natural Science Foundation of China (81922028) and the Youth Innovation Promotion Association of the Chinese Academy of Sciences (grant 2019442).	Andre P, 2018, CELL, V175, P1731, DOI 10.1016/j.cell.2018.10.014; Assmann N, 2017, NAT IMMUNOL, V18, P1197, DOI 10.1038/ni.3838; Cong JJ, 2018, CELL METAB, V28, P243, DOI 10.1016/j.cmet.2018.06.021; Gao X, 2015, J IMMUNOL, V194, P438, DOI 10.4049/jimmunol.1401344; Gurram RK, 2019, CELL MOL IMMUNOL, V16, P225, DOI 10.1038/s41423-019-0210-8; Habif G, 2019, CELL MOL IMMUNOL, V16, P415, DOI 10.1038/s41423-019-0224-2; Josephs DH, 2013, CLIN EXP ALLERGY, V43, P1110, DOI 10.1111/cea.12178; Mager LF, 2015, J CLIN INVEST, V125, P2579, DOI 10.1172/JCI77347; Schuijs MJ, 2020, NAT IMMUNOL, V21, P998, DOI 10.1038/s41590-020-0745-y; Scott KEN, 2016, CELL METAB, V24, P649, DOI 10.1016/j.cmet.2016.10.015; Terren I, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02278; Zhang Q, 2018, NAT IMMUNOL, V19, P723, DOI 10.1038/s41590-018-0132-0; Zheng XH, 2019, NAT IMMUNOL, V20, P1656, DOI 10.1038/s41590-019-0511-1	13	1	1	1	11	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					970	971		10.1038/s41590-020-0738-x	http://dx.doi.org/10.1038/s41590-020-0738-x		AUG 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32747816				2022-12-18	WOS:000555394500002
J	Nadella, V; Nagao, K				Nadella, Vinod; Nagao, Keisuke			A bacteria-chemokine double act repairs the skin	NATURE IMMUNOLOGY			English	Editorial Material								A complex formed by the chemokine CXCL10 and commensal skin microbiota-derived DNA is a crucial component that triggers type I IFN responses to facilitate skin repair.	[Nadella, Vinod; Nagao, Keisuke] NIAMSD, Cutaneous Leukocyte Biol Sect, Dermatol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Nagao, K (corresponding author), NIAMSD, Cutaneous Leukocyte Biol Sect, Dermatol Branch, NIH, Bethesda, MD 20892 USA.	keisuke.nagao@nih.gov	Nadella, Vinod/AHC-8377-2022	Nadella, Vinod/0000-0002-1122-7820	Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health	Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health	This work was supported by the Intramural Research Program of the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health.	Byrd AL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4651; Cole AM, 2001, J IMMUNOL, V167, P623, DOI 10.4049/jimmunol.167.2.623; Di Domizio J, 2020, NAT IMMUNOL, V21, P1034, DOI 10.1038/s41590-020-0721-6; Gregorio J, 2010, J EXP MED, V207, P2921, DOI 10.1084/jem.20101102; Harrison OJ, 2019, SCIENCE, V363, P43, DOI 10.1126/science.aat6280; Kalan LR, 2019, CELL HOST MICROBE, V25, P641, DOI 10.1016/j.chom.2019.03.006; Linehan JL, 2018, CELL, V172, P784, DOI 10.1016/j.cell.2017.12.033; Margulieux KR, 2016, MBIO, V7, DOI 10.1128/mBio.00334-16; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; Rodrigues M, 2019, PHYSIOL REV, V99, P665, DOI 10.1152/physrev.00067.2017	11	1	1	2	13	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					966	967		10.1038/s41590-020-0755-9	http://dx.doi.org/10.1038/s41590-020-0755-9		JUL 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32719522				2022-12-18	WOS:000553242700002
J	Akassoglou, K				Akassoglou, Katerina			The immunology of blood: connecting the dots at the neurovascular interface (vol 15, pg 631, 2020)	NATURE IMMUNOLOGY			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				kakassoglou@gladstone.ucsf.edu		Akassoglou, Katerina/0000-0002-2632-1465				Akassoglou K, 2020, NAT IMMUNOL, V21, P710, DOI 10.1038/s41590-020-0671-z	1	1	1	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					1134	1134		10.1038/s41590-020-0752-z	http://dx.doi.org/10.1038/s41590-020-0752-z		JUL 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32636513	Bronze			2022-12-18	WOS:000546203300001
J	Jin, J; Xiao, YC; Chang, JH; Yu, JY; Hu, HB; Starr, R; Brittain, GC; Chang, MY; Cheng, XH; Sun, SC				Jin, Jin; Xiao, Yichuan; Chang, Jae-Hoon; Yu, Jiayi; Hu, Hongbo; Starr, Robyn; Brittain, George C.; Chang, Mikyoung; Cheng, Xuhong; Sun, Shao-Cong			The kinase TBK1 controls IgA class switching by negatively regulating noncanonical NF-kappa B signaling (vol 53, pg 561, 2012)	NATURE IMMUNOLOGY			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				ssun@mdanderson.org						Jin J, 2012, NAT IMMUNOL, V13, P1101, DOI 10.1038/ni.2423	1	1	1	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2020	21	9					1134	1134		10.1038/s41590-020-0748-8	http://dx.doi.org/10.1038/s41590-020-0748-8		JUL 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	NE3TY	32616919	Bronze			2022-12-18	WOS:000545194100001
J	Mermikides, A				Mermikides, Alex			Drama out of a crisis: the cultural sector responds to healthcare professionals impacted by COVID-19	NATURE IMMUNOLOGY			English	Editorial Material								Support for healthcare workers impacted by COVID-19 comes from the performing arts.	[Mermikides, Alex] Guildhall Sch Mus & Drama, London, England		Mermikides, A (corresponding author), Guildhall Sch Mus & Drama, London, England.	Alex.Mermikides@gsmd.ac.uk							0	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					817	818		10.1038/s41590-020-0734-1	http://dx.doi.org/10.1038/s41590-020-0734-1		JUL 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32612185	Bronze			2022-12-18	WOS:000545511200001
J	Ricciardi-Castagnoli, P				Ricciardi-Castagnoli, Paola			Sensing the gut microbiota	NATURE IMMUNOLOGY			English	Article							CD103(+) DENDRITIC CELLS; RESPONSES; INNATE	Paola Ricciardi-Castagnoli describes how her groups' focus on mucosal immunity led to the discovery of how dendritic cells sense the gut microbiota to maintain homeostasis.	[Ricciardi-Castagnoli, Paola] Toscana Life Sci Fdn, Siena, Italy		Ricciardi-Castagnoli, P (corresponding author), Toscana Life Sci Fdn, Siena, Italy.	p.castagnoli@toascanalifesciences.org		castagnoli, paola/0000-0002-4749-7187				Farache J, 2013, IMMUNITY, V38, P581, DOI 10.1016/j.immuni.2013.01.009; Fric J, 2014, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00513; Fric J, 2012, BLOOD, V120, P1380, DOI 10.1182/blood-2012-02-404475; Granucci F, 2003, EMBO J, V22, P2546, DOI 10.1093/emboj/cdg261; Granucci F, 2001, NAT IMMUNOL, V2, P882, DOI 10.1038/ni0901-882; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Mencarelli A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03495-3; NUSSENZWEIG MC, 1980, J EXP MED, V151, P1196, DOI 10.1084/jem.151.5.1196; Poltorak A, 2000, P NATL ACAD SCI USA, V97, P2163, DOI 10.1073/pnas.040565397; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Ricciardi-Castagnoli P, 2002, NAT REV IMMUNOL, V2, P881, DOI 10.1038/nri936; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317; Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006; Yu HB, 2015, NUCLEIC ACIDS RES, V43, P836, DOI 10.1093/nar/gku1369; Zanoni I, 2009, NATURE, V460, P264, DOI 10.1038/nature08118; Zelante T, 2015, CELL REP, V12, P1789, DOI 10.1016/j.celrep.2015.08.030	17	1	1	0	6	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					704	705		10.1038/s41590-020-0645-1	http://dx.doi.org/10.1038/s41590-020-0645-1			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32577006				2022-12-18	WOS:000542863800004
J	Rodda, LB; Pepper, M				Rodda, Lauren B.; Pepper, Marion			Metabolic constraints on the B cell response to malaria	NATURE IMMUNOLOGY			English	Editorial Material							MEMORY B; T-CELLS; IMMUNITY; MICE	Early plasmablasts responding toPlasmodiuminfection may outcompete germinal center B cells forl-glutamine and delay pathogen control.	[Rodda, Lauren B.; Pepper, Marion] Univ Washington, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Pepper, M (corresponding author), Univ Washington, Dept Immunol, Seattle, WA 98195 USA.	mpepper@uw.edu			NIAID NIH HHS [R01 AI118803] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boothby M, 2017, IMMUNITY, V46, P743, DOI 10.1016/j.immuni.2017.04.009; Crompton PD, 2014, ANNU REV IMMUNOL, V32, P157, DOI 10.1146/annurev-immunol-032713-120220; Crompton PD, 2010, P NATL ACAD SCI USA, V107, P6958, DOI 10.1073/pnas.1001323107; Fontana MF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006192; Fontana MF, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1006046; Hirunpetcharat C, 1997, J IMMUNOL, V159, P3400; Keitany GJ, 2016, CELL REP, V17, P3193, DOI 10.1016/j.celrep.2016.11.060; Krishnamurty AT, 2016, IMMUNITY, V45, P402, DOI 10.1016/j.immuni.2016.06.014; LANGHORNE J, 1990, IMMUNOL LETT, V25, P101, DOI 10.1016/0165-2478(90)90099-C; Perez-Mazliah D, 2017, EBIOMEDICINE, V24, P216, DOI 10.1016/j.ebiom.2017.08.030; Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556; Sullivan RT, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1190-0; Tan J, 2018, NAT MED, V24, P401, DOI 10.1038/nm.4513; Vijay R, 2020, NAT IMMUNOL, V21, P790, DOI 10.1038/s41590-020-0678-5; Weisel F, 2017, ANNU REV IMMUNOL, V35, P255, DOI 10.1146/annurev-immunol-041015-055531; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004	16	1	2	0	4	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2020	21	7					722	724		10.1038/s41590-020-0718-1	http://dx.doi.org/10.1038/s41590-020-0718-1			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MB8RI	32577012	Bronze			2022-12-18	WOS:000542863800012
J	Giladi, A; Wagner, LK; Li, HJ; Dorr, D; Medaglia, C; Paul, F; Shemer, A; Jung, SF; Yona, S; Mack, M; Leutz, A; Amit, I; Mildner, A				Giladi, Amir; Wagner, Lisa Katharina; Li, Hanjie; Doerr, Dorothea; Medaglia, Chiara; Paul, Franziska; Shemer, Anat; Jung, Steffen; Yona, Simon; Mack, Matthias; Leutz, Achim; Amit, Ido; Mildner, Alexander			Cxcl10(+) monocytes define a pathogenic subset in the central nervous system during autoimmune neuroinflammation (vol 21, pg 525, 2020)	NATURE IMMUNOLOGY			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				ido.amit@weizmann.ac.il; alexander.mildner@mdc-berlin.de	Mildner, Alexander/ABG-6122-2020; Yona, Simon/ABE-6572-2020; mildner, alexander/GQA-3761-2022	mildner, alexander/0000-0002-2019-8427				Giladi A, 2020, NAT IMMUNOL, V21, P525, DOI 10.1038/s41590-020-0661-1	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					962	962		10.1038/s41590-020-0742-1	http://dx.doi.org/10.1038/s41590-020-0742-1		JUN 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32581371	Bronze			2022-12-18	WOS:000543109300002
J	Kovacs, MA; Harris, TH				Kovacs, Michael A.; Harris, Tajie H.			Long-'Trm' protection of the CNS	NATURE IMMUNOLOGY			English	Editorial Material							CENTRAL-NERVOUS-SYSTEM; T-CELLS; MEMORY; TISSUE; BRAIN; IMMUNITY	A new report finds that peripheral immunization generates tissue-resident memory CD8(+)T cells in the central nervous system that provide robust protection against local infection.	[Kovacs, Michael A.; Harris, Tajie H.] Univ Virginia, Ctr Brain Immunol & Glia, Dept Neurosci, Charlottesville, VA 22908 USA	University of Virginia	Harris, TH (corresponding author), Univ Virginia, Ctr Brain Immunol & Glia, Dept Neurosci, Charlottesville, VA 22908 USA.	thh9t@virginia.edu		Harris, Tajie/0000-0002-1355-2109				Badovinac VP, 2005, NAT MED, V11, P748, DOI 10.1038/nm1257; Gate D, 2020, NATURE, V577, P399, DOI 10.1038/s41586-019-1895-7; Klein RS, 2017, IMMUNITY, V46, P891, DOI 10.1016/j.immuni.2017.06.012; Logan SAE, 2008, BMJ-BRIT MED J, V336, P36, DOI 10.1136/bmj.39409.673657.AE; Mackay LK, 2012, P NATL ACAD SCI USA, V109, P7037, DOI 10.1073/pnas.1202288109; Mundt S, 2019, TRENDS NEUROSCI, V42, P667, DOI 10.1016/j.tins.2019.07.008; Ritzel RM, 2016, J IMMUNOL, V196, P3318, DOI 10.4049/jimmunol.1502021; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Smolders J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07053-9; Steinbach K, 2016, J EXP MED, V213, P1571, DOI 10.1084/jem.20151916; Urban SL, 2020, NAT IMMUNOL, V21, P938, DOI 10.1038/s41590-020-0711-8; Wakim LM, 2010, P NATL ACAD SCI USA, V107, P17872, DOI 10.1073/pnas.1010201107; Wood LM, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00051	13	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					825	826		10.1038/s41590-020-0716-3	http://dx.doi.org/10.1038/s41590-020-0716-3		JUN 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32572243				2022-12-18	WOS:000542053600001
J	Giladi, A; Wagner, LK; Li, HJ; Dorr, D; Medaglia, C; Paul, F; Shemer, A; Jung, SF; Yona, S; Mack, M; Leutz, A; Amit, I; Mildner, A				Giladi, Amir; Wagner, Lisa Katharina; Li, Hanjie; Dorr, Dorothea; Medaglia, Chiara; Paul, Franziska; Shemer, Anat; Jung, Steffen; Yona, Simon; Mack, Matthias; Leutz, Achim; Amit, Ido; Mildner, Alexander			Cxcl10(+) monocytes define a pathogenic subset in the central nervous system during autoimmune neuroinflammation (vol 47, pg 589, 2020)	NATURE IMMUNOLOGY			English	Correction												ido.amit@weizmann.ac.il; alexander.mildner@mdc-berlin.de	Mildner, Alexander/ABG-6122-2020; mildner, alexander/GQA-3761-2022; Yona, Simon/ABE-6572-2020; Leutz, Achim/K-9643-2013	mildner, alexander/0000-0002-2019-8427; Leutz, Achim/0000-0001-8259-927X				Giladi A, 2020, NAT IMMUNOL, V21, P525, DOI 10.1038/s41590-020-0661-1	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2020	21	8					962	962		10.1038/s41590-020-0722-5	http://dx.doi.org/10.1038/s41590-020-0722-5		JUN 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	MO5NV	32514066	Bronze			2022-12-18	WOS:000539349000001
J	Dempsey, LA				Dempsey, Laurie A.			Immune dysregulation	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					596	596		10.1038/s41590-020-0702-9	http://dx.doi.org/10.1038/s41590-020-0702-9			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32457531	Bronze			2022-12-18	WOS:000535839700006
J	Dempsey, LA				Dempsey, Laurie A.			Vaccines vs antibiotics	NATURE IMMUNOLOGY			English	Editorial Material												l.dempsey@us.nature.com	Dempsey, Laurie A./GLR-6085-2022						0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					596	596		10.1038/s41590-020-0701-x	http://dx.doi.org/10.1038/s41590-020-0701-x			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32457529	Bronze			2022-12-18	WOS:000535839700003
J	Dempsey, LA				Dempsey, Laurie A.			Regulatory DCs	NATURE IMMUNOLOGY			English	Editorial Material												l.dempsey@us.nature.com	Dempsey, Laurie A./GLR-6085-2022						0	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					488	488		10.1038/s41590-020-0683-8	http://dx.doi.org/10.1038/s41590-020-0683-8			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32327754	Bronze			2022-12-18	WOS:000528265700006
J	Ueda, K; Kumari, R; Steidl, U				Ueda, Koki; Kumari, Rajni; Steidl, Ulrich			Fueling clonal dominance through TRAFficking of NF-kappa B signaling	NATURE IMMUNOLOGY			English	Editorial Material							MYELODYSPLASTIC SYNDROMES; STEM; CELLS; TET2	Activation of TLR-TRAF6 signaling by chronic inflammation in myelodysplastic syndromes increases the competitive advantage of HSPCs harboring MDS mutations through the upregulation of the ubiquitin-modifying enzyme A20 and a switch from canonical to non-canonical NF-kappa B signaling.	[Ueda, Koki; Kumari, Rajni; Steidl, Ulrich] Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA; [Ueda, Koki; Kumari, Rajni; Steidl, Ulrich] Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell Res & R, New York, NY 10461 USA; [Steidl, Ulrich] Albert Einstein Coll Med, Montefiore Med Ctr, Dept Med Oncol, New York, NY 10461 USA; [Steidl, Ulrich] Albert Einstein Coll Med, Albert Einstein Canc Ctr, New York, NY 10461 USA	Yeshiva University; Yeshiva University; Montefiore Medical Center; Yeshiva University; Yeshiva University	Steidl, U (corresponding author), Albert Einstein Coll Med, Dept Cell Biol, New York, NY 10461 USA.; Steidl, U (corresponding author), Albert Einstein Coll Med, Ruth L & David S Gottesman Inst Stem Cell Res & R, New York, NY 10461 USA.; Steidl, U (corresponding author), Albert Einstein Coll Med, Montefiore Med Ctr, Dept Med Oncol, New York, NY 10461 USA.; Steidl, U (corresponding author), Albert Einstein Coll Med, Albert Einstein Canc Ctr, New York, NY 10461 USA.	ulrich.steidl@einsteinmed.org	Kumari, Rajni/AAY-9577-2020	Kumari, Rajni/0000-0003-2735-3749; Ueda, Koki/0000-0002-6964-7035				Barreyro L, 2018, BLOOD, V132, P1553, DOI 10.1182/blood-2018-03-784116; Bird L, 2015, NAT REV IMMUNOL, V15, P598, DOI 10.1038/nri3912; Chen JH, 2019, NAT MED, V25, P103, DOI 10.1038/s41591-018-0267-4; Fang J, 2017, NAT IMMUNOL, V18, P236, DOI 10.1038/ni.3654; Muto T, 2020, NAT IMMUNOL, V21, P535, DOI 10.1038/s41590-020-0663-z; Muto T, 2013, J EXP MED, V210, P2627, DOI 10.1084/jem.20131144; Nilsson L, 2002, BLOOD, V100, P259, DOI 10.1182/blood-2001-12-0188; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Sperling AS, 2017, NAT REV CANCER, V17, P5, DOI 10.1038/nrc.2016.112; Thanopoulou E, 2004, BLOOD, V103, P4285, DOI 10.1182/blood-2003-09-3192; Will B, 2015, NAT MED, V21, P1172, DOI 10.1038/nm.3936; Will B, 2012, BLOOD, V120, P2076, DOI 10.1182/blood-2011-12-399683; Yamaguchi N, 2013, SCI REP-UK, V3, DOI 10.1038/srep02568	14	1	1	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2020	21	5					489	490		10.1038/s41590-020-0662-0	http://dx.doi.org/10.1038/s41590-020-0662-0		APR 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LG7GW	32313244				2022-12-18	WOS:000527507900004
J	Dempsey, LA				Dempsey, Laurie A.			Innate Immunity Sirtuin regulation of NLRP3	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	1	1	0	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					358	358		10.1038/s41590-020-0657-x	http://dx.doi.org/10.1038/s41590-020-0657-x			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32205893	Bronze			2022-12-18	WOS:000521274700004
J	Dijkgraaf, FE; Matos, TR; Hoogenboezem, M; Toebes, M; Vredevoogd, DW; Mertz, M; van den Broek, B; Song, JY; Teunissen, MBM; Luiten, RM; Beltman, JB; Schumacher, TN				Dijkgraaf, Feline E.; Matos, Tiago R.; Hoogenboezem, Mark; Toebes, Mireille; Vredevoogd, David W.; Mertz, Marjolijn; van den Broek, Bram; Song, Ji-Ying; Teunissen, Marcel B. M.; Luiten, Rosalie M.; Beltman, Joost B.; Schumacher, Ton N.			Tissue patrol by resident memory CD8(+) T cells in human skin (vol 20, pg 756, 2019)	NATURE IMMUNOLOGY			English	Correction												t.schumacher@nki.nl	Schumacher, Ton/Y-2432-2019	Schumacher, Ton/0000-0003-0517-8804; Mertz, Marjolijn/0000-0002-9188-3579				Dijkgraaf FE, 2019, NAT IMMUNOL, V20, P756, DOI 10.1038/s41590-019-0404-3	1	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					696	696		10.1038/s41590-020-0665-x	http://dx.doi.org/10.1038/s41590-020-0665-x		MAR 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32210390	Bronze			2022-12-18	WOS:000521522400001
J	Redeker, A; Arens, R				Redeker, Anke; Arens, Ramon			'Reverse evolution' in T cell biology	NATURE IMMUNOLOGY			English	Editorial Material							MEMORY INFLATION; INFECTION; DRIVEN	Comprehensive analysis of CD8(+) T cell populations specific to cytomegalovirus reveals that the evolution of the T cell antigen receptor repertoire during chronic infections is characterized by the expansion of low-affinity clones.	[Redeker, Anke; Arens, Ramon] Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Arens, R (corresponding author), Leiden Univ, Med Ctr, Dept Immunohematol & Blood Transfus, Leiden, Netherlands.	R.Arens@lumc.nl	Arens, Ramon/V-4010-2018	Arens, Ramon/0000-0001-5058-4110				Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Busch DH, 1999, J EXP MED, V189, P701, DOI 10.1084/jem.189.4.701; Davenport MP, 2002, J IMMUNOL, V168, P3309, DOI 10.4049/jimmunol.168.7.3309; Hebeisen M, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00582; O'Hara GA, 2012, TRENDS IMMUNOL, V33, P84, DOI 10.1016/j.it.2011.11.005; Redeker A, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01953; Roddie C, 2017, J CLIN INVEST, V127, P2513, DOI 10.1172/JCI90599; Schober K, 2020, NAT IMMUNOL, V21, P434, DOI 10.1038/s41590-020-0628-2; Seckert CK, 2012, MED MICROBIOL IMMUN, V201, P551, DOI 10.1007/s00430-012-0273-y; Smith CJ, 2020, J IMMUNOL, V204, P112, DOI 10.4049/jimmunol.1900455; Speiser DE, 2014, NAT REV IMMUNOL, V14, P768, DOI 10.1038/nri3740; Sylwester AW, 2005, J EXP MED, V202, P673, DOI 10.1084/jem.20050882	12	1	1	0	2	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2020	21	4					360	362		10.1038/s41590-020-0639-z	http://dx.doi.org/10.1038/s41590-020-0639-z		MAR 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KW6KW	32205884				2022-12-18	WOS:000519843600007
J	Crowther, MD; Dolton, G; Legut, M; Caillaud, ME; Lloyd, A; Attaf, M; Galloway, SAE; Rius, C; Farrell, CP; Szomolay, B; Ager, A; Parker, AL; Fuller, A; Donia, M; McCluskey, J; Rossjohn, J; Svane, IM; Phillips, JD; Sewell, AK				Crowther, Michael D.; Dolton, Garry; Legut, Mateusz; Caillaud, Marine E.; Lloyd, Angharad; Attaf, Meriem; Galloway, Sarah A. E.; Rius, Cristina; Farrell, Colin P.; Szomolay, Barbara; Ager, Ann; Parker, Alan L.; Fuller, Anna; Donia, Marco; McCluskey, James; Rossjohn, Jamie; Svane, Inge Marie; Phillips, John D.; Sewell, Andrew K.			Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1 (vol 12, pg 125, 2020)	NATURE IMMUNOLOGY			English	Correction								An amendment to this paper has been published and can be accessed via a link at the top of the paper.				sewellak@cardiff.ac.uk	McCluskey, James/A-1291-2007; Parker, Alan L/B-8187-2009; Sewell, Andrew/GPT-4220-2022; Rossjohn, Jamie/F-9032-2013	McCluskey, James/0000-0002-8597-815X; Parker, Alan L/0000-0002-9302-1761; Sewell, Andrew/0000-0003-3194-3135; Fuller, Anna/0000-0002-8655-6741; Svane, Inge Marie/0000-0002-9451-6037; Rossjohn, Jamie/0000-0002-2020-7522; Legut, Mateusz/0000-0002-8810-6971; Donia, Marco/0000-0003-4966-9752				Crowther MD, 2020, NAT IMMUNOL, V21, P178, DOI 10.1038/s41590-019-0578-8	1	1	1	1	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2020	21	6					695	695		10.1038/s41590-020-0640-6	http://dx.doi.org/10.1038/s41590-020-0640-6		MAR 2020	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	LR6ZD	32123375	Bronze			2022-12-18	WOS:000517740900001
J	Dempsey, LA				Dempsey, Laurie A.			Protection by neuronal IL-18	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					244	244		10.1038/s41590-020-0626-4	http://dx.doi.org/10.1038/s41590-020-0626-4			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32094654	Bronze			2022-12-18	WOS:000544940600014
J	Mackay, F				Mackay, Fabienne			Not from Venus, not from Mars - all equally superstars	NATURE IMMUNOLOGY			English	Editorial Material								Male immunologists are scientists and nothing more; female immunologists are scientists and nothing less.	[Mackay, Fabienne] Univ Melbourne, Dept Microbiol & Immunol, Sch Biomed Sci, Melbourne, Vic, Australia; [Mackay, Fabienne] Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Mackay, Fabienne] Monash Univ, Dept Immunol & Pathol, Clayton, Vic, Australia	University of Melbourne; University of Melbourne; Monash University	Mackay, F (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Sch Biomed Sci, Melbourne, Vic, Australia.; Mackay, F (corresponding author), Univ Melbourne, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Mackay, F (corresponding author), Monash Univ, Dept Immunol & Pathol, Clayton, Vic, Australia.	fabienne.mackay@unimelb.edu.au	Mackay, Fabienne/B-7440-2008	Mackay, Fabienne/0000-0002-6074-2693					0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					238	238		10.1038/s41590-020-0605-9	http://dx.doi.org/10.1038/s41590-020-0605-9			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32094645	Bronze			2022-12-18	WOS:000544940600006
J	Mikulak, J; Di Vito, C; Mavilio, D				Mikulak, Joanna; Di Vito, Clara; Mavilio, Domenico			HIV-1-induced inflammation shapes innate immunity and induces adaptive traits in NK cells	NATURE IMMUNOLOGY			English	Editorial Material							INFECTION; MEMORY	Chronic inflammation associated with HIV-1 infection disrupts the homeostasis of gut-resident innate lymphoid cells and induces the generation and expansion of adaptive NK cells expressing TCF7, a transcription factor that sustains their effector functions and memory-like properties.	[Mikulak, Joanna; Di Vito, Clara; Mavilio, Domenico] Humanitas Clin & Res Ctr, Unit Clin & Expt Immunol, Milan, Italy; [Mikulak, Joanna; Di Vito, Clara; Mavilio, Domenico] Univ Milan, Dept Med Biotechnol & Translat Med BioMeTra, Milan, Italy	University of Milan	Mavilio, D (corresponding author), Humanitas Clin & Res Ctr, Unit Clin & Expt Immunol, Milan, Italy.; Mavilio, D (corresponding author), Univ Milan, Dept Med Biotechnol & Translat Med BioMeTra, Milan, Italy.	domenico.mavilio@unimi.it	mikulak, joanna/AAB-3070-2022; Di Vito, Clara/ABC-3385-2020; Mavilio, Domenico/E-5194-2017	mikulak, joanna/0000-0001-8310-9543; Di Vito, Clara/0000-0001-7248-1710; Mavilio, Domenico/0000-0001-6147-0952				Alzahrani J, 2019, EBIOMEDICINE, V46, P522, DOI 10.1016/j.ebiom.2019.07.027; Belkina AC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02783; Cerwenka A, 2016, NAT REV IMMUNOL, V16, P112, DOI 10.1038/nri.2015.9; Hammer Q, 2018, NAT IMMUNOL, V19, P453, DOI 10.1038/s41590-018-0082-6; Hunt PW, 2014, J INFECT DIS, V210, P1228, DOI 10.1093/infdis/jiu238; Jeevan-Raj B, 2017, CELL REP, V20, P613, DOI 10.1016/j.celrep.2017.06.071; Lucar O, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01850; Mikulak J, 2017, AIDS, V31, P2317, DOI 10.1097/QAD.0000000000001645; Peppa D, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01322; Schlums H, 2015, IMMUNITY, V42, P443, DOI 10.1016/j.immuni.2015.02.008; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Wang YT, 2020, NAT IMMUNOL, V21, P274, DOI 10.1038/s41590-020-0593-9; Wang YF, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00169; Zicari S, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11030200	14	1	1	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					245	247		10.1038/s41590-020-0615-7	http://dx.doi.org/10.1038/s41590-020-0615-7		FEB 2020	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32066946				2022-12-18	WOS:000514067400001
J	Pae, J; Victora, GD				Pae, Juhee; Victora, Gabriel D.			B is for 'Big Mac': GCs crave a high-fat diet	NATURE IMMUNOLOGY			English	Editorial Material							GERMINAL CENTER SELECTION; AFFINITY MATURATION; CELL-CYCLE; MYC	Highly proliferative cells have classically been thought to rely on anaerobic glycolysis for fuel. Weisel et al. show that germinal center B cells break this rule, as they primarily utilize fatty acid oxidation to meet their metabolic demands.	[Pae, Juhee; Victora, Gabriel D.] Rockefeller Univ, Lab Lymphocyte Dynam, 1230 York Ave, New York, NY 10021 USA	Rockefeller University	Victora, GD (corresponding author), Rockefeller Univ, Lab Lymphocyte Dynam, 1230 York Ave, New York, NY 10021 USA.	victora@rockefeller.edu						Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Calado DP, 2012, NAT IMMUNOL, V13, P1092, DOI 10.1038/ni.2418; Dominguez-Sola D, 2012, NAT IMMUNOL, V13, P1083, DOI 10.1038/ni.2428; Ersching J, 2017, IMMUNITY, V46, P1045, DOI 10.1016/j.immuni.2017.06.005; Gitlin AD, 2015, SCIENCE, V349, P643, DOI 10.1126/science.aac4919; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; LIU YJ, 1989, NATURE, V342, P929, DOI 10.1038/342929a0; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.immunol.12.1.117; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032; Weisel FJ, 2020, NAT IMMUNOL, V21, P331, DOI 10.1038/s41590-020-0598-4	11	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2020	21	3					249	250		10.1038/s41590-020-0614-8	http://dx.doi.org/10.1038/s41590-020-0614-8		FEB 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ME8YN	32066952				2022-12-18	WOS:000514067400002
J	Dempsey, LA				Dempsey, Laurie A.			Nuclear ignorance	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	1	1	0	1	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					103	103		10.1038/s41590-020-0592-x	http://dx.doi.org/10.1038/s41590-020-0592-x			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31980813				2022-12-18	WOS:000515153400004
J	Zemans, RL; Hagood, JS				Zemans, Rachel L.; Hagood, James S.			Diversity at the border	NATURE IMMUNOLOGY			English	Editorial Material							MACROPHAGES; MONOCYTES	Comprehensive analysis of lung mononuclear phagocytes reveals four subsets with distinct basal transcriptomic and epigenomic landscapes and differing responses to inflammatory stimuli.	[Zemans, Rachel L.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Zemans, Rachel L.] Univ Michigan, Program Cellular & Mol Biol, Ann Arbor, MI 48109 USA; [Hagood, James S.] Univ N Carolina, Div Pulmonol, Dept Pediat, Chapel Hill, NC 27515 USA; [Hagood, James S.] Univ N Carolina, Program Rare & Interstitial Lung Dis, Chapel Hill, NC 27515 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Hagood, JS (corresponding author), Univ N Carolina, Div Pulmonol, Dept Pediat, Chapel Hill, NC 27515 USA.; Hagood, JS (corresponding author), Univ N Carolina, Program Rare & Interstitial Lung Dis, Chapel Hill, NC 27515 USA.	jhagood@unc.edu		Hagood, James/0000-0003-3938-0330	NHLBI NIH HHS [R01 HL131608] Funding Source: Medline	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Bourdonnay E, 2015, J EXP MED, V212, P729, DOI 10.1084/jem.20141675; Herold S, 2008, J EXP MED, V205, P3065, DOI 10.1084/jem.20080201; Jakubzick C, 2013, IMMUNITY, V39, P599, DOI 10.1016/j.immuni.2013.08.007; Lechner AJ, 2017, CELL STEM CELL, V21, P120, DOI 10.1016/j.stem.2017.03.024; Misharin AV, 2017, J EXP MED, V214, P2387, DOI 10.1084/jem.20162152; Moore BB, 2001, J IMMUNOL, V167, P4368, DOI 10.4049/jimmunol.167.8.4368; Mould KJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126556; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Riemondy KA, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123637; Sajti E, 2020, NAT IMMUNOL, V21, P221, DOI 10.1038/s41590-019-0582-z; Schyns J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11843-0; Tan SYS, 2016, DEVELOPMENT, V143, P1318, DOI 10.1242/dev.129122	12	1	1	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					112	114		10.1038/s41590-019-0585-9	http://dx.doi.org/10.1038/s41590-019-0585-9		JAN 2020	4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31959978				2022-12-18	WOS:000508964100002
J	Kaplan, MJ				Kaplan, Mariana J.			Of larks and owls	NATURE IMMUNOLOGY			English	Editorial Material							NEUTROPHILS	A cell-intrinsic program induces circadian disarming of the toxic machinery of neutrophils in the steady state and prevents tissue injury.	[Kaplan, Mariana J.] NIAMSD, Syst Autoimmun Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Kaplan, MJ (corresponding author), NIAMSD, Syst Autoimmun Branch, Intramural Res Program, NIH, Bethesda, MD 20892 USA.	mariana.kaplan@nih.gov						Adrover JM, 2020, NAT IMMUNOL, V21, P135, DOI 10.1038/s41590-019-0571-2; Adrover JM, 2019, IMMUNITY, V50, P390, DOI 10.1016/j.immuni.2019.01.002; Ella K, 2018, EUR J CLIN INVEST, V48, DOI 10.1111/eci.12965; Ella K, 2016, BRAIN BEHAV IMMUN, V57, P209, DOI 10.1016/j.bbi.2016.04.016; Grayson PC, 2016, ARTHRITIS RHEUMATOL, V68, P2071, DOI 10.1002/art.39745; Gupta S, 2016, NAT REV NEPHROL, V12, P402, DOI 10.1038/nrneph.2016.71; Hidalgo A, 2019, TRENDS IMMUNOL, V40, P584, DOI 10.1016/j.it.2019.04.013; Huppert LA, 2019, SEMIN RESP CRIT CARE, V40, P31, DOI 10.1055/s-0039-1683996; Looney MR, 2006, J CLIN INVEST, V116, P1615, DOI 10.1172/JCI27238; Papayannopoulos V, 2010, J CELL BIOL, V191, P677, DOI 10.1083/jcb.201006052; Schloss MJ, 2016, EMBO MOL MED, V8, P937, DOI 10.15252/emmm.201506083; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367	12	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2020	21	2					104	105		10.1038/s41590-019-0579-7	http://dx.doi.org/10.1038/s41590-019-0579-7		JAN 2020	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9FZ	31932811				2022-12-18	WOS:000508182300005
J	Bernink, JH; Ohne, Y; Teunissen, MBM; Wang, JY; Wu, JC; Krabbendam, L; Guntermann, C; Volckmann, R; Koster, J; van Tol, S; Ramirez, I; Shrestha, Y; de Rie, MA; Spits, H; Ros, XR; Humbles, AA				Bernink, Jochem H.; Ohne, Yoichiro; Teunissen, Marcel B. M.; Wang, Jingya; Wu, Jincheng; Krabbendam, Lisette; Guntermann, Christine; Volckmann, Richard; Koster, Jan; van Tol, Sophie; Ramirez, Ivan; Shrestha, Yashaswi; de Rie, Menno A.; Spits, Hergen; Ros, Xavier Romero; Humbles, Alison A.			c-Kit-positive ILC2s exhibit an ILC3-like signature that may contribute to IL-17-mediated pathologies (vol 20, pg 992, 2019)	NATURE IMMUNOLOGY			English	Correction													de Rie, Menno/GSD-4660-2022; Ohne, Yoichiro/AGE-6061-2022	Koster, Jan/0000-0002-0890-7585; guntermann, christine/0000-0001-8220-2578				Bernink JH, 2019, NAT IMMUNOL, V20, P992, DOI 10.1038/s41590-019-0423-0	1	1	1	1	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2020	21	1					101	101		10.1038/s41590-019-0554-3	http://dx.doi.org/10.1038/s41590-019-0554-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	KN9AB	31723260	Bronze			2022-12-18	WOS:000515136500017
J	Aguado, E; Arbulo-Echevarria, MM				Aguado, Enrique; Arbulo-Echevarria, Mikel M.			Slow phosphor-Y-LAT-ion for TCR ligand discrimination	NATURE IMMUNOLOGY			English	Editorial Material									[Aguado, Enrique; Arbulo-Echevarria, Mikel M.] Inst Biomed Res Cadiz INIBICA, Cadiz, Spain; [Aguado, Enrique] Univ Cadiz, Dept Biomed Biotechnol & Publ Hlth Immunol, Cadiz, Spain	Universidad de Cadiz	Aguado, E (corresponding author), Inst Biomed Res Cadiz INIBICA, Cadiz, Spain.; Aguado, E (corresponding author), Univ Cadiz, Dept Biomed Biotechnol & Publ Hlth Immunol, Cadiz, Spain.	enrique.aguado@uca.es	Aguado, Enrique/L-4908-2014; de Arbulo Echevarria, Miguel Martinez/AAB-6952-2019; FCADIZ, INIBICA/AFS-0591-2022	Aguado, Enrique/0000-0002-7232-2661; de Arbulo Echevarria, Miguel Martinez/0000-0002-1453-6880; 				Arbulo-Echevarria MM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00115; Courtney AH, 2017, MOL CELL, V67, P498, DOI 10.1016/j.molcel.2017.06.024; Dushek O, 2014, TRENDS IMMUNOL, V35, P153, DOI 10.1016/j.it.2014.02.002; Houtman JCD, 2005, J IMMUNOL, V175, P2449, DOI 10.4049/jimmunol.175.4.2449; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Lo WL, 2019, NAT IMMUNOL, V20, P1481, DOI 10.1038/s41590-019-0502-2; Lo WL, 2018, NAT IMMUNOL, V19, P733, DOI 10.1038/s41590-018-0131-1; Malissen B, 2005, ADV IMMUNOL, V87, P1, DOI 10.1016/S0065-2776(05)87001-4; MCKEITHAN TW, 1995, P NATL ACAD SCI USA, V92, P5042, DOI 10.1073/pnas.92.11.5042; Shah NH, 2016, ELIFE, V5, DOI 10.7554/eLife.20105; Stepanek O, 2014, CELL, V159, P333, DOI 10.1016/j.cell.2014.08.042; Valdor R, 2013, SEMIN IMMUNOL, V25, P313, DOI 10.1016/j.smim.2013.10.010; Yousefi OS, 2019, ELIFE, V8, DOI 10.7554/eLife.42475	13	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1420	1422		10.1038/s41590-019-0522-y	http://dx.doi.org/10.1038/s41590-019-0522-y			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31611700				2022-12-18	WOS:000492309600011
J	Conley, JM; Berg, LJ				Conley, James M.; Berg, Leslie J.			TCR signaling: it's all about the numbers	NATURE IMMUNOLOGY			English	Editorial Material							ACTIVATION; MTOR		[Conley, James M.; Berg, Leslie J.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Berg, LJ (corresponding author), Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA.	leslie.berg@cuanschutz.edu		Berg, Leslie J/0000-0001-6031-7542; Conley, James/0000-0001-8901-4713	NIAID NIH HHS [R01 AI132419, T32 AI007349] Funding Source: Medline; U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [5R01AI132419] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI132419] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Health &amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Andreotti AH, 2018, ANNU REV IMMUNOL, V36, P549, DOI 10.1146/annurev-immunol-042617-053344; Araki K, 2010, IMMUNOL REV, V235, P234, DOI 10.1111/j.0105-2896.2010.00898.x; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Balagopalan L, 2015, J BIOL CHEM, V290, P26422, DOI 10.1074/jbc.R115.665869; Courtney AH, 2018, TRENDS BIOCHEM SCI, V43, P108, DOI 10.1016/j.tibs.2017.11.008; Howden AJM, 2019, NAT IMMUNOL, V20, P1542, DOI 10.1038/s41590-019-0495-x; Manna A, 2018, P NATL ACAD SCI USA, V115, pE11914, DOI 10.1073/pnas.1817142115; Voisinne G, 2019, NAT IMMUNOL, V20, P1530, DOI 10.1038/s41590-019-0489-8	8	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1415	1416		10.1038/s41590-019-0520-0	http://dx.doi.org/10.1038/s41590-019-0520-0			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31591572	Green Accepted			2022-12-18	WOS:000492309600008
J	Guey, B; Ablasser, A				Guey, Baptiste; Ablasser, Andrea			A carrier for cyclic dinucleotides	NATURE IMMUNOLOGY			English	Editorial Material							GMP-AMP SYNTHASE; SLC19A1; SENSOR		[Guey, Baptiste; Ablasser, Andrea] Swiss Fed Inst Technol, Global Hlth Inst, Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Ablasser, A (corresponding author), Swiss Fed Inst Technol, Global Hlth Inst, Lausanne, Switzerland.	andrea.ablasser@epfl.ch		Guey, Baptiste/0000-0002-7750-9214				Ablasser A, 2019, SCIENCE, V363, P1055, DOI 10.1126/science.aat8657; Ahn J, 2017, CELL REP, V21, P3873, DOI 10.1016/j.celrep.2017.11.101; An J, 2017, ARTHRITIS RHEUMATOL, V69, P800, DOI 10.1002/art.40002; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Hou ZJ, 2014, CURR TOP MEMBR, V73, P175, DOI 10.1016/B978-0-12-800223-0.00004-9; Jansen G, 2004, ARTHRITIS RHEUM-US, V50, P2130, DOI 10.1002/art.20375; Li LY, 2014, NAT CHEM BIOL, V10, P1043, DOI [10.1038/NChemBio.1661, 10.1038/nchembio.1661]; Luteijn RD, 2019, NATURE, V573, P434, DOI 10.1038/s41586-019-1553-0; Marcus A, 2018, IMMUNITY, V49, P754, DOI 10.1016/j.immuni.2018.09.016; Rajitha P, 2017, CURR PHARM DESIGN, V23, P3550, DOI 10.2174/1381612823666170601105439; Ritchie C, 2019, MOL CELL, V75, P372, DOI 10.1016/j.molcel.2019.05.006; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Wang Y, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/192329	14	1	1	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1418	1420		10.1038/s41590-019-0521-z	http://dx.doi.org/10.1038/s41590-019-0521-z			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31602042				2022-12-18	WOS:000492309600010
J	Langston, PK; Nambu, A; Jung, J; Shibata, M; Aksoylar, HI; Lei, JH; Xu, PN; Doan, MT; Jiang, H; MacArthur, MR; Gao, X; Kong, Y; Chouchani, ET; Locasale, JW; Snyder, NW; Horng, T				Langston, P. Kent; Nambu, Aya; Jung, Jonathan; Shibata, Munehiko; Aksoylar, H. Ibrahim; Lei, Jiahui; Xu, Peining; Doan, Mary T.; Jiang, Helen; MacArthur, Michael R.; Gao, Xia; Kong, Yong; Chouchani, Edward T.; Locasale, Jason W.; Snyder, Nathaniel W.; Horng, Tiffany			Glycerol phosphate shuttle enzyme GPD2 regulates macrophage inflammatory responses (vol 20, pg 1186, 2019)	NATURE IMMUNOLOGY			English	Correction													MacArthur, Michael Robert/AAA-3173-2022; Chouchani, Edward T./HCH-3775-2022; Gao, Xia/CAF-4717-2022; Locasale, Jason W/ABE-6505-2020; Kong, Yong/B-5105-2014	MacArthur, Michael Robert/0000-0003-3593-6995; Gao, Xia/0000-0003-0979-9990; Locasale, Jason W/0000-0002-7766-3502; Kong, Yong/0000-0002-2881-5274; Langston, Paul/0000-0001-6655-1911; Aksoylar, Halil Ibrahim/0000-0002-0527-6124; Nambu, Aya/0000-0002-2797-6420				Langston PK, 2019, NAT IMMUNOL, V20, P1186, DOI 10.1038/s41590-019-0453-7	1	1	1	4	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1555	1555		10.1038/s41590-019-0517-8	http://dx.doi.org/10.1038/s41590-019-0517-8			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31551573	Bronze			2022-12-18	WOS:000492309600025
J	Mastellos, DC; Blom, AM; Connolly, ES; Daha, MR; Geisbrecht, BV; Ghebrehiwet, B; Gros, P; Hajishengallis, G; Holers, VM; Huber-Lang, M; Kinoshita, T; Mollnes, TE; Montgomery, RA; Morgan, BP; Nilsson, B; Pio, R; Ricklin, D; Risitano, AM; Taylor, RP; Mantovani, A; Ioannidis, JPA; Lambris, JD				Mastellos, Dimitrios C.; Blom, Anna M.; Connolly, E. Sander; Daha, Mohamed R.; Geisbrecht, Brian V.; Ghebrehiwet, Berhane; Gros, Piet; Hajishengallis, George; Holers, V. Michael; Huber-Lang, Markus; Kinoshita, Taroh; Mollnes, Tom E.; Montgomery, Robert A.; Morgan, B. Paul; Nilsson, Bo; Pio, Ruben; Ricklin, Daniel; Risitano, Antonio M.; Taylor, Ronald P.; Mantovani, Alberto; Ioannidis, John P. A.; Lambris, John D.			'Stealth' corporate innovation: an emerging threat for therapeutic drug development (vol 20, pg 1409, 2019)	NATURE IMMUNOLOGY			English	Correction													Huber-Lang, Markus/AAJ-2209-2020; Blom, Anna/AFS-7369-2022; Blom, Anna/B-9607-2009; Ioannidis, John P. A./G-9836-2011; Mantovani, Alberto/HCI-7449-2022; Mollnes, Tom/ABI-5183-2020; Pio, Ruben/F-5353-2017	Blom, Anna/0000-0002-1348-1734; Mantovani, Alberto/0000-0001-5578-236X; Pio, Ruben/0000-0002-6831-6111; Ioannidis, John P./0000-0003-3118-6859; Mastellos, Dimitrios/0000-0002-6634-3271; Hajishengallis, George/0000-0001-7392-8852				Mastellos DC, 2019, NAT IMMUNOL, V20, P1409, DOI 10.1038/s41590-019-0503-1	1	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1556	1556		10.1038/s41590-019-0531-x	http://dx.doi.org/10.1038/s41590-019-0531-x			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31605100	Bronze			2022-12-18	WOS:000492309600029
J	Visan, I				Visan, Ioana			IMMUNOTHERAPY CAR T cells for heart disease	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2019	20	11					1414	1414		10.1038/s41590-019-0536-5	http://dx.doi.org/10.1038/s41590-019-0536-5			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JG8DZ	31641290	Bronze			2022-12-18	WOS:000492309600007
J	Feigal, EG; DeWitt, ND; Cantilena, C; Peck, C; Stroncek, D				Feigal, Ellen G.; DeWitt, Natalie D.; Cantilena, Cathy; Peck, Carl; Stroncek, David			At the end of the beginning: immunotherapies as living drugs (vol 20, pg 955, 2019)	NATURE IMMUNOLOGY			English	Correction																		Feigal EG, 2019, NAT IMMUNOL, V20, P955, DOI 10.1038/s41590-019-0452-8	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1405	1405		10.1038/s41590-019-0476-0	http://dx.doi.org/10.1038/s41590-019-0476-0			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31388150	Bronze			2022-12-18	WOS:000486615900026
J	Martens, A; van Loo, G				Martens, Arne; van Loo, Geert			A20 phosphorylation controls A20 function	NATURE IMMUNOLOGY			English	Editorial Material							LINEAR UBIQUITIN; INHIBITION		[Martens, Arne; van Loo, Geert] VIB, Ctr Inflammat Res, Ghent, Belgium; [Martens, Arne; van Loo, Geert] Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium	Flanders Institute for Biotechnology (VIB); Ghent University	van Loo, G (corresponding author), VIB, Ctr Inflammat Res, Ghent, Belgium.; van Loo, G (corresponding author), Univ Ghent, Dept Biomed Mol Biol, Ghent, Belgium.	geert.vanloo@irc.vib-ugent.be	, van Loo Geert/AAD-1220-2019	, van Loo Geert/0000-0002-8427-4775; Martens, Arne/0000-0002-9816-2512				De A, 2014, EMBO REP, V15, P775, DOI 10.15252/embr.201338305; Draber P, 2015, CELL REP, V13, P2258, DOI 10.1016/j.celrep.2015.11.009; Hutti JE, 2007, MOL CELL BIOL, V27, P7451, DOI 10.1128/MCB.01101-07; Lu TT, 2013, IMMUNITY, V38, P896, DOI 10.1016/j.immuni.2013.03.008; Martens A, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a036418; Polykratis A, 2019, NAT CELL BIOL, V21, P731, DOI 10.1038/s41556-019-0324-3; Shigemura T, 2016, RMD OPEN, V2, DOI 10.1136/rmdopen-2015-000223; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wertz IE, 2015, NATURE, V528, P370, DOI 10.1038/nature16165; Zammit NW, 2019, NAT IMMUNOL, V20, P1299, DOI 10.1038/s41590-019-0492-0; Zhou Q, 2016, NAT GENET, V48, P67, DOI 10.1038/ng.3459	11	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1261	1262		10.1038/s41590-019-0481-3	http://dx.doi.org/10.1038/s41590-019-0481-3			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31534239				2022-12-18	WOS:000486615900007
J	Zeng, H; Chi, HB				Zeng, Hu; Chi, Hongbo			Metabolic sleuthing solves a rare immunodeficiency disease	NATURE IMMUNOLOGY			English	Editorial Material							B-LYMPHOCYTES		[Zeng, Hu] Mayo Clin, Dept Med, Div Rheumatol, Rochester, MN 55905 USA; [Zeng, Hu] Mayo Clin, Dept Immunol, Rochester, MN 55905 USA; [Chi, Hongbo] St Jude Childrens Res Hosp, Dept Immunol, 332 N Lauderdale St, Memphis, TN 38105 USA	Mayo Clinic; Mayo Clinic; St Jude Children's Research Hospital	Zeng, H (corresponding author), Mayo Clin, Dept Med, Div Rheumatol, Rochester, MN 55905 USA.; Zeng, H (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55905 USA.	zeng.hu1@mayo.edu; hongbo.chi@stjude.org	Chi, Hongbo/M-9397-2018	Chi, Hongbo/0000-0002-9997-2496; Zeng, Hu/0000-0002-9909-7732	Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.) [AI131703] Funding Source: Medline	Foundation for the National Institutes of Health (Foundation for the National Institutes of Health, Inc.)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Akkaya M, 2018, NAT IMMUNOL, V19, P871, DOI 10.1038/s41590-018-0156-5; Burgener AV, 2019, NAT IMMUNOL, V20, P1311, DOI 10.1038/s41590-019-0482-2; Caro-Maldonado A, 2014, J IMMUNOL, V192, P3626, DOI 10.4049/jimmunol.1302062; Cho SH, 2011, P NATL ACAD SCI USA, V108, P15972, DOI 10.1073/pnas.1017082108; Doughty CA, 2006, BLOOD, V107, P4458, DOI 10.1182/blood-2005-12-4788; Dufort FJ, 2014, J BIOL CHEM, V289, P7011, DOI 10.1074/jbc.M114.551051; Durandy A, 2013, NAT REV IMMUNOL, V13, P519, DOI 10.1038/nri3466; Garraud O, 2012, BMC IMMUNOL, V13, DOI 10.1186/1471-2172-13-63; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Jellusova J, 2017, NAT IMMUNOL, V18, P303, DOI 10.1038/ni.3664; Kornberg MD, 2018, SCIENCE, V360, P449, DOI 10.1126/science.aan4665; Ogura M, 2017, EUR J IMMUNOL, V47, P406, DOI 10.1002/eji.201646342; Waters LR, 2018, ISCIENCE, V5, P99, DOI 10.1016/j.isci.2018.07.005	13	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2019	20	10					1264	1266		10.1038/s41590-019-0499-6	http://dx.doi.org/10.1038/s41590-019-0499-6			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	IY8AH	31527832				2022-12-18	WOS:000486615900009
J	Fehervari, Z				Fehervari, Zoltan			AMBIENT ENVIRONMENT Humidity and immunity	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					776	776		10.1038/s41590-019-0434-x	http://dx.doi.org/10.1038/s41590-019-0434-x			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ID7VW	31213719	Bronze			2022-12-18	WOS:000471891900004
J	Moynagh, PN				Moynagh, Paul N.			IL-15 in autoimmunity and cancer: O-tu-b or not O-tu-b?	NATURE IMMUNOLOGY			English	Editorial Material								The cytokine IL-15 controls the homeostasis and activation of CD8+ T cells and natural killer cells. A new study reveals the deubiquitinase Otub1 to be a negative regulator of IL-15 signaling, with important consequences for autoimmunity and anti-cancer immunity.	[Moynagh, Paul N.] Natl Univ Ireland Maynooth, Maynooth Univ, Human Hlth Res Inst, Dept Biol, Maynooth, Kildare, Ireland; [Moynagh, Paul N.] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland	Maynooth University; Queens University Belfast	Moynagh, PN (corresponding author), Natl Univ Ireland Maynooth, Maynooth Univ, Human Hlth Res Inst, Dept Biol, Maynooth, Kildare, Ireland.; Moynagh, PN (corresponding author), Queens Univ Belfast, Sch Med Dent & Biomed Sci, Wellcome Wolfson Inst Expt Med, Belfast, Antrim, North Ireland.	paul.moynagh@mu.ie		Moynagh, Paul/0000-0002-4139-3061				Castillo EF, 2012, CYTOKINE, V59, P479, DOI 10.1016/j.cyto.2012.06.017; Deshpande P, 2013, J IMMUNOL, V190, P1416, DOI 10.4049/jimmunol.1201620; Hao MG, 2018, BIOCHEM PHARMACOL, V147, P128, DOI 10.1016/j.bcp.2017.11.013; Herhaus L, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.aaa0441; Kurioka A, 2018, IMMUNOLOGY, V154, P547, DOI 10.1111/imm.12925; Li YH, 2014, J BIOL CHEM, V289, P5097, DOI 10.1074/jbc.M113.533109; Lin JX, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a028449; Saldana M, 2019, ENDOCR-RELAT CANCER, V26, pR1, DOI 10.1530/ERC-18-0264; Scholz CC, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002347; Yuan L, 2017, AM J CANCER RES, V7, P159; Zhou XF, 2019, NAT IMMUNOL, V20, P879, DOI 10.1038/s41590-019-0405-2	11	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2019	20	7					780	782		10.1038/s41590-019-0424-z	http://dx.doi.org/10.1038/s41590-019-0424-z			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	JD0SA	31182806				2022-12-18	WOS:000489685100001
J	Fehervari, Z				Fehervari, Zoltan			Controlling PD-L1 in cis	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					665	665		10.1039/s41590-019-0412-3	http://dx.doi.org/10.1039/s41590-019-0412-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31110310				2022-12-18	WOS:000468505100003
J	Giannakis, N; Sansbury, BE; Patsalos, A; Hays, TT; Riley, CO; Han, XL; Spite, M; Nagy, L				Giannakis, Nikolas; Sansbury, Brian E.; Patsalos, Andreas; Hays, Tristan T.; Riley, Colin O.; Han, Xianlin; Spite, Matthew; Nagy, Laszlo			Dynamic changes to lipid mediators support transitions among macrophage subtypes during muscle regeneration (vol 20, pg 626, 2019)	NATURE IMMUNOLOGY			English	Correction													Patsalos, Andreas/L-8957-2019; Patsalos, Andreas/GQY-7136-2022; Nagy, Laszlo/A-3814-2008	Patsalos, Andreas/0000-0002-9022-4985; Patsalos, Andreas/0000-0002-9022-4985; Spite, Matthew/0000-0002-8868-3648; Giannakis, Nikolas/0000-0002-5005-1928; Nagy, Laszlo/0000-0001-6653-2155				Giannakis N, 2019, NAT IMMUNOL, V20, P626, DOI 10.1038/s41590-019-0356-7	1	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					765	767		10.1038/s41590-019-0401-6	http://dx.doi.org/10.1038/s41590-019-0401-6			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31048759	Bronze			2022-12-18	WOS:000468505100020
J	Visan, I				Visan, Ioana			Triggers of inflammation	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					665	665		10.1038/s41590-019-0410-5	http://dx.doi.org/10.1038/s41590-019-0410-5			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31110307	Bronze			2022-12-18	WOS:000468505100005
J	Zikherman, J				Zikherman, Julie			GC B cells 'AKT' to blunt BCR signaling	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR; SELECTION	A novel feedback loop coordinated by germinal center-specific signaling via the kinase AKT activates negative regulators of upstream BCR signaling to attenuate responses to antigen stimulation.	[Zikherman, Julie] Univ Calif San Francisco, Div Rheumatol, Rosalind Russell & Ephraim P Engleman Arthrit Res, Dept Med, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Zikherman, J (corresponding author), Univ Calif San Francisco, Div Rheumatol, Rosalind Russell & Ephraim P Engleman Arthrit Res, Dept Med, San Francisco, CA 94143 USA.	julie.zikherman@ucsf.edu			NIAMS NIH HHS [R01 AR069520] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069520] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Browne CD, 2009, IMMUNITY, V31, P749, DOI 10.1016/j.immuni.2009.08.026; Khalil AM, 2012, SCIENCE, V336, P1178, DOI 10.1126/science.1213368; Kuraoka M, 2016, IMMUNITY, V44, P542, DOI 10.1016/j.immuni.2016.02.010; Luo W, 2019, NAT IMMUNOL, V20, P736, DOI 10.1038/s41590-019-0376-3; Luo W, 2018, IMMUNITY, V48, P313, DOI 10.1016/j.immuni.2018.01.008; Mesin L, 2016, IMMUNITY, V45, P471, DOI 10.1016/j.immuni.2016.09.001; Mueller J, 2015, J IMMUNOL, V194, P2993, DOI 10.4049/jimmunol.1403086; Natkanski E, 2013, SCIENCE, V340, P1587, DOI [10.1126/science.1237572, 10.1126/science.1238328]; Nowosad CR, 2016, NAT IMMUNOL, V17, P870, DOI 10.1038/ni.3458; Smith MJ, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.123384; Tas JMJ, 2016, SCIENCE, V351, P1048, DOI 10.1126/science.aad3439; Turner JS, 2018, CELL REP, V25, P1395, DOI 10.1016/j.celrep.2018.10.042; Victora GD, 2010, CELL, V143, P592, DOI 10.1016/j.cell.2010.10.032	13	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2019	20	6					671	674		10.1038/s41590-019-0384-3	http://dx.doi.org/10.1038/s41590-019-0384-3			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HZ0BI	31011188				2022-12-18	WOS:000468505100009
J	Choi, YJ; Kim, S; Choi, Y; Nielsen, TB; Yan, J; Lu, A; Ruan, JB; Lee, HR; Wu, H; Spellberg, B; Jung, JU				Choi, Youn Jung; Kim, Stephanie; Choi, Younho; Nielsen, Travis B.; Yan, Jun; Lu, Alvin; Ruan, Jianbin; Lee, Hye-Ra; Wu, Hao; Spellberg, Brad; Jung, Jae U.			SERPINB1-mediated checkpoint of inflammatory caspase activation (vol 20, pg 276, 2019)	NATURE IMMUNOLOGY			English	Correction															NCI NIH HHS [P01 CA180779, R35 CA200422] Funding Source: Medline; NIAID NIH HHS [R21 AI127954, R21 AI129496, R01 AI116585, R01 AI140718, R01 AI073099, R01 AI081719, R41 AI106375, R01 AI117211] Funding Source: Medline; NICHD NIH HHS [DP1 HD087988] Funding Source: Medline; NIDCR NIH HHS [R21 DE027888, R01 DE028521] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Choi YJ, 2019, NAT IMMUNOL, V20, P276, DOI 10.1038/s41590-018-0303-z	1	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					664	664		10.1038/s41590-019-0361-x	http://dx.doi.org/10.1038/s41590-019-0361-x			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30846880	Green Accepted, Bronze			2022-12-18	WOS:000465084800025
J	Mueller, SN				Mueller, Scott N.			IL-17 instructs lymphoid stromal cells	NATURE IMMUNOLOGY			English	Editorial Material							RESPONSES; NETWORK; GROWTH	The cytokine IL-17 augments metabolism in fibroblastic reticular cells in lymph nodes, which enhances their proliferation and survival to support B cell responses during autoimmunity.	[Mueller, Scott N.] Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia; [Mueller, Scott N.] Univ Melbourne, Australian Res Council Ctr Excellence Adv Mol Ima, Melbourne, Vic, Australia	University of Melbourne; University of Melbourne	Mueller, SN (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Peter Doherty Inst Infect & Immun, Melbourne, Vic, Australia.; Mueller, SN (corresponding author), Univ Melbourne, Australian Res Council Ctr Excellence Adv Mol Ima, Melbourne, Vic, Australia.	smue@unimelb.edu.au	Mueller, Scott/B-1918-2012	Mueller, Scott/0000-0002-3838-3989				Acton SE, 2014, NATURE, V514, P498, DOI 10.1038/nature13814; Alexandre YO, 2018, IMMUNOL REV, V283, P77, DOI 10.1111/imr.12641; Astarita JL, 2015, NAT IMMUNOL, V16, P75, DOI 10.1038/ni.3035; Chyou S, 2011, J IMMUNOL, V187, P5558, DOI 10.4049/jimmunol.1101724; Cremasco V, 2014, NAT IMMUNOL, V15, P973, DOI 10.1038/ni.2965; Dubey LK, 2016, CELL REP, V15, P1527, DOI 10.1016/j.celrep.2016.04.023; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Gregory JL, 2017, CELL REP, V18, P406, DOI 10.1016/j.celrep.2016.12.038; Majumder S, 2019, NAT IMMUNOL, V20, P534, DOI 10.1038/s41590-019-0367-4; Pikor NB, 2015, IMMUNITY, V43, P1160, DOI 10.1016/j.immuni.2015.11.010; Veldhoen M, 2017, NAT IMMUNOL, V18, P612, DOI 10.1038/ni.3742; Yang CY, 2014, P NATL ACAD SCI USA, V111, pE109, DOI 10.1073/pnas.1312585111	12	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2019	20	5					524	526		10.1038/s41590-019-0375-4	http://dx.doi.org/10.1038/s41590-019-0375-4			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HU2ET	30962592				2022-12-18	WOS:000465084800009
J	Iyer, SS; Huang, YH; Blumberg, RS				Iyer, Shankar S.; Huang, Yu-Hwa; Blumberg, Richard S.			SLAM-ing the brakes on iNKT cell selection	NATURE IMMUNOLOGY			English	Editorial Material							FAMILY RECEPTORS; SAP	Members of the SLAM family of receptors promote the progression of invariant natural killer T cells through the thymic maturation process and facilitate proper host responses to exogenous lipid antigen through the recruitment and activity of SAP-Fyn and SHP-1, respectively.	[Iyer, Shankar S.; Huang, Yu-Hwa; Blumberg, Richard S.] Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Iyer, SS; Blumberg, RS (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Dept Med, Div Gastroenterol Hepatol & Endoscopy, Boston, MA 02115 USA.	ssiyer@bwh.havard.edu; rblumberg@bwh.harvard.edu			NIDDK NIH HHS [R01 DK051362, R01 DK044319] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044319] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Cannons JL, 2011, ANNU REV IMMUNOL, V29, P665, DOI 10.1146/annurev-immunol-030409-101302; Chen SS, 2017, J EXP MED, V214, P475, DOI 10.1084/jem.20161312; Detre C, 2010, SEMIN IMMUNOPATHOL, V32, P157, DOI 10.1007/s00281-009-0193-0; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Griewank K, 2007, IMMUNITY, V27, P751, DOI 10.1016/j.immuni.2007.08.020; Lu Y, 2019, NAT IMMUNOL, V20, P447, DOI 10.1038/s41590-019-0334-0; Moran AE, 2011, J EXP MED, V208, P1279, DOI 10.1084/jem.20110308; Nunez-Cruz S, 2008, J IMMUNOL, V181, P2311, DOI 10.4049/jimmunol.181.4.2311; Veillette A, 2006, IMMUNOL REV, V214, P22, DOI 10.1111/j.1600-065X.2006.00453.x; Wang HG, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01450	10	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					378	379		10.1038/s41590-019-0355-8	http://dx.doi.org/10.1038/s41590-019-0355-8			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30858622	Green Accepted			2022-12-18	WOS:000461904200006
J	Willcox, BE; Willcox, CR				Willcox, Benjamin E.; Willcox, Carrie R.			gamma delta TCR ligands: the quest to solve a 500-million-year-old mystery (vol 20, pg 121, 2019)	NATURE IMMUNOLOGY			English	Correction									[Willcox, Benjamin E.] Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England; Univ Birmingham, Inst Immunol & Immunotherapy, Canc Immunol & Immunotherapy Ctr, Canc Res UK Birmingham Ctr, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Willcox, BE (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England.							Willcox BE, 2019, NAT IMMUNOL, V20, P121, DOI 10.1038/s41590-018-0304-y	1	1	1	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2019	20	4					516	516		10.1038/s41590-019-0358-5	http://dx.doi.org/10.1038/s41590-019-0358-5			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HP7XP	30816307	Bronze			2022-12-18	WOS:000461904200024
J	Krammer, F				Krammer, Florian			Fighting influenza through hemagglutinin diversity	NATURE IMMUNOLOGY			English	Editorial Material									[Krammer, Florian] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Krammer, F (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	florian.krammer@mssm.edu	Krammer, Florian/H-3237-2019	Krammer, Florian/0000-0003-4121-776X	Bill and Melinda Gates Foundation; US Department of Defense; PATH; US National Institute of Allergy and Infectious Diseases; GlaxoSmithKline	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); US Department of Defense(United States Department of Defense); PATH; US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); GlaxoSmithKline(GlaxoSmithKline)	The Icahn School of Medicine at Mount Sinai has filed patent applications for vaccines against influenza virus that name F.K. as an inventor. The Krammer laboratory currently receives funding from the Bill and Melinda Gates Foundation, the US Department of Defense, PATH, the US National Institute of Allergy and Infectious Diseases and GlaxoSmithKline for research on vaccines against influenza virus.	Anderson AM, 2018, J IMMUNOL, V200, P2057, DOI 10.4049/jimmunol.1701088; Andrews SF, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0522; Broecker F, 2018, J VIROL, V92, DOI 10.1128/JVI.01100-18; Ekiert DC, 2012, NATURE, V489, P526, DOI 10.1038/nature11414; Garretson TA, 2018, VACCINE, V36, P4095, DOI 10.1016/j.vaccine.2018.05.086; Kanekiyo M., 2019, NAT IMMUNOL, DOI [10.1038/s41559-018-0305-x, DOI 10.1038/S41559-018-0305-X]; Kirkpatrick E, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28706-1; Krammer F, 2017, EXPERT REV VACCINES, V16, P503, DOI 10.1080/14760584.2017.1299576; Liu STH, 2018, J CLIN INVEST, V128, P4992, DOI 10.1172/JCI122895; Pica N, 2012, P NATL ACAD SCI USA, V109, P2573, DOI 10.1073/pnas.1200039109; Sun WN, 2019, J VIROL, V93, DOI 10.1128/JVI.01673-18; Woodruff MC, 2018, CELL REP, V25, P321, DOI 10.1016/j.celrep.2018.09.029	12	1	1	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					246	247		10.1038/s41590-019-0317-1	http://dx.doi.org/10.1038/s41590-019-0317-1			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30742079				2022-12-18	WOS:000458893600006
J	Lim, AI; Harrison, OJ; Belkaid, Y				Lim, Ai Ing; Harrison, Oliver J.; Belkaid, Yasmine			Pre-birth memory	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; ABUNDANT		[Lim, Ai Ing; Harrison, Oliver J.; Belkaid, Yasmine] NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Belkaid, Yasmine] NIAID, NIAID Microbiome Program, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Belkaid, Yasmine] NIH, Ctr Human Immunol, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA	Belkaid, Y (corresponding author), NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Belkaid, Y (corresponding author), NIAID, NIAID Microbiome Program, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Belkaid, Y (corresponding author), NIH, Ctr Human Immunol, Bldg 10, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov		LIM, AI ING/0000-0001-8834-3136	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001132] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; BYRNE JA, 1994, J IMMUNOL, V152, P3098; Hegazy AN, 2017, GASTROENTEROLOGY, V153, P1320, DOI 10.1053/j.gastro.2017.07.047; Kinder JM, 2017, NAT REV IMMUNOL, V17, P483, DOI 10.1038/nri.2017.38; Li N, 2018, J EXP MED, V215, P1383, DOI 10.1084/jem.20171934; Li X., 2019, NAT IMMUNOL, DOI [10.1038/s41590-019-0514-y, DOI 10.1038/S41590-018-0294-9, DOI 10.1038/S41590-019-0514-Y]; McGovern N, 2017, NATURE, V546, P662, DOI 10.1038/nature22795; Senda T, 2018, MUCOSAL IMMUNOL; Su LF, 2013, IMMUNITY, V38, P373, DOI 10.1016/j.immuni.2012.10.021; Thome JJC, 2016, NAT MED, V22, P72, DOI 10.1038/nm.4008; Zhang X, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008748	12	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2019	20	3					254	256		10.1038/s41590-019-0326-0	http://dx.doi.org/10.1038/s41590-019-0326-0			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HL7CA	30742077				2022-12-18	WOS:000458893600010
J	Soveg, F; Von Moltke, J; Savan, R				Soveg, Frank; Von Moltke, Jakob; Savan, Ram			CIRCling the wagons to protect intestinal stem cells	NATURE IMMUNOLOGY			English	Editorial Material								Innate lymphoid cell-derived cytokine IL-13 promotes the maintenance of intestinal stem cells through stabilization of ss-catenin. The circular RNA circPan3 regulates mRNA encoding the cytokine receptor subunit IL-13R alpha and downstream IL-13 signaling to stabilize the ss-catenin pathway in intestinal stem cells.	[Soveg, Frank; Von Moltke, Jakob; Savan, Ram] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Savan, R (corresponding author), Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98195 USA.	savanram@uw.edu		Savan, Ram/0000-0002-3087-1355	NIGMS NIH HHS [T32 GM007270] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007270] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali N, 2017, CELL, V169, P1119, DOI 10.1016/j.cell.2017.05.002; Allaire JM, 2018, TRENDS IMMUNOL, V39, P677, DOI 10.1016/j.it.2018.04.002; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Biton M, 2018, CELL, V175, P1307, DOI 10.1016/j.cell.2018.10.008; Haber AL, 2017, NATURE, V551, P333, DOI 10.1038/nature24489; Howitt MR, 2016, SCIENCE, V351, P1329, DOI 10.1126/science.aaf1648; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Nusse YM, 2018, NATURE, V559, P109, DOI 10.1038/s41586-018-0257-1; Salzman J, 2016, TRENDS GENET, V32, P309, DOI 10.1016/j.tig.2016.03.002; van Es JH, 2012, MOL CELL BIOL, V32, P1918, DOI 10.1128/MCB.06288-11; von Moltke J, 2016, NATURE, V529, P221, DOI 10.1038/nature16161; Walker M. P., 2013, SCI SIGNAL, V362; Zhu PP, 2019, NAT IMMUNOL, V20, P183, DOI 10.1038/s41590-018-0297-6	14	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2019	20	2					114	116		10.1038/s41590-018-0302-0	http://dx.doi.org/10.1038/s41590-018-0302-0			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2MK	30643260				2022-12-18	WOS:000456279100007
J	Aschenbrenner, D; Foglierini, M; Jarrossay, D; Hu, D; Weiner, HL; Kuchroo, VK; Lanzavecchia, A; Notarbartolo, S; Sallusto, F				Aschenbrenner, Dominik; Foglierini, Mathilde; Jarrossay, David; Hu, Dan; Weiner, Howard L.; Kuchroo, Vijay K.; Lanzavecchia, Antonio; Notarbartolo, Samuele; Sallusto, Federica			An immunoregulatory and tissue-residency program modulated by c-MAF in human T(H)17 cells (vol 19, pg 1126, 2018)	NATURE IMMUNOLOGY			English	Correction													Notarbartolo, Samuele/X-9697-2019	Notarbartolo, Samuele/0000-0001-5910-4910; Aschenbrenner, Dominik/0000-0001-7580-2567; Foglierini, Mathilde/0000-0001-7538-4262; Sallusto, Federica/0000-0003-3750-2752				Aschenbrenner D, 2018, NAT IMMUNOL, V19, P1126, DOI 10.1038/s41590-018-0200-5	1	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					109	109		10.1038/s41590-018-0264-2	http://dx.doi.org/10.1038/s41590-018-0264-2			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30448856	Bronze			2022-12-18	WOS:000456273900019
J	Dempsey, LA				Dempsey, Laurie A.			cDC1 cross-priming	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					1	1		10.1038/s41590-018-0283-z	http://dx.doi.org/10.1038/s41590-018-0283-z			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30538331	Bronze			2022-12-18	WOS:000456273900005
J	Dempsey, LA				Dempsey, Laurie A.			Mst kinase roles	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					1	1		10.1038/s41590-018-0284-y	http://dx.doi.org/10.1038/s41590-018-0284-y			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30538332	Bronze			2022-12-18	WOS:000456273900001
J	Fehervari, Z				Fehervari, Zoltan			Blood-brain barrier integrity	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2019	20	1					1	1		10.1038/s41590-018-0286-9	http://dx.doi.org/10.1038/s41590-018-0286-9			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	HI2KL	30538333	Bronze			2022-12-18	WOS:000456273900003
J	Fehervari, Z				Fehervari, Zoltan			Targeting cancer by Siglecs	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1148	1148		10.1038/s41590-018-0247-3	http://dx.doi.org/10.1038/s41590-018-0247-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30333610	Bronze			2022-12-18	WOS:000447632200005
J	Lok, SM				Lok, Shee-Mei			Flat-lying antibody prevents disease enhancement	NATURE IMMUNOLOGY			English	Editorial Material							CRYSTAL-STRUCTURE; FC; COMPLEX; VIRUS	An antibody to dengue virus that lies flat on its target, neutralizes the virus and also prevents antibody-dependent enhancement of infection is now identified.	[Lok, Shee-Mei] Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore; [Lok, Shee-Mei] Natl Univ Singapore, Ctr BioImaging Sci, Singapore, Singapore	National University of Singapore; National University of Singapore	Lok, SM (corresponding author), Duke NUS Med Sch, Program Emerging Infect Dis, Singapore, Singapore.; Lok, SM (corresponding author), Natl Univ Singapore, Ctr BioImaging Sci, Singapore, Singapore.	sheemei.lok@duke-nus.edu.sg		Lok, Shee-Mei/0000-0003-4631-8041				Fibriansah G, 2013, J VIROL, V87, P7585, DOI 10.1128/JVI.00757-13; Halstead SB, 2003, ADV VIRUS RES, V60, P421, DOI 10.1016/S0065-3527(03)60011-4; Kostyuchenko VA, 2014, J VIROL, V88, P477, DOI 10.1128/JVI.02641-13; Radaev S, 2001, J BIOL CHEM, V276, P16469, DOI 10.1074/jbc.M100350200; Radaev S, 2002, MOL IMMUNOL, V38, P1073, DOI 10.1016/S0161-5890(02)00036-6; Renner M, 2018, NAT IMMUNOL, V19, P1248, DOI 10.1038/s41590-018-0227-7; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sondermann P, 2000, NATURE, V406, P267, DOI 10.1038/35018508; Zhang XK, 2013, NAT STRUCT MOL BIOL, V20, P105, DOI 10.1038/nsmb.2463; Zhang XZ, 2013, P NATL ACAD SCI USA, V110, P6795, DOI 10.1073/pnas.1304300110	10	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1150	1152		10.1038/s41590-018-0239-3	http://dx.doi.org/10.1038/s41590-018-0239-3			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30323339				2022-12-18	WOS:000447632200008
J	Park, JY; Park, JH				Park, Joo-Young; Park, Jung-Hyun			Remote control of gamma c expression by arginine methylation	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; CHAIN; PRMT5; REVEALS; PROTEIN; GENE	Arginine methylation is a post-translational modification that controls the abundance of gamma c cytokine receptor on mature T cells by a post-transcriptional mechanism.	[Park, Joo-Young; Park, Jung-Hyun] NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA; [Park, Joo-Young] Seoul Natl Univ, Dept Oral & Maxillofacial Surg, Dent Hosp, Seoul, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Seoul National University (SNU)	Park, JH (corresponding author), NCI, Expt Immunol Branch, Ctr Canc Res, NIH, Bldg 10, Bethesda, MD 20892 USA.	parkhy@mail.nih.gov	Park, Jung Hyun/B-5712-2015	Park, Jung Hyun/0000-0002-9547-9055; Park, Joo-Young/0000-0002-0333-6349	NATIONAL CANCER INSTITUTE [ZIABC011214] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 CA999999] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Bezzi M, 2013, GENE DEV, V27, P1903, DOI 10.1101/gad.219899.113; Blanc RS, 2017, MOL CELL, V65, P8, DOI 10.1016/j.molcel.2016.11.003; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Geoghegan V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7758; Hong CW, 2014, IMMUNITY, V40, P910, DOI 10.1016/j.immuni.2014.04.020; Inoue M, 2018, NAT IMMUNOL, V19, P1265, DOI 10.1038/s41590-018-0222-z; Liu F, 2015, J CLIN INVEST, V125, P3532, DOI 10.1172/JCI81749; Markiewicz S, 1996, J BIOL CHEM, V271, P14849, DOI 10.1074/jbc.271.25.14849; McCaughtry TM, 2012, J EXP MED, V209, P2263, DOI 10.1084/jem.20121505; Tee WW, 2010, GENE DEV, V24, P2772, DOI 10.1101/gad.606110; Waickman AT, 2016, CELL MOL LIFE SCI, V73, P253, DOI 10.1007/s00018-015-2062-4	12	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1152	1154		10.1038/s41590-018-0240-x	http://dx.doi.org/10.1038/s41590-018-0240-x			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30323340	Green Accepted			2022-12-18	WOS:000447632200009
J	[Anonymous]				[Anonymous]			Old foes and new enemies	NATURE IMMUNOLOGY			English	Editorial Material								Better understanding of the biology of infectious agents and of the mechanisms of efficient immune responses advances strategies to achieve protection against infectious diseases.											0	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2018	19	11					1147	1147		10.1038/s41590-018-0252-6	http://dx.doi.org/10.1038/s41590-018-0252-6			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GX3NT	30333616	Bronze			2022-12-18	WOS:000447632200001
J	Agazio, AE; Pelanda, R; Torres, RM				Agazio, Amanda E.; Pelanda, Roberta; Torres, Raul M.			Silencing of TLM B cells by chronic HIV infection	NATURE IMMUNOLOGY			English	Editorial Material							INDIVIDUALS; POPULATION; COMPARTMENT; EXHAUSTION; EXPRESSION	Chronic infection with human immunodeficiency virus impairs B cell antigen receptor signaling via a newly described mechanism of inhibitory signaling mediated by IgG3 and the IgG Fc receptor FcR gamma IIb (CD32b).	[Agazio, Amanda E.; Pelanda, Roberta; Torres, Raul M.] Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Torres, RM (corresponding author), Univ Colorado, Sch Med, Dept Immunol & Microbiol, Aurora, CO 80045 USA.	raul.torres@ucdenver.edu		Agazio, Amanda/0000-0003-3344-7901	NIAID NIH HHS [R01 AI052310, R01 AI136534, R21 AI131639, R01 AI124474] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI131639, R01AI052310, R01AI124474] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Doi H, 2014, CLIN IMMUNOL, V150, P184, DOI 10.1016/j.clim.2013.12.001; Ehrhardt GRA, 2005, J EXP MED, V202, P783, DOI 10.1084/jem.20050879; Isnardi I, 2010, BLOOD, V115, P5026, DOI 10.1182/blood-2009-09-243071; Kardava L, 2018, NAT IMMUNOL, V19, P1001, DOI 10.1038/s41590-018-0180-5; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; Moir S, 2001, P NATL ACAD SCI USA, V98, P10362, DOI 10.1073/pnas.181347898; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Rubtsova K, 2017, J CLIN INVEST, V127, P1392, DOI 10.1172/JCI91250; Wang TT, 2015, IMMUNITY, V42, P213, DOI 10.1016/j.immuni.2015.01.022; Wei C, 2007, J IMMUNOL, V178, P6624, DOI 10.4049/jimmunol.178.10.6624; Weiss GE, 2009, J IMMUNOL, V183, P2176, DOI 10.4049/jimmunol.0901297; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862	12	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					902	903		10.1038/s41590-018-0191-2	http://dx.doi.org/10.1038/s41590-018-0191-2			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30104630				2022-12-18	WOS:000442365100008
J	Rosenzweig, SD				Rosenzweig, Sergio D.			LOld vaccines, new diseases: when BCG meets SPPL2a	NATURE IMMUNOLOGY			English	Editorial Material							SEVERE COMBINED IMMUNODEFICIENCY; INTRAMEMBRANE PROTEASE SPPL2A; INVARIANT CHAIN; B-CELL; DENDRITIC CELLS; VACCINATION; SURVIVAL; CLEAVAGE	In the current issue of Nature Immunology, Casanova and colleagues demonstrate that humans (and mouse models) with autosomal-recessive SPPL2a deficiency have a severe defect in conventional dendritic cell 2 survival and production of IL-12 and IL-23, and diminished IFN-gamma secretion by mycobacterium-specific memory T cells, thus resulting in increased susceptibility to mycobacterial diseases.	[Rosenzweig, Sergio D.] NIH, Immunol Serv, Dept Lab Med, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH Clinical Center (CC)	Rosenzweig, SD (corresponding author), NIH, Immunol Serv, Dept Lab Med, Clin Ctr, Bldg 10, Bethesda, MD 20892 USA.	srosenzweig@cc.nih.gov			Intramural Research Program, NIH Clinical Center, US National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001122] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL010304] Funding Source: NIH RePORTER	Intramural Research Program, NIH Clinical Center, US National Institutes of Health (NIH); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CLINICAL CENTER	This work was supported by the Intramural Research Program, NIH Clinical Center, US National Institutes of Health (NIH). The content of this article does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government.	[Anonymous], 2013, VACCINES; Beisner DR, 2013, J EXP MED, V210, P23, DOI 10.1084/jem.20121072; Bergmann H, 2013, J EXP MED, V210, P31, DOI 10.1084/jem.20121076; Bustamante J, 2014, SEMIN IMMUNOL, V26, P454, DOI 10.1016/j.smim.2014.09.008; Garly ML, 2003, VACCINE, V21, P2782, DOI 10.1016/S0264-410X(03)00181-6; GOOD RA, 1956, PEDIATRICS, V18, P109; Iwakoshi NN, 2007, J EXP MED, V204, P2267, DOI 10.1084/jem.20070525; Jameson SC, 2018, CSH PERSPECT BIOL, V10, DOI 10.1101/cshperspect.a029132; Jensen KJ, 2015, J INFECT DIS, V211, P956, DOI 10.1093/infdis/jiu508; Kong XF, 2018, NAT IMMUNOL, V19, P973, DOI 10.1038/s41590-018-0178-z; Kwan A, 2014, JAMA-J AM MED ASSOC, V312, P729, DOI 10.1001/jama.2014.9132; Marciano BE, 2014, J ALLERGY CLIN IMMUN, V133, P1134, DOI 10.1016/j.jaci.2014.02.028; Nieuwenhuizen NE, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00121; Schneppenheim J, 2013, J EXP MED, V210, P41, DOI 10.1084/jem.20121069; Schroder B, 2016, BBA-MOL CELL RES, V1863, P1269, DOI 10.1016/j.bbamcr.2016.03.026; Talbot EA, 1997, CLIN INFECT DIS, V24, P1139, DOI 10.1086/513642	16	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2018	19	9					906	907		10.1038/s41590-018-0193-0	http://dx.doi.org/10.1038/s41590-018-0193-0			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GR2BU	30127437	Bronze			2022-12-18	WOS:000442365100010
J	Fehervari, Z				Fehervari, Zoltan			Macrophages: damage control (vol 19, pg 99, 2018)	NATURE IMMUNOLOGY			English	Correction																		Fehervari Z, 2018, NAT IMMUNOL, V19, P99, DOI 10.1038/s41590-017-0040-8	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					898	898		10.1038/s41590-018-0159-2	http://dx.doi.org/10.1038/s41590-018-0159-2			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN9AM	29955110	Bronze			2022-12-18	WOS:000439470900024
J	McGraw, JM; Havran, WL				McGraw, J. Michael; Havran, Wendy L.			gamma delta T cells and IgE team up to prevent tumors	NATURE IMMUNOLOGY			English	Editorial Material							IMMUNITY; CANCER		[McGraw, J. Michael; Havran, Wendy L.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA	Scripps Research Institute	Havran, WL (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	havran@scripps.edu						Crawford G, 2018, NAT IMMUNOL, V19, P859, DOI 10.1038/s41590-018-0161-8; Dalessandri T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12080; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Gieseck RL, 2018, NAT REV IMMUNOL, V18, P62, DOI 10.1038/nri.2017.90; Goon PKC, 2016, ACTA DERM-VENEREOL, V96, P820, DOI 10.2340/00015555-2310; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Nielsen MM, 2017, NAT REV IMMUNOL, V17, P733, DOI 10.1038/nri.2017.101; Silva-Santos B, 2015, NAT REV IMMUNOL, V15, P683, DOI 10.1038/nri3904; Strid J, 2008, NAT IMMUNOL, V9, P146, DOI 10.1038/ni1556; Strid J, 2011, SCIENCE, V334, P1293, DOI 10.1126/science.1211250; Strunk RC, 2006, NEW ENGL J MED, V354, P2689, DOI 10.1056/NEJMct055184; Walker JA, 2018, NAT REV IMMUNOL, V18, P121, DOI 10.1038/nri.2017.118; Wulaningsih W, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1154250	13	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2018	19	8					793	795		10.1038/s41590-018-0167-2	http://dx.doi.org/10.1038/s41590-018-0167-2			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GN9AM	30013144				2022-12-18	WOS:000439470900014
J	Dempsey, LA				Dempsey, Laurie A.			Targeting Ebola	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					647	647		10.1038/s41590-018-0148-5	http://dx.doi.org/10.1038/s41590-018-0148-5			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29925985	Bronze			2022-12-18	WOS:000436341300003
J	[Anonymous]				[Anonymous]			Living with the enemy	NATURE IMMUNOLOGY			English	Editorial Material								Autoimmune disease has proven to be a unique conceptual and medical challenge, but hope for effective targeted therapies is tantalizingly close.											0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2018	19	7					658	658		10.1038/s41590-018-0153-8	http://dx.doi.org/10.1038/s41590-018-0153-8			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GK6ZD	29925995	Bronze			2022-12-18	WOS:000436341300010
J	Klein, L				Klein, Ludger			Bruno Kyewski 1950-2018 obituary	NATURE IMMUNOLOGY			English	Biographical-Item									[Klein, Ludger] Ludwig Maximilians Univ Munchen, Inst Immunol, Munich, Germany	University of Munich	Klein, L (corresponding author), Ludwig Maximilians Univ Munchen, Inst Immunol, Munich, Germany.	ludger.klein@med.uni-muenchen.de	Klein, Ludger/G-8785-2011	Klein, Ludger/0000-0003-2054-071X					0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					509	509		10.1038/s41590-018-0095-1	http://dx.doi.org/10.1038/s41590-018-0095-1			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29643481	Bronze			2022-12-18	WOS:000433041500001
J	Lee, J; Georgiou, G				Lee, Jiwon; Georgiou, George			High-affinity IgA against microbial glycans	NATURE IMMUNOLOGY			English	Editorial Material							COMMENSAL BACTERIA; RESPONSES		[Lee, Jiwon; Georgiou, George] Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Georgiou, G (corresponding author), Univ Texas Austin, Dept Chem Engn, Austin, TX 78712 USA.	gg@che.utexas.edu		Lee, Jiwon/0000-0001-7835-3621				Bunker JJ, 2015, IMMUNITY, V43, P541, DOI 10.1016/j.immuni.2015.08.007; Guachalla LM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06682-2; Hansen DS, 1999, J CLIN MICROBIOL, V37, P56, DOI 10.1128/JCM.37.1.56-62.1999; Lee J, 2016, NAT MED, V22, P1023, DOI 10.1038/nm.4145; Macpherson AJ, 2000, SCIENCE, V288, P2222, DOI 10.1126/science.288.5474.2222; McKenna M, 2013, NATURE, V499, P394, DOI 10.1038/499394a; Pabst O, 2016, TRENDS IMMUNOL, V37, P287, DOI 10.1016/j.it.2016.03.002; Paczosa MK, 2016, MICROBIOL MOL BIOL R, V80, P629, DOI 10.1128/MMBR.00078-15; Pennini ME, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02223-7; Rollenske T., 2018, NAT IMMUNOL, DOI [10.1038/s10.1038/s41590-018-0106-2, DOI 10.1038/S10.1038/S41590-018-0106-2]; Szijarto V, 2017, VIRULENCE, V8, P1203, DOI 10.1080/21505594.2017.1279778	12	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					514	515		10.1038/s41590-018-0116-0	http://dx.doi.org/10.1038/s41590-018-0116-0			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777208				2022-12-18	WOS:000433041500015
J	Tough, DF				Tough, David F.			Influenza's signature move	NATURE IMMUNOLOGY			English	Editorial Material									[Tough, David F.] GSK Med Res Ctr, Oncol & Immunoinflammat Therapy Area Units, Epigenet Discovery Performance Unit, Stevenage, Herts, England	GlaxoSmithKline	Tough, DF (corresponding author), GSK Med Res Ctr, Oncol & Immunoinflammat Therapy Area Units, Epigenet Discovery Performance Unit, Stevenage, Herts, England.	david.f.tough@gsk.com						Chaussabel D, 2008, IMMUNITY, V29, P150, DOI 10.1016/j.immuni.2008.05.012; Dunning J, 2018, NAT IMMUNOL, V19, P625, DOI 10.1038/s41590-018-0111-5; Iuliano AD, 2018, LANCET, V391, P1285, DOI 10.1016/S0140-6736(17)33293-2; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Rynda-Apple A, 2015, INFECT IMMUN, V83, P3764, DOI 10.1128/IAI.00298-15; Schliehe C, 2015, NAT IMMUNOL, V16, P67, DOI 10.1038/ni.3046; Woods CW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052198; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006	8	1	2	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2018	19	6					519	+		10.1038/s41590-018-0115-1	http://dx.doi.org/10.1038/s41590-018-0115-1			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GG9SN	29777225				2022-12-18	WOS:000433041500017
J	Papotto, PH; Silva-Santos, B				Papotto, Pedro H.; Silva-Santos, Bruno			Got my gamma delta 17 T cells to keep me warm	NATURE IMMUNOLOGY			English	Editorial Material							FAT		[Papotto, Pedro H.; Silva-Santos, Bruno] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal	Universidade de Lisboa	Silva-Santos, B (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.	bssantos@medicina.ulisboa.pt		Silva-Santos, Bruno/0000-0003-4141-9302; Papotto, Pedro/0000-0002-2488-7182				Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Haas JD, 2012, IMMUNITY, V37, P48, DOI 10.1016/j.immuni.2012.06.003; Kohlgruber AC, 2018, NAT IMMUNOL, V19, P464, DOI 10.1038/s41590-018-0094-2; Lynch L, 2015, NAT IMMUNOL, V16, P85, DOI 10.1038/ni.3047; Muschaweckh A, 2017, J IMMUNOL, V199, P2668, DOI 10.4049/jimmunol.1700287; Odegaard JI, 2016, CELL, V166, P841, DOI 10.1016/j.cell.2016.06.040; Ono T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10928; Papotto PH, 2017, EMBO REP, V18, P1957, DOI 10.15252/embr.201744200; Papotto PH, 2017, NAT IMMUNOL, V18, P604, DOI 10.1038/ni.3726; Ribot JC, 2009, NAT IMMUNOL, V10, P427, DOI 10.1038/ni.1717; Zuniga LA, 2010, J IMMUNOL, V185, P6947, DOI 10.4049/jimmunol.1001269	12	1	1	1	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2018	19	5					427	429		10.1038/s41590-018-0090-6	http://dx.doi.org/10.1038/s41590-018-0090-6			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GD5QT	29670236	Green Published			2022-12-18	WOS:000430562400003
J	Tangye, SG				Tangye, Stuart G.			Is it dead or alive? TLR8 can tell	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION; DISEASE; CELLS; DEFICIENCY		[Tangye, Stuart G.] Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW, Australia; [Tangye, Stuart G.] Univ New South Wales, St Vincents Clin Sch, Darlinghurst, NSW, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney	Tangye, SG (corresponding author), Garvan Inst Med Res, Immunol Div, Darlinghurst, NSW, Australia.; Tangye, SG (corresponding author), Univ New South Wales, St Vincents Clin Sch, Darlinghurst, NSW, Australia.	s.tangye@garvan.org.au	Tangye, Stuart G/H-4023-2014	Tangye, Stuart G/0000-0002-5360-5180				Amanna IJ, 2009, ANTIVIR RES, V84, P119, DOI 10.1016/j.antiviral.2009.08.008; Crotty S, 2014, IMMUNITY, V41, P529, DOI 10.1016/j.immuni.2014.10.004; De Gregorio E, 2014, NAT REV IMMUNOL, V14, P505, DOI 10.1038/nri3694; Hartmann G., ADV IMMUNOL, V133, P1; Ma CS, 2016, J EXP MED, V213, P1589, DOI 10.1084/jem.20151467; Ma CS, 2012, BLOOD, V119, P3997, DOI 10.1182/blood-2011-11-392985; Oh DY, 2008, J INFECT DIS, V198, P701, DOI 10.1086/590431; Picard C, 2011, CLIN MICROBIOL REV, V24, P490, DOI 10.1128/CMR.00001-11; Schmitt N, 2013, BLOOD, V121, P3375, DOI 10.1182/blood-2012-08-448902; Schmitt N, 2009, IMMUNITY, V31, P158, DOI 10.1016/j.immuni.2009.04.016; Slifka MK, 2014, VACCINE, V32, P2948, DOI 10.1016/j.vaccine.2014.03.078; Tangye SG, 2013, NAT REV IMMUNOL, V13, P412, DOI 10.1038/nri3447; Ugolini M., 2018, NAT IMMUNOL, DOI [10.1038/s41590018-0068-4, DOI 10.1038/S41590018-0068-4]	13	1	1	2	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					324	326		10.1038/s41590-018-0070-x	http://dx.doi.org/10.1038/s41590-018-0070-x			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29556003				2022-12-18	WOS:000428151000012
J	Visan, I				Visan, Ioana			Establishing T cell lineage identity	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2018	19	4					316	316		10.1038/s41590-018-0077-3	http://dx.doi.org/10.1038/s41590-018-0077-3			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	GA2KJ	29563622	Bronze			2022-12-18	WOS:000428151000003
J	Takaoka, A				Takaoka, Akinori			CANCER IMMUNOLOGY Cancer cells deliver a suppressive cargo	NATURE IMMUNOLOGY			English	Editorial Material							TUMOR PROGRESSION; REJECTION; IMMUNITY; IRF3		[Takaoka, Akinori] Hokkaido Univ, Div Signaling Canc & Immunol, Inst Genet Med, Sapporo, Hokkaido, Japan	Hokkaido University	Takaoka, A (corresponding author), Hokkaido Univ, Div Signaling Canc & Immunol, Inst Genet Med, Sapporo, Hokkaido, Japan.	takaoka@igm.hokudai.ac.jp						Benito-Martin A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00066; Bergstroem B, 2010, J BIOL CHEM, V285, P24904, DOI 10.1074/jbc.M109.084822; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Dunn GP, 2006, NAT REV IMMUNOL, V6, P836, DOI 10.1038/nri1961; Gao L, 2018, NAT IMMUNOL; Ho SSW, 2016, IMMUNITY, V44, P1177, DOI 10.1016/j.immuni.2016.04.010; Ng KW, 2018, TRENDS IMMUNOL, V39, P44, DOI 10.1016/j.it.2017.07.013; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Shen YJ, 2015, CELL REP, V11, P460, DOI 10.1016/j.celrep.2015.03.041; Whiteside TL, 2013, BIOCHEM SOC T, V41, P245, DOI 10.1042/BST20120265; Woo SR, 2015, ANNU REV IMMUNOL, V33, P445, DOI 10.1146/annurev-immunol-032414-112043; Zhang BH, 2009, CELL RES, V19, P412, DOI 10.1038/cr.2009.8	12	1	1	3	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2018	19	3					207	208		10.1038/s41590-018-0050-1	http://dx.doi.org/10.1038/s41590-018-0050-1			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FY6XZ	29476187				2022-12-18	WOS:000427007500008
J	Bortnick, A; Murre, C				Bortnick, Alexandra; Murre, Cornelis			mTECs Aire on the side of caution	NATURE IMMUNOLOGY			English	Editorial Material							P-TEFB; EXPRESSION; AUTOIMMUNITY; ELONGATION; REGULATOR; COMPLEXES; ANTIGEN; CELLS		[Bortnick, Alexandra; Murre, Cornelis] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Murre, C (corresponding author), Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA.	murre@biomail.ucsd.edu						Akiyoshi H, 2004, J BIOL CHEM, V279, P33984, DOI 10.1074/jbc.M400702200; Bansal K, 2017, NAT IMMUNOL, V18, P263, DOI 10.1038/ni.3675; Bossen C, 2015, NAT IMMUNOL, V16, P775, DOI 10.1038/ni.3170; Chi TH, 2002, NATURE, V418, P195, DOI 10.1038/nature00876; DeVoss J, 2006, J EXP MED, V203, P2727, DOI 10.1084/jem.20061864; Koh A. S., 2018, NAT IMMUNOL; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Kwon HK, 2017, NAT IMMUNOL, V18, P1238, DOI 10.1038/ni.3835; Minnich M, 2016, NAT IMMUNOL, V17, P331, DOI 10.1038/ni.3349; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Sato K, 2004, BIOCHEM BIOPH RES CO, V318, P935, DOI 10.1016/j.bbrc.2004.04.116; Yoshida H, 2015, P NATL ACAD SCI USA, V112, pE4448, DOI 10.1073/pnas.1512081112	12	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					100	101		10.1038/s41590-017-0033-7	http://dx.doi.org/10.1038/s41590-017-0033-7			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29348498				2022-12-18	WOS:000423435200007
J	Fehervari, Z				Fehervari, Zoltan			Macrophages: damage control	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					99	99		10.1038/s41590-017-0040-8	http://dx.doi.org/10.1038/s41590-017-0040-8			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29348506	Bronze			2022-12-18	WOS:000423435200004
J	Visan, I				Visan, Ioana			Adipose tissue T-M cells	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2018	19	2					99	99		10.1038/s41590-017-0036-4	http://dx.doi.org/10.1038/s41590-017-0036-4			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FT8WZ	29348508	Bronze			2022-12-18	WOS:000423435200006
J	Dempsey, LA				Dempsey, Laurie A.			Microbiota & cancer response	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2018	19	1					1	1		10.1038/s41590-017-0017-7	http://dx.doi.org/10.1038/s41590-017-0017-7			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FS4MA	29242540				2022-12-18	WOS:000419765300003
J	Nikolich-Zugich, J				Nikolich-Zugich, Janko			Charles D. Surh 1960-2017 OBITUARY	NATURE IMMUNOLOGY			English	Biographical-Item									[Nikolich-Zugich, Janko] Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA; [Nikolich-Zugich, Janko] Univ Arizona, Coll Med, Arizona Ctr Aging, Tucson, AZ 85721 USA	University of Arizona; University of Arizona	Nikolich-Zugich, J (corresponding author), Univ Arizona, Coll Med, Dept Immunobiol, Tucson, AZ 85721 USA.; Nikolich-Zugich, J (corresponding author), Univ Arizona, Coll Med, Arizona Ctr Aging, Tucson, AZ 85721 USA.	jnikolich@medadmin.arizona.edu						SURH CD, PUBLICATION LIST	1	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2017	18	12					1273	1273		10.1038/ni.3871	http://dx.doi.org/10.1038/ni.3871			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FM8GS	29144495	Bronze			2022-12-18	WOS:000415324900001
J	Bending, D; Ono, M				Bending, David; Ono, Masahiro			FoxP3 partners up	NATURE IMMUNOLOGY			English	Editorial Material							REGULATORY T-CELLS; CHROMATIN; DIFFERENTIATION; ACTIVATION	By switching its partners, FoxP3 segregates into functional and non-functional transcriptional complexes.	[Bending, David; Ono, Masahiro] Imperial Coll London, Dept Life Sci, Fac Nat Sci, London, England	Imperial College London	Ono, M (corresponding author), Imperial Coll London, Dept Life Sci, Fac Nat Sci, London, England.	m.ono@imperial.ac.uk	Ono, Masahiro/H-2378-2011; Bending, David/AAB-7435-2019	Ono, Masahiro/0000-0002-9284-7326; Bending, David/0000-0003-0071-1163	BBSRC [BB/J013951/2, BB/J013951/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J013951/2, BB/J013951/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Arvey A, 2014, NAT IMMUNOL, V15, P580, DOI 10.1038/ni.2868; Calo E, 2013, MOL CELL, V49, P825, DOI 10.1016/j.molcel.2013.01.038; DuPage M, 2015, IMMUNITY, V42, P227, DOI 10.1016/j.immuni.2015.01.007; Jeong KW, 2011, NAT STRUCT MOL BIOL, V18, P1358, DOI 10.1038/nsmb.2153; Kwon HK, 2017, NAT IMMUNOL, V18, P1238, DOI 10.1038/ni.3835; Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802; Li MO, 2016, NAT REV IMMUNOL, V16, P220, DOI 10.1038/nri.2016.26; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Samstein RM, 2012, CELL, V151, P153, DOI 10.1016/j.cell.2012.06.053; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042	12	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1181	1183		10.1038/ni.3852	http://dx.doi.org/10.1038/ni.3852			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	29044246				2022-12-18	WOS:000413457300001
J	Geng, J; Yu, SJ; Zhao, H; Sun, XF; Li, X; Wang, P; Xiong, XL; Hong, LX; Xie, CC; Gao, JH; Shi, YR; Peng, JQ; Johnson, RL; Xiao, NM; Lu, LR; Han, JH; Zhou, DW; Chen, LF				Geng, Jing; Yu, Shujuan; Zhao, Hao; Sun, Xiufeng; Li, Xun; Wang, Ping; Xiong, Xiaolin; Hong, Lixin; Xie, Changchuan; Gao, Jiahui; Shi, Yiran; Peng, Jiaqi; Johnson, Randy L.; Xiao, Nengming; Lu, Linrong; Han, Jiahuai; Zhou, Dawang; Chen, Lanfen			The transcriptional coactivator TAZ regulates reciprocal differentiation of T(H)17 cells and T-reg cells (vol 18, pg 800, 2017)	NATURE IMMUNOLOGY			English	Correction													xie, chang/GYJ-2493-2022					Geng J, 2017, NAT IMMUNOL, V18, P800, DOI 10.1038/ni.3748	1	1	1	3	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1270	1270		10.1038/ni1117-1270c	http://dx.doi.org/10.1038/ni1117-1270c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	29044235	Bronze			2022-12-18	WOS:000413457300015
J	Linterman, MA; Toellner, KM				Linterman, Michelle A.; Toellner, Kai-Michael			T-FR cells trump autoimmune antibody responses to limit sedition	NATURE IMMUNOLOGY			English	Editorial Material								The differentiation of follicular regulatory T cells can be limited by the cytokine IL-2, preventing the emergence of autoantibodies. This research identifies these cells as key regulators of the germinal center response.	[Linterman, Michelle A.] Babraham Inst, Lymphocyte Signaling & Dev, Cambridge, England; [Toellner, Kai-Michael] Univ Birmingham, Med Sch, Inst Immunol & Immunotherapy, Birmingham, W Midlands, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Birmingham	Linterman, MA (corresponding author), Babraham Inst, Lymphocyte Signaling & Dev, Cambridge, England.	michelle.linterman@babraham.ac.uk	Toellner, Kai-Michael/F-1519-2011; Linterman, Michelle/AAN-4210-2021	Toellner, Kai-Michael/0000-0001-8404-645X; Linterman, Michelle/0000-0001-6047-1996	BBSRC [BBS/E/B/000C0427, BB/M025292/1, BBS/E/B/000C0409] Funding Source: UKRI; MRC [G1001390] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0427, BB/M025292/1] Funding Source: researchfish; Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0409] Funding Source: Medline; Medical Research Council [G1001390] Funding Source: Medline	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Botta D, 2017, NAT IMMUNOL, V18, P1249, DOI 10.1038/ni.3837; Chung Y, 2011, NAT MED, V17, P983, DOI 10.1038/nm.2426; Huehn J, 2004, J EXP MED, V199, P303, DOI 10.1084/jem.20031562; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Linterman MA, 2011, NAT MED, V17, P975, DOI 10.1038/nm.2425; Pierson W, 2013, NAT IMMUNOL, V14, P959, DOI 10.1038/ni.2649; Ritvo PGG, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aan0368; Vinuesa CG, 2016, ANNU REV IMMUNOL, V34, P335, DOI 10.1146/annurev-immunol-041015-055605; Wing JB, 2017, P NATL ACAD SCI USA, V114, pE6400, DOI 10.1073/pnas.1705551114; Wollenberg I, 2011, J IMMUNOL, V187, P4553, DOI 10.4049/jimmunol.1101328; Wu H, 2016, EUR J IMMUNOL, V46, P1152, DOI 10.1002/eji.201546094; Zhang Y, 2016, IMMUNOL REV, V270, P8, DOI 10.1111/imr.12396	12	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2017	18	11					1185	1186		10.1038/ni.3856	http://dx.doi.org/10.1038/ni.3856			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FK4IU	29044242	Green Submitted			2022-12-18	WOS:000413457300003
J	Brown, MA; Russi, AE				Brown, Melissa A.; Russi, Abigail E.			(T) Betting on innate lymphoid cells in CNS inflammatory disease	NATURE IMMUNOLOGY			English	Editorial Material							MULTIPLE-SCLEROSIS; EAE	T-bet(+) NKp46(+) subsets of group 1 and group 3 innate lymphoid cells within the meninges initiate neuroinflammation in central nervous system (CNS)-demyelinating disease by regulating both the stability of pathogenic T-bet(+) T cells and their access to the CNS.	[Brown, Melissa A.; Russi, Abigail E.] Northwestern Univ, Dept Microbiol & Immunol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Brown, MA (corresponding author), Northwestern Univ, Dept Microbiol & Immunol, Feinberg Sch Med, Chicago, IL 60611 USA.	m-brown12@northwestern.edu		Russi, Abigail/0000-0003-4725-2574				Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Axisa PP, 2016, CURR OPIN NEUROL, V29, P345, DOI 10.1097/WCO.0000000000000319; Engelhardt B, 2017, NAT IMMUNOL, V18, P123, DOI 10.1038/ni.3666; Hatfield JK, 2015, CELL IMMUNOL, V297, P69, DOI 10.1016/j.cellimm.2015.06.006; Klose CSN, 2016, NAT IMMUNOL, V17, P765, DOI 10.1038/ni.3489; Kwong B, 2017, NAT IMMUNOL, V18, P1117, DOI 10.1038/ni.3816; Lakhan SE, 2013, FRONT NEUROL, V4; Perry JSA, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004140; Racke MK, 2014, J INTERF CYTOK RES, V34, P623, DOI 10.1089/jir.2014.0020; Ransohoff RM, 2012, NAT REV IMMUNOL, V12, P623, DOI 10.1038/nri3265; Reboldi A, 2009, NAT IMMUNOL, V10, P514, DOI 10.1038/ni.1716; Russi AE, 2016, J AUTOIMMUN, V73, P100, DOI 10.1016/j.jaut.2016.06.015; Schlager C, 2016, NATURE, V530, P349, DOI 10.1038/nature16939	13	1	1	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1063	1064		10.1038/ni.3839	http://dx.doi.org/10.1038/ni.3839			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28926546				2022-12-18	WOS:000411134000003
J	Korn, T				Korn, Thomas			Disentangling the manifold functions of ROR gamma t	NATURE IMMUNOLOGY			English	Editorial Material							T(H)17 CELL-DIFFERENTIATION; NETWORK	A two-amino-acid substitution in the transcription factor ROR gamma t disrupts its effect in establishing the transcriptional program of T(H)17 cells while leaving its function in the development of thymocytes and lymphoid-tissue-inducer cells largely intact.	[Korn, Thomas] Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany; [Korn, Thomas] Munich Cluster Syst Neurol SyNergy, Munich, Germany	Technical University of Munich; University of Munich	Korn, T (corresponding author), Tech Univ Munich, Dept Neurol, Klinikum Rechts Isar, Munich, Germany.; Korn, T (corresponding author), Munich Cluster Syst Neurol SyNergy, Munich, Germany.	thomas.korn@tum.de	Korn, Thomas/AAE-6960-2019	Korn, Thomas/0000-0002-3633-0955				Ciofani M, 2012, CELL, V151, P289, DOI 10.1016/j.cell.2012.09.016; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; He ZH, 2017, NAT IMMUNOL, V18, P1128, DOI 10.1038/ni.3832; Huh JR, 2011, NATURE, V472, P486, DOI 10.1038/nature09978; Ilvanov II, 2006, CURR TOP MICROBIOL, V308, P59; Ivanov II, 2006, CELL, V126, P1121, DOI 10.1016/j.cell.2006.07.035; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Santori FR, 2015, CELL METAB, V21, P286, DOI 10.1016/j.cmet.2015.01.004; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Sun ZM, 2000, SCIENCE, V288, P2369, DOI 10.1126/science.288.5475.2369; Ueda E, 2002, CANCER RES, V62, P901; Xiao S, 2014, IMMUNITY, V40, P477, DOI 10.1016/j.immuni.2014.04.004; Zhang YX, 2017, GENE DEV, V31, P1202, DOI 10.1101/gad.302323.117; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878	14	1	1	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1059	1060		10.1038/ni.3831	http://dx.doi.org/10.1038/ni.3831			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28926531				2022-12-18	WOS:000411134000001
J	Moffett, HF; Cartwright, ANR; Kim, HJ; Godec, J; Pyrdol, J; Aijo, T; Martinez, GJ; Rao, A; Lu, J; Golub, TR; Cantor, H; Sharpe, AH; Novina, CD; Wucherpfennig, KW				Moffett, Howell F.; Cartwright, Adam N. R.; Kim, Hye-Jung; Godec, Jernej; Pyrdol, Jason; Aijo, Tarmo; Martinez, Gustavo J.; Rao, Anjana; Lu, Jun; Golub, Todd R.; Cantor, Harvey; Sharpe, Arlene H.; Novina, Carl D.; Wucherpfennig, Kai W.			The microRNA miR-31 inhibits CD8(+) T cell function in chronic viral infection (vol 18, pg 791, 2017)	NATURE IMMUNOLOGY			English	Correction														Aijo, Tarmo/0000-0002-3008-4634				Moffett HF, 2017, NAT IMMUNOL, V18, P791, DOI 10.1038/ni.3755	1	1	1	0	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1173	1173		10.1038/ni1017-1173d	http://dx.doi.org/10.1038/ni1017-1173d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28926530	Bronze			2022-12-18	WOS:000411134000024
J	Ulas, T; Pirr, S; Fehlhaber, B; Bickes, MS; Loof, TG; Vogl, T; Mellinger, L; Heinemann, AS; Burgmann, J; Schoning, J; Schreek, S; Pfeifer, S; Reuner, F; Vollger, L; Stanulla, M; von Kookritz-Blickwede, M; Glander, S; Barczyk-Kahlert, K; von Kaisenberg, CS; Friesenhagen, J; Fischer-Riepe, L; Zenker, S; Schultze, JL; Roth, J; Viemann, D				Ulas, Thomas; Pirr, Sabine; Fehlhaber, Beate; Bickes, Marie S.; Loof, Torsten G.; Vogl, Thomas; Mellinger, Lara; Heinemann, Anna S.; Burgmann, Johanna; Schoning, Jennifer; Schreek, Sabine; Pfeifer, Sandra; Reuner, Friederike; Vollger, Lena; Stanulla, Martin; von Kockritz-Blickwede, Maren; Glander, Shirin; Barczyk-Kahlert, Katarzyna; von Kaisenberg, Constantin S.; Friesenhagen, Judith; Fischer-Riepe, Lena; Zenker, Stefanie; Schultze, Joachim L.; Roth, Johannes; Viemann, Dorothee			S100-alarmin-induced innate immune programming protects newborn infants from sepsis (vol 18, pg 622, 2017)	NATURE IMMUNOLOGY			English	Correction													Schultze, Joachim L./ABA-8176-2020; von Kaisenberg, Constantin/AAR-2756-2021	Schultze, Joachim L./0000-0003-2812-9853; 				Ulas T, 2017, NAT IMMUNOL, V18, P622, DOI 10.1038/ni.3745	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2017	18	10					1173	1173		10.1038/ni1017-1173b	http://dx.doi.org/10.1038/ni1017-1173b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FH4OF	28926540	Bronze			2022-12-18	WOS:000411134000022
J	Prinz, M; Erny, D; Hagemeyer, N				Prinz, Marco; Erny, Daniel; Hagemeyer, Nora			Ontogeny and homeostasis of CNS myeloid cells (vol 18, pg 385, 2017)	NATURE IMMUNOLOGY			English	Correction													Erny, Daniel/AAU-7015-2020	Erny, Daniel/0000-0001-6000-8838				Prinz M, 2017, NAT IMMUNOL, V18, P385, DOI 10.1038/ni.3703	1	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					951	951		10.1038/ni0817-951d	http://dx.doi.org/10.1038/ni0817-951d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28722712	Bronze			2022-12-18	WOS:000405821100021
J	Vieth, JA; Das, J; Ranaivoson, FM; Comoletti, D; Denzin, LK; Sant'Angelo, DB				Vieth, Joshua A.; Das, Joy; Ranaivoson, Fanomezana M.; Comoletti, Davide; Denzin, Lisa K.; Sant'Angelo, Derek B.			TCR alpha-TCR beta pairing controls recognition of CD1d and directs the development of adipose NKT cells (vol 18, pg 36, 2017)	NATURE IMMUNOLOGY			English	Correction														Vieth, Joshua/0000-0001-8756-2759; Ranaivoson, Fanomezana Moutse/0000-0001-5599-2682				Vieth JA, 2017, NAT IMMUNOL, V18, P36, DOI 10.1038/ni.3622	1	1	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2017	18	8					951	951		10.1038/ni0817-951a	http://dx.doi.org/10.1038/ni0817-951a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FB0FT	28722718	Bronze			2022-12-18	WOS:000405821100018
J	Dempsey, LA				Dempsey, Laurie A.			Zika-neutralizing antibodies	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2017	18	6					603	603		10.1038/ni.3762	http://dx.doi.org/10.1038/ni.3762			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FU7JO	28518162				2022-12-18	WOS:000424028600003
J	Dempsey, LA				Dempsey, Laurie A.			Vitamin C for microglia	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	1	1	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					487	487		10.1038/ni.3740	http://dx.doi.org/10.1038/ni.3740			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FU7JY	28418391	Bronze			2022-12-18	WOS:000424029600002
J	Dempsey, LA				Dempsey, Laurie A.			PD-1 targets CD28	NATURE IMMUNOLOGY			English	Editorial Material													Dempsey, Laurie A./GLR-6085-2022						0	1	1	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					487	487		10.1038/ni.3739	http://dx.doi.org/10.1038/ni.3739			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FU7JY	28418394	Bronze			2022-12-18	WOS:000424029600005
J	Gallagher, MP; Berg, LJ				Gallagher, Michael P.; Berg, Leslie J.			Gene-enhancer variants reveal diverse TCR-mediated differentiation	NATURE IMMUNOLOGY			English	Editorial Material								The transcription factor IRF4 acts as a 'rheostat' for TCR signaling. Discrete levels of IRF4 can activate distinct transcriptional programs in T cells due to binding sites of variable affinity in groups of target genes.	[Gallagher, Michael P.; Berg, Leslie J.] Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Berg, LJ (corresponding author), Univ Massachusetts, Sch Med, Dept Pathol, Worcester, MA 01605 USA.	Leslie.Berg@umassmed.edu		Gallagher, Michael/0000-0002-7799-0546; Berg, Leslie J/0000-0001-6031-7542				Betz BC, 2010, J EXP MED, V207, P933, DOI 10.1084/jem.20091548; Buchholz VR, 2013, SCIENCE, V340, P630, DOI 10.1126/science.1235454; Freedman ML, 2011, NAT GENET, V43, P513, DOI 10.1038/ng.840; Gerlach C, 2013, SCIENCE, V340, P635, DOI 10.1126/science.1235487; Huber M, 2014, EUR J IMMUNOL, V44, P1886, DOI 10.1002/eji.201344279; Iwata A, 2017, NAT IMMUNOL, V18, P563, DOI 10.1038/ni.3714; Mayya V, 2016, TRENDS IMMUNOL, V37, P513, DOI 10.1016/j.it.2016.06.005; Murphy TL, 2013, NAT REV IMMUNOL, V13, P499, DOI 10.1038/nri3470; Schraml BU, 2009, NATURE, V460, P405, DOI 10.1038/nature08114; Tkach K, 2013, CURR OPIN IMMUNOL, V25, P120, DOI 10.1016/j.coi.2012.12.001; Tussiwand R, 2012, NATURE, V490, P502, DOI 10.1038/nature11531; Zehn D, 2012, CELL MOL LIFE SCI, V69, P1565, DOI 10.1007/s00018-012-0965-x	12	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2017	18	5					483	484		10.1038/ni.3729	http://dx.doi.org/10.1038/ni.3729			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	ES2SR	28418392				2022-12-18	WOS:000399378700004
J	Visan, I				Visan, Ioana			Neuroimmune interactions: astrocytes	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2017	18	3					254	254						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	FU8PC	28198833				2022-12-18	WOS:000424114800004
J	Kochi, R; Thelen, F; Vanes, L; Brazao, TF; Fountain, K; Xie, J; Huang, CL; Lyck, R; Stein, JV; Tybulewicz, VLJ				Kochi, Robert; Thelen, Flavian; Vanes, Lesley; Brazao, Tiago F.; Fountain, Kathryn; Xie, Jian; Huang, Chou-Long; Lyck, Ruth; Stein, Jens V.; Tybulewicz, Victor L. J.			WNK1 kinase balances T cell adhesion versus migration in vivo (vol 17, pg 1075, 2016)	NATURE IMMUNOLOGY			English	Correction														Lyck, Ruth/0000-0002-6479-4837; Kochl, Robert/0000-0003-3370-5501				Kochl R, 2016, NAT IMMUNOL, V17, P1075, DOI 10.1038/ni.3495	1	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					246	246						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28102214	Bronze			2022-12-18	WOS:000392360900018
J	Krovi, SH; Gapin, L				Krovi, S. Harsha; Gapin, Laurent			iNKT cells need UTX-tra demethylation	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; JMJD3; DIFFERENTIATION	The epigenetic regulation of gene expression by the histone demethylase UTX is central to the development of invariant natural killer cells.	[Krovi, S. Harsha; Gapin, Laurent] Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO 80309 USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Gapin, L (corresponding author), Univ Colorado, Dept Immunol & Microbiol, Anschutz Med Campus, Aurora, CO 80309 USA.	laurent.gapin@ucdenver.edu		Krovi, S. Harsha/0000-0003-4661-617X	NIAID NIH HHS [R21 AI124076, R21 AI121761, R01 AI092108] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121761] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Beyaz S, 2017, NAT IMMUNOL, V18, P184, DOI 10.1038/ni.3644; Dobenecker MW, 2015, J EXP MED, V212, P297, DOI 10.1084/jem.20141499; Gapin L, 2016, CURR OPIN IMMUNOL, V39, P68, DOI 10.1016/j.coi.2016.01.001; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731; Li QT, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6780; Manna S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9152; Pereira RM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5540; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Stritesky GL, 2012, ANNU REV IMMUNOL, V30, P95, DOI 10.1146/annurev-immunol-020711-075035; Whyte WA, 2013, CELL, V153, P307, DOI 10.1016/j.cell.2013.03.035	12	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					148	150		10.1038/ni.3663	http://dx.doi.org/10.1038/ni.3663			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28102220				2022-12-18	WOS:000392360900008
J	Turner, M; Monzon-Casanova, E				Turner, Martin; Monzon-Casanova, Elisa			RNA-binding proteins mind the GAPs	NATURE IMMUNOLOGY			English	Editorial Material							HNRNP A1	Increased expression of the ubiquitin ligase TRAF6 in hematopoietic stem cells promotes activity of the GTP-binding protein Cdc42 and consequent diminished function of hematopoietic stem cells by ubiquitination of the RNA-binding protein hnRNP-A1, which leads to an inability to properly process pre-mRNA encoding Cdc42-inhibitory GTPase-activating proteins.	[Turner, Martin; Monzon-Casanova, Elisa] Babraham Inst, Lab Lymphocyte Signaling & Dev, Babraham Res Campus, Cambridge, England; [Monzon-Casanova, Elisa] Univ Cambridge, Dept Biochem, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge	Turner, M (corresponding author), Babraham Inst, Lab Lymphocyte Signaling & Dev, Babraham Res Campus, Cambridge, England.	martin.turner@babraham.ac.uk	Turner, Martin/N-9976-2014	Turner, Martin/0000-0002-3801-9896; Monzon-Casanova, Elisa/0000-0001-6617-6138	Biotechnology and Biological Sciences Research Council [BBS/E/B/000C0407, BB/J00152X/1] Funding Source: Medline; BBSRC [BB/J00152X/1, BBS/E/B/000C0407] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Fang J, 2017, NAT IMMUNOL, V18, P236, DOI 10.1038/ni.3654; Huppertz I, 2014, METHODS, V65, P274, DOI 10.1016/j.ymeth.2013.10.011; Jean-Philippe J, 2013, INT J MOL SCI, V14, P18999, DOI 10.3390/ijms140918999; Lee SCW, 2016, NAT MED, V22, P976, DOI 10.1038/nm.4165; Monlish DA, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00390; Tavanez JP, 2012, MOL CELL, V45, P314, DOI 10.1016/j.molcel.2011.11.033; Pellagatti A, 2016, J ADV BIOL; Sibley CR, 2016, NAT REV GENET, V17, P407, DOI 10.1038/nrg.2016.46; Starczynowski DT, 2010, NAT MED, V16, P49, DOI 10.1038/nm.2054; Tenekeci U, 2016, MOL CELL, V62, P943, DOI 10.1016/j.molcel.2016.05.017; Turner M, 2014, NAT IMMUNOL, V15, P484, DOI 10.1038/ni.2887; Wang L, 2006, BLOOD, V107, P98, DOI 10.1182/blood-2005-05-2171	12	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2017	18	2					146	148		10.1038/ni.3662	http://dx.doi.org/10.1038/ni.3662			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EI3AE	28102216				2022-12-18	WOS:000392360900007
J	Tan, SY; Weninger, W				Tan, Sioh-Yang; Weninger, Wolfgang			Phagocyte mayHEME caused by severe hemolysis	NATURE IMMUNOLOGY			English	Editorial Material							DOCK8	Free heme released by hemolysis directly inhibits bacterial phagocytosis by macrophages via alterations of actin cytoskeletal dynamics.	[Tan, Sioh-Yang; Weninger, Wolfgang] Centenary Inst Canc Med & Cell Biol, Immune Imaging Program, Newtown, Tas, Australia; [Tan, Sioh-Yang; Weninger, Wolfgang] Univ Sydney, Sch Med, Sydney, NSW, Australia; [Weninger, Wolfgang] Royal Prince Alfred Hosp, Dept Dermatol, Camperdown, NSW, Australia	University of Sydney; Centenary Institute; University of Sydney; University of Sydney	Weninger, W (corresponding author), Centenary Inst Canc Med & Cell Biol, Immune Imaging Program, Newtown, Tas, Australia.; Weninger, W (corresponding author), Univ Sydney, Sch Med, Sydney, NSW, Australia.; Weninger, W (corresponding author), Royal Prince Alfred Hosp, Dept Dermatol, Camperdown, NSW, Australia.	w.weninger@centenary.org.au						Abtin A, 2014, NAT IMMUNOL, V15, P45, DOI 10.1038/ni.2769; Chimini G, 2000, NAT CELL BIOL, V2, pE191, DOI 10.1038/35036454; Crawford G, 2013, BLOOD, V122, P2052, DOI 10.1182/blood-2013-02-482331; Cunnington AJ, 2012, NAT MED, V18, P120, DOI 10.1038/nm.2601; Dutra FF, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00115; Ganz T, 2012, J INNATE IMMUN, V4, P446, DOI 10.1159/000336423; Harada Y, 2012, BLOOD, V119, P4451, DOI 10.1182/blood-2012-01-407098; Jais A, 2014, CELL, V158, P25, DOI 10.1016/j.cell.2014.04.043; Martins R, 2016, NAT IMMUNOL, V17, P1361, DOI 10.1038/ni.3590; Orf K, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00666; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	11	1	1	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1335	1337		10.1038/ni.3616	http://dx.doi.org/10.1038/ni.3616			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27849198				2022-12-18	WOS:000388056400001
J	Xing, JJ; Weng, LY; Yuan, B; Wang, Z; Jia, L; Jin, R; Lu, HB; Li, XC; Liu, YJ; Zhang, ZQ				Xing, Junji; Weng, Leiyun; Yuan, Bin; Wang, Zhuo; Jia, Li; Jin, Rui; Lu, Hongbo; Li, Xian Chang; Liu, Yong-Jun; Zhang, Zhiqiang			Identification of a role for TRIM29 in the control of innate immunity in the respiratory tract (vol 17, pg 1373, 2016)	NATURE IMMUNOLOGY			English	Correction													Xing, Junji/H-8259-2019	Xing, Junji/0000-0002-3392-5427				Xing JJ, 2016, NAT IMMUNOL, V17, P1373, DOI 10.1038/ni.3580	1	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2016	17	12					1479	1479		10.1038/ni1216-1479a	http://dx.doi.org/10.1038/ni1216-1479a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	EC3VY	27849197	Bronze			2022-12-18	WOS:000388056400018
J	Locci, M; Wu, JE; Arumemi, F; Mikulski, Z; Dahlberg, C; Miller, AT; Crotty, S				Locci, Michela; Wu, Jennifer E.; Arumemi, Fortuna; Mikulski, Zbigniew; Dahlberg, Carol; Miller, Andrew T.; Crotty, Shane			Activin A programs the differentiation of human T-FH cells (vol 17, pg 976, 2016)	NATURE IMMUNOLOGY			English	Correction													Wu, Jennifer/GRX-1831-2022; Crotty, Shane/AAE-8446-2019; Crotty, Shane/AAC-6703-2019	Crotty, Shane/0000-0002-6484-6262				Locci M, 2016, NAT IMMUNOL, V17, P976, DOI 10.1038/ni.3494	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2016	17	8												1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DS2XK					2022-12-18	WOS:000380647000016
J	[Anonymous]				[Anonymous]			A versatile cell population	NATURE IMMUNOLOGY			English	Editorial Material								Innate lymphoid cells serve multiple roles in maintaining tissue homeostasis and responding to tissue insults and can contribute to chronic inflammatory diseases.						Dempsey, Laurie/0000-0002-3304-796X					0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2016	17	7					754	754		10.1038/ni.3496	http://dx.doi.org/10.1038/ni.3496			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DP1XR	27328003	Bronze			2022-12-18	WOS:000378283200005
J	Sobolev, O; Binda, E; O'Farrell, S; Lorenc, A; Pradines, J; Huang, YQ; Duffner, J; Schulz, R; Cason, J; Zambon, M; Malim, MH; Peakman, M; Cope, A; Capila, I; Kaundinya, GV; Hayday, AC				Sobolev, Olga; Binda, Elisa; O'Farrell, Sean; Lorenc, Anna; Pradines, Joel; Huang, Yongqing; Duffner, Jay; Schulz, Reiner; Cason, John; Zambon, Maria; Malim, Michael H.; Peakman, Mark; Cope, Andrew; Capila, Ishan; Kaundinya, Ganesh V.; Hayday, Adrian C.			Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events (vol 17, pg 204, 2016)	NATURE IMMUNOLOGY			English	Correction									[Zambon, Maria] Publ Hlth England, London, England	Public Health England								Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328	1	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					740	740		10.1038/ni0616-740b	http://dx.doi.org/10.1038/ni0616-740b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK		Bronze			2022-12-18	WOS:000376162200020
J	Yang, WH; Marth, JD				Yang, Won Ho; Marth, Jamey D.			Protein glycosylation energizes T cells	NATURE IMMUNOLOGY			English	Editorial Material							O-GLCNACYLATION; BREAST-CANCER; GLCNAC; TRANSCRIPTION; METABOLISM; EXPRESSION; SENSOR; MYC	Nutrient transport is regulated by signaling pathways that together indicate metabolic checkpoints in T cell self-renewal, differentiation and proliferation.	[Yang, Won Ho; Marth, Jamey D.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, SBP Med Discovery Inst, Ctr Nanomed, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara	Marth, JD (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, SBP Med Discovery Inst, Ctr Nanomed, Santa Barbara, CA 93106 USA.	jmarth@sbpdiscovery.com			NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL125352] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK048247] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL125352] Funding Source: Medline; NIDDK NIH HHS [R01 DK048247] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Barron CC, 2016, METABOLISM, V65, P124, DOI 10.1016/j.metabol.2015.10.007; Caldwell SA, 2010, ONCOGENE, V29, P2831, DOI 10.1038/onc.2010.41; Chou TY, 2001, ADV EXP MED BIOL, V491, P413; Hanover JA, 2012, NAT REV MOL CELL BIO, V13, P312, DOI 10.1038/nrm3334; Hart GW, 2014, J BIOL CHEM, V289, P34422, DOI 10.1074/jbc.R114.609776; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Preston GC, 2015, EMBO J, V34, P2008, DOI 10.15252/embj.201490252; Sodi VL, 2015, MOL CANCER RES, V13, P923, DOI 10.1158/1541-7786.MCR-14-0536; Swamy M, 2016, NAT IMMUNOL, V17, P712, DOI 10.1038/ni.3439; Wells L, 2001, SCIENCE, V291, P2376, DOI 10.1126/science.1058714; Zachara NE, 2004, BBA-GEN SUBJECTS, V1673, P13, DOI 10.1016/j.bbagen.2004.03.016	11	1	2	1	20	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2016	17	6					613	614		10.1038/ni.3468	http://dx.doi.org/10.1038/ni.3468			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DM2FK	27196512				2022-12-18	WOS:000376162200004
J	Sobolev, O; Binda, E; O'Farrell, S; Lorenc, A; Pradines, J; Huang, YQ; Duffner, J; Schulz, R; Cason, J; Zambon, M; Malim, MH; Peakman, M; Cope, A; Capila, I; Kaundinya, GV; Hayday, AC				Sobolev, Olga; Binda, Elisa; O'Farrell, Sean; Lorenc, Anna; Pradines, Joel; Huang, Yongqing; Duffner, Jay; Schulz, Reiner; Cason, John; Zambon, Maria; Malim, Michael H.; Peakman, Mark; Cope, Andrew; Capila, Ishan; Kaundinya, Ganesh V.; Hayday, Adrian C.			Adjuvanted influenza-H1N1 vaccination reveals lymphoid signatures of age-dependent early responses and of clinical adverse events (vol 17, pg 204, 2016)	NATURE IMMUNOLOGY			English	Correction													Lorenc, Anna/AAA-3138-2022	Lorenc, Anna/0000-0002-1406-7607; Cope, Andrew/0000-0001-6735-5496				Sobolev O, 2016, NAT IMMUNOL, V17, P204, DOI 10.1038/ni.3328	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4					469	469		10.1038/ni0416-469b	http://dx.doi.org/10.1038/ni0416-469b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR	27002849				2022-12-18	WOS:000372508000023
J	Xia, PY; Ye, BQ; Wang, S; Zhu, XX; Du, Y; Xiong, Z; Tian, Y; Fan, ZS				Xia, Pengyan; Ye, Buqing; Wang, Shuo; Zhu, Xiaoxiao; Du, Ying; Xiong, Zhen; Tian, Yong; Fan, Zusen			Glutamylation of the DNA sensor cGAS regulates its binding and synthase activity in antiviral immunity (vol 17, pg 369, 2016)	NATURE IMMUNOLOGY			English	Correction																		Xia P, 2016, NAT IMMUNOL, V17, P369, DOI 10.1038/ni.3356	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2016	17	4												1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	DH0XR					2022-12-18	WOS:000372508000010
J	Walker, LSK; Ziegler, S; Becher, B				Walker, Lucy S. K.; Ziegler, Steven; Becher, Burkhard			Contemplating autoimmunity in the Aegean islands	NATURE IMMUNOLOGY			English	Editorial Material									[Walker, Lucy S. K.] UCL, Inst Immun & Transplantat, Div Infect & Immun, Royal Free Campus, London, England; [Ziegler, Steven] Benaroya Res Inst, Seattle, WA USA; [Becher, Burkhard] Univ Zurich, Inst Expt Immunol, Inflammat Res Unit, Zurich, Switzerland	University of London; University College London; Benaroya Research Institute; University of Zurich	Walker, LSK (corresponding author), UCL, Inst Immun & Transplantat, Div Infect & Immun, Royal Free Campus, London, England.	lucy.walker@ucl.ac.uk; becher@immunology.uzh.ch	Becher, Burkhard/ABE-4225-2020	Becher, Burkhard/0000-0002-1541-7867	Roche; MRC [G0802382] Funding Source: UKRI; Medical Research Council [G0802382] Funding Source: researchfish	Roche(Roche Holding); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The 7th Aegean Conference on Autoimmunity was made possible through Aegean Conferences and support from Roche.	Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Codarri L, 2011, NAT IMMUNOL, V12, P560, DOI 10.1038/ni.2027; Croxford AL, 2015, TRENDS IMMUNOL, V36, P651, DOI 10.1016/j.it.2015.08.004; Croxford AL, 2015, IMMUNITY, V43, P502, DOI 10.1016/j.immuni.2015.08.010; Getts DR, 2015, TRENDS IMMUNOL, V36, P419, DOI [10.1016/j.it.2015.05.007, 10.1016/j.it.2016.08.003]; Johnston C, 2015, LANCET, V385, P50; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Roederer M, 2015, CELL, V161, P387, DOI 10.1016/j.cell.2015.02.046; Vargas FA, 2015, TRENDS IMMUNOL, V36, P388, DOI 10.1016/j.it.2015.06.001; Wang CJ, 2015, P NATL ACAD SCI USA, V112, P524, DOI 10.1073/pnas.1414576112; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062	12	1	1	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2016	17	3					218	220		10.1038/ni.3367	http://dx.doi.org/10.1038/ni.3367			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VG5ZD	26882250				2022-12-18	WOS:000447602600001
J	Shevach, EM; Margulies, DH				Shevach, Ethan M.; Margulies, David H.			William E. Paul 1936-2015 OBITUARY	NATURE IMMUNOLOGY			English	Biographical-Item									[Shevach, Ethan M.; Margulies, David H.] NIAAA, Immunol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Shevach, EM (corresponding author), NIAAA, Immunol Lab, NIH, Bethesda, MD 20892 USA.	eshevach@niaid.nih.gov						SHEVACH EM, PUBLICATION LIST	1	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2015	16	12					1205	1205		10.1038/ni.3316	http://dx.doi.org/10.1038/ni.3316			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CW5UM	26580498	Bronze			2022-12-18	WOS:000365062100001
J	van der Veen, AG; Maillard, PV; Sousa, CRE				van der Veen, Annemarthe G.; Maillard, Pierre V.; Reis e Sousa, Caetano			Drosha cuts the tethers of myelopoiesis	NATURE IMMUNOLOGY			English	Editorial Material							MICRORNAS; PATHWAY	The RNA endonuclease Drosha is required for myelopoiesis by its direct cleavage of stem-loop structures in mRNAs encoding My19 and Todr1.	[van der Veen, Annemarthe G.; Maillard, Pierre V.; Reis e Sousa, Caetano] Lincolns Inn Fields Lab, Francis Crick Inst, Immunobiol Lab, London, England	Francis Crick Institute	van der Veen, AG (corresponding author), Lincolns Inn Fields Lab, Francis Crick Inst, Immunobiol Lab, London, England.	caetano@crick.ac.uk	Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014; Maillard, Pierre V/V-4305-2019	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Maillard, Pierre V/0000-0003-4611-388X	Cancer Research UK [15689] Funding Source: researchfish; The Francis Crick Institute [10136, 10141] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); The Francis Crick Institute		Alarcon CR, 2015, NATURE, V519, P482, DOI 10.1038/nature14281; Cheloufi S, 2010, NATURE, V465, P584, DOI 10.1038/nature09092; Chong MMW, 2010, GENE DEV, V24, P1951, DOI 10.1101/gad.1953310; Cifuentes D, 2010, SCIENCE, V328, P1694, DOI 10.1126/science.1190809; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Gromak N, 2013, CELL REP, V5, P1499, DOI 10.1016/j.celrep.2013.11.032; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han J, 2009, CELL, V136, P75, DOI 10.1016/j.cell.2008.10.053; Johanson TM, 2015, NAT IMMUNOL, V16, P1134, DOI 10.1038/ni.3293; Johanson TM, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130144; Karginov FV, 2010, MOL CELL, V38, P781, DOI 10.1016/j.molcel.2010.06.001; Knuckles P, 2012, NAT NEUROSCI, V15, P962, DOI 10.1038/nn.3139; Lin YT, 2011, P NATL ACAD SCI USA, V108, P11229, DOI 10.1073/pnas.1105799108; Macias S, 2012, NAT STRUCT MOL BIOL, V19, P760, DOI 10.1038/nsmb.2344; Shapiro JS, 2014, P NATL ACAD SCI USA, V111, P7108, DOI 10.1073/pnas.1319635111	15	1	1	1	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1110	1112		10.1038/ni.3297	http://dx.doi.org/10.1038/ni.3297			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CT8VW	26482971				2022-12-18	WOS:000363096000004
J	[Anonymous]				[Anonymous]			Melatonin zaps T(H)17	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2015	16	11					1113	1113						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VB8EU					2022-12-18	WOS:000418279000001
J	Chiang, JJ; Gack, MU				Chiang, Jessica J.; Gack, Michaela U.			Reading the fine print: sequence-specific activation of cGAS	NATURE IMMUNOLOGY			English	Editorial Material							GMP-AMP SYNTHASE; DNA; IMMUNITY; SENSOR	A unique guanosine-flanked Y-form DNA triggers innate cGAS-dependent responses that lead to upregulation of the production of type I interferons.	[Chiang, Jessica J.; Gack, Michaela U.] Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02114 USA; [Gack, Michaela U.] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	Harvard University; Harvard Medical School; University of Chicago	Chiang, JJ (corresponding author), Harvard Univ, Sch Med, Dept Microbiol & Immunobiol, Boston, MA 02114 USA.	mgack@uchicago.edu						Ablasser A, 2014, J IMMUNOL, V192, P5993, DOI 10.4049/jimmunol.1400737; Ablasser A, 2013, CLIN IMMUNOL, V147, P207, DOI 10.1016/j.clim.2013.01.003; Altfeld M, 2015, NAT IMMUNOL, V16, P554, DOI 10.1038/ni.3157; Doitsh G, 2010, CELL, V143, P789, DOI 10.1016/j.cell.2010.11.001; Herzner AM, 2015, NAT IMMUNOL, V16, P1025, DOI 10.1038/ni.3267; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Paludan SR, 2015, MICROBIOL MOL BIOL R, V79, P225, DOI 10.1128/MMBR.00061-14; Sparrer KMJ, 2015, CURR OPIN MICROBIOL, V26, P1, DOI 10.1016/j.mib.2015.03.001; Stetson DB, 2006, IMMUNITY, V24, P93, DOI 10.1016/j.immuni.2005.12.003; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Volkman HE, 2014, NAT IMMUNOL, V15, P415, DOI 10.1038/ni.2872; Yoh SM, 2015, CELL, V161, P1293, DOI 10.1016/j.cell.2015.04.050; Zhang X, 2014, CELL REP, V6, P421, DOI 10.1016/j.celrep.2014.01.003	13	1	1	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2015	16	10					1009	1010		10.1038/ni.3274	http://dx.doi.org/10.1038/ni.3274			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CR9OO	26382862				2022-12-18	WOS:000361686500004
J	Anderson, G; Jenkinson, WE				Anderson, Graham; Jenkinson, William E.			Co-ordination of intrathymic self-representation	NATURE IMMUNOLOGY			English	Editorial Material							THYMIC EPITHELIAL-CELLS; PROMISCUOUS GENE-EXPRESSION; MEDULLA; SELECTION; PATTERNS	Intrathymic expression of self antigens is key for central tolerance. RNA-sequencing analysis of tissue-restricted antigens in individual medullary thymic epithelial cells reveals co-ordination in the gene-expression patterns that ensures effective self-representation for the production of self-tolerant T cells.	[Anderson, Graham; Jenkinson, William E.] Univ Birmingham, Sch Med, MRC Ctr Immune Regulat, Inst Biomed Res, Birmingham, W Midlands, England	University of Birmingham	Anderson, G (corresponding author), Univ Birmingham, Sch Med, MRC Ctr Immune Regulat, Inst Biomed Res, Birmingham, W Midlands, England.	g.anderson@bham.ac.uk		anderson, graham/0000-0002-2917-4085; Jenkinson, William/0000-0003-3422-8372	Biotechnology and Biological Sciences Research Council [BB/M006522/1] Funding Source: researchfish; BBSRC [BB/M006522/1] Funding Source: UKRI; MRC [MR/N000919/1] Funding Source: UKRI; Medical Research Council [MR/N000919/1] Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Brennecke P, 2015, NAT IMMUNOL, V16, P933, DOI 10.1038/ni.3246; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Giraud M, 2012, P NATL ACAD SCI USA, V109, P535, DOI 10.1073/pnas.1119351109; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Klein L, 2009, NAT IMMUNOL, V10, P809, DOI 10.1038/ni0809-809; Le Borgne M, 2009, NAT IMMUNOL, V10, P823, DOI 10.1038/ni.1761; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Pinto S, 2013, P NATL ACAD SCI USA, V110, pE3497, DOI 10.1073/pnas.1308311110; Rodewald HR, 2001, NATURE, V414, P763, DOI 10.1038/414763a; Sansom SN, 2014, GENOME RES, V24, P1918, DOI 10.1101/gr.171645.113; Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105	13	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					895	896		10.1038/ni.3251	http://dx.doi.org/10.1038/ni.3251			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CP4UA	26287586				2022-12-18	WOS:000359876900003
J	Fehervari, Z				Fehervari, Zoltan			Neonatal non-responsiveness	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	0	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2015	16	9					906	906		10.1038/ncoms8725	http://dx.doi.org/10.1038/ncoms8725			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VB8DZ					2022-12-18	WOS:000418195900001
J	Silke, J; Rickard, JA; Gerlic, M				Silke, John; Rickard, James A.; Gerlic, Motti			The diverse role of RIP kinases in necroptosis and inflammation (vol 16, pg 930, 2016)	NATURE IMMUNOLOGY			English	Correction													Gerlic, Motti/U-3484-2017; Silke, John/B-7622-2008	Gerlic, Motti/0000-0001-9518-1833; Silke, John/0000-0002-7611-5774				SILKE J, 2016, NAT IMMUNOL, V16, P930	1	1	1	0	11	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	AUG	2015	16	8								10.1038/ni0815-889b	http://dx.doi.org/10.1038/ni0815-889b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CN3BT		Bronze			2022-12-18	WOS:000358299200017
J	Tarlinton, DM; Smith, KGC				Tarlinton, David M.; Smith, Kenneth G. C.			How many memories does it take to make an SLE flare?	NATURE IMMUNOLOGY			English	Editorial Material							SYSTEMIC-LUPUS-ERYTHEMATOSUS; 9G4 IDIOTOPE; B-CELLS; DIVERSITY; ORIGIN	Deep-sequencing analyses of immunoglobulin variable-segment genes from antibody-secreting cells have allowed comparisons of conventional immunization responses to disease flares experienced by patients with systemic lupus erythematosus. Such analyses provide insight into B cell recruitment and differentiation processes yielding expanded clones that contribute to this complex autoimmune disease.	[Tarlinton, David M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [Smith, Kenneth G. C.] Univ Cambridge, Sch Clin Med, Dept Med, Cambridge, England; [Smith, Kenneth G. C.] Univ Cambridge, Sch Clin Med, Cambridge Inst Med Res, Cambridge, England	Royal Melbourne Hospital; Walter & Eliza Hall Institute; University of Cambridge; University of Cambridge	Tarlinton, DM (corresponding author), Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia.	tarlinton@wehi.edu.au		Tarlinton, David/0000-0001-9928-686X; Smith, Kenneth/0000-0003-3829-4326	Wellcome Trust [100140] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ISENBERG D, 1993, BRIT J RHEUMATOL, V32, P876; Isenberg DA, 1998, ANN RHEUM DIS, V57, P566, DOI 10.1136/ard.57.9.566; Jacobi AM, 2008, ANN RHEUM DIS, V67, P450, DOI 10.1136/ard.2007.075762; Robinson WH, 2015, NAT REV RHEUMATOL, V11, P171, DOI 10.1038/nrrheum.2014.220; Shlomchik MJ, 2008, IMMUNITY, V28, P18, DOI 10.1016/j.immuni.2007.12.004; Stohl W, 2012, ARTHRITIS RHEUM-US, V64, P2328, DOI 10.1002/art.34400; Tan YC, 2014, ARTHRITIS RHEUMATOL, V66, P2706, DOI 10.1002/art.38754; Tarlinton D, 2013, SCIENCE, V341, P1205, DOI 10.1126/science.1241146; Tipton CM, 2015, NAT IMMUNOL, V16, P755, DOI 10.1038/ni.3175; Yaniv G, 2015, AUTOIMMUN REV, V14, P75, DOI 10.1016/j.autrev.2014.10.003	10	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					685	687		10.1038/ni.3209	http://dx.doi.org/10.1038/ni.3209			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26086136				2022-12-18	WOS:000356445600004
J	Ubelhart, R; Hug, E; Bach, MP; Wossning, T; Duhren-von Minden, M; Horn, AHC; Tsiantoulas, D; Kometani, K; Kurosaki, T; Binder, CJ; Sticht, H; Nitschke, L; Reth, M; Jumaa, H				Uebelhart, Rudolf; Hug, Eva; Bach, Martina P.; Wossning, Thomas; Duehren-von Minden, Marcus; Horn, Anselm H. C.; Tsiantoulas, Dimitrios; Kometani, Kohei; Kurosaki, Tomohiro; Binder, Christoph J.; Sticht, Heinrich; Nitschke, Lars; Reth, Michael; Jumaa, Hassan			Responsiveness of B cells is regulated by the hinge region of IgD (vol 16, pg 534, 2015)	NATURE IMMUNOLOGY			English	Correction													Tsiantoulas, Dimitrios/AAK-9521-2021; Kurosaki, Tomohiro/D-1306-2009	Tsiantoulas, Dimitrios/0000-0002-7743-3192; Kurosaki, Tomohiro/0000-0002-6352-304X; Kometani, Kohei/0000-0003-4281-4371; Sticht, Heinrich/0000-0001-5644-045X; Horn, Anselm/0000-0003-3539-8103				Ubelhart R, 2015, NAT IMMUNOL, V16, P534, DOI 10.1038/ni.3141	1	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2015	16	7					785	785		10.1038/ni0715-785d	http://dx.doi.org/10.1038/ni0715-785d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CK7WH	26086144	Bronze			2022-12-18	WOS:000356445600018
J	Dejnirattisai, W; Wongwiwat, W; Supasa, S; Zhang, XK; Dai, XH; Rouvinski, A; Jumnainsong, A; Edwards, C; Quyen, NTH; Duangchinda, T; Grimes, JM; Tsai, WY; Lai, CY; Wang, WK; Malasit, P; Farrar, J; Simmons, CP; Zhou, ZH; Rey, FA; Mongkolsapaya, J; Screaton, GR				Dejnirattisai, Wanwisa; Wongwiwat, Wiyada; Supasa, Sunpetchuda; Zhang, Xiaokang; Dai, Xinghong; Rouvinski, Alexander; Jumnainsong, Amonrat; Edwards, Carolyn; Quyen, Nguyen Than Ha; Duangchinda, Thaneeya; Grimes, Jonathan M.; Tsai, Wen-Yang; Lai, Chih-Yun; Wang, Wei-Kung; Malasit, Prida; Farrar, Jeremy; Simmons, Cameron P.; Zhou, Z. Hong; Rey, Felix A.; Mongkolsapaya, Juthathip; Screaton, Gavin R.			A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus (vol 16, pg 170, 2015)	NATURE IMMUNOLOGY			English	Correction													Simmons, Cameron P/ABA-3896-2021; Wongwiwat, Wiyada/AAJ-8936-2021; Farrar, Jeremy J./HGA-7610-2022; Zhou, Z Hong/HDN-0747-2022	Simmons, Cameron P/0000-0002-9039-7392; Farrar, Jeremy/0000-0002-2700-623X; Wongwiwat, Wiyada/0000-0002-5889-0929; Grimes, Jonathan Mark/0000-0001-9698-0389; Dai, Xinghong/0000-0002-4102-3175				Dejnirattisai W, 2015, NAT IMMUNOL, V16, P170, DOI 10.1038/ni.3058	1	1	1	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					544	544		10.1038/ni0515-544b	http://dx.doi.org/10.1038/ni0515-544b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25898199	Bronze			2022-12-18	WOS:000353305200018
J	Wehrle-Haller, B				Wehrle-Haller, Bernhard			Cytoplasmic methylation fuels leukocyte invasion	NATURE IMMUNOLOGY			English	Editorial Material							MIGRATION; EZH2; ACETYLATION; HDAC6	The methyltransferase Ezh2, an epigenetic regulator associated with tumor-cell metastasis, also methlyates the cytoplasmic integrin adaptor talin. This modification inhibits the binding of talin to F-actin, which enhances the migration and invasion of dendritic cells and neutrophils.	Univ Geneva, Ctr Med Univ, Dept Cellular Physiol & Metab, Geneva, Switzerland	University of Geneva	Wehrle-Haller, B (corresponding author), Univ Geneva, Ctr Med Univ, Dept Cellular Physiol & Metab, Geneva, Switzerland.	bernhard.wehrle-haller@unige.ch						Martinez JA, 2014, ADV NUTR, V5, P71, DOI 10.3945/an.113.004705; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Deakin NO, 2014, J CELL BIOL, V206, P395, DOI 10.1083/jcb.201403039; Deb G, 2014, MOL CANCER RES, V12, P639, DOI 10.1158/1541-7786.MCR-13-0546; Fischer KD, 1998, CURR BIOL, V8, P554, DOI 10.1016/S0960-9822(98)70224-6; Garcia-Bernal D, 2009, IMMUNITY, V31, P953, DOI 10.1016/j.immuni.2009.09.021; Gunawan M, 2015, NAT IMMUNOL, V16, P505, DOI 10.1038/ni.3125; Kaluza D, 2011, EMBO J, V30, P4142, DOI 10.1038/emboj.2011.298; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; Marino G., 2014, MOL CELL; Simonson WTN, 2006, J IMMUNOL, V177, P7707, DOI 10.4049/jimmunol.177.11.7707; Su I, 2005, CELL, V121, P425, DOI 10.1016/j.cell.2005.02.029; Tien CL, 2015, DEVELOPMENT, V142, P722, DOI 10.1242/dev.111997; Wehrle-Haller B, 2012, CURR OPIN CELL BIOL, V24, P569, DOI 10.1016/j.ceb.2012.06.010; Zingg D, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7051	15	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2015	16	5					441	443		10.1038/ni.3142	http://dx.doi.org/10.1038/ni.3142			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CG5BN	25898189				2022-12-18	WOS:000353305200003
J	Visan, I				Visan, Ioana			Stressed HSCs	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2015	16	4					342	342						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	VB8FG					2022-12-18	WOS:000418297900004
J	Rimoldi, M; Chieppa, M; Salucci, V; Avogadri, F; Sonzogni, A; Sampietro, GM; Nespoli, A; Viale, G; Allavena, P; Rescigno, M				Rimoldi, Monica; Chieppa, Marcello; Salucci, Valentina; Avogadri, Francesca; Sonzogni, Angelica; Sampietro, Gianluca M.; Nespoli, Angelo; Viale, Giuseppe; Allavena, Paola; Rescigno, Maria			Intestinal immune homeostasis is regulated by the crosstalk between epithelial cells and dendritic cells (vol 6, pg 507, 2005)	NATURE IMMUNOLOGY			English	Correction													Chieppa, Marcello/AAG-9835-2019; Chieppa, Marcello/I-8447-2018; Sampietro, Gianluca/AAB-2846-2019; Rescigno, Maria/J-9704-2012; Viale, Giuseppe/AAE-8921-2019; Allavena, Paola/HHM-5218-2022; Sonzogni, Angelica/C-1193-2017	Chieppa, Marcello/0000-0001-9819-0823; Chieppa, Marcello/0000-0001-9819-0823; Sampietro, Gianluca/0000-0001-7168-441X; Rescigno, Maria/0000-0002-6464-509X; Allavena, Paola/0000-0002-6697-6028; Sonzogni, Angelica/0000-0002-4769-4316; Rimoldi, Monica/0000-0002-8333-7420				Rimoldi M, 2005, NAT IMMUNOL, V6, P507, DOI 10.1038/ni1192	1	1	2	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					326	326		10.1038/ni0315-326a	http://dx.doi.org/10.1038/ni0315-326a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25689446	Bronze			2022-12-18	WOS:000349842100016
J	Sawant, DV; Dent, AL				Sawant, Deepali V.; Dent, Alexander L.			It takes CK2 to suppress T(H)2	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTION FACTOR IRF4; REGULATORY T-CELLS; TH2 DIFFERENTIATION; DENDRITIC CELLS; RESPONSES; INFLAMMATION; EXPRESSION		[Sawant, Deepali V.] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA; [Dent, Alexander L.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Indiana University System; Indiana University-Purdue University Indianapolis	Sawant, DV (corresponding author), Univ Pittsburgh, Dept Immunol, Pittsburgh, PA 15260 USA.	dvsawant@pitt.edu; adent2@iupui.edu	Sawant, Deepali/K-1088-2015	Sawant, Deepali/0000-0002-8119-1106				Chaudhry A, 2009, SCIENCE, V326, P986, DOI 10.1126/science.1172702; Cozza G, 2012, EXPERT OPIN THER PAT, V22, P1081, DOI 10.1517/13543776.2012.717615; Dent AL, 1997, SCIENCE, V276, P589, DOI 10.1126/science.276.5312.589; Gao Y, 2013, IMMUNITY, V39, P722, DOI 10.1016/j.immuni.2013.08.028; Jin HS, 2013, J CLIN INVEST, V123, P4923, DOI 10.1172/JCI69355; Koch MA, 2009, NAT IMMUNOL, V10, P595, DOI 10.1038/ni.1731; Sawant D.V, 2014, IMMUNOLOGY, V54, P435; Sawant DV, 2013, MOL IMMUNOL, V54, P435, DOI 10.1016/j.molimm.2013.01.006; Sawant DV, 2012, J IMMUNOL, V189, P4759, DOI 10.4049/jimmunol.1201794; Ulges A, 2015, NAT IMMUNOL, V16, P267, DOI 10.1038/ni.3083; Williams JW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3990; Zheng Y, 2009, NATURE, V458, P351, DOI 10.1038/nature07674	12	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2015	16	3					224	225		10.1038/ni.3104	http://dx.doi.org/10.1038/ni.3104			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	CB7XN	25689435				2022-12-18	WOS:000349842100004
J	Catalfamo, M; Mawle, A; Verthelyi, D				Catalfamo, Marta; Mawle, Alison; Verthelyi, Daniela			Immunology careers at the NIH, FDA and CDC: different paths that focus on advancing public health	NATURE IMMUNOLOGY			English	Article									[Catalfamo, Marta] NIAID, Immunoregulat Lab, US NIH, Bethesda, MD 20892 USA; [Mawle, Alison] Ctr Dis Control & Prevent, Natl Ctr Immunizat & Resp Dis, Atlanta, GA USA; [Verthelyi, Daniela] US FDA, Ctr Drug Evaluat & Res, Off Biotechnol Prod, Div Therapeut Prot, Silver Spring, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Centers for Disease Control & Prevention - USA; US Food & Drug Administration (FDA)	Catalfamo, M (corresponding author), NIAID, Immunoregulat Lab, US NIH, Bldg 10, Bethesda, MD 20892 USA.	catalfam@mail.nih.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Collins FS, 2014, SCIENCE, V345, P274, DOI 10.1126/science.1255860; Fauci AS, 2014, NEW ENGL J MED, V371, P1084, DOI 10.1056/NEJMp1409494; Hackett CJ, 2007, NAT IMMUNOL, V8, P114, DOI 10.1038/ni0207-114; Lee S, 2013, NAT BIOTECHNOL, V31, P220, DOI 10.1038/nbt.2528; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Parks T, 2012, NEW ENGL J MED, V367, P90, DOI [10.1056/NEJMc1202013, 10.1056/NEJMc1204960]; Paul W. E., 1984, NIH ACCOUNT RES ITS, P153; Siegel RM, 2006, NAT IMMUNOL, V7, P1007, DOI 10.1038/ni1006-1007; Varmus H., 2011, SCI TRANSL MED, V3	9	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2015	16	2					129	132		10.1038/ni.3061	http://dx.doi.org/10.1038/ni.3061			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AZ3QZ	25594454	Green Accepted, Green Published			2022-12-18	WOS:000348143100001
J	Mujal, AM; Krummel, M				Mujal, Adriana M.; Krummel, Matthew			The subtle hands of self-reactivity in peripheral T cells	NATURE IMMUNOLOGY			English	Editorial Material							POSITIVE SELECTION; RESPONSES; GUIDANCE; CD5		[Mujal, Adriana M.; Krummel, Matthew] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA	University of California System; University of California San Francisco	Mujal, AM (corresponding author), Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94140 USA.	matthew.krummel@ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007334, R01AI114787, R01AI052116] Funding Source: NIH RePORTER; NIAID NIH HHS [T32 AI007334, R01 AI114787, R01 AI052116] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Azzam HS, 1998, J EXP MED, V188, P2301, DOI 10.1084/jem.188.12.2301; Cho JH, 2010, IMMUNITY, V32, P214, DOI 10.1016/j.immuni.2009.11.014; Dorner BG, 2009, IMMUNITY, V31, P823, DOI 10.1016/j.immuni.2009.08.027; Fulton RB, 2015, NAT IMMUNOL, V16, P107, DOI 10.1038/ni.3043; Kastenmuller W, 2013, IMMUNITY, V38, P502, DOI 10.1016/j.immuni.2012.11.012; Kieper WC, 2004, J IMMUNOL, V172, P40, DOI 10.4049/jimmunol.172.1.40; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Mandl JN, 2013, IMMUNITY, V38, P263, DOI 10.1016/j.immuni.2012.09.011; Palmer MJ, 2011, IMMUNOL CELL BIOL, V89, P581, DOI 10.1038/icb.2011.5; Persaud SP, 2014, NAT IMMUNOL, V15, P266, DOI 10.1038/ni.2822; Smith K, 2001, J EXP MED, V194, P1253, DOI 10.1084/jem.194.9.1253; Sung JH, 2012, CELL, V150, P1249, DOI 10.1016/j.cell.2012.08.015; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; TARAKHOVSKY A, 1995, SCIENCE, V269, P535, DOI 10.1126/science.7542801; VONBOEHMER H, 1994, CELL, V76, P219, DOI 10.1016/0092-8674(94)90330-1; Weber KS, 2012, P NATL ACAD SCI USA, V109, P9511, DOI 10.1073/pnas.1202408109	16	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2015	16	1					10	11		10.1038/ni.3060	http://dx.doi.org/10.1038/ni.3060			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AW8ET	25521673	Green Accepted			2022-12-18	WOS:000346494200003
J	Kim, JS; Skiarz, T; Banks, LB; Gohil, M; Waickman, AT; Skuli, N; Krock, BL; Luo, CT; Hu, WH; Pollizzi, KN; Li, MO; Rathmell, JC; Birnbaum, MJ; Powell, JD; Jordan, MS; Koretzky, GA				Kim, Jiyeon S.; Skiarz, Tammarah; Banks, Lauren B.; Gohil, Mercy; Waickman, Adam T.; Skuli, Nicolas; Krock, Bryan L.; Luo, Chong T.; Hu, Weihong; Pollizzi, Kristin N.; Li, Ming O.; Rathmell, Jeffrey C.; Birnbaum, Morris J.; Powell, Jonathan D.; Jordan, Martha S.; Koretzky, Gary A.			Natural and inducible T(H)17 cells are regulated differently by Akt and mTOR pathways (Retraction of vol 14, pg 611, 2013)	NATURE IMMUNOLOGY			English	Correction													Koretzky, Gary/AAU-5381-2021	Birnbaum, Morris/0000-0001-9972-8680				Kim JS, 2013, NAT IMMUNOL, V14, P611, DOI 10.1038/ni.2607	1	1	1	0	12	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					996	996		10.1038/ni0910-996	http://dx.doi.org/10.1038/ni0910-996			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR		Green Accepted, Bronze			2022-12-18	WOS:000342564800015
J	Rosen, SD; Daneman, R				Rosen, Steven D.; Daneman, Richard			High endothelial venules through a transcriptomics lens	NATURE IMMUNOLOGY			English	Editorial Material							LYMPHOCYTE; TRAFFICKING; LIGANDS	Transcriptional profiling of endothelial cells from diverse secondary lymphoid organs reveals distinctions that underlie their functional specification.	[Rosen, Steven D.] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Rosen, Steven D.] Univ Calif San Francisco, Program Immunol, San Francisco, CA 94143 USA; [Daneman, Richard] Univ Calif San Diego, Dept Pharmacol, San Diego, CA 92103 USA; [Daneman, Richard] Univ Calif San Francisco, Dept Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Diego; University of California System; University of California San Francisco	Rosen, SD (corresponding author), Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA.	steven.rosen@ucsf.edu		Rosen, Steven/0000-0002-6245-701X				Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Daneman R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013741; Girard JP, 2012, NAT REV IMMUNOL, V12, P762, DOI 10.1038/nri3298; GOWANS JL, 1964, PROC R SOC SER B-BIO, V159, P257, DOI 10.1098/rspb.1964.0001; Kawashima H, 2005, NAT IMMUNOL, V6, P1096, DOI 10.1038/ni1259; Kimura N, 2007, J BIOL CHEM, V282, P32200, DOI 10.1074/jbc.M702341200; Lee M, 2014, NAT IMMUNOL, V15, P982, DOI 10.1038/ni.2983; Miyasaka M, 2004, NAT REV IMMUNOL, V4, P360, DOI 10.1038/nri1354; Nitschke L, 1999, J EXP MED, V189, P1513, DOI 10.1084/jem.189.9.1513; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Ruddle NH, 2009, J IMMUNOL, V183, P2205, DOI 10.4049/jimmunol.0804324; Seaman S, 2007, CANCER CELL, V11, P539, DOI 10.1016/j.ccr.2007.04.017; STEVENS SK, 1982, J IMMUNOL, V128, P844; Uchimura K, 2005, NAT IMMUNOL, V6, P1105, DOI 10.1038/ni1258; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222	15	1	1	1	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2014	15	10					906	908		10.1038/ni.2994	http://dx.doi.org/10.1038/ni.2994			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AQ1TR	25232814				2022-12-18	WOS:000342564800005
J	Doreau, A; Belot, A; Bastid, J; Riche, B; Trescol-Biemont, MC; Ranchin, B; Fabien, N; Cochat, P; Pouteil-Noble, C; Trolliet, P; Durieu, I; Tebib, J; Kassai, B; Ansieau, S; Puisieux, A; Eliaou, JF; Bonnefoy-Berard, N				Doreau, Agnes; Belot, Alexandre; Bastid, Jeremy; Riche, Benjamin; Trescol-Biemont, Marie-Claude; Ranchin, Bruno; Fabien, Nicole; Cochat, Pierre; Pouteil-Noble, Claire; Trolliet, Pierre; Durieu, Isabelle; Tebib, Jacques; Kassai, Berhouz; Ansieau, Stephane; Puisieux, Alain; Eliaou, Jean-Francois; Bonnefoy-Berard, Nathalie			Interleukin 17 acts in synergy with B cell-activating factor to influence B cell biology and the pathophysiology of systemic lupus erythematosus (vol 10, pg 778, 2009)	NATURE IMMUNOLOGY			English	Correction													Ansieau, Stephane/I-6195-2016; Belot, Alexandre/C-7378-2013	Belot, Alexandre/0000-0003-4902-5332				Doreau A, 2009, NAT IMMUNOL, V10, P778, DOI 10.1038/ni.1741	1	1	1	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					894	894		10.1038/ni0914-894a	http://dx.doi.org/10.1038/ni0914-894a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP		Bronze			2022-12-18	WOS:000340739400017
J	Kidd, BA; Peters, LA; Schadt, EE; Dudley, JT				Kidd, Brian A.; Peters, Lauren A.; Schadt, Eric E.; Dudley, Joel T.			Unifying immunology with informatics and multiscale biology (vol 15, pg 118, 2014)	NATURE IMMUNOLOGY			English	Correction																		Kidd BA, 2014, NAT IMMUNOL, V15, P118, DOI 10.1038/ni.2787	1	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					894	894		10.1038/ni0914-894c	http://dx.doi.org/10.1038/ni0914-894c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP		Bronze			2022-12-18	WOS:000340739400019
J	Wang, YM; Colonna, M				Wang, Yaming; Colonna, Marco			RNA exosomes keep endogenous RNA under the radar	NATURE IMMUNOLOGY			English	Editorial Material								The unfolded protein response produces modified endogenous RNA substrates for host cytosolic sensors of RNA, which may lead to production of the interferons IFN-alpha and IFN-beta. The accrual of modified RNA is prevented by an RNA nuclease.	[Wang, Yaming; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA	Washington University (WUSTL)	Wang, YM (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63130 USA.	mcolonna@wustl.edu		Colonna, Marco/0000-0001-5222-4987				Bauernfeind F, 2013, EMBO MOL MED, V5, P814, DOI 10.1002/emmm.201201771; Crow YJ, 2013, HAND CLINIC, V113, P1629, DOI 10.1016/B978-0-444-59565-2.00031-9; Ding SW, 2010, NAT REV IMMUNOL, V10, P632, DOI 10.1038/nri2824; Eckard SC, 2014, NAT IMMUNOL, V15, P839, DOI 10.1038/ni.2948; Fernando MMA, 2007, PLOS GENET, V3, P2109, DOI 10.1371/journal.pgen.0030192; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hollien J, 2006, SCIENCE, V313, P104, DOI 10.1126/science.1129631; Holm CK, 2013, CURR OPIN IMMUNOL, V25, P13, DOI 10.1016/j.coi.2012.12.006; Rehwinkel J, 2013, CURR OPIN MICROBIOL, V16, P485, DOI 10.1016/j.mib.2013.04.009; Rice GI, 2014, NAT GENET, V46, P503, DOI 10.1038/ng.2933; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Wu JX, 2014, ANNU REV IMMUNOL, V32, P461, DOI 10.1146/annurev-immunol-032713-120156	12	1	1	0	15	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					830	831		10.1038/ni.2966	http://dx.doi.org/10.1038/ni.2966			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25137466				2022-12-18	WOS:000340739400009
J	Waterfield, M; Khan, IS; Cortez, JT; Fan, U; Metzger, T; Greer, A; Fasano, K; Martinez-Llordella, M; Pollack, JL; Erle, DJ; Su, M; Anderson, MS				Waterfield, Michael; Khan, Imran S.; Cortez, Jessica T.; Fan, Una; Metzger, Todd; Greer, Alexandra; Fasano, Kayla; Martinez-Llordella, Marc; Pollack, Joshua L.; Erle, David J.; Su, Maureen; Anderson, Mark S.			The transcriptional regulator Aire coopts the repressive ATF7ip-MBD1 complex for the induction of immunotolerance (vol 15, pg 258, 2014)	NATURE IMMUNOLOGY			English	Correction																		Waterfield M, 2014, NAT IMMUNOL, V15, P258, DOI 10.1038/ni.2820	1	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					894	894		10.1038/ni0914-894d	http://dx.doi.org/10.1038/ni0914-894d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP		Bronze			2022-12-18	WOS:000340739400020
J	[Anonymous]				[Anonymous]			A primer on TCR signaling	NATURE IMMUNOLOGY			English	Editorial Material														Dempsey, Laurie/0000-0002-3304-796X					0	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2014	15	9					789	789		10.1038/ni.2982	http://dx.doi.org/10.1038/ni.2982			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AN6WP	25137452	Bronze			2022-12-18	WOS:000340739400001
J	Ciucci, T; Bosselut, R				Ciucci, Thomas; Bosselut, Remy			A ROG(ue) in charge of the (natural) killers	NATURE IMMUNOLOGY			English	Editorial Material							REPRESSOR; CELLS; DIFFERENTIATION; REGULATORS; EXPRESSION; EFFECTORS; LINEAGE; FAMILY; GATA	Natural killer (NK) cells are innate lymphocytes that exhibit many features of adaptive immunity, such as long-lived memory. This can now be extended to the transcriptional circuits that control the proliferation of NK cells and lymphocytes.	[Ciucci, Thomas; Bosselut, Remy] NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ciucci, T (corresponding author), NCI, Lab Immune Cell Biol, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	remy@helix.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC010671] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beaulieu AM, 2014, NAT IMMUNOL, V15, P546, DOI 10.1038/ni.2876; Beaulieu AM, 2011, J IMMUNOL, V187, P2841, DOI 10.4049/jimmunol.1004006; Constantinides MG, 2013, CURR OPIN IMMUNOL, V25, P161, DOI 10.1016/j.coi.2013.01.003; Crotty S, 2010, NAT IMMUNOL, V11, P114, DOI 10.1038/ni.1837; Dokun AO, 2001, NAT IMMUNOL, V2, P951, DOI 10.1038/ni714; Hirahara K, 2008, J ALLERGY CLIN IMMUN, V122, P512, DOI 10.1016/j.jaci.2008.06.004; Kallies A, 2011, BLOOD, V117, P1869, DOI 10.1182/blood-2010-08-303123; Miaw SC, 2000, IMMUNITY, V12, P323, DOI 10.1016/S1074-7613(00)80185-5; Paust S, 2011, NAT IMMUNOL, V12, P500, DOI 10.1038/ni.2032; Spits H, 2011, NAT IMMUNOL, V12, P21, DOI 10.1038/ni.1962; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; Yoon HS, 2012, J IMMUNOL, V189, P2393, DOI 10.4049/jimmunol.1103371	12	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					531	532		10.1038/ni.2895	http://dx.doi.org/10.1038/ni.2895			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24840990				2022-12-18	WOS:000336419300007
J	[Anonymous]				[Anonymous]			Modifying immunity	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2014	15	6					483	483						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AH8WQ	24840978	Bronze			2022-12-18	WOS:000336419300001
J	Daeron, M; Vivier, E				Daeron, Marc; Vivier, Eric			Coincidence detection of antibodies and interferon for sensing microbial context	NATURE IMMUNOLOGY			English	Editorial Material							SIGNALING PATHWAY; RECEPTOR; SURVIVAL; ITAM	Functional coupling of receptors for immunoglobulin G (Fc gamma RI) and interferon-gamma (IFN-gamma R) generates a context-dependent signaling pathway in macrophages.	[Daeron, Marc; Vivier, Eric] Ctr Immunol Marseille Luminy, INSERM, U1104, Marseille, France; [Daeron, Marc; Vivier, Eric] CNRS, UMR7280, Marseille, France; [Daeron, Marc; Vivier, Eric] Aix Marseille Univ UM2, Marseille, France; [Daeron, Marc] Inst Pasteur, Paris, France; [Vivier, Eric] Hop Conception, AP HP, Serv Immunol, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Assistance Publique Hopitaux Paris (APHP); UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille	Daeron, M (corresponding author), Ctr Immunol Marseille Luminy, INSERM, U1104, Marseille, France.	daeron@pasteur.fr; vivier@ciml.univ-mrs.fr	Vivier, Eric/F-8939-2010	Vivier, Eric/0000-0001-7022-8287				ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; Bezbradica JS, 2014, NAT IMMUNOL, V15, P333, DOI 10.1038/ni.2845; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; Huber M, 1998, P NATL ACAD SCI USA, V95, P11330, DOI 10.1073/pnas.95.19.11330; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Kuo TC, 2009, CURR OPIN IMMUNOL, V21, P173, DOI 10.1016/j.coi.2009.03.008; Pasquier B, 2005, IMMUNITY, V22, P31, DOI 10.1016/j.immuni.2004.11.017; Ramadani F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001104; Roget K, 2008, J IMMUNOL, V180, P3689, DOI 10.4049/jimmunol.180.6.3689; Roose JP, 2003, PLOS BIOL, V1, P271, DOI 10.1371/journal.pbio.0000053; Schweighoffer E, 2013, IMMUNITY, V38, P475, DOI 10.1016/j.immuni.2012.11.015	11	1	1	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2014	15	4					316	317		10.1038/ni.2851	http://dx.doi.org/10.1038/ni.2851			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AD4WL	24646591				2022-12-18	WOS:000333252000005
J	Lee, YJ; Holzapfel, KL; Zhu, JF; Jameson, SC; Hogquist, KA				Lee, You Jeong; Holzapfel, Keli L.; Zhu, Jinfang; Jameson, Stephen C.; Hogquist, Kristin A.			Steady-state production of IL-4 modulates immunity in mouse strains and is determined by lineage diversity of iNKT cells (vol 14, pg 1146, 2013)	NATURE IMMUNOLOGY			English	Correction													Zhu, Jinfang/B-7574-2012; Jameson, Stephen C/D-9892-2013	Zhu, Jinfang/0000-0002-0117-4745; Jameson, Stephen C/0000-0001-9137-1146; Hogquist, Kristin/0000-0001-9963-5687				Lee YJ, 2013, NAT IMMUNOL, V14, P1146, DOI 10.1038/ni.2731	1	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2014	15	3					305	305		10.1038/ni0314-305b	http://dx.doi.org/10.1038/ni0314-305b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	AB3HY		Bronze			2022-12-18	WOS:000331683100017
J	Puga, I; Cols, M; Barra, CM; He, B; Cassis, L; Gentile, M; Comerma, L; Chorny, A; Shan, MM; Xu, WF; Magri, G; Knowles, DM; Tam, W; Chiu, A; Bussel, JB; Serrano, S; Lorente, JA; Bellosillo, B; Lloreta, J; Juanpere, N; Alameda, F; Baro, T; de Heredia, CD; Toran, N; Catalaa, A; Torrebadell, M; Fortuny, C; Cusi, V; Carreras, C; Diaz, GA; Blander, JM; Farber, CM; Silvestri, G; Cunningham-Rundles, C; Calvillo, M; Dufour, C; Notarangelo, LD; Lougaris, V; Plebani, A; Casanova, JL; Ganal, SC; Diefenbach, A; Arostegui, JI; Juan, M; Yague, J; Mahlaoui, N; Donadieu, J; Chen, K; Cerutti, A				Puga, Irene; Cols, Montserrat; Barra, Carolina M.; He, Bing; Cassis, Linda; Gentile, Maurizio; Comerma, Laura; Chorny, Alejo; Shan, Meimei; Xu, Weifeng; Magri, Giuliana; Knowles, Daniel M.; Tam, Wayne; Chiu, April; Bussel, James B.; Serrano, Sergi; Lorente, Jose Antonio; Bellosillo, Beatriz; Lloreta, Josep; Juanpere, Nuria; Alameda, Francesc; Baro, Teresa; de Heredia, Cristina Diaz; Toran, Nuria; Catala, Albert; Torrebadell, Montserrat; Fortuny, Claudia; Cusi, Victoria; Carreras, Carmen; Diaz, George A.; Blander, J. Magarian; Farber, Claire-Michele; Silvestri, Guido; Cunningham-Rundles, Charlotte; Calvillo, Michaela; Dufour, Carlo; Notarangelo, Lucia Dora; Lougaris, Vassilios; Plebani, Alessandro; Casanova, Jean-Laurent; Ganal, Stephanie C.; Diefenbach, Andreas; Arostegui, Juan Ignacio; Juan, Manel; Yaguee, Jordi; Mahlaoui, Nizar; Donadieu, Jean; Chen, Kang; Cerutti, Andrea			B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen (vol 13, pg 170, 2012)	NATURE IMMUNOLOGY			English	Correction									[Ganal, Stephanie C.] Spemann Grad Sch Biol & Med, Freiburg, Germany				Calvillo, Michaela/AAB-1705-2021; Dufour, Carlo/AAB-1000-2021; Diaz, George/AAF-6199-2021; Juan, Manel/Q-2931-2019; Lloreta-Trull, Josep/AAZ-1229-2020; MAHLAOUI, Nizar/AAH-6103-2020; Lloreta, J/I-2112-2014; Barra, Carolina/AAF-1324-2019; Lloreta-Trull, Josep/GRR-9682-2022	Calvillo, Michaela/0000-0002-5925-4318; MAHLAOUI, Nizar/0000-0002-0030-8094; Lloreta, J/0000-0003-1644-9470; Barra, Carolina/0000-0002-6836-4906; Casanova, Jean-Laurent/0000-0002-7782-4169; Chorny, Alejo/0000-0001-5874-350X; Juan, Manel/0000-0002-3064-1648; Blander, Julie Magarian/0000-0001-9207-1700; Cerutti, Andrea/0000-0003-3026-4704				Puga I, 2012, NAT IMMUNOL, V13, P170, DOI 10.1038/ni.2194	1	1	1	0	16	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2014	15	2					205	205		10.1038/ni0214-205a	http://dx.doi.org/10.1038/ni0214-205a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	295XV		Bronze			2022-12-18	WOS:000330150600015
J	Luscinskas, FW				Luscinskas, Francis W.			Neutrophil recruitment: perivascular macrophages 'duke it out' with Staphylococcus aureus	NATURE IMMUNOLOGY			English	Editorial Material							IN-VIVO	Control of infection with Staphylococcus aureus relies on the production of neutrophil-recruiting chemokines by perivascular macrophages. S. aureus counterattacks by secreting alpha-hemolysin, which lyses tissue macrophages.	[Luscinskas, Francis W.] Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol, Boston, MA 02115 USA; [Luscinskas, Francis W.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Luscinskas, FW (corresponding author), Brigham & Womens Hosp, Dept Pathol, Ctr Excellence Vasc Biol, 75 Francis St, Boston, MA 02115 USA.	fluscinskas@partners.org		Luscinskas, Francis/0000-0001-7100-4103				Abtin A., 2014, NAT IMMUNOL, V15, P45; BRUNS RR, 1968, J CELL BIOL, V37, P244, DOI 10.1083/jcb.37.2.244; Chavakis T, 2007, TRENDS IMMUNOL, V28, P408, DOI 10.1016/j.it.2007.07.002; Cho JS, 2010, J CLIN INVEST, V120, P1762, DOI 10.1172/JCI40891; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Dinarello CA, 2011, EUR J IMMUNOL, V41, P1203, DOI 10.1002/eji.201141550; Lammermann T, 2013, NATURE, V498, P371, DOI 10.1038/nature12175; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Mempel TR, 2006, IMMUNITY, V25, P129, DOI 10.1016/j.immuni.2006.04.015; Proebstl D, 2012, J EXP MED, V209, P1219, DOI 10.1084/jem.20111622; Stark K, 2013, NAT IMMUNOL, V14, P41, DOI 10.1038/ni.2477; Zecconi A, 2013, IMMUNOL LETT, V150, P12, DOI 10.1016/j.imlet.2013.01.004	12	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					10	11		10.1038/ni.2793	http://dx.doi.org/10.1038/ni.2793			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ	24352318				2022-12-18	WOS:000328800500006
J	Quintana, FJ; Jin, H; Burns, EJ; Nadeau, M; Yeste, A; Kumar, D; Rangachari, M; Zhu, C; Xiao, S; Seavitt, J; Georgopoulos, K; Kuchroo, VK				Quintana, Francisco J.; Jin, Hulin; Burns, Evan J.; Nadeau, Meghan; Yeste, Ada; Kumar, Deepak; Rangachari, Manu; Zhu, Chen; Xiao, Sheng; Seavitt, John; Georgopoulos, Katia; Kuchroo, Vijay K.			Aiolos promotes T(H)17 differentiation by directly silencing II2 expression (vol 13, pg 770, 2012)	NATURE IMMUNOLOGY			English	Correction													Quintana, Francisco Javier/AAB-6915-2020					Quintana FJ, 2012, NAT IMMUNOL, V13, P770, DOI 10.1038/ni.2363	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					109	109		10.1038/ni0114-109b	http://dx.doi.org/10.1038/ni0114-109b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ		Bronze			2022-12-18	WOS:000328800500019
J	Sinclair, LV; Rolf, J; Emslie, E; Shi, YB; Taylor, PM; Cantrell, DA				Sinclair, Linda V.; Rolf, Julia; Emslie, Elizabeth; Shi, Yun-Bo; Taylor, Peter M.; Cantrell, Doreen A.			Control of amino-acid transport by antigen receptors coordinates the metabolic reprogramming essential for T cell differentiation (vol 14, pg 500, 2013)	NATURE IMMUNOLOGY			English	Correction														Shi, Yun-Bo/0000-0002-6330-0639				Sinclair LV, 2013, NAT IMMUNOL, V14, P500, DOI 10.1038/ni.2556	1	1	1	1	10	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2014	15	1					109	109		10.1038/ni0114-109c	http://dx.doi.org/10.1038/ni0114-109c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	277DZ		Bronze			2022-12-18	WOS:000328800500020
J	Pierre, P; Gatti, E				Pierre, Philippe; Gatti, Evelina			Loss of translation: a stealth weapon against pathogens?	NATURE IMMUNOLOGY			English	Editorial Material							PROTEIN-SYNTHESIS; IMMUNE-RESPONSE; INHIBITION; ACTIVATION; ELEGANS; SYSTEM	Various receptors alert cells to microbial invasion through the detection of conserved molecular patterns and initiate innate immunity. During infection with Legionella pneumophila, macrophages modulate cytokine responses by downregulating protein synthesis according to the pathogenic potential of the intruder.	[Pierre, Philippe; Gatti, Evelina] Aix Marseille Univ, Ctr Immunol Marseille Luminy, UM2, Marseille, France; [Pierre, Philippe; Gatti, Evelina] INSERM, U1104, F-13258 Marseille, France; [Pierre, Philippe; Gatti, Evelina] CNRS, UMR 7280, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Pierre, P (corresponding author), Aix Marseille Univ, Ctr Immunol Marseille Luminy, UM2, Marseille, France.	pierre@ciml.univ-mrs.fr; gatti@ciml.univ-mrs.fr	Gatti, Evelina/B-7941-2012	Gatti, Evelina/0000-0002-0667-0799; pierre, philippe/0000-0003-0863-8255				Araki K, 2011, CURR OPIN CELL BIOL, V23, P707, DOI 10.1016/j.ceb.2011.08.006; Ceppi Maurizio, 2009, Immunome Res, V5, P5, DOI 10.1186/1745-7580-5-5; Colina R, 2008, NATURE, V452, P323, DOI 10.1038/nature06730; Dunbar TL, 2012, CELL HOST MICROBE, V11, P375, DOI 10.1016/j.chom.2012.02.008; Fontana MF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001289; Herdy B, 2012, NAT IMMUNOL, V13, P543, DOI 10.1038/ni.2291; Ishii KJ, 2008, CELL HOST MICROBE, V3, P352, DOI 10.1016/j.chom.2008.05.003; Ivanov SS, 2013, NAT IMMUNOL, V14, P1219, DOI 10.1038/ni.2740; Lelouard H, 2007, J CELL BIOL, V179, P1427, DOI 10.1083/jcb.200707166; Lemaitre B, 2013, NAT REV MICROBIOL, V11, P365, DOI 10.1038/nrmicro3029; McEwan DL, 2012, CELL HOST MICROBE, V11, P364, DOI 10.1016/j.chom.2012.02.007; Mohr I, 2012, CELL HOST MICROBE, V12, P470, DOI 10.1016/j.chom.2012.09.006; Pierre P, 2009, CURR OPIN IMMUNOL, V21, P70, DOI 10.1016/j.coi.2009.03.003; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/nmeth.1314, 10.1038/NMETH.1314]; Vance RE, 2009, CELL HOST MICROBE, V6, P10, DOI 10.1016/j.chom.2009.06.007	15	1	1	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2013	14	12					1203	1205		10.1038/ni.2759	http://dx.doi.org/10.1038/ni.2759			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	254FG	24240150				2022-12-18	WOS:000327149400002
J	Gounari, F; Kee, BL				Gounari, Fotini; Kee, Barbara L.			Fingerprinting Ikaros	NATURE IMMUNOLOGY			English	Editorial Material							GENE	Zinc fingers 1 and 4 of Ikaros have unique functions in the selection of Ikaros target genes, lymphocyte development and the suppression of leukemogenesis.	[Gounari, Fotini] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Gounari, F (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.	fgounari@uchicago.edu; bkee@bsd.uchicago.edu			NIAID NIH HHS [R01 AI078267, R01 AI079213] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079213, R01AI078267] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		GEORGOPOULOS K, 1994, CELL, V79, P143, DOI 10.1016/0092-8674(94)90407-3; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Kurosaki T, 2010, ANNU REV IMMUNOL, V28, P21, DOI 10.1146/annurev.immunol.021908.132541; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Nakahashi H, 2013, CELL REP, V3, P1678, DOI 10.1016/j.celrep.2013.04.024; Papathanasiou P, 2003, IMMUNITY, V19, P131, DOI 10.1016/S1074-7613(03)00168-7; Reynaud D, 2008, NAT IMMUNOL, V9, P927, DOI 10.1038/ni.1626; Schjerven H, 2013, NAT IMMUNOL, V14, P1073, DOI 10.1038/ni.2707; Wang JH, 1996, IMMUNITY, V5, P537, DOI 10.1016/S1074-7613(00)80269-1; Yoshida T, 2006, NAT IMMUNOL, V7, P382, DOI 10.1038/ni1314; Zhang JW, 2012, NAT IMMUNOL, V13, P86, DOI 10.1038/ni.2150	13	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2013	14	10					1034	1035		10.1038/ni.2709	http://dx.doi.org/10.1038/ni.2709			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	220LH	24048134	Green Accepted			2022-12-18	WOS:000324584700011
J	Pisetsky, DS				Pisetsky, David S.			The danger of sex and death in Scarf1(-/-) autoimmune mice	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTORS; ACTIVATION; CLEARANCE; CELLS; HMGB1		[Pisetsky, David S.] Durham VA Med Ctr, Med Res Serv, Durham, NC USA; [Pisetsky, David S.] Duke Univ, Med Ctr, Durham, NC USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University	Pisetsky, DS (corresponding author), Durham VA Med Ctr, Med Res Serv, Durham, NC USA.	dpiset@acpub.duke.edu						Dillon SR, 2001, J IMMUNOL, V166, P58, DOI 10.4049/jimmunol.166.1.58; Galvan MD, 2012, J LEUKOCYTE BIOL, V92, P489, DOI 10.1189/jlb.0212099; Kahlenberg JM, 2013, J IMMUNOL, V190, P1217, DOI 10.4049/jimmunol.1202388; Lafyatis R, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2321; Lemke G, 2010, ANN NY ACAD SCI, V1209, P23, DOI 10.1111/j.1749-6632.2010.05744.x; Means TK, 2009, J EXP MED, V206, P637, DOI 10.1084/jem.20082109; Miyanishi M, 2012, INT IMMUNOL, V24, P551, DOI 10.1093/intimm/dxs064; Nystrom S, 2013, EMBO J, V32, P86, DOI 10.1038/emboj.2012.328; Pisetsky DS, 2006, SCAND J IMMUNOL, V64, P200, DOI 10.1111/j.1365-3083.2006.01822.x; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Ramirez-Ortiz ZG, 2013, NAT IMMUNOL, V14, P917, DOI 10.1038/ni.2670; Ravishankar B, 2013, CELL MOL LIFE SCI, V70, P3571, DOI 10.1007/s00018-013-1261-0; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Shao WH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3206; Yang H, 2013, J LEUKOCYTE BIOL, V93, P865, DOI 10.1189/jlb.1212662	15	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2013	14	9					888	889		10.1038/ni.2684	http://dx.doi.org/10.1038/ni.2684			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	204OS	23959178				2022-12-18	WOS:000323377700004
J	Peperzak, V; Vikstrom, I; Walker, J; Glaser, SP; LePage, M; Coquery, CM; Erickson, LD; Fairfax, K; Mackay, F; Strasser, A; Nutt, SL; Tarlinton, DM				Peperzak, Victor; Vikstroem, Ingela; Walker, Jennifer; Glaser, Stefan P.; LePage, Melanie; Coquery, Christine M.; Erickson, Loren D.; Fairfax, Kirsten; Mackay, Fabienne; Strasser, Andreas; Nutt, Stephen L.; Tarlinton, David M.			Mcl-1 is essential for the survival of plasma cells (vol 14, pg 290, 2013)	NATURE IMMUNOLOGY			English	Correction													Mackay, Fabienne/B-7440-2008; Strasser, Andreas/C-7581-2013; Nutt, Stephen L/C-9256-2013	Mackay, Fabienne/0000-0002-6074-2693; Strasser, Andreas/0000-0002-5020-4891; Nutt, Stephen L/0000-0002-0020-6637				Peperzak V, 2013, NAT IMMUNOL, V14, P290, DOI 10.1038/ni.2527	1	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					877	877		10.1038/ni0813-877c	http://dx.doi.org/10.1038/ni0813-877c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN		Bronze			2022-12-18	WOS:000322010600024
J	Rankin, L; Groom, JR; Chopin, M; Herold, MJ; Walker, JA; Mielke, LA; McKenzie, ANJ; Carotta, S; Nutt, SL; Belz, GT				Rankin, Lucille; Groom, Joanna R.; Chopin, Michael; Herold, Marco J.; Walker, Jennifer A.; Mielke, Lisa A.; McKenzie, Andrew N. J.; Carotta, Sebastian; Nutt, Stephen L.; Belz, Gabrielle T.			The transcription factor T-bet is essential for the development of NKp46(+) innate lymphocytes via the Notch pathway (vol 14, pg 389, 2013)	NATURE IMMUNOLOGY			English	Correction													Belz, Gabrielle T/C-9350-2013; Chopin, Michael/AAD-3661-2020; Herold, Marco J/C-8039-2013; Nutt, Stephen L/C-9256-2013	Belz, Gabrielle T/0000-0002-9660-9587; Herold, Marco J/0000-0001-7539-7581; Nutt, Stephen L/0000-0002-0020-6637; Groom, Joanna/0000-0001-5251-7835; Michael, Chopin/0000-0001-8812-2763				Rankin LC, 2013, NAT IMMUNOL, V14, P389, DOI 10.1038/ni.2545	1	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2013	14	8					877	877		10.1038/ni0813-877b	http://dx.doi.org/10.1038/ni0813-877b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185ZN		Bronze			2022-12-18	WOS:000322010600023
J	Clark, M; Cooke, A				Clark, Mike; Cooke, Anne			Regulation unmasked by activation	NATURE IMMUNOLOGY			English	Editorial Material								The glycoprotein CD52 is an important target for clinical antibodies, but its receptor and function have remained a mystery. However, it now seems that CD52 may be released in soluble form by a subpopulation of human T cells and may thereby exert an as-yet-unrecognized regulatory function via the inhibitory molecule Siglec-10.	[Clark, Mike; Cooke, Anne] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	University of Cambridge	Clark, M (corresponding author), Univ Cambridge, Dept Pathol, Tennis Court Rd, Cambridge CB2 1QP, England.	ac416@cam.ac.uk	Clark, Michael R/D-2479-2011; Cooke, Anne/S-4763-2019	Clark, Michael R/0000-0002-5539-4997; Cooke, Anne/0000-0003-3327-6081				Bandala-Sanchez E, 2013, NAT IMMUNOL, V14, P741, DOI 10.1038/ni.2610; Cao HA, 2011, IMMUNOLOGY, V132, P18, DOI 10.1111/j.1365-2567.2010.03368.x; Chen GY, 2009, SCIENCE, V323, P1722, DOI 10.1126/science.1168988; Coles AJ, 2013, NEUROTHERAPEUTICS, V10, P29, DOI 10.1007/s13311-012-0159-0; Crocker PR, 2007, NAT REV IMMUNOL, V7, P255, DOI 10.1038/nri2056; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; Razi N, 1999, GLYCOBIOLOGY, V9, P1225, DOI 10.1093/glycob/9.11.1225; ROWAN WC, 1995, INT IMMUNOL, V7, P69, DOI 10.1093/intimm/7.1.69; TREUMANN A, 1995, J BIOL CHEM, V270, P6088, DOI 10.1074/jbc.270.11.6088; XIA MQ, 1993, BIOCHEM J, V293, P633, DOI 10.1042/bj2930633	10	1	1	0	14	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2013	14	7					696	697		10.1038/ni.2646	http://dx.doi.org/10.1038/ni.2646			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	165UB	23778805				2022-12-18	WOS:000320509100010
J	Harly, C; Wherry, EJ; Bhandoola, A				Harly, Christelle; Wherry, E. John; Bhandoola, Avinash			Deconstructing development	NATURE IMMUNOLOGY			English	Editorial Material							REGULATORS; NETWORKS; CELLS		[Harly, Christelle; Bhandoola, Avinash] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Wherry, E. John] Univ Penn, Sch Med, Inst Immunol, Dept Microbiol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Harly, C (corresponding author), Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	bhandooa@mail.med.upenn.edu	Wherry, John/ABI-1280-2020	Harly, Christelle/0000-0002-8045-9166				Arnone MI, 1997, DEVELOPMENT, V124, P1851; BRITTEN RJ, 1969, SCIENCE, V165, P349, DOI 10.1126/science.165.3891.349; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Hosoya-Ohmura S, 2011, MOL CELL BIOL, V31, P1894, DOI 10.1128/MCB.05065-11; Jojic V, 2013, NAT IMMUNOL, V14, P633, DOI 10.1038/ni.2587; Kishi H, 2000, BLOOD, V95, P3845; Mingueneau M, 2013, NAT IMMUNOL, V14, P619, DOI 10.1038/ni.2590; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198; Weber BN, 2011, NATURE, V476, P63, DOI 10.1038/nature10279; Wilczynski B, 2010, DEV BIOL, V340, P161, DOI 10.1016/j.ydbio.2009.10.032; Zhang JLA, 2012, CELL, V149, P467, DOI 10.1016/j.cell.2012.01.056	13	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					529	531		10.1038/ni.2613	http://dx.doi.org/10.1038/ni.2613			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23685815				2022-12-18	WOS:000319107600003
J	Reed, JE				Reed, Janet E.			Publishing and patenting the fruits of academic research: the key to a successful parallel track	NATURE IMMUNOLOGY			English	Article									Potter Anderson & Corroon, Wilmington, DE USA		Reed, JE (corresponding author), Potter Anderson & Corroon, Wilmington, DE USA.	jreed@potteranderson.com						Azoulay P., 2004, NAT BUR EC RES SUMM; Breschi S, 2008, EUR MANAG REV, V5, P91, DOI 10.1057/emr.2008.9	2	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2013	14	6					523	526		10.1038/ni.2618	http://dx.doi.org/10.1038/ni.2618			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	146RG	23685813				2022-12-18	WOS:000319107600001
J	Mermikides, A				Mermikides, Alex			The scientist center stage	NATURE IMMUNOLOGY			English	Article								While rehearsing for a performance for London's Science Museum, I ask how scientists and theater artists might collaborate to produce theater that serves the science as much as the art.	Univ Kingston, Sch Performance & Screen Studies, London, England	Kingston University	Mermikides, A (corresponding author), Univ Kingston, Sch Performance & Screen Studies, London, England.	a.mermikides@kingston.ac.uk			AHRC [AH/K003518/1] Funding Source: UKRI; Arts and Humanities Research Council [AH/K003518/1] Funding Source: researchfish	AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))		Complicite, 2008, DIS NUMB; Complicite, 1999, MNEM; Dowell E, 2012, PUBLIC UNDERST SCI, V21, P891, DOI 10.1177/0963662510394278; Ede S, 2010, ART SCI; Emmott S., 2013, 10 BILLION; Frayn Michael, 1998, COPENHAGEN; Gluckman E., 2004, EBMT HDB HAEMOPOIETI; Heddon D., 2009, DEVISING PERFORMANCE; Naylor H., 2012, GOING DARK; Pollier-Green P, 2008, CONFRONTING MORTALIT; Shepherd-Barr Kirsten, 2006, SCI STAGE DOCTOR FAU; Snow CP, 2001, 2 CULTURES SCI REVOL; Stoppard Tom, 1993, ARCADIA; Wilson Melanie, 2012, AUTOBIOGRAPHER	14	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2013	14	5					416	418		10.1038/ni.2592	http://dx.doi.org/10.1038/ni.2592			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127XL	23598387				2022-12-18	WOS:000317732100002
J	McMichael, AJ; Haynes, BF				McMichael, Andrew J.; Haynes, Barton F.			Lessons learned from HIV-1 vaccine trials: new priorities and directions (vol 13, pg 423, 2012)	NATURE IMMUNOLOGY			English	Correction																		McMichael AJ, 2012, NAT IMMUNOL, V13, P423, DOI 10.1038/ni.2264	1	1	1	0	13	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2013	14	4					413	413		10.1038/ni0413-413a	http://dx.doi.org/10.1038/ni0413-413a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	113EG		Bronze			2022-12-18	WOS:000316648700017
J	Steinman, L				Steinman, Lawrence			A Tip leads cytotoxic T cells to the crime scene in neuroinflammation	NATURE IMMUNOLOGY			English	Editorial Material							MULTIPLE-SCLEROSIS	By increasing the range of epitopes presented to lymphocytes, determinant spreading allows a more diverse response to ensue. Now the cellular culprits responsible for determinant spreading in the central nervous system have been identified: they are specialized dendritic cells that recruit recruiting CD8(+) T cells to an autoimmune 'crime'.	[Steinman, Lawrence] Stanford Univ, Dept Neurol, Dept Neurol Sci, Stanford, CA 94305 USA; [Steinman, Lawrence] Stanford Univ, Interdept Program Immunol, Stanford, CA 94305 USA	Stanford University; Stanford University	Steinman, L (corresponding author), Stanford Univ, Dept Neurol, Dept Neurol Sci, Stanford, CA 94305 USA.	steinman@stanford.edu		Steinman, Lawrence/0000-0002-2437-2250				Axtell RC, 2010, NAT MED, V16, P406, DOI 10.1038/nm.2110; Babbe H, 2000, J EXP MED, V192, P393, DOI 10.1084/jem.192.3.393; Frohman EM, 2006, NEW ENGL J MED, V354, P942, DOI 10.1056/NEJMra052130; Huseby ES, 2001, J EXP MED, V194, P669, DOI 10.1084/jem.194.5.669; Ji QY, 2013, NAT IMMUNOL, V14, P254, DOI 10.1038/ni.2513; Link J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036779; Sawcer S, 2011, NATURE, V476, P214, DOI 10.1038/nature10251; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Steinman L, 2001, J EXP MED, V194, pF27, DOI 10.1084/jem.194.5.F27; Steinman L, 2012, J CELL BIOL, V199, P413, DOI 10.1083/jcb.201207175; Steinman L, 2012, NAT MED, V18, P59, DOI 10.1038/nm.2625; vanOosten BW, 1997, NEUROLOGY, V49, P351, DOI 10.1212/WNL.49.2.351	12	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2013	14	3					196	197		10.1038/ni.2551	http://dx.doi.org/10.1038/ni.2551			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	091QR	23416668				2022-12-18	WOS:000315065400005
J	Onodera, A; Tumes, DJ; Nakayama, T				Onodera, Atsushi; Tumes, Damon John; Nakayama, Toshinori			Too much of a good thing	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL HOMEOSTASIS	Maintenance of the peripheral naive CD8(+) T cell pool depends on T cell antigen receptor (TCR) signals and interleukin 7 (IL-7). TCR signaling limits the duration of IL-7 signals to avoid an interferon-gamma-mediated mechanism of apoptotic death of naive CD8(+) T cells.	[Onodera, Atsushi; Tumes, Damon John; Nakayama, Toshinori] Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan; [Onodera, Atsushi; Tumes, Damon John; Nakayama, Toshinori] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiba, Japan	Chiba University; Japan Science & Technology Agency (JST)	Onodera, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Immunol, Chiba, Japan.	tnakayama@faculty.chiba-u.jp	Nakayama, Toshinori/E-1067-2017; Onodera, Atsushi/E-3136-2017; Erisman, Jan Willem/C-6900-2008; Tumes, Damon/B-9917-2009	Nakayama, Toshinori/0000-0002-1434-2007; Tumes, Damon/0000-0001-5709-857X				Kieper WC, 2002, J EXP MED, V195, P1533, DOI 10.1084/jem.20020067; Kimura MY, 2013, NAT IMMUNOL, V14, P143, DOI 10.1038/ni.2494; Park JH, 2004, IMMUNITY, V21, P289, DOI 10.1016/j.immuni.2004.07.016; Park JH, 2007, NAT IMMUNOL, V8, P1049, DOI 10.1038/ni1512; Shinoda K, 2012, P NATL ACAD SCI USA, V109, P7409, DOI 10.1073/pnas.1118539109; Sprent J, 2011, NAT IMMUNOL, V12, P478, DOI 10.1038/ni.2018; Takada K, 2009, NAT REV IMMUNOL, V9, P823, DOI 10.1038/nri2657; Tokoyoda K, 2009, IMMUNITY, V30, P721, DOI 10.1016/j.immuni.2009.03.015	8	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2013	14	2					112	114		10.1038/ni.2510	http://dx.doi.org/10.1038/ni.2510			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	075WR	23334824				2022-12-18	WOS:000313918400003
J	Goswami, R; Kaplan, MH				Goswami, Ritobrata; Kaplan, Mark H.			Yoking OX40 to regulation of IL-9	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; ALLERGIC INFLAMMATION; LUNG INFLAMMATION; T-HELPER-2 CELLS; CD134; BETA	The secretion of cytokines by helper T cells is affected by the cytokine environment and by costimulatory signals. Engagement of the receptor OX40 on T cells increases expression of the transcription factor TRAF6, activates the alternative transcription factor NF-kappa B pathway and induces the production of interleukin 9.	[Goswami, Ritobrata; Kaplan, Mark H.] Indiana Univ Sch Med, Indianapolis, IN USA	Indiana University System; Indiana University Bloomington	Goswami, R (corresponding author), Indiana Univ Sch Med, Indianapolis, IN USA.	mkaplan2@iupui.edu	Goswami, Ritobrata/W-9057-2019	Goswami, Ritobrata/0000-0002-4388-7962; Kaplan, Mark/0000-0002-2923-8245	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI057459] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI057459] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Chang HC, 2010, NAT IMMUNOL, V11, P527, DOI 10.1038/ni.1867; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677; Goswami R, 2012, J IMMUNOL, V188, P968, DOI 10.4049/jimmunol.1102840; Ito T, 2005, J EXP MED, V202, P1213, DOI 10.1084/jem.20051135; Jash A, 2012, J BIOL CHEM, V287, P15445, DOI 10.1074/jbc.M112.340356; Jember AGH, 2001, J EXP MED, V193, P387, DOI 10.1084/jem.193.3.387; Salek-Ardakani S, 2003, J EXP MED, V198, P315, DOI 10.1084/jem.20021937; Staudt V, 2010, IMMUNITY, V33, P192, DOI 10.1016/j.immuni.2010.07.014; Veldhoen M, 2008, NAT IMMUNOL, V9, P1341, DOI 10.1038/ni.1659; Wilhelm C, 2011, NAT IMMUNOL, V12, P1071, DOI 10.1038/ni.2133; Xiao X, 2012, NAT IMMUNOL, V13, P981, DOI 10.1038/ni.2390	12	1	3	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2012	13	10					942	943		10.1038/ni.2421	http://dx.doi.org/10.1038/ni.2421			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	009PV	22990899	Green Accepted			2022-12-18	WOS:000309038600008
J	Werner, M; Jumaa, H				Werner, Markus; Jumaa, Hassan			DOCKing innate to adaptive signaling for persistent antibody production	NATURE IMMUNOLOGY			English	Editorial Material							CLASS-SWITCH RECOMBINATION; MUTATIONS; CELLS; STAT3		[Werner, Markus; Jumaa, Hassan] Univ Freiburg, Ctr Biol Signaling Studies, D-79106 Freiburg, Germany; [Werner, Markus; Jumaa, Hassan] Max Planck Inst Immunobiol & Epigenet, Freiburg, Germany	University of Freiburg; Max Planck Society	Werner, M (corresponding author), Univ Freiburg, Ctr Biol Signaling Studies, Hugstetter Str 55, D-79106 Freiburg, Germany.	jumaa@immunbio.mpg.de						Cote JF, 2007, TRENDS CELL BIOL, V17, P383, DOI 10.1016/j.tcb.2007.05.001; Cote JF, 2005, NAT CELL BIOL, V7, P797, DOI 10.1038/ncb1280; Geha RS, 2003, NAT REV IMMUNOL, V3, P721, DOI 10.1038/nri1181; Honjo T, 2002, ANNU REV IMMUNOL, V20, P165, DOI 10.1146/annurev.immunol.20.090501.112049; Jabara HH, 2012, NAT IMMUNOL, V13, P612, DOI 10.1038/ni.2305; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Su HC, 2010, CURR OPIN ALLERGY CL, V10, P515, DOI 10.1097/ACI.0b013e32833fd718; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; Uckun FM, 2010, P NATL ACAD SCI USA, V107, P2902, DOI 10.1073/pnas.0909086107; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	11	1	1	0	5	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2012	13	6					525	526		10.1038/ni.2317	http://dx.doi.org/10.1038/ni.2317			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	944LO	22610240				2022-12-18	WOS:000304203900003
J	Bonneville, M				Bonneville, Marc			Thymic signatures of tailored peripheral functions	NATURE IMMUNOLOGY			English	Editorial Material							DELTA T-CELLS; INTERFERON-GAMMA; SELECTION; PLASTICITY; REPERTOIRE; SUBSET	Gene profiling by the Immunological Genome Project consortium has identified distinct transcriptional programs that determine the migratory and functional fates of emerging gamma delta thymocytes.	[Bonneville, Marc] Univ Nantes, Canc Res Ctr Nantes Angers, UMR 892, INSERM, Nantes, France; [Bonneville, Marc] CNRS, UMR6299, Nantes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Centre National de la Recherche Scientifique (CNRS)	Bonneville, M (corresponding author), Univ Nantes, Canc Res Ctr Nantes Angers, UMR 892, INSERM, Nantes, France.	bonnevil@nantes.inserm.fr						Azuara V, 1997, EUR J IMMUNOL, V27, P544, DOI 10.1002/eji.1830270228; Bluestone JA, 2009, NAT REV IMMUNOL, V9, P811, DOI 10.1038/nri2654; Bonneville M, 2010, NAT REV IMMUNOL, V10, P467, DOI 10.1038/nri2781; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Hayday AC, 2009, IMMUNITY, V31, P184, DOI 10.1016/j.immuni.2009.08.006; ITOHARA S, 1993, CELL, V72, P337, DOI 10.1016/0092-8674(93)90112-4; Jensen KDC, 2008, IMMUNITY, V29, P90, DOI 10.1016/j.immuni.2008.04.022; Kreslavsky T, 2009, P NATL ACAD SCI USA, V106, P12453, DOI 10.1073/pnas.0903895106; Lewis JM, 2006, NAT IMMUNOL, V7, P843, DOI 10.1038/ni1363; MacLeod AS, 2011, CELL MOL LIFE SCI, V68, P2399, DOI 10.1007/s00018-011-0702-x; Narayan K, 2012, NAT IMMUNOL, V13, P511, DOI 10.1038/ni.2247; Turchinovich G, 2011, IMMUNITY, V35, P59, DOI 10.1016/j.immuni.2011.04.018; Xiong N, 2004, IMMUNITY, V21, P121, DOI 10.1016/j.immuni.2004.06.008	13	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2012	13	5					431	433		10.1038/ni.2287	http://dx.doi.org/10.1038/ni.2287			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929GD	22513325				2022-12-18	WOS:000303048400004
J	[Anonymous]				[Anonymous]			An inflammatory assemblage	NATURE IMMUNOLOGY			English	Editorial Material								The multiprotein inflammasome complexes are important in responses to microbes but are also increasingly recognized as having key pathogenic roles in a variety of diseases from cancer to obesity.											0	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2012	13	4					320	320						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	913OH	22430783	Bronze			2022-12-18	WOS:000301886800004
J	Chaturvedi, A; Martz, R; Dorward, D; Waisberg, M; Pierce, SK				Chaturvedi, Akanksha; Martz, Rebecca; Dorward, David; Waisberg, Michael; Pierce, Susan K.			Endocytosed BCRs sequentially regulate MAPK and Akt signaling pathways from intracellular compartments (vol 12, pg 1119, 2011)	NATURE IMMUNOLOGY			English	Correction																		Chaturvedi A, 2011, NAT IMMUNOL, V12, P1119, DOI 10.1038/ni.2116	1	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					196	196		10.1038/ni0212-196a	http://dx.doi.org/10.1038/ni0212-196a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL		Bronze			2022-12-18	WOS:000299315000017
J	Smyth, MJ				Smyth, Mark J.			Lloyd John Old 1933-2011 OBITUARY	NATURE IMMUNOLOGY			English	Biographical-Item									[Smyth, Mark J.] Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Smyth, Mark J.] Peter MacCallum Canc Ctr, Canc Immunol Program, Melbourne, Vic, Australia	Peter Maccallum Cancer Center; University of Melbourne; Peter Maccallum Cancer Center	Smyth, MJ (corresponding author), Univ Melbourne, Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia.	mark.smyth@petermac.org	Smyth, Mark J/H-8709-2014	Smyth, Mark J/0000-0001-7098-7240				OLD LJ, PUBLICATION LIST	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2012	13	2					103	103		10.1038/ni.2209	http://dx.doi.org/10.1038/ni.2209			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	879FL		Bronze			2022-12-18	WOS:000299315000001
J	Cain, DW; Gunn, MD				Cain, Derek W.; Gunn, Michael D.			NUR who? An orphan transcription factor holds promise for monomaniacs	NATURE IMMUNOLOGY			English	Editorial Material							NUCLEAR RECEPTOR NUR77; GENE-EXPRESSION; MONOCYTES; CELLS	The generation of Ly6C(-) patrolling monocytes requires the transcription factor NR4A1 (Nur77). This finding provides insight into the development and function of these blood-resident cells.	[Cain, Derek W.] Duke Univ, Med Ctr, Dept Med, Dept Immunol, Durham, NC 27710 USA; [Gunn, Michael D.] Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA	Duke University; Duke University	Cain, DW (corresponding author), Duke Univ, Med Ctr, Dept Med, Dept Immunol, Durham, NC 27710 USA.	michael.gunn@duke.edu		Gunn, Michael/0000-0003-4602-0667				Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; El-Asmar B, 2009, J MOL ENDOCRINOL, V42, P131, DOI 10.1677/JME-08-0016; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hanna RN, 2011, NAT IMMUNOL, V12, P778, DOI 10.1038/ni.2063; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Pei LM, 2006, MOL ENDOCRINOL, V20, P786, DOI 10.1210/me.2005-0331; Scatizzi JC, 2006, AM J PATHOL, V168, P1531, DOI 10.2353/ajpath.2006.050555; Song KH, 2001, ENDOCRINOLOGY, V142, P5116, DOI 10.1210/en.142.12.5116; Sunderkotter C, 2004, J IMMUNOL, V172, P4410, DOI 10.4049/jimmunol.172.7.4410; Yrlid U, 2006, J IMMUNOL, V176, P4155, DOI 10.4049/jimmunol.176.7.4155	10	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2011	12	8					727	729		10.1038/ni.2074	http://dx.doi.org/10.1038/ni.2074			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	794BT	21772283				2022-12-18	WOS:000292870700009
J	An, HZ; Hou, J; Zhou, J; Zhao, W; Xu, HM; Zheng, YJ; Yu, YZ; Liu, SX; Cao, XT				An, Huazhang; Hou, Jin; Zhou, Jun; Zhao, Wei; Xu, Hongmei; Zheng, Yuejuan; Yu, Yizhi; Liu, Shuxun; Cao, Xuetao			Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1 (vol 9, pg 542, 2008)	NATURE IMMUNOLOGY			English	Correction													yu, yizhi/ADP-7854-2022; Zheng, Yuejuan/AAF-5923-2020; Hou, Jin/GRY-4960-2022; xu, hong/GSD-8903-2022					An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604	1	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					271	271		10.1038/ni0311-271e	http://dx.doi.org/10.1038/ni0311-271e			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ		Bronze			2022-12-18	WOS:000287354400019
J	Dinarello, C; Arend, W; Sims, J; Smith, D; Blumberg, H; O'Neill, L; Goldbach-Mansky, R; Pizarro, T; Hoffman, H; Bufler, P; Nold, M; Ghezzi, P; Mantovani, A; Garlanda, C; Boraschi, D; Rubartelli, A; Netea, M; van der Meer, J; Joosten, L; Mandrup-Poulsen, T; Donath, M; Lewis, E; Pfeilschifter, J; Martin, M; Kracht, M; Muehl, H; Novick, D; Lukic, M; Conti, B; Solinger, A; Kelk, P; van de Veerdonk, F; Gabel, C				Dinarello, Charles; Arend, William; Sims, John; Smith, Dirk; Blumberg, Hal; O'Neill, Luke; Goldbach-Mansky, Raphaela; Pizarro, Theresa; Hoffman, H.; Bufler, Philip; Nold, Marcel; Ghezzi, Pietro; Mantovani, Alberto; Garlanda, Cecilia; Boraschi, Diana; Rubartelli, Anna; Netea, Mihai; van der Meer, Jos; Joosten, Leo; Mandrup-Poulsen, Tom; Donath, Marc; Lewis, Eli; Pfeilschifter, Josef; Martin, Michael; Kracht, Michael; Muehl, H.; Novick, Daniela; Lukic, Miodrag; Conti, Bruno; Solinger, Alan; Kelk, Peyman; van de Veerdonk, Frank; Gabel, Chiristopher			IL-1 family nomenclature (vol 11, pg 973, 2010)	NATURE IMMUNOLOGY			English	Correction													Joosten, Leo AB/H-3138-2015; van der Meer, Jos W.M./C-8521-2013; Mantovani, Alberto/HCI-7449-2022; Garlanda, Cecilia/K-4601-2016; Boraschi, Diana/AAA-7171-2020; Netea, Mihai/N-5155-2014; Rubartelli, Anna/AAA-1259-2021; van de Veerdonk, Frank L/C-7256-2008	Joosten, Leo AB/0000-0001-6166-9830; van der Meer, Jos W.M./0000-0001-5120-3690; Mantovani, Alberto/0000-0001-5578-236X; Garlanda, Cecilia/0000-0002-1510-7703; Boraschi, Diana/0000-0002-3953-4056; van de Veerdonk, Frank L/0000-0002-1121-4894				Dinarello C, 2010, NAT IMMUNOL, V11, P973, DOI 10.1038/ni1110-973	1	1	1	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2011	12	3					271	271		10.1038/ni0311-271b	http://dx.doi.org/10.1038/ni0311-271b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	721KZ		Bronze			2022-12-18	WOS:000287354400016
J	Geisler, C				Geisler, Carsten			Control of T cell activation by vitamin D Reply	NATURE IMMUNOLOGY			English	Letter							FRACTION; ALBUMIN; ANALOG; SERUM		Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark	University of Copenhagen	Geisler, C (corresponding author), Univ Copenhagen, Dept Int Hlth Immunol & Microbiol, Copenhagen, Denmark.	cge@sund.ku.dk	Geisler, Carsten/A-7056-2012	Geisler, Carsten/0000-0002-8472-0771				BIKLE DD, 1986, J CLIN ENDOCR METAB, V63, P954, DOI 10.1210/jcem-63-4-954; BUTTKE TM, 1983, ANTIMICROB AGENTS CH, V24, P478, DOI 10.1128/AAC.24.4.478; Gundry RL, 2007, PROTEOM CLIN APPL, V1, P73, DOI 10.1002/prca.200600276; Jirmanova L, 2010, CELL RES, V20, P608, DOI 10.1038/cr.2010.72; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Meyer MB, 2010, J STEROID BIOCHEM, V121, P136, DOI 10.1016/j.jsbmb.2010.02.011; Smolders J, 2008, J NEUROIMMUNOL, V194, P7, DOI 10.1016/j.jneuroim.2007.11.014; SREEKUMAR P, 1995, J CLIN INVEST, V96, P602, DOI 10.1172/JCI118075; von Essen MR, 2010, NAT IMMUNOL, V11, P344, DOI 10.1038/ni.1851; Xie ZJ, 2001, STEROIDS, V66, P339, DOI 10.1016/S0039-128X(00)00163-X; Zhou SH, 2010, ENDOCRINOLOGY, V151, P14, DOI 10.1210/en.2009-0969; Zugel U, 2009, EXP DERMATOL, V18, P619, DOI 10.1111/j.1600-0625.2009.00845.x; Zugel U, 2002, J INVEST DERMATOL, V119, P1434, DOI 10.1046/j.1523-1747.2002.19623.x	13	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JAN	2011	12	1					3	4		10.1038/ni0111-3b	http://dx.doi.org/10.1038/ni0111-3b			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	696TU					2022-12-18	WOS:000285465100003
J	Tracey, KJ				Tracey, Kevin J.			Understanding immunity requires more than immunology (vol 11, pg 561, 2010)	NATURE IMMUNOLOGY			English	Correction														Tracey, Kevin J/0000-0003-1884-6314				Tracey KJ, 2010, NAT IMMUNOL, V11, P561, DOI 10.1038/ni0710-561	1	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2010	11	10					969	969		10.1038/ni1010-969c	http://dx.doi.org/10.1038/ni1010-969c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	651KP		Bronze			2022-12-18	WOS:000281926900019
J	[Anonymous]				[Anonymous]			Elements of a good decision	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2010	11	8					645	645		10.1038/ni0810-645	http://dx.doi.org/10.1038/ni0810-645			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	628UX	20644569	Bronze			2022-12-18	WOS:000280149400001
J	Dzhagalov, I; Robey, EA				Dzhagalov, Ivan; Robey, Ellen A.			Multitasking in the medulla	NATURE IMMUNOLOGY			English	Editorial Material							REGULATORY T-CELLS; DENDRITIC CELLS; ANTIGEN PRESENTATION; CENTRAL TOLERANCE; THYMUS; AIRE		[Dzhagalov, Ivan; Robey, Ellen A.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Dzhagalov, I (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	erobey@berkeley.edu		Dzhagalov, Ivan/0000-0001-9209-4582				Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Bautista JL, 2009, NAT IMMUNOL, V10, P610, DOI 10.1038/ni.1739; Gallegos AM, 2004, J EXP MED, V200, P1039, DOI 10.1084/jem.20041457; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Hinterberger M, 2010, NAT IMMUNOL, V11, P512, DOI 10.1038/ni.1874; Klein L, 2009, NAT REV IMMUNOL, V9, P833, DOI 10.1038/nri2669; Koble C, 2009, J EXP MED, V206, P1505, DOI 10.1084/jem.20082449; Lio CWJQ, 2008, IMMUNITY, V28, P100, DOI 10.1016/j.immuni.2007.11.021; Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005; Millet V, 2008, EUR J IMMUNOL, V38, P1257, DOI 10.1002/eji.200737982; Ohnmacht C, 2009, J EXP MED, V206, P549, DOI 10.1084/jem.20082394; vanMeerwijk JPM, 1997, J EXP MED, V185, P377, DOI 10.1084/jem.185.3.377; Watanabe N, 2005, NATURE, V436, P1181, DOI 10.1038/nature03886	13	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					461	462		10.1038/ni0610-461	http://dx.doi.org/10.1038/ni0610-461			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20485270				2022-12-18	WOS:000277821300003
J	Gascoyne, DM; Long, E; Veiga-Fernandes, H; de Boer, J; Williams, O; Seddon, B; Coles, M; Kioussis, D; Brady, HJM				Gascoyne, Duncan M.; Long, Elaine; Veiga-Fernandes, Henrique; de Boer, Jasper; Williams, Owen; Seddon, Benedict; Coles, Mark; Kioussis, Dimitris; Brady, Hugh J. M.			The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development (vol 10, pg 1118, 2009)	NATURE IMMUNOLOGY			English	Correction													de Boer, Jasper/B-5067-2013	de Boer, Jasper/0000-0002-3220-8776; Veiga-Fernandes, Henrique/0000-0001-6216-1836; Seddon, Benedict/0000-0003-4352-3373				Gascoyne DM, 2009, NAT IMMUNOL, V10, P1118, DOI 10.1038/ni.1787	1	1	1	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					543	543		10.1038/ni0610-543a	http://dx.doi.org/10.1038/ni0610-543a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV		Bronze			2022-12-18	WOS:000277821300016
J	[Anonymous]				[Anonymous]			Dogmas, paradigms and proving hypotheses	NATURE IMMUNOLOGY			English	Editorial Material														Dempsey, Laurie/0000-0002-3304-796X					0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2010	11	6					455	455		10.1038/ni0610-455	http://dx.doi.org/10.1038/ni0610-455			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	598FV	20485268	Bronze			2022-12-18	WOS:000277821300001
J	Koyasu, S				Koyasu, Shigeo			Vanilloid flavor for a good appetite?	NATURE IMMUNOLOGY			English	Editorial Material							RECEPTOR-MEDIATED PHAGOCYTOSIS; MACROPHAGES; TRPV1	Members of the transient receptor potential vanilloid ion-channel family are expressed in a wide variety of cells and function as sensors of mechanical stress. The second such family member, TVRP2, is now also linked to phagocytosis in macrophages.	[Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan; [Koyasu, Shigeo] Japan Soc Promot Sci, Res Ctr Sci Syst, Tokyo, Japan	Keio University; Japan Society for the Promotion of Science	Koyasu, S (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo, Japan.	koyasu@sc.itc.keio.ac.jp	Koyasu, Shigeo/J-5583-2015	Koyasu, Shigeo/0000-0001-9585-3038				Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; De Corte V, 2002, EMBO J, V21, P6781, DOI 10.1093/emboj/cdf680; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; Flannagan RS, 2009, NAT REV MICROBIOL, V7, P355, DOI 10.1038/nrmicro2128; Ivashkiv LB, 2009, NAT IMMUNOL, V10, P340, DOI 10.1038/ni.1706; Link TM, 2010, NAT IMMUNOL, V11, P232, DOI 10.1038/ni.1842; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Stein AT, 2006, J GEN PHYSIOL, V128, P509, DOI 10.1085/jgp.200609576; van den Bout I, 2009, J CELL SCI, V122, P3837, DOI 10.1242/jcs.056127; Yin J, 2010, CELL BIOCHEM BIOPHYS, V56, P1, DOI 10.1007/s12013-009-9067-2	12	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2010	11	3					187	189		10.1038/ni0310-187	http://dx.doi.org/10.1038/ni0310-187			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	556QI	20157297				2022-12-18	WOS:000274605800003
J	Cohen, IR				Cohen, Irun R.			Eli Sercarz 1934-2009 OBITUARY	NATURE IMMUNOLOGY			English	Biographical-Item									Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Cohen, IR (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	irun.cohen@weizmann.ac.il							0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2010	11	1					54	54		10.1038/ni0110-54	http://dx.doi.org/10.1038/ni0110-54			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	533WE		Bronze			2022-12-18	WOS:000272855300012
J	Pelletier, N; McHeyzer-Williams, MG				Pelletier, Nadege; McHeyzer-Williams, Michael G.			B cell memory: how to start and when to end	NATURE IMMUNOLOGY			English	Editorial Material							AFFINITY MATURATION; REVEALS	Antigen-driven selection in germinal centers lays the foundation of effective B cell memory. Two reports in this issue reveal novel mechanisms that control effective formation of germinal centers and their long-term persistence in vivo.	Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Pelletier, N (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	mcheyzer@scripps.edu						Allen CDC, 2007, SCIENCE, V315, P528, DOI 10.1126/science.1136736; Batista FD, 2009, NAT REV IMMUNOL, V9, P15, DOI 10.1038/nri2454; Dogan I, 2009, NAT IMMUNOL, V10, P1292, DOI 10.1038/ni.1814; Hauser AE, 2007, IMMUNITY, V26, P655, DOI 10.1016/j.immuni.2007.04.008; McHeyzer-Williams LJ, 2005, ANNU REV IMMUNOL, V23, P487, DOI 10.1146/annurev.immunol.23.021704.115732; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Phan TG, 2009, NAT IMMUNOL, V10, P786, DOI 10.1038/ni.1745; Randall KL, 2009, NAT IMMUNOL, V10, P1283, DOI 10.1038/ni.1820; Schwickert TA, 2007, NATURE, V446, P83, DOI 10.1038/nature05573; Zhang Q, 2009, NEW ENGL J MED, V361, P2046, DOI 10.1056/NEJMoa0905506	10	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2009	10	12					1233	1235		10.1038/ni1209-1233	http://dx.doi.org/10.1038/ni1209-1233			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	520TX	19915622				2022-12-18	WOS:000271872800005
J	[Anonymous]				[Anonymous]			Lessons learned - Additional work is needed to prepare for the next pandemic viral outbreak	NATURE IMMUNOLOGY			English	Editorial Material								Additional work is needed to prepare for the next pandemic viral outbreak.											0	1	1	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2009	10	11					1133	1133		10.1038/ni1109-1133	http://dx.doi.org/10.1038/ni1109-1133			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	508SO	19841641	Bronze			2022-12-18	WOS:000270955900001
J	Hawiger, D; Flavell, RA				Hawiger, Daniel; Flavell, Richard A.			Regulatory T cells that become autoaggressive	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION; TOLERANCE	Foxp3 expression is not stable and may be extinguished both in vitro and in vivo in regulatory T cells that convert into proinflammatory effector T cells. The loss of Foxp3 in regulatory T cells under autoimmune conditions may result in the conversion of suppressor T cells into highly autoaggressive lymphocytes.	[Hawiger, Daniel; Flavell, Richard A.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA; [Flavell, Richard A.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA	Yale University; Howard Hughes Medical Institute; Yale University	Hawiger, D (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	richard.flavell@yale.edu						Apostolou I, 2008, J CLIN IMMUNOL, V28, P619, DOI 10.1007/s10875-008-9254-8; de Lafaille MAC, 2009, IMMUNITY, V30, P626, DOI 10.1016/j.immuni.2009.05.002; Feuerer M, 2009, NAT IMMUNOL, V10, P689, DOI 10.1038/ni.1760; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Shevach EM, 2008, EUR J IMMUNOL, V38, P915, DOI 10.1002/eji.200738111; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437; Zhou L, 2009, IMMUNITY, V30, P646, DOI 10.1016/j.immuni.2009.05.001; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	11	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					938	939		10.1038/ni0909-938	http://dx.doi.org/10.1038/ni0909-938			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV	19692993				2022-12-18	WOS:000269120900006
J	Hewitt, SL; Yin, B; Ji, YH; Chaumeil, J; Marszalek, K; Tenthorey, J; Salvagiotto, G; Steinel, N; Ramsey, LB; Ghysdael, J; Farrar, MA; Sleckman, BP; Schatz, DG; Busslinger, M; Bassing, CH; Skok, JA				Hewitt, Susannah L.; Yin, Bu; Ji, Yanhong; Chaumeil, Julie; Marszalek, Katarzyna; Tenthorey, Jeannette; Salvagiotto, Giorgia; Steinel, Natalie; Ramsey, Laura B.; Ghysdael, Jacques; Farrar, Michael A.; Sleckman, Barry P.; Schatz, David G.; Busslinger, Meinrad; Bassing, Craig H.; Skok, Jane A.			RAG-1 and ATM coordinate monoallelic recombination and nuclear positioning of immunoglobulin loci (vol 10, pg 655, 2009)	NATURE IMMUNOLOGY			English	Correction													Steinel, Natalie C/R-3682-2018; Busslinger, Meinrad J./J-1249-2016; Yin, Bu/A-2327-2011; GHYSDAEL, Jacques/F-3377-2013; Ramsey, Laura/ABD-6113-2020; Skok, Jane/ABF-7249-2020; Farrar, Michael A/M-7802-2013	Busslinger, Meinrad J./0000-0002-9111-9351; Ramsey, Laura/0000-0001-6417-3961; Skok, Jane/0000-0002-4145-1516; Steinel, Natalie/0000-0002-7585-8402				Hewitt SL, 2009, NAT IMMUNOL, V10, P655, DOI 10.1038/ni.1735	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2009	10	9					1034	1034		10.1038/ni0909-1034	http://dx.doi.org/10.1038/ni0909-1034			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	485KV		Bronze			2022-12-18	WOS:000269120900018
J	Dardalhon, V; Awasthi, A; Kwon, H; Galileos, G; Gao, WD; Sobel, RA; Mitsdoerffer, M; Strom, TB; Elyaman, W; Ho, IC; Khoury, S; Oukka, M; Kuchroo, VK				Dardalhon, Valerie; Awasthi, Amit; Kwon, Hyoung; Galileos, George; Gao, Wenda; Sobel, Raymond A.; Mitsdoerffer, Meike; Strom, Terry B.; Elyaman, Wassim; Ho, I-Cheng; Khoury, Samia; Oukka, Mohamed; Kuchroo, Vijay K.			IL-4 inhibits TGF-beta-induced Foxp3(+) T cells and, together with TGF-beta, generates IL-9(+) Foxp3(-) effector T cells (vol 9, pg 1347, 2008)	NATURE IMMUNOLOGY			English	Correction														khoury, samia/0000-0003-3198-6063; Elyaman, Wassim/0000-0001-7238-374X				Dardalhon V, 2008, NAT IMMUNOL, V9, P1347, DOI 10.1038/ni.1677	1	1	1	0	8	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					551	551		10.1038/ni0509-551b	http://dx.doi.org/10.1038/ni0509-551b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC		Bronze			2022-12-18	WOS:000265394400018
J	Taniguchi, T				Taniguchi, Tadatsugu			Aimez-vous Brahms? A story capriccioso from the discovery of a cytokine family and its regulators	NATURE IMMUNOLOGY			English	Article							HUMAN FIBROBLAST INTERFERON; HUMAN-LEUKOCYTE; TRANSCRIPTION FACTORS; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; GENE; EXPRESSION; CDNA; CELLS	Do you delight in Brahms? Do you delight in immunology? Tada Taniguchi recounts the story of Type 1 interferon and its downstream regulators.	[Taniguchi, Tadatsugu] Univ Tokyo, Dept Immunol, Grad Sch Med, Tokyo, Japan; [Taniguchi, Tadatsugu] Univ Tokyo, Fac Med, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Taniguchi, T (corresponding author), Univ Tokyo, Dept Immunol, Grad Sch Med, Tokyo, Japan.	tada@m.u-tokyo.ac.jp			Kakenhi; Ministry of Education, Culture, Sports, Science and Technology, Japan	Kakenhi(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	I thank J. Vilcek and D. Savitsky for their kind reading of this essay. My particular appreciation goes to my mentor C. Weissmann, from whom I learned so much about science and music (and good jokes), and to the colleagues who spent time in my laboratory through the many facets of the studies described above. I also thank my wife Yoko and my friends, either mentioned herein or not, for their continuous support. Our studies were mostly supported by Kakenhi, Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan. Finally, I also thank baseball's Hanshin Tigers for their long-standing roller coaster of hope and disappointment, which in addition to music has significantly enriched my life.	CAVALIERI RL, 1977, P NATL ACAD SCI USA, V74, P3287, DOI 10.1073/pnas.74.8.3287; DERYNCK R, 1980, NATURE, V285, P542, DOI 10.1038/285542a0; FLAVELL RA, 1974, J MOL BIOL, V89, P255, DOI 10.1016/0022-2836(74)90517-8; FUJITA T, 1987, CELL, V49, P357, DOI 10.1016/0092-8674(87)90288-1; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Honda K, 2006, NAT REV IMMUNOL, V6, P644, DOI 10.1038/nri1900; Kim TK, 1997, MOL CELL, V1, P119, DOI 10.1016/S1097-2765(00)80013-1; KNIGHT E, 1980, SCIENCE, V207, P525, DOI 10.1126/science.7352259; MANTEI N, 1980, GENE, V10, P1, DOI 10.1016/0378-1119(80)90137-7; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; NAGATA S, 1980, NATURE, V284, P316, DOI 10.1038/284316a0; OHNO S, 1982, NUCLEIC ACIDS RES, V10, P967, DOI 10.1093/nar/10.3.967; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; TANIGUCHI T, 1980, P NATL ACAD SCI-BIOL, V77, P5230, DOI 10.1073/pnas.77.9.5230; TANIGUCHI T, 1979, P JPN ACAD B-PHYS, V55, P464, DOI 10.2183/pjab.55.464; TANIGUCHI T, 1978, NATURE, V274, P223, DOI 10.1038/274223a0; TANIGUCHI T, 1983, NATURE, V302, P305, DOI 10.1038/302305a0; TANIGUCHI T, 1980, GENE, V10, P11, DOI 10.1016/0378-1119(80)90138-9; TANIGUCHI T, 1980, NATURE, V285, P547, DOI 10.1038/285547a0; TANIGUCHI T, 1972, B SOC ITAL BIOL SPER, V48, P1115; ZOON KC, 1980, SCIENCE, V207, P527, DOI 10.1126/science.7352260	22	1	1	0	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2009	10	5					447	449		10.1038/ni0509-447	http://dx.doi.org/10.1038/ni0509-447			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	436EC	19381135				2022-12-18	WOS:000265394400002
J	Kedl, RM				Kedl, Ross M.			Revolving doors: from academia to industry and back again	NATURE IMMUNOLOGY			English	Editorial Material								Is it possible to return from the industrial sector back to academia? Although academic scientists have traditionally perceived this to be akin to winning the Nobel prize, the personal experience of Ross Kedl suggests that the reality is something quite different altogether.	Univ Colorado, Dept Immunol, Denver, CO 80262 USA	University of Colorado System; University of Colorado Denver	Kedl, RM (corresponding author), Univ Colorado, Dept Immunol, Denver, CO 80262 USA.	ross.kedl@uchsc.edu							0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2009	10	3					227	229		10.1038/ni0309-227	http://dx.doi.org/10.1038/ni0309-227			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	408SY	19221549				2022-12-18	WOS:000263456500002
J	Debes, GF; Reiner, SL				Debes, Gudrun F.; Reiner, Steven L.			Helping and harming have something in common	NATURE IMMUNOLOGY			English	Editorial Material							CXC CHEMOKINE RECEPTOR-5; FOLLICULAR-HELPER-CELLS; T-CELLS; IMMUNE-RESPONSES; T(H)17 CELLS; DIFFERENTIATION; INTERLEUKIN-21; GENERATION; IL-21	The multifarious fates of CD4(+) T helper cells mediate helpful and harmful immunity. An unexpected kinship between 'harmful' interleukin 17-producing T helper cells and 'helpful' follicular T helper cells has now been found.	[Debes, Gudrun F.] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; [Reiner, Steven L.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Reiner, Steven L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Debes, GF (corresponding author), Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA.	gdebes@vet.upenn.edu; sreiner@mail.med.upenn.edu		Debes, Gudrun/0000-0003-4208-7362				Ansel KM, 1999, J EXP MED, V190, P1123, DOI 10.1084/jem.190.8.1123; Bauquet AT, 2009, NAT IMMUNOL, V10, P167, DOI 10.1038/ni.1690; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Campbell DJ, 2001, NAT IMMUNOL, V2, P876, DOI 10.1038/ni0901-876; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Korn T, 2007, NATURE, V448, P484, DOI 10.1038/nature05970; Nurieva RI, 2008, IMMUNITY, V29, P138, DOI 10.1016/j.immuni.2008.05.009; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Trinchieri G, 2007, J EXP MED, V204, P239, DOI 10.1084/jem.20070104; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Zhou L, 2008, NATURE, V453, P236, DOI 10.1038/nature06878; Zhou LA, 2007, NAT IMMUNOL, V8, P967, DOI 10.1038/ni1488	15	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					138	140		10.1038/ni0209-138	http://dx.doi.org/10.1038/ni0209-138			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19148197				2022-12-18	WOS:000263178500006
J	Kaye, J				Kaye, Jonathan			Niche marketing: regulation of the homeostasis of naive CD4(+) T cells	NATURE IMMUNOLOGY			English	Editorial Material							IL-7	Compared with that of naive CD8(+) T cells, the homeostatic population expansion of naive CD4(+) T cells in a lymphopenic environment is limited. New data indicate that this difference is caused by high systemic concentrations of IL-7, which inhibit the function of dendritic cells.	Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA	Scripps Research Institute	Kaye, J (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA.	jkaye@scripps.edu						Bolotin E, 1999, BONE MARROW TRANSPL, V23, P783, DOI 10.1038/sj.bmt.1701655; Fry TJ, 2004, BLOOD, V104, P2794, DOI 10.1182/blood-2003-11-3789; Grinnell J., 1917, Auk Cambridge Mass, V34; Guimond M, 2009, NAT IMMUNOL, V10, P149, DOI 10.1038/ni.1695; Hakim FT, 2005, J CLIN INVEST, V115, P930, DOI 10.1172/JCI22492; Kassiotis G, 2003, J EXP MED, V197, P1007, DOI 10.1084/jem.20021812; Kieper WC, 2005, J IMMUNOL, V174, P3158, DOI 10.4049/jimmunol.174.6.3158; Mackall CL, 1997, BLOOD, V89, P3700, DOI 10.1182/blood.V89.10.3700.3700_3700_3707; Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898; Schluns KS, 2000, NAT IMMUNOL, V1, P426, DOI 10.1038/80868; Tan JT, 2001, P NATL ACAD SCI USA, V98, P8732, DOI 10.1073/pnas.161126098	11	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					136	138		10.1038/ni0209-136	http://dx.doi.org/10.1038/ni0209-136			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM	19148196				2022-12-18	WOS:000263178500005
J	Pruenster, M; Mudde, L; Bombosi, P; Dimitrova, S; Zsak, M; Middleton, J; Richmond, A; Graham, GJ; Segerer, S; Nibbs, RJB; Rot, A				Pruenster, Monika; Mudde, Liesbeth; Bombosi, Paula; Dimitrova, Svetla; Zsak, Marion; Middleton, Jim; Richmond, Ann; Graham, Gerard J.; Segerer, Stephan; Nibbs, Robert J. B.; Rot, Antal			The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity (vol 10, pg 101, 2008)	NATURE IMMUNOLOGY			English	Correction													Graham, Gerard/D-1240-2009; Richmond, Ann/A-3048-2014	Segerer, Stephan/0000-0002-1936-9719; RICHMOND, ANN/0000-0002-9580-900X				Pruenster M, 2009, NAT IMMUNOL, V10, P101, DOI 10.1038/ni.1675	1	1	1	1	2	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					223	223		10.1038/ni0209-223d	http://dx.doi.org/10.1038/ni0209-223d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM		Bronze			2022-12-18	WOS:000263178500019
J	Vig, M; Kinet, JP				Vig, Monika; Kinet, Jean-Pierre			Calcium signaling in immune cells (vol 10, pg 21, 2009)	NATURE IMMUNOLOGY			English	Correction																		Vig M, 2009, NAT IMMUNOL, V10, P21, DOI 10.1038/ni.f.220	1	1	1	1	9	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2009	10	2					223	223		10.1038/ni0209-223c	http://dx.doi.org/10.1038/ni0209-223c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	404UM		Bronze			2022-12-18	WOS:000263178500018
J	Sirois, CM; Hornung, V; Latz, E				Sirois, Cherilyn M.; Hornung, Veit; Latz, Eicke			'Toll2008' outgrows its name	NATURE IMMUNOLOGY			English	Editorial Material							INNATE IMMUNE-RESPONSE; NALP3 INFLAMMASOME; RECEPTOR; ACTIVATION; DROSOPHILA; PATHWAY		[Sirois, Cherilyn M.; Hornung, Veit; Latz, Eicke] Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA; [Hornung, Veit] Univ Bonn, Inst Clin Chem & Pharmacol, D-5300 Bonn, Germany	University of Massachusetts System; University of Massachusetts Worcester; University of Bonn	Sirois, CM (corresponding author), Univ Massachusetts, Sch Med, Div Infect Dis & Immunol, Worcester, MA 01605 USA.	eicke.latz@umassmed.edu	Latz, Eicke/H-3951-2014	Latz, Eicke/0000-0003-1488-5666; Sirois, Cherilyn M./0000-0002-5472-4288				Chen CJ, 2007, NAT MED, V13, P851, DOI 10.1038/nm1603; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Haas T, 2008, IMMUNITY, V28, P315, DOI 10.1016/j.immuni.2008.01.013; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Kalverda AP, 2009, J MOL BIOL, V385, P843, DOI 10.1016/j.jmb.2008.09.048; Moncrieffe MC, 2008, J BIOL CHEM, V283, P33447, DOI 10.1074/jbc.M805427200; Mullick AE, 2008, J EXP MED, V205, P373, DOI 10.1084/jem.20071096; Naiki Y, 2008, J IMMUNOL, V181, P7176, DOI 10.4049/jimmunol.181.10.7176; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Pamplona A, 2007, NAT MED, V13, P703, DOI 10.1038/nm1586; Park B, 2008, NAT IMMUNOL, V9, P1407, DOI 10.1038/ni.1669; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Wang ZC, 2008, P NATL ACAD SCI USA, V105, P5477, DOI 10.1073/pnas.0801295105; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Yano T, 2008, NAT IMMUNOL, V9, P908, DOI 10.1038/ni.1634	19	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2009	10	1					7	10		10.1038/ni0109-7	http://dx.doi.org/10.1038/ni0109-7			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	385BV					2022-12-18	WOS:000261788800003
J	Fredslund, F; Laursen, NS; Roversi, P; Jenner, L; Oliveira, CLP; Pedersen, JS; Nunn, MA; Lea, SM; Discipio, R; Sottrup-Jensen, L; Andersen, GR				Fredslund, Folmer; Laursen, Nick S.; Roversi, Pietro; Jenner, Lasse; Oliveira, Cristiano L. P.; Pedersen, Jan S.; Nunn, Miles A.; Lea, Susan M.; Discipio, Richard; Sottrup-Jensen, Lars; Andersen, Gregers R.			Structure of and influence of a tick complement inhibitor on human complement component 5 (vol 9, pg 753, 2008)	NATURE IMMUNOLOGY			English	Correction													Oliveira, Cristiano L P/B-4403-2008; Nunn, Miles/E-9233-2010; Fredslund, Folmer/ABH-5821-2020; Roversi, Pietro/AAK-4241-2021; Roversi, Pietro/F-8925-2011; Lea, Susan M/B-7678-2009; Pedersen, Jan Skov/A-8346-2008	Oliveira, Cristiano L P/0000-0002-3426-6507; Fredslund, Folmer/0000-0003-0881-1927; Roversi, Pietro/0000-0001-9280-9437; Roversi, Pietro/0000-0001-9280-9437; Lea, Susan M/0000-0001-9287-8053; Pedersen, Jan Skov/0000-0002-7768-0206				Fredslund F, 2008, NAT IMMUNOL, V9, P753, DOI 10.1038/ni.1625	1	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2008	9	8					945	945		10.1038/ni0808-945	http://dx.doi.org/10.1038/ni0808-945			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	328EN		Bronze			2022-12-18	WOS:000257780700018
J	Rowh, MAW; Bassing, CH				Rowh, Marta A. W.; Bassing, Craig H.			Foxos around make B cells tolerable	NATURE IMMUNOLOGY			English	Editorial Material							TRANSCRIPTION FACTORS; RECOMBINATION; RAGS	B cell tolerance is achieved in part through secondary rearrangements that replace ('edit') exons encoding autoreactive antigen-receptor chains. New findings suggest that Foxo transcription factors are critical regulators of receptor editing by activating the transcription of recombination-activating genes.	[Rowh, Marta A. W.; Bassing, Craig H.] Univ Penn, Childrens Hosp, Sch Med,Immunol Grad Grp,Ctr Childhood Canc Res, Abramson Family Canc Res Inst,Dept Pathol & Lab M, Philadelphia, PA 19104 USA	University of Pennsylvania; Childrens Hospital of Philadelphia	Rowh, MAW (corresponding author), Univ Penn, Childrens Hosp, Sch Med,Immunol Grad Grp,Ctr Childhood Canc Res, Abramson Family Canc Res Inst,Dept Pathol & Lab M, Philadelphia, PA 19104 USA.	bassing@email.chop.edu		Rowh, Marta/0000-0001-9584-7826				Amin RH, 2008, NAT IMMUNOL, V9, P613, DOI 10.1038/ni.1612; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Coffer PJ, 2004, NAT REV IMMUNOL, V4, P889, DOI 10.1038/nri1488; Hayashi K, 2004, J IMMUNOL, V173, P5980, DOI 10.4049/jimmunol.173.10.5980; Herzog S, 2008, NAT IMMUNOL, V9, P623, DOI 10.1038/ni.1616; Hsu LY, 2003, IMMUNITY, V19, P105, DOI 10.1016/S1074-7613(03)00181-X; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Jankovic M, 2004, ANNU REV IMMUNOL, V22, P485, DOI 10.1146/annurev.immunol.22.012703.104707; Nemazee D, 2006, NAT REV IMMUNOL, V6, P728, DOI 10.1038/nri1939; Verkoczy L, 2005, IMMUNITY, V22, P519, DOI 10.1016/j.immuni.2005.03.006; Verkoczy L, 2007, J IMMUNOL, V178, P6332, DOI 10.4049/jimmunol.178.10.6332; Yannoutsos N, 2001, J EXP MED, V194, P471, DOI 10.1084/jem.194.4.471	12	1	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					586	588		10.1038/ni0608-586	http://dx.doi.org/10.1038/ni0608-586			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18490907				2022-12-18	WOS:000256067900007
J	[Anonymous]				[Anonymous]			Assessing the status of human immunology	NATURE IMMUNOLOGY			English	Editorial Material								Although excellent animal model systems are available, more studies of human immunology are needed.						Dempsey, Laurie/0000-0002-3304-796X					0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2008	9	6					569	569		10.1038/ni0608-569	http://dx.doi.org/10.1038/ni0608-569			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	303VB	18490901	Bronze			2022-12-18	WOS:000256067900001
J	Cai, GF; Anumanthan, A; Brown, JA; Greenfield, EA; Zhu, BG; Freeman, GJ				Cai, Guifang; Anumanthan, Anukanth; Brown, Julia A.; Greenfield, Edward A.; Zhu, Baogong; Freeman, Gordon J.			CD160 inhibits activation of human CD4(+) T cells through interaction with herpesvirus entry mediator (vol 9, pg 176, 2008)	NATURE IMMUNOLOGY			English	Correction													Freeman, Gordon/AAC-5380-2019	Freeman, Gordon/0000-0002-7210-5616				Cai GF, 2008, NAT IMMUNOL, V9, P176, DOI 10.1038/ni1554	1	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					567	567		10.1038/ni0508-567	http://dx.doi.org/10.1038/ni0508-567			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM		Bronze			2022-12-18	WOS:000255153500019
J	Maltzman, JS; Koretzky, GA				Maltzman, Jonathan S.; Koretzky, Gary A.			CD3 epsilon: PeRuSing for positive selection	NATURE IMMUNOLOGY			English	Editorial Material							T-CELL RECEPTOR; THYMOCYTES; NCK	How engagement of surface T cell antigen receptors `translates' into intracellular signal cascades remains vague. Genetic and biochemical experiments now allow modification of a model linking ligation of these receptors with CD3 epsilon and other cytoplasmic signal-transduction `machinery'.	[Maltzman, Jonathan S.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Koretzky, Gary A.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Koretzky, Gary A.] Univ Penn, Sch Med, Dept Med, Abramson Family Canc Inst, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Maltzman, JS (corresponding author), Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA.	maltz@mail.med.upenn.edu; koretzky@mail.med.upenn.edu	Koretzky, Gary/AAU-5381-2021					Gil D, 2002, CELL, V109, P901, DOI 10.1016/S0092-8674(02)00799-7; Kesti T, 2007, J IMMUNOL, V179, P878, DOI 10.4049/jimmunol.179.2.878; Mingueneau M, 2008, NAT IMMUNOL, V9, P522, DOI 10.1038/ni.1608; Myers MD, 2006, NAT IMMUNOL, V7, P57, DOI 10.1038/ni1291; Sosinowski T, 2001, IMMUNITY, V15, P457, DOI 10.1016/S1074-7613(01)00195-9; Szymczak AL, 2005, J IMMUNOL, V175, P270, DOI 10.4049/jimmunol.175.1.270; Van Laethem F, 2007, IMMUNITY, V27, P735, DOI 10.1016/j.immuni.2007.10.007	7	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2008	9	5					457	459		10.1038/ni0508-457	http://dx.doi.org/10.1038/ni0508-457			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	290WM	18425097				2022-12-18	WOS:000255153500003
J	[Anonymous]				[Anonymous]			Politicizing science no more	NATURE IMMUNOLOGY			English	Editorial Material								The United States has suffered years of anti-science policy under the Bush regime. In this year of US presidential elections, scientists have an even greater obligation to make science policy part of the election campaign.											0	1	1	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2008	9	3					217	217		10.1038/ni0308-217	http://dx.doi.org/10.1038/ni0308-217			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	266BQ	18285766	Bronze			2022-12-18	WOS:000253406700001
J	Goto, A; Matsushita, K; Gesellchen, V; El Chamy, L; Kuttenkeuler, D; Takeuchi, O; Hoffmann, JA; Akira, S; Boutros, M; Reichhart, JM				Goto, Akira; Matsushita, Kazufumi; Gesellchen, Viola; El Chamy, Laure; Kuttenkeuler, David; Takeuchi, Osamu; Hoffmann, Jules A.; Akira, Shizuo; Boutros, Michael; Reichhart, Jean-Marc			Corrigendum: Akirins are highly conserved nuclear proteins required for NF-kappa B-dependent gene expression in drosophila and mice (vol 9, pg 97, 2008)	NATURE IMMUNOLOGY			English	Correction													Takeuchi, Osamu/AAG-9359-2019; GOTO, Akira/V-7847-2017; Takeuchi, Osamu/D-6007-2011	Takeuchi, Osamu/0000-0002-1260-6232; GOTO, Akira/0000-0003-3395-484X; 				Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543	1	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2008	9	2					216	216		10.1038/ni0208-216	http://dx.doi.org/10.1038/ni0208-216			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	253FB		Bronze			2022-12-18	WOS:000252503000018
J	Schoenborn, JR; Dorschner, MO; Sekimata, M; Santer, DM; Shnyreva, M; Fitzpatrick, DR; Stamatoyannopoulos, JA; Wilson, CB				Schoenborn, Jamie R.; Dorschner, Michael O.; Sekimata, Masayuki; Santer, Deanna M.; Shnyreva, Maria; Fitzpatrick, David R.; Stamatoyannopoulos, John A.; Wilson, Christopher B.			Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma (vol 8, pg 732, 2007)	NATURE IMMUNOLOGY			English	Correction																		Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2007	8	12					1398	1398		10.1038/ni1207-1398b	http://dx.doi.org/10.1038/ni1207-1398b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	235XG		Bronze			2022-12-18	WOS:000251267000022
J	Hodgkin, PD; Heath, WR; Baxter, AG				Hodgkin, Philip D.; Heath, William R.; Baxter, Alan G.			The clonal selection theory: 50 years since the revolution (vol 8, pg 1019, 2007)	NATURE IMMUNOLOGY			English	Correction													Baxter, Alan/A-1412-2010	Baxter, Alan/0000-0002-6960-9821				Hodgkin PD, 2007, NAT IMMUNOL, V8, P1019, DOI 10.1038/ni1007-1019	1	1	1	0	6	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2007	8	11					1266	1266		10.1038/ni1107-1266d	http://dx.doi.org/10.1038/ni1107-1266d			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	222ZR		Bronze			2022-12-18	WOS:000250338900022
J	Burnet, FM				Burnet, F. M.			A modification of Jerne's theory of antibody production using the concept of clonal selection (Reprinted from Australian Journal of Science, vol 20, 1957)	NATURE IMMUNOLOGY			English	Reprint									Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia	Walter & Eliza Hall Institute	Burnet, FM (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic, Australia.							Burnet F. Macfarlane, 1956, ENZYME ANTIGEN VIRUS; Burnet FM, 1949, PRODUCTION ANTIBODIE; BURNET FM, 1957, AUSTRALIAN J SCI, V20; GOWENS JL, 1957, BR J EXP PATHOL, V38, P67; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; SIMONSEN MORTEN, 1957, ACTA PATHOL ET MICROBLOL SCAND, V40, P480; TALMAGE DW, 1957, ANNU REV MED, V8, P239, DOI 10.1146/annurev.me.08.020157.001323	7	1	1	0	25	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1024	1026						3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA					2022-12-18	WOS:000249691400006
J	[Anonymous]				[Anonymous]			Sir Frank Macfarlane Burnet, 1899-1985	NATURE IMMUNOLOGY			English	Biographical-Item																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2007	8	10					1009	1009						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	213UA	17878903				2022-12-18	WOS:000249691400001
J	Schoenborn, JR; Dorschner, MO; Sekimata, M; Santer, DM; Shnyreva, M; Fitzpatrick, DR; Stamatoyonnapoulos, JA; Wilson, CB				Schoenborn, Jamie R.; Dorschner, Michael O.; Sekimata, Masayuki; Santer, Deanna M.; Shnyreva, Maria; Fitzpatrick, David R.; Stamatoyonnapoulos, John A.; Wilson, Christopher B.			Comprehensive epigenetic profiling identifies multiple distal regulatory elements directing transcription of the gene encoding interferon-gamma (vol 8, pg 732, 2007)	NATURE IMMUNOLOGY			English	Correction														Santer, Deanna/0000-0001-6169-7735				Schoenborn JR, 2007, NAT IMMUNOL, V8, P732, DOI 10.1038/ni1474	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	AUG	2007	8	8					893	893		10.1038/ni0807-893b	http://dx.doi.org/10.1038/ni0807-893b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	191ZB		Bronze			2022-12-18	WOS:000248169400018
J	Astrakhan, A; Omori, M; Nguyen, T; Becker-Herman, S; Iseki, M; Aye, T; Hudkins, K; Dooley, J; Farr, A; Alpers, CE; Ziegler, SF; Rawlings, DJ				Astrakhan, Alexander; Omori, Miyuki; Nguyen, Thuc; Becker-Herman, Shirly; Iseki, Masanori; Aye, Theingi; Hudkins, Kelly; Dooley, James; Farr, Andrew; Alpers, Charles E.; Ziegler, Steven F.; Rawlings, David J.			Local increase in thymic stomal lymphopoietin induces systemic alterations in B cell development (vol 8, pg 522, 2007)	NATURE IMMUNOLOGY			English	Correction													Rawlings, David/CAI-4751-2022	Omori-Miyake, Miyuki/0000-0002-4643-4045				Astrakhan A, 2007, NAT IMMUNOL, V8, P522, DOI 10.1038/ni1452	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2007	8	7					780	780		10.1038/ni0707-780c	http://dx.doi.org/10.1038/ni0707-780c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	185NQ		Bronze			2022-12-18	WOS:000247718100021
J	[Anonymous]				[Anonymous]			Spot checks	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAR	2007	8	3					215	215		10.1038/ni0307-215	http://dx.doi.org/10.1038/ni0307-215			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	137EF	17304224	Bronze			2022-12-18	WOS:000244275100001
J	[Anonymous]				[Anonymous]			Increasing public awareness	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2007	8	2					109	109		10.1038/ni0207-109	http://dx.doi.org/10.1038/ni0207-109			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	127PA	17242677	Bronze			2022-12-18	WOS:000243597600001
J	Bonasio, R; Scimone, ML; Schaerli, P; Grabie, N; Lichtman, AH; Von Andrian, UH				Bonasio, Roberto; Scimone, M. Lucila; Schaerli, Patrick; Grabie, Nir; Lichtman, Andrew H.; Von Andrian, Ulrich H.			Clonal deletion of thymocytes by circulating dendritic cells homing to the thymus (vol 7, pg 1092, 2006)	NATURE IMMUNOLOGY			English	Correction																		Bonasio R, 2006, NAT IMMUNOL, V7, P1092, DOI 10.1038/ni1385	1	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1234	1234		10.1038/ni1106-1234b	http://dx.doi.org/10.1038/ni1106-1234b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF		Bronze			2022-12-18	WOS:000241437200020
J	[Anonymous]				[Anonymous]			Moralizing stem cell research	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2006	7	11					1125	1125		10.1038/ni1106-1125	http://dx.doi.org/10.1038/ni1106-1125			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HF	17053791	Bronze			2022-12-18	WOS:000241437200001
J	Siegel, RM				Siegel, Richard M.			A new web resource for NIH immunology	NATURE IMMUNOLOGY			English	Letter									NIAMSD, Autoimmun Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Siegel, RM (corresponding author), NIAMSD, Autoimmun Branch, NIH, Bldg 10,Rm 9N238, Bethesda, MD 20892 USA.	rsiegel@nih.gov	Siegel, Richard/C-7592-2009	Siegel, Richard/0000-0001-5953-9893	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [Z01AR041133] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2006	7	10					1007	1007		10.1038/ni1006-1007	http://dx.doi.org/10.1038/ni1006-1007			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	097HE	16985492	Bronze			2022-12-18	WOS:000241437100002
J	Groh, V; Smythe, K; Dai, ZP; Spies, T				Groh, Veronika; Smythe, Kimberly; Dai, Zhengpeng; Spies, Thomas			Fas ligand-mediated paracrine T cell regulation by the receptor NKG2D in tumor immunity (vol 7, pg 755, 2006)	NATURE IMMUNOLOGY			English	Correction																		Groh V, 2006, NAT IMMUNOL, V7, P755, DOI 10.1038/ni1350	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					1004	1004		10.1038/ni0906-1004a	http://dx.doi.org/10.1038/ni0906-1004a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL		Bronze			2022-12-18	WOS:000239942300020
J	Schubart, K; Massa, S; Schubart, D; Corcoran, LM; Rolink, AG; Matthias, P				Schubart, Karin; Massa, Steffen; Schubart, Daniel; Corcoran, Lynn M.; Rolink, Antonius G.; Matthias, Patrick			B cell development and immunoglobulin gene transcription in the absence of Oct-2 and OBF-1 (vol 2, pg 69, 2001)	NATURE IMMUNOLOGY			English	Correction													Corcoran, Lynn M/C-9316-2013; Schubart, Daniel/AAV-6487-2021					Schubart K, 2001, NAT IMMUNOL, V2, P69, DOI 10.1038/83190	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2006	7	9					1004	1004		10.1038/ni0906-1004b	http://dx.doi.org/10.1038/ni0906-1004b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	076FL		Bronze			2022-12-18	WOS:000239942300021
J	[Anonymous]				[Anonymous]			Assessing research quality	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUL	2006	7	7					673	673						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	054LH	16785879				2022-12-18	WOS:000238377700001
J	Lineberry, N; Fathman, CG				Lineberry, N; Fathman, CG			CYLD: deubiquitination-induced TCR signaling	NATURE IMMUNOLOGY			English	Editorial Material							NEGATIVE REGULATION; ENZYME; RINGS; A20		Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA	Stanford University	Lineberry, N (corresponding author), Stanford Univ, Sch Med, Div Rheumatol & Immunol, Dept Med, Stanford, CA 94305 USA.	cfathman@stanford.edu						Bignell GR, 2000, NAT GENET, V25, P160, DOI 10.1038/76006; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Jackson PK, 2000, TRENDS CELL BIOL, V10, P429, DOI 10.1016/S0962-8924(00)01834-1; Kovalenko A, 2003, NATURE, V424, P801, DOI 10.1038/nature01802; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Reiley WW, 2006, NAT IMMUNOL, V7, P411, DOI 10.1038/ni1315; Thien CBF, 2005, BIOCHEM J, V391, P153, DOI 10.1042/BJ20050892; Trompouki E, 2003, NATURE, V424, P793, DOI 10.1038/nature01803; Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Zhang JY, 2000, SEMIN IMMUNOL, V12, P361, DOI 10.1006/smim.2000.0223	14	1	2	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2006	7	4					369	370		10.1038/ni0406-369	http://dx.doi.org/10.1038/ni0406-369			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	024BX	16550202				2022-12-18	WOS:000236171000009
J	[Anonymous]				[Anonymous]			Good data need good writing	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2005	6	11					1061	1061		10.1038/ni1105-1061	http://dx.doi.org/10.1038/ni1105-1061			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	977WD		Bronze			2022-12-18	WOS:000232833300001
J	Jensen, PE				Jensen, PE			Dendritic cells: caspases keep them young	NATURE IMMUNOLOGY			English	Editorial Material							MHC CLASS-II; MATURATION; ENDOSOMES; LYSOSOMES; TRANSPORT; PROTEINS; CLATHRIN	Dendritic cell maturation leading to efficient antigen presentation is a central event that triggers adaptive immune responses. This maturation process seems to be regulated by the AP-1 adaptor proteins through the action of caspases.	Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah	Jensen, PE (corresponding author), Univ Utah, Dept Pathol, Salt Lake City, UT 84132 USA.	peter.jensen@path.utah.edu						Algeciras-Schimnich A, 2002, CURR OPIN CELL BIOL, V14, P721, DOI 10.1016/S0955-0674(02)00384-8; Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Dugast M, 2005, J BIOL CHEM, V280, P19656, DOI 10.1074/jbc.M501357200; Kleijmeer M, 2001, J CELL BIOL, V155, P53, DOI 10.1083/jcb.200103071; McCormick PJ, 2005, P NATL ACAD SCI USA, V102, P7910, DOI 10.1073/pnas.0502206102; Mellman I, 2001, CELL, V106, P255, DOI 10.1016/S0092-8674(01)00449-4; Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002; Santambrogio L, 2005, NAT IMMUNOL, V6, P1020, DOI 10.1038/ni1250; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Wong SH, 2004, P NATL ACAD SCI USA, V101, P17783, DOI 10.1073/pnas.0408229102	12	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2005	6	10					968	969		10.1038/ni1005-968	http://dx.doi.org/10.1038/ni1005-968			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	966NR	16177803				2022-12-18	WOS:000232027200007
J	Greenberg, S				Greenberg, S			A CAPRIciously translocating rac adaptor	NATURE IMMUNOLOGY			English	Editorial Material							FC-GAMMA-R; MEDIATED PHAGOCYTOSIS; ACTIVATION; PROTEINS; CAPRI; CDC42	Fc gamma receptor - mediated phagocytosis requires Rac and Cdc42 GTPases. New data show that CAPRI, a GTPase-activating protein for Ras, functions as an adaptor for Rac and Cdc42 during phagocytosis and early phases of bacterial immunity.	Columbia Univ, Dept Med, New York, NY 10032 USA; Columbia Univ, Dept Pharmacol, New York, NY 10032 USA	Columbia University; Columbia University	Greenberg, S (corresponding author), Columbia Univ, Dept Med, New York, NY 10032 USA.	smg8@columbia.edu						Cox D, 1997, J EXP MED, V186, P1487, DOI 10.1084/jem.186.9.1487; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; DIVIRGILIO F, 1988, J CELL BIOL, V106, P657, DOI 10.1083/jcb.106.3.657; Liu Q, 2005, J CELL BIOL, V170, P183, DOI 10.1083/jcb.200504167; Lockyer PJ, 2001, CURR BIOL, V11, P981, DOI 10.1016/S0960-9822(01)00261-5; Minagawa T, 2001, BIOCHEM BIOPH RES CO, V288, P87, DOI 10.1006/bbrc.2001.5740; PARK DJ, 1992, J BIOL CHEM, V267, P1496; Patel JC, 2002, MOL BIOL CELL, V13, P1215, DOI 10.1091/mbc.02-01-0002; ROSS MD, 1980, CLIN ONCOL, V6, P167; Scheffzek K, 2000, NAT STRUCT BIOL, V7, P122, DOI 10.1038/72392; Scott CC, 2005, J CELL BIOL, V169, P139, DOI 10.1083/jcb.200412162; Wen RR, 2002, J IMMUNOL, V169, P6743, DOI 10.4049/jimmunol.169.12.6743; Zhang J, 2005, NAT IMMUNOL, V6, P911, DOI 10.1038/ni1232	13	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					864	866		10.1038/ni0905-864	http://dx.doi.org/10.1038/ni0905-864			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16116463				2022-12-18	WOS:000231369800006
J	Newkirk, MM; Richie, E; Lunney, JK				Newkirk, MM; Richie, E; Lunney, JK			Advancing women scientists: the immunology experience	NATURE IMMUNOLOGY			English	Letter									McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ H3G 1A4, Canada; MD Anderson Canc Ctr, Dept Carcinogenesis, Smithville, TX 78957 USA; USDA ARS, Anim Parasit Dis Lab, Anim & Nat Resources Inst, Beltsville, MD 20705 USA	McGill University; University of Texas System; UTMD Anderson Cancer Center; United States Department of Agriculture (USDA)	Newkirk, MM (corresponding author), McGill Univ, Dept Med, Ctr Hlth, Montreal, PQ H3G 1A4, Canada.	jlunney@anri.barc.usda.gov		Richie, Ellen/0000-0003-0786-973X				Bickel J, 2002, ACAD MED, V77, P1044, DOI 10.1097/00001888-200210000-00023; Kavathas P, 2001, NAT IMMUNOL, V2, P985, DOI 10.1038/ni1101-985; LEBEAU C, 2004, CRAINS CHICAGO BUSIN, V27; Lundberg IE, 2005, ARTHRITIS RHEUM, V52, P697, DOI 10.1002/art.20881	4	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2005	6	9					855	855		10.1038/ni0905-855	http://dx.doi.org/10.1038/ni0905-855			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	957KX	16116459	Bronze			2022-12-18	WOS:000231369800002
J	Safford, M; Collins, S; Lutz, MA; Allen, A; Huang, CT; Kowalski, J; Blackford, A; Horton, MR; Drake, C; Schwartz, RH; Powell, JD				Safford, M; Collins, S; Lutz, MA; Allen, A; Huang, CT; Kowalski, J; Blackford, A; Horton, MR; Drake, C; Schwartz, RH; Powell, JD			Egr-2 and Egr-3 are negative regulators of T cell activation (vol 6, pg 472, 2005)	NATURE IMMUNOLOGY			English	Correction														Kowalski, Jeanne/0000-0003-3458-3024				Safford M, 2005, NAT IMMUNOL, V6, P472, DOI 10.1038/ni1193	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVENUE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUL	2005	6	7					737	737		10.1038/ni0705-737	http://dx.doi.org/10.1038/ni0705-737			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	938BS		Bronze			2022-12-18	WOS:000229975500018
J	Hernanz-Falcon, P; Rodriguez-Frade, JM; Serrano, A; Martinez, C; Mellado, M				Hernanz-Falcon, P; Rodriguez-Frade, JM; Serrano, A; Martinez, C; Mellado, M			On the dimerization of CCR5 - Reply	NATURE IMMUNOLOGY			English	Letter							LIVING CELLS; FRET		CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, E-28049 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB)	Hernanz-Falcon, P (corresponding author), CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Darwin 3,Campus Univ Cantoblanco, E-28049 Madrid, Spain.	cmartineza@cnb.uam.es	Frade, Jose Miguel Rodriguez/K-4266-2014; Mellado, Mario/M-9893-2014	Frade, Jose Miguel Rodriguez/0000-0002-7753-1462; Mellado, Mario/0000-0001-6325-1630				Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Pfleger KDG, 2005, BIOCHEM J, V385, P625, DOI 10.1042/BJ20041361; Ramsay D, 2002, BIOCHEM J, V365, P429, DOI 10.1042/BJ20020251; Toth PT, 2004, J PHARMACOL EXP THER, V310, P8, DOI 10.1124/jpet.103.064956	5	1	1	0	7	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					535	536		10.1038/ni0605-535b	http://dx.doi.org/10.1038/ni0605-535b			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR					2022-12-18	WOS:000229385900002
J	Roy, CR				Roy, CR			Trimming the fat: a Brucella abortus survival strategy	NATURE IMMUNOLOGY			English	Editorial Material							PHAGOSOME MATURATION; LIPID RAFTS; SUBVERSION		Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, New Haven, CT 06536 USA	Yale University	Roy, CR (corresponding author), Yale Univ, Sch Med, Boyer Ctr Mol Med, Sect Microbial Pathogenesis, 333 Cedar St, New Haven, CT 06536 USA.	craig.roy@yale.edu		Roy, Craig/0000-0003-4490-440X				Allen LAH, 1996, CURR OPIN IMMUNOL, V8, P36, DOI 10.1016/S0952-7915(96)80102-6; Arellano-Reynoso B, 2005, NAT IMMUNOL, V6, P618, DOI 10.1038/ni1202; Beatty WL, 2000, TRAFFIC, V1, P235, DOI 10.1034/j.1600-0854.2000.010306.x; Duclos S, 2000, CELL MICROBIOL, V2, P365, DOI 10.1046/j.1462-5822.2000.00066.x; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Griffiths G, 2004, TRENDS CELL BIOL, V14, P343, DOI 10.1016/j.tcb.2004.05.010; Helms JB, 2004, TRAFFIC, V5, P247, DOI 10.1111/j.1600-0854.2004.0181.x; Lafont F, 2004, CURR OPIN MICROBIOL, V7, P4, DOI 10.1016/j.mib.2003.12.007; Russell DG, 2003, NAT CELL BIOL, V5, P776, DOI 10.1038/ncb0903-776; Scott CC, 2003, J MEMBRANE BIOL, V193, P137, DOI 10.1007/s00232-002-2008-2; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527; Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691	15	1	1	0	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	JUN	2005	6	6					546	548		10.1038/ni0605-546	http://dx.doi.org/10.1038/ni0605-546			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	929ZR	15908934				2022-12-18	WOS:000229385900007
J	Kranz, DM				Kranz, DM			T cell receptor CDRs: starring versus supporting roles	NATURE IMMUNOLOGY			English	Editorial Material							ANTIGEN RECOGNITION; BINDING; MHC; REPERTOIRE	Specific docking of the three T cell receptor complementary-determining regions (CDRs) onto the peptide-MHC complex is the basis of immune recognition. However, the contribution of each CDR to peptide-MHC binding is not routine.	Univ Illinois, Dept Biochem, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	Kranz, DM (corresponding author), Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.	d-kranz@uiuc.edu						Bankovich AJ, 2003, IMMUNITY, V18, P7, DOI 10.1016/S1074-7613(02)00517-4; Borg NA, 2005, NAT IMMUNOL, V6, P171, DOI 10.1038/ni1155; Correia-Neves M, 2001, IMMUNITY, V14, P21, DOI 10.1016/S1074-7613(01)00086-3; Degano M, 2000, IMMUNITY, V12, P251, DOI 10.1016/S1074-7613(00)80178-8; DeLano WL, 2002, CURR OPIN STRUC BIOL, V12, P14, DOI 10.1016/S0959-440X(02)00283-X; Lee PUY, 2000, J EXP MED, V191, P1355, DOI 10.1084/jem.191.8.1355; Manning TC, 1998, IMMUNITY, V8, P413, DOI 10.1016/S1074-7613(00)80547-6; Reiser JB, 2003, NAT IMMUNOL, V4, P241, DOI 10.1038/ni891; Rudolph MG, 2002, ANNU REV BIOPH BIOM, V31, P121, DOI 10.1146/annurev.biophys.31.082901.134423; Sim BC, 1996, SCIENCE, V273, P963, DOI 10.1126/science.273.5277.963; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Zerrahn J, 1997, CELL, V88, P627, DOI 10.1016/S0092-8674(00)81905-4	12	1	3	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					130	132		10.1038/ni0205-130	http://dx.doi.org/10.1038/ni0205-130			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15662440				2022-12-18	WOS:000226468100008
J	Osborne, BA; Kee, BL				Osborne, BA; Kee, BL			Lymphoid development: it's not 'all Greek to us' any more	NATURE IMMUNOLOGY			English	Article							T-CELL; PROGENITORS; COMMITMENT; NOTCH1	Lymphocyte lineage specification involves multiple regulatory factors that act in reciprocal fashion to ensure lineage committment and identity. New insights on how these factors interact were presented at the second Aegean Workshop on Gene Regulation in Lymphocyte Development.	Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA; Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; Univ Chicago, Comm Immunol Canc Biol, Chicago, IL 60637 USA; Univ Chicago, Comm Dev Biol, Chicago, IL 60637 USA	University of Massachusetts System; University of Massachusetts Amherst; University of Chicago; University of Chicago; University of Chicago	Osborne, BA (corresponding author), Univ Massachusetts, Dept Vet & Anim Sci, Amherst, MA 01003 USA.	osborne@vasci.umass.edu; bkee@bsd.uchicago.edu						Allman D, 2003, NAT IMMUNOL, V4, P168, DOI 10.1038/ni878; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Miller JP, 2002, J EXP MED, V196, P705, DOI 10.1084/jem.20020784; Nutt SL, 1999, NATURE, V401, P556, DOI 10.1038/44076; Okada A, 1994, Semin Immunol, V6, P185, DOI 10.1006/smim.1994.1024; Porritt HE, 2004, IMMUNITY, V20, P735, DOI 10.1016/j.immuni.2004.05.004; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Quong MW, 2002, ANNU REV IMMUNOL, V20, P301, DOI 10.1146/annurev.immunol.20.092501.162048; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164; Schubart DB, 1996, NATURE, V383, P538, DOI 10.1038/383538a0; Schwarz BA, 2004, NAT IMMUNOL, V5, P953, DOI 10.1038/ni1101; Smith E, 2004, J LEUKOCYTE BIOL, V75, P973, DOI 10.1189/jlb.1103554	14	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					119	123		10.1038/ni0205-119	http://dx.doi.org/10.1038/ni0205-119			5	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL	15662436				2022-12-18	WOS:000226468100004
J	Unniraman, S; Zhou, SM; Schatz, DG				Unniraman, S; Zhou, SM; Schatz, DG			Amplifying Igh translocations - Reply	NATURE IMMUNOLOGY			English	Letter							C-MYC; CHROMOSOMAL TRANSLOCATIONS; PLASMA-CELLS; MICE; RECOMBINATIONS		Howard Hughes Med Inst, New Haven, CT 06520 USA; Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Howard Hughes Medical Institute; Yale University	Unniraman, S (corresponding author), Howard Hughes Med Inst, New Haven, CT 06520 USA.	david.schatz@yale.edu	Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176				JANZ S, 1993, P NATL ACAD SCI USA, V90, P7361, DOI 10.1073/pnas.90.15.7361; Kovalchuk AL, 2000, LEUKEMIA, V14, P1127, DOI 10.1038/sj.leu.2401767; Kovalchuk AL, 1997, ONCOGENE, V15, P2369, DOI 10.1038/sj.onc.1201409; Kovalchuk AL, 2002, P NATL ACAD SCI USA, V99, P1509, DOI 10.1073/pnas.022643999; Muller JR, 1996, CANCER RES, V56, P419; Muller JR, 1997, BLOOD, V89, P291, DOI 10.1182/blood.V89.1.291.291_291_296; Potter M, 2003, IMMUNOL REV, V194, P177, DOI 10.1034/j.1600-065X.2003.00061.x; Potter M, 1997, HEMATOL ONCOL CLIN N, V11, P323, DOI 10.1016/S0889-8588(05)70434-2; Ramiro AR, 2004, CELL, V118, P431, DOI 10.1016/j.cell.2004.08.006; Roschke V, 1997, ONCOGENE, V14, P3011, DOI 10.1038/sj.onc.1201156; Unniraman S, 2004, NAT IMMUNOL, V5, P1117, DOI 10.1038/ni1127	11	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	FEB	2005	6	2					118	118		10.1038/ni0205-118	http://dx.doi.org/10.1038/ni0205-118			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	889UL		Bronze			2022-12-18	WOS:000226468100003
J	Wilson, JDK				Wilson, JDK			MASTering toxins	NATURE IMMUNOLOGY			English	News Item																		2004, NAT IMMUNOL, V432, P512	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					15	15		10.1038/ni0105-15	http://dx.doi.org/10.1038/ni0105-15			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA		Bronze			2022-12-18	WOS:000225888500006
J	Wilson, JDK				Wilson, JDK			Possible HIV vaccine candidate	NATURE IMMUNOLOGY			English	News Item																		Hovanessian AG, 2004, IMMUNITY, V21, P617, DOI 10.1016/j.immuni.2004.08.015	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2005	6	1					15	15						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	881SA		Bronze			2022-12-18	WOS:000225888500011
J	[Anonymous]				[Anonymous]			Biosecurity with 'bio-sense'	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2004	5	12					1191	1191		10.1038/ni1204-1191	http://dx.doi.org/10.1038/ni1204-1191			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	874MC	15549113	Green Published, Bronze			2022-12-18	WOS:000225353500001
J	Jaeckel, E; Lipes, MA; von Boehmer, H				Jaeckel, E; Lipes, MA; von Boehmer, H			Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes (vol 5, pg 1028, 2003)	NATURE IMMUNOLOGY			English	Correction																		Jaeckel E, 2004, NAT IMMUNOL, V5, P1028, DOI 10.1038/ni1120	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2004	5	11					1190	1190		10.1038/ni1104-1190a	http://dx.doi.org/10.1038/ni1104-1190a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	865HG		Bronze			2022-12-18	WOS:000224692700017
J	Silverstein, AM				Silverstein, AM			Cultures and identities	NATURE IMMUNOLOGY			English	Letter									Johns Hopkins Inst Hist Med, Falmouth, MA 02540 USA	Johns Hopkins University	Silverstein, AM (corresponding author), Johns Hopkins Inst Hist Med, 38 Fells Rd, Falmouth, MA 02540 USA.	arts@jhmi.edu						Maestroni G, 2004, NAT IMMUNOL, V5, P763, DOI 10.1038/ni0804-763	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1005	1005		10.1038/ni1004-1005	http://dx.doi.org/10.1038/ni1004-1005			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15454925				2022-12-18	WOS:000224156600013
J	Sims, TN; Dustin, ML				Sims, TN; Dustin, ML			A polarizing situation	NATURE IMMUNOLOGY			English	Editorial Material							CELLS	The physical location of key proteins may turn out to significantly influence the differentiation tack that a cell takes. If clusters of antigen receptors include interferon-gamma receptors in their midst, the fate of that T cell may be tipped.	NYU, Sch Med, Skirball Inst Mol Med, Dept Pathol, New York, NY 10016 USA	New York University	Sims, TN (corresponding author), NYU, Sch Med, Skirball Inst Mol Med, Dept Pathol, New York, NY 10016 USA.	dustin@saturn.med.nyu.edu	Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389				Boes M, 2002, NATURE, V418, P983, DOI 10.1038/nature01004; Couzin J, 2004, SCIENCE, V305, P773, DOI 10.1126/science.305.5685.773; Dustin ML, 2002, SCIENCE, V298, P785, DOI 10.1126/science.1076386; Frucht DM, 2001, TRENDS IMMUNOL, V22, P556, DOI 10.1016/S1471-4906(01)02005-1; Heissmeyer V, 2004, NAT IMMUNOL, V5, P255, DOI 10.1038/ni1047; KUPFER A, 1983, P NATL ACAD SCI-BIOL, V80, P7224, DOI 10.1073/pnas.80.23.7224; Lee KH, 2003, SCIENCE, V302, P1218, DOI 10.1126/science.1086507; MOLDONADO RA, 2004, NATURE, DOI DOI 10.1038/NATURE02916; MOSMANN TR, 1986, J IMMUNOL, V136, P2348; POO WJ, 1988, NATURE, V332, P378, DOI 10.1038/332378a0; Szabo SJ, 1997, J EXP MED, V185, P817, DOI 10.1084/jem.185.5.817; Wakil AE, 1998, J EXP MED, V188, P1651, DOI 10.1084/jem.188.9.1651	12	1	4	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2004	5	10					1012	1013		10.1038/ni1004-1012	http://dx.doi.org/10.1038/ni1004-1012			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	857YO	15454929				2022-12-18	WOS:000224156600017
J	Chuang, TH; Ulevitch, RJ				Chuang, TH; Ulevitch, RJ			Triad3A, an E3 ubiquitin-protein ligase regulating Toll-like receptors (vol 5, pg 495, 2004)	NATURE IMMUNOLOGY			English	Correction																		Chuang TH, 2004, NAT IMMUNOL, V5, P495, DOI 10.1038/ni1066	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					968	968		10.1038/ni0904-968	http://dx.doi.org/10.1038/ni0904-968			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI		Bronze			2022-12-18	WOS:000223612500026
J	Homann, D; Gill, RG				Homann, D; Gill, RG			To help and help not	NATURE IMMUNOLOGY			English	Editorial Material							T-CELLS; MEMORY; ANTIBODY; CD4	Although CD4(+) T cell help is required for effective pathogen control, persistent antiviral CD4(+) T cell help can, paradoxically, impair the generation of neutralizing antibody responses and thus potentially limit protective immunity.	Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, Denver, CO 80262 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Homann, D (corresponding author), Univ Colorado, Hlth Sci Ctr, Barbara Davis Ctr Childhood Diabet, 4200 E 9th Ave, Denver, CO 80262 USA.	dirk.homann@uchsc.edu; ron.g.gill@uchsc.edu	Gill, Ronald/GWM-5338-2022	Homann, Dirk/0000-0002-7622-5754				AWWAD M, 1988, J EXP MED, V168, P2193, DOI 10.1084/jem.168.6.2193; Heinzel FP, 1999, J EXP MED, V189, P1895, DOI 10.1084/jem.189.12.1895; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; Janssen EM, 2003, NATURE, V421, P852, DOI 10.1038/nature01441; Kitchen SG, 2004, P NATL ACAD SCI USA, V101, P8727, DOI 10.1073/pnas.0401500101; Marzo AL, 2004, J IMMUNOL, V173, P969, DOI 10.4049/jimmunol.173.2.969; Mittrucker HW, 2004, EUR J IMMUNOL, V34, P306, DOI 10.1002/eji.200324578; Recher M, 2004, NAT IMMUNOL, V5, P934, DOI 10.1038/ni1102; Shedlock DJ, 2003, SCIENCE, V300, P337, DOI 10.1126/science.1082305; Sun JC, 2003, SCIENCE, V300, P339, DOI 10.1126/science.1083317; Tyznik AJ, 2004, J EXP MED, V199, P559, DOI 10.1084/jem.20031961	11	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2004	5	9					878	880		10.1038/ni0904-878	http://dx.doi.org/10.1038/ni0904-878			4	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	850LI	15334082				2022-12-18	WOS:000223612500008
J	Winau, F; Schwierzeck, V; Hurwitz, R; Remmel, N; Sieling, PA; Modlin, RL; Porcelli, SA; Brinkmann, V; Sugita, M; Sandhoff, K; Kaufmann, SHE; Schaible, UE				Winau, F; Schwierzeck, V; Hurwitz, R; Remmel, N; Sieling, PA; Modlin, RL; Porcelli, SA; Brinkmann, V; Sugita, M; Sandhoff, K; Kaufmann, SHE; Schaible, UE			Saposin C is required for lipid presentation by human CD1b (vol 5, pg 169, 2004)	NATURE IMMUNOLOGY			English	Correction													Schwierzeck, Vera/AAL-3028-2020	Schwierzeck, Vera/0000-0003-4254-3700; Sugita, Masahiko/0000-0001-5511-1304				Winau F, 2004, NAT IMMUNOL, V5, P169, DOI 10.1038/ni1035	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAR	2004	5	3					344	344		10.1038/ni0304-344c	http://dx.doi.org/10.1038/ni0304-344c			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	779ZV		Bronze			2022-12-18	WOS:000189344600020
J	Kincade, PW; Kelsoe, G				Kincade, PW; Kelsoe, G			A birthday for B cells: Lymphopoiesis II, a scientific symposium honoring Max Cooper	NATURE IMMUNOLOGY			English	Editorial Material							FETAL LIVER; THYMUS; MOUSE; BURSA; SUPPRESSION; LYMPHOCYTES; PRECURSORS; CHICKENS; RECEPTOR; INVITRO		Duke Univ, Durham, NC 27710 USA; Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Duke University; Oklahoma Medical Research Foundation	Kelsoe, G (corresponding author), Duke Univ, Durham, NC 27710 USA.							Blery M, 1998, P NATL ACAD SCI USA, V95, P2446, DOI 10.1073/pnas.95.5.2446; CAIN WA, 1968, NATURE, V217, P87, DOI 10.1038/217087a0; Cooper M D, 1980, N Engl J Med, V302, P964, DOI 10.1056/NEJM198004243021710; COOPER MD, 1968, JNCI-J NATL CANCER I, V41, P373; COOPER MD, 1966, J EXP MED, V123, P75, DOI 10.1084/jem.123.1.75; COOPER MD, 1973, NEW ENGL J MED, V288, P966, DOI 10.1056/NEJM197305032881814; COOPER MD, 1966, SCIENCE, V151, P471, DOI 10.1126/science.151.3709.471; Dunon D, 1997, J EXP MED, V186, P977, DOI 10.1084/jem.186.7.977; KEIGHTLEY RG, 1975, LANCET, V2, P850; KINCADE PW, 1970, P NATL ACAD SCI USA, V67, P1918, DOI 10.1073/pnas.67.4.1918; Kong FK, 1999, P NATL ACAD SCI USA, V96, P1536, DOI 10.1073/pnas.96.4.1536; Kubagawa H, 1997, P NATL ACAD SCI USA, V94, P5261, DOI 10.1073/pnas.94.10.5261; LEVITT D, 1980, CELL, V19, P617, DOI 10.1016/S0092-8674(80)80038-9; McDonald W H, 1983, Ala Med, V53, P6; MILLER JF, 1961, LANCET, V2, P748; MILLER JFA, 1967, NATURE, V216, P659, DOI 10.1038/216659a0; OWEN JJT, 1974, NATURE, V249, P361, DOI 10.1038/249361a0; RAFF MC, 1976, NATURE, V259, P224, DOI 10.1038/259224a0; RAFF MC, 1975, J EXP MED, V142, P1052, DOI 10.1084/jem.142.5.1052; VOGLER LB, 1978, NEW ENGL J MED, V298, P872, DOI 10.1056/NEJM197804202981603	20	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2003	4	12					1155	1157		10.1038/ni1203-1155	http://dx.doi.org/10.1038/ni1203-1155			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	746VZ	14639461				2022-12-18	WOS:000186769500004
J	Del Val, M; Yewdell, JW				Del Val, M; Yewdell, JW			The latest killer AP	NATURE IMMUNOLOGY			English	Editorial Material							MHC CLASS-II; TRANSPORT; TRAFFICKING; LYSOSOMES; DEFICIENT; PERFORIN; MEMBRANE; CELLS	Patients with type 2 Hermansky-Pudlak syndrome are immunodeficient. Mutations in AP-3 that prevent movement of lytic granules along microtubules in CD8(+) T cells help explain these patients' susceptibility to infection.	Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Immunol Viral, Madrid, Spain; NIAID, Viral Dis Lab, Bethesda, MD 20892 USA	Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Del Val, M (corresponding author), Inst Salud Carlos III, Ctr Nacl Microbiol, Unidad Immunol Viral, Madrid, Spain.		Del Val, Margarita/E-4769-2010; yewdell, jyewdell@nih.gov jonathan/A-1702-2012	Del Val, Margarita/0000-0001-6769-4279; 	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [Z01AI000653] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bonifacino JS, 2003, NAT REV MOL CELL BIO, V4, P409, DOI 10.1038/nrm1099; Caplan S, 2000, IMMUNOL LETT, V72, P113, DOI 10.1016/S0165-2478(00)00176-0; Chow A, 2002, NATURE, V418, P988, DOI 10.1038/nature01006; Clark RH, 2003, NAT IMMUNOL, V4, P1111, DOI 10.1038/ni1000; ESTEBAN C, 1999, MOL CELL, V3, P11; Faigle W, 1998, J CELL BIOL, V141, P1121, DOI 10.1083/jcb.141.5.1121; Miranda LR, 2002, P NATL ACAD SCI USA, V99, P8031, DOI 10.1073/pnas.122696599; Sevilla LM, 2001, CELL IMMUNOL, V210, P143, DOI 10.1006/cimm.2001.1817; Stepp SE, 1999, SCIENCE, V286, P1957, DOI 10.1126/science.286.5446.1957; Stepp SE, 2000, IMMUNOL TODAY, V21, P254, DOI 10.1016/S0167-5699(00)01622-4; Sugita M, 2002, IMMUNITY, V16, P697, DOI 10.1016/S1074-7613(02)00311-4	12	1	1	1	3	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1049	1050		10.1038/ni1103-1049	http://dx.doi.org/10.1038/ni1103-1049			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN	14586420				2022-12-18	WOS:000186241100006
J	Liu, NS				Liu, NS			The role of T-bet in B cells - Reply	NATURE IMMUNOLOGY			English	Letter									Bayer Yakuhin, Res Ctr Kyoto, Kuzo, Kyoto 6190216, Japan	Bayer AG	Liu, NS (corresponding author), Bayer Yakuhin, Res Ctr Kyoto, 6-5-1-3 Kunimidai, Kuzo, Kyoto 6190216, Japan.	ningshu.liu.nl@bayer.co.jp						Liu NS, 2003, NAT IMMUNOL, V4, P687, DOI 10.1038/ni941; Shen CH, 2001, J IMMUNOL, V166, P411, DOI 10.4049/jimmunol.166.1.411	2	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2003	4	11					1041	1041		10.1038/ni1103-1041b	http://dx.doi.org/10.1038/ni1103-1041b			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	737PN					2022-12-18	WOS:000186241100003
J	Garg, S; Oran, A; Wajchman, J; Sasaki, S; Maris, CH; Kapp, JA; Jacob, J				Garg, S; Oran, A; Wajchman, J; Sasaki, S; Maris, CH; Kapp, JA; Jacob, J			Genetic tagging shows increased frequency and longevity of antigen-presenting, skin-derived dendritic cells in vivo (vol 4, pg 907, 2003)	NATURE IMMUNOLOGY			English	Correction																		Garg S, 2003, NAT IMMUNOL, V4, P907, DOI 10.1038/ni962	1	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					1037	1037		10.1038/ni1003-1037	http://dx.doi.org/10.1038/ni1003-1037			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG		Bronze			2022-12-18	WOS:000185590100021
J	Hunziker, L; Recher, M; Macpherson, AJ; Hengartner, H; Zinkernagel, RM				Hunziker, L; Recher, M; Macpherson, AJ; Hengartner, H; Zinkernagel, RM			On the implications of polyclonal B cell activation - Reply	NATURE IMMUNOLOGY			English	Letter							INDUCTION		Univ Zurich Hosp, Inst Expt Immunol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital	Hunziker, L (corresponding author), Univ Zurich Hosp, Inst Expt Immunol, Schmelzbergstr 12, CH-8091 Zurich, Switzerland.	lhunziker@uhbs.ch						AHMED R, 1984, CONCEPTS VIRAL PATHO, P231; Benedict CL, 1999, IMMUNITY, V10, P607, DOI 10.1016/S1074-7613(00)80060-6; Bernasconi NL, 2002, SCIENCE, V298, P2199, DOI 10.1126/science.1076071; Bloom B R, 1971, Adv Immunol, V13, P101, DOI 10.1016/S0065-2776(08)60184-4; Boyd WC, 1937, J IMMUNOL, V33, P111; COUTELIER JP, 1994, J AUTOIMMUN, V7, P589, DOI 10.1006/jaut.1994.1043; HIRSCH RS, 1975, VIRAL IMMUNOLOGY IMM, P419; Hunziker L, 2003, NAT IMMUNOL, V4, P343, DOI 10.1038/ni911; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; MOXON ER, 1979, J INFECT DIS, V140, P471, DOI 10.1093/infdis/140.4.471; RAMSEIER H, 1969, J EXP MED, V130, P1279, DOI 10.1084/jem.130.6.1279; Rich AR, 1935, P SOC EXP BIOL MED, V32, P1349; SHIMADA K, 1975, CELL IMMUNOL, V18, P484, DOI 10.1016/0008-8749(75)90075-1; Silverstein AM, 2000, SEMIN IMMUNOL, V12, P173, DOI 10.1006/smim.2000.0228; SILVERSTEIN AM, 1963, J IMMUNOL, V91, P384; SNAPPER CM, 1999, FUNDAMENTAL IMMUNOLO, P831	16	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2003	4	10					932	932		10.1038/ni1003-932	http://dx.doi.org/10.1038/ni1003-932			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	726GG					2022-12-18	WOS:000185590100003
J	Imami, N; Gotch, F				Imami, N; Gotch, F			Twenty years of HIV-1 research: what the future holds	NATURE IMMUNOLOGY			English	Letter							INFECTION		Chelsea & Westminster Hosp, Imperial Coll London, Dept Immunol, London SW10 9NH, England	Imperial College London	Imami, N (corresponding author), Chelsea & Westminster Hosp, Imperial Coll London, Dept Immunol, 369 Fulham Rd, London SW10 9NH, England.			Imami, Nesrina/0000-0001-9673-2895				Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Haynes BF, 2000, ANNU REV IMMUNOL, V18, P529, DOI 10.1146/annurev.immunol.18.1.529; Imami N, 2001, EXPERT OPIN BIOL TH, V1, P803, DOI 10.1517/14712598.1.5.803; Kaech SM, 2003, SCIENCE, V300, P263, DOI 10.1126/science.1084511; Migueles SA, 2002, NAT IMMUNOL, V3, P1061, DOI 10.1038/ni845; Pierson T, 2000, ANNU REV IMMUNOL, V18, P665, DOI 10.1146/annurev.immunol.18.1.665; Wilson JDK, 2000, J INFECT DIS, V182, P792, DOI 10.1086/315764	7	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					501	501		10.1038/ni0603-501	http://dx.doi.org/10.1038/ni0603-501			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC	12774067				2022-12-18	WOS:000183175500002
J	Medzhitov, R				Medzhitov, R			Charles A. Janeway, Jr. - 1943-2003 - Obituary	NATURE IMMUNOLOGY			English	Biographical-Item									Yale Univ, Sch Med, Immunobiol Sect, New Haven, CT 06520 USA	Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Immunobiol Sect, 333 Cedar St, New Haven, CT 06520 USA.								0	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JUN	2003	4	6					502	502		10.1038/ni0603-502	http://dx.doi.org/10.1038/ni0603-502			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	683XC		Bronze			2022-12-18	WOS:000183175500003
J	Tordjman, R; Lepelletier, Y; Lemarchandel, V; Cambot, M; Gaulard, P; Hermine, O; Romeo, PH				Tordjman, R; Lepelletier, Y; Lemarchandel, V; Cambot, M; Gaulard, P; Hermine, O; Romeo, PH			A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response (vol 3, pg 477, 2002)	NATURE IMMUNOLOGY			English	Correction													lepelletier, yves/AAF-1546-2020; Romeo, Paul-Henri/L-5989-2017; Hermine, Olivier/Q-7072-2018	lepelletier, yves/0000-0001-7746-5170; Romeo, Paul-Henri/0000-0002-8294-0367; 				Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789	1	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					394	394		10.1038/ni0403-394a	http://dx.doi.org/10.1038/ni0403-394a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG		Bronze			2022-12-18	WOS:000181987700021
J	[Anonymous]				[Anonymous]			Reviewing peer review	NATURE IMMUNOLOGY			English	Editorial Material																			0	1	1	0	4	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	APR	2003	4	4					297	297		10.1038/ni0403-297	http://dx.doi.org/10.1038/ni0403-297			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	663CG	12660722	Bronze			2022-12-18	WOS:000181987700001
J	Parnes, OS				Parnes, OS			The specificity of the clonal selection theory	NATURE IMMUNOLOGY			English	Letter									UCL, Wellcome Trust Ctr Hist Med, Dept Anat & Dev Biol, London NW1 1AD, England	University of London; University College London	Parnes, OS (corresponding author), UCL, Wellcome Trust Ctr Hist Med, Dept Anat & Dev Biol, 24 Eversholt St, London NW1 1AD, England.	o.parnes@ucl.ac.uk							0	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2003	4	2					95	95		10.1038/ni0203-95	http://dx.doi.org/10.1038/ni0203-95			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	640JW	12555088				2022-12-18	WOS:000180686500002
J	Ward, SG; Finan, P; Welham, MJ				Ward, SG; Finan, P; Welham, MJ			PI3K comes of age	NATURE IMMUNOLOGY			English	Letter									Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England; Novartis Horsham Res Ctr, Horsham RH12 4AB, W Sussex, England	University of Bath; Novartis	Ward, SG (corresponding author), Univ Bath, Dept Pharm & Pharmacol, Bath BA2 7AY, Avon, England.		Ward, Stephen/AAE-4341-2020	Ward, Stephen G./0000-0002-6795-6002				Costello PS, 2002, NAT IMMUNOL, V3, P1082, DOI 10.1038/ni848; Laffargue M, 2002, IMMUNITY, V16, P441, DOI 10.1016/S1074-7613(02)00282-0; Okkenhaug K, 2002, SCIENCE, V297, P1031; Welch HCE, 2002, CELL, V108, P809, DOI 10.1016/S0092-8674(02)00663-3	4	1	1	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2003	4	1					2	2		10.1038/ni0103-2	http://dx.doi.org/10.1038/ni0103-2			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	629MG	12496966				2022-12-18	WOS:000180053000002
J	Wallach, D				Wallach, D			Up the down staircase	NATURE IMMUNOLOGY			English	Editorial Material							KINASE-C-THETA; ACTIVATION; CARMA1; TCR; RECRUITMENT; BCL10		Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Wallach, D (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	David.Wallach@weizmann.ac.il						Bertin J, 2001, J BIOL CHEM, V276, P11877, DOI 10.1074/jbc.M010512200; Gaide O, 2002, NAT IMMUNOL, V3, P836, DOI 10.1038/ni830; Gaide O, 2001, FEBS LETT, V496, P121, DOI 10.1016/S0014-5793(01)02414-0; Ghosh S, 2002, CELL, V109, pS81, DOI 10.1016/S0092-8674(02)00703-1; Isakov N, 2002, ANNU REV IMMUNOL, V20, P761, DOI 10.1146/annurev.immunol.20.100301.064807; Khoshnan A, 2000, J IMMUNOL, V165, P6933, DOI 10.4049/jimmunol.165.12.6933; Matsumoto M, 2002, J IMMUNOL, V169, P1151, DOI 10.4049/jimmunol.169.3.1151; McAllister-Lucas LM, 2001, J BIOL CHEM, V276, P30589, DOI 10.1074/jbc.M103824200; POERANTZ JL, 2002, IN PRESS EMBO J; RUDLAND J, 2000, IMMUNITY, V104, P33; Wang DH, 2002, NAT IMMUNOL, V3, P830, DOI 10.1038/ni824; Yaffe MB, 2002, STRUCTURE, V10, P3, DOI 10.1016/S0969-2126(01)00705-5; Zhang SQ, 2000, IMMUNITY, V12, P301, DOI 10.1016/S1074-7613(00)80183-1	13	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	SEP	2002	3	9					802	803		10.1038/ni0902-802	http://dx.doi.org/10.1038/ni0902-802			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	588GZ	12205467				2022-12-18	WOS:000177694900006
J	Killeen, N				Killeen, N			A new spin on an unusual tail	NATURE IMMUNOLOGY			English	Editorial Material							NF-KAPPA-B; PRE-TCR; PT-ALPHA; ACTIVATION		Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Killeen, N (corresponding author), Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA.	nigel@itsa.ucsf.edu						Aifantis I, 2002, NAT IMMUNOL, V3, P483, DOI 10.1038/ni779; Aifantis I, 2001, NAT IMMUNOL, V2, P403, DOI 10.1038/87704; Fehling HJ, 1997, IMMUNITY, V6, P703, DOI 10.1016/S1074-7613(00)80446-X; Freund C, 1999, NAT STRUCT BIOL, V6, P656, DOI 10.1038/10712; Gibbons D, 2001, J EXP MED, V194, P695, DOI 10.1084/jem.194.5.695; Kruisbeek AM, 2000, IMMUNOL TODAY, V21, P637, DOI 10.1016/S0167-5699(00)01744-8; Lacorazza HD, 2001, J IMMUNOL, V167, P5689, DOI 10.4049/jimmunol.167.10.5689; Saint-Ruf C, 2000, NATURE, V406, P524, DOI 10.1038/35020093; Voll RE, 2000, IMMUNITY, V13, P677, DOI 10.1016/S1074-7613(00)00067-4; Wiest DL, 1999, SEMIN IMMUNOL, V11, P251, DOI 10.1006/smim.1999.0181	10	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	MAY	2002	3	5					419	421		10.1038/ni0502-419	http://dx.doi.org/10.1038/ni0502-419			3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	548VU	11976716				2022-12-18	WOS:000175411200007
J	Kyewski, B; Derbinski, J; Schulte, A; Klein, L				Kyewski, B; Derbinski, J; Schulte, A; Klein, L			Lymphoid organs contain diverse cells expressing self-molecules - Response	NATURE IMMUNOLOGY			English	Letter							GENE		German Canc Res Ctr, Div Cellular Immunol, Tumor Immunol Program, INF 280, D-69120 Heidelberg, Germany; Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Helmholtz Association; German Cancer Research Center (DKFZ); Harvard University; Dana-Farber Cancer Institute	Kyewski, B (corresponding author), German Canc Res Ctr, Div Cellular Immunol, Tumor Immunol Program, INF 280, D-69120 Heidelberg, Germany.							CHELLY J, 1989, P NATL ACAD SCI USA, V86, P2617, DOI 10.1073/pnas.86.8.2617; Derbinski J, 2001, NAT IMMUNOL, V2, P1032, DOI 10.1038/ni723; Klein L, 2000, NAT MED, V6, P56, DOI 10.1038/71540; Pugliese A, 2001, J CLIN INVEST, V107, P555, DOI 10.1172/JCI10860; SARAKAR G, 1989, SCIENCE, V244, P331; Smith KM, 1997, INT IMMUNOL, V9, P1355, DOI 10.1093/intimm/9.9.1355; Throsby M, 1998, ENDOCRINOLOGY, V139, P2399, DOI 10.1210/en.139.5.2399	7	1	1	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2002	3	4					336	336		10.1038/ni0402-336	http://dx.doi.org/10.1038/ni0402-336			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	535BD		Bronze			2022-12-18	WOS:000174623600009
J	Strominger, JL				Strominger, JL			Don Craig Wiley (1944-2001): a reminiscence	NATURE IMMUNOLOGY			English	Biographical-Item									Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University	Strominger, JL (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.								0	1	1	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	FEB	2002	3	2					103	104		10.1038/ni0202-103	http://dx.doi.org/10.1038/ni0202-103			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	516PJ	11812980				2022-12-18	WOS:000173562400004
J	Fabre, JW				Fabre, JW			The last unknown fact	NATURE IMMUNOLOGY			English	Letter									Kings Coll London Hosp, Guys Kings & St Thomas Sch Med, Inst Liver Studies, Dept Clin Sci, London SE5 9PJ, England	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	Fabre, JW (corresponding author), Kings Coll London Hosp, Guys Kings & St Thomas Sch Med, Inst Liver Studies, Dept Clin Sci, Bressemer Rd, London SE5 9PJ, England.	john.fabre@kcl.ac.uk						Hawking S., 1988, BRIEF HIST TIME BIG, DOI [10.1063/1.2811637, DOI 10.1063/1.2811637]; MANDELBAUM A, 1988, DIVINE COMEDY DANTE, P34; POTTER P, 1995, HIPPOCRATES, V8, P93; Silverstein AM, 1999, HIST SCI, V37, P407, DOI 10.1177/007327539903700402; Silverstein AM, 2001, NAT IMMUNOL, V2, P893, DOI 10.1038/ni1001-893	5	1	1	0	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	JAN	2002	3	1					3	3		10.1038/ni0102-3a	http://dx.doi.org/10.1038/ni0102-3a			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	509LF	11753397	Bronze			2022-12-18	WOS:000173148700001
J	MacDonald, HR; Held, W				MacDonald, HR; Held, W			CD8(+) T cell development: CD4 to the rescue	NATURE IMMUNOLOGY			English	Editorial Material							GENE-EXPRESSION		Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland	Ludwig Institute for Cancer Research; University of Lausanne	MacDonald, HR (corresponding author), Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res, CH-1066 Epalinges, Switzerland.	hughrobson.macdonald@isrec.unil.ch; werner.held@isrec.unil.ch						Ellmeier W, 1999, ANNU REV IMMUNOL, V17, P523, DOI 10.1146/annurev.immunol.17.1.523; ELMEIER W, 1998, CELL, V9, P485; Hostert A, 1998, IMMUNITY, V9, P497, DOI 10.1016/S1074-7613(00)80633-0; Leung RKM, 2001, NAT IMMUNOL, V2, P1167, DOI 10.1038/ni733; MacDonald HR, 2001, TRENDS IMMUNOL, V22, P155; Robey E, 1994, Semin Immunol, V6, P207, DOI 10.1006/smim.1994.1026; SAWADA S, 1994, CELL, V77, P917, DOI 10.1016/0092-8674(94)90140-6; SIU G, 1994, EMBO J, V13, P3570, DOI 10.1002/j.1460-2075.1994.tb06664.x; von Boehmer H, 2000, CURR BIOL, V10, pR642, DOI 10.1016/S0960-9822(00)00665-5; Zou YR, 2001, NAT GENET, V29, P332, DOI 10.1038/ng750	10	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	DEC	2001	2	12					1091	1092		10.1038/ni1201-1091	http://dx.doi.org/10.1038/ni1201-1091			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	497UE	11725294				2022-12-18	WOS:000172473200006
J	Gearhart, PJ; Zeng, XM				Gearhart, PJ; Zeng, XM			Smaller role for pol eta? Response 2	NATURE IMMUNOLOGY			English	Letter									NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Gearhart, PJ (corresponding author), NIA, Lab Mol Gerontol, NIH, Baltimore, MD 21224 USA.		Gearhart, Patricia/Y-7227-2019					Rogozin IB, 2001, NAT IMMUNOL, V2, P530, DOI 10.1038/88732; Zeng XM, 2001, NAT IMMUNOL, V2, P537, DOI 10.1038/88740	2	1	1	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2001	2	11					984	984		10.1038/ni1101-984	http://dx.doi.org/10.1038/ni1101-984			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	490JY		Bronze			2022-12-18	WOS:000172049800005
J	Klein, JR				Klein, JR			More about peer review: is it time for double-blind reviews?	NATURE IMMUNOLOGY			English	Letter									Univ Texas, Hlth Sci Ctr, Dept Basic Sci, Dent Branch, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Klein, JR (corresponding author), Univ Texas, Hlth Sci Ctr, Dept Basic Sci, Dent Branch, Houston, TX 77030 USA.								0	1	1	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	OCT	2001	2	10					892	892		10.1038/ni1001-892	http://dx.doi.org/10.1038/ni1001-892			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	478TM	11577338	Bronze			2022-12-18	WOS:000171361500002
J	Jones, EY				Jones, EY			Blueprints for life or death	NATURE IMMUNOLOGY			English	News Item							MHC CLASS-I; CRYSTAL-STRUCTURE; INHIBITORY RECEPTOR; LIGAND		Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Oxford OX3 7BN, England	University of Oxford; Wellcome Centre for Human Genetics	Jones, EY (corresponding author), Univ Oxford, Wellcome Trust Ctr Human Genet, Div Struct Biol, Roosevelt Dr, Oxford OX3 7BN, England.		Jones, Yvonne/N-8111-2019	Jones, Yvonne/0000-0002-3834-1893				Boyington JC, 2000, NATURE, V405, P537, DOI 10.1038/35014520; Fan QR, 1997, NATURE, V389, P96, DOI 10.1038/38028; Fan QR, 2001, NAT IMMUNOL, V2, P452, DOI 10.1038/87766; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Li PW, 1999, IMMUNITY, V10, P577, DOI 10.1016/S1074-7613(00)80057-6; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; LJUGGREN HG, 1990, IMMUNOL TODAY, V11, P237; Lopez-Botet M, 1999, CURR OPIN IMMUNOL, V11, P301, DOI 10.1016/S0952-7915(99)80048-X; Maenaka K, 1999, STRUCTURE, V7, P391, DOI 10.1016/S0969-2126(99)80052-5; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Wolan DW, 2001, NAT IMMUNOL, V2, P248, DOI 10.1038/85311	11	1	1	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					379	380		10.1038/87673	http://dx.doi.org/10.1038/87673			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ	11323686				2022-12-18	WOS:000168549800006
J	Jordan, MS				Jordan, MS			Thymic selection of CD4(+)CD25(+) regulatory T cells induced by an agonist self-peptide (vol 2, pg 301, 2001)	NATURE IMMUNOLOGY			English	Correction																		Jordan MS, 2001, NAT IMMUNOL, V2, P301, DOI 10.1038/86302	1	1	1	0	2	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	MAY	2001	2	5					468	468						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	429ZZ					2022-12-18	WOS:000168549800022
J	Sinclair, NRS				Sinclair, NRS			CTLA-4 up-regulation plays a role in tolerance mediated by CD45	NATURE IMMUNOLOGY			English	Letter									Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada	Western University (University of Western Ontario)	Sinclair, NRS (corresponding author), Univ Western Ontario, Dept Microbiol & Immunol, London, ON N6A 5C1, Canada.							BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; Fecteau S, 2001, NAT IMMUNOL, V2, P58, DOI 10.1038/83175; Fong DC, 2000, J IMMUNOL, V165, P4453, DOI 10.4049/jimmunol.165.8.4453; Lazarovits AI, 1996, NATURE, V380, P717, DOI 10.1038/380717a0; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; SCHWARTZ RH, 1989, COLD SPRING HARB SYM, V54, P605; SINCLAIR NRS, 1990, CELL IMMUNOL, V130, P204, DOI 10.1016/0008-8749(90)90174-P; Sinclair NRS, 2000, CRIT REV IMMUNOL, V20, P89	8	1	1	0	3	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	APR	2001	2	4					278	278		10.1038/86278	http://dx.doi.org/10.1038/86278			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	420AZ	11276192				2022-12-18	WOS:000167982900003
J	Desiderio, S				Desiderio, S			Somatic evolution of antibody specificity: setting the clock forward	NATURE IMMUNOLOGY			English	News Item							IMMUNOGLOBULIN		Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA; Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University	Desiderio, S (corresponding author), Johns Hopkins Univ, Sch Med, Dept Mol Biol & Genet, Baltimore, MD 21205 USA.							Bemark M, 2000, J EXP MED, V192, P1509, DOI 10.1084/jem.192.10.1509; BRENNER S, 1966, NATURE, V211, P242, DOI 10.1038/211242a0; Darwin C., 1859, ORIGIN SPECIES MEANS, DOI 10.5962/bhl.title.162283; Holbeck SL, 1997, GENETICS, V147, P1017; KLECKNER N, 1984, COLD SPRING HARB SYM, V49, P235, DOI 10.1101/SQB.1984.049.01.027; Kuppers R, 1999, NEW ENGL J MED, V341, P1520; Lee J, 1999, IMMUNITY, V11, P771, DOI 10.1016/S1074-7613(00)80151-X; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Papavasiliou FN, 2000, NATURE, V408, P216, DOI 10.1038/35041599; Peters A, 1996, IMMUNITY, V4, P57, DOI 10.1016/S1074-7613(00)80298-8; Sale JE, 1998, IMMUNITY, V9, P859, DOI 10.1016/S1074-7613(00)80651-2; WEIGERT MG, 1970, NATURE, V228, P1045, DOI 10.1038/2281045a0	12	1	1	0	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					463	464		10.1038/82704	http://dx.doi.org/10.1038/82704			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR	11101864				2022-12-18	WOS:000165724600007
J	Jiang, K				Jiang, K			Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells (vol 1, pg 419, 2000)	NATURE IMMUNOLOGY			English	Correction																		Jiang K, 2000, NAT IMMUNOL, V1, P419, DOI 10.1038/80859	1	1	1	1	1	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	DEC	2000	1	6					541	541						1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	380VR					2022-12-18	WOS:000165724600020
J	Kelsoe, G				Kelsoe, G			Remembrance of things past	NATURE IMMUNOLOGY			English	News Item							MEMORY; DEATH; CELL		Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA	Duke University	Kelsoe, G (corresponding author), Duke Univ, Med Ctr, Dept Immunol, Durham, NC 27710 USA.							Ahmed R, 1996, SCIENCE, V272, P54, DOI 10.1126/science.272.5258.54; Kelsoe G, 1996, IMMUNITY, V4, P107, DOI 10.1016/S1074-7613(00)80675-5; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Maruyama M, 2000, NATURE, V407, P636, DOI 10.1038/35036600; McHeyzer-Williams MG, 1999, CURR OPIN IMMUNOL, V11, P172, DOI 10.1016/S0952-7915(99)80029-6; Takahashi Y, 1998, J EXP MED, V187, P885, DOI 10.1084/jem.187.6.885	6	1	1	0	0	NATURE AMERICA INC	NEW YORK	345 PARK AVE SOUTH, NEW YORK, NY 10010-1707 USA	1529-2908			NAT IMMUNOL	Nat. Immunol.	NOV	2000	1	5					375	376		10.1038/80811	http://dx.doi.org/10.1038/80811			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	369PL	11062494				2022-12-18	WOS:000165076100008
J	Buclin, T; Spertini, F				Buclin, T; Spertini, F			Type IIFNs in human versus mouse	NATURE IMMUNOLOGY			English	Letter									CHU Vaudois, Univ Lausanne Hosp, Div Clin Pharmacol, CH-1011 Lausanne, Switzerland; CHU Vaudois, Univ Lausanne Hosp, Div Immunol & Allergol, CH-1011 Lausanne, Switzerland	University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Buclin, T (corresponding author), CHU Vaudois, Univ Lausanne Hosp, Div Clin Pharmacol, CH-1011 Lausanne, Switzerland.	Thierry.Buclin@chuv.hospvd.ch	Buclin, Thierry/P-1640-2014	Buclin, Thierry/0000-0003-0639-5536				Nguyen KB, 2000, NAT IMMUNOL, V1, P70, DOI 10.1038/76940; O'Shea JJ, 2000, NAT IMMUNOL, V1, P17, DOI 10.1038/76872; Rothuizen LE, 1999, J NEUROIMMUNOL, V99, P131, DOI 10.1016/S0165-5728(99)00029-6	3	1	1	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2000	1	4					265	265		10.1038/79701	http://dx.doi.org/10.1038/79701			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	364AK	11017090	Bronze			2022-12-18	WOS:000089869700002
J	Tang, K; Zhang, HF; Deng, JH; Wang, DH; Liu, SC; Lu, SY; Cui, QF; Chen, C; Liu, JC; Yang, ZS; Li, YG; Chen, J; Lv, JD; Ma, JW; Huang, B				Tang, Ke; Zhang, Huafeng; Deng, Jinghui; Wang, Dianheng; Liu, Shichuan; Lu, Shuya; Cui, Qingfa; Chen, Chen; Liu, Jincheng; Yang, Zhuoshun; Li, Yonggang; Chen, Jie; Lv, Jiadi; Ma, Jingwei; Huang, Bo			Ammonia detoxification promotes CD8(+) T cell memory development by urea and citrulline cycles	NATURE IMMUNOLOGY			English	Article; Early Access							NITRIC-OXIDE; TRANSPORTER; METABOLISM; CANCER; S-NITROS(YL)ATION; INHIBITOR; IMMUNITY; ACID	Amino acid metabolism is essential for cell survival, while the byproduct ammonia is toxic and can injure cellular longevity. Here we show that CD8(+) memory T (T-M) cells mobilize the carbamoyl phosphate (CP) metabolic pathway to clear ammonia, thus promoting memory development. CD8(+) T-M cells use beta-hydroxybutyrylation to upregulate CP synthetase 1 and trigger the CP metabolic cascade to form arginine in the cytosol. This cytosolic arginine is then translocated into the mitochondria where it is split by arginase 2 to urea and ornithine. Cytosolic arginine is also converted to nitric oxide and citrulline by nitric oxide synthases. Thus, both the urea and citrulline cycles are employed by CD8(+) T cells to clear ammonia and enable memory development. This ammonia clearance machinery might be targeted to improve T cell-based cancer immunotherapies.	[Tang, Ke; Deng, Jinghui; Liu, Shichuan; Lu, Shuya; Cui, Qingfa; Chen, Chen; Liu, Jincheng; Yang, Zhuoshun; Huang, Bo] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan, Peoples R China; [Tang, Ke] Huazhong Univ Sci & Technol, Cell Architecture Res Ctr, Wuhan, Peoples R China; [Zhang, Huafeng] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Pathol, Wuhan, Peoples R China; [Wang, Dianheng; Chen, Jie; Lv, Jiadi; Huang, Bo] Chinese Acad Med Sci CAMS & Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China; [Wang, Dianheng; Chen, Jie; Lv, Jiadi; Huang, Bo] Chinese Acad Med Sci CAMS & Peking Union Med Coll, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing, Peoples R China; [Li, Yonggang] Hubei Prov Ctr Dis Control & Prevent, Hubei Prov Key Lab Appl Toxicol, Wuhan, Peoples R China; [Ma, Jingwei] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Immunol, Wuhan, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Peking Union Medical College; Huazhong University of Science & Technology	Huang, B (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Biochem & Mol Biol, Wuhan, Peoples R China.; Huang, B (corresponding author), Chinese Acad Med Sci CAMS & Peking Union Med Coll, Inst Basic Med Sci, Dept Immunol, Beijing, Peoples R China.; Huang, B (corresponding author), Chinese Acad Med Sci CAMS & Peking Union Med Coll, Inst Basic Med Sci, Natl Key Lab Med Mol Biol, Beijing, Peoples R China.	tjhuangbo@hotmail.com			Natural Science Foundation of China; CAMS Innovation Fund for Medical Sciences; Program for HUST Academic Frontier Youth Team; Key R&D program of Hubei Province; Young Top-notch Talent Cultivation Program of Hubei Province;  [81788101];  [82071864];  [82150103];  [2021-1-I2M-021];  [2018QYTD01];  [2020BCA068]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CAMS Innovation Fund for Medical Sciences; Program for HUST Academic Frontier Youth Team; Key R&D program of Hubei Province; Young Top-notch Talent Cultivation Program of Hubei Province; ; ; ; ; ; 	AcknowledgementsThis work was supported by the Natural Science Foundation of China (81788101 to B.H. and 82071864, 82150103 to K.T.), CAMS Innovation Fund for Medical Sciences (2021-1-I2M-021 to B.H.), Program for HUST Academic Frontier Youth Team (2018QYTD01 to K.T.), the Key R&D program of Hubei Province (2020BCA068 to K.T.) and the Young Top-notch Talent Cultivation Program of Hubei Province (K.T.).	Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Amsen D, 2018, NAT IMMUNOL, V19, P538, DOI 10.1038/s41590-018-0114-2; Bogdan C, 2015, TRENDS IMMUNOL, V36, P161, DOI 10.1016/j.it.2015.01.003; Carlstrom M, 2021, NAT REV NEPHROL, V17, P575, DOI 10.1038/s41581-021-00429-z; Cheong H, 2011, P NATL ACAD SCI USA, V108, P11121, DOI 10.1073/pnas.1107969108; Cotter G, 2000, CIRCULATION, V101, P1358, DOI 10.1161/01.CIR.101.12.1358; Dasarathy S, 2017, METAB BRAIN DIS, V32, P529, DOI 10.1007/s11011-016-9938-3; De Chiara F, 2018, J HEPATOL, V69, P905, DOI 10.1016/j.jhep.2018.06.023; Eng CH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000911; Fouda AY, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.00277; Garvey EP, 1997, J BIOL CHEM, V272, P4959, DOI 10.1074/jbc.272.8.4959; Hajaj E, 2021, MOL CELL, V81, P3749, DOI 10.1016/j.molcel.2021.08.005; Huang H, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe2771; Kaczmarska Z, 2017, NAT CHEM BIOL, V13, P21, DOI [10.1038/NCHEMBIO.2217, 10.1038/nchembio.2217]; Keshet R, 2018, NAT REV CANCER, V18, P634, DOI 10.1038/s41568-018-0054-z; Kok L, 2022, NAT REV IMMUNOL, V22, P283, DOI 10.1038/s41577-021-00590-3; Kurmi K, 2020, TRENDS CELL BIOL, V30, P408, DOI 10.1016/j.tcb.2020.02.005; Lampson BL, 2012, CANCER RES, V72, P4472, DOI 10.1158/0008-5472.CAN-12-0057; Lee JS, 2018, CELL, V174, P1559, DOI 10.1016/j.cell.2018.07.019; Leone RD, 2020, NAT REV CANCER, V20, P516, DOI 10.1038/s41568-020-0273-y; Lercher A, 2019, IMMUNITY, V51, P1074, DOI 10.1016/j.immuni.2019.10.014; Li L, 2019, NATURE, V567, P253, DOI 10.1038/s41586-019-0996-7; Luedike P, 2012, CIRCULATION, V125, P1880, DOI 10.1161/CIRCULATIONAHA.111.069104; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; Ma RH, 2018, NAT CELL BIOL, V20, P21, DOI 10.1038/s41556-017-0002-2; Majumdar U, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abe3706; Matsumoto S, 2019, J HUM GENET, V64, P833, DOI 10.1038/s10038-019-0614-4; McGovern N, 2017, NATURE, V546, P662, DOI 10.1038/nature22795; Mehta MM, 2017, NAT REV IMMUNOL, V17, P608, DOI 10.1038/nri.2017.66; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Peng WX, 2019, DNA CELL BIOL, V38, P597, DOI 10.1089/dna.2018.4552; Porcelli V, 2014, J BIOL CHEM, V289, P13374, DOI 10.1074/jbc.M114.547448; Purwono A. R., 2017, J MAT ENV SCI, V8, P4915; Raup-Konsavage WM, 2017, AM J PHYSIOL-RENAL, V313, pF522, DOI 10.1152/ajprenal.00620.2016; Seth D, 2018, MOL CELL, V69, P451, DOI 10.1016/j.molcel.2017.12.025; Shayakul C, 2013, MOL ASPECTS MED, V34, P313, DOI 10.1016/j.mam.2012.12.003; Sies H, 2020, NAT REV MOL CELL BIO, V21, P363, DOI 10.1038/s41580-020-0230-3; Srinivas US, 2019, REDOX BIOL, V25, DOI 10.1016/j.redox.2018.101084; Sun JH, 2013, FREE RADICAL BIO MED, V54, P105, DOI 10.1016/j.freeradbiomed.2012.09.005; Wang YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08033-9; Weiner ID, 2015, CLIN J AM SOC NEPHRO, V10, P1444, DOI 10.2215/CJN.10311013; Xiang T, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03440-1; Yoo HC, 2020, CELL METAB, V31, P267, DOI 10.1016/j.cmet.2019.11.020; Zhang F, 2011, NEUROCHEM RES, V36, P1903, DOI 10.1007/s11064-011-0512-4; Zhang HF, 2020, NAT CELL BIOL, V22, P18, DOI 10.1038/s41556-019-0440-0; Zhang J, 2017, EMBO J, V36, P1302, DOI 10.15252/embj.201696151; Zhang XR, 2019, CELL DISCOV, V5, DOI 10.1038/s41421-019-0103-0; Zhao YZ, 2015, J PHARMACOL SCI, V129, P83, DOI 10.1016/j.jphs.2015.09.002	48	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01365-1	http://dx.doi.org/10.1038/s41590-022-01365-1		DEC 2022	26	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6T8ZN	36471170				2022-12-18	WOS:000893963300001
J	Pedroza-Pacheco, I; McMichael, AJ				Pedroza-Pacheco, Isabela; McMichael, Andrew J.			Immune signature atlas of vaccines: learning from the good responders	NATURE IMMUNOLOGY			English	Editorial Material; Early Access							RESPONSES	Understanding immune determinants of vaccine-mediated immunogenicity could further provide rational vaccine design. Two research groups revealed pre-existing and early innate immune signatures associated with better vaccine-mediated antibody responses.	[Pedroza-Pacheco, Isabela; McMichael, Andrew J.] Univ Oxford, Nuffield Dept Clin Med, Oxford, England	University of Oxford	McMichael, AJ (corresponding author), Univ Oxford, Nuffield Dept Clin Med, Oxford, England.	andrew.mcmichael@ndm.ox.ac.uk		mcmichael, andrew/0000-0002-9101-7478	US National Institutes of Health/National Institute of Allergy and Infectious Diseases [UM1 AI 00645]; Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery	US National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery	I.P.-P. and A.J.M. are funded by US National Institutes of Health/National Institute of Allergy and Infectious Diseases UM1 AI 00645 and the Duke Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery.	Arunachalam PS., 2021, NATURE, V596, P410, DOI [10.1038/s41586-021-03791-x, DOI 10.1038/S41586-021-03791-X]; Atyeo CG, 2022, NAT COMMUN, V13, DOI 10.1038/s41467-022-31169-8; Bradley T, 2018, CELL, V175, P387, DOI 10.1016/j.cell.2018.08.064; Fourati S., 2022, NAT IMMUNOL, DOI [10.1038/s41590-021-01065-2(2021), DOI 10.1038/S41590-021-01065-2(2021), 10.1038/s41590-022-01329-5, DOI 10.1038/S41590-022-01354-4]; Hagan T, 2022, NAT IMMUNOL, DOI 10.1038/s41590-022-01328-6; Klein SL, 2016, NAT REV IMMUNOL, V16, P626, DOI 10.1038/nri.2016.90; Klein SL, 2010, LANCET INFECT DIS, V10, P338, DOI 10.1016/S1473-3099(10)70049-9; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Rondy M, 2017, J INFECTION, V75, P381, DOI 10.1016/j.jinf.2017.09.010; Sweeney TE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7165; Thurmond S, 2018, VIRUSES-BASEL, V10, DOI 10.3390/v10120712; Wang W, 2022, J BIOL RHYTHM, V37, P124, DOI 10.1177/07487304211059315	12	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01361-5	http://dx.doi.org/10.1038/s41590-022-01361-5		NOV 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6N3DK	36443516	Bronze			2022-12-18	WOS:000889437700001
J	Zhang, ZR; Venditti, R; Ran, L; Liu, ZZ; Vivot, K; Schurmann, A; Bonifacino, JS; De Matteis, MA; Ricci, R				Zhang, Zhirong; Venditti, Rossella; Ran, Li; Liu, Zengzhen; Vivot, Karl; Schurmann, Annette; Bonifacino, Juan S.; De Matteis, Maria Antonietta; Ricci, Romeo			Distinct changes in endosomal composition promote NLRP3 inflammasome activation	NATURE IMMUNOLOGY			English	Article; Early Access							TRANS-GOLGI; PLASMA-MEMBRANE; CELL-SURFACE; INNATE; TRAFFICKING; RECOGNITION; PROTEINS; RECEPTOR; COMPLEX; TOXINS	Inflammasome complexes are pivotal in the innate immune response. The NLR family pyrin domain containing protein 3 (NLRP3) inflammasome is activated in response to a broad variety of cellular stressors. However, a primary and converging sensing mechanism by the NLRP3 receptor initiating inflammasome assembly remains ill defined. Here, we demonstrate that NLRP3 inflammasome activators primarily converge on disruption of endoplasmic reticulum-endosome membrane contact sites (EECS). This defect causes endosomal accumulation of phosphatidylinositol 4-phosphate (PI4P) and a consequent impairment of endosome-to-trans-Golgi network trafficking (ETT), necessary steps for endosomal recruitment of NLRP3 and subsequent inflammasome activation. Lowering endosomal PI4P levels prevents endosomal association of NLRP3 and inhibits inflammasome activation. Disruption of EECS or ETT is sufficient to enhance endosomal PI4P levels, to recruit NLRP3 to endosomes and to potentiate NLRP3 inflammasome activation. Mice with defects in ETT in the myeloid compartment are more susceptible to lipopolysaccharide-induced sepsis. Our study thus identifies a distinct cellular mechanism leading to endosomal NLRP3 recruitment and inflammasome activation. A dogma in the inflammasome field is that NLRP3 activation occurs at dispersed vesicles of the trans-Golgi network. Here, Ricci and colleagues find that these vesicles are of endosomal origin and that endosomes comprise the compartment where NLRP3 is activated.	[Zhang, Zhirong; Ran, Li; Liu, Zengzhen; Vivot, Karl; Ricci, Romeo] Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Zhang, Zhirong; Ran, Li; Liu, Zengzhen; Vivot, Karl; Ricci, Romeo] Ctr Natl Rech Sci, UMR7104, Illkirch Graffenstaden, France; [Zhang, Zhirong; Ran, Li; Liu, Zengzhen; Vivot, Karl; Ricci, Romeo] Inst Natl Sante & Rech Med, U964, Illkirch Graffenstaden, France; [Zhang, Zhirong; Ran, Li; Liu, Zengzhen; Vivot, Karl; Ricci, Romeo] Univ Strasbourg, Illkirch Graffenstaden, France; [Venditti, Rossella; De Matteis, Maria Antonietta] Telethon Inst Genet & Med, Pozzuoli, Italy; [Venditti, Rossella; De Matteis, Maria Antonietta] Univ Napoli Federico II, Med Sch, Dept Mol Med & Med Biotechnol, Naples, Italy; [Schurmann, Annette] German Inst Human Nutr Potsdam Rehbrucke, Dept Expt Diabetol, Nuthetal, Germany; [Bonifacino, Juan S.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Neurosci & Cellular & Struct Biol Div, NIH, Bethesda, MD USA; [Ricci, Romeo] Nouvel Hop Civil, Lab Biochim & Biol Mol, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM); University of Naples Federico II; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); CHU Strasbourg	Zhang, ZR; Ricci, R (corresponding author), Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France.; Zhang, ZR; Ricci, R (corresponding author), Ctr Natl Rech Sci, UMR7104, Illkirch Graffenstaden, France.; Zhang, ZR; Ricci, R (corresponding author), Inst Natl Sante & Rech Med, U964, Illkirch Graffenstaden, France.; Zhang, ZR; Ricci, R (corresponding author), Univ Strasbourg, Illkirch Graffenstaden, France.; De Matteis, MA (corresponding author), Telethon Inst Genet & Med, Pozzuoli, Italy.; De Matteis, MA (corresponding author), Univ Napoli Federico II, Med Sch, Dept Mol Med & Med Biotechnol, Naples, Italy.; Ricci, R (corresponding author), Nouvel Hop Civil, Lab Biochim & Biol Mol, Strasbourg, France.	zhirong.zhang@igbmc.fr; dematteis@tigem.it; romeo.ricci@igbmc.fr		Schurmann, Annette/0000-0002-4113-4377	Agence nationale de la recherche (ANR); USIAS fellowship of the University of Strasbourg; Fondation pour la recherche medicale (FRM) - Program: Equipe FRM [EQU201903007859]; French State funds [ANR-10-LABX0030-INRT, ANR-11-INBS-0009-INGESTEM]; China Scholarship Council (CSC); European Research Council [670881]; Italian Association for Cancer Research [MFAG 2020_25174, IG 2017_20815]; Italian Ministry of University and Research (PRIN) [2020PKLEPN]; German Research Foundation [DFG] [SFB 958]; Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH [ZIA HD001607]	Agence nationale de la recherche (ANR)(French National Research Agency (ANR)); USIAS fellowship of the University of Strasbourg; Fondation pour la recherche medicale (FRM) - Program: Equipe FRM; French State funds; China Scholarship Council (CSC)(China Scholarship Council); European Research Council(European Research Council (ERC)European Commission); Italian Association for Cancer Research(Fondazione AIRC per la ricerca sul cancro); Italian Ministry of University and Research (PRIN)(Ministry of Education, Universities and Research (MIUR)Research Projects of National Relevance (PRIN)); German Research Foundation [DFG](German Research Foundation (DFG)); Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We acknowledge Anne Spang at the Biozentrum, University of Basel, for providing HeLa cells stably expressing mApple-tagged RAB5. We thank Fabien Alpy and Izabela Sumara for helpful suggestions and discussions. We also thank the scientific platforms at the IGBMC, including the cell cytometry facility, the cell culture facility, the imaging facility and the animal facility, for their help during the entire project. Work in the laboratory of R.R. was supported by Agence nationale de la recherche (ANR) (AAPG 2017 LYSODIABETES), the USIAS fellowship grant 2017 of the University of Strasbourg, the Fondation pour la recherche medicale (FRM) -Program: Equipe FRM (EQU201903007859, Prix Roger PROPICE pour la recherche sur le cancer du pancreas), grants from French State funds managed by the ANR under the frame program Investissements d'Avenir (ANR-10-LABX0030-INRT and ANR-11-INBS-0009-INGESTEM). L.R. acknowledges the support from the China Scholarship Council (CSC). M.A.D.M. acknowledges the support from the European Research Council Advanced Investigator grant 670881 (SYSMET), the Italian Association for Cancer Research (grant IG 2017_20815), and the Italian Ministry of University and Research (PRIN, 2020PKLEPN). R.V. acknowledges the support from the Italian Association for Cancer Research (grant MFAG 2020_25174). A.S. acknowledges the support from the `German Research Foundation [DFG, SFB 958]'. J.S.B. acknowledges the support from the Intramural Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and the NIH (project ZIA HD001607 to J.S.B.).	Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Balla A, 2006, TRENDS CELL BIOL, V16, P351, DOI 10.1016/j.tcb.2006.05.003; Behnia R, 2004, NAT CELL BIOL, V6, P405, DOI 10.1038/ncb1120; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Broz P, 2016, NAT REV IMMUNOL, V16, P407, DOI 10.1038/nri.2016.58; Bulbarelli A, 2002, J CELL SCI, V115, P1689; Burd C, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016774; CHAPMAN RE, 1994, EMBO J, V13, P2305, DOI 10.1002/j.1460-2075.1994.tb06514.x; Chen JQ, 2018, NATURE, V564, P71, DOI 10.1038/s41586-018-0761-3; Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239; Christgen S, 2020, CURR OPIN IMMUNOL, V62, P39, DOI 10.1016/j.coi.2019.11.007; de Graaf P, 2004, MOL BIOL CELL, V15, P2038, DOI 10.1091/mbc.E03-12-0862; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Dong R, 2016, CELL, V166, P408, DOI 10.1016/j.cell.2016.06.037; Hammond GRV, 2009, BIOCHEM J, V422, P23, DOI 10.1042/BJ20090428; Hemmi H, 2000, NATURE, V408, P740, DOI 10.1038/35047123; Hidmark A, 2012, J IMMUNOL, V189, P2717, DOI 10.4049/jimmunol.1200898; Hoyer MJ, 2018, CELL, V175, P254, DOI 10.1016/j.cell.2018.08.030; Ishida M, 2019, J CELL BIOL, V218, P3681, DOI 10.1083/jcb.201905097; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kagan JC, 2012, CELL, V151, P1168, DOI 10.1016/j.cell.2012.11.011; LADINSKY MS, 1992, EUR J CELL BIOL, V59, P92; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lleres D, 2017, CELL REP, V18, P1791, DOI 10.1016/j.celrep.2017.01.043; Luo X, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004965; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Muschalik N, 2018, CURR BIOL, V28, pR374, DOI 10.1016/j.cub.2018.01.006; Ohto U, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2121353119; Oldenburg M, 2012, SCIENCE, V337, P1111, DOI 10.1126/science.1220363; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rathinam VAK, 2016, CELL, V165, P792, DOI 10.1016/j.cell.2016.03.046; REAVES B, 1993, MOL BIOL CELL, V4, P93, DOI 10.1091/mbc.4.1.93; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Sandvig K, 2005, GENE THER, V12, P865, DOI 10.1038/sj.gt.3302525; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; Venditti R, 2019, J CELL BIOL, V218, P1055, DOI 10.1083/jcb.201812020; Zahn C, 2008, J BIOL CHEM, V283, P27179, DOI 10.1074/jbc.M802108200; Zhang ZR, 2017, J EXP MED, V214, P2671, DOI 10.1084/jem.20162040	39	0	0	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01355-3	http://dx.doi.org/10.1038/s41590-022-01355-3		NOV 2022	32	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6N3DK	36443515	Green Submitted, hybrid			2022-12-18	WOS:000889437700002
J	Bernard, NJ				Bernard, Nicholas J.			Immunosuppressive ferroptosis	NATURE IMMUNOLOGY			English	Editorial Material; Early Access												Nick.Bernard@nature.com							0	0	0	4	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01383-z	http://dx.doi.org/10.1038/s41590-022-01383-z		NOV 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6I9EA	36414718				2022-12-18	WOS:000886431100001
J	Block, KE; Iijima, K; Pierson, MJ; Walsh, DA; Tei, R; Kucaba, TA; Xu, JL; Khan, MH; Staley, C; Griffith, TS; McSorley, HJ; Kita, H; Jameson, SC				Block, Katharine E.; Iijima, Koji; Pierson, Mark J.; Walsh, Daniel A.; Tei, Rinna; Kucaba, Tamara A.; Xu, Julie; Khan, Mohammad Haneef; Staley, Christopher; Griffith, Thomas S.; McSorley, Henry J.; Kita, Hirohito; Jameson, Stephen C.			Physiological microbial exposure transiently inhibits mouse lung ILC2 responses to allergens	NATURE IMMUNOLOGY			English	Article; Early Access							INNATE LYMPHOID-CELLS; ADAPTIVE TYPE-2 IMMUNITY; GUT MICROBIOTA; INCREASED RISK; ASTHMA; INFLAMMATION; ACTIVATION; CHILDREN; MICE; FARM	Here the authors show that mice exposed to a variety of pathogens initially have impaired innate type 2 responses to lung allergens, but reactivity resets over time, indicating that microbial experience does not stably inhibit innate immunity to allergens. Lung group 2 innate lymphoid cells (ILC2s) control the nature of immune responses to airway allergens. Some microbial products, including those that stimulate interferons, block ILC2 activation, but whether this occurs after natural infections or causes durable ILC2 inhibition is unclear. In the present study, we cohoused laboratory and pet store mice as a model of physiological microbial exposure. Laboratory mice cohoused for 2 weeks had impaired ILC2 responses and reduced lung eosinophilia to intranasal allergens, whereas these responses were restored in mice cohoused for >= 2 months. ILC2 inhibition at 2 weeks correlated with increased interferon receptor signaling, which waned by 2 months of cohousing. Reinduction of interferons in 2-month cohoused mice blocked ILC2 activation. These findings suggest that ILC2s respond dynamically to environmental cues and that microbial exposures do not control long-term desensitization of innate type 2 responses to allergens.	[Block, Katharine E.; Pierson, Mark J.; Walsh, Daniel A.; Jameson, Stephen C.] Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA; [Block, Katharine E.; Pierson, Mark J.; Walsh, Daniel A.; Griffith, Thomas S.; Jameson, Stephen C.] Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA; [Iijima, Koji; Tei, Rinna; Kita, Hirohito] Mayo Clin Arizona, Div Allergy Asthma & Clin Immunol, Scottsdale, AZ 85259 USA; [Iijima, Koji; Tei, Rinna; Kita, Hirohito] Mayo Clin Arizona, Dept Med, Scottsdale, AZ 85259 USA; [Tei, Rinna] Dokkyo Med Univ, Dept Pulm Med & Clin Immunol, Mibu, Tochigi, Japan; [Kucaba, Tamara A.; Xu, Julie; Griffith, Thomas S.] Univ Minnesota, Dept Urol, Minneapolis, MN USA; [Khan, Mohammad Haneef; Staley, Christopher] Univ Minnesota, Dept Surg, Box 242 UMHC, Minneapolis, MN 55455 USA; [McSorley, Henry J.] Univ Dundee, Sch Life Sci, Div Cell Signaling & Immunol, Dundee, Scotland	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Mayo Clinic; Mayo Clinic Phoenix; Mayo Clinic; Mayo Clinic Phoenix; Dokkyo Medical University; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Dundee	Jameson, SC (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Minneapolis, MN 55455 USA.; Jameson, SC (corresponding author), Univ Minnesota, Ctr Immunol, Minneapolis, MN 55455 USA.; Kita, H (corresponding author), Mayo Clin Arizona, Div Allergy Asthma & Clin Immunol, Scottsdale, AZ 85259 USA.; Kita, H (corresponding author), Mayo Clin Arizona, Dept Med, Scottsdale, AZ 85259 USA.	kita.hirohito@mayo.edu; james024@umn.edu		Khan, Mohammad Haneef/0000-0001-9603-7593; Block, Katharine/0000-0001-9488-3577	UMN BSL-3 Program; UMN Research Animal Resources; NIH [R01HL117823, T32HL007741, R35GM140881]; Minnesota Partnership for Biotechnology and Medical Genomics [16.48]; UMN Medical School [AIRP-CP-21]; UMN Flow Cytometry Resource Facility; CFI Dirty Mouse Colony; Minnesota Supercomputing Institute; Cytokine Reference Laboratory	UMN BSL-3 Program; UMN Research Animal Resources; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics; UMN Medical School; UMN Flow Cytometry Resource Facility; CFI Dirty Mouse Colony; Minnesota Supercomputing Institute; Cytokine Reference Laboratory	We thank UMN Flow Cytometry Resource Facility, CFI Dirty Mouse Colony, UMN BSL-3 Program, Minnesota Supercomputing Institute, Cytokine Reference Laboratory and UMN Research Animal Resources for support. We thank Jamequist and Kita lab members for thoughtful discussion. This work was supported by the NIH (grant nos. R01HL117823 to H.K., T32HL007741 to K.E.B. and R35GM140881 to T.S.G.), Minnesota Partnership for Biotechnology and Medical Genomics (grant no. 16.48 to S.C.J. and H.K.) and UMN Medical School (grant no. AIRP-CP-21 to S.C.J.).	Abt MC, 2012, IMMUNITY, V37, P158, DOI 10.1016/j.immuni.2012.04.011; Anderson KG, 2014, NAT PROTOC, V9, P209, DOI 10.1038/nprot.2014.005; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Aronesty E., 2013, OPEN BIOINFORMA J, V7, P1, DOI [10.2174/1875036201307010001, DOI 10.2174/1875036201307010001]; Ball TM, 2000, NEW ENGL J MED, V343, P538, DOI 10.1056/NEJM200008243430803; Bartemes KR, 2012, J IMMUNOL, V188, P1503, DOI 10.4049/jimmunol.1102832; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Bisgaard H, 2011, J ALLERGY CLIN IMMUN, V128, P646, DOI 10.1016/j.jaci.2011.04.060; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Croisant S, 2014, ADV EXP MED BIOL, V795, P17, DOI 10.1007/978-1-4614-8603-9_2; da Silva HB, 2018, NATURE, V559, P264, DOI 10.1038/s41586-018-0282-0; Duerr CU, 2016, NAT IMMUNOL, V17, P65, DOI 10.1038/ni.3308; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fay EJ, 2021, J EXP MED, V219, DOI 10.1084/jem.20211220; Fiege JK, 2021, CELL HOST MICROBE, V29, P1815, DOI 10.1016/j.chom.2021.10.001; Gohl DM, 2016, NAT BIOTECHNOL, V34, P942, DOI 10.1038/nbt.3601; Halim TYF, 2018, IMMUNITY, V48, P1195, DOI 10.1016/j.immuni.2018.05.003; Halim TYF, 2016, NAT IMMUNOL, V17, P57, DOI 10.1038/ni.3294; Halim TYF, 2014, IMMUNITY, V40, P425, DOI 10.1016/j.immuni.2014.01.011; Halim TYF, 2012, IMMUNITY, V36, P451, DOI 10.1016/j.immuni.2011.12.020; Hamilton SE, 2020, J IMMUNOL, V205, P3, DOI 10.4049/jimmunol.2000171; Hartmann S, 2009, CLIN EXP ALLERGY, V39, P1585, DOI 10.1111/j.1365-2222.2009.03290.x; Hild B, 2021, NAT METAB, V3, P1042, DOI 10.1038/s42255-021-00439-y; Holgate ST, 2012, NAT MED, V18, P673, DOI 10.1038/nm.2731; Huggins MA, 2019, CELL REP, V28, P1729, DOI 10.1016/j.celrep.2019.07.028; Ikutani M, 2012, J IMMUNOL, V188, P703, DOI 10.4049/jimmunol.1101270; Jiang ZF, 2003, J BIOL CHEM, V278, P16713, DOI 10.1074/jbc.M300562200; KAPLAN BA, 1992, J BIOSOC SCI, V24, P25, DOI 10.1017/S0021932000006775; Kato A, 2019, CHEST, V156, P141, DOI 10.1016/j.chest.2019.04.101; Kim BJ, 2014, ALLERGY ASTHMA IMMUN, V6, P389, DOI 10.4168/aair.2014.6.5.389; Kline JN, 1998, J IMMUNOL, V160, P2555; Knights D, 2011, NAT METHODS, V8, P761, DOI 10.1038/nmeth.1650; Kramer U, 1999, LANCET, V353, P450, DOI 10.1016/S0140-6736(98)06329-6; Kubo M, 2017, IMMUNOL REV, V278, P162, DOI 10.1111/imr.12557; Machiels B, 2017, NAT IMMUNOL, V18, P1310, DOI 10.1038/ni.3857; Maizels RM, 2020, ALLERGY, V75, P524, DOI 10.1111/all.13944; Marra F, 2009, PEDIATRICS, V123, P1003, DOI 10.1542/peds.2008-1146; Masopust D, 2017, J IMMUNOL, V199, P383, DOI 10.4049/jimmunol.1700453; McSorley HJ, 2014, MUCOSAL IMMUNOL, V7, P1068, DOI 10.1038/mi.2013.123; Melo-Gonzalez F, 2022, FRONT IMMUNOL, V13, DOI 10.3389/fimmu.2022.877533; MILNE J, 1975, BRIT J IND MED, V32, P302; Molofsky AB, 2015, IMMUNITY, V43, P161, DOI 10.1016/j.immuni.2015.05.019; Moro K, 2016, NAT IMMUNOL, V17, P76, DOI 10.1038/ni.3309; Oboki K, 2010, P NATL ACAD SCI USA, V107, P18581, DOI 10.1073/pnas.1003059107; Osbourn M, 2017, IMMUNITY, V47, P739, DOI 10.1016/j.immuni.2017.09.015; Pivniouk V, 2022, J ALLERGY CLIN IMMUN, V149, P943, DOI 10.1016/j.jaci.2021.09.013; Pivniouk V, 2020, CLIN EXP ALLERGY, V50, P282, DOI 10.1111/cea.13508; Pruesse E, 2007, NUCLEIC ACIDS RES, V35, P7188, DOI 10.1093/nar/gkm864; Reese TA, 2016, CELL HOST MICROBE, V19, P713, DOI 10.1016/j.chom.2016.04.003; Riedler J, 2000, CLIN EXP ALLERGY, V30, P194, DOI 10.1046/j.1365-2222.2000.00799.x; Rosshart SP, 2019, SCIENCE, V365, P461, DOI 10.1126/science.aaw4361; Rosshart SP, 2017, CELL, V171, P1015, DOI 10.1016/j.cell.2017.09.016; Sabatel C, 2017, IMMUNITY, V46, P457, DOI 10.1016/j.immuni.2017.02.016; Scadding GK, 2021, J ALLER CL IMM-PRACT, V9, P1851, DOI 10.1016/j.jaip.2021.02.013; Schloss PD, 2020, APPL ENVIRON MICROB, V86, DOI 10.1128/AEM.02343-19; Schloss PD, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000844; Schuijs MJ, 2015, SCIENCE, V349, P1106, DOI 10.1126/science.aac6623; Sjogren YM, 2009, CLIN EXP ALLERGY, V39, P518, DOI 10.1111/j.1365-2222.2008.03156.x; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; STAEHELI P, 1988, MOL CELL BIOL, V8, P4518, DOI 10.1128/MCB.8.10.4518; Staley C, 2018, MICROBIOME, V6, DOI 10.1186/s40168-018-0549-6; Stein MM, 2016, NEW ENGL J MED, V375, P411, DOI 10.1056/NEJMoa1508749; Steinert EM, 2015, CELL, V161, P737, DOI 10.1016/j.cell.2015.03.031; Sur S, 1999, J IMMUNOL, V162, P6284; Tei R, 2022, J ALLERGY CLIN IMMUN, V149, P1044, DOI 10.1016/j.jaci.2021.07.041; Uccellini MB, 2018, CELL REP, V25, P2784, DOI 10.1016/j.celrep.2018.11.030; Vivier E, 2018, CELL, V174, P1054, DOI 10.1016/j.cell.2018.07.017; Wark PAB, 2018, SEMIN RESP CRIT CARE, V39, P45, DOI 10.1055/s-0037-1617412	69	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01350-8	http://dx.doi.org/10.1038/s41590-022-01350-8		NOV 2022	21	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6J3SL	36411381	Green Submitted			2022-12-18	WOS:000886745100001
J	Halper-Stromberg, A; Jabri, B				Halper-Stromberg, Ariel; Jabri, Bana			Maladaptive consequences of inflammatory events shape individual immune identity	NATURE IMMUNOLOGY			English	Article; Early Access							INNATE LYMPHOID-CELLS; REGULATORY T-CELLS; RECEPTOR RET; STEM-CELLS; EARLY-LIFE; INFECTION; PATHOGENESIS; MACROPHAGES; EXHAUSTION; TOLERANCE	Halper-Stromberg and Jabri discuss the molecular and functional adaptations to inflammatory or pathogenic stimuli that shape the immune identity of each individual. The vertebrate immune system develops in layers, as modes of immunity have evolved on top of each other through time with the expansion of organismal complexity. The maturation timing of immune cell subsets, such as innate immune cells, innate-like cells and adaptive cells, corresponds to their physiological roles in protective immunity. While various cell subsets have specialized roles, they also complement each other to clear pathogens, resolve inflammation and maintain homeostasis, especially at barrier sites with high microbial density. Immune cells adapt to inflammatory insults through mechanisms including epigenetic and metabolic reprogramming, clonal expansion and enhanced communication with the surrounding tissue environment. Over time, these adaptations shape an individual immune identity, reflective of the overlay between the genetic predisposition and the antigenic and environmental exposures of each individual. While some aspects of this immune shaping are natural consequences of immune maturation over time, others are maladaptive and predispose to irreversible pathology. In this Perspective, we provide a framework for categorizing the shaping events of the immune response, in terms of mechanisms, contexts and functional outcomes. We aim to clarify how these terms can be appropriately applied to future findings that impact immune function.	[Halper-Stromberg, Ariel; Jabri, Bana] Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Jabri, Bana] Univ Chicago, Comm Immunol, Chicago, IL 60637 USA; [Jabri, Bana] Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Jabri, Bana] Univ Chicago, Dept Pediat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Jabri, B (corresponding author), Univ Chicago, Dept Med, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Jabri, B (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.; Jabri, B (corresponding author), Univ Chicago, Dept Pathol, 5841 S Maryland Ave, Chicago, IL 60637 USA.; Jabri, B (corresponding author), Univ Chicago, Dept Pediat, Chicago, IL 60637 USA.	bjabri@bsd.uchicago.edu			National Institutes of Health [R01DK067180, R01DK098435, R01DK063158, R01DK126487]; Digestive Diseases Research Core Center at the University of Chicago [P30 C-IID DK42086]; Helmsley Charitable trust grant [2019PG-CD015]; Duchossois Family Institute (DFI) Fellowship Grant; Gastro-Intestinal Research Foundation (GIRF) Pilot Award;  [5T32DK007074-49]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Digestive Diseases Research Core Center at the University of Chicago; Helmsley Charitable trust grant; Duchossois Family Institute (DFI) Fellowship Grant; Gastro-Intestinal Research Foundation (GIRF) Pilot Award; 	We would like to thank B. McDonald and D. Sharma for careful review of this manuscript and the many related discussions that helped strengthen the key points. We thank D. Mucida and M. Constantinides for helpful discussions that enhanced our understanding of neuro-immune axis perturbations and MAIT cells, respectively. This work was supported by the National Institutes of Health R01DK067180 (to B. J.), R01DK098435 (to B. J.), R01DK063158 (to B. J.), R01DK126487 (to B. J.) and the Digestive Diseases Research Core Center P30 C-IID DK42086 (to B. J.) at the University of Chicago, the 2019PG-CD015 Helmsley Charitable trust grant (to B. J), 5T32DK007074-49 (to A. H.-S.), Duchossois Family Institute (DFI) Fellowship Grant (to A. H.-S.), and the Gastro-Intestinal Research Foundation (GIRF) Pilot Award Grant (to A. H.-S).	Allie SR, 2019, NAT IMMUNOL, V20, P97, DOI 10.1038/s41590-018-0260-6; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Barbee SD, 2011, P NATL ACAD SCI USA, V108, P3330, DOI 10.1073/pnas.1010890108; Barros RD, 2016, CELL, V167, P203, DOI 10.1016/j.cell.2016.08.030; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Belai A, 1997, GUT, V40, P767, DOI 10.1136/gut.40.6.767; Bendelac A, 2007, ANNU REV IMMUNOL, V25, P297, DOI 10.1146/annurev.immunol.25.022106.141711; Berg DR, 2019, INFLAMM BOWEL DIS, V25, P1896, DOI 10.1093/ibd/izz059; Besedovsky L, 2019, PHYSIOL REV, V99, P1325, DOI 10.1152/physrev.00010.2018; Bouziat R, 2018, CELL HOST MICROBE, V24, P677, DOI 10.1016/j.chom.2018.10.004; Bouziat R, 2017, SCIENCE, V356, P44, DOI 10.1126/science.aah5298; Boyden LM, 2008, NAT GENET, V40, P656, DOI 10.1038/ng.108; Cahenzli J, 2013, CELL HOST MICROBE, V14, P559, DOI 10.1016/j.chom.2013.10.004; Choi J, 2012, CURR OPIN IMMUNOL, V24, P651, DOI 10.1016/j.coi.2012.10.004; Christophersen A, 2019, NAT MED, V25, P734, DOI 10.1038/s41591-019-0403-9; Christophersen A, 2014, UNITED EUR GASTROENT, V2, P268, DOI 10.1177/2050640614540154; Constantinides MG, 2021, SCIENCE, V374, P1338, DOI 10.1126/science.abf0095; Constantinides MG, 2019, SCIENCE, V366, P445, DOI 10.1126/science.aax6624; Cooper MA, 2009, P NATL ACAD SCI USA, V106, P1915, DOI 10.1073/pnas.0813192106; Czepielewski RS, 2021, IMMUNITY, V54, P2795, DOI 10.1016/j.immuni.2021.10.003; da Fonseca DM, 2015, CELL, V163, P354, DOI 10.1016/j.cell.2015.08.030; DILUZIO NR, 1978, INFECT IMMUN, V20, P804, DOI 10.1128/IAI.20.3.804-810.1978; Emilsson L, 2020, GASTROENTEROLOGY, V159, P1686, DOI 10.1053/j.gastro.2020.07.007; Fonseca-Pereira D, 2014, NATURE, V514, P98, DOI 10.1038/nature13498; Fransen NL, 2020, BRAIN, V143, P1714, DOI 10.1093/brain/awaa117; Godfrey DI, 2019, NAT IMMUNOL, V20, P1110, DOI 10.1038/s41590-019-0444-8; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Gollwitzer ES, 2014, NAT MED, V20, P642, DOI 10.1038/nm.3568; Gonzales KAU, 2021, SCIENCE, V374, P1097, DOI 10.1126/science.abh2444; Han A, 2013, P NATL ACAD SCI USA, V110, P13073, DOI 10.1073/pnas.1311861110; Hensel N, 2021, NAT IMMUNOL, V22, P229, DOI 10.1038/s41590-020-00817-w; Heuckeroth RO, 2018, NAT REV GASTRO HEPAT, V15, P152, DOI 10.1038/nrgastro.2017.149; Huh JR, 2020, NAT REV IMMUNOL, V20, P217, DOI 10.1038/s41577-019-0247-z; Jabri B, 2015, NAT REV IMMUNOL, V15, P771, DOI 10.1038/nri3919; JENSEN KE, 1956, J EXP MED, V104, P199, DOI 10.1084/jem.104.2.199; Khan N, 2020, CELL, V183, P752, DOI 10.1016/j.cell.2020.09.062; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Kronman MP, 2012, PEDIATRICS, V130, pE794, DOI 10.1542/peds.2011-3886; Kugler DG, 2016, J EXP MED, V213, P3041, DOI 10.1084/jem.20151636; Kumar BV, 2018, IMMUNITY, V48, P202, DOI 10.1016/j.immuni.2018.01.007; Lau CM, 2018, NAT IMMUNOL, V19, P963, DOI 10.1038/s41590-018-0176-1; Legoux F, 2019, SCIENCE, V366, P494, DOI 10.1126/science.aaw2719; Levy M, 2017, NAT REV IMMUNOL, V17, P219, DOI 10.1038/nri.2017.7; Lim AI, 2021, SCIENCE, V373, DOI 10.1126/science.abf3002; Martinez-Gonzalez I, 2016, IMMUNITY, V45, P198, DOI 10.1016/j.immuni.2016.06.017; Matheis F, 2020, CELL, V180, P64, DOI 10.1016/j.cell.2019.12.002; Mayassi T, 2021, NATURE, V595, P501, DOI 10.1038/s41586-021-03578-0; Mayassi T, 2019, CELL, V176, P967, DOI 10.1016/j.cell.2018.12.039; McDonald BD, 2018, NAT REV IMMUNOL, V18, P514, DOI 10.1038/s41577-018-0013-7; Moorlag SJCFM, 2020, CELL REP, V31, DOI 10.1016/j.celrep.2020.107634; Mubanga M, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.5245; Naik S, 2017, NATURE, V550, P475, DOI 10.1038/nature24271; Netea MG, 2020, NAT REV IMMUNOL, V20, P375, DOI 10.1038/s41577-020-0285-6; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Park SH, 1999, J EXP MED, V190, P885, DOI 10.1084/jem.190.6.885; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Peng H, 2013, J CLIN INVEST, V123, P1444, DOI 10.1172/JCI66381; Rao DA, 2017, NATURE, V542, P110, DOI 10.1038/nature20810; Risnes LF, 2018, J CLIN INVEST, V128, P2642, DOI 10.1172/JCI98819; Roquilly A, 2020, NAT IMMUNOL, V21, P636, DOI 10.1038/s41590-020-0673-x; Rosas-Ballina M, 2011, SCIENCE, V334, P98, DOI 10.1126/science.1209985; Saligrama N, 2019, NATURE, V572, P481, DOI 10.1038/s41586-019-1467-x; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Seidman JS, 2020, IMMUNITY, V52, P1057, DOI 10.1016/j.immuni.2020.04.001; Shaw SY, 2010, AM J GASTROENTEROL, V105, P2687, DOI 10.1038/ajg.2010.398; Shi CX, 2011, INFECT IMMUN, V79, P3940, DOI 10.1128/IAI.00148-11; Sullivan ZA, 2021, SCIENCE, V371, P1223, DOI 10.1126/science.aba8310; Sun JC, 2009, NATURE, V457, P557, DOI 10.1038/nature07665; TRIBOULEY J, 1978, CR SOC BIOL, V172, P902; VANTWOUT JW, 1992, SCAND J IMMUNOL, V36, P713; Veiga-Fernandes H, 2007, NATURE, V446, P547, DOI 10.1038/nature05597; Walk J, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08659-3; Wallrapp A, 2017, NATURE, V549, P351, DOI 10.1038/nature24029; Wang XW, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07405-5; Weyand CM, 2000, RHEUMATOLOGY, V39, P3, DOI 10.1093/oxfordjournals.rheumatology.a031491; White JP, 2018, CELL, V175, P1198, DOI 10.1016/j.cell.2018.08.069; Wijeyesinghe S, 2021, NATURE, V592, P457, DOI 10.1038/s41586-021-03351-3; Xia CM, 2011, NEUROGASTROENT MOTIL, V23, P801, DOI 10.1111/j.1365-2982.2011.01728.x; Xu YL, 2022, SCIENCE, V377, P1085, DOI 10.1126/science.abj2674; Yang SY, 2015, SCIENCE, V348, P589, DOI 10.1126/science.aaa7017; Yates KB, 2021, NAT IMMUNOL, V22, P1020, DOI 10.1038/s41590-021-00979-1; Zaid A, 2014, P NATL ACAD SCI USA, V111, P5307, DOI 10.1073/pnas.1322292111	85	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01342-8	http://dx.doi.org/10.1038/s41590-022-01342-8		NOV 2022	12	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6J3SL	36411382				2022-12-18	WOS:000886745100003
J	Houston, S				Houston, Stephanie			iNKT cells circulate	NATURE IMMUNOLOGY			English	Editorial Material; Early Access												stephanie.houston@us.nature.com							0	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01382-0	http://dx.doi.org/10.1038/s41590-022-01382-0		NOV 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6I9EA	36414719				2022-12-18	WOS:000886431100002
J	Umetsu, DT				Umetsu, Dale T.			Understanding microorganisms in the prevention of allergy	NATURE IMMUNOLOGY			English	Editorial Material; Early Access							HAY-FEVER; EXPOSURE; ASTHMA	Mechanisms that explain the hygiene hypothesis for allergy and asthma are unclear. A mouse model that cohouses 'dirty' pet-store mice with clean laboratory mice might help to understand this immunology.	[Umetsu, Dale T.] Stanford Univ, Dept Med, Stanford, CA 94305 USA; [Umetsu, Dale T.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA	Stanford University; University of California System; University of California San Francisco	Umetsu, DT (corresponding author), Stanford Univ, Dept Med, Stanford, CA 94305 USA.; Umetsu, DT (corresponding author), Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA.	dale.umetsu@gmail.com						Abdel-Gadir A, 2019, NAT MED, V25, P1164, DOI 10.1038/s41591-019-0461-z; Atarashi K, 2011, SCIENCE, V331, P337, DOI 10.1126/science.1198469; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Feehley T, 2019, NAT MED, V25, P448, DOI 10.1038/s41591-018-0324-z; Fourati S., 2022, NAT IMMUNOL, DOI [10.1038/s41590-021-01065-2(2021), DOI 10.1038/S41590-021-01065-2(2021), 10.1038/s41590-022-01329-5, DOI 10.1038/S41590-022-01354-4]; Fujimura KE, 2014, P NATL ACAD SCI USA, V111, P805, DOI 10.1073/pnas.1310750111; Huggins MA, 2019, CELL REP, V28, P1729, DOI 10.1016/j.celrep.2019.07.028; Kero J, 2002, PEDIATR RES, V52, P6, DOI 10.1023/01.PDR.0000017263.01840.F0; Kummeling I, 2007, PEDIATRICS, V119, pE225, DOI 10.1542/peds.2006-0896; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Shanahan F, 2010, CLIN EXP IMMUNOL, V160, P92, DOI 10.1111/j.1365-2249.2010.04135.x; STRACHAN DP, 1989, BRIT MED J, V299, P1259, DOI 10.1136/bmj.299.6710.1259; Von Ehrenstein OS, 2000, CLIN EXP ALLERGY, V30, P187, DOI 10.1046/j.1365-2222.2000.00801.x	13	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01356-2	http://dx.doi.org/10.1038/s41590-022-01356-2		NOV 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6I9EA	36414720				2022-12-18	WOS:000886431100004
J	Visan, I				Visan, Ioana			Protecting the CNS	NATURE IMMUNOLOGY			English	Editorial Material; Early Access												i.visan@us.nature.com							0	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01381-1	http://dx.doi.org/10.1038/s41590-022-01381-1		NOV 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6I9EA	36414717				2022-12-18	WOS:000886431100003
J	Zhang, YY; Bailey, JT; Xu, E; Singh, K; Lavaert, M; Link, VM; D'Souza, S; Hafiz, A; Cao, J; Cao, GY; Sant'Angelo, DB; Sun, W; Belkaid, Y; Bhandoola, A; McGavern, DB; Yang, Q				Zhang, Yuanyue; Bailey, Jacob T.; Xu, En; Singh, Kunal; Lavaert, Marieke; Link, Verena M.; D'Souza, Shanti; Hafiz, Alex; Cao, Jian; Cao, Gaoyuan; Sant'Angelo, Derek B.; Sun, Wei; Belkaid, Yasmine; Bhandoola, Avinash; McGavern, Dorian B.; Yang, Qi			Mucosal-associated invariant T cells restrict reactive oxidative damage and preserve meningeal barrier integrity and cognitive function	NATURE IMMUNOLOGY			English	Article; Early Access							TISSUE-REPAIR; COENZYME-Q10; ACTIVATION; TCR	Increasing evidence indicates close interaction between immune cells and the brain, revising the traditional view of the immune privilege of the brain. However, the specific mechanisms by which immune cells promote normal neural function are not entirely understood. Mucosal-associated invariant T cells (MAIT cells) are a unique type of innate-like T cell with molecular and functional properties that remain to be better characterized. In the present study, we report that MAIT cells are present in the meninges and express high levels of antioxidant molecules. MAIT cell deficiency in mice results in the accumulation of reactive oxidative species in the meninges, leading to reduced expression of junctional protein and meningeal barrier leakage. The presence of MAIT cells restricts neuroinflammation in the brain and preserves learning and memory. Together, our work reveals a new functional role for MAIT cells in the meninges and suggests that meningeal immune cells can help maintain normal neural function by preserving meningeal barrier homeostasis and integrity. Yang and colleagues report that MAIT cells are present in the meninges where they play an essential role in repressing tissue ROS accumulation and preserving meningeal barrier integrity.	[Zhang, Yuanyue; Xu, En; Singh, Kunal; Sant'Angelo, Derek B.; Yang, Qi] Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA; [Bailey, Jacob T.; D'Souza, Shanti; Sun, Wei] Albany Med Coll, Dept Immunol & Microbial Dis, Albany, NY 12208 USA; [Lavaert, Marieke; Bhandoola, Avinash] NCI, Lab Genome Integr, NIH, Bethesda, MD 20892 USA; [Link, Verena M.; Belkaid, Yasmine] NIAID, Metaorganism Immun Sect, Lab Immune Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Link, Verena M.; Belkaid, Yasmine] NIAID, Lab Host Immun & Microbiome, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Hafiz, Alex; Cao, Jian] Rutgers Robert Wood Johnson Med Sch, Rutgers Canc Inst New Jersey, New Brunswick, NJ USA; [Cao, Jian] Rutgers Robert Wood Johnson Med Sch, Dept Med, New Brunswick, NJ USA; [Cao, Gaoyuan; Yang, Qi] Rutgers Robert Wood Johnson Med Sch, Rutgers Inst Translat Med & Sci, New Brunswick, NJ 08901 USA; [Sant'Angelo, Derek B.; Yang, Qi] Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA; [Belkaid, Yasmine] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [McGavern, Dorian B.] NINDS, Viral Immunol & Intravital Imaging Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Albany Medical College; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Yang, Q (corresponding author), Rutgers Robert Wood Johnson Med Sch, Child Hlth Inst New Jersey, New Brunswick, NJ 08901 USA.; Yang, Q (corresponding author), Rutgers Robert Wood Johnson Med Sch, Rutgers Inst Translat Med & Sci, New Brunswick, NJ 08901 USA.; Yang, Q (corresponding author), Rutgers Robert Wood Johnson Med Sch, Dept Pediat, New Brunswick, NJ 08901 USA.	qy117@rwjms.rutgers.edu		Cao, Jian/0000-0003-3424-6802	US NIH [R01HL137813, R01AG057782, R01HL155021]; NIH Intramural Research Programs; Robert Wood Johnson Foundation [74260]	US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Intramural Research Programs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	We thank A. Rabson, H. Ching Lin, P. Jiang and Z. Pang for critical discussion and technical help. This work was supported by the US NIH (grant nos. R01HL137813, R01AG057782 and R01HL155021 to Q.Y.), the NIH Intramural Research Programs (to D.B.M., Y.B. and A.B.) and support to the Child Health Institute of New Jersey from the Robert Wood Johnson Foundation (grant no. 74260).	Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; de Lima KA, 2020, NAT IMMUNOL, V21, P1421, DOI 10.1038/s41590-020-0776-4; Augusto-Oliveira M, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8101293; Bachiller S, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00488; Banks WA, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0434-1; Brombacher TM, 2017, J IMMUNOL, V198, P2681, DOI 10.4049/jimmunol.1601546; Buckley MW, 2022, IMMUNOL REV, V306, P58, DOI 10.1111/imr.13066; Chen Y, 2021, J EXP MED, V218, DOI 10.1084/jem.20202717; Constantinides MG, 2019, SCIENCE, V366, P445, DOI 10.1126/science.aax6624; Corbett AJ, 2014, NATURE, V509, P361, DOI 10.1038/nature13160; Derecki NC, 2010, J EXP MED, V207, P1067, DOI 10.1084/jem.20091419; Derk J, 2021, FRONT CELL NEUROSCI, V15, DOI 10.3389/fncel.2021.703944; Filiano AJ, 2016, NATURE, V535, P425, DOI 10.1038/nature18626; Fung ITH, 2020, J EXP MED, V217, DOI 10.1084/jem.20190915; Galea I, 2007, TRENDS IMMUNOL, V28, P12, DOI 10.1016/j.it.2006.11.004; Herz J, 2021, NEURON, V109, P3609, DOI 10.1016/j.neuron.2021.10.022; Hinks TSC, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01014; Hinks TSC, 2019, CELL REP, V28, P3249, DOI 10.1016/j.celrep.2019.07.039; Horng S, 2017, J CLIN INVEST, V127, P3136, DOI 10.1172/JCI91301; Jones HE, 2022, NEUROPHOTONICS, V9, DOI 10.1117/1.NPh.9.2.021911; Kashiba M, 2017, J CLIN BIOCHEM NUTR, V60, P81, DOI 10.3164/jcbn.16-32; Kashiba M, 2014, J CLIN BIOCHEM NUTR, V55, P85, DOI 10.3164/jcbn.13-106; Kjer-Nielsen L, 2012, NATURE, V491, P717, DOI 10.1038/nature11605; Koay HF, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay6039; Kumar S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026912; Lamichhane R, 2019, CELL REP, V28, P3061, DOI 10.1016/j.celrep.2019.08.054; Legoux F, 2020, IMMUNITY, V53, P710, DOI 10.1016/j.immuni.2020.09.009; Legoux F, 2019, SCIENCE, V366, P494, DOI 10.1126/science.aaw2719; Leng TQ, 2019, CELL REP, V28, P3077, DOI 10.1016/j.celrep.2019.08.050; Li XK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06318-5; Marsh SE, 2022, NAT NEUROSCI, V25, P306, DOI 10.1038/s41593-022-01022-8; Mastorakos P, 2021, NAT NEUROSCI, V24, P245, DOI 10.1038/s41593-020-00773-6; Mukherjee C, 2020, CELL METAB, V32, P259, DOI 10.1016/j.cmet.2020.05.019; Ocanas SR, 2022, ENEURO, V9, DOI 10.1523/ENEURO.0348-21.2022; Pomaznoy Mikhail, 2020, Immunohorizons, V4, P292, DOI 10.4049/immunohorizons.2000031; Ribeiro M, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aay5199; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rudak PT, 2018, J LEUKOCYTE BIOL, V104, P473, DOI 10.1002/JLB.4RI0118-023R; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Shah R, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/9630175; Steinbrenner H, 2016, ARCH BIOCHEM BIOPHYS, V595, P113, DOI 10.1016/j.abb.2015.06.024; Tian RL, 2021, NAT NEUROSCI, V24, P1020, DOI 10.1038/s41593-021-00862-0; Treiner E, 2003, NATURE, V422, P164, DOI 10.1038/nature01433; Varvel NH, 2016, P NATL ACAD SCI USA, V113, pE5665, DOI 10.1073/pnas.1604263113; Voet S, 2019, TRENDS MOL MED, V25, P112, DOI 10.1016/j.molmed.2018.11.005; Yaman OM, 2019, MEDICINA-LITHUANIA, V55, DOI 10.3390/medicina55050187; Ye LY, 2020, J ALLERGY CLIN IMMUN, V145, P1469, DOI 10.1016/j.jaci.2019.12.891	47	0	0	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01349-1	http://dx.doi.org/10.1038/s41590-022-01349-1		NOV 2022	29	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6J3SL	36411380				2022-12-18	WOS:000886745100002
J	Biltz, RG; Sawicki, CM; Sheridan, JF; Godbout, JP				Biltz, Rebecca G.; Sawicki, Caroline M.; Sheridan, John F.; Godbout, Jonathan P.			The neuroimmunology of social-stress-induced sensitization	NATURE IMMUNOLOGY			English	Review							DEFEAT STRESS; GLUCOCORTICOID RESISTANCE; MYOCARDIAL-INFARCTION; IMMUNE ACTIVATION; GENE-EXPRESSION; WHITE-MATTER; BONE-MARROW; MICROGLIA; BRAIN; INFLAMMATION	Godbout and colleagues discuss the neuroimmune mechanisms that underlie social-stress defeat, anxiety, and post-traumatic stress disorder. Myriad clinical findings provide links between chronic stressors, inflammation, and mood disorders. Furthermore, traumatic or chronic exposure to psychological stressors may promote stress sensitization, in which individuals have long-term complications, including increased vulnerability to subsequent stressors. Post-traumatic stress disorder (PTSD) is a clinically relevant example of stress sensitization. PTSD alters neuronal circuitry and mood; however, the mechanisms underlying long-term stress sensitization within this disorder are unclear. Rodent models of chronic social defeat recapitulate several key physiological, immunological, and behavioral responses associated with psychological stress in humans. Repeated social defeat (RSD) uniquely promotes the convergence of neuronal, central inflammatory (microglial), and peripheral immune (monocyte) pathways, leading to prolonged anxiety, social withdrawal, and cognitive impairment. Moreover, RSD promotes stress sensitization, in which mice are highly sensitive to subthreshold stress exposure and recurrence of anxiety weeks after the cessation of stress. Therefore, the purpose of this Review is to discuss the influence of social-defeat stress on the immune system that may underlie stress sensitization within three key cellular compartments: neurons, microglia, and monocytes. Delineating the mechanisms of stress sensitization is critical in understanding and treating conditions such as PTSD.	[Biltz, Rebecca G.; Sheridan, John F.; Godbout, Jonathan P.] Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA; [Sawicki, Caroline M.; Sheridan, John F.] Ohio State Univ, Div Biosci, Coll Dent, Columbus, OH 43210 USA; [Sheridan, John F.; Godbout, Jonathan P.] Ohio State Univ, Chron Brain Injury Program, Columbus, OH 43210 USA; [Sheridan, John F.; Godbout, Jonathan P.] Ohio State Univ, Wexner Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Sheridan, JF; Godbout, JP (corresponding author), Ohio State Univ, Wexner Med Ctr, Dept Neurosci, Columbus, OH 43210 USA.; Sheridan, JF (corresponding author), Ohio State Univ, Div Biosci, Coll Dent, Columbus, OH 43210 USA.; Sheridan, JF; Godbout, JP (corresponding author), Ohio State Univ, Chron Brain Injury Program, Columbus, OH 43210 USA.; Sheridan, JF; Godbout, JP (corresponding author), Ohio State Univ, Wexner Med Ctr, Inst Behav Med Res, Columbus, OH 43210 USA.	John.Sheridan@osumc.edu; Jonathan.Godbout@osumc.edu		Sheridan, John/0000-0002-6927-0266	NIMH [R01-MH-119670, R56-MH116670]; NIDCR [T32-DE014320, F30-DE026075]	NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by NIMH grants R01-MH-119670 and R56-MH116670 (to J. P. G. and J. F. S.). C. M. S. was supported by both NIDCR Training Grant T32-DE014320 and F30-DE026075.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Anacker C, 2016, BIOL PSYCHIAT, V79, P840, DOI 10.1016/j.biopsych.2015.08.009; Avitsur R, 2002, J NEUROIMMUNOL, V124, P54, DOI 10.1016/S0165-5728(02)00010-3; Badura-Brack A, 2018, BIOL PSYCHOL, V132, P228, DOI 10.1016/j.biopsycho.2018.01.005; Bailey MT, 2007, AM J PHYSIOL-REG I, V293, pR1180, DOI 10.1152/ajpregu.00307.2007; Bandoli G, 2017, PSYCHOL MED, V47, P2379, DOI 10.1017/S0033291717001064; Bellavance MA, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00136; Bellinger DL, 2008, CELL IMMUNOL, V252, P27, DOI 10.1016/j.cellimm.2007.09.005; Bergamini G, 2018, NEUROBIOL STRESS, V8, P42, DOI 10.1016/j.ynstr.2018.01.004; Berton O, 2006, SCIENCE, V311, P864, DOI 10.1126/science.1120972; Beumer W, 2012, J LEUKOCYTE BIOL, V92, P959, DOI 10.1189/jlb.0212100; Bhatt S, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15930-5; Carvalho LA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2013.118; Christoffel DJ, 2011, J NEUROSCI, V31, P314, DOI 10.1523/JNEUROSCI.4763-10.2011; Cole SW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r189; Cole SW, 2011, P NATL ACAD SCI USA, V108, P3080, DOI 10.1073/pnas.1014218108; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Deri Yael, 2021, Brain Behav Immun Health, V16, P100287, DOI 10.1016/j.bbih.2021.100287; DiSabato DJ, 2021, MOL PSYCHIATR, V26, P4770, DOI 10.1038/s41380-020-0788-3; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Feng XM, 2017, JCI INSIGHT, V2, DOI 10.1172/jci.insight.91229; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Gandolfi D, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00184; Godbout JP, 2008, NEUROPSYCHOPHARMACOL, V33, P2341, DOI 10.1038/sj.npp.1301649; Godbout JP, 2005, FASEB J, V19, P1329, DOI 10.1096/fj.05-3776fje; Gola H, 2013, BMC PSYCHIATRY, V13, DOI 10.1186/1471-244X-13-40; Golden SA, 2011, NAT PROTOC, V6, P1183, DOI 10.1038/nprot.2011.361; Guo YY, 2021, PHYTOTHER RES, V35, P3936, DOI 10.1002/ptr.7106; Hall C., 1932, U CALIF PUBL PSYCHOL, V6, P1; Hammen C, 2000, J CONSULT CLIN PSYCH, V68, P782, DOI 10.1037/0022-006X.68.5.782; Hanke ML, 2012, BRAIN BEHAV IMMUN, V26, P1150, DOI 10.1016/j.bbi.2012.07.011; Harkness KL, 2015, J ABNORM PSYCHOL, V124, P1, DOI 10.1037/abn0000041; Haroon E, 2012, NEUROPSYCHOPHARMACOL, V37, P137, DOI 10.1038/npp.2011.205; Hodes GE, 2014, P NATL ACAD SCI USA, V111, P16136, DOI 10.1073/pnas.1415191111; Iwata M, 2016, BIOL PSYCHIAT, V80, P12, DOI 10.1016/j.biopsych.2015.11.026; Jonker I, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.62; Katrinli S, 2019, BRAIN BEHAV IMMUN, V81, P655, DOI 10.1016/j.bbi.2019.07.016; Kohler CA, 2017, ACTA PSYCHIAT SCAND, V135, P373, DOI 10.1111/acps.12698; Koo JW, 2008, P NATL ACAD SCI USA, V105, P751, DOI 10.1073/pnas.0708092105; Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018; Leuschner F, 2012, J EXP MED, V209, P123, DOI 10.1084/jem.20111009; Lindqvist D, 2017, PSYCHIAT RES, V258, P330, DOI 10.1016/j.psychres.2017.08.052; Lisboa SF, 2018, NEUROPSYCHOPHARMACOL, V43, P1924, DOI 10.1038/s41386-018-0064-2; Liu XY, 2019, IMMUNITY, V50, P317, DOI [10.1016/j.immuni.2019.02.012, 10.1016/j.immuni.2018.12.012]; Logue MW, 2018, BIOL PSYCHIAT, V83, P244, DOI 10.1016/j.biopsych.2017.09.006; McKim DB, 2018, MOL PSYCHIATR, V23, P1421, DOI 10.1038/mp.2017.64; Mckim DB, 2018, CELL REP, V25, P2552, DOI 10.1016/j.celrep.2018.10.102; McKim DB, 2016, J NEUROSCI, V36, P2590, DOI 10.1523/JNEUROSCI.2394-15.2016; McKim DB, 2016, BIOL PSYCHIAT, V79, P803, DOI 10.1016/j.biopsych.2015.07.010; Menard C, 2017, NAT NEUROSCI, V20, P1752, DOI 10.1038/s41593-017-0010-3; Miller GE, 2008, BIOL PSYCHIAT, V64, P266, DOI 10.1016/j.biopsych.2008.03.017; Miller GE, 2014, BRAIN BEHAV IMMUN, V41, P191, DOI 10.1016/j.bbi.2014.05.016; Mondelli V, 2017, LANCET PSYCHIAT, V4, P563, DOI 10.1016/S2215-0366(17)30101-3; Nahvi RJ, 2019, FRONT BEHAV NEUROSCI, V13, DOI 10.3389/fnbeh.2019.00017; Niraula A, 2019, BIOL PSYCHIAT, V85, P679, DOI 10.1016/j.biopsych.2018.09.030; Niraula A, 2018, J NEUROSCI, V38, P2328, DOI 10.1523/JNEUROSCI.2568-17.2018; Niraula A, 2017, NEUROPSYCHOPHARMACOL, V42, P318, DOI 10.1038/npp.2016.185; Norden DM, 2016, GLIA, V64, P300, DOI 10.1002/glia.22930; Pace TWW, 2011, BRAIN BEHAV IMMUN, V25, P6, DOI 10.1016/j.bbi.2010.10.003; Pace TWW, 2012, BRAIN BEHAV IMMUN, V26, P13, DOI 10.1016/j.bbi.2011.07.232; Park YM, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10050254; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Poulos AM, 2014, BIOL PSYCHIAT, V76, P306, DOI 10.1016/j.biopsych.2013.10.007; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Raison CL, 2006, TRENDS IMMUNOL, V27, P24, DOI 10.1016/j.it.2005.11.006; Ramirez K, 2016, BRAIN BEHAV IMMUN, V51, P154, DOI 10.1016/j.bbi.2015.08.011; Ramirez K, 2015, BRAIN BEHAV IMMUN, V46, P212, DOI 10.1016/j.bbi.2015.01.016; Rauch PJ, 2012, SCIENCE, V335, P597, DOI 10.1126/science.1215173; Raut SB, 2022, J PSYCHIATR RES, V150, P246, DOI 10.1016/j.jpsychires.2022.03.045; Reu P, 2017, CELL REP, V20, P779, DOI 10.1016/j.celrep.2017.07.004; Reus GZ, 2015, NEUROSCIENCE, V300, P141, DOI 10.1016/j.neuroscience.2015.05.018; Robbins CS, 2012, CIRCULATION, V125, P364, DOI 10.1161/CIRCULATIONAHA.111.061986; Russo SJ, 2012, NAT NEUROSCI, V15, P1475, DOI 10.1038/nn.3234; Sawicki CM, 2015, NEUROSCIENCE, V302, P151, DOI 10.1016/j.neuroscience.2014.10.004; Sawicki CM, 2019, J NEUROSCI, V39, P1139, DOI 10.1523/JNEUROSCI.2785-18.2018; Sawicki CM, 2018, BRAIN BEHAV IMMUN, V69, P113, DOI 10.1016/j.bbi.2017.11.005; Schnieder TP, 2014, J NEUROPATH EXP NEUR, V73, P880, DOI 10.1097/NEN.0000000000000107; Setiawan E, 2015, JAMA PSYCHIAT, V72, P268, DOI 10.1001/jamapsychiatry.2014.2427; Shand FHW, 2014, P NATL ACAD SCI USA, V111, P7771, DOI 10.1073/pnas.1402914111; Shimamoto A, 2018, INT REV NEUROBIOL, V140, P271, DOI 10.1016/bs.irn.2018.07.009; Stoddard FJ, 2006, AM J PSYCHIAT, V163, P1084, DOI 10.1176/appi.ajp.163.6.1084; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Takahashi A, 2022, MOL PSYCHIATR, V27, P2563, DOI 10.1038/s41380-021-01110-4; Takahashi A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12811-8; Torres-Platas SG, 2014, BRAIN BEHAV IMMUN, V42, P50, DOI 10.1016/j.bbi.2014.05.007; Tsyglakova M, 2019, FRONT NEUROENDOCRIN, V54, DOI 10.1016/j.yfrne.2019.100771; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; Voorhees JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058488; Wang Z, 2016, HUM IMMUNOL, V77, P652, DOI 10.1016/j.humimm.2016.05.018; Weber GF, 2015, SCIENCE, V347, P1260, DOI 10.1126/science.aaa4268; Weber MD, 2019, BIOL PSYCHIAT, V85, P667, DOI 10.1016/j.biopsych.2018.10.009; Wohleb ES, 2014, BIOL PSYCHIAT, V75, P970, DOI 10.1016/j.biopsych.2013.11.029; Wohleb ES, 2014, J NEUROSCI, V34, P2583, DOI 10.1523/JNEUROSCI.3723-13.2014; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Wohleb ES, 2012, PSYCHONEUROENDOCRINO, V37, P1491, DOI 10.1016/j.psyneuen.2012.02.003; Wohleb ES, 2011, J NEUROSCI, V31, P6277, DOI 10.1523/JNEUROSCI.0450-11.2011; Wu YP, 2019, NEURAL REGEN RES, V14, P298, DOI 10.4103/1673-5374.244792; Zhang JQ, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abb9888; ZHOU DH, 1993, ENDOCRINOLOGY, V133, P2523, DOI 10.1210/en.133.6.2523	99	0	0	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1527	1535		10.1038/s41590-022-01321-z	http://dx.doi.org/10.1038/s41590-022-01321-z		NOV 2022	9	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36369271				2022-12-18	WOS:000881881200001
J	Kashiwagi, M; Georgopoulos, K				Kashiwagi, Mariko; Georgopoulos, Katia			Notch gives early T cell progenitors time to grow up	NATURE IMMUNOLOGY			English	Editorial Material								A stage-specific enhancer augments Notch1 signaling from the early thymic progenitor (ETP) through double-negative thymocyte stages. Enhanced Notch1 activity is required for T cell lineage differentiation at the later end of this developmental interval, but Notch1 also suppresses precocious T lineage commitment in ETPs and promotes their expansion as multi-lineage progenitors.	[Kashiwagi, Mariko; Georgopoulos, Katia] Harvard Med Sch, Cutaneous Biol Res Ctr, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Kashiwagi, M (corresponding author), Harvard Med Sch, Cutaneous Biol Res Ctr, Boston, MA 02115 USA.							Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Koch U, 2011, ANNU REV CELL DEV BI, V27, P539, DOI 10.1146/annurev-cellbio-092910-154008; Thompson PK, 2011, SEMIN IMMUNOL, V23, P350, DOI 10.1016/j.smim.2011.08.007; Zhou W, 2019, CELL SYST, V9, P321, DOI 10.1016/j.cels.2019.09.008	5	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1523	1524		10.1038/s41590-022-01323-x	http://dx.doi.org/10.1038/s41590-022-01323-x		NOV 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36357784				2022-12-18	WOS:000882692200001
J	Qi, H; Liu, X				Qi, Hai; Liu, Xin			Mouse long-lived plasma cells develop from multiple origins	NATURE IMMUNOLOGY			English	Editorial Material							HUMORAL IMMUNITY	By combining single-cell mRNA sequencing and a genetic pulse-chase mouse model, we identified multiple subsets of mouse long-lived plasma cells and showed that these cells can originate from diverse developmental routes.	[Qi, Hai; Liu, Xin] Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing, Peoples R China	Tsinghua University	Qi, H (corresponding author), Tsinghua Univ, Inst Immunol, Lab Dynam Immunobiol, Beijing, Peoples R China.							Amanna IJ, 2007, NEW ENGL J MED, V357, P1903, DOI 10.1056/NEJMoa066092; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; Robinson MJ, 2020, IMMUNOL REV, V296, P87, DOI 10.1111/imr.12895; Slifka MK, 1998, IMMUNITY, V8, P363, DOI 10.1016/S1074-7613(00)80541-5	5	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1521	1522		10.1038/s41590-022-01346-4	http://dx.doi.org/10.1038/s41590-022-01346-4		NOV 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36357783				2022-12-18	WOS:000882692200002
J	Houston, S				Houston, Stephanie			Immunosuppression	NATURE IMMUNOLOGY			English	Editorial Material												stephanie.houston@us.nature.com							0	0	0	3	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1520	1520		10.1038/s41590-022-01362-4	http://dx.doi.org/10.1038/s41590-022-01362-4		NOV 2022	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36333609				2022-12-18	WOS:000878981200001
J	Visan, I				Visan, Ioana			Broken hierarchies	NATURE IMMUNOLOGY			English	Editorial Material												i.visan@us.nature.com							0	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1520	1520		10.1038/s41590-022-01363-3	http://dx.doi.org/10.1038/s41590-022-01363-3		NOV 2022	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36333608				2022-12-18	WOS:000878981200002
J	Draber, P				Draber, Peter			CMTM4 is required for IL-17A signaling	NATURE IMMUNOLOGY			English	Editorial Material							PD-L1	We identified the transmembrane protein CMTM4 as an essential component of the IL-17 receptor. CMTM4 is required for membrane expression of IL-17 receptor subunit C and activation of IL-17A pro-inflammatory signaling. Lack of CMTM4 largely protects mice from experimental psoriasis, which suggests that targeting CMTM4 might alleviate IL-17-mediated autoimmunity.	[Draber, Peter] Charles Univ Prague, Fac Med 1, BIOCEV, Vestec, Czech Republic	Charles University Prague	Draber, P (corresponding author), Charles Univ Prague, Fac Med 1, BIOCEV, Vestec, Czech Republic.							Burr ML, 2017, NATURE, V549, P101, DOI 10.1038/nature23643; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Draberova H, 2020, EMBO J, V39, DOI 10.15252/embj.2019104202; Li XX, 2019, NAT IMMUNOL, V20, P1594, DOI 10.1038/s41590-019-0514-y; Mezzadra R, 2017, NATURE, V549, P106, DOI 10.1038/nature23669	5	0	0	4	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1525	1526		10.1038/s41590-022-01344-6	http://dx.doi.org/10.1038/s41590-022-01344-6			2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36316477				2022-12-18	WOS:000883668400010
J	Fourati, S; Tomalin, LE; Mule, MP; Chawla, DG; Gerritsen, B; Rychkov, D; Henrich, E; Miller, HER; Hagan, T; Diray-Arce, J; Dunn, P; Levy, O; Gottardo, R; Sarwal, MM; Tsang, JS; Suarez-Farinas, M; Pulendran, B; Kleinstein, SH; Sekaly, RP				Fourati, Slim; Tomalin, Lewis E.; Mule, Matthew P.; Chawla, Daniel G.; Gerritsen, Bram; Rychkov, Dmitry; Henrich, Evan; Miller, Helen E. R.; Hagan, Thomas; Diray-Arce, Joann; Dunn, Patrick; Levy, Ofer; Gottardo, Raphael; Sarwal, Minnie M.; Tsang, John S.; Suarez-Farinas, Mayte; Pulendran, Bali; Kleinstein, Steven H.; Sekaly, Rafick-Pierre		Human Immunology Project Consortiu	Pan-vaccine analysis reveals innate immune endotypes predictive of antibody responses to vaccination	NATURE IMMUNOLOGY			English	Article; Early Access							INFLUENZA VACCINATION	Several studies have shown that the pre-vaccination immune state is associated with the antibody response to vaccination. However, the generalizability and mechanisms that underlie this association remain poorly defined. Here, we sought to identify a common pre-vaccination signature and mechanisms that could predict the immune response across 13 different vaccines. Analysis of blood transcriptional profiles across studies revealed three distinct pre-vaccination endotypes, characterized by the differential expression of genes associated with a pro-inflammatory response, cell proliferation, and metabolism alterations. Importantly, individuals whose pre-vaccination endotype was enriched in pro-inflammatory response genes known to be downstream of nuclear factor-kappa B showed significantly higher serum antibody responses 1 month after vaccination. This pro-inflammatory pre-vaccination endotype showed gene expression characteristic of the innate activation state triggered by Toll-like receptor ligands or adjuvants. These results demonstrate that wide variations in the transcriptional state of the immune system in humans can be a key determinant of responsiveness to vaccination. Sekaly and colleagues reveal a common pre-vaccination peripheral blood transcriptional signature that is predictive of antibody responses across 13 different vaccines.	[Fourati, Slim; Sekaly, Rafick-Pierre] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Tomalin, Lewis E.; Suarez-Farinas, Mayte] Icahn Sch Med Mt Sinai, Ctr Biostat, New York, NY 10029 USA; [Mule, Matthew P.; Tsang, John S.] NIH, NIAID, Lab Immune Syst Biol, Multiscale Syst Biol Sect, Bldg 10, Bethesda, MD 20892 USA; [Mule, Matthew P.; Tsang, John S.] NIH, Ctr Human Immunol CHI, Bldg 10, Bethesda, MD 20892 USA; [Mule, Matthew P.] Univ Cambridge, NIH Oxford Cambridge Scholars Program, Cambridge, England; [Chawla, Daniel G.; Gerritsen, Bram; Kleinstein, Steven H.] Yale Sch Med, New Haven, CT 06510 USA; [Rychkov, Dmitry; Sarwal, Minnie M.] Univ Calif San Francisco, Div Transplant Surg, San Francisco, CA 94143 USA; [Henrich, Evan; Miller, Helen E. R.; Gottardo, Raphael] Fred Hutchinson Canc Res Ctr, 1124 Columbia St, Seattle, WA 98104 USA; [Hagan, Thomas; Pulendran, Bali] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Diray-Arce, Joann; Levy, Ofer] Boston Childrens Hosp, Precis Vaccines Program, Boston, MA USA; [Diray-Arce, Joann; Levy, Ofer] Harvard Med Sch, Boston, MA 02115 USA; [Dunn, Patrick] NG Hlth Solut, ImmPort Curat Team, Rockville, MD USA; [Gottardo, Raphael] Univ Lausanne, Biomed Data Sci Ctr, Lausanne, Switzerland; [Gottardo, Raphael] Lausanne Univ Hosp, Lausanne, Switzerland; [Gottardo, Raphael] Swiss Inst Bioinformat, Lausanne, Switzerland	Emory University; Icahn School of Medicine at Mount Sinai; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; University of Cambridge; Yale University; University of California System; University of California San Francisco; Fred Hutchinson Cancer Center; Stanford University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics	Sekaly, RP (corresponding author), Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA.; Kleinstein, SH (corresponding author), Yale Sch Med, New Haven, CT 06510 USA.	steven.kleinstein@yale.edu; rafick.sekaly@emory.edu		Chawla, Daniel/0000-0001-7667-9337	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH) [U19AI118608, U19AI128949, U19AI090023, U19AI118626, U19AI089992, U19AI128914, U19AI128910, U19AI118610, U19AI128913]; Intramural Program of NIAID; NIH	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Program of NIAID; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was performed as a project of the Human Immunology Project Consortium (HIPC) and supported by the National Institute of Allergy and Infectious Diseases (NIAID). This work was supported in part by National Institutes of Health (NIH) grants U19AI118608 (to O.L.), U19AI128949 and U19AI090023 (to B.P.), U19AI118626 and U19AI089992 (to S.H.K.), U19AI128914 and U19AI128910 (to R.-P.S.), U19AI118610 (to M.S.-F.) and U19AI128913, and the Intramural Program of NIAID and NIH institutes supporting the Trans-NIH Center for Human Immunology.	A.-N. Pelletier, 2021, medRxiv, DOI 10.1101/2021.09.25.21264123; Aran D, 2017, GENOME BIOL, V18, DOI 10.1186/s13059-017-1349-1; Avey S, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal4656; Avnir Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep20842; Bartholomeus E, 2018, VACCINE, V36, P6282, DOI 10.1016/j.vaccine.2018.09.001; Blanco S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001660; Chambers C, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy211; Diray-Arce J., 2021, BIORXIV, DOI [10.1101/2021.11.05.465336, DOI 10.1101/2021.11.05.465336]; Fourati S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10369; Franco LM, 2013, ELIFE, V2, DOI 10.7554/eLife.00299; Fuchs K, 2018, EMBO REP, V19, DOI 10.15252/embr.201846065; Furman D, 2019, NAT MED, V25, P1822, DOI 10.1038/s41591-019-0675-0; Furman D, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.15; Gerstein MB, 2012, NATURE, V489, P91, DOI 10.1038/nature11245; Goodwin K, 2006, VACCINE, V24, P1159, DOI 10.1016/j.vaccine.2005.08.105; Gundem G, 2012, GENOME MED, V4, DOI 10.1186/gm327; Hagan T, 2022, BIORXIV, DOI [10.1101/2022.04.20.488939, DOI 10.1101/2022.04.20.488939]; Hagan T, 2019, CELL, V178, P1313, DOI 10.1016/j.cell.2019.08.010; Haynes WA, 2017, BIOCOMPUTING, P144, DOI 10.1142/9789813207813_0015; James Melville, 2020, Arxiv, DOI arXiv:1802.03426; Korsunsky I., BIORXIV, DOI [10.1101/653253, DOI 10.1101/653253]; Kotliarov Y, 2020, NAT MED, V26, P618, DOI 10.1038/s41591-020-0769-8; Kurupati R, 2016, ONCOTARGET, V7, P62898, DOI 10.18632/oncotarget.11704; Li J., 2009, BATCH EFFECTS NOISE, P141; Li S, 2014, NAT IMMUNOL, V15, P195, DOI 10.1038/ni.2789; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Moncunill G, 2022, ELIFE, V11, DOI [10.7554/eLife.70393, 10.7554/eLife.70393.sa1, 10.7554/eLife.70393.sa2]; Mule M. P., 2022, NAT COMMUN, V13, DOI [10.1038/s41467-022-29356-8, DOI 10.1038/S41467-022-29356-8]; Nakaya HI, 2015, IMMUNITY, V43, P1186, DOI 10.1016/j.immuni.2015.11.012; Newman AM, 2015, NAT METHODS, V12, P453, DOI [10.1038/NMETH.3337, 10.1038/nmeth.3337]; Oh JZ, 2014, IMMUNITY, V41, P478, DOI 10.1016/j.immuni.2014.08.009; Pandey S, 2020, CELL SYST, V11, P495, DOI 10.1016/j.cels.2020.10.001; Parvandeh S, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7030079; Poland GA, 2008, VACCINE, V26, pD35, DOI 10.1016/j.vaccine.2008.07.065; Qiu SH, 2018, HUM VACC IMMUNOTHER, V14, P1763, DOI 10.1080/21645515.2018.1450122; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Sergushichev AA., 2016, BIORXIV, DOI [10.1101/060012, DOI 10.1101/060012]; Shi JJ, 2014, NATURE, V514, P187, DOI 10.1038/nature13683; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Sweeney TE, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7165; Tsang JS, 2020, TRENDS IMMUNOL, V41, P457, DOI 10.1016/j.it.2020.04.001; Tsang JS, 2014, CELL, V157, P499, DOI 10.1016/j.cell.2014.03.031	42	0	0	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01329-5	http://dx.doi.org/10.1038/s41590-022-01329-5		OCT 2022	23	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5V0GW	36316476	Green Published, hybrid			2022-12-18	WOS:000876917700004
J	Lee, RD; Knutson, TP; Munro, SA; Miller, JT; Heltemes-Harris, LM; Mullighan, CG; Jepsen, K; Farrar, MA				Lee, Robin D.; Knutson, Todd P.; Munro, Sarah A.; Miller, Jeffrey T.; Heltemes-Harris, Lynn M.; Mullighan, Charles G.; Jepsen, Kristen; Farrar, Michael A.			Nuclear corepressors NCOR1/NCOR2 regulate B cell development, maintain genomic integrity and prevent transformation	NATURE IMMUNOLOGY			English	Article; Early Access							STAT5 ACTIVATION; MEDIATED RECOMBINATION; GENE-EXPRESSION; PRO-B; TRANSCRIPTION; DIFFERENTIATION; TRANSLOCATIONS; COMPLEXES; LEUKEMIA; NETWORKS	Farrar and colleagues perform an extensive analysis of Ncor1/2 function in B cell development. Loss of both genes results in defective pre-BCR signaling, increased accessibility of STAT5 chromatin motifs and inappropriate Rag gene expression, leading to accelerated leukemic transformation. The nuclear corepressors NCOR1 and NCOR2 interact with transcription factors involved in B cell development and potentially link these factors to alterations in chromatin structure and gene expression. Herein, we demonstrate that Ncor1/2 deletion limits B cell differentiation via impaired recombination, attenuates pre-BCR signaling and enhances STAT5-dependent transcription. Furthermore, NCOR1/2-deficient B cells exhibited derepression of EZH2-repressed gene modules, including the p53 pathway. These alterations resulted in aberrant Rag1 and Rag2 expression and accessibility. Whole-genome sequencing of Ncor1/2 DKO B cells identified increased number of structural variants with cryptic recombination signal sequences. Finally, deletion of Ncor1 alleles in mice facilitated leukemic transformation, whereas human leukemias with less NCOR1 correlated with worse survival. NCOR1/2 mutations in human leukemia correlated with increased RAG expression and number of structural variants. These studies illuminate how the corepressors NCOR1/2 regulate B cell differentiation and provide insights into how NCOR1/2 mutations may promote B cell transformation.	[Lee, Robin D.; Heltemes-Harris, Lynn M.; Farrar, Michael A.] Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Knutson, Todd P.; Munro, Sarah A.; Miller, Jeffrey T.] Univ Minnesota, Supercomp Inst Adv Computat Res, Minneapolis, MN USA; [Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Jepsen, Kristen] Univ Calif San Diego, Inst Genom Med, San Diego, CA 92103 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; St Jude Children's Research Hospital; University of California System; University of California San Diego	Farrar, MA (corresponding author), Univ Minnesota, Dept Lab Med & Pathol, Ctr Immunol, Masonic Canc Ctr, Minneapolis, MN 55455 USA.	farra005@umn.edu	; Mullighan, Charles/H-3253-2011	Lee, Robin/0000-0003-2998-8131; Farrar, Michael/0000-0002-5569-0366; Mullighan, Charles/0000-0002-1871-1850; Miller, Jeffrey/0000-0003-2326-1855	National Institutes of Health (NIH) [F30CA232399, T32 GM008244]; NIH [R35CA197695, R01AI124512, R01AI147540, R01CA232317]; Virginia and David Utz endowed chair in fundamental immunobiology; St Jude Children's Research Hospital Cancer Center Core Grant [CA021765]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Virginia and David Utz endowed chair in fundamental immunobiology; St Jude Children's Research Hospital Cancer Center Core Grant	We thank G. Hubbard, A. Rost and N. Keller for technical assistance and mouse husbandry; E. Stanley, J. Daniels and K. Beckman and the University of Minnesota Genomics Center for 10x Genomics single-cell capture and sequencing; J. Motl, R. Arora and P. Champoux for cell sorting and Flow Cytometry Core Facility maintenance at University of Minnesota (5P01AI035296); and S. Dehm and K. Schwertfeger (University of Minnesota) for comments on the manuscript. We thank E. Olson (UT-Southwestern), W. Ellmeier (Medical University of Vienna) and J. Auwerx (Ecole Polytechnique Federale, Lausanne, Switzerland) for providing the Ncor1<SUP>FL/FL</SUP> mice. The Minnesota Supercomputing Institute at the University of Minnesota provided bioinformatic support and resources that contributed to the research results reported within this paper. We are thankful for support from the German Gene Trap Consortium, which assisted in the generation of the Ncor2<SUP>FL/FL</SUP> mice. This work was supported by an individual predoctoral F30 fellowship from the National Institutes of Health (NIH) (F30CA232399) and a T32 training grant (T32 GM008244) to R.D.L.; St Jude Children's Research Hospital Cancer Center Core Grant CA021765 and NIH grant R35CA197695 to C.G.M.; and NIH grants R01AI124512, R01AI147540 and R01CA232317 to M.A.F. M.A.F. was supported by the Virginia and David Utz endowed chair in fundamental immunobiology.	Abdelrasoul H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-16927-w; Ba ZQ, 2020, NATURE, V586, P305, DOI 10.1038/s41586-020-2578-0; Bhaskara S, 2010, CANCER CELL, V18, P436, DOI 10.1016/j.ccr.2010.10.022; Bunis DG, 2020, BIOINFORMATICS, V36, P5535, DOI 10.1093/bioinformatics/btaa1011; Burchill MA, 2003, J IMMUNOL, V171, P5853, DOI 10.4049/jimmunol.171.11.5853; Carlson CM, 2006, NATURE, V442, P299, DOI 10.1038/nature04882; Chan LN, 2020, NATURE, V583, P845, DOI 10.1038/s41586-020-2513-4; Chikina MD, 2012, BIOINFORMATICS, V28, P607, DOI 10.1093/bioinformatics/bts009; Degner SC, 2011, P NATL ACAD SCI USA, V108, P9566, DOI 10.1073/pnas.1019391108; Fischer U, 2015, NAT GENET, V47, P1020, DOI 10.1038/ng.3362; Fornes O, 2020, NUCLEIC ACIDS RES, V48, pD87, DOI 10.1093/nar/gkz1001; Gentles AJ, 2015, NAT MED, V21, P938, DOI 10.1038/nm.3909; Goetz CA, 2004, J IMMUNOL, V172, P4770, DOI 10.4049/jimmunol.172.8.4770; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; Gu ZH, 2019, NAT GENET, V51, P296, DOI 10.1038/s41588-018-0315-5; Hafemeister C, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1874-1; Han J, 2010, J BIOL CHEM, V285, P22473, DOI 10.1074/jbc.M109.081042; Hao YH, 2021, CELL, V184, P3573, DOI 10.1016/j.cell.2021.04.048; HARDY RR, 1991, J EXP MED, V173, P1213, DOI 10.1084/jem.173.5.1213; Hart GT, 2011, P NATL ACAD SCI USA, V108, P716, DOI 10.1073/pnas.1013168108; Hatzi K, 2013, CELL REP, V4, P578, DOI 10.1016/j.celrep.2013.06.016; Heizmann B, 2013, J EXP MED, V210, P2823, DOI 10.1084/jem.20131735; Heltemes-Harris LM, 2016, ONCOGENE, V35, P3454, DOI 10.1038/onc.2015.405; Heltemes-Harris LM, 2021, ONCOGENE, V40, P6166, DOI 10.1038/s41388-021-02012-z; Heltemes-Harris LM, 2011, J EXP MED, V208, P1135, DOI 10.1084/jem.20101947; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Jacobsen JA, 2017, J IMMUNOL, V198, P4682, DOI 10.4049/jimmunol.1700319; Jepsen K, 2000, CELL, V102, P753, DOI 10.1016/S0092-8674(00)00064-7; Jepsen K, 2007, NATURE, V450, P415, DOI 10.1038/nature06270; Katerndahl CDS, 2017, NAT IMMUNOL, V18, P694, DOI 10.1038/ni.3716; Khoury A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13753-7; Layer RM, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-6-r84; Lee RD, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-27232-5; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Melchers F, 2015, J CLIN INVEST, V125, P2203, DOI 10.1172/JCI78083; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Mottis A, 2013, GENE DEV, V27, P819, DOI 10.1101/gad.214023.113; Muller L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15918-0; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Nakayama J, 2009, BLOOD, V113, P1483, DOI 10.1182/blood-2008-07-166355; Narendra V, 2015, SCIENCE, V347, P1017, DOI 10.1126/science.1262088; Ou JH, 2019, NAT METHODS, V16, P453, DOI 10.1038/s41592-019-0430-y; Papaemmanuil E, 2014, NAT GENET, V46, P116, DOI 10.1038/ng.2874; Qin Q, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-1934-6; Reddy A, 2017, CELL, V171, P481, DOI 10.1016/j.cell.2017.09.027; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Schnutgen F, 2003, NAT BIOTECHNOL, V21, P562, DOI 10.1038/nbt811; Skon CN, 2013, NAT IMMUNOL, V14, P1285, DOI 10.1038/ni.2745; Stengel KR, 2019, NUCLEIC ACIDS RES, V47, P10612, DOI 10.1093/nar/gkz816; Stuart T, 2021, NAT METHODS, V18, P1333, DOI 10.1038/s41592-021-01282-5; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swaminathan S, 2015, NAT IMMUNOL, V16, P766, DOI 10.1038/ni.3160; Teng G, 2015, CELL, V162, P751, DOI 10.1016/j.cell.2015.07.009; Tomasini R, 2002, EUR J CELL BIOL, V81, P294, DOI 10.1078/0171-9335-00248; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Waanders E, 2020, BLOOD CANCER DISCOV, V1, P96, DOI [10.1158/2643-3249.BCD-19-0041, 10.1158/0008-5472.BCD-19-0041]; Wang JR, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00931-8; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017; You SH, 2013, NAT STRUCT MOL BIOL, V20, P182, DOI 10.1038/nsmb.2476; Zhang JH, 2016, NAT GENET, V48, P1481, DOI 10.1038/ng.3691; Zhou X, 2016, NAT GENET, V48, P4, DOI 10.1038/ng.3466	66	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.												10.1038/s41590-022-01343-7	http://dx.doi.org/10.1038/s41590-022-01343-7		OCT 2022	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5V0GW	36316474				2022-12-18	WOS:000876917700001
J	Tellier, J; Nutt, SL				Tellier, Julie; Nutt, Stephen L.			The secret to longevity, plasma cell style	NATURE IMMUNOLOGY			English	Editorial Material							BONE-MARROW		[Tellier, Julie; Nutt, Stephen L.] Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia; [Tellier, Julie; Nutt, Stephen L.] Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia	Walter & Eliza Hall Institute; University of Melbourne	Nutt, SL (corresponding author), Walter & Eliza Hall Inst Med Res, Parkville, Vic, Australia.; Nutt, SL (corresponding author), Univ Melbourne, Dept Med Biol, Parkville, Vic, Australia.	nutt@wehi.edu.au	; Nutt, Stephen/C-9256-2013	Tellier, Julie/0000-0003-2787-8174; Nutt, Stephen/0000-0002-0020-6637	National Health and Medical Research Council Australia [1155342]; Cancer Council Victoria	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); Cancer Council Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria)	This work was supported by the National Health and Medical Research Council Australia (1155342 to S.L.N) and the Cancer Council Victoria Grant-in-Aid (to J.T. and S.L.N.)	Amanna IJ, 2020, CURR TOP MICROBIOL, V428, P1, DOI 10.1007/82_2018_102; Halliley JL, 2015, IMMUNITY, V43, P132, DOI 10.1016/j.immuni.2015.06.016; Higgins BW, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2121260119; Khoury DS, 2021, NAT MED, V27, P1205, DOI 10.1038/s41591-021-01377-8; Lam WY, 2018, TRENDS IMMUNOL, V39, P19, DOI 10.1016/j.it.2017.08.007; Landsverk OJB, 2017, J EXP MED, V214, P309, DOI 10.1084/jem.20161590; Lemke A, 2016, MUCOSAL IMMUNOL, V9, P83, DOI 10.1038/mi.2015.38; Liu X, 2022, NAT IMMUNOL, V23, P1564, DOI 10.1038/s41590-022-01345-5; Nguyen DC, 2021, IMMUNOL REV, V303, P138, DOI 10.1111/imr.13013; Price MJ, 2019, J IMMUNOL, V203, P2121, DOI 10.4049/jimmunol.1900285; Shi W, 2015, NAT IMMUNOL, V16, P663, DOI 10.1038/ni.3154; Tellier J, 2019, EUR J IMMUNOL, V49, P30, DOI 10.1002/eji.201847517; Tellier J, 2017, EUR J IMMUNOL, V47, P1276, DOI 10.1002/eji.201747168; Wilmore JR, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.791095; Wilmore JR, 2017, EUR J IMMUNOL, V47, P1386, DOI 10.1002/eji.201746944	15	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1507	1508		10.1038/s41590-022-01340-w	http://dx.doi.org/10.1038/s41590-022-01340-w		OCT 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36316478	Bronze			2022-12-18	WOS:000876917700003
J	Yamashita, M; Taniuchi, I				Yamashita, Motoi; Taniuchi, Ichiro			Fine-tuning Notch1 by the stage-specific enhancer	NATURE IMMUNOLOGY			English	Editorial Material							LOCUS; SEQUENCE; CELLS		[Yamashita, Motoi; Taniuchi, Ichiro] RIKEN, Lab Transcript Regulat, Ctr Integrat Med Sci IMS, Yokohama, Kanagawa, Japan	RIKEN	Taniuchi, I (corresponding author), RIKEN, Lab Transcript Regulat, Ctr Integrat Med Sci IMS, Yokohama, Kanagawa, Japan.	ichiro.taniuchi@riken.jp	Taniuchi, Ichiro/N-6399-2015	Taniuchi, Ichiro/0000-0002-9853-9068				Assumpcao ALFV, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.197319; Gomez-del Arco P, 2010, IMMUNITY, V33, P685, DOI 10.1016/j.immuni.2010.11.008; Joshi I, 2014, NAT IMMUNOL, V15, P294, DOI 10.1038/ni.2821; Kashiwagi M, 2022, NAT IMMUNOL, V23, P1628, DOI 10.1038/s41590-022-01322-y; KIDD S, 1986, MOL CELL BIOL, V6, P3094, DOI 10.1128/MCB.6.9.3094; Pui JC, 1999, IMMUNITY, V11, P299, DOI 10.1016/S1074-7613(00)80105-3; Radtke F, 1999, IMMUNITY, V10, P547, DOI 10.1016/S1074-7613(00)80054-0; Taghon T, 2006, IMMUNITY, V24, P53, DOI 10.1016/j.immuni.2005.11.012; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; WHARTON KA, 1985, CELL, V43, P567, DOI 10.1016/0092-8674(85)90229-6; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Yashiro-Ohtani Y, 2009, GENE DEV, V23, P1665, DOI 10.1101/gad.1793709	12	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1509	1511		10.1038/s41590-022-01341-9	http://dx.doi.org/10.1038/s41590-022-01341-9		OCT 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36316481				2022-12-18	WOS:000876917700002
J	Daniel, B; Yost, KE; Hsiung, SN; Sandor, K; Xia, Y; Qi, YY; Hiam-Galvez, KJ; Black, M; Raposo, CJ; Shi, QM; Meier, SL; Belk, JA; Giles, JR; Wherry, EJ; Chang, HY; Egawa, T; Satpathy, AT				Daniel, Bence; Yost, Kathryn E.; Hsiung, Sunnie; Sandor, Katalin; Xia, Yu; Qi, Yanyan; Hiam-Galvez, Kamir J.; Black, Mollie; Raposo, Colin J.; Shi, Quanming; Meier, Stefanie L.; Belk, Julia A.; Giles, Josephine R.; Wherry, E. John; Chang, Howard Y.; Egawa, Takeshi; Satpathy, Ansuman T.			Divergent clonal differentiation trajectories of T cell exhaustion	NATURE IMMUNOLOGY			English	Article							CHRONIC INFECTION; EPIGENETIC LANDSCAPE; EFFECTOR; PERSISTENCE; REVEALS; CANCER; RNA; TRANSITION; PROGENITOR; SUBSETS	Chronic antigen exposure during viral infection or cancer promotes an exhausted T cell (Tex) state with reduced effector function. However, whether all antigen-specific T cell clones follow the same Tex differentiation trajectory remains unclear. Here, we generate a single-cell multiomic atlas of T cell exhaustion in murine chronic viral infection that redefines Tex phenotypic diversity, including two late-stage Tex subsets with either a terminal exhaustion (Tex(term)) or a killer cell lectin-like receptor-expressing cytotoxic (Tex(KLR)) phenotype. We use paired single-cell RNA and T cell receptor sequencing to uncover clonal differentiation trajectories of Tex(term)-biased, Tex(KLR)-biased or divergent clones that acquire both phenotypes. We show that high T cell receptor signaling avidity correlates with Tex(term), whereas low avidity correlates with effector-like Tex(KLR) fate. Finally, we identify similar clonal differentiation trajectories in human tumor-infiltrating lymphocytes. These findings reveal clonal heterogeneity in the T cell response to chronic antigen that influences Tex fates and persistence. Daniel, Yost, Hsiung, et al. generate a single-cell multiomic atlas of T cell exhaustion in chronic viral infection, which reveals molecular programs of exhausted T cell subsets, identifies divergent clonal exhausted T cell differentiation trajectories and nominates TCR signal strength as a driver of clonal fate.	[Daniel, Bence; Sandor, Katalin; Qi, Yanyan; Hiam-Galvez, Kamir J.; Black, Mollie; Raposo, Colin J.; Shi, Quanming; Meier, Stefanie L.; Belk, Julia A.; Satpathy, Ansuman T.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Daniel, Bence; Yost, Kathryn E.; Shi, Quanming; Chang, Howard Y.] Stanford Univ, Ctr Personal Dynam Regulomes, Stanford, CA 94305 USA; [Daniel, Bence; Sandor, Katalin; Hiam-Galvez, Kamir J.; Black, Mollie; Raposo, Colin J.; Meier, Stefanie L.; Belk, Julia A.; Satpathy, Ansuman T.] Gladstone UCSF Inst Genom Immunol, San Francisco, CA 94143 USA; [Hsiung, Sunnie; Xia, Yu; Egawa, Takeshi] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA; [Meier, Stefanie L.; Satpathy, Ansuman T.] Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA; [Giles, Josephine R.; Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Giles, Josephine R.; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Giles, Josephine R.; Wherry, E. John] Univ Penn, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Satpathy, Ansuman T.] Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Washington University (WUSTL); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Howard Hughes Medical Institute; Stanford University; Stanford Cancer Institute; Stanford University	Satpathy, AT (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.; Satpathy, AT (corresponding author), Gladstone UCSF Inst Genom Immunol, San Francisco, CA 94143 USA.; Satpathy, AT (corresponding author), Parker Inst Canc Immunotherapy, San Francisco, CA 94129 USA.; Satpathy, AT (corresponding author), Stanford Univ, Stanford Canc Inst, Stanford, CA 94305 USA.	satpathy@stanford.edu		Sandor, Katalin/0000-0003-2892-4865; Belk, Julia/0000-0003-4724-6158; Daniel, Bence/0000-0002-2410-8767; Hsiung, Sunnie/0000-0002-4813-7220; Raposo, Colin/0000-0002-5230-7931; Hiam, Kamir/0000-0002-1956-0257; Meier, Stefanie/0000-0002-2709-8429	National Institutes of Health (NIH) [K08CA230188, U01CA260852, RM1-HG007735, R01AI130152, R21AI161040]; Career Award for Medical Scientists from the Burroughs Wellcome Fund; Lloyd J. Old STAR Award from the Cancer Research Institute; American Society of Hematology; Parker Institute for Cancer Immunotherapy; Pew-Stewart Scholars for Cancer Research Award; Baxter Foundation Faculty Scholar Award; Leukemia and Lymphoma Society Scholar Award; Scleroderma Research Foundation; National Science Foundation Graduate Research Fellowship Program [NSF DGE-1656518]; Stanford Graduate Fellowship; NCI Predoctoral to Postdoctoral Fellow Transition Award [NIH F99CA253729]; Stanford School of Medicine Propel Postdoctoral Scholarship; National Science Foundation Graduate Research Fellowship [DGE-1656518]; NIH training grant through the Stanford Immunology Program [5T32AI007290-38]; NIH training grant [T32CA009547]; Cancer Research Institute-Mark Foundation Fellowship [T32CA009140]; Stanford Innovative Medicines Accelerator (IMA); NIH [S10OD018220, 1S10OD021763]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Award for Medical Scientists from the Burroughs Wellcome Fund(Burroughs Wellcome Fund); Lloyd J. Old STAR Award from the Cancer Research Institute; American Society of Hematology; Parker Institute for Cancer Immunotherapy; Pew-Stewart Scholars for Cancer Research Award; Baxter Foundation Faculty Scholar Award; Leukemia and Lymphoma Society Scholar Award(Leukemia and Lymphoma Society); Scleroderma Research Foundation; National Science Foundation Graduate Research Fellowship Program(National Science Foundation (NSF)); Stanford Graduate Fellowship(Stanford University); NCI Predoctoral to Postdoctoral Fellow Transition Award; Stanford School of Medicine Propel Postdoctoral Scholarship; National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); NIH training grant through the Stanford Immunology Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research Institute-Mark Foundation Fellowship; Stanford Innovative Medicines Accelerator (IMA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the members of the Satpathy, Egawa and Chang laboratories for stimulating discussions; K. Murphy, Washington University, for providing the NFAT-GFP reporter cells; and C.-S. Hsieh, Washington University, for providing the MSCV-based retroviral plasmid MigCaRCh. This work was supported by the National Institutes of Health (NIH) K08CA230188 (A.T.S.), U01CA260852 (A.T.S.), RM1-HG007735 (H.Y.C.), R01AI130152 (T.E.), R21AI161040 (T.E.), a Career Award for Medical Scientists from the Burroughs Wellcome Fund (A.T.S.), a Technology Impact Award and a Lloyd J. Old STAR Award from the Cancer Research Institute (A.T.S.), an ASH Scholar Award from the American Society of Hematology (A.T.S.), the Parker Institute for Cancer Immunotherapy (E.J.W., H.Y.C. and A.T.S.), a Pew-Stewart Scholars for Cancer Research Award (A.T.S.), a Baxter Foundation Faculty Scholar Award, a Leukemia and Lymphoma Society Scholar Award (T.E.) and the Scleroderma Research Foundation (H.Y.C.). H.Y.C. is an investigator of the Howard Hughes Medical Institute. K.E.Y. was supported by the National Science Foundation Graduate Research Fellowship Program (NSF DGE-1656518) and a Stanford Graduate Fellowship and a NCI Predoctoral to Postdoctoral Fellow Transition Award (NIH F99CA253729). K.H.G. was supported by a Stanford School of Medicine Propel Postdoctoral Scholarship. J.A.B was supported by a Stanford Graduate Fellowship and a National Science Foundation Graduate Research Fellowship under grant number DGE-1656518. C.J.R. was funded by an NIH training grant through the Stanford Immunology Program (5T32AI007290-38). S.H. was supported by an NIH training grant (T32CA009547). J.R.G. was supported by a Cancer Research Institute-Mark Foundation Fellowship and T32CA009140. M.B. was supported by the Stanford Innovative Medicines Accelerator (IMA). The sequencing data were generated with instrumentation purchased with NIH funds: S10OD018220 and 1S10OD021763.	Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Aran D, 2019, NAT IMMUNOL, V20, P163, DOI 10.1038/s41590-018-0276-y; Belk JA, 2022, NAT IMMUNOL, V23, P848, DOI 10.1038/s41590-022-01224-z; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Blank CU, 2019, NAT REV IMMUNOL, V19, P665, DOI 10.1038/s41577-019-0221-9; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Chen Y, 2021, NAT IMMUNOL, V22, P996, DOI 10.1038/s41590-021-00965-7; Chou C, 2016, IMMUNITY, V45, P570, DOI 10.1016/j.immuni.2016.07.023; Chung HK, 2021, J EXP MED, V218, DOI 10.1084/jem.20201730; Daniels MA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00617; Evrard M, 2022, J EXP MED, V219, DOI 10.1084/jem.20210116; Good CR, 2021, CELL, V184, P6081, DOI 10.1016/j.cell.2021.11.016; Granja JM, 2021, NAT GENET, V53, P403, DOI 10.1038/s41588-021-00790-6; Hao Yuhan, 2021, Cell, V184, P3573, DOI 10.1016/j.cell.2021.04.048; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; He R, 2016, NATURE, V537, P412, DOI 10.1038/nature19317; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Ise W, 2010, NAT IMMUNOL, V11, P129, DOI 10.1038/ni.1835; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; LETOURNEUR F, 1989, EUR J IMMUNOL, V19, P2269, DOI 10.1002/eji.1830191214; Liu XD, 2019, NATURE, V567, P525, DOI 10.1038/s41586-019-0979-8; Martinez GJ, 2015, IMMUNITY, V42, P265, DOI 10.1016/j.immuni.2015.01.006; MATLOUBIAN M, 1993, J VIROL, V67, P7340, DOI 10.1128/JVI.67.12.7340-7349.1993; McGinnis CS, 2019, CELL SYST, V8, P329, DOI 10.1016/j.cels.2019.03.003; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Milner JJ, 2020, P NATL ACAD SCI USA, V117, P25667, DOI 10.1073/pnas.2008571117; Mold JE, 2021, CELL REP, V35, DOI 10.1016/j.celrep.2021.109174; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2019, CURR OPIN IMMUNOL, V58, P98, DOI 10.1016/j.coi.2019.04.014; Pliner HA, 2018, MOL CELL, V71, P858, DOI 10.1016/j.molcel.2018.06.044; Pritykin Y, 2021, MOL CELL, V81, P2477, DOI 10.1016/j.molcel.2021.03.045; Qiu XJ, 2022, CELL, V185, P690, DOI 10.1016/j.cell.2021.12.045; Raju S, 2021, J IMMUNOL, V206, P2924, DOI 10.4049/jimmunol.2001348; Sandu I, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108078; Satpathy AT, 2019, NAT BIOTECHNOL, V37, P925, DOI 10.1038/s41587-019-0206-z; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Seo H, 2019, P NATL ACAD SCI USA, V116, P12410, DOI 10.1073/pnas.1905675116; Shan Q, 2017, NAT IMMUNOL, V18, P931, DOI 10.1038/ni.3773; Song L, 2021, NAT METHODS, V18, P627, DOI 10.1038/s41592-021-01142-2; Stadtmauer EA, 2020, SCIENCE, V367, P1001, DOI 10.1126/science.aba7365; Stelekati E, 2018, CELL REP, V23, P2142, DOI 10.1016/j.celrep.2018.04.038; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Utzschneider DT, 2020, NAT IMMUNOL, V21, P1256, DOI 10.1038/s41590-020-0760-z; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; van Dijk D, 2018, CELL, V174, P716, DOI 10.1016/j.cell.2018.05.061; Wu TQ, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aai8593; Yao C, 2021, NAT IMMUNOL, V22, P370, DOI 10.1038/s41590-021-00868-7; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zheng LT, 2021, SCIENCE, V374, P1462, DOI 10.1126/science.abe6474	57	0	0	10	10	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1614	+		10.1038/s41590-022-01337-5	http://dx.doi.org/10.1038/s41590-022-01337-5		OCT 2022	35	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36289450	Green Submitted			2022-12-18	WOS:000876022900002
J	Grassmann, S; Sun, JSC				Grassmann, Simon; Sun, Joseph C.			Thanks for the NK cell memories	NATURE IMMUNOLOGY			English	Editorial Material							INNATE	Clonal expansion and immunological memory of lymphocytes provide protective immunity against repeated pathogen exposure in mammals. New technologies are enabling the investigation of these intricate processes, focusing on human natural killer cells during human cytomegalovirus infection.	[Grassmann, Simon; Sun, Joseph C.] Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA; [Sun, Joseph C.] Weill Cornell Med Coll, Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Cornell University	Sun, JSC (corresponding author), Mem Sloan Kettering Canc Ctr, Immunol Program, 1275 York Ave, New York, NY 10021 USA.; Sun, JSC (corresponding author), Weill Cornell Med Coll, Grad Sch Med Sci, Immunol & Microbial Pathogenesis Program, New York, NY 10021 USA.	sunj@mskcc.org		Sun, Joseph/0000-0001-8062-9033; Grassmann, Simon/0000-0002-8336-3418	Cancer Research Institute; Ludwig Center for Cancer Immunotherapy; American Cancer Society; Burroughs Wellcome Fund; NIH [AI100874, AI130043, AI155558]	Cancer Research Institute; Ludwig Center for Cancer Immunotherapy; American Cancer Society(American Cancer Society); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	S.G. is supported by a fellowship from the Cancer Research Institute. J.C.S. is supported by the Ludwig Center for Cancer Immunotherapy, the American Cancer Society, the Burroughs Wellcome Fund and the NIH (AI100874, AI130043 and AI155558).	Adams NM, 2020, NAT REV IMMUNOL, V20, P694, DOI 10.1038/s41577-020-0307-4; Adams NM, 2019, IMMUNITY, V50, P1381, DOI 10.1016/j.immuni.2019.04.009; Flommersfeld S, 2021, IMMUNITY, V54, P2288, DOI 10.1016/j.immuni.2021.08.002; Grassmann S, 2020, NAT IMMUNOL, V21, P1563, DOI 10.1038/s41590-020-00807-y; Grassmann S, 2019, IMMUNITY, V50, P1391, DOI 10.1016/j.immuni.2019.04.015; Hammer Q, 2018, NAT IMMUNOL, V19, P453, DOI 10.1038/s41590-018-0082-6; Jenkins MK, 2010, ANNU REV IMMUNOL, V28, P275, DOI 10.1146/annurev-immunol-030409-101253; Lau CM, 2018, NAT IMMUNOL, V19, P963, DOI 10.1038/s41590-018-0176-1; Lopez-Verg?s S., 2011, P NATL ACAD SCI USA, V108, P14725, DOI [10.1073/pnas.1110900108, DOI 10.1073/PNAS.1110900108]; Mujal AM, 2021, ANNU REV IMMUNOL, V39, P417, DOI 10.1146/annurev-immunol-101819-074948; Ruckert T, 2022, NAT IMMUNOL, V23, P1551, DOI 10.1038/s41590-022-01327-7; Wu CF, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aat9781	12	0	0	3	3	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1512	1514		10.1038/s41590-022-01336-6	http://dx.doi.org/10.1038/s41590-022-01336-6		OCT 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36289448				2022-12-18	WOS:000876022900001
J	Bedoui, S; Gebhardt, T				Bedoui, Sammy; Gebhardt, Thomas			Unappreciated complexity in T cell help for dendritic cells	NATURE IMMUNOLOGY			English	Editorial Material								CD40 has long been known as a co-stimulatory molecule involved in T cell help for dendritic cells, and thereby as a contributor to CD8(+) T cell immunity against cancers and infections. However, CD40 signaling drives complex functional responses that can contribute to tumor-specific CD8(+) T cell responses in unexpected ways.	[Bedoui, Sammy; Gebhardt, Thomas] Univ Melbourne, Dept Microbiol & Immunol, Doherty Inst Infect & Immun, Melbourne, Vic, Australia	University of Melbourne	Bedoui, S (corresponding author), Univ Melbourne, Dept Microbiol & Immunol, Doherty Inst Infect & Immun, Melbourne, Vic, Australia.	sbedoui@unimelb.edu.au						Ahrends T, 2017, IMMUNITY, V47, P848, DOI 10.1016/j.immuni.2017.10.009; Ardouin L, 2016, IMMUNITY, V45, P305, DOI 10.1016/j.immuni.2016.07.019; Bedoui S, 2016, IMMUNOL REV, V272, P52, DOI 10.1111/imr.12426; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Busselaar J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.592569; Ferris ST, 2020, NATURE, V584, P624, DOI 10.1038/s41586-020-2611-3; Roberts EW, 2016, CANCER CELL, V30, P324, DOI 10.1016/j.ccell.2016.06.003; Wu R, 2022, NAT IMMUNOL, V23, P1536, DOI 10.1038/s41590-022-01324-w	8	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1515	1516		10.1038/s41590-022-01335-7	http://dx.doi.org/10.1038/s41590-022-01335-7		OCT 2022	2	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36271150				2022-12-18	WOS:000870950100003
J	Giles, JR; Ngiow, SF; Manne, S; Baxter, AE; Khan, O; Wang, P; Staupe, R; Abdel-Hakeem, MS; Huang, H; Mathew, D; Painter, MM; Wu, JE; Huang, YJ; Goel, RR; Yan, PK; Karakousis, GC; Xu, XW; Mitchell, TC; Huang, AC; Wherry, EJ				Giles, Josephine R.; Ngiow, Shin Foong; Manne, Sasikanth; Baxter, Amy E.; Khan, Omar; Wang, Ping; Staupe, Ryan; Abdel-Hakeem, Mohamed S.; Huang, Hua; Mathew, Divij; Painter, Mark M.; Wu, Jennifer E.; Huang, Yinghui Jane; Goel, Rishi R.; Yan, Patrick K.; Karakousis, Giorgos C.; Xu, Xiaowei; Mitchell, Tara C.; Huang, Alexander C.; Wherry, E. John			Shared and distinct biological circuits in effector, memory and exhausted CD8(+) T cells revealed by temporal single-cell transcriptomics and epigenetics	NATURE IMMUNOLOGY			English	Article							TERMINAL DIFFERENTIATION; CHRONIC INFECTION; SELF-RENEWAL; EXPRESSION; ZEB2; QUIESCENCE; RECEPTORS; LANDSCAPE; COOPERATE; PROGRAMS	Naive CD8(+) T cells can differentiate into effector (T-eff), memory (T-mem) or exhausted (T-ex) T cells. These developmental pathways are associated with distinct transcriptional and epigenetic changes that endow cells with different functional capacities and therefore therapeutic potential. The molecular circuitry underlying these developmental trajectories and the extent of heterogeneity within T-eff, T-mem and T-ex populations remain poorly understood. Here, we used the lymphocytic choriomeningitis virus model of acute-resolving and chronic infection to address these gaps by applying longitudinal single-cell RNA-sequencing (scRNA-seq) and single-cell assay for transposase-accessible chromatin sequencing (scATAC-seq) analyses. These analyses uncovered new subsets, including a subpopulation of T-ex cells expressing natural killer cell-associated genes that is dependent on the transcription factor Zeb2, as well as multiple distinct TCF-1(+) stem/progenitor-like subsets in acute and chronic infection. These data also revealed insights into the reshaping of T-ex subsets following programmed death 1 (PD-1) pathway blockade and identified a key role for the cell stress regulator, Btg1, in establishing the T-ex population. Finally, these results highlighted how the same biological circuits such as cytotoxicity or stem/progenitor pathways can be used by CD8(+) T cell subsets with highly divergent underlying chromatin landscapes generated during different infections. Wherry and colleagues provide a comparative analysis of paired single-cell RNA-sequencing and single-cell assay for transposase-accessible chromatin sequencing profiles of CD8(+) T cells in acute and chronic lymphocytic choriomeningitis virus infections, identifying new features about T-ex cell subsets and epigenetic differences from acutely infected precursors seen at early time points in infection.	[Giles, Josephine R.; Ngiow, Shin Foong; Manne, Sasikanth; Baxter, Amy E.; Khan, Omar; Wang, Ping; Staupe, Ryan; Abdel-Hakeem, Mohamed S.; Huang, Hua; Mathew, Divij; Painter, Mark M.; Wu, Jennifer E.; Huang, Yinghui Jane; Goel, Rishi R.; Yan, Patrick K.; Wherry, E. John] Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [Giles, Josephine R.; Ngiow, Shin Foong; Manne, Sasikanth; Baxter, Amy E.; Khan, Omar; Wang, Ping; Abdel-Hakeem, Mohamed S.; Huang, Hua; Mathew, Divij; Painter, Mark M.; Wu, Jennifer E.; Huang, Yinghui Jane; Goel, Rishi R.; Huang, Alexander C.; Wherry, E. John] Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA; [Giles, Josephine R.; Ngiow, Shin Foong; Wu, Jennifer E.; Huang, Alexander C.; Wherry, E. John] Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA; [Wang, Ping; Huang, Alexander C.] Univ Penn, Dept Canc Biol, Philadelphia, PA 19104 USA; [Huang, Hua] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Karakousis, Giorgos C.; Xu, Xiaowei] Univ Penn, Dept Surg, Philadelphia, PA 19104 USA; [Mitchell, Tara C.] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA USA; [Huang, Alexander C.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA; [Staupe, Ryan] Merck & Co Inc, MRL, Infect Dis & Vaccines, West Point, PA USA; [Abdel-Hakeem, Mohamed S.] Emory Univ, Sch Med, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Yan, Patrick K.] Stanford Univ, Immunol Grad Program, Stanford, CA 94305 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Merck & Company; Emory University; Stanford University	Wherry, EJ (corresponding author), Univ Penn, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Inst Immunol, Philadelphia, PA 19104 USA.; Wherry, EJ (corresponding author), Univ Penn, Perelman Sch Med, Parker Inst Canc Immunotherapy, Philadelphia, PA 19104 USA.	wherry@pennmedicine.upenn.edu		Abdel Hakeem, Mohamed/0000-0003-0226-3464; Baxter, Amy/0000-0002-1555-0713; Khan, Omar/0000-0002-7641-6163	Cancer Research Institute-Mark Foundation Fellowship [T32 CA009140]; Parker Institute for Cancer Immunotherapy and Stand Up to Cancer; National Institutes of Health (NIH) [AI155577, AI149680, AI108545, AI082630, DK127768, CA210944]; Parker Institute for Cancer Immunotherapy; Australia NHMRC C.J. Martin Fellowship [GNT1111469]; Mark Foundation Momentum Fellowship; NIAID F30 fellowship [F30AI129263]; American Association of Immunologists Intersect Fellowship Program for Computational Scientists and Immunologists; PICI Scholar award; National Science Foundation graduate research fellowship; NIH [K08-CA230157]; Damon Runyon Clinical Investigator Award; Doris Duke Clinical Scientist Development Award; W. W. Smith Charitable Trust Award; Tara Miller Foundation [P50 CA174523]; SPORE grant;  [P50CA261608]	Cancer Research Institute-Mark Foundation Fellowship; Parker Institute for Cancer Immunotherapy and Stand Up to Cancer; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker Institute for Cancer Immunotherapy; Australia NHMRC C.J. Martin Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Mark Foundation Momentum Fellowship; NIAID F30 fellowship; American Association of Immunologists Intersect Fellowship Program for Computational Scientists and Immunologists; PICI Scholar award; National Science Foundation graduate research fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Clinical Investigator Award; Doris Duke Clinical Scientist Development Award(Doris Duke Charitable Foundation (DDCF)); W. W. Smith Charitable Trust Award; Tara Miller Foundation; SPORE grant; 	We thank members of the laboratory of E.J.W. This work was supported by T32 CA009140 and a Cancer Research Institute-Mark Foundation Fellowship (to J.G.), by the Parker Institute for Cancer Immunotherapy and Stand Up to Cancer and National Institutes of Health (NIH) grants AI155577, AI149680, AI108545, AI082630, DK127768 and CA210944 (to E.J.W.). Work in the Wherry laboratory is supported by the Parker Institute for Cancer Immunotherapy. S.F.N. was supported by an Australia NHMRC C.J. Martin Fellowship (GNT1111469) and the Mark Foundation Momentum Fellowship. O.K. was supported by an NIAID F30 fellowship (F30AI129263). D.M. was supported through The American Association of Immunologists Intersect Fellowship Program for Computational Scientists and Immunologists. J.E.W. was supported by a PICI Scholar award. Y.J.H. was supported by a National Science Foundation graduate research fellowship. A.C.H. was supported by NIH grant K08-CA230157, the Damon Runyon Clinical Investigator Award, Doris Duke Clinical Scientist Development Award, W. W. Smith Charitable Trust Award, the Tara Miller Foundation and P50 CA174523. The melanoma clinical trial was supported by SPORE grant P50CA261608.	Abdel-Hakeem MS, 2021, NAT IMMUNOL, V22, P1008, DOI 10.1038/s41590-021-00975-5; Alfei F, 2019, NATURE, V571, P265, DOI 10.1038/s41586-019-1326-9; Angelosanto JM, 2012, J VIROL, V86, P8161, DOI 10.1128/JVI.00889-12; Araki K, 2017, NAT IMMUNOL, V18, P1046, DOI 10.1038/ni.3795; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Blackburn SD, 2008, P NATL ACAD SCI USA, V105, P15016, DOI 10.1073/pnas.0801497105; Chen ZY, 2021, CELL, V184, P1262, DOI 10.1016/j.cell.2021.02.019; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Chung HK, 2021, J EXP MED, V218, DOI 10.1084/jem.20201730; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Dominguez CX, 2015, J EXP MED, V212, P2041, DOI 10.1084/jem.20150186; Fellmann C, 2013, CELL REP, V5, P1704, DOI 10.1016/j.celrep.2013.11.020; Giles JR, 2022, IMMUNITY, V55, P557, DOI 10.1016/j.immuni.2022.02.004; Good CR, 2021, CELL, V184, P6081, DOI 10.1016/j.cell.2021.11.016; Guan TX, 2018, J EXP MED, V215, P1153, DOI 10.1084/jem.20171352; Huang AC, 2019, NAT MED, V25, P454, DOI 10.1038/s41591-019-0357-y; Huang C, 2010, J GENET GENOMICS, V37, P441, DOI 10.1016/S1673-8527(09)60063-1; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Khan O, 2019, NATURE, V571, P211, DOI 10.1038/s41586-019-1325-x; Krishna S, 2020, SCIENCE, V370, P1328, DOI 10.1126/science.abb9847; Kurachi M, 2017, NAT PROTOC, V12, P1980, DOI 10.1038/nprot.2017.083; Lane N, 2010, NATURE, V467, P929, DOI 10.1038/nature09486; Martin MD, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02692; Masopust D, 2019, ANNU REV IMMUNOL, V37, P521, DOI 10.1146/annurev-immunol-042617-053214; Mathewson ND, 2021, CELL, V184, P1281, DOI 10.1016/j.cell.2021.01.022; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; McMahon CW, 2001, CURR OPIN IMMUNOL, V13, P465, DOI 10.1016/S0952-7915(00)00242-9; McMahon CW, 2002, J IMMUNOL, V169, P1444, DOI 10.4049/jimmunol.169.3.1444; Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993; Nussing S, 2020, J IMMUNOL, V204, P2308, DOI 10.4049/jimmunol.1901396; Odorizzi PM, 2015, J EXP MED, V212, P1125, DOI 10.1084/jem.20142237; Omilusik KD, 2015, J EXP MED, V212, P2027, DOI 10.1084/jem.20150194; Paley MA, 2012, SCIENCE, V338, P1220, DOI 10.1126/science.1229620; Pauken KE, 2016, SCIENCE, V354, P1160, DOI 10.1126/science.aaf2807; Philip M, 2017, NATURE, V545, P452, DOI 10.1038/nature22367; Raulet DH, 2017, IMMUNOL REV, V280, P93, DOI 10.1111/imr.12600; Scott AC, 2019, NATURE, V571, P270, DOI 10.1038/s41586-019-1324-y; Sen DR, 2016, SCIENCE, V354, P1165, DOI 10.1126/science.aae0491; Shin H, 2007, J EXP MED, V204, P941, DOI 10.1084/jem.20061937; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; van Montfoort N, 2018, CELL, V175, P1744, DOI 10.1016/j.cell.2018.10.028; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Wherry EJ, 2003, NAT IMMUNOL, V4, P225, DOI 10.1038/ni889; Wherry EJ, 2004, P NATL ACAD SCI USA, V101, P16004, DOI 10.1073/pnas.0407192101; Will B, 2013, NAT IMMUNOL, V14, P437, DOI 10.1038/ni.2572; Yao C, 2021, NAT IMMUNOL, V22, P370, DOI 10.1038/s41590-021-00868-7; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4; Yates KB, 2021, NAT IMMUNOL, V22, P1020, DOI 10.1038/s41590-021-00979-1; Yoshida H, 2019, CELL, V176, P897, DOI 10.1016/j.cell.2018.12.036; Yuniati L, 2019, J CELL PHYSIOL, V234, P5379, DOI 10.1002/jcp.27407; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zheng LT, 2021, SCIENCE, V374, P1462, DOI 10.1126/science.abe6474	55	0	0	8	8	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1600	+		10.1038/s41590-022-01338-4	http://dx.doi.org/10.1038/s41590-022-01338-4		OCT 2022	31	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36271148				2022-12-18	WOS:000870950100005
J	Knizkova, D; Pribikova, M; Draberova, H; Semberova, T; Trivic, T; Synackova, A; Ujevic, A; Stefanovic, J; Drobek, A; Huranova, M; Niederlova, V; Tsyklauri, O; Neuwirth, A; Tureckova, J; Stepanek, O; Draber, P				Knizkova, Daniela; Pribikova, Michaela; Draberova, Helena; Semberova, Tereza; Trivic, Tijana; Synackova, Alzbeta; Ujevic, Andrea; Stefanovic, Jana; Drobek, Ales; Huranova, Martina; Niederlova, Veronika; Tsyklauri, Oksana; Neuwirth, Ales; Tureckova, Jolana; Stepanek, Ondrej; Draber, Peter			CMTM4 is a subunit of the IL-17 receptor and mediates autoimmune pathology	NATURE IMMUNOLOGY			English	Article							T-CELLS; SKIN INFLAMMATION; ACT1; PSORIASIS; CYTOKINE; PROTEIN; PD-L1; QUANTIFICATION; IDENTIFICATION; EXPRESSION	Draber and colleagues show that the tetra-transmembrane protein CMTM4 is a subunit of the IL-17 receptor. Interleukin-17A (IL-17A) is a key mediator of protective immunity to yeast and bacterial infections but also drives the pathogenesis of several autoimmune diseases, such as psoriasis or psoriatic arthritis. Here we show that the tetra-transmembrane protein CMTM4 is a subunit of the IL-17 receptor (IL-17R). CMTM4 constitutively associated with IL-17R subunit C to mediate its stability, glycosylation and plasma membrane localization. Both mouse and human cell lines deficient in CMTM4 were largely unresponsive to IL-17A, due to their inability to assemble the IL-17R signaling complex. Accordingly, CMTM4-deficient mice had a severe defect in the recruitment of immune cells following IL-17A administration and were largely resistant to experimental psoriasis, but not to experimental autoimmune encephalomyelitis. Collectively, our data identified CMTM4 as an essential component of IL-17R and a potential therapeutic target for treating IL-17-mediated autoimmune diseases.	[Knizkova, Daniela; Pribikova, Michaela; Draberova, Helena; Semberova, Tereza; Trivic, Tijana; Synackova, Alzbeta; Ujevic, Andrea; Stefanovic, Jana; Draber, Peter] Charles Univ Prague, Fac Med 1, BIOCEV, Lab Immun & Cell Commun, Vestec, Czech Republic; [Knizkova, Daniela; Drobek, Ales; Huranova, Martina; Niederlova, Veronika; Tsyklauri, Oksana; Neuwirth, Ales; Stepanek, Ondrej; Draber, Peter] Czech Acad Sci, Inst Mol Genet, Lab Adapt Immun, Prague, Czech Republic; [Tureckova, Jolana] Czech Acad Sci, Inst Mol Genet, Czech Ctr Phenogen, Vestec, Czech Republic; [Tureckova, Jolana] Czech Acad Sci, Inst Mol Genet, Lab Transgen Models Dis, Vestec, Czech Republic	Charles University Prague; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Draber, P (corresponding author), Charles Univ Prague, Fac Med 1, BIOCEV, Lab Immun & Cell Commun, Vestec, Czech Republic.; Stepanek, O; Draber, P (corresponding author), Czech Acad Sci, Inst Mol Genet, Lab Adapt Immun, Prague, Czech Republic.	ondrej.stepanek@img.cas.cz; peter.draber@lf1.cuni.cz	Niederlova, Veronika/HGA-7771-2022; Draber, Peter/G-3141-2014	Synackova, Alzbeta/0000-0002-6854-4405; Trivic, Tijana/0000-0003-2566-253X; Draber, Peter/0000-0001-8658-4614	Czech Science Foundation [20-24912Y]; EMBO Installation [4420]; Charles University [UNCE/MED/016]; European Union [802878]; ERC; Institute of Molecular Genetics of the Czech Academy of Sciences, Czech Republic (IMG ASCR) [RVO 68378050]; National Institute for Cancer Research [LX22NPO5102, LX22NPO5103]; European Union-Next Generation EU; SVV [260521]; Ministry of Education, Youth and Sports of the Czech Republic (MEYS); ASCR; MEYS [LM2018129, CZ.02.1.01/0.0/0.0/18_046/0016045]	Czech Science Foundation(Grant Agency of the Czech Republic); EMBO Installation(European Molecular Biology Organization (EMBO)); Charles University; European Union(European Commission); ERC(European Research Council (ERC)European Commission); Institute of Molecular Genetics of the Czech Academy of Sciences, Czech Republic (IMG ASCR); National Institute for Cancer Research; European Union-Next Generation EU; SVV; Ministry of Education, Youth and Sports of the Czech Republic (MEYS)(Ministry of Education, Youth & Sports - Czech Republic); ASCR(Czech Academy of Sciences); MEYS	We thank L. Cupak for technical assistance. We thank K. Harant and P. Talacko from the Laboratory of Mass Spectrometry, Biocev, Charles University, Faculty of Science, where proteomics and mass spectrometric analysis had been done. This project was supported by the Czech Science Foundation (grant no. 20-24912Y to P.D.), EMBO Installation (grant no. 4420 to P.D.), Charles University (grant no. PRIMUS/20/MED/003 to P.D.) and the European Union (Horizon 2020 research and innovation program under grant agreement no. 802878, ERC Starting Grant FunDiT to O.S.). We acknowledge Charles University institutional funding (Cooperatio and UNCE/MED/016), core funding of the Institute of Molecular Genetics of the Czech Academy of Sciences, Czech Republic (IMG ASCR) (RVO 68378050), the project National Institute for Cancer Research (Programme EXCELES, LX22NPO5102) and the project National Institute of virology and bacteriology (Programme EXCELES, LX22NPO5103)-both funded by the European Union-Next Generation EU and grant no. SVV 260521 provided by the Ministry of Education, Youth and Sports of the Czech Republic (MEYS). The animal housing and Cmtm4<SUP>-/-</SUP> line rederivation and histology analysis were performed in the Czech Centre for Phenogenomics at IMG, ASCR supported by MEYS (LM2018126). We acknowledge the Light Microscopy Core Facility, IMG ASCR, supported by MEYS (LM2018129, CZ.02.1.01/0.0/0.0/18_046/0016045), for their help with the microscopy.	Birling MC, 2021, NAT GENET, V53, P416, DOI 10.1038/s41588-021-00825-y; Boisson B, 2013, IMMUNITY, V39, P676, DOI 10.1016/j.immuni.2013.09.002; Burr ML, 2017, NATURE, V549, P101, DOI 10.1038/nature23643; Carroll MC, 2004, NAT IMMUNOL, V5, P981, DOI 10.1038/ni1113; Chang SH, 2006, J BIOL CHEM, V281, P35603, DOI 10.1074/jbc.C600256200; Cox J, 2014, MOL CELL PROTEOMICS, V13, P2513, DOI 10.1074/mcp.M113.031591; Cua DJ, 2010, NAT REV IMMUNOL, V10, P479, DOI 10.1038/nri2800; Dai XM, 2021, MOL CELL, V81, P2317, DOI 10.1016/j.molcel.2021.03.037; Draberova H, 2020, EMBO J, V39, DOI 10.15252/embj.2019104202; El Malki K, 2013, J INVEST DERMATOL, V133, P441, DOI 10.1038/jid.2012.318; Goepfert A, 2020, IMMUNITY, V52, P499, DOI 10.1016/j.immuni.2020.02.004; Haak S, 2009, J CLIN INVEST, V119, P61, DOI 10.1172/JCI35997; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; He S, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-02210-0; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hofstetter HH, 2005, CELL IMMUNOL, V237, P123, DOI 10.1016/j.cellimm.2005.11.002; Hruz Tomas, 2008, Advances in Bioinformatics, V2008, P420747, DOI 10.1155/2008/420747; Hu Y, 2010, J IMMUNOL, V184, P4307, DOI 10.4049/jimmunol.0903614; Huang XD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132802; Komiyama Y, 2006, J IMMUNOL, V177, P566, DOI 10.4049/jimmunol.177.1.566; Kuestner RE, 2007, J IMMUNOL, V179, P5462, DOI 10.4049/jimmunol.179.8.5462; Labun K, 2019, NUCLEIC ACIDS RES, V47, pW171, DOI 10.1093/nar/gkz365; Levy R, 2016, P NATL ACAD SCI USA, V113, pE8277, DOI 10.1073/pnas.1618300114; Li BS, 2014, J INVEST DERMATOL, V134, P1828, DOI 10.1038/jid.2014.28; Li XX, 2019, NAT IMMUNOL, V20, P1594, DOI 10.1038/s41590-019-0514-y; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Ling Y, 2015, J EXP MED, V212, P619, DOI 10.1084/jem.20141065; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Matsumoto R, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.121175; McGeachy MJ, 2019, IMMUNITY, V50, P892, DOI 10.1016/j.immuni.2019.03.021; Mezzadra R, 2017, NATURE, V549, P106, DOI 10.1038/nature23669; Moos S, 2019, J INVEST DERMATOL, V139, P1110, DOI 10.1016/j.jid.2019.01.006; Moudra A, 2021, J IMMUNOL, V206, P2109, DOI 10.4049/jimmunol.2001028; Park H, 2005, NAT IMMUNOL, V6, P1133, DOI 10.1038/ni1261; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Puel A, 2011, SCIENCE, V332, P65, DOI 10.1126/science.1200439; Qian YC, 2007, NAT IMMUNOL, V8, P247, DOI 10.1038/ni1439; Qu FF, 2012, MOL CELL BIOL, V32, P3925, DOI 10.1128/MCB.00268-12; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Regen T, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.aaz6563; Schwandner R, 2000, J EXP MED, V191, P1233, DOI 10.1084/jem.191.7.1233; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sole-Boldo L, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-0922-4; Stanley P, 2016, J MOL BIOL, V428, P3166, DOI 10.1016/j.jmb.2016.03.025; Stanley Pamela, 2011, Cold Spring Harb Perspect Biol, V3, DOI 10.1101/cshperspect.a005199; Stuart T, 2019, CELL, V177, P1888, DOI 10.1016/j.cell.2019.05.031; Su Y, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9657; Toy D, 2006, J IMMUNOL, V177, P36, DOI 10.4049/jimmunol.177.1.36; Tsoi LC, 2019, J INVEST DERMATOL, V139, P1480, DOI 10.1016/j.jid.2018.12.018; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/NMETH.3901, 10.1038/nmeth.3901]; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; Witowski J, 2000, J IMMUNOL, V165, P5814, DOI 10.4049/jimmunol.165.10.5814; Wright JF, 2008, J IMMUNOL, V181, P2799, DOI 10.4049/jimmunol.181.4.2799; Yao ZB, 1995, IMMUNITY, V3, P811, DOI 10.1016/1074-7613(95)90070-5; Zhao JJ, 2020, J EXP MED, V217, DOI 10.1084/jem.20190297	56	0	0	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1644	+		10.1038/s41590-022-01325-9	http://dx.doi.org/10.1038/s41590-022-01325-9		OCT 2022	28	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36271145	hybrid, Green Published			2022-12-18	WOS:000870950100006
J	Ni, XH; Xu, Y; Wang, W; Kong, BD; Ouyang, J; Chen, JW; Yan, M; Wu, YW; Chen, Q; Wang, XX; Li, HQ; Gao, XG; Guo, HQ; Cui, L; Chen, ZY; Shi, YL; Zhu, RH; Li, W; Shi, TL; Wang, LF; Huang, JL; Dong, C; Lai, YP				Ni, Xinhui; Xu, Yi; Wang, Wang; Kong, Baida; Ouyang, Jian; Chen, Jiwei; Yan, Man; Wu, Yawei; Chen, Qi; Wang, Xinxin; Li, Hongquan; Gao, Xiaoguang; Guo, Hongquan; Cui, Lian; Chen, Zeyu; Shi, Yuling; Zhu, Ronghui; Li, Wei; Shi, Tieliu; Wang, Lin-Fa; Huang, Jinling; Dong, Chen; Lai, Yuping			IL-17D-induced inhibition of DDX5 expression in keratinocytes amplifies IL-36R-mediated skin inflammation	NATURE IMMUNOLOGY			English	Article							ATOPIC-DERMATITIS; IL-17 FAMILY; PIVOTAL ROLE; PSORIASIS; RESPONSES; INSIGHTS; HEALTH; CELLS; SITE	Aberrant RNA splicing in keratinocytes drives inflammatory skin disorders. In the present study, we found that the RNA helicase DDX5 was downregulated in keratinocytes from the inflammatory skin lesions in patients with atopic dermatitis and psoriasis, and that mice with keratinocyte-specific deletion of Ddx5 (Ddx5( increment KC)) were more susceptible to cutaneous inflammation. Inhibition of DDX5 expression in keratinocytes was induced by the cytokine interleukin (IL)-17D through activation of the CD93-p38 MAPK-AKT-SMAD2/3 signaling pathway and led to pre-messenger RNA splicing events that favored the production of membrane-bound, intact IL-36 receptor (IL-36R) at the expense of soluble IL-36R (sIL-36R) and to the selective amplification of IL-36R-mediated inflammatory responses and cutaneous inflammation. Restoration of sIL-36R in Ddx5( increment KC) mice with experimental atopic dermatitis or psoriasis suppressed skin inflammation and alleviated the disease phenotypes. These findings indicate that IL-17D modulation of DDX5 expression controls inflammation in keratinocytes during inflammatory skin diseases. Lai and colleagues show that the RNA helicase DDX5 mediates the alternative splicing of the IL-36R mRNA in keratinocytes and modulates skin inflammation downstream of IL-17D signaling.	[Ni, Xinhui; Xu, Yi; Wang, Wang; Kong, Baida; Ouyang, Jian; Chen, Jiwei; Yan, Man; Wu, Yawei; Chen, Qi; Wang, Xinxin; Li, Hongquan; Gao, Xiaoguang; Guo, Hongquan; Shi, Tieliu; Lai, Yuping] East China Normal Univ, Shanghai Frontiers Sci Ctr Genome Editing & Cell, Shanghai Key Lab Regulatory Biol, Sch Life Sci, Shanghai, Peoples R China; [Cui, Lian; Chen, Zeyu; Shi, Yuling] Tongji Univ, Sch Med, Shanghai Peoples Hosp 10, Dept Dermatol, Shanghai, Peoples R China; [Shi, Yuling] Tongji Univ, Sch Med, Shanghai Skin Dis Hosp, Shanghai, Peoples R China; [Zhu, Ronghui; Li, Wei] Fudan Univ, Huashan Hosp, Dept Dermatol, Shanghai, Peoples R China; [Wang, Lin-Fa] Duke NUS Grad Med Sch, Emerging Infect Dis Program, Singapore, Singapore; [Wang, Lin-Fa] Singhlth Duke NUS Global Hlth Inst, Singapore, Singapore; [Huang, Jinling; Dong, Chen] Tsinghua Univ, Inst Immunol, Beijing, Peoples R China; [Huang, Jinling; Dong, Chen] Tsinghua Univ, Sch Med, Beijing, Peoples R China; [Dong, Chen] Shanghai Jiao Tong Univ, Sch Med, Affiliated Renji Hosp, Shanghai Immune Therapy Inst, Shanghai, Peoples R China	East China Normal University; Tongji University; Tongji University; Fudan University; National University of Singapore; Tsinghua University; Tsinghua University; Shanghai Jiao Tong University	Lai, YP (corresponding author), East China Normal Univ, Shanghai Frontiers Sci Ctr Genome Editing & Cell, Shanghai Key Lab Regulatory Biol, Sch Life Sci, Shanghai, Peoples R China.	yplai@bio.ecnu.edu.cn	dong, chen/B-3181-2009	dong, chen/0000-0002-0084-9130; Ouyang, Jian/0000-0002-7851-7064	National Natural Science Foundation of China [82071785, 31670925]; National Key Research and Development Program of China [2016YFC0906200/2016YFC0906202]; ECNU Multifunctional Platform for Innovation; Innovation Program of Shanghai Municipal Education Commission [no.2019-01-07-00-07-E00046]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; ECNU Multifunctional Platform for Innovation; Innovation Program of Shanghai Municipal Education Commission(Innovation Program of Shanghai Municipal Education Commission)	This work is supported by the National Natural Science Foundation of China (grant nos. 82071785 and 31670925 to Y.L.), the National Key Research and Development Program of China (grant no. 2016YFC0906200/2016YFC0906202 to Y.L.), the ECNU Multifunctional Platform for Innovation (011) and the Innovation Program of Shanghai Municipal Education Commission (grant no.2019-01-07-00-07-E00046 to Y.S.). We thank C. Xu from Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences and Y. Zhang from University of California, San Diego for critical reading and helpful suggestions.	Bantz Selene K, 2014, J Clin Cell Immunol, V5; Bassoy EY, 2018, IMMUNOL REV, V281, P169, DOI 10.1111/imr.12610; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Chung SH, 2021, INT IMMUNOL, V33, P723, DOI 10.1093/intimm/dxab075; Frankiw L, 2019, NAT REV IMMUNOL, V19, P675, DOI 10.1038/s41577-019-0195-7; Fuller-Pace FV, 2013, RNA BIOL, V10, P121, DOI 10.4161/rna.23312; Geuens T, 2016, HUM GENET, V135, P851, DOI 10.1007/s00439-016-1683-5; Ghoreschi K, 2003, NAT MED, V9, P40, DOI 10.1038/nm804; Graveley BR, 1998, EMBO J, V17, P6747, DOI 10.1093/emboj/17.22.6747; Gros E, 2009, J ALLERGY CLIN IMMUN, V124, P753, DOI 10.1016/j.jaci.2009.07.004; Guttman-Yassky E, 2017, CURR OPIN IMMUNOL, V48, P68, DOI 10.1016/j.coi.2017.08.008; Guttman-Yassky E, 2011, J ALLERGY CLIN IMMUN, V127, P1110, DOI 10.1016/j.jaci.2011.01.053; Han JH, 2011, MOL CELL BIOL, V31, P793, DOI 10.1128/MCB.01117-10; Han Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15649-3; Hashemi V, 2019, J CELL PHYSIOL, V234, P5478, DOI 10.1002/jcp.26912; Hawkes JE, 2018, J IMMUNOL, V201, P1605, DOI 10.4049/jimmunol.1800013; Huang JL, 2021, IMMUNITY, V54, P673, DOI 10.1016/j.immuni.2021.03.018; Hvid M, 2011, J INVEST DERMATOL, V131, P150, DOI 10.1038/jid.2010.277; Jiang ZW, 2017, J INVEST DERMATOL, V137, P2620, DOI 10.1016/j.jid.2017.07.820; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; KRAINER AR, 1990, CELL, V62, P35, DOI 10.1016/0092-8674(90)90237-9; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Langan SM, 2020, LANCET, V396, P345, DOI 10.1016/S0140-6736(20)31286-1; Lee Y, 2015, ANNU REV BIOCHEM, V84, P291, DOI 10.1146/annurev-biochem-060614-034316; Lee YJ, 2018, GENE DEV, V32, P1060, DOI 10.1101/gad.316034.118; Lee YH, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01172; Legrand JMD, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09972-7; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li J, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22284-y; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Ma J, 2019, NUCLEIC ACIDS RES, V47, pD1211, DOI 10.1093/nar/gky869; Marrakchi S, 2011, NEW ENGL J MED, V365, P620, DOI 10.1056/NEJMoa1013068; McGeachy MJ, 2019, IMMUNITY, V50, P892, DOI 10.1016/j.immuni.2019.03.021; Montes M, 2019, TRENDS GENET, V35, P68, DOI 10.1016/j.tig.2018.10.002; Ni XH, 2020, J LEUKOCYTE BIOL, V108, P485, DOI 10.1002/JLB.5MR0120-439R; Noda S, 2015, J ALLERGY CLIN IMMUN, V136, P1254, DOI 10.1016/j.jaci.2015.08.015; O'Sullivan T, 2014, CELL REP, V7, P989, DOI 10.1016/j.celrep.2014.03.073; Patrick GJ, 2021, J CLIN INVEST, V131, DOI 10.1172/JCI143334; Reynolds G, 2021, SCIENCE, V371, P364, DOI 10.1126/science.aba6500; Sachen KL, 2022, CYTOKINE, V156, DOI 10.1016/j.cyto.2022.155897; Schaub A, 2017, INT IMMUNOL, V29, P173, DOI 10.1093/intimm/dxx026; Schwingen J, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21030699; Shao S, 2021, J INVEST DERMATOL, V141, P2436, DOI 10.1016/j.jid.2021.03.019; Shen SH, 2014, P NATL ACAD SCI USA, V111, pE5593, DOI 10.1073/pnas.1419161111; Spena S, 2006, RNA, V12, P948, DOI 10.1261/rna.2269306; Starnes T, 2002, J IMMUNOL, V169, P642, DOI 10.4049/jimmunol.169.2.642; Su Y, 2019, SCI IMMUNOL, V4, DOI 10.1126/sciimmunol.aau9657; Tortola L, 2012, J CLIN INVEST, V122, P3965, DOI 10.1172/JCI63451; Tsang MSM, 2020, CURR ALLERGY ASTHM R, V20, DOI 10.1007/s11882-020-00937-1; Tsoi LC, 2019, J INVEST DERMATOL, V139, P1480, DOI 10.1016/j.jid.2018.12.018; Valcarcel J, 1996, TRENDS BIOCHEM SCI, V21, P296, DOI 10.1016/0968-0004(96)10039-6; Wu TZ, 2021, INNOVATION-AMSTERDAM, V2, DOI 10.1016/j.xinn.2021.100141; Xing XY, 2016, J INVEST DERMATOL, V136, P2498, DOI 10.1016/j.jid.2016.07.008; Xing Z, 2019, WIRES RNA, V10, DOI 10.1002/wrna.1519; Xu J, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009530; Xu M, 2018, IMMUNITY, V48, P787, DOI 10.1016/j.immuni.2018.03.019	60	0	0	12	12	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1577	+		10.1038/s41590-022-01339-3	http://dx.doi.org/10.1038/s41590-022-01339-3		OCT 2022	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36271146	hybrid, Green Published			2022-12-18	WOS:000870950100004
J	Quast, I; Tarlinton, D				Quast, Isaak; Tarlinton, David			Time is of the essence for vaccine success	NATURE IMMUNOLOGY			English	Editorial Material							MEMORY B	Effective vaccines elicit neutralizing antibodies and long-lasting memory, but this can be challenging with some pathogens, such as HIV. A new study shows how a slow-delivery protein immunization strategy administered in dose-escalation format over 12 days increased the durability of germinal centers and improved immunological outcomes.	[Quast, Isaak; Tarlinton, David] Monash Univ, Dept Immunol & Pathol, Melbourne, Vic, Australia	Monash University	Tarlinton, D (corresponding author), Monash Univ, Dept Immunol & Pathol, Melbourne, Vic, Australia.	david.tarlinton@monash.edu		Quast, Isaak/0000-0001-6517-8537; Tarlinton, David/0000-0001-9928-686X	National Health and Medical Research Council (NHMRC) Australia [APP1175411, APP1145136]	National Health and Medical Research Council (NHMRC) Australia(National Health and Medical Research Council (NHMRC) of Australia)	D.T. and I.Q. are funded by Investigator (APP1175411) and Peter Doherty Early Career fellowship (APP1145136) awards respectively from National Health and Medical Research Council (NHMRC) Australia.	Akkaya M, 2020, NAT REV IMMUNOL, V20, P229, DOI 10.1038/s41577-019-0244-2; Cirelli KM, 2019, CELL, V177, P1153, DOI 10.1016/j.cell.2019.04.012; Kuraoka M, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abn5311; Lee JH, 2022, NATURE, V609, P998, DOI 10.1038/s41586-022-05216-9; Lee JH, 2021, SEMIN IMMUNOL, V51, DOI 10.1016/j.smim.2021.101470; Mesin L, 2020, CELL, V180, P92, DOI 10.1016/j.cell.2019.11.032; Quast Isaak, 2022, Immunity, V55, P1414, DOI 10.1016/j.immuni.2022.06.020; Saunders Kevin O, 2022, Sci Transl Med, V14, peabo5598, DOI 10.1126/scitranslmed.abo5598; Silva M, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abf1152; Smith KGC, 1997, EMBO J, V16, P2996, DOI 10.1093/emboj/16.11.2996; Tam HH, 2016, P NATL ACAD SCI USA, V113, pE6639, DOI 10.1073/pnas.1606050113; Turner JS, 2021, NATURE, V596, P109, DOI 10.1038/s41586-021-03738-2; Weisel FJ, 2016, IMMUNITY, V44, P116, DOI 10.1016/j.immuni.2015.12.004	13	0	0	4	4	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1517	1519		10.1038/s41590-022-01347-3	http://dx.doi.org/10.1038/s41590-022-01347-3		OCT 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36271149	Bronze, Green Published			2022-12-18	WOS:000870950100001
J	Zhao, B; Gong, WP; Ma, AJ; Chen, JW; Velegraki, M; Dong, H; Liu, ZH; Wang, LL; Okimoto, T; Jones, DM; Lei, YL; Long, MX; Oestreich, KJ; Ma, Q; Xin, G; Carbone, DP; He, K; Li, ZH; Wen, HT				Zhao, Bao; Gong, Weipeng; Ma, Anjun; Chen, Jianwen; Velegraki, Maria; Dong, Hong; Liu, Zihao; Wang, Lingling; Okimoto, Tamio; Jones, Devin M.; Lei, Yu L.; Long, Meixiao; Oestreich, Kenneth J.; Ma, Qin; Xin, Gang; Carbone, David P.; He, Kai; Li, Zihai; Wen, Haitao			SUSD2 suppresses CD8(+) T cell antitumor immunity by targeting IL-2 receptor signaling	NATURE IMMUNOLOGY			English	Article							SELECTIVE STIMULATION; CHRONIC INFECTION; INTERLEUKIN-2; CANCER; SUBSETS; LYMPHOCYTES; EXPRESSION; RESISTANCE; RESPONSES; PROTECTS	Wen and colleagues show that the transmembrane protein SUSD2 is a specific negative regulator of CD8(+) T cells activation in the tumor environment by interacting with IL-2 receptor alpha and interfering with IL-2 binding to the receptor. Dysfunctional CD8(+) T cells, which have defective production of antitumor effectors, represent a major mediator of immunosuppression in the tumor microenvironment. Here, we show that SUSD2 is a negative regulator of CD8(+) T cell antitumor function. Susd2(-/-) effector CD8(+) T cells showed enhanced production of antitumor molecules, which consequently blunted tumor growth in multiple syngeneic mouse tumor models. Through a quantitative mass spectrometry assay, we found that SUSD2 interacted with interleukin (IL)-2 receptor alpha through sushi domain-dependent protein interactions and that this interaction suppressed the binding of IL-2, an essential cytokine for the effector functions of CD8(+) T cells, to IL-2 receptor alpha. SUSD2 was not expressed on regulatory CD4(+) T cells and did not affect the inhibitory function of these cells. Adoptive transfer of Susd2(-/-) chimeric antigen receptor T cells induced a robust antitumor response in mice, highlighting the potential of SUSD2 as an immunotherapy target for cancer.	[Zhao, Bao; Gong, Weipeng; Chen, Jianwen; Dong, Hong; Liu, Zihao; Jones, Devin M.; Oestreich, Kenneth J.; Xin, Gang; Wen, Haitao] Ohio State Univ, Infect Dis Inst, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Zhao, Bao; Velegraki, Maria; Wang, Lingling; Okimoto, Tamio; Long, Meixiao; Ma, Qin; Xin, Gang; Carbone, David P.; He, Kai; Li, Zihai; Wen, Haitao] Ohio State Univ, Comprehens Canc Ctr, Pelotonia Inst Immunooncol, Columbus, OH 43210 USA; [Ma, Anjun; Ma, Qin] Ohio State Univ, Dept Biomed Informat, Columbus, OH 43210 USA; [Wang, Lingling; Long, Meixiao] Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA; [Okimoto, Tamio; Carbone, David P.; He, Kai] Ohio State Univ, Dept Internal Med, Div Med Oncol, Columbus, OH 43210 USA; [Lei, Yu L.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of Michigan System; University of Michigan	Wen, HT (corresponding author), Ohio State Univ, Infect Dis Inst, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.; Wen, HT (corresponding author), Ohio State Univ, Comprehens Canc Ctr, Pelotonia Inst Immunooncol, Columbus, OH 43210 USA.	Haitao.Wen@osumc.edu	Velegraki, Maria/HDZ-6889-2022; Ma, Qin/O-1525-2013	Zhao, Bao/0000-0003-3599-1230; Ma, Qin/0000-0002-3264-8392	National Institutes of Health [R01GM135234, R01AI162779, R01AI077283, R01CA262089, R01GM131399, R01DE026728, R01AI134972]; Ohio State University Comprehensive Cancer Center Intramural Research Program	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ohio State University Comprehensive Cancer Center Intramural Research Program	We thank members of the Wen laboratory for discussion; Y. Wan for critical feedback; M. Croft for the OT-II mice; Y. Fu for the MC38 cell line; Y. Yu from the University of Delaware Mass Spectrometry Core Facility for the assistance of mass spectrometry assay; P. Yan and X. Chen from the Genomics Shared Resource at the Ohio State University for the assistance of bulk RNA-seq and scRNA-seq assay. This work was supported by National Institutes of Health grants R01GM135234 and R01AI162779 (H.W.), R01AI077283 and R01CA262089 (Z.L.), R01GM131399 (Q.M.), R01DE026728 (Y.L.), R01AI134972 (K.J.O.) and The Ohio State University Comprehensive Cancer Center Intramural Research Program (A.M., D.M.J., K.H. and H.W.)	Altorki NK, 2019, NAT REV CANCER, V19, P9, DOI 10.1038/s41568-018-0081-9; Andrews LP, 2019, NAT IMMUNOL, V20, P1425, DOI 10.1038/s41590-019-0512-0; Bachmann MF, 2007, EUR J IMMUNOL, V37, P1502, DOI 10.1002/eji.200637023; Beltra JC, 2020, IMMUNITY, V52, P825, DOI 10.1016/j.immuni.2020.04.014; Binnewies M, 2018, NAT MED, V24, P541, DOI 10.1038/s41591-018-0014-x; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Cai CX, 2015, ONCOL LETT, V10, P3619, DOI 10.3892/ol.2015.3737; Chen J, 2019, NATURE, V567, P530, DOI 10.1038/s41586-019-0985-x; Chen ZY, 2019, IMMUNITY, V51, P840, DOI 10.1016/j.immuni.2019.09.013; Dudley ME, 2002, SCIENCE, V298, P850, DOI 10.1126/science.1076514; Hashimoto M, 2018, ANNU REV MED, V69, P301, DOI 10.1146/annurev-med-012017-043208; Hudson WH, 2019, IMMUNITY, V51, P1043, DOI 10.1016/j.immuni.2019.11.002; Hultgren EM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177089; Kalbasi Anusha, 2020, Nat Rev Immunol, V20, P25, DOI 10.1038/s41577-019-0218-4; Kalia V, 2010, IMMUNITY, V32, P91, DOI 10.1016/j.immuni.2009.11.010; Kochenderfer JN, 2010, BLOOD, V116, P3875, DOI 10.1182/blood-2010-01-265041; Krieg C, 2010, P NATL ACAD SCI USA, V107, P11906, DOI 10.1073/pnas.1002569107; Kwon H, 2022, SCI IMMUNOL, V7, DOI 10.1126/sciimmunol.abq2630; Leonard WJ, 2019, IMMUNITY, V50, P832, DOI 10.1016/j.immuni.2019.03.028; Li XH, 2017, J EXP MED, V214, P1093, DOI 10.1084/jem.20161105; Lin H, 2018, J CLIN INVEST, V128, P805, DOI 10.1172/JCI96113; Lin YH, 2019, J PROTEOME RES, V18, P1907, DOI 10.1021/acs.jproteome.9b00037; LOTZE MT, 1986, JAMA-J AM MED ASSOC, V256, P3117, DOI 10.1001/jama.256.22.3117; Matek TR, 2008, ANNU REV IMMUNOL, V26, P453, DOI 10.1146/annurev.immunol.26.021607.090357; McLane LM, 2019, ANNU REV IMMUNOL, V37, P457, DOI 10.1146/annurev-immunol-041015-055318; Miller BC, 2019, NAT IMMUNOL, V20, P326, DOI 10.1038/s41590-019-0312-6; Mo F, 2021, NATURE, V597, P544, DOI 10.1038/s41586-021-03861-0; MORGAN DA, 1976, SCIENCE, V193, P1007, DOI 10.1126/science.181845; Pan W, 2014, SCI REP-UK, V4, DOI 10.1038/srep06812; Pipkin ME, 2010, IMMUNITY, V32, P79, DOI 10.1016/j.immuni.2009.11.012; Rickert M, 2005, SCIENCE, V308, P1477, DOI 10.1126/science.1109745; Schoenfeld AJ, 2020, CANCER CELL, V37, P443, DOI 10.1016/j.ccell.2020.03.017; Scott EN, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.702726; Sheets JN, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2016.64; Souri M, 2008, BIOCHEMISTRY-US, V47, P8656, DOI 10.1021/bi8006143; Spangler JB, 2015, IMMUNITY, V42, P815, DOI 10.1016/j.immuni.2015.04.015; Spolski R, 2018, NAT REV IMMUNOL, V18, P648, DOI 10.1038/s41577-018-0046-y; Sugahara T, 2007, CANCER SCI, V98, P900, DOI 10.1111/j.1349-7006.2007.00466.x; Tyanova S, 2016, NAT PROTOC, V11, P2301, DOI 10.1038/nprot.2016.136; Umeda S, 2018, CANCER MED-US, V7, P5194, DOI 10.1002/cam4.1793; Van Gassen S, 2015, CYTOM PART A, V87A, P636, DOI 10.1002/cyto.a.22625; Wang XQ, 2005, SCIENCE, V310, P1159, DOI 10.1126/science.1117893; Watson AP, 2013, MOL CANCER RES, V11, P74, DOI 10.1158/1541-7786.MCR-12-0501-T; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; West EE, 2013, J CLIN INVEST, V123, P2604, DOI 10.1172/JCI67008; Williams MA, 2006, NATURE, V441, P890, DOI 10.1038/nature04790; Ye LP, 2022, CELL METAB, V34, P595, DOI 10.1016/j.cmet.2022.02.009; Zander R, 2019, IMMUNITY, V51, P1028, DOI 10.1016/j.immuni.2019.10.009; Zhang SQ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183681; Zilionis R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.154; Zuo DM, 2007, NUCLEIC ACIDS RES, V35, pD680, DOI 10.1093/nar/gkl898	53	0	0	14	14	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	NOV	2022	23	11					1588	+		10.1038/s41590-022-01326-8	http://dx.doi.org/10.1038/s41590-022-01326-8		OCT 2022	30	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	6E9BZ	36266363				2022-12-18	WOS:000870640700001
J	Heuser, C; Gattinoni, L				Heuser, Christoph; Gattinoni, Luca			c-Myb redefines the hierarchy of stem-like T cells	NATURE IMMUNOLOGY			English	Editorial Material							DIFFERENTIATION	Akin to adult stem cells, precursor exhausted T cells are hierarchically organized, with long-lived CD62L(+) stem-like T cells at the apex of the system. The transcription factor c-Myb controls the formation, maintenance and therapeutic function of these cells, with important implications for their clinical utilization.	[Heuser, Christoph; Gattinoni, Luca] Leibniz Inst Immunotherapy LIT, Div Funct Immune Cell Modulat, Regensburg, Germany; [Gattinoni, Luca] Univ Hosp Regensburg, Ctr Immunomed Transplantat & Oncol CITO, Regensburg, Germany; [Gattinoni, Luca] Univ Regensburg, Regensburg, Germany	University of Regensburg; University of Regensburg	Gattinoni, L (corresponding author), Leibniz Inst Immunotherapy LIT, Div Funct Immune Cell Modulat, Regensburg, Germany.; Gattinoni, L (corresponding author), Univ Hosp Regensburg, Ctr Immunomed Transplantat & Oncol CITO, Regensburg, Germany.; Gattinoni, L (corresponding author), Univ Regensburg, Regensburg, Germany.	luca.gattinoni@ukr.de	Gattinoni, Luca/A-2281-2008	Gattinoni, Luca/0000-0003-2239-3282; Heuser, Christoph/0000-0003-1410-7573				Bresser K, 2022, NAT IMMUNOL, V23, P791, DOI 10.1038/s41590-022-01171-9; Chen ZY, 2017, CELL REP, V20, P2584, DOI 10.1016/j.celrep.2017.08.060; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ferreira DP, 2020, IMMUNITY, V53, P985, DOI 10.1016/j.immuni.2020.09.005; Galletti G, 2020, NAT IMMUNOL, V21, P1552, DOI 10.1038/s41590-020-0791-5; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Gautam S, 2019, NAT IMMUNOL, V20, P337, DOI 10.1038/s41590-018-0311-z; Im SJ, 2016, NATURE, V537, P417, DOI 10.1038/nature19330; Johnnidis JB, 2021, SCI IMMUNOL, V6, DOI 10.1126/sciimmunol.abe3702; Tsui C, 2022, NATURE, V609, P354, DOI 10.1038/s41586-022-05105-1; Utzschneider DT, 2016, IMMUNITY, V45, P415, DOI 10.1016/j.immuni.2016.07.021; Yao C, 2019, NAT IMMUNOL, V20, P890, DOI 10.1038/s41590-019-0403-4	12	0	0	5	5	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2022	23	10					1405	1407		10.1038/s41590-022-01319-7	http://dx.doi.org/10.1038/s41590-022-01319-7		OCT 2022	3	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5G2XG	36192534				2022-12-18	WOS:000865198400001
J	Houston, S				Houston, Stephanie			Sugar not fat	NATURE IMMUNOLOGY			English	Editorial Material																			0	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2022	23	10					1400	1400		10.1016/j.cell.2022.08.005	http://dx.doi.org/10.1016/j.cell.2022.08.005			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5G2XG					2022-12-18	WOS:000866866400022
J	Visan, I				Visan, Ioana			Imprinting tissue immunity	NATURE IMMUNOLOGY			English	Editorial Material																			0	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2022	23	10					1400	1400		10.1016/j.immuni.2022.07.019	http://dx.doi.org/10.1016/j.immuni.2022.07.019			1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5G2XG					2022-12-18	WOS:000866866400020
J	Baixauli, F; Piletic, K; Puleston, DJ; Villa, M; Field, CS; Flachsmann, LJ; Quintana, A; Rana, N; Edwards-Hicks, J; Matsushita, M; Stanczak, MA; Grzes, KM; Kabat, AM; Fabri, M; Caputa, G; Kelly, B; Corrado, M; Musa, Y; Duda, KJ; Mittler, G; O'Sullivan, D; Sesaki, H; Jenuwein, T; Buescher, JM; Pearce, EJ; Sanin, DE; Pearce, EL				Baixauli, Francesc; Piletic, Klara; Puleston, Daniel J.; Villa, Matteo; Field, Cameron S.; Flachsmann, Lea J.; Quintana, Andrea; Rana, Nisha; Edwards-Hicks, Joy; Matsushita, Mai; Stanczak, Michal A.; Grzes, Katarzyna M.; Kabat, Agnieszka M.; Fabri, Mario; Caputa, George; Kelly, Beth; Corrado, Mauro; Musa, Yaarub; Duda, Katarzyna J.; Mittler, Gerhard; O'Sullivan, David; Sesaki, Hiromi; Jenuwein, Thomas; Buescher, Joerg M.; Pearce, Edward J.; Sanin, David E.; Pearce, Erika L.			An LKB1-mitochondria axis controls T(H)17 effector function	NATURE IMMUNOLOGY			English	Article							T-CELLS; METABOLIC-CONTROL; REGULATORY T; TH17 CELLS; LKB1; FATE; MITOCHONDRIA; RESPIRATION; FUSION; CHAIN	CD4(+) T cell differentiation requires metabolic reprogramming to fulfil the bioenergetic demands of proliferation and effector function, and enforce specific transcriptional programmes(1-3). Mitochondrial membrane dynamics sustains mitochondrial processes(4), including respiration and tricarboxylic acid (TCA) cycle metabolism(5), but whether mitochondrial membrane remodelling orchestrates CD4(+) T cell differentiation remains unclear. Here we show that unlike other CD4(+) T cell subsets, T helper 17 (T(H)17) cells have fused mitochondria with tight cristae. T cell-specific deletion of optic atrophy 1 (OPA1), which regulates inner mitochondrial membrane fusion and cristae morphology(6), revealed that T(H)17 cells require OPA1 for its control of the TCA cycle, rather than respiration. OPA1 deletion amplifies glutamine oxidation, leading to impaired NADH/NAD(+) balance and accumulation of TCA cycle metabolites and 2-hydroxyglutarate-a metabolite that influences the epigenetic landscape(5,7). Our multi-omics approach revealed that the serine/threonine kinase liver-associated kinase B1 (LKB1) couples mitochondrial function to cytokine expression in T(H)17 cells by regulating TCA cycle metabolism and transcriptional remodelling. Mitochondrial membrane disruption activates LKB1, which restrains IL-17 expression. LKB1 deletion restores IL-17 expression in T(H)17 cells with disrupted mitochondrial membranes, rectifying aberrant TCA cycle glutamine flux, balancing NADH/NAD(+) and preventing 2-hydroxyglutarate production from the promiscuous activity of the serine biosynthesis enzyme phosphoglycerate dehydrogenase (PHGDH). These findings identify OPA1 as a major determinant of T(H)17 cell function, and uncover LKB1 as a sensor linking mitochondrial cues to effector programmes in T(H)17 cells.	[Baixauli, Francesc; Piletic, Klara; Puleston, Daniel J.; Villa, Matteo; Field, Cameron S.; Flachsmann, Lea J.; Quintana, Andrea; Rana, Nisha; Edwards-Hicks, Joy; Matsushita, Mai; Stanczak, Michal A.; Grzes, Katarzyna M.; Kabat, Agnieszka M.; Fabri, Mario; Caputa, George; Kelly, Beth; Corrado, Mauro; Musa, Yaarub; Duda, Katarzyna J.; Mittler, Gerhard; O'Sullivan, David; Jenuwein, Thomas; Buescher, Joerg M.; Pearce, Edward J.; Sanin, David E.; Pearce, Erika L.] Max Planck Inst Immunobior & Epigenet, Freiburg, Germany; [Fabri, Mario] Univ Cologne, Dept Dermatol, Cologne, Germany; [Sesaki, Hiromi] Johns Hopkins Univ, Sch Med, Dept Cell Biol Johns, Baltimore, MD USA; [Pearce, Edward J.; Sanin, David E.; Pearce, Erika L.] Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Dept Oncol, Baltimore, MD 21218 USA; [Pearce, Edward J.] Johns Hopkins Bloomberg Sch Publ Hearth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Pearce, Erika L.] Johns Hopkins Bloomberg Sch Publ Hearth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA	University of Cologne; Johns Hopkins University; Johns Hopkins University	Pearce, EL (corresponding author), Max Planck Inst Immunobior & Epigenet, Freiburg, Germany.; Pearce, EL (corresponding author), Johns Hopkins Univ, Bloomberg Kimmel Inst Canc Immunotherapy, Dept Oncol, Baltimore, MD 21218 USA.; Pearce, EL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hearth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA.	epearce6@jhmi.edu	Baixauli, Francesc/L-4957-2016	Baixauli, Francesc/0000-0002-9676-2901	Max Planck Society; Leibniz Prize; Johns Hopkins University; National Institutes of Health [R01AI156274, R35GM144103]; Marie Sklodowska-Curie actions Individual Fellowship (MSCA-IF); Henry Wellcome Fellowship; Alexander von Humboldt Postdoctoral Fellowship	Max Planck Society(Max Planck SocietyFoundation CELLEX); Leibniz Prize(German Research Foundation (DFG)); Johns Hopkins University(Johns Hopkins University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie Sklodowska-Curie actions Individual Fellowship (MSCA-IF); Henry Wellcome Fellowship; Alexander von Humboldt Postdoctoral Fellowship(Alexander von Humboldt Foundation)	We thank the members of the Immunometabolism Department at the MPI-IE for helpful discussion; the Electron Microscopy Laboratory at the University of Padova for the invaluable help; and the Imaging, Metabolomics, FACS, Sequencing and Animal facilities at the MPI-IE for their excellent technical support. This work was supported in part by the Max Planck Society, the Leibniz Prize (to E.L.P.), two Bloomberg Distinguished Professorships from Johns Hopkins University (E.L.P. and E.J.P.), the National Institutes of Health R01AI156274 (to E.L.P.) and R35GM144103 (to H.S.), a Marie Sklodowska-Curie actions Individual Fellowship (MSCA-IF) (to F.B.), a Sir Henry Wellcome Fellowship (to D.J.P.) and an Alexander von Humboldt Postdoctoral Fellowship (to M.V.).	Arguello RJ, 2020, CELL METAB, V32, DOI 10.1016/j.cmet.2020.11.007; Bailis W, 2019, NATURE, V571, P403, DOI 10.1038/s41586-019-1311-3; Baksh SC, 2021, TRENDS CELL BIOL, V31, P24, DOI 10.1016/j.tcb.2020.09.010; Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; Birsoy K, 2014, NATURE, V508, P108, DOI 10.1038/nature13110; Blagih J, 2012, IMMUNOL REV, V249, P59, DOI 10.1111/j.1600-065X.2012.01157.x; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Buck MD, 2017, CELL, V169, P570, DOI 10.1016/j.cell.2017.04.004; Buck MD, 2016, CELL, V166, P63, DOI 10.1016/j.cell.2016.05.035; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Buenrostro Jason D, 2015, Curr Protoc Mol Biol, V109, DOI 10.1002/0471142727.mb2129s109; Chan DC, 2020, ANNU REV PATHOL-MECH, V15, P235, DOI 10.1146/annurev-pathmechdis-012419-032711; Cogliati S, 2013, CELL, V155, P160, DOI 10.1016/j.cell.2013.08.032; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Esplugues E, 2011, NATURE, V475, P514, DOI 10.1038/nature10228; Fan J, 2015, ACS CHEM BIOL, V10, P510, DOI 10.1021/cb500683c; Faubert B, 2014, P NATL ACAD SCI USA, V111, P2554, DOI 10.1073/pnas.1312570111; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; Giacomello M, 2020, NAT REV MOL CELL BIO, V21, P204, DOI 10.1038/s41580-020-0210-7; He NH, 2017, P NATL ACAD SCI USA, V114, P12542, DOI 10.1073/pnas.1715363114; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Herkenne S, 2020, CELL METAB, V31, P987, DOI 10.1016/j.cmet.2020.04.007; Hirota K, 2011, NAT IMMUNOL, V12, P255, DOI 10.1038/ni.1993; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Intlekofer AM, 2017, NAT CHEM BIOL, V13, P494, DOI [10.1038/NCHEMBIO.2307, 10.1038/nchembio.2307]; Intlekofer AM, 2015, CELL METAB, V22, P304, DOI 10.1016/j.cmet.2015.06.023; Ishihara N, 2006, EMBO J, V25, P2966, DOI 10.1038/sj.emboj.7601184; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johnson MO, 2018, CELL, V175, P1780, DOI 10.1016/j.cell.2018.10.001; Korn T, 2009, ANNU REV IMMUNOL, V27, P485, DOI 10.1146/annurev.immunol.021908.132710; Kottakis F, 2016, NATURE, V539, P390, DOI 10.1038/nature20132; Kullmann L, 2018, ONCOGENE, V37, P3045, DOI 10.1038/s41388-018-0145-z; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Locasale JW, 2011, NAT GENET, V43, P869, DOI 10.1038/ng.890; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; Lun ATL, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1191; Lun ATL, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku351; MacIver NJ, 2011, J IMMUNOL, V187, P4187, DOI 10.4049/jimmunol.1100367; MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186; Martinez-Reyes I, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13668-3; Matilainen O, 2017, TRENDS CELL BIOL, V27, P453, DOI 10.1016/j.tcb.2017.02.004; Mohrs K, 2005, IMMUNITY, V23, P419, DOI 10.1016/j.immuni.2005.09.006; Musa YR, 2018, J PROTEOME RES, V17, P76, DOI 10.1021/acs.jproteome.7b00369; Nikkanen J, 2016, CELL METAB, V23, P635, DOI 10.1016/j.cmet.2016.01.019; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Reinhardt RL, 2009, NAT IMMUNOL, V10, P385, DOI 10.1038/ni.1715; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Sinclair LV, 2018, NAT COMMUN, V9, DOI [10.1038/s41467-018-04366-7, 10.1038/S41467-018-04366-7]; Song ZY, 2007, J CELL BIOL, V178, P749, DOI 10.1083/jcb.200704110; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Tiainen M, 1999, P NATL ACAD SCI USA, V96, P9248, DOI 10.1073/pnas.96.16.9248; Wagner A, 2021, CELL, V184, P4168, DOI 10.1016/j.cell.2021.05.045; Wan YSY, 2005, P NATL ACAD SCI USA, V102, P5126, DOI 10.1073/pnas.0501701102; Wu L, 2020, CELL, V182, P641, DOI 10.1016/j.cell.2020.06.014; Xu T, 2017, NATURE, V548, P228, DOI 10.1038/nature23475; Yang K, 2017, NATURE, V548, P602, DOI 10.1038/nature23665; Yang LF, 2020, CELL METAB, V31, P809, DOI 10.1016/j.cmet.2020.02.017; Ye D, 2018, TRENDS CANCER, V4, P151, DOI 10.1016/j.trecan.2017.12.005; Youle RJ, 2012, SCIENCE, V337, P1062, DOI 10.1126/science.1219855; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	66	0	0	17	17	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2022	23	10					1400	1400		10.1038/s41586-022-05264-1	http://dx.doi.org/10.1038/s41586-022-05264-1		SEP 2022	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5G2XG	36171294				2022-12-18	WOS:000861426000002
J	Bernard, NJ				Bernard, Nicholas J.			Sugar not fat	NATURE IMMUNOLOGY			English	Editorial Material												Nick.Bernard@nature.com							0	0	0	1	1	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2022	23	10					1399	1399		10.1038/s41590-022-01333-9	http://dx.doi.org/10.1038/s41590-022-01333-9		SEP 2022	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5G2XG	36168058				2022-12-18	WOS:000860376800001
J	Bernard, N				Bernard, Nick			Targeting neoantigens	NATURE IMMUNOLOGY			English	Editorial Material												Nick.Bernard@nature.com							0	0	0	2	2	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2022	23	10					1399	1399		10.1038/s41590-022-01334-8	http://dx.doi.org/10.1038/s41590-022-01334-8		SEP 2022	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5G2XG	36168061				2022-12-18	WOS:000860376800007
J	Dempsey, LA				Dempsey, Laurie A.			Imprinting tissue immunity	NATURE IMMUNOLOGY			English	Editorial Material												l.dempsey@us.nature.com							0	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2022	23	10					1399	1399		10.1038/s41590-022-01331-x	http://dx.doi.org/10.1038/s41590-022-01331-x		SEP 2022	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5G2XG	36168060				2022-12-18	WOS:000860376800003
J	Houston, S				Houston, Stephanie			Mitochondria controls T(H)17 cells	NATURE IMMUNOLOGY			English	Editorial Material												stephanie.houston@us.nature.com							0	0	0	0	0	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	1529-2908	1529-2916		NAT IMMUNOL	Nat. Immunol.	OCT	2022	23	10					1400	1400		10.1038/s41590-022-01332-w	http://dx.doi.org/10.1038/s41590-022-01332-w		SEP 2022	1	Immunology	Science Citation Index Expanded (SCI-EXPANDED)	Immunology	5G2XG	36168059				2022-12-18	WOS:000860376800002
